Citrus Sinensis ID: 004999
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | 2.2.26 [Sep-21-2011] | |||||||
| F4I114 | 714 | Probable serine/threonine | no | no | 0.768 | 0.774 | 0.552 | 0.0 | |
| Q9ZVM9 | 572 | Probable serine/threonine | no | no | 0.619 | 0.779 | 0.622 | 1e-171 | |
| Q5JK68 | 513 | Cyclin-dependent kinase C | no | no | 0.45 | 0.631 | 0.529 | 4e-99 | |
| Q9LFT8 | 505 | Cyclin-dependent kinase C | no | no | 0.573 | 0.817 | 0.459 | 6e-99 | |
| Q6I5Y0 | 519 | Cyclin-dependent kinase C | no | no | 0.451 | 0.626 | 0.529 | 1e-98 | |
| Q8W4P1 | 513 | Cyclin-dependent kinase C | no | no | 0.448 | 0.629 | 0.521 | 1e-95 | |
| B5DE93 | 1239 | Cyclin-dependent kinase 1 | yes | no | 0.387 | 0.225 | 0.468 | 2e-75 | |
| D2H526 | 1491 | Cyclin-dependent kinase 1 | yes | no | 0.433 | 0.209 | 0.450 | 2e-75 | |
| Q14AX6 | 1484 | Cyclin-dependent kinase 1 | no | no | 0.387 | 0.188 | 0.468 | 7e-75 | |
| Q69ZA1 | 1511 | Cyclin-dependent kinase 1 | no | no | 0.427 | 0.203 | 0.453 | 8e-75 |
| >sp|F4I114|Y1960_ARATH Probable serine/threonine-protein kinase At1g09600 OS=Arabidopsis thaliana GN=At1g09600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 649 bits (1674), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/643 (55%), Positives = 433/643 (67%), Gaps = 90/643 (13%)
Query: 89 HHPGMGSIPKASEGE---QVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKSLSIFSRS 145
P M I S GE QV AGWP+WLA+VAGEAI GW+PR+ADSFEKL+K
Sbjct: 117 QQPKMTRICSVSNGERGAQVMAGWPSWLASVAGEAINGWIPRKADSFEKLEK-------- 168
Query: 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IGQGTYS+VY+ARDL+ ++VALKKVRF N++P+SVRFMAREI ILRRLDH NV+KL
Sbjct: 169 ---IGQGTYSSVYKARDLETNQLVALKKVRFANMDPDSVRFMAREIIILRRLDHPNVMKL 225
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
EGL+TSR+S S+YL+FEYMEHDLAGLAS PG+ FSEAQ+KCYM+QLL GL+HCHSRGVLH
Sbjct: 226 EGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSEAQIKCYMKQLLHGLEHCHSRGVLH 285
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RDIKGSNLL+D+N LKI DFGLA+FY Q QPLTSRVVTLWYRPPELLLG+T YG V
Sbjct: 286 RDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLTSRVVTLWYRPPELLLGSTDYGVTV 345
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
DLWSTGCILAEL+ GKPIMPGRTEVEQLHKIFKLCGSPSE+YW+ SKLPHATIFKPQQPY
Sbjct: 346 DLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCGSPSEEYWKISKLPHATIFKPQQPY 405
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPS 445
KRCVAETFK P+ ALAL+E LL+++P RG+ ASAL SEFFT PL DPSSLPKY P
Sbjct: 406 KRCVAETFKSLPSSALALVEVLLAVEPDARGTTASALESEFFTTSPLASDPSSLPKYQPR 465
Query: 446 KEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNSKS 505
KE D K ++EEA+R+ + ++ D ++ +RES+A+PAPD+NAE + S+QKRQ Q+N S
Sbjct: 466 KEIDVKAQEEEAKRKKDTSSKQND-SKQVSRESKAVPAPDSNAESLTSIQKRQGQHNQVS 524
Query: 506 RSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASHSGPLAQRAAWAKAGKNT 565
S+KFNP E A+ F I+P +S GH R + +N
Sbjct: 525 NSDKFNPG--EDAASFRIEP------LKSGTAKDGHT------------RYGVSSVNRNG 564
Query: 566 DDAPKISTGADLSTGLVAARRSLLSEDRRERS----GSAQPEVPKLIARFPGSFKEASES 621
++ ++ + RS E R +RS G+AQ ++RF S S
Sbjct: 565 ENV------------MMGSSRSPRKELRTQRSFVQRGTAQ------LSRF-------SNS 599
Query: 622 FIQHDQKHHAQGVAGSHQKEDGR-----------------------IGNKDPILLGYGSK 658
D H A +A ED +K+ I + G K
Sbjct: 600 VAARDGSHFA--IANPRWFEDSYNNNNGRQNGGAWSQRLVVKHKEFTKHKESITVN-GEK 656
Query: 659 GHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVR 701
++H SGPL+ GN+D+MLK+H+RQIQ AVR+AR DK R
Sbjct: 657 KERMHCSGPLVSAGGNLDEMLKEHERQIQLAVRKARVDKKTNR 699
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9ZVM9|Y1461_ARATH Probable serine/threonine-protein kinase At1g54610 OS=Arabidopsis thaliana GN=At1g54610 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 602 bits (1551), Expect = e-171, Method: Compositional matrix adjust.
Identities = 292/469 (62%), Positives = 361/469 (76%), Gaps = 23/469 (4%)
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
+++ NG DR+R + +P + + K GEQVAAGWP+WL+ GEA
Sbjct: 53 NEEANGDKERKSSKGDRRRS------TKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEA 106
Query: 121 IQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE 180
+ GWVPR+AD+FEK+DK IGQGTYSNVY+A+D+ KIVALKKVRFDNLE
Sbjct: 107 LNGWVPRKADTFEKIDK-----------IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE 155
Query: 181 PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFS 240
PESV+FMAREI +LRRLDH NV+KLEGLVTSRMSCSLYLVF+YM+HDLAGLAS P +KFS
Sbjct: 156 PESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFS 215
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300
E++VKC M+QL+ GL+HCHSRGVLHRDIKGSNLLID+ G+LKIADFGLA+ +DP+ +P+
Sbjct: 216 ESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPM 275
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
TSRVVTLWYR PELLLGAT YG +DLWS GCILAEL AG+PIMPGRTEVEQLHKI+KLC
Sbjct: 276 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLC 335
Query: 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420
GSPSEDYW+K K H I+KP++PYKR + ETFKDFP +L L++ LLSI+P DR +A++
Sbjct: 336 GSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASA 395
Query: 421 ALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRG---TRE 477
AL+SEFFT +P C+P+ LPKYPPSKE DAK RDEE RRQ + + D R+ R
Sbjct: 396 ALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARKNRHRDRS 455
Query: 478 SRAIPAPDANAELVLSMQKRQ--SQYNSKSRSEKF-NPHPEEVASGFPI 523
+RA+PAP+ANAEL ++ +R+ + N+KS+SEKF PH + A G P+
Sbjct: 456 NRALPAPEANAELQSNVDRRRLITHANAKSKSEKFPPPHQDGGAMGVPL 504
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (931), Expect = 4e-99, Method: Compositional matrix adjust.
Identities = 187/353 (52%), Positives = 235/353 (66%), Gaps = 29/353 (8%)
Query: 124 WVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES 183
W R D FEKL++ IG+GTY VY A++ + +IVALKK+R DN E E
Sbjct: 17 WGSRSVDCFEKLEQ-----------IGEGTYGQVYMAKETETNEIVALKKIRMDN-EREG 64
Query: 184 VRFMA-REIHILRRLDHINVIKLEGLVTS---------------RMSCSLYLVFEYMEHD 227
A REI IL++L H NVI+L+ +VTS + S+Y+VFEYM+HD
Sbjct: 65 FPITAIREIKILKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHD 124
Query: 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287
L GLA PG++F+ Q+KCYM+QLL GL +CH VLHRDIKGSNLLIDN G LK+ADFG
Sbjct: 125 LTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 184
Query: 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 347
LA + D N LT+RV+TLWYRPPELLLG+T YG AVD+WS GCI AEL GKPI+ G+
Sbjct: 185 LARSFSSDHNGNLTNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPILTGK 244
Query: 348 TEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMET 406
E EQL KIF+LCG+P E W +K+P FKPQ+P KR V E+FK F AL L+E
Sbjct: 245 NEPEQLSKIFELCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHFDQHALDLLEK 304
Query: 407 LLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARR 459
+L++DP+ R SA AL +E+F PLPCDP SLPKY S EF K + ++ R+
Sbjct: 305 MLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYEASHEFQTKKKRQQQRQ 357
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q9LFT8|CDKC1_ARATH Cyclin-dependent kinase C-1 OS=Arabidopsis thaliana GN=CDKC-1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 362 bits (929), Expect = 6e-99, Method: Compositional matrix adjust.
Identities = 203/442 (45%), Positives = 256/442 (57%), Gaps = 29/442 (6%)
Query: 124 WVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES 183
W R D FEKL++ IG+GTY VY A+++ +IVALKK+R DN E E
Sbjct: 18 WGSRSVDCFEKLEQ-----------IGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREG 65
Query: 184 VRFMA-REIHILRRLDHINVIKLEGLVTS--------------RMSCSLYLVFEYMEHDL 228
A REI IL++L H NVI+L+ +VTS + +Y+VFEYM+HDL
Sbjct: 66 FPITAIREIKILKKLHHENVIQLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDL 125
Query: 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288
GLA PGL+F+ Q+KCYM+QLL GL +CH VLHRDIKGSNLLIDN G LK+ADFGL
Sbjct: 126 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 185
Query: 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT 348
A Y D LT+RV+TLWYRPPELLLGAT YG A+D+WS GCI AEL KPI+PG+
Sbjct: 186 ARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLHAKPILPGKN 245
Query: 349 EVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETL 407
E EQL+KIF+LCGSP E W SK+P FKP +P KR V E F+ F AL L+E +
Sbjct: 246 EQEQLNKIFELCGSPDEKLWPGVSKMPWFNNFKPARPLKRRVREFFRHFDRHALELLEKM 305
Query: 408 LSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQR 467
L +DPA R SA AL +E+F PLPCDP SLP Y S EF K + + +RQ +R
Sbjct: 306 LVLDPAQRISAKDALDAEYFWTDPLPCDPKSLPTYESSHEFQTK-KKRQQQRQNEEAAKR 364
Query: 468 MDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPR 527
L+ + SR P + + + + P G P PP
Sbjct: 365 QKLQHPPLQHSRLPPLQHGGQSHAAPHWPAGPNHPTNNAPPQVPAGPSHNFYGKPRGPPG 424
Query: 528 QSQVTESSAGPQGHNHKRASHS 549
++ S G+N R +S
Sbjct: 425 PNRYPPSGNQSGGYNQSRGGYS 446
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6I5Y0|CDKC1_ORYSJ Cyclin-dependent kinase C-1 OS=Oryza sativa subsp. japonica GN=CDKC-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 361 bits (926), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 191/361 (52%), Positives = 235/361 (65%), Gaps = 36/361 (9%)
Query: 124 WVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES 183
W R D FEKL++ IG+GTY VY AR+ + ++IVALKK+R DN E E
Sbjct: 17 WGSRSVDCFEKLEQ-----------IGEGTYGQVYMARETETQEIVALKKIRMDN-EREG 64
Query: 184 VRFMA-REIHILRRLDHINVIKLEGLVTS---------------RMSCSLYLVFEYMEHD 227
A REI IL++L H NVI+L+ +VTS + S+Y+VFEYM+HD
Sbjct: 65 FPITAIREIKILKKLHHQNVIQLKEIVTSPGPERDEQGKPIHGNKYKGSIYMVFEYMDHD 124
Query: 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287
L GLA PG++F+ Q+KCYM+QLL GL +CH VLHRDIKGSNLLIDN G LK+ADFG
Sbjct: 125 LTGLADRPGMRFTVPQIKCYMKQLLTGLHYCHINQVLHRDIKGSNLLIDNEGNLKLADFG 184
Query: 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 347
LA + D N LT+RV+TLWYRPPELLLG+T YG AVD+WS GCI AEL GKPI+PG+
Sbjct: 185 LARSFSNDHNGNLTNRVITLWYRPPELLLGSTKYGPAVDMWSVGCIFAELLNGKPILPGK 244
Query: 348 TEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMET 406
E EQL KIF +CG+P E W +K+P FKP + KR V E FK F AL L+E
Sbjct: 245 NEPEQLSKIFDVCGTPDESNWPGVTKMPWYNNFKPPRQLKRRVKEYFKHFDRLALDLLEK 304
Query: 407 LLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIR-------DEEARR 459
+L++DPA R SA AL +E+F PLPCDP SLPKY S EF K + DE A+R
Sbjct: 305 MLTLDPAQRISAQDALDAEYFWSDPLPCDPKSLPKYESSHEFQTKKKRQQMRQADEAAKR 364
Query: 460 Q 460
Q
Sbjct: 365 Q 365
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q8W4P1|CDKC2_ARATH Cyclin-dependent kinase C-2 OS=Arabidopsis thaliana GN=CDKC-2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 183/351 (52%), Positives = 227/351 (64%), Gaps = 28/351 (7%)
Query: 124 WVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES 183
W R D FEKL++ IG+GTY VY A+++ +IVALKK+R DN E E
Sbjct: 18 WGSRSVDCFEKLEQ-----------IGEGTYGQVYMAKEIKTGEIVALKKIRMDN-EREG 65
Query: 184 VRFMA-REIHILRRLDHINVIKLEGLVTS--------------RMSCSLYLVFEYMEHDL 228
A REI IL++L H NVI L+ +VTS + +Y+VFEYM+HDL
Sbjct: 66 FPITAIREIKILKKLHHENVIHLKEIVTSPGRDRDDQGKPDNNKYKGGIYMVFEYMDHDL 125
Query: 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288
GLA PGL+F+ Q+KCYM+QLL GL +CH VLHRDIKGSNLLIDN G LK+ADFGL
Sbjct: 126 TGLADRPGLRFTVPQIKCYMKQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFGL 185
Query: 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT 348
A Y D LT+RV+TLWYRPPELLLGAT YG A+D+WS GCI AEL GKPI+PG+T
Sbjct: 186 ARSYSHDHTGNLTNRVITLWYRPPELLLGATKYGPAIDMWSVGCIFAELLNGKPILPGKT 245
Query: 349 EVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETL 407
E EQL+KI++LCGSP E W SK+P K +P KR V E ++ F AL L+E +
Sbjct: 246 ENEQLNKIYELCGSPDESNWPGVSKMPWYNQMKSSRPLKRRVREIYRHFDRHALELLEKM 305
Query: 408 LSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEAR 458
L +DP+ R A AL +E+F PLPCDP SLP Y S EF K + ++ R
Sbjct: 306 LVLDPSQRICAKDALDAEYFWTDPLPCDPKSLPTYESSHEFQTKKKRQQMR 356
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|B5DE93|CDK12_XENTR Cyclin-dependent kinase 12 OS=Xenopus tropicalis GN=cdk12 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 136/290 (46%), Positives = 192/290 (66%), Gaps = 11/290 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLE 206
+IG+GTY VY+A+D D ++VALKKVR DN E E A REI ILR+L H +V+ ++
Sbjct: 715 IIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLIHKSVVNMK 773
Query: 207 GLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+VT + + YLVFEYM+HDL GL ++FSE +K +M+QL+ GL++C
Sbjct: 774 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVQFSEDHIKSFMKQLMEGLEYC 833
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
H + LHRDIK SN+L++N+G +K+ADFGLA Y ++++P T++V+TLWYRPPELLLG
Sbjct: 834 HKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGE 893
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHAT 377
Y A+D+WS GCIL EL+ KPI E+ QL I +LCGSP W KLP+
Sbjct: 894 ERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFN 953
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
KP++ Y+R + E F P PAL L++ +L++DP+ R +A L+S+F
Sbjct: 954 TMKPKKQYRRRLREEFSFVPTPALDLLDHMLTLDPSKRCTAEQTLQSDFL 1003
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit rpb1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating srsf1/sf2. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|D2H526|CDK12_AILME Cyclin-dependent kinase 12 OS=Ailuropoda melanoleuca GN=CDK12 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 284 bits (726), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 147/326 (45%), Positives = 206/326 (63%), Gaps = 14/326 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLE 206
+IG+GTY VY+A+D D ++VALKKVR DN E E A REI ILR+L H +V+ ++
Sbjct: 733 IIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLIHRSVVNMK 791
Query: 207 GLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+VT + + YLVFEYM+HDL GL + FSE +K +M+QL+ GLD+C
Sbjct: 792 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYC 851
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
H + LHRDIK SN+L++N+G +K+ADFGLA Y+ ++++P T++V+TLWYRPPELLLG
Sbjct: 852 HKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 911
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHAT 377
Y A+D+WS GCIL EL+ KPI E+ QL I +LCGSP W KLP+
Sbjct: 912 ERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFN 971
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP-CDP 436
KP++ Y+R + E F P+ AL L++ +L++DP+ R +A L+S+F L DP
Sbjct: 972 TMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFLKDVELSKMDP 1031
Query: 437 SSLPKYPPSKEFDAKIRDEEARRQGG 462
LP + E +K R + RQ G
Sbjct: 1032 PDLPHWQDCHELWSKKRRRQ--RQSG 1055
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q14AX6|CDK12_MOUSE Cyclin-dependent kinase 12 OS=Mus musculus GN=Cdk12 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 7e-75, Method: Compositional matrix adjust.
Identities = 136/290 (46%), Positives = 192/290 (66%), Gaps = 11/290 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLE 206
+IG+GTY VY+A+D D ++VALKKVR DN E E A REI ILR+L H +V+ ++
Sbjct: 728 IIGEGTYGQVYKAKDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLVHQSVVNMK 786
Query: 207 GLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+VT + + YLVFEYM+HDL GL + FSE +K +M+QL+ GLD+C
Sbjct: 787 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLMEGLDYC 846
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
H + LHRDIK SN+L++N+G +K+ADFGLA Y+ ++++P T++V+TLWYRPPELLLG
Sbjct: 847 HKKNFLHRDIKCSNILLNNSGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE 906
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHAT 377
Y A+D+WS GCIL EL+ KPI E+ QL I +LCGSP W KLP+
Sbjct: 907 ERYTPAIDVWSCGCILGELFTKKPIFQANLELAQLELISRLCGSPCPAVWPDVIKLPYFN 966
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
KP++ Y+R + E F P+ AL L++ +L++DP+ R +A L+S+F
Sbjct: 967 TMKPKKQYRRRLREEFSFIPSAALDLLDHMLTLDPSKRCTAEQTLQSDFL 1016
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogn inhibitors. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q69ZA1|CDK13_MOUSE Cyclin-dependent kinase 13 OS=Mus musculus GN=Cdk13 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 8e-75, Method: Compositional matrix adjust.
Identities = 147/324 (45%), Positives = 203/324 (62%), Gaps = 16/324 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLE 206
+IG+GTY VY+ARD D ++VALKKVR DN E E A REI ILR+L H ++I ++
Sbjct: 710 IIGEGTYGQVYKARDKDTGEMVALKKVRLDN-EKEGFPITAIREIKILRQLTHQSIINMK 768
Query: 207 GLVTSRMSC--------SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+VT + + YLVFEYM+HDL GL + F+E +K +M+QL+ GLD+C
Sbjct: 769 EIVTDKEDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFNENHIKSFMRQLMEGLDYC 828
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
H + LHRDIK SN+L++N G +K+ADFGLA Y ++++P T++V+TLWYRPPELLLG
Sbjct: 829 HKKNFLHRDIKCSNILLNNRGQIKLADFGLARLYSSEESRPYTNKVITLWYRPPELLLGE 888
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHAT 377
Y A+D+WS GCIL EL+ KPI E+ QL I ++CGSP W KLP+
Sbjct: 889 ERYTPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRICGSPCPAVWPDVIKLPYFN 948
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF-TMKPLPCDP 436
KP++ Y+R + E F PA AL L + +L++DP+ R +A AL+ EF ++P P
Sbjct: 949 TMKPKKQYRRKLREEFVFIPAAALDLFDYMLALDPSKRCTAEQALQCEFLRDVEPSKMPP 1008
Query: 437 SSLPKYPPSKEFDAKIRDEEARRQ 460
LP + E +K R RRQ
Sbjct: 1009 PDLPLWQDCHELWSKKR----RRQ 1028
|
Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | ||||||
| 224114928 | 713 | predicted protein [Populus trichocarpa] | 0.983 | 0.992 | 0.870 | 0.0 | |
| 224128322 | 713 | predicted protein [Populus trichocarpa] | 0.983 | 0.992 | 0.860 | 0.0 | |
| 302143004 | 712 | unnamed protein product [Vitis vinifera] | 0.983 | 0.994 | 0.852 | 0.0 | |
| 225461467 | 713 | PREDICTED: probable serine/threonine-pro | 0.983 | 0.992 | 0.852 | 0.0 | |
| 356544039 | 708 | PREDICTED: probable serine/threonine-pro | 0.976 | 0.992 | 0.833 | 0.0 | |
| 356549726 | 712 | PREDICTED: probable serine/threonine-pro | 0.976 | 0.987 | 0.821 | 0.0 | |
| 357452947 | 712 | Serine/threonine protein kinase cdk9 [Me | 0.976 | 0.987 | 0.809 | 0.0 | |
| 356543323 | 710 | PREDICTED: probable serine/threonine-pro | 0.977 | 0.991 | 0.809 | 0.0 | |
| 356517145 | 710 | PREDICTED: probable serine/threonine-pro | 0.977 | 0.991 | 0.807 | 0.0 | |
| 449457023 | 707 | PREDICTED: probable serine/threonine-pro | 0.976 | 0.994 | 0.806 | 0.0 |
| >gi|224114928|ref|XP_002316895.1| predicted protein [Populus trichocarpa] gi|222859960|gb|EEE97507.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1285 bits (3325), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 631/725 (87%), Positives = 659/725 (90%), Gaps = 17/725 (2%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+C KPSAIEDSKESPRERLSSKASSDLR SRATSSRREE YR KDR D NDGR MLI
Sbjct: 1 MGCLCCKPSAIEDSKESPRERLSSKASSDLRVSRATSSRREEAYRAKDRCDGNDGRTMLI 60
Query: 61 DKQVNGSVRLHG-ENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGE 119
DKQVNGS+R+HG E+ +RKR+K EY V HHPGMGSIPKA+EGEQVAAGWP+WLAAVAGE
Sbjct: 61 DKQVNGSLRVHGGEHVERKRDKSEYAVV-HHPGMGSIPKATEGEQVAAGWPSWLAAVAGE 119
Query: 120 AIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL 179
AI+GW+PRRADSFEKLDK IGQGTYSNVYRARDLDQKKIVALKKVRFDNL
Sbjct: 120 AIKGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLDQKKIVALKKVRFDNL 168
Query: 180 EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF 239
EPESVRFMAREIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA+HPGLKF
Sbjct: 169 EPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAAHPGLKF 228
Query: 240 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299
+EAQVKCYMQQLL GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP QP
Sbjct: 229 TEAQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPAHVQP 288
Query: 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 359
LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL
Sbjct: 289 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 348
Query: 360 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA 419
CGSPSEDYWRKSKLPHATIFKPQQPY+RCVA+TFK+FP PALALMETLLSIDPADRGSAA
Sbjct: 349 CGSPSEDYWRKSKLPHATIFKPQQPYRRCVADTFKEFPPPALALMETLLSIDPADRGSAA 408
Query: 420 SALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRE 477
SALRSEFF KPLPCDPSS PKYPPSKEFDAK+RDEEARRQG GSKGQ+ D+ERRG RE
Sbjct: 409 SALRSEFFITKPLPCDPSSFPKYPPSKEFDAKMRDEEARRQGAAGSKGQKSDMERRGRRE 468
Query: 478 SRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAG 537
SRA+PAPDANAELVLSMQKR Q NSKSRSEKFNPHPEEVASGFPIDPPR SQ ES+
Sbjct: 469 SRAVPAPDANAELVLSMQKRHGQSNSKSRSEKFNPHPEEVASGFPIDPPRPSQAAESNMD 528
Query: 538 PQGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRE 595
PQGH HKRASHSGPL+ RAAWAKA +N DDAPKISTGADLST LVAARRSLLSEDR E
Sbjct: 529 PQGHQHKRASHSGPLSHRAAWAKASRNPDDAPKISTGADLSTISSLVAARRSLLSEDRNE 588
Query: 596 RSGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGY 655
RSG AQPEVPKL+ARFPGSFKE SESF Q D +H +QGVAG HQKEDGR +KDP+LLGY
Sbjct: 589 RSGLAQPEVPKLMARFPGSFKETSESFTQQDPRHPSQGVAGFHQKEDGRNSSKDPVLLGY 648
Query: 656 GSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSL 715
GSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRAR DK KVRKVQ E NQ+STNSL
Sbjct: 649 GSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARLDKEKVRKVQAESNQISTNSL 708
Query: 716 FVSGR 720
FVSGR
Sbjct: 709 FVSGR 713
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128322|ref|XP_002329133.1| predicted protein [Populus trichocarpa] gi|222869802|gb|EEF06933.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1271 bits (3288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 624/725 (86%), Positives = 657/725 (90%), Gaps = 17/725 (2%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+C KPSAIEDSKESPRERLSSK SSDLR SRATSSRREE YR KD++DSNDGR MLI
Sbjct: 1 MGCMCCKPSAIEDSKESPRERLSSKPSSDLRVSRATSSRREEAYRAKDQYDSNDGRTMLI 60
Query: 61 DKQVNGSVRLHG-ENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGE 119
DKQVNGS+R+HG E+ DRKR+K EY V HHPGMGSIPKA+EGEQVAAGWP+WLAAVAGE
Sbjct: 61 DKQVNGSLRVHGVEHVDRKRDKSEYAVL-HHPGMGSIPKATEGEQVAAGWPSWLAAVAGE 119
Query: 120 AIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL 179
AI+GW+PRRADSFEKLDK IGQGTYSNVYRARDLDQKKIVALKKVRFDNL
Sbjct: 120 AIKGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLDQKKIVALKKVRFDNL 168
Query: 180 EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF 239
EPESVRFMAREIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL F
Sbjct: 169 EPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLNF 228
Query: 240 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299
+EAQVKCYMQQLL GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP Q QP
Sbjct: 229 TEAQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPAQVQP 288
Query: 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 359
LTSRVVTLWYRPPELLLGATYYG AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL
Sbjct: 289 LTSRVVTLWYRPPELLLGATYYGIAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 348
Query: 360 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA 419
CGSPSEDYWRKSKLPHATIFKPQQPY+RCVAETFK+FPAPALALMETLL+IDP DRGSAA
Sbjct: 349 CGSPSEDYWRKSKLPHATIFKPQQPYRRCVAETFKEFPAPALALMETLLAIDPVDRGSAA 408
Query: 420 SALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRE 477
SALRSEFFT KPLPCDPSSLP YPPSKEFDAK+RDEEARRQG GSKGQ+ D+ERRG RE
Sbjct: 409 SALRSEFFTTKPLPCDPSSLPDYPPSKEFDAKMRDEEARRQGAAGSKGQKPDMERRGQRE 468
Query: 478 SRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAG 537
SRA+PAPDANAELVLSMQKR + NSKSRSEKFNPHPEEVASGFPIDPPR SQ ES+
Sbjct: 469 SRAVPAPDANAELVLSMQKRHGRPNSKSRSEKFNPHPEEVASGFPIDPPRPSQAAESNMD 528
Query: 538 PQGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRE 595
PQGH HKRASHSGPL+ R+ WAKAG+N DDAPKI TGADLST L AARRSLLSED RE
Sbjct: 529 PQGHQHKRASHSGPLSHRSGWAKAGRNPDDAPKIYTGADLSTISSLEAARRSLLSEDHRE 588
Query: 596 RSGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGY 655
RSG +QPEVPKL+ARFPGSFKE SESF Q D + +QGVAGSHQKEDGR +KDP+LLGY
Sbjct: 589 RSGLSQPEVPKLMARFPGSFKETSESFAQQDPQRLSQGVAGSHQKEDGRNNSKDPVLLGY 648
Query: 656 GSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSL 715
GSK HKIHYSGPLIVPSGN+DQMLKDHDRQIQEAVRRARFDKA+VRKVQ E Q+S NSL
Sbjct: 649 GSKAHKIHYSGPLIVPSGNMDQMLKDHDRQIQEAVRRARFDKARVRKVQAESYQISANSL 708
Query: 716 FVSGR 720
FVSGR
Sbjct: 709 FVSGR 713
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302143004|emb|CBI20299.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1259 bits (3257), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 617/724 (85%), Positives = 655/724 (90%), Gaps = 16/724 (2%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGCIC KPSAIEDS+ESPRERLSSKASS+LR + SSRREE YRVKDRFDSNDGR MLI
Sbjct: 1 MGCICCKPSAIEDSRESPRERLSSKASSNLRVAGPASSRREEAYRVKDRFDSNDGRTMLI 60
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
+KQ NGSVRLHGEN +RKRE+ EYVVAQH PG+GSIPKA EGEQVAAGWPAWL+AVAGEA
Sbjct: 61 EKQANGSVRLHGENVERKRERGEYVVAQH-PGLGSIPKAMEGEQVAAGWPAWLSAVAGEA 119
Query: 121 IQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE 180
I+GW+PRRADSFEKLDK IGQGTYSNVYRARDLDQ+KIVALKKVRFDNLE
Sbjct: 120 IRGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLDQRKIVALKKVRFDNLE 168
Query: 181 PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFS 240
PESVRFMAREIH+LRRLDH N+IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF+
Sbjct: 169 PESVRFMAREIHVLRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFT 228
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300
E QVKCYMQQLL GLDHCHSRGVLHRDIKGSNLLIDN+GILKIADFGLASF+DP Q QPL
Sbjct: 229 EPQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNSGILKIADFGLASFFDPHQIQPL 288
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC
Sbjct: 289 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 348
Query: 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420
GSPSEDYWRKSKLPHATIFKPQQPY+RCVAETFKDFP PAL LMETLLSIDPADRGSAAS
Sbjct: 349 GSPSEDYWRKSKLPHATIFKPQQPYRRCVAETFKDFPTPALGLMETLLSIDPADRGSAAS 408
Query: 421 ALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS-KGQRMDLERRGTRESR 479
AL+SEFFT+KPLPCDPSSLPKYPPSKEFDAK+RDEEARRQG + KGQR+D ER+G RESR
Sbjct: 409 ALKSEFFTVKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQGATGKGQRLDHERKGIRESR 468
Query: 480 AIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTE-SSAGP 538
A+PAPDANAELVLSMQKRQ Q NSKSRSEKFNPHPEEVASGFPIDPPR SQ E S
Sbjct: 469 AVPAPDANAELVLSMQKRQGQSNSKSRSEKFNPHPEEVASGFPIDPPRPSQAIEDGSIDT 528
Query: 539 QGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRER 596
QG HKRASHSGPLA RA WAKAGKN DDAPK+STGADLST LVAARRSLLSEDRRE+
Sbjct: 529 QGPLHKRASHSGPLAHRAVWAKAGKNLDDAPKVSTGADLSTMSSLVAARRSLLSEDRREK 588
Query: 597 SGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYG 656
SGS+QP+V KLI RFPGSFKEASES IQ DQKH QG QKEDGR+ +KDP+LLGYG
Sbjct: 589 SGSSQPDVSKLIVRFPGSFKEASESTIQQDQKHQMQGAGRCTQKEDGRMTSKDPVLLGYG 648
Query: 657 SKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLF 716
SKGHKIHYSGPL+VPSG VDQMLKDHDRQIQ+A RRAR D+ K+RKVQ+EGN++S NSLF
Sbjct: 649 SKGHKIHYSGPLLVPSGKVDQMLKDHDRQIQDAERRARLDREKLRKVQVEGNKISANSLF 708
Query: 717 VSGR 720
VSGR
Sbjct: 709 VSGR 712
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461467|ref|XP_002285008.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1258 bits (3256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 617/724 (85%), Positives = 655/724 (90%), Gaps = 16/724 (2%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGCIC KPSAIEDS+ESPRERLSSKASS+LR + SSRREE YRVKDRFDSNDGR MLI
Sbjct: 2 MGCICCKPSAIEDSRESPRERLSSKASSNLRVAGPASSRREEAYRVKDRFDSNDGRTMLI 61
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
+KQ NGSVRLHGEN +RKRE+ EYVVAQH PG+GSIPKA EGEQVAAGWPAWL+AVAGEA
Sbjct: 62 EKQANGSVRLHGENVERKRERGEYVVAQH-PGLGSIPKAMEGEQVAAGWPAWLSAVAGEA 120
Query: 121 IQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE 180
I+GW+PRRADSFEKLDK IGQGTYSNVYRARDLDQ+KIVALKKVRFDNLE
Sbjct: 121 IRGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLDQRKIVALKKVRFDNLE 169
Query: 181 PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFS 240
PESVRFMAREIH+LRRLDH N+IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF+
Sbjct: 170 PESVRFMAREIHVLRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFT 229
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300
E QVKCYMQQLL GLDHCHSRGVLHRDIKGSNLLIDN+GILKIADFGLASF+DP Q QPL
Sbjct: 230 EPQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNSGILKIADFGLASFFDPHQIQPL 289
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC
Sbjct: 290 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 349
Query: 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420
GSPSEDYWRKSKLPHATIFKPQQPY+RCVAETFKDFP PAL LMETLLSIDPADRGSAAS
Sbjct: 350 GSPSEDYWRKSKLPHATIFKPQQPYRRCVAETFKDFPTPALGLMETLLSIDPADRGSAAS 409
Query: 421 ALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS-KGQRMDLERRGTRESR 479
AL+SEFFT+KPLPCDPSSLPKYPPSKEFDAK+RDEEARRQG + KGQR+D ER+G RESR
Sbjct: 410 ALKSEFFTVKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQGATGKGQRLDHERKGIRESR 469
Query: 480 AIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTE-SSAGP 538
A+PAPDANAELVLSMQKRQ Q NSKSRSEKFNPHPEEVASGFPIDPPR SQ E S
Sbjct: 470 AVPAPDANAELVLSMQKRQGQSNSKSRSEKFNPHPEEVASGFPIDPPRPSQAIEDGSIDT 529
Query: 539 QGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRER 596
QG HKRASHSGPLA RA WAKAGKN DDAPK+STGADLST LVAARRSLLSEDRRE+
Sbjct: 530 QGPLHKRASHSGPLAHRAVWAKAGKNLDDAPKVSTGADLSTMSSLVAARRSLLSEDRREK 589
Query: 597 SGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYG 656
SGS+QP+V KLI RFPGSFKEASES IQ DQKH QG QKEDGR+ +KDP+LLGYG
Sbjct: 590 SGSSQPDVSKLIVRFPGSFKEASESTIQQDQKHQMQGAGRCTQKEDGRMTSKDPVLLGYG 649
Query: 657 SKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLF 716
SKGHKIHYSGPL+VPSG VDQMLKDHDRQIQ+A RRAR D+ K+RKVQ+EGN++S NSLF
Sbjct: 650 SKGHKIHYSGPLLVPSGKVDQMLKDHDRQIQDAERRARLDREKLRKVQVEGNKISANSLF 709
Query: 717 VSGR 720
VSGR
Sbjct: 710 VSGR 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356544039|ref|XP_003540463.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1222 bits (3161), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/725 (83%), Positives = 646/725 (89%), Gaps = 22/725 (3%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+C KPSAIEDSKESPRERLSSKA SDLR SR SSRREE +RVKDR+D+NDGR LI
Sbjct: 1 MGCMCCKPSAIEDSKESPRERLSSKAVSDLRVSRGASSRREEAFRVKDRYDNNDGRTALI 60
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
DKQ NGSVR+ GE+F+RKREKMEY VAQH PG+GS+PKA EGEQVAAGWP+WLAAVAGEA
Sbjct: 61 DKQGNGSVRVQGESFERKREKMEYAVAQH-PGIGSVPKAMEGEQVAAGWPSWLAAVAGEA 119
Query: 121 IQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE 180
I+GW+PRRADSFEKLDK IGQGTYSNVYRARDL+Q+K+VALKKVRFDNLE
Sbjct: 120 IKGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLEQRKVVALKKVRFDNLE 168
Query: 181 PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFS 240
PESVRFMAREIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF+
Sbjct: 169 PESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFT 228
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300
EAQVKCYMQQLL GLDHCHS GVLHRDIKGSNLLIDNNGILKIADFGLASF+DP+Q QPL
Sbjct: 229 EAQVKCYMQQLLRGLDHCHSCGVLHRDIKGSNLLIDNNGILKIADFGLASFFDPNQAQPL 288
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC
Sbjct: 289 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 348
Query: 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420
GSPSEDYWRKSKLPHATIFKPQQPY+RCV+ETFK+FPAPA+ L+ETLLSIDPADRG++AS
Sbjct: 349 GSPSEDYWRKSKLPHATIFKPQQPYRRCVSETFKEFPAPAIELIETLLSIDPADRGTSAS 408
Query: 421 ALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRES 478
AL SEFF+ KPLPCDPSSLPKYPPSKEFDAK+RDEEARRQG GSKGQR DLERRG RES
Sbjct: 409 ALNSEFFSTKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQGAAGSKGQRHDLERRGARES 468
Query: 479 RAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGP 538
RAIPAPDANAELVLSMQKRQ Q NS+S+SEKFNPHPEEVASGFPIDPPR SQ A P
Sbjct: 469 RAIPAPDANAELVLSMQKRQGQANSQSKSEKFNPHPEEVASGFPIDPPRPSQAAGLIADP 528
Query: 539 QGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRRER 596
H HKRASHSGPL RAAWAKAGKN DDAPKIS DLST GLVAARRS+LS+DRRER
Sbjct: 529 PVHQHKRASHSGPLTHRAAWAKAGKNQDDAPKISMVGDLSTVSGLVAARRSMLSDDRRER 588
Query: 597 SGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGR-IGNKDPILLGY 655
SGS+Q PKLI RFPGSFKEASES +Q DQK+HA QKE+GR NKD L+GY
Sbjct: 589 SGSSQTVAPKLINRFPGSFKEASESMMQQDQKYHAH----VPQKEEGRGSSNKDSNLVGY 644
Query: 656 GSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSL 715
GSKGHKIH+SGPL+VPS N DQMLKDHDRQIQE VRRAR DKAK+R++Q EGNQ+ TNSL
Sbjct: 645 GSKGHKIHHSGPLLVPSSNHDQMLKDHDRQIQEVVRRARLDKAKMRRLQTEGNQI-TNSL 703
Query: 716 FVSGR 720
FVSGR
Sbjct: 704 FVSGR 708
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549726|ref|XP_003543242.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1196 bits (3095), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/729 (82%), Positives = 648/729 (88%), Gaps = 26/729 (3%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSD---LRGSRATSSRREEVYRVKDRFDSNDGRA 57
MGC+C KPSAIEDSKESPRERLSSK+ LR SR TSSRREE + +KDR+D+NDGRA
Sbjct: 1 MGCMCCKPSAIEDSKESPRERLSSKSDKSVSDLRVSRGTSSRREEAFWLKDRYDNNDGRA 60
Query: 58 MLIDKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVA 117
LIDKQ NGSVR+ GE+F+RKREKMEY VAQH PG+GS+PKA EGEQVAAGWP+WLAAVA
Sbjct: 61 ALIDKQGNGSVRVQGESFERKREKMEYTVAQH-PGIGSVPKAMEGEQVAAGWPSWLAAVA 119
Query: 118 GEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFD 177
GEAI+GW+PRRADSFEKLDK IGQGTYSNVYRARDL+Q+KIVALKKVRFD
Sbjct: 120 GEAIKGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLEQRKIVALKKVRFD 168
Query: 178 NLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL 237
NLEPESVRFMAREIHILRRL+H NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL
Sbjct: 169 NLEPESVRFMAREIHILRRLNHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL 228
Query: 238 KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297
KF+EAQVKCYMQQLL GLDHCHS GVLHRDIKGSNLLIDN+GILKIADFGLASF+DP+Q
Sbjct: 229 KFTEAQVKCYMQQLLRGLDHCHSCGVLHRDIKGSNLLIDNSGILKIADFGLASFFDPNQA 288
Query: 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357
QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF
Sbjct: 289 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 348
Query: 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 417
KLCGSPSEDYWRKSKLPHATIFKPQQPY+RCV+ETFK+FPAPA+ L+E LLSIDPADRG+
Sbjct: 349 KLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVSETFKEFPAPAIELIEILLSIDPADRGT 408
Query: 418 AASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGT 475
+ASAL SEFF+ KPLPCDPSSLPKYPPSKEFDAK+RDEEARRQG GSKGQR D+ERRG
Sbjct: 409 SASALNSEFFSTKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQGAAGSKGQRHDIERRGA 468
Query: 476 RESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESS 535
RESRAIPAPDANAELVLS+QKRQ Q NS+SRSEKFNPHPEEVASGFPIDPPR SQ
Sbjct: 469 RESRAIPAPDANAELVLSIQKRQGQANSQSRSEKFNPHPEEVASGFPIDPPRPSQAAGLI 528
Query: 536 AGPQGHNHKRASHSGPLAQRAAWA-KAGKNTDDAPKISTGADLST--GLVAARRSLLSED 592
A P H HKR+SHSGPL RAAWA KAGKN +DAPKIS G DLST GLVAARRS+LS+D
Sbjct: 529 ADPPVHQHKRSSHSGPLTHRAAWANKAGKNQEDAPKISMGGDLSTVSGLVAARRSMLSDD 588
Query: 593 RRERSGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIG-NKDPI 651
RRE SGS+Q E PKLI+RFPGSFKEASES +Q DQKHHA + QKE+GR NKD
Sbjct: 589 RREWSGSSQAEAPKLISRFPGSFKEASESMMQQDQKHHAH----APQKEEGRGSRNKDSN 644
Query: 652 LLGYGSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLS 711
L+GYGSKGHKIHYSGPL+VPS N DQMLKDHDRQIQEAVRRAR DKAK+R++Q EG+Q+S
Sbjct: 645 LVGYGSKGHKIHYSGPLLVPSSNHDQMLKDHDRQIQEAVRRARLDKAKMRRLQAEGSQIS 704
Query: 712 TNSLFVSGR 720
NSLFVSGR
Sbjct: 705 -NSLFVSGR 712
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357452947|ref|XP_003596750.1| Serine/threonine protein kinase cdk9 [Medicago truncatula] gi|355485798|gb|AES67001.1| Serine/threonine protein kinase cdk9 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1196 bits (3093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/729 (80%), Positives = 643/729 (88%), Gaps = 26/729 (3%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSN-DGRAML 59
MGC+C KPSAIEDSK+SPRERLS+K D R SR SSRREE YRVKDR D+N D R L
Sbjct: 1 MGCMCCKPSAIEDSKDSPRERLSNKPVLDSRVSRGASSRREEAYRVKDRNDNNNDARMAL 60
Query: 60 IDK--QVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVA 117
IDK Q NGSVR+HG+NF+RKREKMEYV+A H PG+GS+PKA EGE VAAGWP+WLAAVA
Sbjct: 61 IDKHGQGNGSVRVHGDNFERKREKMEYVIAPH-PGIGSVPKAMEGEHVAAGWPSWLAAVA 119
Query: 118 GEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFD 177
G+AI+GW+PRRADSFEKLDK IGQGTYSNVYRARDL+Q+KIVALKKVRFD
Sbjct: 120 GDAIKGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLEQRKIVALKKVRFD 168
Query: 178 NLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL 237
NLEPESVRFMAREIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL
Sbjct: 169 NLEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGL 228
Query: 238 KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297
KF+E+QVKCYMQQLL GLDHCHSRGVLHRDIKGSNLLIDNNG+LKIADFGLASF+DP+ N
Sbjct: 229 KFTESQVKCYMQQLLRGLDHCHSRGVLHRDIKGSNLLIDNNGVLKIADFGLASFFDPNLN 288
Query: 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357
QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF
Sbjct: 289 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 348
Query: 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 417
KLCGSPSEDYWRKSKLPHATIFKPQQPY+RCVAETFK+FPAPA+ L+ETLLSIDPADRG+
Sbjct: 349 KLCGSPSEDYWRKSKLPHATIFKPQQPYRRCVAETFKEFPAPAIELIETLLSIDPADRGT 408
Query: 418 AASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGT 475
+ASAL SEFF+ KPLPCDPSSLPKYPPSKEFDAK+RDEEARRQG GSKGQR D ERRG
Sbjct: 409 SASALISEFFSTKPLPCDPSSLPKYPPSKEFDAKVRDEEARRQGAAGSKGQRHDPERRGV 468
Query: 476 RESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESS 535
RESRA+PAPDANAELV+SMQKRQ Q S+SRSEKFNPHPE+ SGFPI+PPR SQ E++
Sbjct: 469 RESRAVPAPDANAELVVSMQKRQGQNYSQSRSEKFNPHPEDAGSGFPIEPPRPSQAAEAN 528
Query: 536 AGPQGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDR 593
PQ + HKRASHSGPL RAAWAKAGKN DDAPKIS G DLST GLVAARRS+LS+DR
Sbjct: 529 VDPQANQHKRASHSGPLTHRAAWAKAGKNQDDAPKISVGGDLSTMSGLVAARRSMLSDDR 588
Query: 594 RERSGSAQPEVPKLIARFPGSFKEASESFIQ--HDQKHHAQGVAGSHQKEDGRIGNKDPI 651
RE SGS+Q E PKLI RFPGSFKEASES +Q +QKHH + QKED + NKDP
Sbjct: 589 RESSGSSQVEAPKLITRFPGSFKEASESLMQQNQNQKHHVH----ASQKEDAKGSNKDPN 644
Query: 652 LLGYGSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLS 711
+GYGSKG+KIHYSGPL+VPS N+DQMLKDHDRQIQEAVRRAR DKAK+R++Q EGNQ++
Sbjct: 645 NVGYGSKGYKIHYSGPLLVPSSNMDQMLKDHDRQIQEAVRRARLDKAKMRRLQAEGNQIN 704
Query: 712 TNSLFVSGR 720
NSLFVSGR
Sbjct: 705 -NSLFVSGR 712
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356543323|ref|XP_003540111.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1179 bits (3050), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/726 (80%), Positives = 633/726 (87%), Gaps = 22/726 (3%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASS-DLRGSRATSSRREEVYRVKDRFDSNDGRAML 59
MG +C KPSAIEDSKESPRER+S+KA+S D R SR S RRE+ YR KDR+D ND R L
Sbjct: 1 MGGVCCKPSAIEDSKESPRERMSTKAASLDSRVSRGASLRREDAYRGKDRYDGNDVRTAL 60
Query: 60 IDKQVNGSVRLHGENFDRKREKMEYVVA-QHHPGMGSIPKASEGEQVAAGWPAWLAAVAG 118
IDKQ NGSVRL EN +RKRE+ME VVA Q HPG GS+PKA EGEQVAAGWP+WLAAVAG
Sbjct: 61 IDKQGNGSVRLQDENIERKRERMECVVAAQQHPGAGSVPKAMEGEQVAAGWPSWLAAVAG 120
Query: 119 EAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN 178
EAI+GW+PRRADSFEKLDK IGQGTYSNVYRARDL+Q KIVALKKVRFDN
Sbjct: 121 EAIKGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLEQNKIVALKKVRFDN 169
Query: 179 LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK 238
LEPESVRFMAREIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHP LK
Sbjct: 170 LEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPKLK 229
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
F+EAQVKCYMQQLL GLDHCH+ GVLHRDIKGSNLLIDNNGILKIADFGLAS +DP+Q Q
Sbjct: 230 FTEAQVKCYMQQLLQGLDHCHNCGVLHRDIKGSNLLIDNNGILKIADFGLASVFDPNQTQ 289
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK
Sbjct: 290 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 349
Query: 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
LCGSPSEDYWRKSKLPHATIFKP+QPY RCVA+TFKDFPAPALALMETLLSIDPADRG+A
Sbjct: 350 LCGSPSEDYWRKSKLPHATIFKPRQPYWRCVADTFKDFPAPALALMETLLSIDPADRGTA 409
Query: 419 ASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTR 476
ASAL+S+FFT KPLPCDPSSLPKYPPSKEFDAK+RDE+ARRQG GS+GQR DLERRG +
Sbjct: 410 ASALKSDFFTTKPLPCDPSSLPKYPPSKEFDAKLRDEQARRQGATGSRGQRHDLERRGAK 469
Query: 477 ESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSA 536
ESRA+PAPDANAEL LSMQKRQSQ SKSRSEKFNPHPEE ASGFPIDPPR SQ E
Sbjct: 470 ESRAVPAPDANAELPLSMQKRQSQAQSKSRSEKFNPHPEE-ASGFPIDPPRSSQAVEVGI 528
Query: 537 GPQGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRR 594
Q HKRASHSGPLA R AWAK+GKN DDAPKIS G DLST GLVAA RS+LS+DRR
Sbjct: 529 ETQVPQHKRASHSGPLAHRTAWAKSGKNQDDAPKISVGGDLSTISGLVAA-RSMLSDDRR 587
Query: 595 ERSGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLG 654
ERSGS+Q E KL RFPGSFK+ SES I+ DQ+HH QG G+ QKE+GR NKD +L+G
Sbjct: 588 ERSGSSQTEASKLTNRFPGSFKDFSESSIKQDQRHHVQGQVGTSQKEEGRSSNKDLVLVG 647
Query: 655 YGSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNS 714
YGS+GHKIHYSGPL S N+DQ+LKDHDRQIQEAVRRAR DKAK+R++Q EGNQ+ TNS
Sbjct: 648 YGSEGHKIHYSGPLT--SSNMDQVLKDHDRQIQEAVRRARLDKAKIRRLQAEGNQV-TNS 704
Query: 715 LFVSGR 720
LFVS R
Sbjct: 705 LFVSKR 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356517145|ref|XP_003527250.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1172 bits (3031), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 586/726 (80%), Positives = 631/726 (86%), Gaps = 22/726 (3%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASS-DLRGSRATSSRREEVYRVKDRFDSNDGRAML 59
MG +C KPSAIEDSKESPRER+S+K++S D R S RRE+ YRVKDR+D N+ R L
Sbjct: 1 MGGVCCKPSAIEDSKESPRERMSTKSASLDSCVPRGASLRREDAYRVKDRYDGNNVRTAL 60
Query: 60 IDKQVNGSVRLHGENFDRKREKMEYVVA-QHHPGMGSIPKASEGEQVAAGWPAWLAAVAG 118
IDKQ NGSVRL EN +RKRE+ME VVA Q HPG GS+PKA EGEQVAAGWP+WLAAVAG
Sbjct: 61 IDKQGNGSVRLQSENVERKRERMECVVAAQQHPGAGSVPKALEGEQVAAGWPSWLAAVAG 120
Query: 119 EAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN 178
EAI+GW+PRRADSFEKLDK IGQGTYSNVYRARDL+QKKIVALKKVRFDN
Sbjct: 121 EAIKGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLEQKKIVALKKVRFDN 169
Query: 179 LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK 238
LEPESVRFMAREIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHP LK
Sbjct: 170 LEPESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPKLK 229
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
F+EAQVKCYMQQLL GL+HCH+ GVLHRDIKGSNLLIDNNGILKIADFGLAS +DP++ Q
Sbjct: 230 FTEAQVKCYMQQLLRGLEHCHNCGVLHRDIKGSNLLIDNNGILKIADFGLASVFDPNRTQ 289
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK
Sbjct: 290 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 349
Query: 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
LCGSPSEDYWRKSKLPHATIFKPQQPY+RCVA+TFKDF APALALMETLLSIDPADRG+A
Sbjct: 350 LCGSPSEDYWRKSKLPHATIFKPQQPYRRCVADTFKDFAAPALALMETLLSIDPADRGTA 409
Query: 419 ASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTR 476
ASAL+SEFFT KPLPCDPSSLPKYPPSKE DAK+RDE+ARRQG GSKGQR DLERRG R
Sbjct: 410 ASALKSEFFTTKPLPCDPSSLPKYPPSKELDAKLRDEQARRQGATGSKGQRHDLERRGAR 469
Query: 477 ESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSA 536
ESRA+PAPDANAEL LSMQKRQSQ SKSRSEKFNPH EE ASGFPIDPPR SQ E
Sbjct: 470 ESRAVPAPDANAELPLSMQKRQSQAQSKSRSEKFNPHLEE-ASGFPIDPPRPSQAVEVGI 528
Query: 537 GPQGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLST--GLVAARRSLLSEDRR 594
PQ HKRASHSGPLA R AW KAGKN DDAPKIS G DLST GLVAA RS+LS+DRR
Sbjct: 529 EPQVPQHKRASHSGPLAHRTAWGKAGKNQDDAPKISVGGDLSTISGLVAA-RSMLSDDRR 587
Query: 595 ERSGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLG 654
ERSGS+Q E KL+ RFPGSFK+ SE I+ DQ+HH G G+ QKE+GR NKD +L+G
Sbjct: 588 ERSGSSQMEASKLMNRFPGSFKDISELLIKQDQRHHVPGQVGTSQKEEGRSSNKDLVLVG 647
Query: 655 YGSKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNS 714
YGSKGHKIHYSGPL S N+DQ+LKDHDRQIQEAVRRAR DKAK+R++Q EGNQ+ TNS
Sbjct: 648 YGSKGHKIHYSGPLT--SSNMDQVLKDHDRQIQEAVRRARLDKAKMRRLQAEGNQI-TNS 704
Query: 715 LFVSGR 720
LFVSGR
Sbjct: 705 LFVSGR 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449457023|ref|XP_004146248.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] gi|449526203|ref|XP_004170103.1| PREDICTED: probable serine/threonine-protein kinase At1g54610-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1170 bits (3028), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 584/724 (80%), Positives = 633/724 (87%), Gaps = 21/724 (2%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGC+C KPSAIEDSKESPR+R+SSK SSDLR +R TSS REE YR KD++D ND R LI
Sbjct: 1 MGCVCCKPSAIEDSKESPRDRVSSKTSSDLRVARLTSSSREEAYRAKDQYDGNDARVTLI 60
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAAVAGEA 120
DKQVNGS RL GEN +RKREKME++ AQH P MG IPKA+EG+ +AAGWP WLAAVAGEA
Sbjct: 61 DKQVNGSGRLPGENCERKREKMEHMTAQH-PSMGRIPKAAEGDHIAAGWPPWLAAVAGEA 119
Query: 121 IQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE 180
I+GW+PRRADSFEKLDK IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE
Sbjct: 120 IRGWLPRRADSFEKLDK-----------IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE 168
Query: 181 PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFS 240
PESVRFMAREIHILRRLDH NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG+KF+
Sbjct: 169 PESVRFMAREIHILRRLDHPNVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGVKFT 228
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300
EAQVKCYMQQLL GLDHCHS GVLHRDIKGSNLLIDN+GILKIADFGLASF+D QNQPL
Sbjct: 229 EAQVKCYMQQLLRGLDHCHSHGVLHRDIKGSNLLIDNHGILKIADFGLASFFDIHQNQPL 288
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC
Sbjct: 289 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 348
Query: 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420
GSPSEDYWRKS+LPHATIFKPQQPY+RCVA+TFKDFPAPALAL+ETLLSIDPADRGSAA
Sbjct: 349 GSPSEDYWRKSRLPHATIFKPQQPYRRCVADTFKDFPAPALALIETLLSIDPADRGSAAL 408
Query: 421 ALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG--GSKGQRMDLERRGTRES 478
AL+SEFF+ KPLPCDPSSLPKYPPSKEFDAKIRDEEARRQG GSKG R+DL+R+ R+S
Sbjct: 409 ALKSEFFSAKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGAVGSKGHRLDLQRK-DRDS 467
Query: 479 RAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGP 538
RA+PAPDANAEL SMQKRQ +SKSRSEKFNPHPEE ASGFPIDPPR SQ E
Sbjct: 468 RAVPAPDANAELASSMQKRQGLSSSKSRSEKFNPHPEE-ASGFPIDPPRPSQGAE-RMDS 525
Query: 539 QGHNHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADL--STGLVAARRSLLSEDRRER 596
Q + K+ASHSGPLAQRAAWAKA +N DD PKISTG + ++GLVAARRS+L+ED RE+
Sbjct: 526 QVRHPKKASHSGPLAQRAAWAKASRNPDDPPKISTGTETFATSGLVAARRSMLAEDCREK 585
Query: 597 SGSAQPEVPKLIARFPGSFKEASESFIQHDQKHHAQGVAGSHQKEDGRIGNKDPILLGYG 656
S S+Q EV KLI RFPGSFKE SES + DQK +AGSH KE R KDPI++GYG
Sbjct: 586 SDSSQGEVQKLIGRFPGSFKETSESSMLPDQKFSNHSIAGSHDKE--RSSTKDPIVVGYG 643
Query: 657 SKGHKIHYSGPLIVPSGNVDQMLKDHDRQIQEAVRRARFDKAKVRKVQMEGNQLSTNSLF 716
SKGHKIHYSGPL+VPSGN+DQMLKDHDR IQEAVRRAR DKAKVRK+Q +G Q+STNSLF
Sbjct: 644 SKGHKIHYSGPLLVPSGNMDQMLKDHDRHIQEAVRRARLDKAKVRKIQADGKQISTNSLF 703
Query: 717 VSGR 720
VSGR
Sbjct: 704 VSGR 707
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 720 | ||||||
| TAIR|locus:2037042 | 694 | AT1G53050 [Arabidopsis thalian | 0.840 | 0.871 | 0.697 | 4.5e-255 | |
| TAIR|locus:2012290 | 714 | AT1G09600 [Arabidopsis thalian | 0.686 | 0.691 | 0.585 | 4.5e-165 | |
| TAIR|locus:2020708 | 740 | AT1G03740 [Arabidopsis thalian | 0.695 | 0.677 | 0.546 | 1.4e-152 | |
| TAIR|locus:2012643 | 614 | AT1G33770 [Arabidopsis thalian | 0.722 | 0.846 | 0.523 | 5.7e-152 | |
| TAIR|locus:2152740 | 580 | AT5G50860 [Arabidopsis thalian | 0.566 | 0.703 | 0.675 | 4.8e-149 | |
| TAIR|locus:2199491 | 573 | AT1G54610 [Arabidopsis thalian | 0.619 | 0.778 | 0.606 | 2.4e-147 | |
| TAIR|locus:2158715 | 644 | AT5G44290 [Arabidopsis thalian | 0.65 | 0.726 | 0.562 | 1e-145 | |
| TAIR|locus:2034944 | 709 | IBS1 "IMPAIRED IN BABA-INDUCED | 0.637 | 0.647 | 0.541 | 7.2e-139 | |
| TAIR|locus:2140543 | 469 | AT4G10010 [Arabidopsis thalian | 0.477 | 0.733 | 0.656 | 1.7e-137 | |
| TAIR|locus:2019115 | 699 | AT1G74330 [Arabidopsis thalian | 0.827 | 0.852 | 0.467 | 2.5e-136 |
| TAIR|locus:2037042 AT1G53050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2166 (767.5 bits), Expect = 4.5e-255, Sum P(2) = 4.5e-255
Identities = 441/632 (69%), Positives = 495/632 (78%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSR-ATSSRREEVYRVKDRFDSNDGRAML 59
MGC+C KPSAIEDSK+SPRER SSK+SS+ R SR SSRREE R+K+R D R +L
Sbjct: 1 MGCVCGKPSAIEDSKDSPRERFSSKSSSEFRVSRPVASSRREEPLRIKERSDVVSVRPVL 60
Query: 60 IDKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMG-SIPKASEGEQXXXXXXXXXXXXXX 118
+KQ N S+ L GEN R+ +++E V A M +I KA+EGE
Sbjct: 61 SNKQSNVSLHLRGENLSRREKRIENVAATSPLAMSITIAKATEGEYVAAGWPPWLASVAG 120
Query: 119 EAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN 178
EAI+GWVPRRADSFEKLDK IGQGTYSNVYRARDLDQKKIVALKKVRFDN
Sbjct: 121 EAIRGWVPRRADSFEKLDK-----------IGQGTYSNVYRARDLDQKKIVALKKVRFDN 169
Query: 179 LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK 238
LEPESVRFMAREI ILRRLDH N+IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHP +K
Sbjct: 170 LEPESVRFMAREIQILRRLDHPNIIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPAIK 229
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
FSE+QVKCY+QQLL GLDHCHSRGVLHRDIKGSNLLIDN+G+LKIADFGLASF+DP Q Q
Sbjct: 230 FSESQVKCYLQQLLHGLDHCHSRGVLHRDIKGSNLLIDNSGVLKIADFGLASFFDPRQTQ 289
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
PLTSRVVTLWYRPPELLLGAT YG AVDLWS GCILAELYAGKPIMPGRTEVEQLHKIFK
Sbjct: 290 PLTSRVVTLWYRPPELLLGATRYGAAVDLWSAGCILAELYAGKPIMPGRTEVEQLHKIFK 349
Query: 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
LCGSP+EDYW KS+LPHATIFKP QPYKR V ETFK+FP PALAL+ETLLS++P DRG+A
Sbjct: 350 LCGSPTEDYWVKSRLPHATIFKPTQPYKRLVGETFKEFPQPALALLETLLSVNPDDRGTA 409
Query: 419 ASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ-GGSKGQRMDLERRGTRE 477
+AL+SEFF+ +PLPCDPSSLPKYPPSKE DA++RDEE+RRQ GG++ QR ERRGT+E
Sbjct: 410 TAALKSEFFSTRPLPCDPSSLPKYPPSKELDARMRDEESRRQVGGNRDQRHQ-ERRGTKE 468
Query: 478 SRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPR-QSQVTESSA 536
SRAIPAPDANAELV SMQKRQSQ ++SRSEKFNPHPEEVASGFPIDPPR SQ E +
Sbjct: 469 SRAIPAPDANAELVASMQKRQSQSTNRSRSEKFNPHPEEVASGFPIDPPRPSSQAFEPNR 528
Query: 537 GPQGH--NHKRASHSGPLAQRAAWAKAGKNTDDAPKISTGADLSTGLVAAXXXXXXXXXX 594
QG+ HKRASHSGPL++R+A AK +N D+ K+S+ AD S
Sbjct: 529 ESQGNIIPHKRASHSGPLSRRSASAKGRRNYQDSQKVSSIADYSA---------MPGFAA 579
Query: 595 XXXXXAQPEVPKLIARFPGSFKEASESFIQHD 626
Q E + + R PGSFKE SE Q +
Sbjct: 580 TRTGAPQQETCRGMTRLPGSFKETSEEANQEE 611
|
|
| TAIR|locus:2012290 AT1G09600 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1489 (529.2 bits), Expect = 4.5e-165, Sum P(2) = 4.5e-165
Identities = 307/524 (58%), Positives = 380/524 (72%)
Query: 15 KESPRERLSSKASSDLRGSRA-----TSSRREEVYRVKDRFDSN-DGRAMLIDKQVNGSV 68
K++P+++ SK++S + + ++ +E + D+ D + +K+VN
Sbjct: 36 KKTPKKKKKSKSASSSKDNNVGFEERSNDNKEASLTLLIPIDAKKDDES---EKKVNLER 92
Query: 69 RLHGENFDRKREKMEY----VVAQHHPGMGSIPKASEGE---QXXXXXXXXXXXXXXEAI 121
+ F R+ +E + P M I S GE Q EAI
Sbjct: 93 KSSRLVFQRRPTGIEVGANNIGTLQQPKMTRICSVSNGERGAQVMAGWPSWLASVAGEAI 152
Query: 122 QGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP 181
GW+PR+ADSFEKL+K IGQGTYS+VY+ARDL+ ++VALKKVRF N++P
Sbjct: 153 NGWIPRKADSFEKLEK-----------IGQGTYSSVYKARDLETNQLVALKKVRFANMDP 201
Query: 182 ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSE 241
+SVRFMAREI ILRRLDH NV+KLEGL+TSR+S S+YL+FEYMEHDLAGLAS PG+ FSE
Sbjct: 202 DSVRFMAREIIILRRLDHPNVMKLEGLITSRVSGSMYLIFEYMEHDLAGLASTPGINFSE 261
Query: 242 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301
AQ+KCYM+QLL GL+HCHSRGVLHRDIKGSNLL+D+N LKI DFGLA+FY Q QPLT
Sbjct: 262 AQIKCYMKQLLHGLEHCHSRGVLHRDIKGSNLLLDHNNNLKIGDFGLANFYQGHQKQPLT 321
Query: 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 361
SRVVTLWYRPPELLLG+T YG VDLWSTGCILAEL+ GKPIMPGRTEVEQLHKIFKLCG
Sbjct: 322 SRVVTLWYRPPELLLGSTDYGVTVDLWSTGCILAELFTGKPIMPGRTEVEQLHKIFKLCG 381
Query: 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421
SPSE+YW+ SKLPHATIFKPQQPYKRCVAETFK P+ ALAL+E LL+++P RG+ ASA
Sbjct: 382 SPSEEYWKISKLPHATIFKPQQPYKRCVAETFKSLPSSALALVEVLLAVEPDARGTTASA 441
Query: 422 LRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAI 481
L SEFFT PL DPSSLPKY P KE D K ++EEA+R+ + ++ D ++ +RES+A+
Sbjct: 442 LESEFFTTSPLASDPSSLPKYQPRKEIDVKAQEEEAKRKKDTSSKQND-SKQVSRESKAV 500
Query: 482 PAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDP 525
PAPD+NAE + S+QKRQ Q+N S S+KFNP E+ AS F I+P
Sbjct: 501 PAPDSNAESLTSIQKRQGQHNQVSNSDKFNPG-EDAAS-FRIEP 542
|
|
| TAIR|locus:2020708 AT1G03740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1357 (482.7 bits), Expect = 1.4e-152, Sum P(3) = 1.4e-152
Identities = 291/532 (54%), Positives = 361/532 (67%)
Query: 42 EVYRVK-DRFDSNDGRAMLIDKQ-VNGSVRLHGENFDRKREKMEY-----VVAQHHPGMG 94
+V + K DR++S D + LI+ + ++ S+ ++ EK E VV +
Sbjct: 114 KVVKAKLDRWNSKDSKVRLIESEKLSSSMFSEHHQIEKGVEKPEVEASVRVVHRELKRGS 173
Query: 95 SI--PKASEGEQXXXXXXXXXXXXXXEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQG 152
SI PK +E +Q E++ W PRRA++FEKL+K IGQG
Sbjct: 174 SIVSPKDAERKQVAAGWPSWLVSVAGESLVDWAPRRANTFEKLEK-----------IGQG 222
Query: 153 TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR 212
TYS+VYRARDL KIVALKKVRFD + ESV+FMAREI ++RRLDH NV+KLEGL+T+
Sbjct: 223 TYSSVYRARDLLHNKIVALKKVRFDLNDMESVKFMAREIIVMRRLDHPNVLKLEGLITAP 282
Query: 213 MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSN 272
+S SLYLVFEYM+HDL GL+S PG+KF+E QVKCYM+QLL GL+HCHSRGVLHRDIKGSN
Sbjct: 283 VSSSLYLVFEYMDHDLLGLSSLPGVKFTEPQVKCYMRQLLSGLEHCHSRGVLHRDIKGSN 342
Query: 273 LLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGC 332
LLID+ G+LKIADFGLA+F+DP ++ LTS VVTLWYRPPELLLGA++YG VDLWSTGC
Sbjct: 343 LLIDSKGVLKIADFGLATFFDPAKSVSLTSHVVTLWYRPPELLLGASHYGVGVDLWSTGC 402
Query: 333 ILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAET 392
IL ELYAGKPI+PG+TEVEQLHKIFKLCGSP+E+YWRK KLP + FK PY+R V+E
Sbjct: 403 ILGELYAGKPILPGKTEVEQLHKIFKLCGSPTENYWRKQKLPSSAGFKTAIPYRRKVSEM 462
Query: 393 FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKI 452
FKDFPA L+L+ETLLSIDP R SA AL SE+F KP CDPS+LPKYPPSKE DAK+
Sbjct: 463 FKDFPASVLSLLETLLSIDPDHRSSADRALESEYFKTKPFACDPSNLPKYPPSKEIDAKM 522
Query: 453 RDEEARRQG--GSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNS-KSRSEK 509
RDE R+Q K +R D R + E + +P AN L ++M+K QY +SR++
Sbjct: 523 RDEAKRQQPMRAEKQERQDSMTRISHERKFVPPVKANNSLSMTMEK---QYKDLRSRNDS 579
Query: 510 FNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASHSGPLAQRAAWAKA 561
F EE P+ P + + G R SHSGPL AK+
Sbjct: 580 FKSFKEERTPHGPV--PDYQNMQHNRNNQTG---VRISHSGPLMSNRNMAKS 626
|
|
| TAIR|locus:2012643 AT1G33770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1346 (478.9 bits), Expect = 5.7e-152, Sum P(2) = 5.7e-152
Identities = 284/542 (52%), Positives = 368/542 (67%)
Query: 1 MGCICFKPSAI-EDSKESPRERLS---SKASSDLRGSRATSSRREEVYRVKDRFDSNDGR 56
MGCIC K +A E+ RE+ + +K+SS + S++ + ++ D R
Sbjct: 1 MGCICSKGAAEDEEGVVYHREKANEYWNKSSSVQLIAPLPSNKDDFSHKAVDGSSGGGRR 60
Query: 57 AMLIDKQVNGSVRLHGENFDR-KREKMEYVVAQHHPGMG----SIPKASEGEQXXXXXXX 111
A + ++ S +R R + V+ + G G ++P+++E E
Sbjct: 61 ASGLIVPIDDSHDGKTVIVERPSRSQRGRRVSDNGKGGGLIISNVPRSAEAELIAAGWPY 120
Query: 112 XXXXXXXEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVAL 171
EAI+GWVPRRADSFEKLDK IGQGTYS VY+ARDL+ KIVA+
Sbjct: 121 WLTSVAGEAIKGWVPRRADSFEKLDK-----------IGQGTYSIVYKARDLETGKIVAM 169
Query: 172 KKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 231
KKVRF N++PESVRFMAREI+ILR+LDH NV+KL+ LVTS++S SL+LVFEYMEHDL+GL
Sbjct: 170 KKVRFANMDPESVRFMAREINILRKLDHPNVMKLQCLVTSKLSGSLHLVFEYMEHDLSGL 229
Query: 232 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291
A PG+KF+E Q+KC+M+QLLCGL+HCHSRG+LHRDIKGSNLL++N+G+LKI DFGLASF
Sbjct: 230 ALRPGVKFTEPQIKCFMKQLLCGLEHCHSRGILHRDIKGSNLLVNNDGVLKIGDFGLASF 289
Query: 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 351
Y PDQ+QPLTSRVVTLWYR PELLLG+T YG A+DLWS GCILAEL+ KPIMPGRTEVE
Sbjct: 290 YKPDQDQPLTSRVVTLWYRAPELLLGSTEYGPAIDLWSVGCILAELFVCKPIMPGRTEVE 349
Query: 352 QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSID 411
Q+HKIFKLCGSPSE++W +K P AT +KPQ PYKR + ETFK+ + +L L++ LLS++
Sbjct: 350 QMHKIFKLCGSPSEEFWNTTKFPQATSYKPQHPYKRVLLETFKNLSSSSLDLLDKLLSVE 409
Query: 412 PADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS--KGQRMD 469
P R SA+S L SEFFT +PLPC SSLPKYPPSKE DAK+RDEEA+R+ K + +
Sbjct: 410 PEKRCSASSTLLSEFFTTEPLPCHISSLPKYPPSKELDAKVRDEEAKRKKAEAVKWRGHE 469
Query: 470 LERRGTRESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQS 529
RRG R+S+ P A+ +S+ + + HP ++ + P R +
Sbjct: 470 SVRRGLRDSKVTPEFIASGNSNVSLTTPSFKKEKRFTDTNSVIHPSSRSNVGEVKPSRSN 529
Query: 530 QV 531
V
Sbjct: 530 NV 531
|
|
| TAIR|locus:2152740 AT5G50860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1455 (517.2 bits), Expect = 4.8e-149, P = 4.8e-149
Identities = 292/432 (67%), Positives = 344/432 (79%)
Query: 119 EAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN 178
++I+ PRRA ++EKL+K IGQGTYSNVY+A+DL KIVALKKVRFDN
Sbjct: 101 DSIKDLTPRRATTYEKLEK-----------IGQGTYSNVYKAKDLLSGKIVALKKVRFDN 149
Query: 179 LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK 238
LE ESV+FMAREI +LRRL+H NVIKL+GLVTSR+SCSLYLVFEYMEHDL+GLA+ GLK
Sbjct: 150 LEAESVKFMAREILVLRRLNHPNVIKLQGLVTSRVSCSLYLVFEYMEHDLSGLAATQGLK 209
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
F QVKC+M+QLL GL+HCHSRGVLHRDIKGSNLLIDN+GILKIADFGLA+FYDP Q Q
Sbjct: 210 FDLPQVKCFMKQLLSGLEHCHSRGVLHRDIKGSNLLIDNDGILKIADFGLATFYDPKQKQ 269
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
+TSRVVTLWYRPPELLLGAT YGT VDLWS GCI+AEL AGKP+MPGRTEVEQLHKIFK
Sbjct: 270 TMTSRVVTLWYRPPELLLGATSYGTGVDLWSAGCIMAELLAGKPVMPGRTEVEQLHKIFK 329
Query: 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
LCGSPS+ YW+K +LP+AT+FKPQ PYKRCVAE F F ++ L+ETLL+IDPADRG++
Sbjct: 330 LCGSPSDSYWKKYRLPNATLFKPQHPYKRCVAEAFNGFTPSSVHLVETLLTIDPADRGTS 389
Query: 419 ASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGG--SKGQRMDLERR--- 473
SAL SEFFT +PLPCDPSSLPKYPPSKE + K+RDEE RRQ G KG +D RR
Sbjct: 390 TSALNSEFFTTEPLPCDPSSLPKYPPSKELNVKLRDEELRRQKGLAGKGSGIDGARRIRY 449
Query: 474 -GTRESRAIPAPDANAELVLSMQKRQS--QYNSKSRSEKFNPHPEEVASGFPI-DPPRQS 529
G R RAIPAP+ANAE ++ + +S Q N KS+SEKF P ++ A G+P+ D +++
Sbjct: 450 RGDRTGRAIPAPEANAESQANLDRWRSISQTNGKSKSEKFPPPHQDGAVGYPLEDLSKKT 509
Query: 530 QV----TESSAG 537
V TE+S G
Sbjct: 510 SVFGAKTETSFG 521
|
|
| TAIR|locus:2199491 AT1G54610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1439 (511.6 bits), Expect = 2.4e-147, P = 2.4e-147
Identities = 285/470 (60%), Positives = 349/470 (74%)
Query: 61 DKQVNGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQXXXXXXXXXXXXXXEA 120
+++ NG DR+R + +P + + K GEQ EA
Sbjct: 53 NEEANGDKERKSSKGDRRRS------TKPNPRLSNPSKHWRGEQVAAGWPSWLSDACGEA 106
Query: 121 IQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE 180
+ GWVPR+AD+FEK+DK IGQGTYSNVY+A+D+ KIVALKKVRFDNLE
Sbjct: 107 LNGWVPRKADTFEKIDK-----------IGQGTYSNVYKAKDMLTGKIVALKKVRFDNLE 155
Query: 181 PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFS 240
PESV+FMAREI +LRRLDH NV+KLEGLVTSRMSCSLYLVF+YM+HDLAGLAS P +KFS
Sbjct: 156 PESVKFMAREILVLRRLDHPNVVKLEGLVTSRMSCSLYLVFQYMDHDLAGLASSPVVKFS 215
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300
E++VKC M+QL+ GL+HCHSRGVLHRDIKGSNLLID+ G+LKIADFGLA+ +DP+ +P+
Sbjct: 216 ESEVKCLMRQLISGLEHCHSRGVLHRDIKGSNLLIDDGGVLKIADFGLATIFDPNHKRPM 275
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
TSRVVTLWYR PELLLGAT YG +DLWS GCILAEL AG+PIMPGRTEVEQLHKI+KLC
Sbjct: 276 TSRVVTLWYRAPELLLGATDYGVGIDLWSAGCILAELLAGRPIMPGRTEVEQLHKIYKLC 335
Query: 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420
GSPSEDYW+K K H I+KP++PYKR + ETFKDFP +L L++ LLSI+P DR +A++
Sbjct: 336 GSPSEDYWKKGKFTHGAIYKPREPYKRSIRETFKDFPPSSLPLIDALLSIEPEDRQTASA 395
Query: 421 ALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ-GGSK--GQRMDLERRGTRE 477
AL+SEFFT +P C+P+ LPKYPPSKE DAK RDEE RRQ SK G R R
Sbjct: 396 ALKSEFFTSEPYACEPADLPKYPPSKEIDAKRRDEETRRQRAASKAQGDGARKNRHRDRS 455
Query: 478 SRAIPAPDANAELVLSMQKRQ---SQYNSKSRSEKFNP-HPEEVASGFPI 523
+RA+PAP+ANAEL ++ +R+ + N+KS+SEKF P H + A G P+
Sbjct: 456 NRALPAPEANAELQSNVDQRRRLITHANAKSKSEKFPPPHQDGGAMGVPL 505
|
|
| TAIR|locus:2158715 AT5G44290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1318 (469.0 bits), Expect = 1.0e-145, Sum P(3) = 1.0e-145
Identities = 282/501 (56%), Positives = 338/501 (67%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
MGCI K K+SP+ K + + R SR SSR ++ + K+ D ++ + LI
Sbjct: 1 MGCIISK-------KKSPKRNPPWKETLEKRSSRINSSRIDDSSQTKEEQDRSN-KVRLI 52
Query: 61 DKQVNGSVRLHGENFDRKR--EKMEYVVAQHHPGMGS-------IPKA----SEGEQXXX 107
+ + S R ++ + + E HHP IP + S+ +
Sbjct: 53 ESEKFSSSRFSEKHQEIAEIGDTDEDEDDDHHPPEELKREPSVVIPPSPETVSKEAELAA 112
Query: 108 XXXXXXXXXXXEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKK 167
EA+ W PRRA +FEKL+K IGQGTYS+VY+ARDL K
Sbjct: 113 GWPAWLVSVAGEALVNWTPRRASTFEKLEK-----------IGQGTYSSVYKARDLTNNK 161
Query: 168 IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227
IVALK+VRFD + ESV+FMAREI ++RRLDH NV+KLEGL+T+ +S SLYLVFEYM+HD
Sbjct: 162 IVALKRVRFDLSDLESVKFMAREIIVMRRLDHPNVLKLEGLITASVSSSLYLVFEYMDHD 221
Query: 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287
L GLAS PG+KFSE QVKCYMQQLL GL HCHSRGVLHRDIKGSNLLID+NG+LKIADFG
Sbjct: 222 LVGLASIPGIKFSEPQVKCYMQQLLSGLHHCHSRGVLHRDIKGSNLLIDSNGVLKIADFG 281
Query: 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 347
LA+F+DP PLTSRVVTLWYRPPELLLGA +YG VDLWSTGCIL ELY+GKPI+ G+
Sbjct: 282 LATFFDPQNCVPLTSRVVTLWYRPPELLLGACHYGVGVDLWSTGCILGELYSGKPILAGK 341
Query: 348 TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETL 407
TEVEQLHKIFKLCGSP+EDYWRK KLP + F+P PY R VAE FKD P L+L+E L
Sbjct: 342 TEVEQLHKIFKLCGSPTEDYWRKLKLPPSAAFRPALPYGRRVAEMFKDLPTNVLSLLEAL 401
Query: 408 LSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEAR-RQGGSKGQ 466
LSIDP RGSAA AL SE+F +P CDPSSLPKYPPSKE DAKIRD+ R R K +
Sbjct: 402 LSIDPDRRGSAARALESEYFRTEPFACDPSSLPKYPPSKEIDAKIRDDAKRQRPTQEKHE 461
Query: 467 RMDLERRGTRESRAIPAPDAN 487
R D + R + E + IP AN
Sbjct: 462 RQDSQTRRSHERKLIPPVKAN 482
|
|
| TAIR|locus:2034944 IBS1 "IMPAIRED IN BABA-INDUCED STERILITY 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1255 (446.8 bits), Expect = 7.2e-139, Sum P(2) = 7.2e-139
Identities = 274/506 (54%), Positives = 333/506 (65%)
Query: 93 MGSIPKASEGEQXXXXXXXXXXXXXXEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQG 152
+G++ K E EQ EAI GWVP R+D+FEKL+K IGQG
Sbjct: 92 LGNLSKYLEAEQVAAGWPAWLSNVAGEAIHGWVPFRSDAFEKLEK-----------IGQG 140
Query: 153 TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR 212
TYS+V+RAR+ + +IVALKKVRFDN EPESVRFMAREI ILR+L+H N+IKLEG+VTS+
Sbjct: 141 TYSSVFRARETETGRIVALKKVRFDNFEPESVRFMAREILILRKLNHPNIIKLEGIVTSK 200
Query: 213 MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSN 272
+SCS++LVFEYMEHDL GL S P + F+ Q+KCYM+QLL GLDHCH+RGV+HRDIKGSN
Sbjct: 201 LSCSIHLVFEYMEHDLTGLLSSPDIDFTTPQIKCYMKQLLSGLDHCHARGVMHRDIKGSN 260
Query: 273 LLIDNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTG 331
LL++N GILK+ADFGLA+F + N QPLTSRVVTLWYRPPELLLGAT YG +VDLWS G
Sbjct: 261 LLVNNEGILKVADFGLANFCNASGNKQPLTSRVVTLWYRPPELLLGATEYGASVDLWSVG 320
Query: 332 CILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAE 391
C+ AEL GKP++ GRTEVEQLHKIFKLCGSP EDYW+KSKLPHA +FKPQQ Y C+ E
Sbjct: 321 CVFAELLIGKPVLQGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQHYDGCLRE 380
Query: 392 TFK--DFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFD 449
T K + L+ETLLSI P RG+A++AL S++FT KP CDPSSLP Y PSKE D
Sbjct: 381 TLKLKGLSDADINLIETLLSIQPHKRGTASTALVSQYFTSKPFACDPSSLPVYSPSKEID 440
Query: 450 AKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNSKSRSEK 509
AK R++ R++ G RRGT + P A A+L + R ++S+ + +K
Sbjct: 441 AKHREDTTRKKISGNG------RRGTESRKPTRKPPAFAKLAPAEDVR---HHSQ-KFQK 490
Query: 510 FNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASH-----------SGPL----AQ 554
N H V + D S + E P H ASH SGPL +
Sbjct: 491 RNGH--SVHNSIDSD----STLFEKMQKPSNHEKDEASHVKNASQGDVPFSGPLQVSVSS 544
Query: 555 RAAWAKAGKNTDDAPKISTGADLSTG 580
AWAK K DD S LS G
Sbjct: 545 GFAWAKRRK--DDICVRSHNRSLSRG 568
|
|
| TAIR|locus:2140543 AT4G10010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1219 (434.2 bits), Expect = 1.7e-137, Sum P(2) = 1.7e-137
Identities = 233/355 (65%), Positives = 289/355 (81%)
Query: 168 IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227
+VA+KKVRF N++PESVRFMAREI+ILR+LDH NV+KLE LVTS++S SLYLVFEYMEHD
Sbjct: 1 MVAMKKVRFVNMDPESVRFMAREINILRKLDHPNVMKLECLVTSKLSGSLYLVFEYMEHD 60
Query: 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287
L+GLA PG+KF+E+Q+KCYM+QLL GL+HCHSRG+LHRDIKG NLL++N+G+LKI DFG
Sbjct: 61 LSGLALRPGVKFTESQIKCYMKQLLSGLEHCHSRGILHRDIKGPNLLVNNDGVLKIGDFG 120
Query: 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 347
LA+ Y P+Q+QPLTSRVVTLWYR PELLLGAT YG +DLWS GCIL EL+ GKPIMPGR
Sbjct: 121 LANIYHPEQDQPLTSRVVTLWYRAPELLLGATEYGPGIDLWSVGCILTELFLGKPIMPGR 180
Query: 348 TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETL 407
TEVEQ+HKIFK CGSPS+DYW+K+KLP AT FKPQQPYKR + ETFK+ P ALAL++ L
Sbjct: 181 TEVEQMHKIFKFCGSPSDDYWQKTKLPLATSFKPQQPYKRVLLETFKNLPPSALALVDKL 240
Query: 408 LSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS--KG 465
LS++PA RG+A+S L S+FFTM+PLPC+ SSLPKYPPSKE DAK+RDEEARR+ KG
Sbjct: 241 LSLEPAKRGTASSTLSSKFFTMEPLPCNVSSLPKYPPSKELDAKVRDEEARRKKSETVKG 300
Query: 466 QRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASG 520
+ + RRG+R+ ++ E V S Q + + +++FNP E+ +G
Sbjct: 301 RGPESVRRGSRDFKSTAT---TPEFVASGQSKDT-----ITTKRFNPQ-EDSRTG 346
|
|
| TAIR|locus:2019115 AT1G74330 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1335 (475.0 bits), Expect = 2.5e-136, P = 2.5e-136
Identities = 299/640 (46%), Positives = 396/640 (61%)
Query: 93 MGSIPKASEGEQXXXXXXXXXXXXXXEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQG 152
+G++ + E EQ EAI GWVP R+D+FEKL+K IGQG
Sbjct: 82 LGNVSRYLEAEQVAAGWPAWLSNVAGEAIHGWVPLRSDAFEKLEK-----------IGQG 130
Query: 153 TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR 212
TYSNV+RA + + +IVALKKVRFDN EPESV+FMAREI ILRRL+H N+IKLEGL+TS+
Sbjct: 131 TYSNVFRAVETETGRIVALKKVRFDNFEPESVKFMAREILILRRLNHPNIIKLEGLITSK 190
Query: 213 MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSN 272
+SC++ LVFEYMEHDL GL S P +KF+ Q+KCYM+QLL GLDHCHSRGV+HRDIKGSN
Sbjct: 191 LSCNIQLVFEYMEHDLTGLLSSPDIKFTTPQIKCYMKQLLSGLDHCHSRGVMHRDIKGSN 250
Query: 273 LLIDNNGILKIADFGLASFYDPD--QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWST 330
LL+ N GILK+ADFGLA+F + + +PLTSRVVTLWYRPPELLLGAT YG +VDLWS
Sbjct: 251 LLLSNEGILKVADFGLANFSNSSGHKKKPLTSRVVTLWYRPPELLLGATDYGASVDLWSV 310
Query: 331 GCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVA 390
GC+ AEL GKPI+ GRTEVEQLHKIFKLCGSP EDYW+KSKLPHA +FKPQQ Y C+
Sbjct: 311 GCVFAELLLGKPILRGRTEVEQLHKIFKLCGSPPEDYWKKSKLPHAMLFKPQQTYDSCLR 370
Query: 391 ETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDA 450
ET KD + L+ETLLSIDP RG+A+SAL S++FT KP CDPSSLP YPPSKE D
Sbjct: 371 ETLKDLSETEINLIETLLSIDPHKRGTASSALVSQYFTTKPFACDPSSLPIYPPSKEIDT 430
Query: 451 KIRDEEARRQGGSKGQRMDLERRGTRESRAIP--APDANAELVLSMQKRQSQYNSKSRSE 508
K RDE AR++ G+R R+ +R++ + APD + + QKR S E
Sbjct: 431 KHRDEAARKKISGNGRRGIDPRKPSRKAHSFNRLAPDVRHQTE-TFQKRIGHLVHSS-IE 488
Query: 509 KFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASHSGPL----AQRAAWAKAGKN 564
++ + P+D ++ + + QG SGPL + AWAK K
Sbjct: 489 SDARLCGKLQN--PLDH-KKDEASHVKHASQGD----VPFSGPLQVSKSNSFAWAKREK- 540
Query: 565 TDDAPKISTGADLSTGLVAAXXXXXXXXXXXXXXXAQ----PEVPKLIARFPGSFKEASE 620
DD LS G + + ++ + K +R S++
Sbjct: 541 -DDVCVRVHNRSLSRGYIPSLSGHSPAFNGKSDVESKINKDEKEDKTDSRGEESYEMVKR 599
Query: 621 SFIQHD---QKHHAQGVAGSHQKEDGRIG--NKDPILLGYGSK---GHKIHYSGPLIVPS 672
S ++ ++ + G + + ++ +G +D + G+ G KI +SGPL+ S
Sbjct: 600 SMLKQWRQLERPDSFGASDEYHSQELSLGLYQRDEMAKKMGNNLGDGDKIEFSGPLLSQS 659
Query: 673 GNVDQMLKDHDRQIQEAVRRARFDKA--KVRKVQMEGNQL 710
VD++L+ H+R I++ +R+ F K K +K+ + ++L
Sbjct: 660 YGVDELLERHERNIRKLIRKPWFQKVQDKQKKILLFSSEL 699
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pm.C_LG_XI0294 | hypothetical protein (714 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 720 | |||
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-152 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-117 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-109 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-108 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-101 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-101 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-100 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-91 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-89 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-86 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-84 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-83 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-82 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-81 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-77 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-74 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-74 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-74 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-72 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-71 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-70 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-70 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-69 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-69 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-68 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-68 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-61 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-61 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-61 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-58 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-58 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-58 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-57 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-56 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-56 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-56 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-56 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-54 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-53 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-53 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-52 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-52 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-50 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-48 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-47 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-47 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-46 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-45 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-44 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-44 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-43 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-42 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-41 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-40 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-40 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-39 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-38 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-37 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-37 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-37 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-36 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-35 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-35 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-34 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-33 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-31 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-30 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-27 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-26 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-25 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-21 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-20 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-19 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-19 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-19 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-18 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-18 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-17 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-16 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-16 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-13 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-13 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-12 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-12 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 442 bits (1140), Expect = e-152
Identities = 157/298 (52%), Positives = 211/298 (70%), Gaps = 13/298 (4%)
Query: 132 FEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI 191
+EK+ + IG+GTY VY+AR+ ++VALKK+R +N + REI
Sbjct: 1 YEKIAQ-----------IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREI 49
Query: 192 HILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 251
+L++L H N+++L+ +VTS+ S+Y+VFEYM+HDL GL P +KF+E+Q+KCYM+QL
Sbjct: 50 KLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL 109
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 311
L GL + HS G+LHRDIKGSN+LI+N+G+LK+ADFGLA Y + T+RV+TLWYRP
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 312 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK- 370
PELLLGAT YG VD+WS GCILAEL+ GKPI G TE+EQL KIF+LCGSP+++ W
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229
Query: 371 SKLPHATIFKPQQPYKRCVAETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFF 427
SKLP KP++PYKR + E FK P AL L++ LL++DP R SA AL+ E+F
Sbjct: 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 351 bits (904), Expect = e-117
Identities = 125/301 (41%), Positives = 176/301 (58%), Gaps = 24/301 (7%)
Query: 132 FEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----PESVRFM 187
+EKL+K +G+GTY VY+ARD +IVALKK+R DN E ++R
Sbjct: 1 YEKLEK-----------LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-- 47
Query: 188 AREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCY 247
EI +L+ L H N++KL ++ + LYLVFEY + DL S +K
Sbjct: 48 --EISLLKELKHPNIVKLLDVIHTERK--LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSI 103
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307
M QLL GL +CHS +LHRD+K N+LI+ +G+LK+ADFGLA + T VVTL
Sbjct: 104 MYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVVTL 162
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
WYR PE+LLG+ +Y TAVD+WS GCI AE+ GKP+ PG +E++QL KIF++ G+P+E+
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222
Query: 368 WRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
W +KLP P+ P K + + + L+ +L +PA R SA AL+ +
Sbjct: 223 WPGVTKLPDYKPTFPKFPPKD-LEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
Query: 427 F 427
F
Sbjct: 282 F 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 333 bits (856), Expect = e-109
Identities = 150/315 (47%), Positives = 195/315 (61%), Gaps = 17/315 (5%)
Query: 132 FEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-RE 190
FEKL++ IG+GTY VYRARD +IVALKKVR DN E + + + RE
Sbjct: 9 FEKLNR-----------IGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLRE 56
Query: 191 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 250
I +L L H N+++L+ +V + S++LV EY E DLA L + FSE+QVKC M Q
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQ 116
Query: 251 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 310
LL GL + H ++HRD+K SNLL+ + G LKIADFGLA Y P+T +VVTLWYR
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPKVVTLWYR 175
Query: 311 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370
PELLLG T Y TA+D+W+ GCILAEL A KP++PG++E+EQL I +L G+P+E W
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235
Query: 371 -SKLPHATIFK-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
S LP F P+QPY + F L L+ LL DP R +A AL S +F
Sbjct: 236 FSDLPLVGKFTLPKQPYNN-LKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
Query: 429 MKPLPCDPSSLPKYP 443
KPLPC+P +P +P
Sbjct: 295 EKPLPCEPEMMPTFP 309
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 331 bits (850), Expect = e-108
Identities = 124/298 (41%), Positives = 183/298 (61%), Gaps = 11/298 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMA-REIHILRRLDHINVIK 204
+G+GTY+ VY+ARD + +IVA+KK++ + + + F A REI +L+ L H N+I
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
L + + + + LVFE+ME DL + + + A +K YM L GL++ HS +L
Sbjct: 67 LLDVFGHKSN--INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWIL 124
Query: 265 HRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
HRD+K +NLLI ++G+LK+ADFGLA SF P++ +T +VVT WYR PELL GA +YG
Sbjct: 125 HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGV 182
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQ 382
VD+WS GCI AEL P +PG ++++QL KIF+ G+P+E+ W + LP FKP
Sbjct: 183 GVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPF 242
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
P + + F AL L++ LL+++P R +A AL +F+ P P PS LP
Sbjct: 243 PPTP--LKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQLP 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 312 bits (801), Expect = e-101
Identities = 144/313 (46%), Positives = 198/313 (63%), Gaps = 22/313 (7%)
Query: 124 WVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES 183
W R D F+ + + IG+GTY VY+ARD D ++VALKKVR DN E E
Sbjct: 1 WGKRCVDKFDIIGQ-----------IGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEG 48
Query: 184 VRFMA-REIHILRRLDHINVIKLEGLVTSRMSC--------SLYLVFEYMEHDLAGLASH 234
A REI ILR+L+H N++ L+ +VT + + YLVFEYM+HDL GL
Sbjct: 49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES 108
Query: 235 PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294
+ FSE +K +M+QLL GL++CH + LHRDIK SN+L++N G +K+ADFGLA Y+
Sbjct: 109 GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 295 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLH 354
++++P T++V+TLWYRPPELLLG YG A+D+WS GCIL EL+ KPI E+ QL
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228
Query: 355 KIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA 413
I +LCGSP W KLP+ KP++ Y+R + E F P PAL L++ +L++DP+
Sbjct: 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPS 288
Query: 414 DRGSAASALRSEF 426
R +A AL S +
Sbjct: 289 KRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 311 bits (798), Expect = e-101
Identities = 142/310 (45%), Positives = 188/310 (60%), Gaps = 27/310 (8%)
Query: 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF 186
R D +EKL++ I +GTY VYRARD +IVALKK++ + E E
Sbjct: 2 RSVDEYEKLNR-----------IEEGTYGVVYRARDKKTGEIVALKKLKMEK-EKEGFPI 49
Query: 187 MA-REIHILRRLDHINVIKL-EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQV 244
+ REI+IL +L H N++ + E +V S + +Y+V EY+EHDL L F +++V
Sbjct: 50 TSLREINILLKLQHPNIVTVKEVVVGSNLD-KIYMVMEYVEHDLKSLMETMKQPFLQSEV 108
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
KC M QLL G+ H H +LHRD+K SNLL++N GILKI DFGLA Y +P T V
Sbjct: 109 KCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLV 167
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
VTLWYR PELLLGA Y TA+D+WS GCI AEL KP+ PG++E++QL+KIFKL G+P+
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227
Query: 365 EDYWRK-SKLPHATIFKPQ-QPYKRCVAETFKDFPAPALA-----LMETLLSIDPADRGS 417
E W S+LP A PY + K FPA +L+ L+ LL+ DPA R S
Sbjct: 228 EKIWPGFSELPGAKKKTFTKYPYNQ----LRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283
Query: 418 AASALRSEFF 427
A AL+ +F
Sbjct: 284 AEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 309 bits (794), Expect = e-100
Identities = 131/297 (44%), Positives = 181/297 (60%), Gaps = 19/297 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLEG 207
+G+GT+ VY+AR + ++VALKK+ N E + A REI IL++L H NV+ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHN-EKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 208 LV------TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+ + R S+Y+V YM+HDL+GL +P +K +E+Q+KCYM QLL G+++ H
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN 134
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP----------LTSRVVTLWYRP 311
+LHRDIK +N+LIDN GILKIADFGLA YD P T+ VVT WYRP
Sbjct: 135 HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRP 194
Query: 312 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK- 370
PELLLG Y TAVD+W GC+ AE++ +PI+ G+++++QLH IFKLCG+P+E+ W
Sbjct: 195 PELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGW 254
Query: 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
LP Y R + E F L L+ LLS+DP R +A+ AL +F
Sbjct: 255 RSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 286 bits (734), Expect = 4e-91
Identities = 135/292 (46%), Positives = 178/292 (60%), Gaps = 14/292 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKL-- 205
IGQGT+ V++AR K+IVALKKV +N E E A REI IL+ L H NV+ L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 206 ----EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+ +R S YLVFE+ EHDLAGL S+ +KF+ +++K M+ LL GL + H
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN 138
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQP--LTSRVVTLWYRPPELLLGA 318
+LHRD+K +N+LI +GILK+ADFGLA +F ++P T+RVVTLWYRPPELLLG
Sbjct: 139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT 377
YG +D+W GCI+AE++ PIM G TE QL I +LCGS + + W KL
Sbjct: 199 RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFK 258
Query: 378 IFKPQQPYKRCVAETFKDF--PAPALALMETLLSIDPADRGSAASALRSEFF 427
+ Q KR V E K + AL L++ LL +DPA R A +AL +FF
Sbjct: 259 KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 280 bits (718), Expect = 4e-89
Identities = 118/280 (42%), Positives = 163/280 (58%), Gaps = 4/280 (1%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+GTY VY+ARD +IVA+KK++ + REI +L+ L+H N+IKL +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI 268
+ LYLVFE+M+ DL L E+ +K Y+ QLL GL CHS G+LHRD+
Sbjct: 67 FRHKGD--LYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124
Query: 269 KGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLW 328
K NLLI+ G+LK+ADFGLA + +P T VVT WYR PELLLG Y T VD+W
Sbjct: 125 KPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIW 183
Query: 329 STGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKR 387
S GCI AEL + +P+ PG++E++QL KIF+ G+P + W K + L F +
Sbjct: 184 SVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGM 243
Query: 388 CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+ + F + AL L+ +L DP R +A AL +F
Sbjct: 244 PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 271 bits (696), Expect = 8e-86
Identities = 121/293 (41%), Positives = 171/293 (58%), Gaps = 24/293 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLD---HIN 201
IG+G Y VY+ARDL+ + VALKKVR E P S REI +L++L+ H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLS---TLREIALLKQLESFEHPN 62
Query: 202 VIKL----EGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLD 256
+++L G T R L LVFE+++ DLA L+ P +K M+QLL G+D
Sbjct: 63 IVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
HS ++HRD+K N+L+ ++G +KIADFGLA Y LTS VVTLWYR PE+LL
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVLL 179
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW-RKSKLPH 375
++Y T VD+WS GCI AEL+ +P+ G +E +QL KIF + G PSE+ W R LP
Sbjct: 180 QSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238
Query: 376 ATI-FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
++ + +K V E ++ L L++ +L+ +P R SA AL+ +F
Sbjct: 239 SSFPSYTPRSFKSFVPEICEE----GLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 3e-84
Identities = 104/282 (36%), Positives = 149/282 (52%), Gaps = 35/282 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G+G++ VY ARD K+VA+K ++ ++ + R + REI IL++L H N+++L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL-REIKILKKLKHPNIVRLYD 64
Query: 208 -LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
LYLV EY E DL L G + SE + + Y++Q+L L++ HS+G++H
Sbjct: 65 VFEDED---KLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K N+L+D +G +K+ADFGLA DP + LT+ V T Y PE+LLG YG AV
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLG-KGYGKAV 177
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
D+WS G IL EL GKP PG +QL ++FK G P +
Sbjct: 178 DIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPPFPPP--------------- 219
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
D A L+ LL DP R +A AL+ FF
Sbjct: 220 -------EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 3e-83
Identities = 125/318 (39%), Positives = 182/318 (57%), Gaps = 31/318 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-----------VRFMA-REIHILRR 196
+G+GTY V +A D KIVA+KKV+ + + + F RE+ I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 197 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 256
+ H N++ L + + LV + M DL + ++ +E+QVKC + Q+L GL+
Sbjct: 77 IKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLN 133
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY----------DPDQNQP---LTSR 303
H +HRD+ +N+ I++ GI KIADFGLA Y + Q +TS+
Sbjct: 134 VLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193
Query: 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 363
VVTLWYR PELL+GA Y AVD+WS GCI AEL GKP+ PG E++QL +IF+L G+P
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTP 253
Query: 364 SEDYW-RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422
+ED W + KLP T F P++P + + F + A+ L+++LL ++P +R SA AL
Sbjct: 254 NEDNWPQAKKLPLYTEFTPRKP--KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 423 RSEFFTMKPLPCDPSSLP 440
+ E+F PLPCDPS LP
Sbjct: 312 KHEYFKSDPLPCDPSQLP 329
|
Length = 335 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 1e-82
Identities = 119/289 (41%), Positives = 162/289 (56%), Gaps = 19/289 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLDHINVIKL 205
IG+G + V++A+D + + VALKKV LE P REI L+ H V+KL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA---LREIKALQACQHPYVVKL 64
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGL---ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L LV EYM DL+ + P EAQVK YM+ LL G+ + H+ G
Sbjct: 65 --LDVFPHGSGFVLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHANG 119
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRD+K +NLLI +G+LKIADFGLA + ++ + + +V T WYR PELL GA Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHAT--IF 379
VDLW+ GCI AEL G P+ PG ++EQL +F+ G+P+E+ W + LP F
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
+P + E F D AL L++ LL DP+ R SAA ALR +FT
Sbjct: 240 PESKPIP--LEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 5e-81
Identities = 127/304 (41%), Positives = 180/304 (59%), Gaps = 29/304 (9%)
Query: 132 FEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-RE 190
++K++K IG+GTY VY+ARD +IVALKK+R + E E V A RE
Sbjct: 1 YQKVEK-----------IGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIRE 48
Query: 191 IHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQ 249
I +L+ L+H N+++L +V S LYLVFE+++ DL + S P +K Y+
Sbjct: 49 ISLLKELNHPNIVRLLDVVHSENK--LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL---TSRVVT 306
QLL G+ +CHS VLHRD+K NLLID G LK+ADFGLA + P+ T VVT
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF----GVPVRTYTHEVVT 162
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366
LWYR PE+LLG+ Y T VD+WS GCI AE+ +P+ PG +E++QL +IF+ G+P ED
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDED 222
Query: 367 YWRK-SKLPHATIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
W + LP +KP P ++ +++ + L L+ +L DPA R SA +AL+
Sbjct: 223 VWPGVTSLPD---YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279
Query: 424 SEFF 427
+F
Sbjct: 280 HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 8e-80
Identities = 115/322 (35%), Positives = 174/322 (54%), Gaps = 13/322 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG G Y V A D + VA+KK+ FD+L + + REI +LR L H N+I L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLI--DAKRILREIKLLRHLRHENIIGL 64
Query: 206 EGLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
++ +Y+V E ME DL + P ++ ++ ++ Q+L GL + HS
Sbjct: 65 LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN 123
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSRVVTLWYRPPELLLGATY 320
V+HRD+K SN+L+++N LKI DFGLA DPD+++ LT VVT WYR PELLL ++
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR 183
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
Y A+D+WS GCI AEL KP+ PGR ++QL+ I ++ G+PSE+ + A +
Sbjct: 184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243
Query: 381 PQQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD-PS 437
P K+ +++ F A+ L+E +L DP R +A AL + P D P
Sbjct: 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303
Query: 438 SLPKYPPSKEFDAKIRDEEARR 459
+ P + D ++ +EE +
Sbjct: 304 AKPPFDFDFFDDDELTEEELKE 325
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 247 bits (634), Expect = 4e-77
Identities = 101/281 (35%), Positives = 142/281 (50%), Gaps = 29/281 (10%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G++ VY+A+ KIVA+K ++ + + + + REI ILRRL H N+++L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
LYLV EY E DL S G SE + K Q+L GL++ HS G++HRD
Sbjct: 67 FED--KDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSNGIIHRD 123
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 327
+K N+L+D NG++KIADFGLA + LT+ V T WY PE+LLG YG VD+
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLLKS-SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDV 182
Query: 328 WSTGCILAELYAGKPIMPGRTEVEQLHKIFK-LCGSPSEDYWRKSKLPHATIFKPQQPYK 386
WS G IL EL GKP G ++QL I + L D P
Sbjct: 183 WSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE----------------PKW 226
Query: 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+E KD ++ L+ DP+ R +A L+ +F
Sbjct: 227 SSGSEEAKDL-------IKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 1e-74
Identities = 126/305 (41%), Positives = 174/305 (57%), Gaps = 29/305 (9%)
Query: 131 SFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-R 189
+F+K++K IG+GTY VY+AR+ ++VALKK+R D E E V A R
Sbjct: 1 NFQKVEK-----------IGEGTYGVVYKARNKLTGEVVALKKIRLD-TETEGVPSTAIR 48
Query: 190 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYM 248
EI +L+ L+H N++KL ++ + LYLVFE++ DL + + P +K Y+
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENK--LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYL 106
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL 307
QLL GL CHS VLHRD+K NLLI+ G +K+ADFGLA +F P + T VVTL
Sbjct: 107 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTL 164
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
WYR PE+LLG YY TAVD+WS GCI AE+ + + PG +E++QL +IF+ G+P E
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 224
Query: 368 WRK-SKLPHATIFKPQQPYKRCVAETFKDFPAP----ALALMETLLSIDPADRGSAASAL 422
W + LP +KP P + + F P L+ +L DP R SA +AL
Sbjct: 225 WPGVTSLPD---YKPSFP--KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279
Query: 423 RSEFF 427
FF
Sbjct: 280 AHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 2e-74
Identities = 109/285 (38%), Positives = 169/285 (59%), Gaps = 14/285 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKV--RFDNLEPESVRFMAREIHILRRL-DHINVIKL 205
+G GT+ +VY AR+ + ++VA+KK+ +F + E E + RE+ LR+L +H N++KL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNL--REVKSLRKLNEHPNIVKL 63
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ + R + LY VFEYME +L L G FSE+ ++ + Q+L GL H H G
Sbjct: 64 KEVF--RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF 121
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRD+K NLL+ ++KIADFGLA + P T V T WYR PE+LL +T Y +
Sbjct: 122 HRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSP 179
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHATIFK-PQ 382
VD+W+ GCI+AELY +P+ PG +E++QL+KI + G+P++ W + KL F+ PQ
Sbjct: 180 VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+ + + A+ L++ +L DP R +A+ AL+ +F
Sbjct: 240 FAPTS-LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 3e-74
Identities = 125/301 (41%), Positives = 172/301 (57%), Gaps = 21/301 (6%)
Query: 131 SFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-R 189
+EKL+K IG+GTY V++A++ + +IVALK+VR D+ + E V A R
Sbjct: 1 KYEKLEK-----------IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALR 48
Query: 190 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 249
EI +L+ L H N+++L ++ S L LVFEY + DL VK +M
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKK--LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMF 106
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLW 308
QLL GL CHS VLHRD+K NLLI+ NG LK+ADFGLA +F P + ++ VVTLW
Sbjct: 107 QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLW 164
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
YRPP++L GA Y T++D+WS GCI AEL AG+P+ PG +QL +IF+L G+P+E+
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES 224
Query: 368 WRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
W SKLP + V K L++ LL +P R SA AL+ +
Sbjct: 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNST-GRDLLQNLLVCNPVQRISAEEALQHPY 283
Query: 427 F 427
F
Sbjct: 284 F 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 2e-72
Identities = 117/310 (37%), Positives = 173/310 (55%), Gaps = 31/310 (10%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+ ++++KLDK +G+G+Y+ VY+ R ++VALK++R + E F
Sbjct: 3 KLETYKKLDK-----------LGEGSYATVYKGRSKLTGQLVALKEIRLE--HEEGAPFT 49
Query: 188 A-REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVK 245
A RE +L+ L H N++ L ++ ++ + L LVFEY++ DL + G S V+
Sbjct: 50 AIREASLLKDLKHANIVTLHDIIHTKKT--LTLVFEYLDTDLKQYMDDCGGG-LSMHNVR 106
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD-PDQNQPLTSRV 304
++ QLL GL +CH R VLHRD+K NLLI G LK+ADFGLA P + ++ V
Sbjct: 107 LFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEV 164
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGSP 363
VTLWYRPP++LLG+T Y T++D+W GCI E+ G+P+ PG T+V +QLHKIF++ G+P
Sbjct: 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTP 224
Query: 364 SEDYWRK-SKLPHATIFKPQQ-----PYKRCVAETFKDFPAPALALMETLLSIDPADRGS 417
+E+ W S P FKP P D L L +P R S
Sbjct: 225 TEETWPGVSSNPE---FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS 281
Query: 418 AASALRSEFF 427
AA A++ +F
Sbjct: 282 AAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 8e-71
Identities = 129/310 (41%), Positives = 179/310 (57%), Gaps = 28/310 (9%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA- 188
D++EKL+K IG+GTY VY+ARD + K+VALKK R + ++ E + A
Sbjct: 1 DAYEKLEK-----------IGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTAL 48
Query: 189 REIHILRRLDH-INVIKL---EGLVTSRMSCSLYLVFEYMEHDLA----GLASHPGLKFS 240
REI +L+ L I +++L E + SLYLVFEY++ DL PG
Sbjct: 49 REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLP 108
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLA-SFYDPDQNQ 298
+K +M QLL G+ HCH GV+HRD+K NLL+D G+LKIAD GL +F P ++
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS- 167
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
T +VTLWYR PE+LLG+T+Y T VD+WS GCI AE+ +P+ PG +E++QL IFK
Sbjct: 168 -YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226
Query: 359 LCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 417
L G+P+E W SKL F +P ++ D L L++ +L DPA R S
Sbjct: 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQD--LSRAVPDLSPEGLDLLQKMLRYDPAKRIS 284
Query: 418 AASALRSEFF 427
A +AL +F
Sbjct: 285 AKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 2e-70
Identities = 124/286 (43%), Positives = 175/286 (61%), Gaps = 15/286 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLEG 207
IG+GTY VY+ R+ +IVA+KK+R ++ E E V A REI +L+ L H N++ L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 208 LVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQ-VKCYMQQLLCGLDHCHSRGVLH 265
++ LYL+FE++ DL L S P ++ +A+ VK Y+ Q+L G+ CHSR VLH
Sbjct: 67 VLMQ--ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124
Query: 266 RDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
RD+K NLLIDN G++K+ADFGLA +F P + T VVTLWYR PE+LLG+ Y T
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQ 383
VD+WS G I AE+ KP+ G +E++QL +IF++ G+P+ED W + LP +K
Sbjct: 183 VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD---YKNTF 239
Query: 384 P--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
P K + K+ L L+E +L DPA R SA AL +F
Sbjct: 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 2e-70
Identities = 113/303 (37%), Positives = 170/303 (56%), Gaps = 25/303 (8%)
Query: 131 SFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMA 188
+F++L+K +G+GTY+ VY+ R+ +IVALK++ D E P +
Sbjct: 1 NFKQLEK-----------LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---I 46
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLA---GLASHPGLKFSEAQVK 245
REI +++ L H N+++L ++ + L LVFEYM+ DL G VK
Sbjct: 47 REISLMKELKHENIVRLHDVIHTE--NKLMLVFEYMDKDLKKYMDTHGVRG-ALDPNTVK 103
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305
+ QLL G+ CH VLHRD+K NLLI+ G LK+ADFGLA + N ++ VV
Sbjct: 104 SFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV 162
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365
TLWYR P++LLG+ Y T++D+WS GCI+AE+ G+P+ PG +QL KIF++ G+P+E
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTE 222
Query: 366 DYW-RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424
W S+LP P+ P + + + F + L+ LL ++P R SA AL+
Sbjct: 223 STWPGISQLPEYKPTFPRYP-PQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281
Query: 425 EFF 427
+F
Sbjct: 282 PWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 228 bits (582), Expect = 4e-69
Identities = 125/303 (41%), Positives = 181/303 (59%), Gaps = 22/303 (7%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA- 188
D +EK++K IG+GTY VY+ARD + +ALKK+R + E E V A
Sbjct: 2 DQYEKVEK-----------IGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAI 49
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCY 247
REI +L+ + H N+++L+ +V S LYLVFEY++ DL + S P + +K Y
Sbjct: 50 REISLLKEMQHGNIVRLQDVVHSEKR--LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTY 107
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLA-SFYDPDQNQPLTSRVV 305
+ Q+L G+ +CHS VLHRD+K NLLID LK+ADFGLA +F P + T VV
Sbjct: 108 LYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVV 165
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365
TLWYR PE+LLG+ +Y T VD+WS GCI AE+ KP+ PG +E+++L KIF++ G+P+E
Sbjct: 166 TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNE 225
Query: 366 DYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424
+ W + LP P+ P K +A + L+ +L +DP+ R +A +AL
Sbjct: 226 ETWPGVTSLPDYKSAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284
Query: 425 EFF 427
E+F
Sbjct: 285 EYF 287
|
Length = 294 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 5e-69
Identities = 102/285 (35%), Positives = 152/285 (53%), Gaps = 9/285 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
++G+G Y V + R+ +IVA+KK + + + + RE+ +LR+L H N++ L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL-- 65
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGL--ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
R LYLVFEY+E L L AS GL V+ Y+ QLL + +CHS ++H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGL--PPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RDIK N+L+ +G+LK+ DFG A PLT V T WYR PELL+G T YG V
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV 183
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS-PSEDYWRKSKLPHATIFK-PQQ 383
D+W+ GCI+AEL G+P+ PG ++++QL+ I K G P S P P+
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243
Query: 384 PYKRCVAETF-KDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+ + +PAL ++ L +DP +R + L+ +F
Sbjct: 244 SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 226 bits (578), Expect = 6e-68
Identities = 114/314 (36%), Positives = 165/314 (52%), Gaps = 36/314 (11%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFD---NLEPESVRFMAREIHILRRL-DHINVIK 204
+G+G Y V++A D K++VALKK+ FD N F REI L+ L DH N++K
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTF--REIMFLQELGDHPNIVK 71
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDL-----AGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
L ++ + +YLVFEYME DL A + L+ + + M QLL L + H
Sbjct: 72 LLNVIKAENDKDIYLVFEYMETDLHAVIRANI-----LE--DVHKRYIMYQLLKALKYIH 124
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLA----SFYDPDQNQPLTSRVVTLWYRPPELL 315
S V+HRD+K SN+L++++ +K+ADFGLA + +N LT V T WYR PE+L
Sbjct: 125 SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL 184
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR--KSKL 373
LG+T Y VD+WS GCIL E+ GKP+ PG + + QL KI ++ G PS + KS
Sbjct: 185 LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244
Query: 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR----SEFFTM 429
+ ++ + E AL L++ LL +P R +A AL ++F
Sbjct: 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH-- 302
Query: 430 KPLPCDPSSLPKYP 443
+PS P P
Sbjct: 303 -----NPSDEPVLP 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 8e-68
Identities = 108/310 (34%), Positives = 155/310 (50%), Gaps = 32/310 (10%)
Query: 149 IGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKL 205
IG+GTY VY+A+ + K K A+KK + D + + A REI +LR L H NV+ L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGL----ASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+ S+YL+F+Y EHDL + + + VK + Q+L G+ + HS
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN 127
Query: 262 GVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSR--VVTLWYRPPELL 315
VLHRD+K +N+L+ G++KI D GLA ++ VVT+WYR PELL
Sbjct: 128 WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL 187
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLCGSPSED 366
LGA +Y A+D+W+ GCI AEL +PI GR +QL +IF++ G+P+E
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEK 247
Query: 367 YWRK-SKLPH----ATIFKPQQPYKRCV----AETFKDFPAPALALMETLLSIDPADRGS 417
W K+P FK + Y E K + L+ LL DP R +
Sbjct: 248 DWPDIKKMPEYDTLMKDFKT-KTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306
Query: 418 AASALRSEFF 427
A AL +F
Sbjct: 307 AEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 207 bits (530), Expect = 1e-61
Identities = 105/288 (36%), Positives = 153/288 (53%), Gaps = 21/288 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK--KVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 205
IG+GT+S V +A+ K A+K K F +LE + REI LRRL H N+++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNL--REIQALRRLSPHPNILRL 63
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
++ R + L LVFE M+ +L L P E +VK YM QLL LDH H G
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRP---LPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
+ HRDIK N+LI ++ ILK+ADFG S P T + T WYR PE LL YYG
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG--SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI---F 379
+D+W+ GC+ E+ + P+ PG E++Q+ KI + G+P + +K + F
Sbjct: 178 PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKSRHMNYNF 236
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
++ + + + A L L++ LL+ DP +R +A ALR +F
Sbjct: 237 PSKKG--TGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 7e-61
Identities = 118/289 (40%), Positives = 156/289 (53%), Gaps = 18/289 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKL 205
IG G Y VY+ARD VALK VR E RE+ +L+RL DH N+++L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 206 EGL-VTSRM--SCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCH 259
+ TSR + LVFE+++ DL PGL +K M+Q L GLD H
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLDFLH 125
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
+ ++HRD+K N+L+ + G +K+ADFGLA Y LT VVTLWYR PE+LL +T
Sbjct: 126 ANCIVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVLLQST 183
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW-RKSKLPHATI 378
Y T VD+WS GCI AE++ KP+ G +E +QL KIF L G P ED W R LP
Sbjct: 184 Y-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA- 241
Query: 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
F P+ P R V + L+ +L+ +P R SA AL+ FF
Sbjct: 242 FSPRGP--RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 8e-61
Identities = 118/311 (37%), Positives = 173/311 (55%), Gaps = 36/311 (11%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+ +++ KLDK +G+GTY+ V++ R + +VALK++R ++ E +
Sbjct: 3 KLETYVKLDK-----------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI 51
Query: 188 AREIHILRRLDHINVIKLEGLV-TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKC 246
RE+ +L+ L H N++ L ++ T R L LVFEY++ DL + G S VK
Sbjct: 52 -REVSLLKNLKHANIVTLHDIIHTER---CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI 107
Query: 247 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306
+M QLL GL +CH R +LHRD+K NLLI+ G LK+ADFGLA + ++ VVT
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVT 166
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366
LWYRPP++LLG+T Y T +D+W GCIL E+ G+P+ PG T E+LH IF+L G+P+E+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE 226
Query: 367 YWRKSKLPHATIFK-------PQ---QPYKRCVAETFKDFPAPALALMETLLSIDPADRG 416
W P T + PQ QP D + L+ +LL + R
Sbjct: 227 TW-----PGITSNEEFRSYLFPQYRAQPLINHAPRLDTD----GIDLLSSLLLYETKSRI 277
Query: 417 SAASALRSEFF 427
SA +ALR +F
Sbjct: 278 SAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 1e-60
Identities = 100/309 (32%), Positives = 157/309 (50%), Gaps = 34/309 (11%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 189
+ +EKL K IG+G+Y V++ R+ + +IVA+KK +P + R
Sbjct: 1 EKYEKLSK-----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR 49
Query: 190 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHP-GLKFSEAQVKCY 247
EI +L++L H N++ L + R L+LVFEY +H L L +P G+ E +K
Sbjct: 50 EIRMLKQLKHPNLVNL--IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV--PEHLIKKI 105
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307
+ Q L ++ CH +HRD+K N+LI G +K+ DFG A T V T
Sbjct: 106 IWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATR 164
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS----- 362
WYR PELL+G T YG VD+W+ GC+ AEL G+P+ PG+++V+QL+ I K G
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224
Query: 363 ----PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
+ +++ +P +P + F + +PAL+ ++ L +DP +R S
Sbjct: 225 QQIFSTNQFFKGLSIPEPETREP-------LESKFPNISSPALSFLKGCLQMDPTERLSC 277
Query: 419 ASALRSEFF 427
L +F
Sbjct: 278 EELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 76/191 (39%), Positives = 111/191 (58%), Gaps = 6/191 (3%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G + VY ARD K VA+K ++ ++ + REI IL++L+H N++KL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-REIEILKKLNHPNIVKLYGV 59
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
LYLV EY E L L K SE ++ + Q+L GL++ HS G++HRD
Sbjct: 60 FEDE--NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 268 IKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
+K N+L+D+ NG +K+ADFGL+ D++ L + V T Y PE+LLG YY D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSL-LKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 327 LWSTGCILAEL 337
+WS G IL EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-58
Identities = 123/322 (38%), Positives = 178/322 (55%), Gaps = 18/322 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG+G Y V A++ + + VA+KK+ FDN ++ R + REI +LR LDH NVI ++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRI-DAKRTL-REIKLLRHLDHENVIAIK 70
Query: 207 GLV--TSRMSCS-LYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
++ R + + +Y+V+E M+ DL + S L S+ + ++ QLL GL + HS
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTL--SDDHCQYFLYQLLRGLKYIHSAN 128
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
VLHRD+K SNLL++ N LKI DFGLA ++ +T VVT WYR PELLL + Y
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWYRAPELLLNCSEYT 187
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
TA+D+WS GCI AEL KP+ PG+ V QL I +L GSPSE+ + A +
Sbjct: 188 TAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS 247
Query: 383 QPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
PY ++ A F A+ L+E +L DP+ R + AL + L DPS P
Sbjct: 248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA--SLH-DPSDEP 304
Query: 441 --KYPPSKEFDAKIRDEEARRQ 460
+ P S +F+ EE ++
Sbjct: 305 VCQTPFSFDFEEDALTEEDIKE 326
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-58
Identities = 111/318 (34%), Positives = 154/318 (48%), Gaps = 31/318 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKV--RFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG G Y V A D K VA+KK+ FD P + RE+ ILR H N+I +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 207 GLVTSRMS--CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
++ + +Y+V + ME DL + H +E ++ ++ QLL GL + HS V+
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLKYIHSANVI 129
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDP---DQNQPLTSRVVTLWYRPPELLLGATYY 321
HRD+K SNLL++ + L+I DFG+A + +T V T WYR PELLL Y
Sbjct: 130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEY 189
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE--------DYWRKS-- 371
TA+D+WS GCI AE+ + + PG+ V QL I + GSPSE D RK
Sbjct: 190 TTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQ 249
Query: 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431
LP K P+ + F AL L+ +L DP +R + AL+ F
Sbjct: 250 NLPR----KQPVPWS----KIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301
Query: 432 LPCDPSSLPKYPPSKEFD 449
DP P PP +FD
Sbjct: 302 ---DPDDEPTCPPPFDFD 316
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 3e-57
Identities = 110/302 (36%), Positives = 167/302 (55%), Gaps = 18/302 (5%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+ +++ KLDK +G+GTY+ VY+ R +VALK++R ++ E +
Sbjct: 4 KLETYIKLDK-----------LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI 52
Query: 188 AREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCY 247
RE+ +L+ L H N++ L ++ + S L LVFEY++ DL G + VK +
Sbjct: 53 -REVSLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNSINMHNVKLF 109
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307
+ QLL GL++CH R VLHRD+K NLLI+ G LK+ADFGLA + ++ VVTL
Sbjct: 110 LFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTL 168
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
WYRPP++LLG+T Y T +D+W GCI E+ G+P+ PG T EQLH IF++ G+P+E+
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228
Query: 368 WRK--SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425
W S + P+ C+ + L+ LL + R SA A++
Sbjct: 229 WPGILSNEEFKSYNYPKY-RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 426 FF 427
+F
Sbjct: 288 YF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 1e-56
Identities = 111/323 (34%), Positives = 161/323 (49%), Gaps = 16/323 (4%)
Query: 149 IGQGTYSNVYRARDLDQKK--IVALKKVR--FDNLEPESVRFMAREIHILRRL-DHINVI 203
+GQG Y V AR+ + + VA+KK+ F + RE+ +LR H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFRGHKNIT 65
Query: 204 KLEGL--VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
L + V LYL E ME DL + G ++A + ++ Q+LCGL + HS
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQII-RSGQPLTDAHFQSFIYQILCGLKYIHSA 124
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--QNQP-LTSRVVTLWYRPPELLLGA 318
VLHRD+K NLL++ + LKI DFGLA + + +N +T V T WYR PE++L
Sbjct: 125 NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF 184
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378
Y A+D+WS GCILAEL KP+ G+ V+QL++I ++ G+P E+ + P A
Sbjct: 185 QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQN 244
Query: 379 FKPQQPYKRCVA-ETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 436
+ P E+ P AL L+E LL+ DP R S AL + + P D
Sbjct: 245 YIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDE 304
Query: 437 SSLPKYPPSKEFDAKIRDEEARR 459
K P F+++ EE R
Sbjct: 305 PVCQK-PFDFSFESEDSMEELRD 326
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 2e-56
Identities = 114/336 (33%), Positives = 164/336 (48%), Gaps = 41/336 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILRRLDHINVI 203
IG+G Y V A VA+KK+ P + REI ILRR H N+I
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKI-----SPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 204 KLEGLVTSRMSCSL---YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
+ ++ S Y+V E ME DL L L S ++ ++ Q+L GL + HS
Sbjct: 67 GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHL--SNDHIQYFLYQILRGLKYIHS 124
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP--DQNQPLTSRVVTLWYRPPELLLGA 318
VLHRD+K SNLL++ N LKI DFGLA DP D LT V T WYR PE++L +
Sbjct: 125 ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNS 184
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS-EDYW----RKSK- 372
Y A+D+WS GCILAE+ + +P+ PG+ + QL+ I + G+PS ED +++
Sbjct: 185 KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARN 244
Query: 373 ----LPHATIFKPQQPYKRCVAETFKDFP---APALALMETLLSIDPADRGSAASALRSE 425
LP FKP+ P+ + FP AL L++ +L+ +P R + AL
Sbjct: 245 YIKSLP----FKPKVPWNKL-------FPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293
Query: 426 FFTMKPLPCD-PSSLPKYPPSKEFDAKIRDEEARRQ 460
+ P D P + +P E + E+ +
Sbjct: 294 YLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKLKEL 329
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 2e-56
Identities = 118/286 (41%), Positives = 164/286 (57%), Gaps = 14/286 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLEG 207
+G+G+Y+ VY+ ++VALK + E V F A RE +L+ L H N++ L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 208 LVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
++ ++ + L VFEYM DLA + HPG V+ +M QLL GL + H + +LHR
Sbjct: 71 IIHTKET--LTFVFEYMHTDLAQYMIQHPG-GLHPYNVRLFMFQLLRGLAYIHGQHILHR 127
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+K NLLI G LK+ADFGLA +Q +S VVTLWYRPP++LLGAT Y +A+D
Sbjct: 128 DLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALD 186
Query: 327 LWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGSPSEDYWRK-SKLPH--ATIFKPQ 382
+W GCI E+ G+P PG ++V EQL KI+ + G P+ED W SKLP+ F P
Sbjct: 187 IWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPC 246
Query: 383 QPYK-RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+P + R V + P A L +L + P DR SA AL +F
Sbjct: 247 KPQQLRVVWKRLSRPPK-AEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 5e-56
Identities = 103/286 (36%), Positives = 167/286 (58%), Gaps = 13/286 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLE 206
L+G+G+Y V + + + +IVA+KK ++ + + V+ +A REI +L++L H N++ L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNL- 65
Query: 207 GLVTSRMSCSLYLVFEYMEHD-LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ R LYLVFE+++H L L +P GL S +V+ Y+ Q+L G++ CHS ++
Sbjct: 66 -IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDES--RVRKYLFQILRGIEFCHSHNII 122
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRDIK N+L+ +G++K+ DFG A + T V T WYR PELL+G T YG A
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY---WRKSKLPHATIFKP 381
VD+W+ GC++ E+ G+P+ PG ++++QL+ I K G+ + ++K+ L A + P
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL-FAGMRLP 240
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+ + + F L L + L IDP DR S++ L EFF
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 2e-54
Identities = 107/309 (34%), Positives = 168/309 (54%), Gaps = 32/309 (10%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+ +++ KL+K +G+GTY+ V++ R + +VALK++R ++ E +
Sbjct: 4 KMETYIKLEK-----------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI 52
Query: 188 AREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCY 247
RE+ +L+ L H N++ L +V + S L LVFEY++ DL G S VK +
Sbjct: 53 -REVSLLKDLKHANIVTLHDIVHTDKS--LTLVFEYLDKDLKQYMDDCGNIMSMHNVKIF 109
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307
+ Q+L GL +CH R VLHRD+K NLLI+ G LK+ADFGLA + ++ VVTL
Sbjct: 110 LYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTL 168
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
WYRPP++LLG++ Y T +D+W GCI E+ +G+P+ PG T ++LH IF+L G+P+E+
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228
Query: 368 W---------RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
W + P +KPQ + + L+ L + R SA
Sbjct: 229 WPGISSNDEFKNYNFPK---YKPQP-----LINHAPRLDTEGIELLTKFLQYESKKRISA 280
Query: 419 ASALRSEFF 427
A++ +F
Sbjct: 281 EEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 3e-54
Identities = 88/292 (30%), Positives = 140/292 (47%), Gaps = 50/292 (17%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
L+G+G++ +VY A D D +++A+K V E + + REI IL L H N+++ G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 208 LVTSRMSCSLYLVFEYMEHDLAG--LASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+L + EY+ +G L+S K E ++ Y +Q+L GL + HS G+
Sbjct: 67 SERDEEKNTLNIFLEYV----SGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
+HRDIKG+N+L+D++G++K+ADFG A D + + S T ++ PE++ G YG
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYG 181
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK-- 380
A D+WS GC + E+ GKP W + P A ++K
Sbjct: 182 RAADIWSLGCTVIEMATGKPP------------------------WSELGNPMAALYKIG 217
Query: 381 -----PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
P+ P ++E KDF + L DP R +A L+ F
Sbjct: 218 SSGEPPEIP--EHLSEEAKDF-------LRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 1e-53
Identities = 119/314 (37%), Positives = 174/314 (55%), Gaps = 31/314 (9%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+ADS+EKL+K +G+G+Y+ VY+ + K+VALK +R E E F
Sbjct: 3 KADSYEKLEK-----------LGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFT 49
Query: 188 A-REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVK 245
A RE +L+ L H N++ L ++ ++ + L LVFEY+ DL + HPG VK
Sbjct: 50 AIREASLLKGLKHANIVLLHDIIHTKET--LTLVFEYVHTDLCQYMDKHPG-GLHPENVK 106
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305
++ QLL GL + H R +LHRD+K NLLI + G LK+ADFGLA + ++ VV
Sbjct: 107 LFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVV 165
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGSPS 364
TLWYRPP++LLG+T Y T +D+W GCI E+ G PG +++ QL +IF + G+P+
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225
Query: 365 EDYWRK-SKLPHATIFKPQQPYKRCVAETFK------DFPAPALALMETLLSIDPADRGS 417
ED W LPH FKP++ + + + + A L LL P +R S
Sbjct: 226 EDTWPGVHSLPH---FKPER-FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS 281
Query: 418 AASALRSEFFTMKP 431
A +AL E+F+ P
Sbjct: 282 AQAALSHEYFSDLP 295
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 7e-53
Identities = 108/315 (34%), Positives = 156/315 (49%), Gaps = 16/315 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G Y V A D + VA+KK+ F + + RE+ +L+ +DH NVI L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 207 GLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ T S +YLV M DL + K S+ ++ + Q+L GL + HS G
Sbjct: 81 DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAG 138
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRD+K SN+ ++ + LKI DFGLA D + +T V T WYR PE++L +Y
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYN 194
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
VD+WS GCI+AEL GK + PG ++QL +I L G+P E+ +K A +
Sbjct: 195 QTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQS 254
Query: 383 QPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
P K+ E F A+ L+E +L +DP R +AA AL + P D P
Sbjct: 255 LPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVAP 314
Query: 441 KYPPSKEFDAKIRDE 455
Y S E DE
Sbjct: 315 PYDQSFESRDLTVDE 329
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 2e-52
Identities = 105/290 (36%), Positives = 147/290 (50%), Gaps = 11/290 (3%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V ARD + VA+KK+ P + RE+ +L+ L H N+I L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQ-VKCYMQQLLCGLDHCHSRGVLHRD 267
S + +Y V E + DL L + L E Q ++ ++ Q+L GL + HS GV+HRD
Sbjct: 78 FISPLE-DIYFVTELLGTDLHRLLTSRPL---EKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 327
+K SN+LI+ N LKI DFGLA DP +T V T +YR PE++L Y VD+
Sbjct: 134 LKPSNILINENCDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDI 189
Query: 328 WSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY-- 385
WS GCI AE+ GKP+ PG+ V Q I L G+P +D + F P
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435
+E FK+ A+ L+E +L DP R SAA AL + P D
Sbjct: 250 PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTD 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-52
Identities = 113/324 (34%), Positives = 165/324 (50%), Gaps = 23/324 (7%)
Query: 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G G+ V+ A D D K VA+KK+ +P+SV+ REI I+RRLDH N++
Sbjct: 8 MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIV 65
Query: 204 KLEGLVTSRMS------------CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 251
K+ ++ S S+Y+V EYME DLA + L SE + +M QL
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL--SEEHARLFMYQL 123
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQP--LTSRVVTLW 308
L GL + HS VLHRD+K +N+ I+ +LKI DFGLA DP + L+ +VT W
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368
YR P LLL Y A+D+W+ GCI AE+ GKP+ G E+EQ+ I + E+
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243
Query: 369 RK--SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
+ + +P +P +R + + AL +E +L+ +P DR +A AL +
Sbjct: 244 NELLNVIPSFVRNDGGEP-RRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302
Query: 427 FTMKPLPCD-PSSLPKYPPSKEFD 449
+ P D P SL + E D
Sbjct: 303 MSCYSCPFDEPVSLHPFHIEDELD 326
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 3e-50
Identities = 120/289 (41%), Positives = 161/289 (55%), Gaps = 17/289 (5%)
Query: 149 IGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIK 204
IG+G Y V++ARDL + + VALK+VR E RE+ +LR L+ H NV++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 205 LEGLVT-SRM--SCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
L + T SR L LVFE+++ DL L P +K M QLL GLD HS
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
V+HRD+K N+L+ ++G +K+ADFGLA Y LTS VVTLWYR PE+LL ++Y
Sbjct: 129 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLLQSSY 186
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW-RKSKLPHATIF 379
T VDLWS GCI AE++ KP+ G ++V+QL KI + G P E+ W R LP
Sbjct: 187 -ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 245
Query: 380 -KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
K QP ++ V D L+ L+ +PA R SA SAL +F
Sbjct: 246 SKSAQPIEKFVT----DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 8e-48
Identities = 108/326 (33%), Positives = 168/326 (51%), Gaps = 24/326 (7%)
Query: 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILRRLDHI 200
S +G G Y +V A D + VA+KK+ P A RE+ +L+ + H
Sbjct: 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS----RPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 201 NVIKLEGLVTSRMSC----SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 256
NVI L + TS +S YLV YM+ DL + HP SE +V+ + Q+LCGL
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSEDKVQYLVYQMLCGLK 131
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
+ HS G++HRD+K NL ++ + LKI DFGLA D + +T VVT WYR PE++L
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVIL 187
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376
+Y VD+WS GCI+AE+ GK + G+ ++QL +I K+ G P ++ +K + A
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247
Query: 377 TIF---KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
+ P+ P ++ + F A+ L+E +L +D R +A AL +F
Sbjct: 248 KSYIKSLPKYP-RKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 434 CDPSSLPKYPPSKEFDAKIRDEEARR 459
+ + Y S E + K+ +E ++
Sbjct: 307 DEETEQQPYDDSLE-NEKLSVDEWKK 331
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-47
Identities = 109/277 (39%), Positives = 151/277 (54%), Gaps = 18/277 (6%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLE 206
++G+G Y V + R + K+IVA+KK + D+ E E V+ RE+ +LR L N+++L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFK-DSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 207 GLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
R LYLVFEY+E + L L P E +V+ Y+ QL+ + CH ++H
Sbjct: 67 EAFRRR--GKLYLVFEYVEKNMLELLEEMPNGVPPE-KVRSYIYQLIKAIHWCHKNDIVH 123
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RDIK NLLI +N +LK+ DFG A N T V T WYR PELLLGA YG AV
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAV 182
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS-PSEDYW------RKSKLPHATI 378
D+WS GCIL EL G+P+ PG +E++QL I K+ G P+E R L +
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242
Query: 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
PQ +R + L LM+ LL ++P DR
Sbjct: 243 NHPQSLERRYLG----ILSGVLLDLMKNLLKLNPTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 2e-47
Identities = 105/285 (36%), Positives = 155/285 (54%), Gaps = 15/285 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIK-L 205
IG G + V+ D K VALKK+ F NL S + + RE+ +L H NV+ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSAL 65
Query: 206 EGLVTSRMSC--SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ L + +Y+V E M+ DL + P S VK ++ Q+L GL + HS G+
Sbjct: 66 DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
LHRDIK NLL+++N +LKI DFGLA +PD+++ +T VVT +YR PE+L+G+ +Y +
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS 184
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS-EDYWRKSKLPHATIFKPQ 382
AVD+WS GCI AEL + + ++ ++QL I L G+PS E +S A +
Sbjct: 185 AVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM--RSACEGARAHILR 242
Query: 383 QPYK-RCVAETFK---DFPAPALALMETLLSIDPADRGSAASALR 423
P+K + + A+ L+ +L DP R SAA AL
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 115/331 (34%), Positives = 175/331 (52%), Gaps = 31/331 (9%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKL 205
+IG+G+Y V A D + VA+KK+ F+++ ++ R + REI +LR L H +++++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVS-DATRIL-REIKLLRLLRHPDIVEI 64
Query: 206 EGLV---TSRMSCSLYLVFEYMEHDLAGLASHPGLK----FSEAQVKCYMQQLLCGLDHC 258
+ ++ + R +Y+VFE ME DL H +K + + ++ QLL L +
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDL-----HQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLA--SFYDPDQNQPLTSRVVTLWYRPPELLL 316
H+ V HRD+K N+L + + LKI DFGLA +F D T V T WYR PEL
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELC- 178
Query: 317 GATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374
G+ + Y A+D+WS GCI AE+ GKP+ PG+ V QL I L G+PS + + +
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238
Query: 375 HATIFKPQQPYKRCVAETFKDFPAP---ALALMETLLSIDPADRGSAASALRSEFFTMKP 431
A + K+ V + K FP AL L+E LL+ DP DR +A AL +F K
Sbjct: 239 KARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALADPYF--KG 295
Query: 432 LPC---DPSSLPKYPPSKEFDA-KIRDEEAR 458
L +PS+ P EF+ ++ E+ R
Sbjct: 296 LAKVEREPSAQPITKLEFEFERRRLTKEDVR 326
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 3e-46
Identities = 93/324 (28%), Positives = 137/324 (42%), Gaps = 40/324 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESVRFMAREIHILRRLDH-INVIKL 205
+G+G++ VY ARD +K+VALK + + + V REI IL L+H N++KL
Sbjct: 7 KLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 206 EGLVTSRMSCSLYLVFEYME-HDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRG 262
SLYLV EY++ L L G SE++ + Q+L L++ HS+G
Sbjct: 64 YDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 263 VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQ-----NQPLTSRVVTLWYRPPELLL 316
++HRDIK N+L+D + ++K+ DFGLA ++ V T Y PE+LL
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 317 GAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSEDYWRKS 371
G + Y ++ D+WS G L EL G P G Q KI +PS
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431
P A L++ LL+ DP +R S++S L +
Sbjct: 242 SNPE-------------------LISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282
Query: 432 LPCDPSSLPKYPPSKEFDAKIRDE 455
L S P
Sbjct: 283 LKESDLSDLLKPDDSAPLRLSLPP 306
|
Length = 384 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 3e-45
Identities = 105/312 (33%), Positives = 159/312 (50%), Gaps = 20/312 (6%)
Query: 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILRRLDH 199
R +G G Y V A D VA+KK+ P A RE+ +L+ + H
Sbjct: 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY----RPFQSELFAKRAYRELRLLKHMKH 73
Query: 200 INVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGL 255
NVI L + T +S YLV +M DL L H K SE +++ + Q+L GL
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE--KLSEDRIQFLVYQMLKGL 131
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
+ H+ G++HRD+K NL ++ + LKI DFGLA D + +T VVT WYR PE++
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVI 187
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375
L +Y VD+WS GCI+AE+ GKP+ G ++QL +I K+ G+PS+++ +K +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 376 ATIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
A + + P K+ + A+ ++E +L +D R +AA AL +F P
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 434 CDPSSLPKYPPS 445
D + P Y S
Sbjct: 308 EDETEAPPYDDS 319
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 7e-45
Identities = 104/313 (33%), Positives = 161/313 (51%), Gaps = 12/313 (3%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G Y +V A D ++ VA+KK+ R RE+ +L+ + H NVI L +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 209 VTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
T S +YLV M DL + K S+ V+ + QLL GL + HS G++
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAGII 140
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRD+K SN+ ++ + L+I DFGLA D + +T V T WYR PE++L +Y
Sbjct: 141 HRDLKPSNVAVNEDCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQT 196
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
VD+WS GCI+AEL GK + PG ++QL +I ++ G+PS + +K HA + P
Sbjct: 197 VDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256
Query: 385 Y--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKY 442
+ ++ + + F+ A+ L+E +L +D R SA+ AL +F+ P D Y
Sbjct: 257 HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPY 316
Query: 443 PPSKEFDAKIRDE 455
S E + +E
Sbjct: 317 DESPENKERTIEE 329
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 4e-44
Identities = 80/285 (28%), Positives = 122/285 (42%), Gaps = 38/285 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL-E 206
IG+G++ VY R K+ LK++ N+ + E+ IL++L+H N+IK E
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGL---ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L +V EY + DL+ G F E Q+ + QL L + HSR
Sbjct: 67 SFEEK---GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
+LHRDIK N+ + +NG++K+ DFG++ + + V T +Y PEL Y
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNKP-YN 181
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
D+WS GC+L EL K G +E KI +
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGENLLELALKI---------------------LKGQY 220
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
P + ++ L+ +LL DP +R S A L+S F
Sbjct: 221 PPIPSQYSSELRN-------LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 7e-44
Identities = 110/317 (34%), Positives = 165/317 (52%), Gaps = 46/317 (14%)
Query: 149 IGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G+GTY +VY+A+ D K + ALK++ + + REI +LR L H NVI L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA----CREIALLRELKHPNVISLQ 64
Query: 207 GLVTSRMSCSLYLVFEYMEHDL--------AGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+ S ++L+F+Y EHDL A A+ ++ VK + Q+L G+ +
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 259 HSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSR------VVTLW 308
H+ VLHRD+K +N+L+ G +KIAD G A + N PL VVT W
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLADLDPVVVTFW 180
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKL 359
YR PELLLGA +Y A+D+W+ GCI AEL +PI R E +QL +IF +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240
Query: 360 CGSPSEDYWRK-SKLP-HATIFKP--QQPYKRC----VAETFKDFP-APALALMETLLSI 410
G P++ W K+P H+T+ K + Y C E K P + A L++ LL++
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 300
Query: 411 DPADRGSAASALRSEFF 427
DP R ++ A++ +F
Sbjct: 301 DPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 8e-43
Identities = 72/198 (36%), Positives = 121/198 (61%), Gaps = 10/198 (5%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
LIG+G + VY+ +L+ VA+K++ + ++ E+++ + +EI +L+ L H N++K G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + S SLY++ EY E+ L + G F E+ V Y+ Q+L GL + H +GV+HR
Sbjct: 67 SIET--SDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQGVIHR 123
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL--GATYYGTA 324
DIK +N+L +G++K+ADFG+A+ D ++ S V T ++ PE++ GA+ TA
Sbjct: 124 DIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIEMSGAS---TA 179
Query: 325 VDLWSTGCILAELYAGKP 342
D+WS GC + EL G P
Sbjct: 180 SDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 5e-42
Identities = 108/319 (33%), Positives = 162/319 (50%), Gaps = 50/319 (15%)
Query: 149 IGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G+GTY +VY+A+ D K K ALK++ + + REI +LR L H NVI L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA----CREIALLRELKHPNVIALQ 64
Query: 207 GLVTSRMSCSLYLVFEYMEHDL--------AGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+ S ++L+F+Y EHDL A A+ ++ + VK + Q+L G+ +
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 259 HSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSR------VVTLW 308
H+ VLHRD+K +N+L+ G +KIAD G A + N PL VVT W
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF----NSPLKPLADLDPVVVTFW 180
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKL 359
YR PELLLGA +Y A+D+W+ GCI AEL +PI R E +QL +IF +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240
Query: 360 CGSPSEDYWRK-SKLPHATIFKPQQPYKRCV---------AETFKDFP-APALALMETLL 408
G P++ W K+P Q+ ++R E K P + L++ LL
Sbjct: 241 MGFPADKDWEDIRKMPEYPTL--QKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298
Query: 409 SIDPADRGSAASALRSEFF 427
++DP R ++ AL+ +F
Sbjct: 299 TMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 7e-41
Identities = 89/307 (28%), Positives = 132/307 (42%), Gaps = 61/307 (19%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKV--RFDNLEPESVRFMAREIHILRRLD-HINVIK 204
+IG+G++S V A++ + K A+K + R E + V+++ E +L RL+ H +IK
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L T + +LY V EY + +L G E + Y ++L L++ HS+G+
Sbjct: 67 LYY--TFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGI 123
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPD---------------QNQPLTSR----V 304
+HRD+K N+L+D + +KI DFG A DP+ Q + R V
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFV 183
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
T Y PELL G + DLW+ GCI+ ++ GKP G E KI KL
Sbjct: 184 GTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE---- 238
Query: 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR----GSAAS 420
P +FP A L+E LL +DP DR
Sbjct: 239 ------YSFPP-------------------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273
Query: 421 ALRSEFF 427
FF
Sbjct: 274 LKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 1e-40
Identities = 101/320 (31%), Positives = 153/320 (47%), Gaps = 17/320 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G Y +V A D VA+KK+ + RE+ +L+ + H NVI L +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 209 VTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
T S +YLV M DL + K ++ V+ + Q+L GL + HS ++
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADII 142
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRD+K SNL ++ + LKI DFGLA D + +T V T WYR PE++L +Y
Sbjct: 143 HRDLKPSNLAVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQT 198
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
VD+WS GCI+AEL G+ + PG ++QL I +L G+P + +K A +
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 258
Query: 385 Y--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKY 442
K A F A+ L+E +L +D R +AA AL +F DP P
Sbjct: 259 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH---DPDDEPVA 315
Query: 443 PP-SKEFDAKIRD-EEARRQ 460
P + F+++ +E +
Sbjct: 316 DPYDQSFESRDLLIDEWKSL 335
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 76/279 (27%), Positives = 130/279 (46%), Gaps = 34/279 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + VY+AR K VA+K ++ + E + EI IL++ H N++K G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
+ L++V E+ L L +E+Q+ ++LL GL++ HS G++HRD
Sbjct: 66 YLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRD 123
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 327
IK +N+L+ ++G +K+ DFGL++ + + V T ++ PE++ G Y D+
Sbjct: 124 IKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVING-KPYDYKADI 180
Query: 328 WSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKR 387
WS G EL GKP ++ L KI + + P++
Sbjct: 181 WSLGITAIELAEGKPPYSELPPMKALFKI--------------ATNGPPGLRNPEK---- 222
Query: 388 CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
++ FKDF ++ L +P R +A L+ F
Sbjct: 223 -WSDEFKDF-------LKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 84/286 (29%), Positives = 140/286 (48%), Gaps = 38/286 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG GT+ VY A +LD +++A+K++R + +P++++ +A E+ +L L H N++K G+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 209 VTSRMSCSLYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
R +Y+ EY L L H G E ++ Y QLL GL + HS G++HRD
Sbjct: 68 EVHREK--VYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGATY--Y 321
IK +N+ +D+NG++K+ DFG + + + V +L Y PE++ G +
Sbjct: 125 IKPANIFLDHNGVIKLGDFG-CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI-FKLCGSPSEDYWRKSKLPHATIFK 380
G A D+WS GC++ E+ GK E++ +I F + K
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWS---ELDNEFQIMFHVGAGH----------------K 224
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
P P ++ KDF ++ L DP R +A+ L+ F
Sbjct: 225 PPIPDSLQLSPEGKDF-------LDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-39
Identities = 116/342 (33%), Positives = 169/342 (49%), Gaps = 30/342 (8%)
Query: 143 SRSFYL---IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 199
++S+ L IG G++ VY A +D + VA+KKV D P+ + RE+ I++ L+H
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQ---YKNRELLIMKNLNH 118
Query: 200 INVIKL------EGLVTSRMSCSLYLVFEYME---HDLAGLASHPGLKFSEAQVKCYMQQ 250
IN+I L E + + L +V E++ H + VK Y Q
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178
Query: 251 LLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 309
L L + HS+ + HRD+K NLLID N LK+ DFG A Q S + + +Y
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFY 236
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369
R PEL+LGAT Y T +DLWS GCI+AE+ G PI G++ V+QL +I ++ G+P+ED +
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296
Query: 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429
+ +A I P K K P A+ + L +P R + AL FF
Sbjct: 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356
Query: 430 KPLPCDPSSLPKY----PPSKEF-DAKIRD--EEARRQGGSK 464
PC LPKY P F DA+I++ + RR+ K
Sbjct: 357 LRDPC--IKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396
|
Length = 440 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 5e-38
Identities = 93/286 (32%), Positives = 129/286 (45%), Gaps = 44/286 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+GQG+ VY+ R KI ALKK+ D + E + + RE+ LR + V+K G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 209 VTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGV 263
+ +V EYM+ DL L K E + +Q+L GLD+ H+ R +
Sbjct: 68 FYK--EGEISIVLEYMDGGSLADL--LKKVG--KIPEPVLAYIARQILKGLDYLHTKRHI 121
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRDIK SNLLI++ G +KIADFG++ + +Q T V T+ Y PE + G Y
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGE-SYSY 179
Query: 324 AVDLWSTGCILAELYAGK-PIMPGRTE--VEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
A D+WS G L E GK P +P E + I C P
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CDGPP---------------- 220
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
P P + E F+DF + L DP R SAA L+ F
Sbjct: 221 PSLPAEEFSPE-FRDF-------ISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 19/216 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G+G++ V R D K+ A+K ++ ++ + V E +IL R++H ++KL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 208 LVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
+ LYLV EY +L S G +FSE + + Y +++ L++ HS
Sbjct: 59 ------HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHS 111
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
G+++RD+K N+L+D +G +K+ DFGLA + + T Y PE+LLG
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKG- 169
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
YG AVD WS G +L E+ GKP E KI
Sbjct: 170 YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 106/361 (29%), Positives = 173/361 (47%), Gaps = 58/361 (16%)
Query: 130 DSFEKLDKSLSIFSR--SFYLIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVR 185
S E D + ++ R + IG G V A D + VA+KK+ F N +
Sbjct: 3 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAK 60
Query: 186 FMAREIHILRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLAS----HPGL 237
RE+ +++ ++H N+I L + T + S +YLV E M+ +L + H +
Sbjct: 61 RAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERM 120
Query: 238 KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-----SFY 292
+ + Q+LCG+ H HS G++HRD+K SN+++ ++ LKI DFGLA SF
Sbjct: 121 SY-------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 173
Query: 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 352
+T VVT +YR PE++LG Y VD+WS GCI+ E+ G + PG ++Q
Sbjct: 174 -------MTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ 225
Query: 353 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKD------FPAP------- 399
+KI + G+PS+++ + + P + +P + +F++ FP
Sbjct: 226 WNKIIEQLGTPSDEFMSRLQ-PTVRNYVENRP--KYAGYSFEELFPDVLFPPDSESHNKL 282
Query: 400 ----ALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDE 455
A L+ +L IDP R S AL+ + + DPS + + PP +D I +
Sbjct: 283 KASQARDLLSKMLVIDPEKRISVDDALQHPYIN---VWYDPSEV-EAPPPAPYDHSIDER 338
Query: 456 E 456
E
Sbjct: 339 E 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 90/292 (30%), Positives = 145/292 (49%), Gaps = 41/292 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKV--------RFDNLEPESVRFMAREIHILRRLDH 199
LIG+GTY VY A ++ +++A+K+V R D+ + + V+ + EI L+ LDH
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 200 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+N+++ G T+ S++L EY+ + G +F E V+ + +Q+L GL +
Sbjct: 68 LNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYL 124
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGL----ASFYDPDQNQPLTSRVVTLWYRPPEL 314
HS+G+LHRD+K NLL+D +GI KI+DFG+ YD DQN + V W P +
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV--FWMAPEVI 182
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374
+ Y VD+WS GC++ E++AG+ P E E + +FKL S
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGR--RPWSDE-EAIAAMFKLGNKRS---------- 229
Query: 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
P P + + AL + +I+P +R +A L+ F
Sbjct: 230 -----APPIP-----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 41/296 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG- 207
IG+G VY+A D K VA+KK+R E + EI I++ H N++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYDS 83
Query: 208 -LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
LV L++V EYM+ L + + ++ +E Q+ +++L GL++ HS+ V+H
Sbjct: 84 YLV---GDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIH 139
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RDIK N+L+ +G +K+ADFG A+ ++++ S V T ++ PE++ YG V
Sbjct: 140 RDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR-NSVVGTPYWMAPEVIKR-KDYGPKV 197
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
D+WS G + E+ G+P P L +F + +K P
Sbjct: 198 DIWSLGIMCIEMAEGEP--P-YLREPPLRALFLI----------TTKGI------PPLKN 238
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPK 441
+ FKDF + L DP R SA L+ F C
Sbjct: 239 PEKWSPEFKDF-------LNKCLVKDPEKRPSAEELLQHPFLKK---ACPKEEFAP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 2e-36
Identities = 105/346 (30%), Positives = 169/346 (48%), Gaps = 31/346 (8%)
Query: 131 SFEKLDKSLSIFSRSFYL--IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 188
S + D + ++ R L IG G V A D VA+KK+ +
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY 68
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQV 244
RE+ +L+ ++H N+I L + T + S +YLV E M+ +L + ++ ++
Sbjct: 69 RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH---MELDHERM 125
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
+ Q+LCG+ H HS G++HRD+K SN+++ ++ LKI DFGLA N +T V
Sbjct: 126 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYV 183
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
VT +YR PE++LG Y VD+WS GCI+ EL G I G ++Q +K+ + G+PS
Sbjct: 184 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242
Query: 365 EDYWRK--SKLPHATIFKPQQPYKRCVAETFKDFPAP------------ALALMETLLSI 410
++ + + + +PQ P E F D+ P A L+ +L I
Sbjct: 243 AEFMNRLQPTVRNYVENRPQYP-GISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301
Query: 411 DPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEE 456
DP R S ALR + T+ P + + PP + +DA++ + E
Sbjct: 302 DPDKRISVDEALRHPYITVWYDPAEAEA----PPPQIYDAQLEERE 343
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 140 bits (353), Expect = 3e-36
Identities = 99/340 (29%), Positives = 167/340 (49%), Gaps = 25/340 (7%)
Query: 131 SFEKLDKSLSIFSRSFYL--IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 188
S E D + ++ R L IG G V A D ++ VA+KK+ +
Sbjct: 12 SVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY 71
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQV 244
RE+ +++ ++H N+I L + T + S +Y+V E M+ +L + ++ ++
Sbjct: 72 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERM 128
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
+ Q+LCG+ H HS G++HRD+K SN+++ ++ LKI DFGLA + +T V
Sbjct: 129 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 186
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
VT +YR PE++LG Y VD+WS GCI+ E+ G + PG ++Q +K+ + G+P
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245
Query: 365 EDYWRKSKLPHATIFKPQQPYKRCVAET-FKD--FPA----------PALALMETLLSID 411
++ +K + T + + Y E F D FPA A L+ +L ID
Sbjct: 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 305
Query: 412 PADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAK 451
+ R S AL+ + + P + + P P K+ D +
Sbjct: 306 ASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDER 345
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 87/283 (30%), Positives = 142/283 (50%), Gaps = 36/283 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN---LEPESVRFMAREIHILRRLDHINVIK 204
L+G G++ +VY +LD A+K+V + E+V+ + +EI +L +L H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
G T R +LY+ E + LA L G F E ++ Y +Q+L GL++ H R
Sbjct: 67 YLG--TEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRDIKG+N+L+D NG++K+ADFG+A + S + ++ PE++ YG
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
A D+WS GC + E+ GKP +++E + +FK+ S LP
Sbjct: 182 AADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKE--------LP--------- 221
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
P +++ KDF + L DP+ R +AA L F
Sbjct: 222 PIPDHLSDEAKDF-------ILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-35
Identities = 103/346 (29%), Positives = 174/346 (50%), Gaps = 31/346 (8%)
Query: 131 SFEKLDKSLSIFSRSFYL--IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 188
S E D + ++ R L IG G V A D + VA+KK+ +
Sbjct: 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY 64
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQV 244
RE+ +++ ++H N+I L + T + S +YLV E M+ +L + ++ ++
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHERM 121
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
+ Q+LCG+ H HS G++HRD+K SN+++ ++ LKI DFGLA + +T V
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 179
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
VT +YR PE++LG Y VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P
Sbjct: 180 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 365 EDYWRKSKLPHATIFKPQQPYKRCVA--ETFKD--FPA----------PALALMETLLSI 410
++ +K + P + +P + + F D FPA A L+ +L I
Sbjct: 239 PEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 411 DPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEE 456
DPA R S AL+ + + DP+ + + PP + +D ++ + E
Sbjct: 298 DPAKRISVDEALQHPYINVW---YDPAEV-EAPPPQIYDKQLDERE 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 69/219 (31%), Positives = 109/219 (49%), Gaps = 11/219 (5%)
Query: 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG+G++ V + R KI+ K++ + N+ + + + E++ILR L H N+++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ R + +LY+V EY E DLA L E + + QLL L CH+R
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 263 -----VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 317
VLHRD+K +N+ +D N +K+ DFGLA + + V T +Y PE L
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVGTPYYMSPEQLNH 184
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
+ Y D+WS GC++ EL A P R +++ KI
Sbjct: 185 MS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 68/197 (34%), Positives = 107/197 (54%), Gaps = 11/197 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIK-LE 206
IG+G +S VY+A L ++VALKKV+ F+ ++ ++ + +EI +L++LDH NVIK L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ + L +V E + DL+ + H E + Y QL L+H HS+
Sbjct: 70 SFIENNE---LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRDIK +N+ I G++K+ D GL F+ + S V T +Y PE + Y
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENG-YN 184
Query: 323 TAVDLWSTGCILAELYA 339
D+WS GC+L E+ A
Sbjct: 185 FKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 71/237 (29%), Positives = 114/237 (48%), Gaps = 23/237 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV--RFMAREIHILRRLDHINVIKL- 205
I +G Y V+ A+ I A+K ++ ++ ++ + + E IL + V+KL
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLT-ERDILSQAQSPYVVKLY 59
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ +LYLV EY+ DLA L + G E + Y+ +++ L++ HS G++
Sbjct: 60 YSFQGKK---NLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASF------YDPDQNQPLTSRVV-TLWYRPPELLLG 317
HRD+K N+LID+NG LK+ DFGL+ + + ++ R+V T Y PE++LG
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI------FKLCGSPSEDYW 368
+ VD WS GCIL E G P G T E I + S++
Sbjct: 176 QG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAI 231
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 79/259 (30%), Positives = 122/259 (47%), Gaps = 16/259 (6%)
Query: 147 YLIGQGTYSNVYRARDLDQKKIVALKK-VRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+IG+G + V + D KK+ A+K + +E SVR + E IL+ L+H ++ L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAG-LASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ + ++YLV + + L G L H +KFSE QVK ++ +++ L++ HS+G
Sbjct: 66 W--YSFQDEENMYLVVDLL---LGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRDIK N+L+D G + I DF +A+ PD TS T Y PE+L Y
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQ-GYS 177
Query: 323 TAVDLWSTGCILAELYAGKPIMPG--RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
AVD WS G E GK G RT +Q+ + W +
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 381 PQQPYKR--CVAETFKDFP 397
+ P KR + K+ P
Sbjct: 238 ERDPQKRLGDNLKDLKNHP 256
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + VY+ + VA+K ++ E E F+ E I+++L H N+++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFL-EEASIMKKLSHPNIVR 65
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L G+ T LY+V EYM DL G K + + Q+ G+++ S+
Sbjct: 66 LLGVCTQGEP--LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNF 123
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASF-YDPDQNQPLTSRVVTL-WYRPPELLLGATYY 321
+HRD+ N L+ N ++KI+DFGL+ Y+ D + + + W PE L +
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESLKDGKFT 182
Query: 322 GTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKIFK 358
+ D+WS G +L E+ +P PG + E L +
Sbjct: 183 -SKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEVLELLED 219
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + VY+ ++ VA+K ++ D E + F+ RE I+R+LDH N++K
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFL-REARIMRKLDHPNIVK 65
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L G+ T L +V EYM DL L + + S + + + Q+ G+++ S+
Sbjct: 66 LLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPPELLLGATYY 321
+HRD+ N L+ N ++KI+DFGL+ D + + + W PE L +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-APESLKEGK-F 181
Query: 322 GTAVDLWSTGCILAELY 338
+ D+WS G +L E++
Sbjct: 182 TSKSDVWSFGVLLWEIF 198
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 13/197 (6%)
Query: 149 IGQGTYSNVYRA--RDLDQKKI--VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + VY+ + KK VA+K ++ D E + F+ RE I+R+LDH NV+K
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFL-REARIMRKLDHPNVVK 65
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L G+ T LY+V EYME DL L + K S + + + Q+ G+++ S+
Sbjct: 66 LLGVCTEEEP--LYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEYLESKN 122
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPPELLLGATYY 321
+HRD+ N L+ N ++KI+DFGL+ D + + W PE L +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-APESLKEGKFT 181
Query: 322 GTAVDLWSTGCILAELY 338
+ D+WS G +L E++
Sbjct: 182 -SKSDVWSFGVLLWEIF 197
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 77/233 (33%), Positives = 124/233 (53%), Gaps = 24/233 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRF----DNLEPESVRFMAREIHILRRLDHINVI 203
+G G +S+ Y+ARD+ ++A+K+V + + + E V + +EI ++ RL+H ++I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
++ G +L++ E+M ++ L S G F EA + Y +QLL GL + H
Sbjct: 67 RMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 263 VLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPD-------QNQPLTSRVVTLWYRPPEL 314
++HRD+KG+NLLID+ G L+IADFG A+ Q Q L T+ + PE+
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG----TIAFMAPEV 179
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC---GSPS 364
L G YG + D+WS GC++ E+ KP L IFK+ +PS
Sbjct: 180 LRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 149 IGQGTYSNVYRAR---DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+G+G + VY+ + + VA+K ++ D E E F+ +E ++++L H NV++L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-KEARVMKKLGHPNVVRL 61
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DL--------AGLASHPGLKFSEAQVKCYMQQLLCGLD 256
G+ T LYLV EYME DL S S + + Q+ G++
Sbjct: 62 LGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPEL 314
+ S+ +HRD+ N L+ + ++KI+DFGL+ D + ++ W PE
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-APES 178
Query: 315 LLGATYYGTAVDLWSTGCILAELY 338
L + + D+WS G +L E++
Sbjct: 179 LKDGI-FTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 9e-29
Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 52/295 (17%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMAREIHILRRLDHINVIKLE 206
IG G + VY A L + VA+K++ +LE SV + +E+ + + +H NV+K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 207 GLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L+LV Y+ D+ +S+P EA + ++++L GL++ HS G
Sbjct: 66 TSFVVGDE--LWLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGL-ASFYDPDQNQPLTSRVV--TLWYRPPELLLGAT 319
+HRDIK N+L+ +G +KIADFG+ AS D + T + PE++
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF-------KLCGSPSEDYWRKSK 372
Y D+WS G EL G P K L P
Sbjct: 183 GYDFKADIWSFGITAIELATGAA--PY-------SKYPPMKVLMLTLQNDPP-------S 226
Query: 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
L +K +++F+ + L DP+ R +A L+ +FF
Sbjct: 227 LETGADYKK-------YSKSFRKM-------ISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 47/286 (16%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G++ VY+A D ++VA+K + + E E + + +EI L + + K G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYITKYYG 66
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
L+++ EY G PG K E + ++++L GL++ H G +
Sbjct: 67 SFLKG--SKLWIIMEYCG---GGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKI 120
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR----VVTLWYRPPELLLGATY 320
HRDIK +N+L+ G +K+ADFG++ Q S+ V T ++ PE++ +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSG-----QLTSTMSKRNTFVGTPFWMAPEVIKQ-SG 174
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
Y D+WS G EL G+P + + L I K PS L K
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPS--------LEGNKFSK 225
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
P FKDF + L+ DP +R SA L+ +F
Sbjct: 226 P-----------FKDF-------VSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 19/227 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIK 204
L+GQG + VY D+D + +A+K+V FD PE+ V + EI +L+ L H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 205 LEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
G + + S+++ EYM D L ++ L +E + Y +Q+L G+++ HS
Sbjct: 69 YYGCLRDDETLSIFM--EYMPGGSVKDQ--LKAYGAL--TETVTRKYTRQILEGVEYLHS 122
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGA 318
++HRDIKG+N+L D+ G +K+ DFG + + + V T ++ PE++ G
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365
YG D+WS GC + E+ KP E E + IFK+ P+
Sbjct: 183 G-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN 225
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 74/232 (31%), Positives = 130/232 (56%), Gaps = 20/232 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-------VRFMAREIHILRRLDHI 200
LIG G++ +VY + +++A+K+V ++ S + +AREI +L+ L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
N+++ G +S + L + EY+ +A L ++ G F E V+ +++Q+L GL++ H
Sbjct: 67 NIVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH 123
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGL-----ASFYDPDQNQPLTSRVVTLWYRPPEL 314
+RG++HRDIKG+N+L+DN G +KI+DFG+ A+ N S ++++ PE
Sbjct: 124 NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366
++ T Y D+WS GC++ E+ GK P + QL IFK+ + S +
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFKIGENASPE 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 91/300 (30%), Positives = 130/300 (43%), Gaps = 68/300 (22%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
++G+GTY VY ARDL + +A+K++ + V+ + EI + L H N+++ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 208 LVTSRMSCSLYLVFE-YMEHDLAG-----LASHPG-LKFSEAQVKCYMQQLLCGLDHCHS 260
S S F+ +ME G L S G LK +E + Y +Q+L GL + H
Sbjct: 73 ------SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 261 RGVLHRDIKGSNLLIDN-NGILKIADFG----LASFYDPDQNQPLTSRVV-TLWYRPPEL 314
++HRDIKG N+L++ +G++KI+DFG LA P T TL Y PE+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI------NPCTETFTGTLQYMAPEV 180
Query: 315 L-LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373
+ G YG D+WS GC + E+ GKP P F G
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGKP--P-----------FIELGE----------- 216
Query: 374 PHATIFKPQQPYKRCVAETFKDFP-------APALALMETLLSIDPADRGSAASALRSEF 426
P A +FK FK P A A + DP R SA L+ F
Sbjct: 217 PQAAMFK---------VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 98/336 (29%), Positives = 132/336 (39%), Gaps = 86/336 (25%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMA 188
D FE + +IG+G + V+ RD D ++ A+K +R D ++ + +
Sbjct: 1 DDFEVIK-----------VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVR 49
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSE 241
E IL D ++KL S LYLV EYM DL L + F E
Sbjct: 50 AERDILADADSPWIVKLY--------YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPE 100
Query: 242 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS---------FY 292
+ Y+ +L+ LD H G +HRDIK N+LID +G +K+ADFGL +Y
Sbjct: 101 ETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160
Query: 293 DPDQNQPLTSRVVTLWYRP-------------------PELLLGATYYGTAVDLWSTGCI 333
D + L V + R PE+L G T YG D WS G I
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVI 219
Query: 334 LAE-LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAET 392
L E LY P T E +KI W++S F P P
Sbjct: 220 LYEMLYGFPPFY-SDTLQETYNKIIN---------WKES-----LRFPPDPPV------- 257
Query: 393 FKDFPAPALALMETLLSIDPADR-GSAASALRSEFF 427
A+ L+ LL DP DR GS FF
Sbjct: 258 ----SPEAIDLICRLL-CDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 20/205 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG GTY +VY+ARD+ ++VA+K ++ + + + +EI +L+ H N++ G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 209 VTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
R L++V EY D+ + P SE Q+ ++ L GL + H G +
Sbjct: 69 YLRRDK--LWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLHETGKI 123
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR---VVTLWYRPPELLLGATY- 320
HRDIKG+N+L+ +G +K+ADFG+++ + R + T ++ PE+
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSA----QLTATIAKRKSFIGTPYWMAPEVAAVERKG 179
Query: 321 -YGTAVDLWSTGCILAELYAGKPIM 344
Y D+W+ G EL +P M
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPM 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 10/213 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G+G+Y +VY+ + L + ALK+V ++ + EI IL ++H N+I +
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 208 LVTSRMSCSLYLVFEYME-HDLAGLASHPGLK---FSEAQVKCYMQQLLCGLDHCHSRGV 263
L +V EY DL+ S K E ++ QLL GL H + +
Sbjct: 67 --AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI 124
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
LHRD+K +N+L+ N ++KI D G++ + +++ T Y PE+ G Y
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGRPYSYK 181
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
+ D+WS GC+L E+ P R+ + +K+
Sbjct: 182 S-DIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 73/226 (32%), Positives = 116/226 (51%), Gaps = 17/226 (7%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIK 204
L+GQG + VY D+D + +A K+V+FD PE+ V + EI +L+ L H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK----FSEAQVKCYMQQLLCGLDHCHS 260
G + R +L + EYM G + LK +E+ + Y +Q+L G+ + HS
Sbjct: 69 YYGCLRDRAEKTLTIFMEYM----PGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGA 318
++HRDIKG+N+L D+ G +K+ DFG + R V T ++ PE++ G
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
YG D+WS GC + E+ KP E E + IFK+ P+
Sbjct: 185 G-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 75/282 (26%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G++ +Y A+ + +K++ + + +E+ +L ++ H N++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF--F 65
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + + L++V EY + DL + G+ FSE Q+ + Q+ GL H H R +LHR
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHR 125
Query: 267 DIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
DIK N+ + NG + K+ DFG+A + D + + V T +Y PE+ Y
Sbjct: 126 DIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEICQNRP-YNNKT 183
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
D+WS GC+L EL K G + QL + K+C F P P
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNN-LHQL--VLKICQG---------------YFAPISP- 224
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+F +L+ L + P DR S S L+ F
Sbjct: 225 ---------NFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 43/286 (15%)
Query: 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G+G+Y +VY+A + ++VA+K V + E ++ + +EI IL++ D ++K
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYY 64
Query: 207 GLVTSRMSCS-LYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
G S + L++V EY D+ + + +E ++ + Q L GL++ HS
Sbjct: 65 G---SYFKNTDLWIVMEYCGAGSVSDIMKITNKT---LTEEEIAAILYQTLKGLEYLHSN 118
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
+HRDIK N+L++ G K+ADFG+ S D + + T ++ PE++ Y
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGV-SGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381
A D+WS G E+ GKP P +++ + IF + P T+ P
Sbjct: 178 NKA-DIWSLGITAIEMAEGKP--P-YSDIHPMRAIFMIPNKPPP-----------TLSDP 222
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
++ + F DF L DP +R SA L+ F
Sbjct: 223 EK-----WSPEFNDFVK-------KCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 78/246 (31%), Positives = 121/246 (49%), Gaps = 33/246 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIK-LE 206
IG+G +S VYRA L +K VALKKV+ F+ ++ ++ + +EI +L++L+H NVIK L+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK---FSEAQVKCYMQQLLCGLDHCHSRG 262
+ L +V E + DL+ + + + E V Y QL ++H HSR
Sbjct: 70 SFIEDN---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
V+HRDIK +N+ I G++K+ D GL F+ + S V T +Y PE + Y
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGYN 184
Query: 323 TAVDLWSTGCILAEL-------YAGK---------------PIMPGRTEVEQLHKIFKLC 360
D+WS GC+L E+ Y K P +P E+L ++ +C
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMC 244
Query: 361 GSPSED 366
P D
Sbjct: 245 IYPDPD 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 13/224 (5%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIK 204
L+GQG + VY D D + +A+K+V+FD PE+ V + EI +L+ L H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
G + M +L + E+M L S+ L +E + Y +Q+L G+ + HS
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGAL--TENVTRKYTRQILEGVSYLHSNM 126
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--QNQPLTSRVVTLWYRPPELLLGATY 320
++HRDIKG+N+L D+ G +K+ DFG + + S T ++ PE++ G
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG- 185
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
YG D+WS GC + E+ KP E E + IFK+ P+
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPT 226
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 25/226 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 206
+IG+GTY VY+AR ++VA+K + E E ++ E +ILR+ +H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK---EEYNILRKYSNHPNIATFY 69
Query: 207 GLVTSRMSCS----LYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
G + L+LV E DL G + E + +++ L GL +
Sbjct: 70 GAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG- 317
H V+HRDIKG N+L+ N +K+ DFG+++ D + T + T ++ PE++
Sbjct: 130 HENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWMAPEVIACD 188
Query: 318 ---ATYYGTAVDLWSTGCILAELYAGKP----IMPGRTEVEQLHKI 356
Y D+WS G EL GKP + P R L KI
Sbjct: 189 EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKI 230
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 28/205 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G++ V R K ALK + ++ + V + E IL+ + H ++ L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 208 LVTSRMSCSLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQLLCGLDHCHSR 261
+ + +LYLV EY + G L SH L +F E + Y Q++ L++ HS
Sbjct: 69 --SFQDDSNLYLVMEY----VPGGELFSH--LRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----YRPPELLLG 317
+++RD+K NLL+D++G +KI DFG A + R TL Y PE++L
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKR--------VKGRTYTLCGTPEYLAPEIILS 172
Query: 318 ATYYGTAVDLWSTGCILAELYAGKP 342
YG AVD W+ G ++ E+ AG P
Sbjct: 173 KG-YGKAVDWWALGILIYEMLAGYP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 76/221 (34%), Positives = 110/221 (49%), Gaps = 10/221 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G +S VYRA L VALKKV+ FD ++ ++ +EI +L++L+H NVIK
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK---FSEAQVKCYMQQLLCGLDHCHSRGV 263
L +V E + DL+ + H + E V Y QL L+H HSR V
Sbjct: 70 SFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRDIK +N+ I G++K+ D GL F+ + S V T +Y PE + Y
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE-RIHENGYNF 185
Query: 324 AVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSP 363
D+WS GC+L E+ A P + + L K + C P
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 75/228 (32%), Positives = 108/228 (47%), Gaps = 27/228 (11%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREI-HILRRLDHINVIKLEG 207
+GQG Y V+ A+ D +IVALK+++ +S+ F E+ H+L D + K E
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMK------KSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 208 LVTSRMSC----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
LV + LYL EY+ D L ++ G+ SE + YM ++ +D H G
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALHELG 121
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
+HRD+K N LID +G +K+ DFGL+ N S V + Y PE+L G Y
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN----SVVGSPDYMAPEVLRG-KGYD 176
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370
VD WS GC+L E G P G T E + YW++
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK---------YWKE 215
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 23/204 (11%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + V R + + VA+K + E + REI ILR LDH N++K
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-EEQHRSDFEREIEILRTLDHENIVK 70
Query: 205 LEGLVTSRMSCSLYLVFEY-----MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
+G+ SL L+ EY + L LK ++ + Q+ G+D+
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK----RLLLFSSQICKGMDYLG 126
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-----NQPLTSRVVTLWYRPPEL 314
S+ +HRD+ N+L+++ ++KI+DFGLA D+ +P S + WY PE
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FWY-APEC 183
Query: 315 LLGATYYGTAVDLWSTGCILAELY 338
L + + +A D+WS G L EL+
Sbjct: 184 LRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 9e-23
Identities = 75/284 (26%), Positives = 131/284 (46%), Gaps = 39/284 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI---NVIK 204
LIG+G Y VYR + + ++VALK + D + + V + RE+ +L +L N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNITK 66
Query: 205 LEG--LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
G L R L+++ EY E G +E + ++++L L + H G
Sbjct: 67 YYGSYLKGPR----LWIIMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVG 121
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
V+HRDIK +N+L+ N G +K+ DFG+A+ + + ++ T V T ++ PE++ YY
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF-VGTPYWMAPEVITEGKYYD 180
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
T D+WS G + E+ G P + L +P + KP
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSD----VDAFRAMML-------------IPKS---KPP 220
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
+ ++ ++F + L +P +R SA L+S++
Sbjct: 221 RLEDNGYSKLLREF-------VAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 64/217 (29%), Positives = 97/217 (44%), Gaps = 12/217 (5%)
Query: 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK-L 205
IG+G++ V++ K++ A+K++ + E +L +LD +I+
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 206 EGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
E + L +V EY E H L L G E QV + Q+L GL H HS+
Sbjct: 66 ESFLDKGK---LNIVMEYAENGDLHKL--LKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
+LHRDIK NL +D +KI D G+A + N T V T +Y PEL Y
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI-VGTPYYLSPELCEDKPYN 179
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
+ D+W+ G +L E GK + + KI +
Sbjct: 180 EKS-DVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 78/299 (26%), Positives = 140/299 (46%), Gaps = 44/299 (14%)
Query: 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMAREIHILRRLDHINVI 203
+F IG+G+ V A D + VA+KK+ +L + R + E+ I+R H N++
Sbjct: 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKM---DLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 204 KLEG--LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
++ LV L++V E++E L + +H + +E Q+ +L L H+
Sbjct: 80 EMYSSYLVGDE----LWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHA 133
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
+GV+HRDIK ++L+ ++G +K++DFG + + + S V T ++ PE ++
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR-KSLVGTPYWMAPE-VISRLP 191
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
YGT VD+WS G ++ E+ G+P ++ + +I R + P
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI------------RDNLPPKL---- 235
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439
+ +K V+ + F ++ +L DPA R +AA L F PSS+
Sbjct: 236 -KNLHK--VSPRLRSF-------LDRMLVRDPAQRATAAELLNHPFLA---KAGPPSSI 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 84/312 (26%), Positives = 141/312 (45%), Gaps = 48/312 (15%)
Query: 133 EKLDKSLSIFS--------RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV 184
E L+K +I S F IGQG VY A D+ + VA+K++ NL+ +
Sbjct: 3 EILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPK 59
Query: 185 R-FMAREIHILRRLDHINVIKLEGLVTSRMSC-SLYLVFEYMEH-DLAGLASHPGLKFSE 241
+ + EI ++R H N++ + S + L++V EY+ L + + + E
Sbjct: 60 KELIINEILVMRENKHPNIVNY---LDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--E 114
Query: 242 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301
Q+ ++ L L+ HS V+HRDIK N+L+ +G +K+ DFG + P+Q++ +
Sbjct: 115 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-S 173
Query: 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 361
+ V T ++ PE++ YG VD+WS G + E+ G+P + L+ I
Sbjct: 174 TMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----- 227
Query: 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421
AT P+ ++ F+DF + L +D RGSA
Sbjct: 228 --------------ATNGTPELQNPEKLSAIFRDF-------LNRCLEMDVEKRGSAKEL 266
Query: 422 LRSEFFTM-KPL 432
L+ F + KPL
Sbjct: 267 LQHPFLKIAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEG 207
IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L++L H N I+ +G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 208 LVTSRMSCSLYLVFEYM---EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ +LV EY D+ + P E ++ L GL + HS +
Sbjct: 83 CYLREHTA--WLVMEYCLGSASDILEVHKKP---LQEVEIAAICHGALQGLAYLHSHERI 137
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT--YYG 322
HRDIK N+L+ G +K+ADFG AS P S V T ++ PE++L Y
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPAN-----SFVGTPYWMAPEVILAMDEGQYD 192
Query: 323 TAVDLWSTGCILAELYAGKP 342
VD+WS G EL KP
Sbjct: 193 GKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 149 IGQGTY--SNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G+G + + +YR + D +V K+V L + R EI IL L H N+I
Sbjct: 8 LGKGAFGEATLYRRTEDDS--LVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+L + EY L G F E V Y+ Q++ + + H G+L
Sbjct: 66 NHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRDIK N+ + G++K+ DFG++ + + T V T +Y PEL G Y +
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFKS 182
Query: 325 VDLWSTGCILAEL 337
D+W+ GC+L EL
Sbjct: 183 -DIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 80/287 (27%), Positives = 129/287 (44%), Gaps = 44/287 (15%)
Query: 149 IGQGTYSNVYRARD---LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+G+G++ VY +D + ++++ LK++ L P +E +L +LDH ++K
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 206 EGLVTSRMSCSLYLVFEYME-HDL---AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
R + ++ EY E DL H G SE QV + QLL G+ + H R
Sbjct: 68 HASFLERDA--FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFY--DPDQNQPLTSRVVTLWYRPPELLLGAT 319
+LHRD+K N+ + NN +LKI DFG++ D T T +Y PE L
Sbjct: 126 RILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTG---TPYYMSPE-ALKHQ 180
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
Y + D+WS GCIL E+ G+ + + +I + +PS LP
Sbjct: 181 GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPS--------LPET--- 228
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
+ ++M+++L+ DP+ R SAA LR+ F
Sbjct: 229 ----------------YSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 77/273 (28%), Positives = 116/273 (42%), Gaps = 43/273 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVIK 204
I +G + +VY A+ A+K ++ ++ + +V+ + I + V K
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG--ESPYVAK 61
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L S+ LYLV EY+ D A L G E K Y+ +++ G++ H RG+
Sbjct: 62 LYYSFQSKDY--LYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYG 322
+HRDIK NLLID G LK+ DFGL+ +N + V T Y PE +LG
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVG-DD 171
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
D WS GC++ E G P E +F + I P+
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPF----HAETPDAVFD-------------NILSRRINWPE 214
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
+ + C E A+ L+ LL +DPA R
Sbjct: 215 EVKEFCSPE--------AVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 6e-21
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIH------ILRRLDHIN 201
+G GT+ V+ RD + ALK + PE +R + +E H +L+ + H
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAI----PEVIR-LKQEQHVHNEKRVLKEVSHPF 62
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
+I+L T LY++ EY+ +L + G +FS + Y +++C L++ HS
Sbjct: 63 IIRLF--WTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHS 119
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----YRPPELLL 316
+ +++RD+K N+L+D G +K+ DFG A + L R TL Y PE ++
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFA--------KKLRDRTWTLCGTPEYLAPE-VI 170
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
+ + AVD W+ G ++ E+ G P KI
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR----FDNLEPESVRFMAREIHILRRLDHINVIK 204
+G G + V + + + ALK V+ + + E + E IL +H ++K
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57
Query: 205 LEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L T + +Y++ EY +L + GL F E + Y+ ++ ++ H+RG+
Sbjct: 58 L--YRTFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLHNRGI 114
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYG 322
++RD+K NLL+D+NG +K+ DFG A ++ T T Y PE++L Y
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKG-YD 170
Query: 323 TAVDLWSTGCILAELYAGKP 342
+VD WS G +L EL G+P
Sbjct: 171 FSVDYWSLGILLYELLTGRP 190
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 1e-20
Identities = 68/227 (29%), Positives = 111/227 (48%), Gaps = 17/227 (7%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIK 204
L+G+G + VY D D + +A+K+V FD E+ V + EI +L+ L H +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK----FSEAQVKCYMQQLLCGLDHCHS 260
G + L + EYM G + LK +E + Y +Q+L G+ + HS
Sbjct: 69 YYGCLRDPEEKKLSIFVEYM----PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP--DQNQPLTSRVVTLWYRPPELLLGA 318
++HRDIKG+N+L D+ G +K+ DFG + + S T ++ PE++ G
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365
YG D+WS C + E+ KP E E + IFK+ P++
Sbjct: 185 G-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTK 227
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 73/209 (34%), Positives = 103/209 (49%), Gaps = 23/209 (11%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G VY+ ++ ALK V + N E R + REI ILR ++H NV+K +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALK-VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
+ + ++ E+M+ L G +H E + +Q+L G+ + H R ++HRD
Sbjct: 141 FDH--NGEIQVLLEFMDGGSLEG--THIA---DEQFLADVARQILSGIAYLHRRHIVHRD 193
Query: 268 IKGSNLLIDNNGILKIADFG----LASFYDPDQNQPLTSRVVTLWYRPPEL----LLGAT 319
IK SNLLI++ +KIADFG LA D P S V T+ Y PE L
Sbjct: 194 IKPSNLLINSAKNVKIADFGVSRILAQTMD-----PCNSSVGTIAYMSPERINTDLNHGA 248
Query: 320 YYGTAVDLWSTGCILAELYAGK-PIMPGR 347
Y G A D+WS G + E Y G+ P GR
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 4e-20
Identities = 64/195 (32%), Positives = 101/195 (51%), Gaps = 5/195 (2%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+GT+ VY+ R D ++I A+K + + + + + V E +IL R + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 208 LVTSRMSCS-LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
L S + S LYLV +YM +L G +FSE + K Y+ +L+ L+H H +++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVY 119
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K N+L+D G + + DFGL S + N+ + T Y PE+LL Y V
Sbjct: 120 RDLKPENILLDATGHIALCDFGL-SKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178
Query: 326 DLWSTGCILAELYAG 340
D WS G ++ E+ G
Sbjct: 179 DFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 8e-20
Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 15/229 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEG 207
IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L+R+ H N I+ +G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
+ +LV EY + L E ++ L GL + HS ++HRD
Sbjct: 93 CYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT--YYGTAV 325
IK N+L+ G +K+ADFG AS P S V T ++ PE++L Y V
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVILAMDEGQYDGKV 205
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK-----LCGSPSEDYWR 369
D+WS G EL KP + + L+ I + L + DY+R
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 9e-20
Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 12/234 (5%)
Query: 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESV 184
P A+ F K D +FS IG G++ VY ARD+ ++VA+KK+ + + E
Sbjct: 2 PDVAELFFK-DDPEKLFS-DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 185 RFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQV 244
+ + +E+ L++L H N I+ G + +LV EY + L E ++
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTA--WLVMEYCLGSASDLLEVHKKPLQEVEI 117
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
L GL + HS ++HRD+K N+L+ G++K+ DFG AS P V
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFV 172
Query: 305 VTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
T ++ PE++L Y VD+WS G EL KP + + L+ I
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 51/191 (26%), Positives = 96/191 (50%), Gaps = 6/191 (3%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G++ + + K +K++ + P+ +E+ +L + H N+++ +
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE- 66
Query: 209 VTSRMSCSLYLVFEYMEH-DL-AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + +LY+V +Y E DL + + G+ F E Q+ + Q+ L H H R +LHR
Sbjct: 67 -SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHR 125
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
DIK N+ + +G +K+ DFG+A + T + T +Y PE+ Y + D
Sbjct: 126 DIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC-IGTPYYLSPEICENRPYNNKS-D 183
Query: 327 LWSTGCILAEL 337
+W+ GC+L E+
Sbjct: 184 IWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-19
Identities = 65/216 (30%), Positives = 97/216 (44%), Gaps = 9/216 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
L+G+G + V R+ I A+K ++ L E+V F E IL + + +L
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL- 66
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ +LYLV EY DL L + +F E + Y+ +L+ + H G +H
Sbjct: 67 -QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL-----GATY 320
RDIK N+LID G +K+ADFG A+ ++ V T Y PE+L G
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
YG D WS G I E+ G+ T + + I
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 65/206 (31%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G + V R K++ A+K + +F+ ++ F E I+ H N E
Sbjct: 50 VIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA---HANS---E 103
Query: 207 GLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
+V ++ + LY+V EYM DL L S+ E + Y +++ LD H
Sbjct: 104 WIV--QLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIH 159
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL--- 316
S G +HRD+K N+L+D +G LK+ADFG D + + V T Y PE+L
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219
Query: 317 GATYYGTAVDLWSTGCILAELYAGKP 342
G YYG D WS G L E+ G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDT 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 26/205 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G + V + K+ A KK+ L+ MA +N K+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA-----------LNEKKILEK 49
Query: 209 VTSRMSCSLYLVFEYMEH-----------DLAGLASHPGLK-FSEAQVKCYMQQLLCGLD 256
V+SR SL FE + DL + G F EA+ Y Q++CGL+
Sbjct: 50 VSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLE 109
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
H H R +++RD+K N+L+D++G ++I+D GLA + + + R T Y PE+L
Sbjct: 110 HLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAV--ELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 317 GATYYGTAVDLWSTGCILAELYAGK 341
G Y +VD ++ GC L E+ AG+
Sbjct: 168 GEV-YDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 40/281 (14%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G++ V++ D +++VA+K + + E E + + +EI +L + D V K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG- 69
Query: 209 VTSRMSCSLYLVFEYME--HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ L+++ EY+ L L + P F E Q+ ++++L GLD+ HS +HR
Sbjct: 70 -SYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKKIHR 125
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
DIK +N+L+ G +K+ADFG+A Q + T W P ++ + Y + D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--VIQQSAYDSKAD 183
Query: 327 LWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK-PQQPY 385
+WS G EL G+P P+ D P +F P+
Sbjct: 184 IWSLGITAIELAKGEP--------------------PNSDMH-----PMRVLFLIPKNNP 218
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
E K F ++ L+ DP+ R +A L+ +F
Sbjct: 219 PTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 71/234 (30%), Positives = 111/234 (47%), Gaps = 12/234 (5%)
Query: 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESV 184
P AD F K D IF + IG G++ VY A + ++VA+KK+ + + E
Sbjct: 8 PEIADLFYKDDPE-EIFV-GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW 65
Query: 185 RFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQV 244
+ + +E+ L++L H N I+ +G + +LV EY + L E ++
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA--WLVMEYCLGSASDLLEVHKKPLQEVEI 123
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
L GL + HS ++HRDIK N+L+ G +K+ADFG AS ++ P S V
Sbjct: 124 AAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFV 178
Query: 305 VTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
T ++ PE++L Y VD+WS G EL KP + + L+ I
Sbjct: 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 36/289 (12%)
Query: 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
F IGQG VY A D+ + VA+K++ +P+ + EI ++R + N++
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKK-ELIINEILVMRENKNPNIVNY 81
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
L + + L++V EY+ L + + + E Q+ ++ L LD HS V+
Sbjct: 82 --LDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALDFLHSNQVI 137
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++ YG
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-YGPK 195
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
VD+WS G + E+ G+P + L+ I AT P+
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------------ATNGTPELQ 236
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPL 432
++ F+DF + L +D RGSA L+ F + KPL
Sbjct: 237 NPERLSAVFRDF-------LNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 72/253 (28%), Positives = 122/253 (48%), Gaps = 19/253 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEG 207
+G GTY +VY+AR+L ++ A+K ++ LEP + + +EI +++ H N++ G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
SR L++ EY H SE Q+ ++ L GL + HS+G +HRD
Sbjct: 74 SYLSREK--LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRD 131
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY--YGTAV 325
IKG+N+L+ +NG +K+ADFG+A+ + S + T ++ PE+ Y
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKITATIAKR-KSFIGTPYWMAPEVAAVEKNGGYNQLC 190
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK----- 380
D+W+ G EL +P M ++ + +F + S + K K ++ F
Sbjct: 191 DIWAVGITAIELAELQPPM---FDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247
Query: 381 --PQQPYKRCVAE 391
+ P KR AE
Sbjct: 248 SLTKNPKKRPTAE 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 78/287 (27%), Positives = 138/287 (48%), Gaps = 38/287 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMAREIHILRRLDHINVIKLEG 207
IGQG V+ A D+ + VA+K++ NL+ + + + EI +++ L + N++
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNF-- 81
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
L + + L++V EY+ L + + + EAQ+ ++ L L+ H+ V+HR
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCM--DEAQIAAVCRECLQALEFLHANQVIHR 139
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
DIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++ YG VD
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-YGPKVD 197
Query: 327 LWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386
+WS G + E+ G+P + L+ I G+P + Q P K
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLI-ATNGTP----------------ELQNPEK 240
Query: 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPL 432
++ F+DF + L +D RGSA L+ F + KPL
Sbjct: 241 --LSPIFRDF-------LNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 10/202 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G +V + R + I ALK + D P+ + + RE+ I + ++K G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 209 VTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
S S+ + EY E + G + E + + +L GL + HSR ++
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKII 127
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRDIK SN+L+ G +K+ DFG++ T T +Y PE + G Y T+
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQGKPYSITS 184
Query: 325 VDLWSTGCILAELYAGK-PIMP 345
D+WS G L E+ + P P
Sbjct: 185 -DVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 61/194 (31%), Positives = 103/194 (53%), Gaps = 6/194 (3%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G++ V++ D +K+VA+K + + E E + + +EI +L + D V K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG- 69
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI 268
+ L+++ EY+ A PG E Q+ ++++L GLD+ HS +HRDI
Sbjct: 70 -SYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 269 KGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLW 328
K +N+L+ +G +K+ADFG+A D + V T ++ PE++ + Y A D+W
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVIKQSAYDSKA-DIW 185
Query: 329 STGCILAELYAGKP 342
S G EL G+P
Sbjct: 186 SLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 8e-19
Identities = 78/289 (26%), Positives = 136/289 (47%), Gaps = 36/289 (12%)
Query: 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
F IGQG VY A D+ + VA++++ +P+ + EI ++R + N++
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKK-ELIINEILVMRENKNPNIVNY 82
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
L + + L++V EY+ L + + + E Q+ ++ L L+ HS V+
Sbjct: 83 --LDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSNQVI 138
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++ YG
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-YGPK 196
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
VD+WS G + E+ G+P + L+ I G+P + Q P
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-ATNGTP----------------ELQNP 239
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPL 432
K ++ F+DF + L +D RGSA L+ +F + KPL
Sbjct: 240 EK--LSAIFRDF-------LNRCLDMDVEKRGSAKELLQHQFLKIAKPL 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 73/290 (25%), Positives = 135/290 (46%), Gaps = 35/290 (12%)
Query: 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
++ IG+G+ V AR+ + VA+K + + + F E+ I+R H NV++
Sbjct: 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF--NEVVIMRDYQHQNVVE 82
Query: 205 LEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ + + L+++ E+++ L + S + +E Q+ + +L L + HS+GV
Sbjct: 83 M--YKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGV 138
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRDIK ++L+ +G +K++DFG + D + S V T ++ PE ++ T YGT
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPE-VISRTPYGT 196
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
VD+WS G ++ E+ G+P + V+ + ++ R S P
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPPPKLKNAHKIS 244
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
P +DF +E +L+ +P +R +A L F LP
Sbjct: 245 P-------VLRDF-------LERMLTREPQERATAQELLDHPFLLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 36/285 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + VY+A+ + A K ++ ++ E E FM EI IL H N++ L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMV-EIDILSECKHPNIVGL--Y 68
Query: 209 VTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
L+++ E+ + L + +E Q++ +Q+L L+ HS V+HRD
Sbjct: 69 EAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY----YGT 323
+K N+L+ +G +K+ADFG+ S + Q + + T ++ PE++ T+ Y
Sbjct: 129 LKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
D+WS G L EL +P P E+ + + K+ S + SK
Sbjct: 188 KADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEPPTLDQPSKW---------- 234
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
+ +F DF L DP DR +AA L+ F +
Sbjct: 235 ------SSSFNDFLKSCLVK-------DPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G++ VY+ D K++VA+K + + E E + + +EI +L + D + + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYYG- 69
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI 268
+ L+++ EY+ A PG E + ++++L GLD+ HS +HRDI
Sbjct: 70 -SYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 269 KGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLW 328
K +N+L+ G +K+ADFG+A Q + T W P ++ + Y D+W
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE--VIKQSAYDFKADIW 185
Query: 329 STGCILAELYAGKP 342
S G EL G+P
Sbjct: 186 SLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 148 LIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLE--------PESVRFMAREIHILR-RL 197
+G G + VY+ R + + ++ALK++ N +S+ + E+ I++ +L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 198 DHINVIK-----LEGLVTSRMSCSLYLVFEYMEHDLAGLASH------PGLKFSEAQVKC 246
H N+++ LE LY+V + +E A L H +F+E ++
Sbjct: 67 RHPNIVRYYKTFLEN-------DRLYIVMDLIEG--APLGEHFNSLKEKKQRFTEERIWN 117
Query: 247 YMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305
Q++ L + H + ++HRD+ +N+++ + + I DFGLA P LTS V
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP--ESKLTSVVG 175
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP 342
T+ Y PE++ YG D+W+ GCIL ++ +P
Sbjct: 176 TILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQP 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 60/199 (30%), Positives = 105/199 (52%), Gaps = 9/199 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEG 207
IG GTY +VY+AR+++ ++ A+K ++ LEP E + +EI +++ H N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
R L++ E+ H SE+Q+ ++ L GL + HS+G +HRD
Sbjct: 74 SYLRRDK--LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRD 131
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL--LLGATYYGTAV 325
IKG+N+L+ +NG +K+ADFG+++ + S + T ++ PE+ + Y
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKR-KSFIGTPYWMAPEVAAVERKGGYNQLC 190
Query: 326 DLWSTGCILAELYAGKPIM 344
D+W+ G EL +P M
Sbjct: 191 DIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 149 IGQGTYSNV----YRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + V Y + ++VA+K ++ + ++ +EI+IL+ L H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVK 70
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+G + + L L+ EY+ L L + P K + AQ+ + QQ+ G+ + HS+
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHY 128
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLAS-------FY--DPDQNQPLTSRVVTLWYRPPEL 314
+HRD+ N+L+DN+ ++KI DFGLA +Y D + P+ WY L
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV------FWYAVECL 182
Query: 315 LLGATYYGTAVDLWSTGCILAEL 337
Y A D+WS G L EL
Sbjct: 183 KENKFSY--ASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRRLDHINVIKLEG 207
IG+G++ V + R D ++I ALK +R ++ S V E +L +++ ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
S LYLV ++ +L G +F ++ + Y +LLC L++ H V++R
Sbjct: 61 SFQSPEK--LYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+K N+L+D G + + DFGL D ++ T T Y PELLLG Y AVD
Sbjct: 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF-CGTPEYLAPELLLGHG-YTKAVD 175
Query: 327 LWSTGCILAELYAGKP 342
W+ G +L E+ G P
Sbjct: 176 WWTLGVLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 149 IGQGTYSNV----YRARDLDQKKIVALKKVRFDNLEPES----VRFMAREIHILRRLDHI 200
+G+G + V Y + + VA+K +L+PES + + +EI ILR L H
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVK-----SLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYM-----EHDLAGLASHPGLKFSEAQVKCYMQQLLCGL 255
N++K +G+ T + L+ E++ + L + LK Q Y Q+ G+
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK----QQLKYAVQICKGM 122
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-----NQPLTSRVVTLWYR 310
D+ SR +HRD+ N+L+++ +KI DFGL + D+ L S V WY
Sbjct: 123 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV--FWY- 179
Query: 311 PPELLLGATYYGTAVDLWSTGCILAEL 337
PE L+ + +Y A D+WS G L EL
Sbjct: 180 APECLIQSKFY-IASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV----RFMAREIHILRRLDHINVI 203
++G+G Y VY +Q +++A+K+V D + + E+ +L+ L H+N++
Sbjct: 7 VLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 204 KLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ G T ++ + E++ + E Y +Q+L G+ + H+ V
Sbjct: 66 QYLG--TCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFY-----DPDQNQPLTSRVVTLWYRPPELLLGA 318
+HRDIKG+N+++ NGI+K+ DFG A + L S T ++ PE ++
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINE 182
Query: 319 TYYGTAVDLWSTGCILAELYAGKP 342
+ YG D+WS GC + E+ GKP
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + V+ + K++VA+K ++ + ++ + RE +L H N++
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASH-PGLKF-----------SEAQVKCYMQ 249
K G+ T +VFEYMEH DL L SH P F + +Q+
Sbjct: 72 KFYGVCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLW 308
Q+ G+ + S+ +HRD+ N L+ + ++KI DFG++ Y D + ++ +
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAELYA-GK 341
+ PPE ++ + T D+WS G +L E++ GK
Sbjct: 190 WMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-18
Identities = 61/232 (26%), Positives = 109/232 (46%), Gaps = 12/232 (5%)
Query: 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINV 202
R + ++G+G + V + K+ A KK+ ++ MA E IL +++ V
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 62
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHC 258
+ L ++ + L LV M DL + PG F E + Y ++ CGL+
Sbjct: 63 VSLAYAYETKDA--LCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDL 118
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
H +++RD+K N+L+D+ G ++I+D GLA + + + + RV T+ Y PE++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIRISDLGLAV--EIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370
Y + D W GC++ E+ GK R E + ++ + E+Y K
Sbjct: 177 R-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 79/312 (25%), Positives = 123/312 (39%), Gaps = 44/312 (14%)
Query: 145 SFYLIGQGTYSN--VYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 202
LIG+ V+ A+ +VA+KK+ D+ E ++ + +EI R+L H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 203 IKLEGLVTSRMSCS-LYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 257
+ VTS + S LY+V M + DL L +H E + ++ +L LD+
Sbjct: 62 LP---YVTSFIVDSELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDY 116
Query: 258 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQ-----PLTSRVVTLWYRP 311
HS+G +HR +K S++L+ +G + ++ + S + Q S V L +
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLS 176
Query: 312 PELL----LGATYYGTAVDLWSTGCILAEL------YAGKPIMPGRTE-----VEQLHKI 356
PE+L G Y D++S G EL + P E V L
Sbjct: 177 PEVLQQNLQG---YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK 233
Query: 357 FKLCGSPSEDYWRKSKLPHATIFKPQQ-PYKRCVAETFKDFPAPALALMETLLSIDPADR 415
+S H PY R +E F F +E L DP R
Sbjct: 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQF-------VELCLQRDPESR 286
Query: 416 GSAASALRSEFF 427
SA+ L FF
Sbjct: 287 PSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 71/263 (26%), Positives = 100/263 (38%), Gaps = 73/263 (27%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G + V + D I A+KK+R + LE E V + E IL D+ V+K
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK-- 65
Query: 207 GLVTSRMSCS------LYLVFEYMEHDLAGLASHPG-------LK---FSEAQVKCYMQQ 250
+ S LYL+ EY+ PG +K F+E + + Y+ +
Sbjct: 66 ------LYYSFQDENYLYLIMEYL----------PGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 251 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL---------ASFY-DPDQNQPL 300
+ +D H G +HRDIK NLL+D G +K++DFGL FY P
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 301 TSRVVTL-----------W----------------YRPPELLLGATYYGTAVDLWSTGCI 333
W Y PE+ L T Y D WS G I
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVI 228
Query: 334 LAELYAGKPIMPGRTEVEQLHKI 356
+ E+ G P E KI
Sbjct: 229 MYEMLVGYPPFCSDNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 86/320 (26%), Positives = 130/320 (40%), Gaps = 70/320 (21%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+IG+G + VY R D K+ A+K K R + E++ R I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-------------IM 47
Query: 205 LEGLVTSRMSCSLYLVFEYMEH---------------DLAGLASHPGLKFSEAQVKCYMQ 249
L + S C + Y H DL S G+ FSEA+++ Y
Sbjct: 48 LS--LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAA 104
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 309
+++ GL+H H+R V++RD+K +N+L+D +G ++I+D GLA D + +P S V T Y
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGY 161
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369
PE+L Y ++ D +S GC+L +L G SP +
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH--------------------SPFRQHKT 201
Query: 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR----GSAASALR-S 424
K K + E F +L+E LL D R G A ++
Sbjct: 202 KDKHEIDRMTLTMAV------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255
Query: 425 EFFTMKPLPCDPSSLPKYPP 444
FF + L L KYPP
Sbjct: 256 PFF--RSLDWQMVFLQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 3e-17
Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES---VRFMAREIHILRRLDHINVIK 204
++G+G++ + ++ + A+K++R P+S V +E +L ++ H N++
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRL----PKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 205 LEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ + LY+V EY + + + G F E + + Q+ G+ H H +
Sbjct: 63 FKE--SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
VLHRDIK N+ + NG +K+ DFG A T V T +Y PPE+ Y
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPYNN 179
Query: 323 TAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLC 360
+ D+WS GCIL EL K P + + I K+C
Sbjct: 180 KS-DIWSLGCILYELCTLKHPFQANSWK----NLILKVC 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 64/198 (32%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G + V R +K+ A+K + +F+ ++ F E I+ + V++L
Sbjct: 50 VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 108
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ LY+V EYM DL L S+ E K Y +++ LD HS G++H
Sbjct: 109 -FCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIH 165
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL---GATYYG 322
RD+K N+L+D +G LK+ADFG D + V T Y PE+L G YYG
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 323 TAVDLWSTGCILAELYAG 340
D WS G L E+ G
Sbjct: 226 RECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 38/269 (14%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G + V+ L+++K VA+K +R + E E ++ +L H +++L G+
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI---EEAQVMMKLSHPKLVQLYGV 67
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCG--LDHCH------S 260
T R + LVFE+MEH G S + AQ + Q+ L G LD C S
Sbjct: 68 CTER--SPICLVFEFMEH---GCLS----DYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
V+HRD+ N L+ N ++K++DFG+ F DQ T + + PE + +
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPE-VFSFSK 177
Query: 321 YGTAVDLWSTGCILAELYA-GKPIMPGRTE---VEQLHKIFKLCGSPSEDYWRKSKLPHA 376
Y + D+WS G ++ E+++ GK R+ VE ++ F+L K +L
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL---------YKPRLASQ 228
Query: 377 TIFKPQQPYKRCVAETFKDFPAPALALME 405
++++ Q C E +D P+ +L L +
Sbjct: 229 SVYELMQ---HCWKERPEDRPSFSLLLHQ 254
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 149 IGQGTYSNVYRA---RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK 204
IG+GTY VY+ +D + L + + E E+ E +IL+ L +H NV+K
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA------EYNILQSLPNHPNVVK 83
Query: 205 LEGLVTSRMSCS---LYLVFEY-----MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 256
G+ L+LV E + + GL G + EA + + L GL
Sbjct: 84 FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQ 142
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
H H+ ++HRD+KG+N+L+ G +K+ DFG+++ + + TS W P +
Sbjct: 143 HLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 202
Query: 317 GATY---YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
Y Y D+WS G EL G P + V+ L KI
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G + +VY+ L VA+K R L P+ R +E IL++ DH N++KL G
Sbjct: 2 KIGKGNFGDVYKGV-LKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLC-----GLDHCHSRG 262
+ + +Y+V E + L + L+ + ++ + G+++ S+
Sbjct: 60 VCVQKQP--IYIVMELVPG--GSLLTF--LRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--QNQPLTSRVVTLWYRPPELLLGATY 320
+HRD+ N L+ N +LKI+DFG++ + ++ W P L G
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR-- 171
Query: 321 YGTAVDLWSTGCILAELYAG 340
Y + D+WS G +L E ++
Sbjct: 172 YTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
++G+G++ V+ A + A+K ++ D V M ++ + + E
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKD------VVLMDDDVECTMVEKRVLSLAWEH 55
Query: 208 LVTSRMSCS------LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+ + C+ L+ V EY+ KF + Y +++CGL HS+
Sbjct: 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP----PELLLG 317
G+++RD+K N+L+D +G +KIADFG+ +N ++ T P PE+LLG
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
Y T+VD WS G +L E+ G+ G E E I
Sbjct: 171 QK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G + V R +K+ A+K + +F+ ++ F E I+ + V++L
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 108
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ LY+V EYM DL L S+ E + Y +++ LD HS G +H
Sbjct: 109 -FYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIH 165
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL---GATYYG 322
RD+K N+L+D +G LK+ADFG + + + V T Y PE+L G YYG
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 225
Query: 323 TAVDLWSTGCILAELYAG 340
D WS G L E+ G
Sbjct: 226 RECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 36/104 (34%), Positives = 63/104 (60%), Gaps = 1/104 (0%)
Query: 238 KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297
F+E++V+ Y+ +++ LDH H G+++RDIK N+L+D+ G + + DFGL+ + ++
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160
Query: 298 QPLTSRVVTLWYRPPELLLGATY-YGTAVDLWSTGCILAELYAG 340
+ S T+ Y PE++ G + + AVD WS G + EL G
Sbjct: 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 76/290 (26%), Positives = 133/290 (45%), Gaps = 35/290 (12%)
Query: 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+F IG+G+ V A K+VA+KK+ + + F E+ I+R H NV++
Sbjct: 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF--NEVVIMRDYQHENVVE 81
Query: 205 LEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ + + L++V E++E L + +H + +E Q+ +L L H++GV
Sbjct: 82 MYN--SYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGV 137
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRDIK ++L+ ++G +K++DFG + + S V T ++ PE L+ YG
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPE-LISRLPYGP 195
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
VD+WS G ++ E+ G+P ++ + I + LP P+
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLP------PKL 236
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
V+ + K F ++ LL DPA R +AA L+ F P
Sbjct: 237 KNLHKVSPSLKGF-------LDRLLVRDPAQRATAAELLKHPFLAKAGPP 279
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 43/176 (24%), Positives = 85/176 (48%), Gaps = 10/176 (5%)
Query: 190 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCY 247
E ++ +L H N+++L G+ T + +++V EYM + L L G K +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRP--IFIVTEYMANGCLLNYLRERKG-KLGTEWLLDM 105
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307
+ +++ S G +HRD+ N L+ + ++K++DFGLA + DQ +
Sbjct: 106 CSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTE---VEQLHKIFKL 359
+ PPE+ + + + D+WS G ++ E+++ GK + VE + ++L
Sbjct: 166 KWAPPEVFD-YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 72/252 (28%), Positives = 105/252 (41%), Gaps = 48/252 (19%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG G + V R +D + A+K +R D L + E IL D+ V+KL
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL-- 66
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + +LY V +Y+ D+ L G+ F E + Y+ +L C ++ H G +HR
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVHKMGFIHR 125
Query: 267 DIKGSNLLIDNNGILKIADFGLAS---------FYDPDQN-------------------- 297
DIK N+LID +G +K+ DFGL + +Y +
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRL 185
Query: 298 QPLTSR-------------VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 344
+PL R V T Y PE+LL T Y D WS G IL E+ G+P
Sbjct: 186 KPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPF 244
Query: 345 PGRTEVEQLHKI 356
T E K+
Sbjct: 245 LADTPAETQLKV 256
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 148 LIGQGTYSNVYRAR-DLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + +V R D Q ++VA+KK++ E +R REI IL+ L H N++
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIV 68
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
K +G+ S +L LV EY+ + L + ++ Y Q+ G+++ S+
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-----QPLTSRVVTLWYRPPELLLG 317
+HRD+ N+L+++ +KI DFGL D+ +P S + WY P L
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI--FWYAPES--LT 184
Query: 318 ATYYGTAVDLWSTGCILAELY 338
+ + A D+WS G +L EL+
Sbjct: 185 ESKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 63/223 (28%), Positives = 98/223 (43%), Gaps = 19/223 (8%)
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
FSE +V+ Y +++ L+H H G+++RDIK N+L+D+ G + + DFGL+ + ++ +
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP--IMPGR--TEVEQLH 354
S T+ Y PE++ G +G AVD WS G ++ EL G + G T+ E
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 355 KIFKLCGS-PSEDYWRKSKLPHATIFKPQQPYKRCVAET-----------FKDFPAPALA 402
+I K PS L H + K P KR A FK ALA
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLLRK--DPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279
Query: 403 LMETLLSIDPADRGSA-ASALRSEFFTMKPLPCDPSSLPKYPP 444
L + P+ R EF ++P+ + P
Sbjct: 280 LRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGTPPSGAR 322
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 72/290 (24%), Positives = 135/290 (46%), Gaps = 35/290 (12%)
Query: 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
SF IG+G+ V A + K VA+KK+ + + F E+ I+R H NV+
Sbjct: 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF--NEVVIMRDYHHENVVD 83
Query: 205 LEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ + + L++V E++E L + +H + +E Q+ +L L + H++GV
Sbjct: 84 MYN--SYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGV 139
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRDIK ++L+ ++G +K++DFG + + + S V T ++ PE ++ YGT
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR-KSLVGTPYWMAPE-VISRLPYGT 197
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
VD+WS G ++ E+ G+P ++ + +I + LP P+
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI-------------RDNLP------PRV 238
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
V+ + F ++ +L +P+ R +A L+ F + P
Sbjct: 239 KDSHKVSSVLRGF-------LDLMLVREPSQRATAQELLQHPFLKLAGPP 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 31/208 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+IG+G + VY R D K+ A+K + ++ + +A I+ L
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL---------- 50
Query: 208 LVTSRMSCSLYLVFEYMEH---------------DLAGLASHPGLKFSEAQVKCYMQQLL 252
S C + Y H DL S G+ FSE +++ Y +++
Sbjct: 51 --VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEII 107
Query: 253 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 312
GL+H H+R V++RD+K +N+L+D +G ++I+D GLA D + +P S V T Y P
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHAS-VGTHGYMAP 164
Query: 313 ELLLGATYYGTAVDLWSTGCILAELYAG 340
E+L T Y ++ D +S GC+L +L G
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 55/194 (28%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
++G+G + V+ R +K+V +K++ + + + E +L+ L H N+I E
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII--EY 64
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK-FSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+L +V EY LA E + + Q+L L H H++ +LH
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH 124
Query: 266 RDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGT 323
RD+K N+L+D + ++KI DFG++ ++ VV T Y PEL G Y
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 324 AVDLWSTGCILAEL 337
+ D+W+ GC+L EL
Sbjct: 182 S-DIWALGCVLYEL 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 6e-16
Identities = 65/218 (29%), Positives = 109/218 (50%), Gaps = 15/218 (6%)
Query: 148 LIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAR---EIHILRRLDHIN 201
++GQG++ V+ R + D ++ A+K ++ L+ VR R E IL ++H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK---VRDRVRTKMERDILAEVNHPF 59
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
++KL + LYL+ +++ DL S + F+E VK Y+ +L LDH HS
Sbjct: 60 IVKLH--YAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHS 116
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
G+++RD+K N+L+D G +K+ DFGL S D + S T+ Y PE ++
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 174
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
+ + D WS G ++ E+ G G+ E + I K
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
++G+G++ V A + A+K ++ D LE + V E +L + E
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVL-------ALAWE 54
Query: 207 GLVTSRMSCS------LYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHC 258
+ + C+ L+ V EY+ L H +F EA+ + Y +++CGL
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNG--GDLMFHIQSSGRFDEARARFYAAEIICGLQFL 112
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----YRPPEL 314
H +G+++RD+K N+L+D +G +KIADFG+ +N + T Y PE+
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-----ENMNGEGKASTFCGTPDYIAPEI 167
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
L G Y +VD WS G +L E+ G+ G E E I
Sbjct: 168 LKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 58/234 (24%), Positives = 109/234 (46%), Gaps = 16/234 (6%)
Query: 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINV 202
R + ++G+G + V + K+ A K++ ++ MA E IL +++ V
Sbjct: 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV 62
Query: 203 IKLEGLVTSRMSCSLYLV------FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 256
+ L ++ + L L ++ +++ +PG F E + Y ++LCGL+
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG----NPG--FEEERALFYAAEILCGLE 116
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
H ++RD+K N+L+D+ G ++I+D GLA + + + RV T+ Y PE +L
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPE-VL 173
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370
Y + D W GC++ E+ G+ GR E + ++ + E Y K
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 33/275 (12%)
Query: 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINV 202
R + ++G+G + V + K+ A KK+ ++ MA E IL +++ V
Sbjct: 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFV 62
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHS 260
+ L ++ + L LV M DL H G F E + Y ++ CGL+ H
Sbjct: 63 VSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
+++RD+K N+L+D++G ++I+D GLA Q + RV T+ Y PE++ Y
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERY 178
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
+ D W+ GC+L E+ AG+ R + + ++ +L E+Y K F
Sbjct: 179 TFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK--------FS 229
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
P A +L + LL DP +R
Sbjct: 230 PD-----------------ARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-16
Identities = 75/258 (29%), Positives = 112/258 (43%), Gaps = 52/258 (20%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRF-DNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G + V AR +D K + A+K +R D L V + E IL D+ V++L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL-- 66
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + +LY V +Y+ D+ L G+ F E + Y+ +L C ++ H G +HR
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKMGFIHR 125
Query: 267 DIKGSNLLIDNNGILKIADFGLASFY---------------------------DP----- 294
DIK N+LID +G +K+ DFGL + + DP
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 295 -DQNQPLTSR-------------VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG 340
D+ +PL R V T Y PE+LL T Y D WS G IL E+ G
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLVG 244
Query: 341 KPIMPGRTEVEQLHKIFK 358
+P +T +E K+
Sbjct: 245 QPPFLAQTPLETQMKVIN 262
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 85/304 (27%), Positives = 129/304 (42%), Gaps = 57/304 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVI 203
LI G Y VY R + ++ A+KK+ NL + + V F+ R+I L ++ V+
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQV-FVERDI--LTFAENPFVV 64
Query: 204 KLEG-LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+ T R C +V EY+E D A L + G + + Y + + L++ H+
Sbjct: 65 SMFCSFETKRHLC---MVMEYVEGGDCATLLKNIGALPVD-MARMYFAETVLALEYLHNY 120
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLAS-------------FYDPDQNQPLTSRVV-TL 307
G++HRD+K NLLI + G +K+ DFGL+ + D + L +V T
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
Y PE++L YG VD W+ G IL E G G T E ++ S+D
Sbjct: 181 EYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------SDD- 232
Query: 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR---GSAASALRS 424
I P E + PA A L+ LL +P +R G A +
Sbjct: 233 ----------IEWP---------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273
Query: 425 EFFT 428
FF
Sbjct: 274 RFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 44/230 (19%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
++G+G++ V A ++ A+K ++ D L+ + V E +L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVL---------ALA 52
Query: 207 G---LVTSRMSC-----SLYLVFEY------MEHDLAGLASHPGLKFSEAQVKCYMQQLL 252
G +T SC L+ V EY M H +F E + + Y +++
Sbjct: 53 GKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFH------IQRSGRFDEPRARFYAAEIV 106
Query: 253 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW---- 308
GL H RG+++RD+K N+L+D+ G +KIADFG+ + + V T
Sbjct: 107 LGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC-------KEGILGGVTTSTFCGT 159
Query: 309 --YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
Y PE+L YG AVD W+ G +L E+ AG+ G E E I
Sbjct: 160 PDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ K VA+K ++ + PE+ +E I+++L H +++L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEA---FLQEAQIMKKLRHDKLVQLYAV 69
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ +Y+V EYM L L S G K Q+ Q+ G+ + SR +HR
Sbjct: 70 CSEEEP--IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHR 127
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT--- 323
D+ N+L+ N + KIADFGLA + D+ + + PE A YG
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE----AANYGRFTI 183
Query: 324 AVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+WS G +L E+ G+ PG T E L ++
Sbjct: 184 KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 57/206 (27%), Positives = 105/206 (50%), Gaps = 16/206 (7%)
Query: 148 LIGQGTYSNVYRAR-DLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+IG G + V R R L K+ VA+K ++ E + F++ E I+ + DH N+I
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-EASIMGQFDHPNIIH 69
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
LEG+VT S + ++ E+ME+ L +F+ Q+ ++ + G+ +
Sbjct: 70 LEGVVTK--SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-----LTSRVVTLWYRPPELLLGA 318
+HRD+ N+L+++N + K++DFGL+ F + D + P L ++ W P +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-- 185
Query: 319 TYYGTAVDLWSTGCILAEL--YAGKP 342
+ +A D+WS G ++ E+ Y +P
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-15
Identities = 67/259 (25%), Positives = 108/259 (41%), Gaps = 30/259 (11%)
Query: 190 EIHILRRLDHINVIKL-EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 248
E +L+ ++H +VI++ + LV+ ++C +V + DL + Q
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITC---MVLPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF--YDPDQNQPLTSRVVT 306
+Q+L GL + H++ ++HRD+K N+ I++ + I D G A F P L V T
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-FLGLAGTVET 222
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA----------GKPIMPGRTEVEQLHKI 356
PE+L Y + D+WS G +L E+ A P ++ L KI
Sbjct: 223 ---NAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI 278
Query: 357 FKLCGSPSEDYWRK--SKLPHATIFKP---QQPYKR--CVAETFKDFPAPALALMETLLS 409
E++ R S+L I +QPY R C + P L+ +L+
Sbjct: 279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRV--NLPIDGEFLVHKMLT 336
Query: 410 IDPADRGSAASALRSEFFT 428
D A R SA L F
Sbjct: 337 FDAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-15
Identities = 81/271 (29%), Positives = 118/271 (43%), Gaps = 45/271 (16%)
Query: 165 QKKIVALKKVRFDNLEPESVRFMAR-EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223
++K+VA +F L E AR E+H L DH ++K S L L+ EY
Sbjct: 93 KEKVVA----KFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIMEY 146
Query: 224 MEH-DLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 277
DL L H L F E +V Q++ LD HSR ++HRD+K +N+ +
Sbjct: 147 GSGGDLNKQIKQRLKEH--LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP 204
Query: 278 NGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAE 336
GI+K+ DFG + Y + + S T +Y PEL Y A D+WS G IL E
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA-DMWSLGVILYE 263
Query: 337 LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF 396
L LH+ FK PS+ ++ ++ P+ V+ K
Sbjct: 264 LLT-------------LHRPFK---GPSQ-----REIMQQVLYGKYDPFPCPVSSGMK-- 300
Query: 397 PAPALALMETLLSIDPADRGSAASALRSEFF 427
AL++ LLS +PA R + L +EF
Sbjct: 301 -----ALLDPLLSKNPALRPTTQQLLHTEFL 326
|
Length = 478 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 149 IGQGTYSNVYRAR-DLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG G + V R R L KK VA+K ++ + + + + F+ E I+ + DH N+I+L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-TEASIMGQFDHPNIIRL 70
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
EG+VT + ++ EYME+ L KF+ Q+ ++ + G+ + +
Sbjct: 71 EGVVTKSRP--VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV 128
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR---VVTLWYRPPELLLGATYY 321
HRD+ N+L+++N + K++DFGL S D T++ + W P + +
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGL-SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK--F 185
Query: 322 GTAVDLWSTGCILAEL--YAGKP 342
+A D+WS G ++ E+ Y +P
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH-INVIKLE 206
L+G GTY VY+ R + ++ A+K + E E ++ +EI++L++ H N+
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK---QEINMLKKYSHHRNIATYY 69
Query: 207 GLVTSR----MSCSLYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
G + M L+LV E+ DL + + G E + +++L GL H
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL-- 316
H V+HRDIKG N+L+ N +K+ DFG+++ D + T + T ++ PE++
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVIACD 186
Query: 317 ---GATYYGTAVDLWSTGCILAELYAGKP 342
ATY + DLWS G E+ G P
Sbjct: 187 ENPDATYDFKS-DLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 61/204 (29%), Positives = 108/204 (52%), Gaps = 14/204 (6%)
Query: 148 LIGQGTYSNVYRAR-DLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+IG G + V R L K+ VA+K ++ E + F++ E I+ + DH N+I
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLS-EASIMGQFDHPNIIH 69
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDL--AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
LEG+VT S + +V EYME+ A L H G +F+ Q+ ++ + G+ + G
Sbjct: 70 LEGVVTK--SKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMG 126
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR--VVTLWYRPPELLLGATY 320
+HRD+ N+L+++N + K++DFGL+ + D T+R + + + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE-AIAYRK 185
Query: 321 YGTAVDLWSTGCILAEL--YAGKP 342
+ +A D+WS G ++ E+ Y +P
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 72/285 (25%), Positives = 114/285 (40%), Gaps = 43/285 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G+Y V R K +KK+ N + +E +L +L H N+
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI------ 61
Query: 209 VTSRMS-----CSLYLVFEYMEH-DL-AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
V R S LY+V + E DL L G E QV + Q+ L + H +
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
+LHRD+K N+ + I+K+ D G+A + +Q ++ + T +Y PEL Y
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKP-Y 179
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381
D+W+ GC + E+ K + +++I + KL P
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------------EGKL-------P 220
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
P KD+ L+ T+LS P R S S LR +
Sbjct: 221 PMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 75/288 (26%), Positives = 120/288 (41%), Gaps = 58/288 (20%)
Query: 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVI 203
S +IG+G + V + D + A+K +R D LE E V + E IL D + V+
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
K+ +++ LYL+ E++ D+ L +E + + Y+ + + +D H G
Sbjct: 65 KMFYSFQDKLN--LYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLG 121
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGL---------------------------------- 288
+HRDIK NLL+D+ G +K++DFGL
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT 348
A + ++ Q S V T Y PE+ + T Y D WS G I+ E+ G P T
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 349 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF 396
E K+ W+++ IF P+ P ++E KD
Sbjct: 241 PQETYKKVMN---------WKET-----LIFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 50/143 (34%), Positives = 72/143 (50%), Gaps = 8/143 (5%)
Query: 217 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 275
LY V EY+ DL G KF E Y ++ GL HS+G+++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 276 DNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGATYYGTAVDLWSTGCI 333
D G +KIADFG+ + T+R T Y PE++ YG +VD W+ G +
Sbjct: 135 DAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVL 190
Query: 334 LAELYAGKPIMPGRTEVEQLHKI 356
L E+ AG+P G E E I
Sbjct: 191 LYEMLAGQPPFDGEDEDELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 4e-15
Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
L+G+G V+ R K+ ALK + + + ++ V+ + E IL LDH + L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 207 GLVTSRMSCSLYLVFEY-MEHDL-AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ + L LV +Y +L L PG SE + Y ++L L++ H G++
Sbjct: 68 A--SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIV 125
Query: 265 HRDIKGSNLLIDNNGILKIADFGLA----------------SFYDPDQNQPLTSRVV--- 305
+RD+K N+L+ +G + ++DF L+ N +
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185
Query: 306 ---------TLWYRPPELLLGATYYGTAVDLWSTGCILAE-LYAGKP 342
T Y PE++ G +G+AVD W+ G +L E LY P
Sbjct: 186 SFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 36/104 (34%), Positives = 62/104 (59%), Gaps = 1/104 (0%)
Query: 238 KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297
+F E +V+ Y +++ L+H H G+++RDIK N+L+D+NG + + DFGL+ + D+
Sbjct: 101 RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160
Query: 298 QPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAG 340
+ S T+ Y P+++ G + AVD WS G ++ EL G
Sbjct: 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 82/295 (27%), Positives = 133/295 (45%), Gaps = 44/295 (14%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + VY+A++ + + A K + + E E +M EI IL +H ++KL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMV-EIEILATCNHPYIVKLLGA 77
Query: 209 VTSRMSCSLYLVFEYMEH---DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
L+++ E+ D L GL + QV C +Q+L L + HS ++H
Sbjct: 78 FY--WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC--RQMLEALQYLHSMKIIH 133
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY----Y 321
RD+K N+L+ +G +K+ADFG+ S + Q S + T ++ PE+++ T Y
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGV-SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381
D+WS G L E+ I P E+ + + K+ KS+ P +
Sbjct: 193 DYKADIWSLGITLIEM---AQIEPPHHELNPMRVLLKIA---------KSEPPTLS---- 236
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF----TMKPL 432
QP K + F+DF ++T L P R SAA L F + +PL
Sbjct: 237 -QPSKWSM--EFRDF-------LKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 44/225 (19%)
Query: 149 IGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
IGQG + V++AR + +VA+K ++ + F RE ++ DH N++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDHPNIV 71
Query: 204 KLEGL-VTSRMSCSLYLVFEYMEH-DL---------------------AGLASHPGLKFS 240
KL G+ + C L+FEYM + DL A L S
Sbjct: 72 KLLGVCAVGKPMC---LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL------ASFYDP 294
+ C +Q+ G+ + R +HRD+ N L+ N ++KIADFGL A +Y
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 295 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 339
+N + R + PPE + Y T D+W+ G +L E+++
Sbjct: 189 SENDAIPIR-----WMPPESIFYNR-YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 14/215 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G V + KI+A+K +R + + + + RE+ IL + + ++ G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHR 266
+ + + + EYM+ L + + E + +L GL + H ++HR
Sbjct: 68 FYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+K SN+L+++ G +K+ DFG++ N + V T Y PE + G Y D
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQG-NDYSVKSD 181
Query: 327 LWSTGCILAELYAGK-----PIMPGRTEVEQLHKI 356
+WS G L EL G+ P E L I
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-15
Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 20/220 (9%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
++G+G++ V A ++ A+K ++ D ++ + V E +L D
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK------P 60
Query: 207 GLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
+T SC LY V EY+ DL G KF E Q Y ++ GL H
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHR 119
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGA 318
RG+++RD+K N+++D+ G +KIADFG+ +T+R T Y PE ++
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPE-IIAY 175
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
YG +VD W+ G +L E+ AG+P G E E I +
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 57/217 (26%), Positives = 104/217 (47%), Gaps = 10/217 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
L+G+G + V++ L K VA+K + D + ++F++ E IL++ DH N++KL G
Sbjct: 2 LLGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLS-EARILKQYDHPNIVKLIG 59
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ T R +Y+V E + D + Q+ + G+ + S+ +HR
Sbjct: 60 VCTQRQP--IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+ N L+ N +LKI+DFG++ D + + + + PE L Y + D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPE-ALNYGRYSSESD 176
Query: 327 LWSTGCILAELYA----GKPIMPGRTEVEQLHKIFKL 359
+WS G +L E ++ P M + EQ+ K +++
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM 213
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-14
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 34/208 (16%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G++ V A+ + A+K ++ L+ + V+ +A+E IL L H ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN--- 82
Query: 208 LVTSRMSCS------LYLVFEYMEHDLAG-LASH--PGLKFSEAQVKCYMQQLLCGLDHC 258
M CS +Y + E++ + G L +H +F K Y +L+ ++
Sbjct: 83 -----MMCSFQDENRVYFLLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----YRPPEL 314
HS+ +++RD+K NLL+DN G +K+ DFG A + + R TL Y PE
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFA--------KKVPDRTFTLCGTPEYLAPE- 185
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKP 342
++ + +G AVD W+ G +L E AG P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYP 213
|
Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 21/228 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRL-DHINVIKLE 206
IG+GTY V++ + A+K + +++ E + E +IL+ L DH NV+K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEAEYNILKALSDHPNVVKFY 81
Query: 207 GLVTSRMSCS---LYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
G+ + + L+LV E DL G + E + + + L GL H H
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP----ELL 315
+HRD+KG+N+L+ G +K+ DFG+++ + + TS W P E
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ 201
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 363
L +T Y D+WS G EL G P + ++ + +FK+ +P
Sbjct: 202 LDST-YDARCDVWSLGITAIELGDGDPPL---ADLHPMRALFKIPRNP 245
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 76/288 (26%), Positives = 117/288 (40%), Gaps = 58/288 (20%)
Query: 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVI 203
S +IG+G + V + D I A+K +R D LE E V + E IL D V+
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
K+ + + +LYL+ E++ D+ L SE + Y+ + + +D H G
Sbjct: 65 KM--FYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLG 121
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGL---------------------------------- 288
+HRDIK NLL+D G +K++DFGL
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT 348
A + ++ Q S V T Y PE+ + T Y D WS G I+ E+ G P T
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240
Query: 349 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF 396
E K+ W+++ +F P+ P ++E KD
Sbjct: 241 PQETYRKVMN---------WKET-----LVFPPEVP----ISEKAKDL 270
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 16/218 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ K VA+K ++ + PES E I+++L H +++L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQLYAV 69
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
V+ +Y+V EYM L L G + Q+ G+ + +HR
Sbjct: 70 VSEE---PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 126
Query: 267 DIKGSNLLIDNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
D++ +N+L+ + + KIADFGLA D + ++ W P L G +
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 184
Query: 326 DLWSTGCILAELYA-GK---PIMPGRTEVEQLHKIFKL 359
D+WS G +L EL G+ P M R +EQ+ + +++
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 10/211 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ ++ + VA+K ++ D+L + +E+ L+RL H ++I L +
Sbjct: 14 LGSGYFGEVWEGLWKNRVR-VAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ +Y++ E ME LA L S G A + Q+ G+ + + +HR
Sbjct: 71 CSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+ N+L+ + + K+ADFGLA D ++ W P G + T D
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT--FSTKSD 186
Query: 327 LWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
+WS G +L E++ G+ PG E +I
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 10/210 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR-EIHILRRLDHINVIKLEG 207
+G+G + V + + K+ A KK+ L+ +S MA E IL +++ ++ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSE-AQVKCYMQQLLCGLDHCHSRGVLH 265
S+ L LV M DL + G + E +V Y Q+ CG+ H HS +++
Sbjct: 61 AFESKTH--LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K N+L+D+ G +++D GLA + + +T R T Y PE+L Y V
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEP-YSYPV 175
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHK 355
D ++ GC + E+ AG+ P + E++ K
Sbjct: 176 DWFAMGCSIYEMVAGR--TPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 21/223 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + VY+A++ + ++A KV E E +M EI IL DH N++KL L
Sbjct: 13 LGDGAFGKVYKAQN-KETGVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKL--L 68
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGL-----KFSEAQVKCYMQQLLCGLDHCHSRGV 263
+L+++ E+ AG A + +E Q++ +Q L L++ H +
Sbjct: 69 DAFYYENNLWILIEF----CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY--- 320
+HRD+K N+L +G +K+ADFG+++ + Q S + T ++ PE+++ T
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 321 -YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 362
Y D+WS G L E+ I P E+ + + K+ S
Sbjct: 184 PYDYKADVWSLGITLIEM---AQIEPPHHELNPMRVLLKIAKS 223
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 10/192 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G Y VY VA+K ++ D +E E F+ +E +++ + H N+++L G+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKEIKHPNLVQLLGV 70
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYM-QQLLCGLDHCHSRGVLHR 266
T Y++ E+M + +L + A V YM Q+ +++ + +HR
Sbjct: 71 CT--REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHR 128
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATYYGTAV 325
D+ N L+ N ++K+ADFGL+ D ++ W P L +
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKS 186
Query: 326 DLWSTGCILAEL 337
D+W+ G +L E+
Sbjct: 187 DVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 57/209 (27%), Positives = 104/209 (49%), Gaps = 17/209 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ K VA+K ++ ++ PE+ F+A E +++++L H +++L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEA--FLA-EANLMKQLQHPRLVRLYAV 69
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
VT +Y++ EYME+ + L + G+K + ++ Q+ G+ + +HR
Sbjct: 70 VTQE---PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHR 126
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT--- 323
D++ +N+L+ KIADFGLA + ++ + + PE A YGT
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPE----AINYGTFTI 182
Query: 324 AVDLWSTGCILAELYA-GKPIMPGRTEVE 351
D+WS G +L E+ G+ PG T E
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 9/197 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
L+G+GT+ V R+ K A+K ++ + + + V E +L+ H + L+
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 207 -GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
T C V EY +L S + FSE + + Y +++ L + HS V+
Sbjct: 62 YSFQTHDRLC---FVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
+RD+K NL++D +G +KI DFGL + + T Y PE+L YG A
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND-YGRA 175
Query: 325 VDLWSTGCILAELYAGK 341
VD W G ++ E+ G+
Sbjct: 176 VDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 40/117 (34%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
FSE + Y ++ GL + H +++RD+K NLL+D G +KIADFGL +
Sbjct: 98 FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-----EGM 152
Query: 299 PLTSRVVTLWYRP----PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 351
R T P PE+L + Y AVD W G ++ E+ G+ PG E E
Sbjct: 153 GFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 25/200 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG- 207
+G G VY+A L ++I+A+K + D + E + + E+ IL + D +I G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 208 -LVTSRMS-CSLYLVFEYMEH---DLAGLASHPGL-KFSEAQVKCYMQQLLCGLDHCHSR 261
V +R+S C+ E+M+ D+ L + + A VK GL + S
Sbjct: 68 FFVENRISICT-----EFMDGGSLDVYRKIPEHVLGRIAVAVVK--------GLTYLWSL 114
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
+LHRD+K SN+L++ G +K+ DFG+++ N + V T Y PE + G Y
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQ-Y 170
Query: 322 GTAVDLWSTGCILAELYAGK 341
G D+WS G EL G+
Sbjct: 171 GIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G + +V QK VA+K ++ D+ ++ F+A E ++ L H N+++L G
Sbjct: 13 TIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQA--FLA-EASVMTTLRHPNLVQLLG 67
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC------HSR 261
+V LY+V EYM L + L+ V QQL LD C +
Sbjct: 68 VVLQ--GNPLYIVTEYMAK--GSLVDY--LRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
+HRD+ N+L+ + + K++DFGLA + Q Q + ++ W P L +
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQD-SGKLPVKWTAPEALREKK--F 176
Query: 322 GTAVDLWSTGCILAELYA 339
T D+WS G +L E+Y+
Sbjct: 177 STKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH-INVIKLE 206
++G GTY VY+ R + ++ A+K + E E ++ EI++L++ H N+
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRNIATYY 79
Query: 207 GLVTSRMSC----SLYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
G + L+LV E+ DL + + G E + +++L GL H
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDL--VKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL-- 316
H+ V+HRDIKG N+L+ N +K+ DFG+++ D + T + T ++ PE++
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMAPEVIACD 196
Query: 317 --GATYYGTAVDLWSTGCILAELYAGKP 342
Y D+WS G E+ G P
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 69/264 (26%), Positives = 106/264 (40%), Gaps = 51/264 (19%)
Query: 217 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 275
L+ V E++ DL G +F + Y +++CGL HS+G+++RD+K N+++
Sbjct: 71 LFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129
Query: 276 DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP----PELLLGATYYGTAVDLWSTG 331
D +G +KIADFG+ +N +R T P PE+L G Y +VD WS G
Sbjct: 130 DRDGHIKIADFGMCK-----ENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFG 183
Query: 332 CILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAE 391
+L E+ G+ G E E I + PH Y R + +
Sbjct: 184 VLLYEMLIGQSPFHGDDEDELFESI-------------RVDTPH---------YPRWITK 221
Query: 392 TFKDFPAPALALMETLLSIDPADRGSAASALRSEFF-------TMKPLPCDPSSLPKYPP 444
KD ++E L DP R +R F ++ DP PK
Sbjct: 222 ESKD-------ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKS 274
Query: 445 SKE---FDAKIRDEEARRQGGSKG 465
+ FD + E+ R K
Sbjct: 275 PSDYSNFDREFLSEKPRLSYSDKN 298
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 55/212 (25%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+GQG + V+ + VA+K ++ + PE+ +E ++++L H +++L +
Sbjct: 14 LGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQLYAV 69
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
V+ +Y+V EYM L L G Q+ Q+ G+ + +HR
Sbjct: 70 VSEE---PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 267 DIKGSNLLIDNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
D++ +N+L+ N + K+ADFGLA D + ++ W P L G +
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 184
Query: 326 DLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+WS G +L EL G+ PG E L ++
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 20/217 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + V + QK VA+K ++ D + + E ++ +L H N+++L G+
Sbjct: 14 IGEGEFGAVLQGEYTGQK--VAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + LY+V E M +L L + S Q+ + + G+++ S+ ++HR
Sbjct: 68 I---LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR 124
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+ N+L+ +G+ K++DFGLA S++ W P L + + D
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKLPVKWTAPEALKHKK--FSSKSD 179
Query: 327 LWSTGCILAELY----AGKPIMPGRTEVEQLHKIFKL 359
+WS G +L E++ A P M + E + K +++
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM 216
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 64/222 (28%), Positives = 108/222 (48%), Gaps = 21/222 (9%)
Query: 148 LIGQGTYSNVYRARDL---DQKKIVA---LKKVRFDNLEPESVRFMAREIHILRRLDHIN 201
++G+G Y V++ R + D KI A LKK + ++ A E +IL + H
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA-ERNILEAVKHPF 61
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEHDLAG--LASH---PGLKFSEAQVKCYMQQLLCGLD 256
++ L + + LYL+ EY L+G L H G+ F E Y+ ++ L+
Sbjct: 62 IVDL--IYAFQTGGKLYLILEY----LSGGELFMHLEREGI-FMEDTACFYLSEISLALE 114
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
H H +G+++RD+K N+L+D G +K+ DFGL + + T+ Y PE+L+
Sbjct: 115 HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
+ +G AVD WS G ++ ++ G P + + KI K
Sbjct: 174 RSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 10/198 (5%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKL 205
+IG+G+Y+ V R ++I A+K V+ + + + E + ++ E H+ + +H ++ L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ L+ V EY+ K E + Y ++ L++ H RG+++
Sbjct: 62 HSCFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIY 119
Query: 266 RDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
RD+K N+L+D+ G +K+ D+G+ D T Y PE+L G YG
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG---TPNYIAPEILRGED-YGF 175
Query: 324 AVDLWSTGCILAELYAGK 341
+VD W+ G ++ E+ AG+
Sbjct: 176 SVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 14/213 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ + VA+K ++ ++P+ F+ E I+++L H +I+L +
Sbjct: 14 LGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKD--FL-AEAQIMKKLRHPKLIQLYAV 69
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
T + +Y+V E M++ L L G Q+ Q+ G+ + ++ +HR
Sbjct: 70 CT--LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY--YGTA 324
D+ N+L+ N I K+ADFGLA D + + + PE A Y +
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE---AALYNRFSIK 184
Query: 325 VDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+WS G +L E+ G+ PG T E L ++
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/189 (30%), Positives = 95/189 (50%), Gaps = 19/189 (10%)
Query: 164 DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223
Q +VA+K +R D + F+ +EI I+ RL + N+I+L G+ S L ++ EY
Sbjct: 42 GQPVLVAVKMLRADVTKTARNDFL-KEIKIMSRLKNPNIIRLLGVCVS--DDPLCMITEY 98
Query: 224 MEH-DLAGLASHPGL--KFSEAQ-VKC-------YMQ-QLLCGLDHCHSRGVLHRDIKGS 271
ME+ DL S + F+ A + YM Q+ G+ + S +HRD+
Sbjct: 99 MENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158
Query: 272 NLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL-WYRPPELLLGATYYGTAVDLWS 329
N L+ N+ +KIADFG++ + Y D + V+ + W +LLG + TA D+W+
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWA 216
Query: 330 TGCILAELY 338
G L E++
Sbjct: 217 FGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 53/199 (26%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 148 LIGQGTYSNVYRAR-DLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+IG G + V+R + +K VA+K ++ E + F++ E I+ + H N+I+
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-EASIMGQFSHHNIIR 70
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
LEG+VT ++ EYME+ L H G +FS Q+ ++ + G+ +
Sbjct: 71 LEGVVTKFKP--AMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFY--DPDQNQPLTSRVVTLWYRPPELLLGATY 320
+HRD+ N+L+++N K++DFGL+ DP+ + + + + PE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE-AIAYRK 186
Query: 321 YGTAVDLWSTGCILAELYA 339
+ +A D+WS G ++ E+ +
Sbjct: 187 FTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 6/196 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G+Y+ V R +I A+K V+ + + + E + ++ E H+ + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF--LV 59
Query: 207 GLVTSRMSCS-LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
GL + + S L+LV EY+ K E + Y ++ L+ H RG+++
Sbjct: 60 GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K N+L+D +G +K+ D+G+ ++ T Y PE+L G YG +V
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSV 177
Query: 326 DLWSTGCILAELYAGK 341
D W+ G ++ E+ AG+
Sbjct: 178 DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 24/209 (11%)
Query: 149 IGQGTYSNVYRARDL----DQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + V+ A +Q KI VA+K ++ + + + RE +L L H +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLK--DASDNARKDFHREAELLTNLQHEHIV 70
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASH-----------PGLKFSEAQVKCYMQQ 250
K G+ L +VFEYM+H DL L +H + +++Q+ QQ
Sbjct: 71 KFYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 251 LLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWY 309
+ G+ + S+ +HRD+ N L+ N ++KI DFG++ Y D + ++ + +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 188
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAELY 338
PPE ++ + T D+WS G +L E++
Sbjct: 189 MPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-12
Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 12/181 (6%)
Query: 186 FMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEA--- 242
+ EI L RL+H N++K+E ++ R + Y++ + + DL + +
Sbjct: 209 QLENEILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266
Query: 243 -QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301
Q + M+QLLC +++ H + ++HRDIK N+ ++ +G + + DFG A ++ ++
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP----GRTEVEQLHKIF 357
V T+ PE+L G Y D+WS G IL ++ + P G +QL KI
Sbjct: 327 GWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKII 384
Query: 358 K 358
Sbjct: 385 D 385
|
Length = 501 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 48/145 (33%), Positives = 68/145 (46%), Gaps = 5/145 (3%)
Query: 217 LYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 275
LYLV +Y + DL L S + E + Y+ +++ +D H G +HRDIK N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
Query: 276 DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL----GATYYGTAVDLWSTG 331
D NG +++ADFG D V T Y PE+L G YG D WS G
Sbjct: 136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLG 195
Query: 332 CILAELYAGKPIMPGRTEVEQLHKI 356
+ E+ G+ + VE KI
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 51/195 (26%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + V+ R VA+K R + L P+ +E IL++ H N+++L G+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
T + +Y+V E ++ D G + ++ ++ G+++ S+ +HRD
Sbjct: 62 CTQKQP--IYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRD 119
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS---RVVTLWYRPPELLLGATYYGTA 324
+ N L+ +LKI+DFG+ S + D T ++ W P L G Y +
Sbjct: 120 LAARNCLVTEKNVLKISDFGM-SREEEDGVYASTGGMKQIPVKWTAPEALNYGR--YSSE 176
Query: 325 VDLWSTGCILAELYA 339
D+WS G +L E ++
Sbjct: 177 SDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 34/217 (15%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + VY+ + VA+K ++ +N EP+ + +E ++ L H N++
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 204 KLEGLVT-SRMSCSLYLVFEYMEH-DLAG-LASH-----PGLKFSEAQVKCYMQ------ 249
L G+ T + +C L FEY+ H DL L + G + + VK +
Sbjct: 72 CLLGVCTKEQPTCML---FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 250 ---QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV 305
Q+ G+++ S +HRD+ N L+ +KI+DFGL+ Y D + + ++
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 306 TLWYRPPELLLGATYYG---TAVDLWSTGCILAELYA 339
+ + PPE +L YG T D+WS G +L E+++
Sbjct: 189 PVRWMPPEAIL----YGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 22/199 (11%)
Query: 169 VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228
VA+K ++ D L F+ +E I+ LDH N+I+L G+V ++ L +V E L
Sbjct: 26 VAVKCLKSDKLSDIMDDFL-KEAAIMHSLDHENLIRLYGVV---LTHPLMMVTE-----L 76
Query: 229 AGLAS------HPGLKFSEAQVKC-YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 281
A L S L C Y Q+ G+ + S+ +HRD+ N+L+ ++ +
Sbjct: 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136
Query: 282 KIADFGLA-SFYDPDQNQPLT-SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL-- 337
KI DFGL + + + + V + PE L T + A D+W G L E+
Sbjct: 137 KIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFT 195
Query: 338 YAGKPIMPGRTEVEQLHKI 356
Y +P G + + L KI
Sbjct: 196 YGEEPWA-GLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHIL-RRLDHINVIKLEG 207
IG+G++ V A+ K A+K L+ +++ + HI+ R + +K
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKV-----LQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 208 LVTSRMSCS----LYLVFEYMEHDLAGLASHPGLK--FSEAQVKCYMQQLLCGLDHCHSR 261
LV S LY V +Y+ L H + F E + + Y ++ L + HS
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNG--GELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
+++RD+K N+L+D+ G + + DFGL + ++ ++ T Y PE+L Y
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQP-Y 173
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
VD W G +L E+ G P R E I
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 47/145 (32%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 217 LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 275
LY V EY+ DL G +F E Y ++ GL HS+G+++RD+K N+++
Sbjct: 76 LYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 276 DNNGILKIADFGLA--SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCI 333
D+ G +KIADFG+ + +D + T Y PE ++ YG +VD W+ G +
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCG---TPDYIAPE-IIAYQPYGKSVDWWAFGVL 190
Query: 334 LAELYAGKPIMPGRTEVEQLHKIFK 358
L E+ AG+ G E E I +
Sbjct: 191 LYEMLAGQAPFEGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 41/122 (33%), Positives = 66/122 (54%), Gaps = 6/122 (4%)
Query: 234 HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 293
+PG F E + Y Q++ GL+H H R +++RD+K N+L+DN+G ++I+D GLA
Sbjct: 91 NPG--FPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148
Query: 294 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 353
Q++ T + PELL G Y +VD ++ G L E+ A + P R E++
Sbjct: 149 DGQSKT-KGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARG--PFRARGEKV 204
Query: 354 HK 355
Sbjct: 205 EN 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ A ++ VA+K ++ ++ SV E ++++ L H ++KL +
Sbjct: 14 LGAGQFGEVWMA-TYNKHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
VT +Y++ E+M L L S G K ++ + Q+ G+ R +HR
Sbjct: 70 VTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV- 325
D++ +N+L+ + + KIADFGLA + ++ + + PE A +G+
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE----AINFGSFTI 182
Query: 326 --DLWSTGCILAELYA-GKPIMPGRTEVE 351
D+WS G +L E+ G+ PG + E
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPE 211
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 49/162 (30%), Positives = 91/162 (56%), Gaps = 15/162 (9%)
Query: 190 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCY 247
E ++ +L H +++L G+ T + +Y+V EYM + L L H G +F +Q+
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRP--IYIVTEYMSNGCLLNYLREH-GKRFQPSQLLEM 105
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307
+ + G+ + S+ +HRD+ N L+D+ G +K++DFGL+ + D+ TS V +
Sbjct: 106 CKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSK 162
Query: 308 W---YRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMP 345
+ + PPE+LL + + + D+W+ G ++ E+Y+ GK MP
Sbjct: 163 FPVRWSPPEVLL-YSKFSSKSDVWAFGVLMWEVYSLGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 188 AREIHILRRLDHINVIKLEGLVT-SRMSCSLYLVFEYMEHDL-AGLASHPGLKFSEAQVK 245
A E HILR ++H ++I+L+G T ++ +C L+ + DL LA+ + + +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTC---LILPRYKTDLYCYLAAKRNIAICD--IL 185
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF-YDPDQNQPLTSRV 304
+ +L + + H ++HRDIK N+ I++ G + + DFG A F D + N+
Sbjct: 186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWA 244
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 341
T+ PE LL YG AVD+WS G +L E+
Sbjct: 245 GTIATNAPE-LLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ + Q K VA+K + + E F+ E ++ +L H +++L G+
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEED--FI-EEAKVMMKLSHPKLVQLYGV 67
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
T + LY+V E+ME+ L L G K S+ + Q + G+++ +HR
Sbjct: 68 CTQQKP--LYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+ N L+ + G++K++DFG+ + D+ + + + PPE+ + Y + D
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN-FSKYSSKSD 183
Query: 327 LWSTGCILAELYA-GKPIMP 345
+WS G ++ E++ GK MP
Sbjct: 184 VWSFGVLMWEVFTEGK--MP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 7/196 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
L+G+GT+ V R+ + A+K +R + + + V E +L+ H + L+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 207 -GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
T C V EY F+E + + Y +++ L++ HSR V++
Sbjct: 62 YAFQTHDRLC---FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RDIK NL++D +G +KI DFGL D + + T Y PE+L YG AV
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDND-YGRAV 176
Query: 326 DLWSTGCILAELYAGK 341
D W G ++ E+ G+
Sbjct: 177 DWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-12
Identities = 48/149 (32%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 190 EIHILRRLDHINVIKLEGL-VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 248
E +LRRL H V+ L + V ++C LV DL AQV
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC---LVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TL 307
+QLL +D+ H G++HRDIK N+L++ + + DFG A F + P + T+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAE 336
PE+L G Y +VD+WS G ++ E
Sbjct: 327 DTNAPEVLAGDP-YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 57/194 (29%), Positives = 86/194 (44%), Gaps = 26/194 (13%)
Query: 162 DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221
+ D +VA+K +R D + F+ +E+ IL RL N+ +L G+ T L ++
Sbjct: 42 NADAPVLVAVKVLRPDASDNAREDFL-KEVKILSRLSDPNIARLLGVCTV--DPPLCMIM 98
Query: 222 EYMEH-DLAG-LASH--------PGLKFSEAQVKCYM-QQLLCGLDHCHSRGVLHRDIKG 270
EYME+ DL L H K YM Q+ G+ + S +HRD+
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158
Query: 271 SNLLIDNNGILKIADFGLAS------FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
N L+ N +KIADFG++ +Y PL R W +LLG + T
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGK--FTTK 212
Query: 325 VDLWSTGCILAELY 338
D+W+ G L E+
Sbjct: 213 SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 68/253 (26%), Positives = 101/253 (39%), Gaps = 54/253 (21%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRF-DNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G + V A +D + A+K +R D L V + E IL D+ V+KL
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + LY V +Y+ D+ L + F E + Y+ +L ++ H G +HR
Sbjct: 69 SFQDKDN--LYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 267 DIKGSNLLIDNNGILKIADFGLAS--------------------------FYDPDQNQPL 300
DIK N+LID +G +K+ DFGL + +D N
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRC 185
Query: 301 TSRVVTLWYR--------------------PPELLLGATYYGTAVDLWSTGCILAELYAG 340
R+ TL R PE+LL Y D WS G IL E+ G
Sbjct: 186 GDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVG 244
Query: 341 KP--IMPGRTEVE 351
+P + P TE +
Sbjct: 245 QPPFLAPTPTETQ 257
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 8e-12
Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 51/244 (20%)
Query: 149 IGQGTYSNV----YRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G G + +V Y + + + VA+K ++ + RE ++ +LDH +++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE-VAVKTLK-QEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF-------SEAQVKCYMQQLLCGLDH 257
L G+ LV E LA L P LK+ + +K Q+ G+ +
Sbjct: 61 LIGVCKGEPLM---LVME-----LAPLG--PLLKYLKKRREIPVSDLKELAHQVAMGMAY 110
Query: 258 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---------PLTSRVVTLW 308
S+ +HRD+ N+L+ N KI+DFG++ + PL W
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK------W 164
Query: 309 YRPPELLLGATYYGT---AVDLWSTGCILAEL--YAGKPI--MPGRTEVEQLHKIFKLCG 361
Y P + YG D+WS G L E Y KP M G + L +L
Sbjct: 165 YAPECI-----NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL-P 218
Query: 362 SPSE 365
P E
Sbjct: 219 RPEE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 16/234 (6%)
Query: 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINV 202
R + ++G+G + V + K+ A KK+ ++ MA E IL +++ V
Sbjct: 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV 62
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH------PGLKFSEAQVKCYMQQLLCGLD 256
+ L +L LV M L H PG F E + Y +L CGL+
Sbjct: 63 VSLA--YAYETKDALCLVLTIMNG--GDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLE 116
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
+++RD+K N+L+D+ G ++I+D GLA + + + RV T+ Y PE++
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAV--QIPEGETVRGRVGTVGYMAPEVIN 174
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370
Y + D W GC++ E+ G+ R E + ++ + E+Y K
Sbjct: 175 NEKYTFSP-DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 4/127 (3%)
Query: 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID 276
L+ V EY+ KF E + + Y ++ L H GV++RD+K N+L+D
Sbjct: 71 LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130
Query: 277 NNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILA 335
G K+ADFG+ + N T+ T Y PE +L YG +VD W+ G ++
Sbjct: 131 AEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMY 187
Query: 336 ELYAGKP 342
E+ AG+P
Sbjct: 188 EMMAGQP 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 61/238 (25%), Positives = 109/238 (45%), Gaps = 35/238 (14%)
Query: 149 IGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HI 200
+G+G + V RA DQ VA+K ++ DN + + + E+ +++ + H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK-DNATDKDLADLISEMELMKLIGKHK 78
Query: 201 NVIKLEGLVTSRMSCSLYLVFEY-----------------MEHDLAGLASHPGLKFSEAQ 243
N+I L G+ T LY++ EY ++ +
Sbjct: 79 NIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 244 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTS 302
V C Q+ G+++ SR +HRD+ N+L+ + ++KIADFGLA +D D + ++
Sbjct: 137 VSC-AYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIFK 358
+ + + PE L Y + D+WS G ++ E++ G P PG VE+L K+ +
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQS-DVWSFGILMWEIFTLGGSP-YPG-IPVEELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 51/216 (23%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 149 IGQGTYSNVYRAR---DLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G G + VY+ + ++ KI VA+K +R + P++ + + E +++ +DH +V++
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 205 LEGLVTSRMSCSLYLVFEYMEH---------DLAGLASHPGLKFSEAQVKCYMQQLLCGL 255
L G+ +S + L+ + M + S L + Q+ G+
Sbjct: 74 LLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--------QIAKGM 122
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPE 313
+ + ++HRD+ N+L+ +KI DFGLA D D+ + +V W
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 314 LLLGATYYGTAVDLWSTGCILAEL-------YAGKP 342
+L Y D+WS G + EL Y G P
Sbjct: 183 ILHRI--YTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 13/212 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+GQG + V+ K VA+K ++ + PE+ +E I+++L H ++ L +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPLYAV 69
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
V+ +Y+V E+M L L G Q+ Q+ G+ + +HR
Sbjct: 70 VSEE---PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 267 DIKGSNLLIDNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
D++ +N+L+ +N + KIADFGLA D + ++ W P L G +
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 184
Query: 326 DLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+WS G +L EL G+ PG E L ++
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 8/197 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G+Y+ V ++I A+K ++ + + + E + ++ E H+ N L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS--NHPFLV 59
Query: 207 GLVTSRMSCS-LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
GL + + S L+ V E++ K E + Y ++ L+ H RG+++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIY 119
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTA 324
RD+K N+L+D G +K+ D+G+ + + TS T Y PE+L G YG +
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEILRGED-YGFS 176
Query: 325 VDLWSTGCILAELYAGK 341
VD W+ G ++ E+ AG+
Sbjct: 177 VDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 5/195 (2%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
L+G+GT+ V R+ K A+K ++ + + + V E +L+ H + L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + L V EY+ FSE + + Y +++ LD+ HS +++R
Sbjct: 62 --YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+K NL++D +G +KI DFGL D + + T Y PE+L YG AVD
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDND-YGRAVD 177
Query: 327 LWSTGCILAELYAGK 341
W G ++ E+ G+
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 8/216 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G + V + + K+ A+K + +++ L+ E +L D+ + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 207 GLVTSRMSCSLYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ +LYLV +Y + DL L S + E + Y+ +++ +D H +H
Sbjct: 68 --YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH 125
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL----GATYY 321
RDIK N+L+D NG +++ADFG D + V T Y PE+L G Y
Sbjct: 126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKY 185
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357
G D WS G + E+ G+ + VE KI
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 46/145 (31%), Positives = 68/145 (46%), Gaps = 5/145 (3%)
Query: 217 LYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 275
LYLV +Y + DL L S + E + Y+ +++ + H +HRDIK N+L+
Sbjct: 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135
Query: 276 DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL----GATYYGTAVDLWSTG 331
D NG +++ADFG + D + V T Y PE+L G YG D WS G
Sbjct: 136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLG 195
Query: 332 CILAELYAGKPIMPGRTEVEQLHKI 356
+ E+ G+ + VE KI
Sbjct: 196 VCMYEMLYGETPFYAESLVETYGKI 220
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 16/218 (7%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
++G+G++ V AR + ++ A+K ++ D L+ + V E IL ++ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRIL------SLARNH 55
Query: 207 GLVTSRMSC-----SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+T C L+ V E++ +F EA+ + Y ++ L H +
Sbjct: 56 PFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATY 320
G+++RD+K N+L+D+ G K+ADFG+ + N TS T Y PE +L
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPE-ILQEML 172
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
YG +VD W+ G +L E+ G E + I
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ + K VA+K ++ + SV+ E ++++ L H +++L +
Sbjct: 14 LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 209 VTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
VT +Y++ EYM L L S G K ++ + Q+ G+ + + +HR
Sbjct: 70 VTKEEP--IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV- 325
D++ +N+L+ + + KIADFGLA + ++ + + PE A +G+
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE----AINFGSFTI 183
Query: 326 --DLWSTGCILAELYA-GKPIMPGRTEVE 351
D+WS G +L E+ GK PG + +
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPYPGMSNSD 212
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + V+ A K +VA+K ++ L + RE +L L H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLA---------------GLASHPGLKFSEAQVKCY 247
K G+ L +VFEYM+H DL G + +Q+
Sbjct: 71 KFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVT 306
Q+ G+ + S+ +HRD+ N L+ N ++KI DFG++ Y D + ++
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELY 338
+ + PPE ++ + T D+WS G IL E++
Sbjct: 189 IRWMPPESIM-YRKFTTESDVWSFGVILWEIF 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 148 LIGQGTYSNVYRA--RDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHIN 201
+G+G + V +A LD + VA+K ++ D E + ++ E+ +++ + H N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS-EMEMMKMIGKHKN 77
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEHD-----------LAGLASHPGLKFSEAQVKCY--- 247
+I L G+ T LY+V EY H AS + E +
Sbjct: 78 IINLLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 248 --MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA------SFYDPDQNQP 299
Q+ G++ S+ +HRD+ N+L+ + ++KIADFGLA +Y N
Sbjct: 136 SFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN-- 193
Query: 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIF 357
R+ W P L Y D+WS G +L E++ G P PG VE+L K+
Sbjct: 194 --GRLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFTLGGSP-YPG-IPVEELFKLL 247
Query: 358 K 358
K
Sbjct: 248 K 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 62/257 (24%), Positives = 100/257 (38%), Gaps = 52/257 (20%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G + V + D KI A+K + + + + + + E +L D V+ L
Sbjct: 8 VIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL- 66
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ + + LYL+ E++ DL + FSE + YM + + ++ H G +H
Sbjct: 67 -YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAVHKLGFIH 124
Query: 266 RDIKGSNLLIDNNGILKIADFGLAS-FYDPDQN----QPLTSRVVT-------------- 306
RDIK N+LID G +K++DFGL++ F+ + + L +
Sbjct: 125 RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSI 184
Query: 307 -----------LW----------------YRPPELLLGATYYGTAVDLWSTGCILAELYA 339
W Y PE+ L YG D WS G I+ E
Sbjct: 185 NLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLI 243
Query: 340 GKPIMPGRTEVEQLHKI 356
G P E KI
Sbjct: 244 GWPPFCSENSHETYRKI 260
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 6/212 (2%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKL 205
+IG+G++ V AR ++K A+K ++ + + E M+ +L+ + H ++ L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ + + LY V +Y+ F E + + Y ++ L + HS +++
Sbjct: 62 H--FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K N+L+D+ G + + DFGL + + N ++ T Y PE+L Y T V
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT-V 177
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357
D W G +L E+ G P R E I
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 66/240 (27%), Positives = 115/240 (47%), Gaps = 39/240 (16%)
Query: 149 IGQGTYSNVYRAR----DLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRL-DHI 200
+G+G + V A D D+ K VA+K ++ D+ + + + E+ +++ + H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHK 81
Query: 201 NVIKLEGLVTSRMSCSLYLVFEY-----------------MEH--DLAGLASHPGLKFSE 241
N+I L G T LY++ EY ME+ D+A + + F +
Sbjct: 82 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ-MTFKD 138
Query: 242 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPL 300
V C Q+ G+++ S+ +HRD+ N+L+ N ++KIADFGLA + D +
Sbjct: 139 L-VSC-TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIFK 358
T+ + + + PE L Y + D+WS G ++ E++ G P PG VE+L K+ K
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLMWEIFTLGGSP-YPG-IPVEELFKLLK 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 169 VALKKVRFDNLEPESVRF-MAREIHILRRLDHINVIKL--EGLVTSRMSCSLYLVFEYME 225
VA+K +R D E E R RE + RL H N++ L G + L+ VFEY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAVFEYVP 62
Query: 226 -HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---L 281
L + + G + M Q+L L H++G++HRD+K N+++ G+
Sbjct: 63 GRTLREVLAADGA-LPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 282 KIADFGLAS----FYDPDQNQ-PLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILA 335
K+ DFG+ + D D T+ V+ T Y PE L G + DL++ G I
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAWGLIFL 180
Query: 336 ELYAGKPIMPGRTEVEQLHK 355
E G+ ++ G + E L++
Sbjct: 181 ECLTGQRVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 60/235 (25%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 149 IGQGTYSNVYRA------RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHIN 201
+G+G + V A +D K + K+ D+ + + + E+ +++ + H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 202 VIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLC---- 253
+I L G T LY++ EY + PG+ +S K +QL
Sbjct: 80 IINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 254 --------GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRV 304
G+++ S+ +HRD+ N+L+ + ++KIADFGLA ++ D + T+
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGR 197
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 358
+ + + PE L Y + D+WS G +L E++ G PG VE+L K+ K
Sbjct: 198 LPVKWMAPEALFDRVYTHQS-DVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 14/225 (6%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKL 205
+IG+G++ V A+ A+K ++ + + E MA +L+ L H ++ L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ + + LY V +Y+ F E + + Y ++ + + HS +++
Sbjct: 62 H--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTA 324
RD+K N+L+D+ G + + DFGL + + + TS T Y PE+L Y
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRT 176
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQ-----LHKIFKLCGSPS 364
VD W G +L E+ G P R +V Q LHK +L G +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILHKPLQLPGGKT 220
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 5/116 (4%)
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSR 303
CY Q+ G++ SR +HRD+ N+L+ N ++KI DFGLA + DPD + ++R
Sbjct: 178 CYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 358
+ W P + Y T D+WS G +L E+++ G PG E+ + K
Sbjct: 238 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 18/188 (9%)
Query: 164 DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223
+Q +VA+K +R D + F+ +EI I+ RL N+I+L L S L ++ EY
Sbjct: 44 NQPVLVAVKMLREDANKNARNDFL-KEIKIMSRLKDPNIIRL--LAVCITSDPLCMITEY 100
Query: 224 ME----------HDLAGLASHPGLKFSEAQVKCYMQ-QLLCGLDHCHSRGVLHRDIKGSN 272
ME H+ A + +M Q+ G+ + S +HRD+ N
Sbjct: 101 MENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160
Query: 273 LLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL-WYRPPELLLGATYYGTAVDLWST 330
L+ N +KIADFG++ + Y D + V+ + W +LLG + TA D+W+
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAF 218
Query: 331 GCILAELY 338
G L E+
Sbjct: 219 GVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 40/160 (25%), Positives = 78/160 (48%), Gaps = 24/160 (15%)
Query: 148 LIGQGTYSNVYRARDLDQK--KI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
IG+G + +VY+ + + KI VA+K + +F+ E +I+R+ DH +++K
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-EAYIMRQFDHPHIVK 71
Query: 205 LEGLVTSRMSCSLYLVFE---------YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGL 255
L G++T +++V E Y++ + L + + Y QL L
Sbjct: 72 LIGVITEN---PVWIVMELAPLGELRSYLQVNKYSLDLASLILY------SY--QLSTAL 120
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295
+ S+ +HRDI N+L+ + +K+ DFGL+ + + +
Sbjct: 121 AYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 48/181 (26%), Positives = 72/181 (39%), Gaps = 13/181 (7%)
Query: 162 DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221
D +KK++ REI IL+ + H +I L + R ++ +V
Sbjct: 116 DEQRKKVIVKAVTGGKTPG--------REIDILKTISHRAIINL--IHAYRWKSTVCMVM 165
Query: 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 281
+ DL G Q ++LL L + H RG++HRD+K N+ +D
Sbjct: 166 PKYKCDLFTYVDRSG-PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENA 224
Query: 282 KIADFGLASFYDPDQNQPLT-SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG 340
+ DFG A D + P TL PELL Y D+WS G +L E+
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVK 283
Query: 341 K 341
Sbjct: 284 N 284
|
Length = 392 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 64/238 (26%), Positives = 113/238 (47%), Gaps = 35/238 (14%)
Query: 149 IGQGTYSNVYRAR--DLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRL-DHI 200
+G+G + V A LD++K VA+K ++ D E + ++ E+ +++ + H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLIS-EMEMMKMIGKHK 84
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFS-------------EAQ 243
N+I L G T LY++ EY + PG+++ +
Sbjct: 85 NIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 244 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTS 302
V C Q+ G+++ S+ +HRD+ N+L+ + ++KIADFGLA + D + T+
Sbjct: 143 VSC-AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIFK 358
+ + + PE L Y + D+WS G +L E++ G P PG VE+L K+ K
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQS-DVWSFGVLLWEIFTLGGSP-YPG-VPVEELFKLLK 256
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-10
Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 30/263 (11%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-----ESVRFMAREIHILRRL-DHINV 202
+G G + V A K A+ KV L+P E M+ E+ I+ L +H N+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-ELKIMSHLGNHENI 101
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQ-VKCYMQQLLCGLDHCHS 260
+ L G T + + ++ EY + DL F + + + Q+ G+ S
Sbjct: 102 VNLLGACT--IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL--TSRVVTLWYRPPELLLGA 318
+ +HRD+ N+L+ + I+KI DFGLA D N + +R+ W P +
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219
Query: 319 TYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377
Y D+WS G +L E+++ G PG + +K+ K + +R ++ HA
Sbjct: 220 --YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK-------EGYRMAQPEHA- 269
Query: 378 IFKPQQPY---KRCVAETFKDFP 397
P + Y K C P
Sbjct: 270 ---PAEIYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 26/235 (11%)
Query: 148 LIGQGTYSNVYRA-RDLD---------QKKIVALKKVRFDNLEPESVRFMAREIHILRRL 197
+IG+G++ V A R LD QKKIV +K E MA +L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRK--------EQKHIMAERNVLLKNV 53
Query: 198 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 257
H ++ L + + + LY V +++ F E + + Y ++ L +
Sbjct: 54 KHPFLVGLH--YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGY 111
Query: 258 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 317
HS +++RD+K N+L+D+ G + + DFGL Q+ T+ T Y PE++
Sbjct: 112 LHSINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ----LHKIFKLCGSPSEDYW 368
Y T VD W G +L E+ G P R E LHK L S W
Sbjct: 171 QPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAW 224
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 18/222 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL-E 206
++G G V A+ + + A+K V + + E+ L D +++K E
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 207 GLVTS-----RMSCSLYLVFEYMEHDLAG-------LASHPGLKFSEAQVKCYMQQLLCG 254
+ LV +Y AG + F E + Q+L
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYAN---AGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 255 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPE 313
+ H HS+ ++HRDIK +N+L+ +NG++K+ DFG + Y + + T +Y PE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 314 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 355
+ Y A D++S G +L EL K G E +HK
Sbjct: 216 IWRRKPYSKKA-DMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
|
Length = 496 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 26/228 (11%)
Query: 127 RRADSFEKLDKSLSIFSRSFYLI---GQGTYSNVYRARDLDQK-KIVALKKVRFDN---L 179
+ +DS ++ + + F I G G++ V A ++ VA+K RF+ +
Sbjct: 13 KDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIK--RFEKSKII 70
Query: 180 EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF 239
+ + V + E IL ++H + L G + + LYLV E++ +F
Sbjct: 71 KQKQVDHVFSERKILNYINHPFCVNLYG--SFKDESYLYLVLEFVIGGEFFTFLRRNKRF 128
Query: 240 SEAQVKC-YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
V C Y Q++ ++ S +++RD+K NLL+D +G +K+ DFG A D
Sbjct: 129 PN-DVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----- 182
Query: 299 PLTSRVVTLWYRP----PELLLGATYYGTAVDLWSTGCILAELYAGKP 342
+R TL P PE+LL +G A D W+ G + E+ G P
Sbjct: 183 ---TRTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCP 226
|
Length = 340 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHINV 202
+G+G + V+ A K +VA+K ++ + ES R RE +L L H ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHI 69
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASH-PGLKFSE------------AQVKCY 247
++ G+ T L +VFEYM H DL L SH P K Q+
Sbjct: 70 VRFYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVT 306
Q+ G+ + S +HRD+ N L+ ++KI DFG++ Y D + ++
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELY 338
+ + PPE +L + T D+WS G +L E++
Sbjct: 188 IRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSR 303
CY Q+ G++ SR +HRD+ N+L+ N ++KI DFGLA + DPD + +R
Sbjct: 183 CYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 346
+ W P + Y D+WS G +L E+++ G PG
Sbjct: 243 LPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 62/239 (25%), Positives = 98/239 (41%), Gaps = 44/239 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKI------VALKKVRFDNLEPESVRFMAREIHILRRLDHIN 201
+G G + VY D VA+K +R + E F+ E H++ +H N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK-EAHLMSNFNHPN 60
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLASH--PGLKFSEAQVKC------ 246
++KL G+ ++ Y++ E ME DL A + P L E C
Sbjct: 61 IVKLLGVCL--LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 247 --YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-----ILKIADFGLA-SFYDPDQNQ 298
Y++Q+ H +HRD+ N L+ G ++KI DFGLA Y D +
Sbjct: 119 CVYLEQM-------H---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE-LYAGKPIMPGRTEVEQLHKI 356
++ + + PE LL + T D+WS G ++ E L G+ P E L +
Sbjct: 169 KEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 37/104 (35%), Positives = 58/104 (55%), Gaps = 3/104 (2%)
Query: 239 FSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297
FSE + + Y +++ LD+ HS + V++RD+K NL++D +G +KI DFGL D
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G 150
Query: 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 341
+ + T Y PE+L YG AVD W G ++ E+ G+
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 56/217 (25%), Positives = 102/217 (47%), Gaps = 18/217 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + +V D K VA+K ++ D + F+A E ++ +L H N+++L G+
Sbjct: 14 IGKGEFGDVMLG-DYRGNK-VAVKCIKND---ATAQAFLA-EASVMTQLRHSNLVQLLGV 67
Query: 209 VTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQVKCYMQQLLC-GLDHCHSRGVLHR 266
+ LY+V EYM + L G +C +++ + +HR
Sbjct: 68 IVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+ N+L+ + + K++DFGL Q+ T ++ W P L + T D
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD---TGKLPVKWTAPEALR--EKKFSTKSD 181
Query: 327 LWSTGCILAELYA-GK---PIMPGRTEVEQLHKIFKL 359
+WS G +L E+Y+ G+ P +P + V ++ K +K+
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 33/223 (14%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G + V+ + ++ K + + L+ + E++++R L H N+++
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 209 VTSRMSCSLYLVFEY-----MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS--- 260
++ + LY++ E+ + ++ G K E + +QLL L +CH+
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG-KIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 261 ----RGVLHRDIKGSNLLIDN---------------NG--ILKIADFGLASFYDPDQNQP 299
VLHRD+K N+ + NG I KI DFGL+ +
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGIESM 197
Query: 300 LTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGK 341
S V T +Y PELLL T Y D+W+ GCI+ EL +GK
Sbjct: 198 AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 40/183 (21%), Positives = 86/183 (46%), Gaps = 19/183 (10%)
Query: 165 QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224
++ VA+ +R + + F+A E L + DH N+++LEG++T ++ +V EYM
Sbjct: 32 RELPVAIHTLRAGCSDKQRRGFLA-EALTLGQFDHSNIVRLEGVITR--GNTMMIVTEYM 88
Query: 225 EHDL--AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILK 282
+ + L H G + Q+ + L G+ + G +H+ + +L++++ + K
Sbjct: 89 SNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCK 147
Query: 283 IADFG------LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE 336
I+ F + Y ++ + LW P + ++ +A D+WS G ++ E
Sbjct: 148 ISGFRRLQEDKSEAIY-----TTMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWE 200
Query: 337 LYA 339
+ +
Sbjct: 201 VMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 31/227 (13%)
Query: 149 IGQGTYSNVY----RARDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G G + VY R RD D ++ VA+K + E + F+ E I+ + +H N++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL-MEALIMSKFNHQNIV 72
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLA----SHPGLKFSEAQVKCYMQQLL-CGLD- 256
+L G+ R+ +++ E M DL P S M+ LL C D
Sbjct: 73 RLIGVSFERLP--RFILLELMAGGDLKSFLRENRPRPERPSSLT-----MKDLLFCARDV 125
Query: 257 --HCH---SRGVLHRDIKGSNLLIDNNG---ILKIADFGLA-SFYDPDQNQPLTSRVVTL 307
C +HRDI N L+ G + KIADFG+A Y + ++ +
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 353
+ PPE L + + D+WS G +L E+++ G PGRT E +
Sbjct: 186 KWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 72/262 (27%), Positives = 119/262 (45%), Gaps = 20/262 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G V + + I+A K + + ++P + RE+ +L + ++ G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRD 267
S S+ + E+M+ + E + +L GL + + ++HRD
Sbjct: 72 FYSDGEISICM--EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRD 129
Query: 268 IKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
+K SN+L+++ G +K+ DFG++ D N S V T Y PE L G T+Y D
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQG-THYSVQSD 184
Query: 327 LWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
+WS G L EL G+ PI P + ++L IF G P D + PH+ +P+ P
Sbjct: 185 IWSMGLSLVELAIGRYPIPP--PDAKELEAIF---GRPVVD--GEEGEPHSISPRPRPP- 236
Query: 386 KRCVAETFKDFPAPALALMETL 407
R V+ D PA+A+ E L
Sbjct: 237 GRPVSGHGMD-SRPAMAIFELL 257
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 149 IGQGTYSNVYRA-----RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+GQG++ VY + + VA+K V + E + F+ E +++ + +V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-EASVMKEFNCHHVV 72
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASH-------PGLKFSEAQVKCYMQ-QLLC 253
+L G+V+ +V E M DL L S PGL Q M ++
Sbjct: 73 RLLGVVS--TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 254 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPP 312
G+ + ++ +HRD+ N ++ + +KI DFG+ Y+ D + ++ + + P
Sbjct: 131 GMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 313 ELLLGATYYGTAVDLWSTGCILAEL 337
E L + T D+WS G +L E+
Sbjct: 191 ESLKDG-VFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 53/266 (19%)
Query: 133 EKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIH 192
E +D S F + L+G+GT+ V A D +K+ A+K VR N+ P+ R EI
Sbjct: 122 EDIDVSTQRF-KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR--NV-PKYTRDAKIEIQ 177
Query: 193 ILRRL------DHINVIKLEGLVTSRMSCSLYLVFEY--------MEHDLAGLASHPGLK 238
+ ++ D ++K++ + ++ +Y M+H G SH L
Sbjct: 178 FMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH---GPFSHRHL- 233
Query: 239 FSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGI----------------L 281
AQ+ + Q LD+ H+ ++H D+K N+L++ + +
Sbjct: 234 ---AQI---IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287
Query: 282 KIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY-YGTAVDLWSTGCILAELYAG 340
+I D G D+ T+ V T YR PE++LG + Y T D+WS GCI+ ELY G
Sbjct: 288 RICDLGGCC----DERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTG 341
Query: 341 KPIMPGRTEVEQLHKIFK-LCGSPSE 365
K + +E LH + K L PSE
Sbjct: 342 KLLYDTHDNLEHLHLMEKTLGRLPSE 367
|
Length = 467 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 148 LIGQGTYSNVYRAR-DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 205
+IG+G + V +AR D ++ A K + + R A E+ +L +L H N+I L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 206 EGLVTSRMSCSLYLVFEYMEH---------------DLA-GLASHPGLKFSEAQVKCYMQ 249
G R LYL EY H D A +A+ S Q+ +
Sbjct: 74 LGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 309
+ G+D+ + +HRD+ N+L+ N + KIADFGL+ + + + R+ W
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWM 190
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAELYA--GKP 342
L + Y T D+WS G +L E+ + G P
Sbjct: 191 AIES--LNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 44/209 (21%)
Query: 216 SLYLVFEYMEHDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNL 273
S++LV ++ E L SH L E VK + +++ LD H G++ RD+ +N+
Sbjct: 59 SVFLVLQHAEG--GKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNI 116
Query: 274 LIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT-AVDLWSTGC 332
L+D+ G +++ F S + + + Y PE +G T A D WS G
Sbjct: 117 LLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE--VGGISEETEACDWWSLGA 170
Query: 333 ILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAET 392
IL EL GK ++ + H PS H T+ P+ V+E
Sbjct: 171 ILFELLTGKTLV-------ECH--------PS------GINTHTTLNIPE-----WVSE- 203
Query: 393 FKDFPAPALALMETLLSIDPADRGSAASA 421
A +L++ LL +P +R A A
Sbjct: 204 ------EARSLLQQLLQFNPTERLGAGVA 226
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 5/104 (4%)
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSR 303
Y Q+ G++ SR +HRD+ N+L+ N ++KI DFGLA + DPD + +R
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 346
+ W P + Y T D+WS G +L E+++ G PG
Sbjct: 237 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 149 IGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + V +A K VA+K ++ +N +R + E ++L++++H +VI
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-------------DLAGLAS----------HPGLK-F 239
KL G + L L+ EY ++ + L S +P +
Sbjct: 67 KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 240 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQ 298
+ + + Q+ G+ + ++HRD+ N+L+ +KI+DFGL+ Y+ D
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 299 PLT-SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 337
+ R+ W L Y T D+WS G +L E+
Sbjct: 185 KRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G + V + I+A+K++R E E R + ++R D ++K G
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFS----EAQVKCYMQQLLC--------GL 255
+ C ++ E M+ L KF E +++L L
Sbjct: 71 ALFREGDC--WICMELMDISLD--------KFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 256 DHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP--- 311
++ ++HRD+K SN+L+D NG +K+ DFG++ Q ++ RP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG-----QLVDSIAKTRDAGCRPYMA 175
Query: 312 PELLLGATYYGTAV--DLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGSP 363
PE + + G V D+WS G L E+ GK P V +QL ++ K G P
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDP 228
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 148 LIGQGTYSNVYRAR--DLDQKKI-VALKKV-RFDNLEPESVRFMAREIHILRRLDHINVI 203
+IG+G + VY D D +KI A+K + R +LE V +E I++ H NV+
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFSHPNVL 59
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L G+ L +V YM+H DL + + + Q+ G+++ S+
Sbjct: 60 SLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL---WYRPPELLLGA 318
+HRD+ N ++D + +K+ADFGLA YD + L W L
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL---Q 175
Query: 319 TY-YGTAVDLWSTGCILAEL 337
T + T D+WS G +L EL
Sbjct: 176 TQKFTTKSDVWSFGVLLWEL 195
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 148 LIGQGTYSNVYRAR---DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
++G+G + +V A+ + + VA+K ++ D + RE ++ DH NVIK
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 205 LEGL-VTSRMSCSL---YLVFEYMEH-DLAG--LASHPG---LKFSEAQVKCYMQQLLCG 254
L G+ + SR L ++ +M+H DL L S G + +M + G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 255 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPD-QNQPLTSRVVTLWYRPP 312
+++ S+ +HRD+ N +++ N + +ADFGL+ Y D Q S++ W
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALE 185
Query: 313 ELLLGATYYGTAVDLWSTGCILAEL-------YAG 340
L Y T D+W+ G + E+ YAG
Sbjct: 186 S--LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 35/219 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G Y +VY+ +A+K++R + L+ + E+ IL + ++ G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 209 VTSRMSCSLYLVFEYM----------EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+ ++Y+ EYM L+ V ++ L L
Sbjct: 68 FF--IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV---VKGLKF-LKEE 121
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT----LWYRPPEL 314
H+ ++HRD+K +N+L++ NG +K+ DFG++ + S T Y PE
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSG-------NLVASLAKTNIGCQSYMAPER 172
Query: 315 LLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRT 348
+ Y D+WS G + E+ G+ P T
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 49/213 (23%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+ + +Y+ +D ++VA+K ++ D P+ +E ++ L H N++
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 205 LEGLVTSRMSCSLYLVFEYME----HDLAGLAS-HPGLKFS---EAQVKCYMQ------- 249
L G+VT + ++FEY+ H+ + S H + S + VK +
Sbjct: 72 LLGVVTQEQP--VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 250 --QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVT 306
Q+ G+++ S +H+D+ N+LI +KI+D GL+ Y D + ++
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA 339
+ + PPE ++ + + D+WS G +L E+++
Sbjct: 190 IRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 30/203 (14%)
Query: 156 NVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 215
NV + R L +VA+K +R D + F+ +E+ IL RL N+I+L G+
Sbjct: 40 NVRKGRPL----LVAVKILRPDANKNARNDFL-KEVKILSRLKDPNIIRLLGVCVD--ED 92
Query: 216 SLYLVFEYMEH-DL------------------AGLASHPGLKFSEAQVKCYMQQLLCGLD 256
L ++ EYME+ DL A +H S + + Q+ G+
Sbjct: 93 PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL-WYRPPEL 314
+ S +HRD+ N L+ N +KIADFG++ + Y D + V+ + W +
Sbjct: 153 YLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI 212
Query: 315 LLGATYYGTAVDLWSTGCILAEL 337
L+G + TA D+W+ G L E+
Sbjct: 213 LMGK--FTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 29/231 (12%)
Query: 149 IGQGTYSNVYRA--RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G + V + + +K VA+K ++ DN +P + RE +++++LD+ ++++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKF-------SEAQVKCYMQQLLCGLDHCH 259
G+ + S LV E LA L P KF +E + + Q+ G+ +
Sbjct: 63 GICEAE---SWMLVME-----LAELG--PLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN---QPLTSRVVTLWYRPPELLL 316
+HRD+ N+L+ KI+DFGL+ D+N + WY P +
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE--CM 170
Query: 317 GATYYGTAVDLWSTGCILAEL--YAGKPI--MPGRTEVEQLHKIFKLCGSP 363
+ + D+WS G ++ E Y KP M G EV Q+ + + P
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQMIESGERMECP 220
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 71/292 (24%), Positives = 118/292 (40%), Gaps = 58/292 (19%)
Query: 148 LIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
++G+G + +V + D Q K VA+K ++ D + E ++ DH NV+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLK-VAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 204 KLEGLVTSRMSC-----SLYLVFEYMEH-DLAG--LASHPGLKFSEAQVKCYMQQLL--- 252
KL G V S ++ +M+H DL L S + K +Q LL
Sbjct: 65 KLIG-VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS----RLGGLPEKLPLQTLLKFM 119
Query: 253 ----CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPD-QNQPLTSRVVT 306
G+++ +R +HRD+ N ++ + + +ADFGL+ Y D Q +++
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 365
W L Y + D+W+ G + E+ G+ PG VE H+I+
Sbjct: 180 KWIAIES--LADRVYTSKSDVWAFGVTMWEIATRGQTPYPG---VEN-HEIYDY------ 227
Query: 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 417
L H K QP + C+ E + LM + DP DR +
Sbjct: 228 -------LRHGNRLK--QP-EDCLDELY--------DLMYSCWRADPKDRPT 261
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 10/106 (9%)
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYR 310
L L H ++HRD+K SN+L+++ G +K+ DFG++ D N S V T Y
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYM 165
Query: 311 PPELLLGATYYGTAVDLWSTGCILAELYAGK-PI-MPGRTEVEQLH 354
PE L G T+Y D+WS G L E+ G+ PI P E+E +
Sbjct: 166 SPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 39/107 (36%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
++HRD+K SN+L+++ G +K+ DFG++ D N S V T Y PE L G T+Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQG-THY 179
Query: 322 GTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIF--KLCGSPSE 365
D+WS G L E+ G+ PI P + ++L +F + G P+E
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEGDPAE 224
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 80/332 (24%), Positives = 127/332 (38%), Gaps = 45/332 (13%)
Query: 149 IGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG+G ++VY AR +V ++ +N E ++ + E+ + H N++
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ T+ L+++ +M + A L ++ SEA + + L GL++ H G +
Sbjct: 66 TVFTT--GSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI 123
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---------PLTSRVVTLWYRPPELL 315
HR+IK S++LI +G++ ++ GL+ Y +N P S V W PELL
Sbjct: 124 HRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS-PELL 180
Query: 316 LGATY-YGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373
Y Y D++S G EL G+ P L K+ SP +
Sbjct: 181 RQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP----LDITTF 236
Query: 374 PH---------------------ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDP 412
P A +R + K F L+E L DP
Sbjct: 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDP 296
Query: 413 ADRGSAASALRSEFFTMKPLPCDPSSLPKYPP 444
R SA+S L FF S L PP
Sbjct: 297 EKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
I +G + VY R + K+ A+K V+ ++ ++ M ++ R D + + K +
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKN---MVHQVQAER--DALALSKSPFI 66
Query: 209 VT---SRMSCS-LYLVFEYM-EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
V S S + +YLV EY+ D+ L G F E Y+ ++ LD+ H G+
Sbjct: 67 VHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHRHGI 125
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLA 289
+HRD+K N+LI N G +K+ DFGL+
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 68/294 (23%), Positives = 120/294 (40%), Gaps = 51/294 (17%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH-INVIKLEG 207
+G+G Y V + R + I+A+K++R + + + + ++ I R + G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRA-TVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSR-GV 263
+ +++ E M+ L GL E + ++ L++ HS+ V
Sbjct: 68 ALFRE--GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV 125
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-----WYRPPELL--- 315
+HRD+K SN+LI+ NG +K+ DFG++ + S T+ Y PE +
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISG-------YLVDSVAKTIDAGCKPYMAPERINPE 178
Query: 316 LGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374
L Y D+WS G + EL G+ P +T +QL ++ + PS +LP
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE---EPS------PQLP 229
Query: 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
F P+ F+DF L + +R + L+ FF
Sbjct: 230 AEK-FSPE----------FQDFVNKC-------LKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 63/228 (27%), Positives = 96/228 (42%), Gaps = 37/228 (16%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKK-VRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG GT VY+ R ++A+K+ R N E M ++ +L+ D ++K
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDV-VLKSHDCPYIVKCY 80
Query: 207 GLVTSRMSCSLYLVFEYME------HDLAGLASHP------GLKFSEAQVKC--YMQQLL 252
G + VF ME L P G K + A VK Y+++
Sbjct: 81 GYFITDSD-----VFICMELMSTCLDKLLKRIQGPIPEDILG-KMTVAIVKALHYLKE-- 132
Query: 253 CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 312
GV+HRD+K SN+L+D +G +K+ DFG++ + + ++ Y P
Sbjct: 133 -------KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA--YMAP 183
Query: 313 ELLLGATY---YGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKI 356
E + Y D+WS G L EL G+ P +TE E L KI
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI 231
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 65/267 (24%), Positives = 108/267 (40%), Gaps = 46/267 (17%)
Query: 148 LIGQGTYSNVYRAR-DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 205
+IG+G + V RA D K+ A K+ + R A E+ +L +L H N+I L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 206 EGLVTSRMSCSLYLVFEY---------------MEHDLAGLASH-PGLKFSEAQVKCYMQ 249
G +R LY+ EY +E D A H + Q+ +
Sbjct: 69 LGACENR--GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 309
+ G+ + + +HRD+ N+L+ N KIADFGL+ + + + R+ W
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM-GRLPVRWM 185
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
L + Y T D+WS G +L E+ + G P CG +
Sbjct: 186 AIES--LNYSVYTTKSDVWSFGVLLWEIVSLGGTP----------------YCGMTCAEL 227
Query: 368 WRKSKLPHATIFKPQQPYKRCVAETFK 394
+ KLP ++ ++P + C E ++
Sbjct: 228 YE--KLPQG--YRMEKP-RNCDDEVYE 249
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 77/311 (24%), Positives = 118/311 (37%), Gaps = 66/311 (21%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV--RFMAREIHILRRLDHINVIKL 205
LIG+G VY A D + VALKK+R D E + RF+ RE I L H ++ +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFL-REAKIAADLIHPGIVPV 67
Query: 206 EGLVTSRMSCSLYLVFEYME-----HDLAGLASHPGLKFSEAQVKCYMQQLL-------C 253
+ + +Y Y+E L + L E K + L
Sbjct: 68 YSICSD--GDPVYYTMPYIEGYTLKSLLKSVWQKESLS-KELAEKTSVGAFLSIFHKICA 124
Query: 254 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA----------SFYDPDQNQPLTSR 303
+++ HS+GVLHRD+K N+L+ G + I D+G A D D+ S
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 304 -------VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
V T Y PE LLG + D+++ G I L+++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVI-------------------LYQM 224
Query: 357 FKLCGSPSEDYWRKSKLPHATIFKPQQ--PYKRCVAETFKDFPAPALALMETLLSIDPAD 414
L RK I P + PY ++ P + L++DPA+
Sbjct: 225 LTLSFPYRRKKGRKISYRD-VILSPIEVAPY--------REIPPFLSQIAMKALAVDPAE 275
Query: 415 RGSAASALRSE 425
R S+ L+ +
Sbjct: 276 RYSSVQELKQD 286
|
Length = 932 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 144 RSFYLIGQGTYSNVYRA----RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH 199
L+ +GT+ ++ +++ V +K V+ D+ V + +E +L L H
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLSH 67
Query: 200 INVIKLEGLVTSRMSCSLYLVFEYMEH----------DLAGLASHPGLKFSEAQVKCYMQ 249
N++ + V ++++ YM L + L S Q+
Sbjct: 68 QNILPI-LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAI 124
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--------QNQPLT 301
Q+ CG+ + H RGV+H+DI N +ID +KI D L+ P +N+P+
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184
Query: 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 337
W L+ Y +A D+WS G +L EL
Sbjct: 185 ------WMALESLV--NKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKI--VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G+G + +V + I VA+K ++ + E ++ DH NV++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 207 GLVTSRMSCSLY----LVFEYMEH-DL------AGLASHPGLKFSEAQVKCYMQQLLCGL 255
G+ + Y ++ +M+H DL + L P ++ VK +M + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPD-QNQPLTSRVVTLWYRPPE 313
++ S+ +HRD+ N +++ N + +ADFGL+ Y+ D Q +++ W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIES 185
Query: 314 LLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 346
L Y T D+WS G + E+ G+ PG
Sbjct: 186 --LADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 30/200 (15%)
Query: 157 VYRARDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 215
VY+ R +K+I VA+K ++ +N E M RE I+ +LD+ ++++ G+ +
Sbjct: 15 VYKMR---KKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE--- 67
Query: 216 SLYLVFEYMEHDLAGLASHPGLKFSEAQ--------VKCYMQQLLCGLDHCHSRGVLHRD 267
+L LV ME G P KF + V M Q+ G+ + + +HRD
Sbjct: 68 ALMLV---MEMASGG----PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW---YRPPELLLGATYYGTA 324
+ N+L+ N KI+DFGL+ D + +R W + PE + + +
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECIN-FRKFSSR 178
Query: 325 VDLWSTGCILAEL--YAGKP 342
D+WS G + E Y KP
Sbjct: 179 SDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 144 RSFYLIGQGTYSNVYRA---RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 200
R L+G G + V++ + D KI K D ++ + + + + LDH
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+++L G+ SL LV + L + H ++ + Q+ G+ +
Sbjct: 70 YIVRLLGICPG---ASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYL 125
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT--LWYRPPELLL 316
++HR++ N+L+ ++ I++IADFG+A PD + S T W +L
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 317 GATYYGTAVDLWSTGCILAEL--YAGKP 342
G Y D+WS G + E+ Y +P
Sbjct: 186 GR--YTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 148 LIGQGTYSNVYRAR-DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 205
+IG+G + V +AR D ++ A K + + R A E+ +L +L H N+I L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 206 EGLVTSRMSCSLYLVFEY---------------MEHDLAGLASH-PGLKFSEAQVKCYMQ 249
G R LYL EY +E D A ++ S Q+ +
Sbjct: 62 LGACEHR--GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 309
+ G+D+ + +HRD+ N+L+ N + KIADFGL+ + + + R+ W
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM-GRLPVRWM 178
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAEL 337
L + Y T D+WS G +L E+
Sbjct: 179 AIES--LNYSVYTTNSDVWSYGVLLWEI 204
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 36/218 (16%)
Query: 149 IGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+ + VY+ +Q + VA+K ++ D E E + RL H N++
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLA------SHPGLKFSEAQVKCYMQ------- 249
L G+VT S+ +F Y H DL S G + VK ++
Sbjct: 72 CLLGVVTKEQPLSM--IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 250 --QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL------ASFYDPDQNQPLT 301
Q+ G++ S V+H+D+ N+L+ + +KI+D GL A +Y N L
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 339
R W P ++ G + D+WS G +L E+++
Sbjct: 190 IR----WMSPEAIMYGK--FSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 30/142 (21%), Positives = 55/142 (38%), Gaps = 16/142 (11%)
Query: 156 NVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 215
VY D+ ++ + + + RE+ IL+ L + + L +
Sbjct: 13 RVYLLGTKDEDYVL-----KINPSREKGADR-EREVAILQLLARKGLPVPKVLASGESDG 66
Query: 216 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS---RGVLHRDIKGSN 272
YL+ E++E + SE + + +QL L H + H D+ N
Sbjct: 67 WSYLLMEWIE-------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGN 119
Query: 273 LLIDNNGILKIADFGLASFYDP 294
+L+D+ IL I D+ A + P
Sbjct: 120 ILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 54/219 (24%), Positives = 99/219 (45%), Gaps = 28/219 (12%)
Query: 141 IFSRS----FYLIGQGTYSNVYRAR-------DLDQKKIV-ALKKVRFDNLEPESVRFMA 188
F RS +G+G + V+ A+ + +V AL+K + +NL+ E
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE----FR 56
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME-HDLAG--LASHPGLK------F 239
RE+ + R+L H NV++L GL R + Y++ EY + DL A+ +
Sbjct: 57 RELDMFRKLSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 240 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299
S Q Q+ G+DH + +HRD+ N L+ + +K++ L+ +
Sbjct: 115 STKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY 338
L + ++ L + PE + + T D+WS G ++ E++
Sbjct: 175 LRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEVF 212
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 25/182 (13%)
Query: 240 SEAQVKCYMQ------QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 293
+E+ YM Q+ G++ S+ +HRD+ N+LI ++KI DFGLA
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 294 PDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY--AGKPIMPGRTEV 350
D N S + L + PE + Y T D+WS G +L E++ G P P
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTP-YPELPMN 348
Query: 351 EQLHKIFKLCGSPSEDYWRKSKLPHAT--IFKPQQPYKRCVAETFKDFP--APALALMET 406
EQ + + + +R +K HA+ I++ Q +C E F+ P + + L+
Sbjct: 349 EQFY-------NAIKRGYRMAKPAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVHLVGD 398
Query: 407 LL 408
LL
Sbjct: 399 LL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 45/222 (20%)
Query: 152 GTYSNVY--RARDLDQK----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
G + V + + QK KI+ K F+ +EP +H L + D+ N IKL
Sbjct: 27 GKFGKVSVLKHKP-TQKLFVQKIIKAKN--FNAIEPM--------VHQLMK-DNPNFIKL 74
Query: 206 EGLVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
VT+ L+ +Y+ + DL L G K SEA+VK ++QL+ L+ H ++
Sbjct: 75 YYSVTT--LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 265 HRDIKGSNLLID-NNGILKIADFGLA------SFYDPDQNQPLTSRVVTLWYRPPELLLG 317
H DIK N+L D + + D+GL S YD TL Y PE + G
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDG-----------TLDYFSPEKIKG 180
Query: 318 ATYYGTAVDLWSTGCILAELYAGK-PIMPGRTE---VEQLHK 355
Y + D W+ G + EL GK P E +E L K
Sbjct: 181 HN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221
|
Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 5/112 (4%)
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL--TSRVVTL 307
Q+ G+D S+ +HRD+ N+L+ + + KI DFGLA D N + +R+
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 358
W P + Y D+WS G +L E+++ GK PG + +K+ K
Sbjct: 280 WMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK 329
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 23/46 (50%), Positives = 31/46 (67%)
Query: 244 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
+K M+Q+L GL H G++HRDIK NLL+ +G +KI DFG A
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 59/231 (25%), Positives = 107/231 (46%), Gaps = 25/231 (10%)
Query: 148 LIGQGTYSNVYRA---RDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRRLDHINVI 203
++G G + VY+ + + KI K+ + P++ V FM E I+ +DH +++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM-DEALIMASMDHPHLV 72
Query: 204 KLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+L G+ +S ++ LV + M H L + H S+ + + Q+ G+ + R
Sbjct: 73 RLLGVC---LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN-WCVQIAKGMMYLEER 128
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLTSRVVTLWYRPPELLLGAT 319
++HRD+ N+L+ + +KI DFGLA + D+ + ++ W + L
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-----MALECI 183
Query: 320 YYGTAV---DLWSTGCILAEL--YAGKPI--MPGRTEVEQLHKIFKLCGSP 363
+Y D+WS G + EL + GKP +P R + L K +L P
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 40/140 (28%), Positives = 62/140 (44%), Gaps = 13/140 (9%)
Query: 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 281
E +E D L + L FS Q+ G+ S+ +HRD+ N+L+ + I
Sbjct: 202 EILEEDELALDTEDLLSFS--------YQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 282 KIADFGLASFYDPDQNQPL--TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA 339
KI DFGLA D N + +R+ W P + Y D+WS G +L E+++
Sbjct: 254 KICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFS 311
Query: 340 -GKPIMPGRTEVEQLHKIFK 358
G PG + +K+ K
Sbjct: 312 LGSSPYPGMPVDSKFYKMIK 331
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 56/207 (27%), Positives = 84/207 (40%), Gaps = 23/207 (11%)
Query: 149 IGQGTYSNVY--RARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG G + V A K V +K++R E + F+ +E+ R L+H NV++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFL-QEVQPYRELNHPNVLQCL 61
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQ---QLLCGLDHCHSR 261
G S LV E+ DL L S+ G+ AQ + ++ GL H
Sbjct: 62 GQCIE--SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPEL------ 314
+H D+ N + + +KI D+GLA Y D V L + PEL
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 315 -LLGA--TYYGTAVDLWSTGCILAELY 338
LL T ++WS G + EL+
Sbjct: 180 DLLPKDQTKKS---NIWSLGVTMWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 46/223 (20%), Positives = 80/223 (35%), Gaps = 43/223 (19%)
Query: 136 DKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPESVRFMAREIHIL 194
S+ I I +G ++N K V ++ +F + EI L
Sbjct: 23 YTSVLIKENDQNSIYKGIFNN----------KEVIIRTFKKFHKGHKVLIDITENEIKNL 72
Query: 195 RRLDHINVIKLEGLVTSRMS--CSLYLVFEY-----------MEHDLAGLASHPGLKFSE 241
RR+D N++K+ G + + L L+ EY E DL
Sbjct: 73 RRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDL------------S 120
Query: 242 AQVKCYMQQLLC-GLDHCH-SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299
+ K M C GL + + ++++ + L+ N LKI + P
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI---ICHGLEKILSSPP 177
Query: 300 LTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGK 341
V + Y ++L + Y D++S G +L E++ GK
Sbjct: 178 F-KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 72/314 (22%), Positives = 118/314 (37%), Gaps = 59/314 (18%)
Query: 169 VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228
V ++++ + E V F+ E+H+ + +H N++ + L++V +M +
Sbjct: 28 VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFMAYGS 85
Query: 229 AG--LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286
A + +H SE + +Q +L LD+ H G +HR +K S++LI +G K+
Sbjct: 86 AKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLS 143
Query: 287 GLASFY---DPDQNQ------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL 337
GL S + Q P S V W P L Y D++S G EL
Sbjct: 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203
Query: 338 YAGK-PI--MPG-RTEVEQLHKI-------------------------FKLCGSPSEDYW 368
G P MP + +E+L+ L S +
Sbjct: 204 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTP 263
Query: 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
R S PY R + F F +E L +P R SA++ L FF
Sbjct: 264 RPSNGE-----SSSHPYNRTFSPHFHHF-------VEQCLQRNPDARPSASTLLNHSFFK 311
Query: 429 -MKPLPCDPSSLPK 441
+K + +LP+
Sbjct: 312 QIKRRASE--ALPE 323
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 33/213 (15%)
Query: 148 LIGQGTYSNVYRA---RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
++G G + VY+ + ++ KI VA+K++R + P++ + + E +++ +D+ +V
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHVC 72
Query: 204 KLEG--------LVTSRM--SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLC 253
+L G L+T M C L V E+ + + + Q+
Sbjct: 73 RLLGICLTSTVQLITQLMPFGCLLDYVREHKD------------NIGSQYLLNWCVQIAK 120
Query: 254 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--QPLTSRVVTLWYRP 311
G+++ R ++HRD+ N+L+ +KI DFGLA D+ +V W
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM-A 179
Query: 312 PELLLGATYYGTAVDLWSTGCILAEL--YAGKP 342
E +L Y + D+WS G + EL + KP
Sbjct: 180 LESILHRIYTHQS-DVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 30/103 (29%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 247 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS--FYDPDQNQPLTSRV 304
+ Q+ G++ S+ +HRD+ N+L+ I+KI DFGLA +D + ++ +
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 346
W P + Y T D+WS G +L E+++ G PG
Sbjct: 302 PVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 40/210 (19%)
Query: 195 RRLDHINVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLC 253
R L H N+++ G + LVFEY E DL S +Q+ +Q++ C
Sbjct: 50 RILQHPNILQCLGQCVE--AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQL-LLLQRMAC 106
Query: 254 ----GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLW 308
G+ H H LH D+ N + ++ +K+ D+G+ S Y D + + V L
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 309 YRPPEL-------LLGA--TYYGTAVDLWSTGCILAELY--AGKPIMPGRTEVEQLHKIF 357
+ PEL L+ A T ++W+ G L EL+ A +P ++ E L+ +
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPS---NVWALGVTLWELFENAAQP-YSHLSDREVLNHVI 222
Query: 358 KLCGSPSEDYWRKSKLPHATIFKPQ--QPY 385
K ++ KL FKPQ PY
Sbjct: 223 KD---------QQVKL-----FKPQLELPY 238
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 52/231 (22%), Positives = 101/231 (43%), Gaps = 17/231 (7%)
Query: 144 RSFYLIGQGTYSNVYR---ARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI 200
+ ++G G + VY+ D + KI KV +N P++ + + E +++ +
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
V +L G+ ++ ++ LV + M + L + + + + + Q+ G+ +
Sbjct: 70 YVCRLLGIC---LTSTVQLVTQLMPYGCLLDYVRENKD-RIGSQDLLNWCVQIAKGMSYL 125
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPELLL 316
++HRD+ N+L+ + +KI DFGLA D D+ + +V W +L
Sbjct: 126 EEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL- 184
Query: 317 GATYYGTAVDLWSTGCILAEL--YAGKPI--MPGRTEVEQLHKIFKLCGSP 363
+ D+WS G + EL + KP +P R + L K +L P
Sbjct: 185 -HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPP 234
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 29/79 (36%), Positives = 43/79 (54%), Gaps = 4/79 (5%)
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRDIK SN+L+++ G +K+ DFG++ N + V T Y PE + G Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTSTYMSPERIQGGK-YT 180
Query: 323 TAVDLWSTGCILAELYAGK 341
D+WS G + EL GK
Sbjct: 181 VKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 57/231 (24%), Positives = 89/231 (38%), Gaps = 53/231 (22%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI-------------- 193
LIG G + VY + I + +NLE E+ + E +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENET---IVMETLVYNNIYDIDKIALWK 75
Query: 194 -LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCY----- 247
+ +DH+ + K G S C +Y F +E L + F ++KC
Sbjct: 76 NIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEK----LVENTKEIFK--RIKCKNKKLI 128
Query: 248 ---MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
M+ +L L++ H G+ H DIK N+++D N I D+G+AS + S+
Sbjct: 129 KNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKE 188
Query: 305 VTLWYRPPELLLGATYY-------GTAV----DLWSTG-CILAELYAGKPI 343
+R G YY G V DL S G C+L +AG +
Sbjct: 189 QKDLHR------GTLYYAGLDAHNGACVTRRGDLESLGYCMLK--WAGIKL 231
|
Length = 294 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 3/74 (4%)
Query: 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 277
Y V Y+ + L GL+ ++ M+Q+L LD HS G++HRD+K N++
Sbjct: 233 YNVEPYLLGKVQDLP--KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 278 -NGILKIADFGLAS 290
+G KI D G A+
Sbjct: 291 GSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 20/205 (9%)
Query: 149 IGQGTYSNVYR--ARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+GQG++ VY ARD+ + + VA+K V E + F+ E +++ +V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFL-NEASVMKGFTCHHVV 72
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGL--------ASHPGLKFSEAQVKCYMQ-QLLC 253
+L G+V S+ +L +V E M H DL ++PG Q M ++
Sbjct: 73 RLLGVV-SKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 254 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPP 312
G+ + +++ +HRD+ N ++ ++ +KI DFG+ Y+ D + ++ + + P
Sbjct: 131 GMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 313 ELLLGATYYGTAVDLWSTGCILAEL 337
E L + T+ D+WS G +L E+
Sbjct: 191 ESLKDGV-FTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 45/208 (21%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 149 IGQGTYSNVYRA------RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 202
+GQG++ VY +D + + VA+K V E + F+ E +++ + +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERIEFL-NEASVMKEFNCHHV 71
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH-----PGLKFSEAQVKCYMQQLLC---- 253
++L G+V+ ++ E M L S+ P ++ + Q +++++
Sbjct: 72 VRLLGVVSQGQPT--LVIMELMTR--GDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 254 ---GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWY 309
G+ + ++ +HRD+ N ++ + +KI DFG+ Y+ D + ++ + +
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAEL 337
PE L + T D+WS G +L E+
Sbjct: 188 MSPESLKDGV-FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.35 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.3 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.08 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.0 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.87 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.86 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.65 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.53 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.38 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.31 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.22 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.08 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.07 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.01 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.95 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.72 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.53 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.44 | |
| PLN02236 | 344 | choline kinase | 95.94 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.93 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.86 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.75 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.51 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.05 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.93 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.91 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.74 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.68 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.46 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 93.89 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.74 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 93.44 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.09 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 92.45 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 91.46 |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-88 Score=727.21 Aligned_cols=423 Identities=70% Similarity=1.147 Sum_probs=399.1
Q ss_pred CCCCCCCCCchhhhhcCCCchhhhhhhhhhcCCCCCCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEE
Q 004999 92 GMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVAL 171 (720)
Q Consensus 92 ~~~slp~~~~~~~~~~~~P~~~~~~~g~~i~g~~p~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAI 171 (720)
..++.+.....++.+++||.|+..++|+++.+|.|.+.+.|+++++ ||+|+||.||+|++..||+.|||
T Consensus 79 ~~~~~~~~~e~~~~~a~~p~~l~~~~ge~~~~w~~r~~~~feki~k-----------IGeGTyg~VYkAr~~~tgkivAL 147 (560)
T KOG0600|consen 79 RPSSVPKSTEAEQVAAGWPAWLSSVAGEALHGWGPRRADSFEKIEK-----------IGEGTYGQVYKARDLETGKIVAL 147 (560)
T ss_pred CCCCCCCcchhhhhhccCccccccccccccccccccchHHHHHHHH-----------hcCcchhheeEeeecccCcEEEE
Confidence 4455556666789999999999999999999999999999999999 99999999999999999999999
Q ss_pred EEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhh
Q 004999 172 KKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL 251 (720)
Q Consensus 172 K~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QI 251 (720)
|++++++.+......+.|||.||++|+||||++|.+++++...+.+|||||||++||..++...+.+|++.++++||+||
T Consensus 148 KKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQL 227 (560)
T KOG0600|consen 148 KKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQL 227 (560)
T ss_pred EEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHH
Confidence 99999998889999999999999999999999999999987778999999999999999999999999999999999999
Q ss_pred hhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhH
Q 004999 252 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTG 331 (720)
Q Consensus 252 l~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG 331 (720)
+.||+|||.+||+|||||.+|||||.+|.+||+|||||+++.......+|..+.|+||+|||+|+|...|+.++|+||+|
T Consensus 228 l~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~G 307 (560)
T KOG0600|consen 228 LEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVG 307 (560)
T ss_pred HHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhh
Confidence 99999999999999999999999999999999999999999988888899999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccC
Q 004999 332 CILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSID 411 (720)
Q Consensus 332 ~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~D 411 (720)
|||.||++|+|+|.|.++++|+++|+++||+|.+.+|...++|++..|++..+|++++.+.++.++..+++|+.+||.+|
T Consensus 308 CIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ld 387 (560)
T KOG0600|consen 308 CILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLD 387 (560)
T ss_pred HHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHhCccCCCCCCCCCCCCCCCCCCChHHHHhhHHHHHHHcCCCCCCCccccccCCcCCCCCCCCccchHHH
Q 004999 412 PADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELV 491 (720)
Q Consensus 412 P~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (720)
|.+|.||.++|+|+||+..|.+|+|+.||.|++.+|++++.++++++++.+...++... .++.+.++++++++++++.+
T Consensus 388 P~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~s~E~~~K~r~e~~r~~~~~~~~~~~~-~~~~~~~r~~p~~~~~~~~~ 466 (560)
T KOG0600|consen 388 PDKRGTASSALQSEYFTTEPLPCDPSSLPKYPPSHELDAKRRREQKRRNKGGASKRRIR-ERGDRGSRAIPAQPANAESQ 466 (560)
T ss_pred ccccccHHHHhcCcccccCCCCCCcccCCCCCcchhHHHHHHHHHhhcccccccccccc-cccccccCCCCCCCCCHHHh
Confidence 99999999999999999999999999999999999999999999988777444433322 44577889999999999999
Q ss_pred HhHhhhhccccccccCCCCCCCccccCCCCCCCCCCCc
Q 004999 492 LSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQS 529 (720)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 529 (720)
++.+.+ +.|..+.+++|.|+++++ .||++++.+..
T Consensus 467 ~~~~~~--~~n~~~~s~kf~p~~~~~-~~~~~~~~~~~ 501 (560)
T KOG0600|consen 467 ASPQRR--KSNSRSNSEKFPPPEQDG-VGFPIGPSRRS 501 (560)
T ss_pred cccccc--ccCCcCcccCCCCccccc-cCcccCCcccc
Confidence 999988 789999999999988776 99999987764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-60 Score=490.86 Aligned_cols=308 Identities=44% Similarity=0.756 Sum_probs=273.6
Q ss_pred CCCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeee
Q 004999 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 126 p~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
+..++.|++|.+ |++|+||.||+|+|+.|++.||+|+++.+.-....--.-+|||.+|.+++|||||.+
T Consensus 72 Crsv~efe~lnr-----------I~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~v 140 (419)
T KOG0663|consen 72 CRSVEEFEKLNR-----------IEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEV 140 (419)
T ss_pred cccHHHHHHHhh-----------cccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeee
Confidence 567889999999 999999999999999999999999998764222211234799999999999999999
Q ss_pred ccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeec
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 285 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~D 285 (720)
..+.....-+.+|||||||++|+..++..-..+|...++++++.|+++||+|||.+.|+||||||+|+|++..|.+||+|
T Consensus 141 kEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaD 220 (419)
T KOG0663|consen 141 KEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIAD 220 (419)
T ss_pred EEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecc
Confidence 99988766778999999999999988888778999999999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 286 FGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 286 FGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
||+|+.++. ...++|..+.|+||+|||+|+|...|+.++||||+|||++||++++|+|+|..+.+|+.+|++.+|.|++
T Consensus 221 FGLAR~ygs-p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 221 FGLAREYGS-PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred cchhhhhcC-CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 999998865 3567889999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCcc--ccCCCCccchhhhcccCC--CCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCCC
Q 004999 366 DYWRKSKLPHAT--IFKPQQPYKRCVAETFKD--FPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPK 441 (720)
Q Consensus 366 ~~w~~~~l~~~~--~~~~~~~~~~~~~e~~~~--~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~ 441 (720)
..|.+.....+. .-.+..+|.. +...|.. +++...+|+..+|.+||.+|.||.++|+|.||...|.|++|..+|.
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~-lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNN-LRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPT 378 (419)
T ss_pred ccCCCccccchhhccccCCCCchh-hhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCC
Confidence 999986554433 3344555544 3333433 5699999999999999999999999999999999999999999999
Q ss_pred CCCCh
Q 004999 442 YPPSK 446 (720)
Q Consensus 442 ~~p~~ 446 (720)
||...
T Consensus 379 ~P~k~ 383 (419)
T KOG0663|consen 379 WPAKS 383 (419)
T ss_pred Ccccc
Confidence 98643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-59 Score=465.36 Aligned_cols=297 Identities=43% Similarity=0.748 Sum_probs=265.0
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
..|..++. ||+|+||.||+|++..||+.||||+++..+..........|||+.|+.++|+||+.|+++|
T Consensus 2 ~rY~~~~~-----------lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F 70 (318)
T KOG0659|consen 2 DRYEKLEK-----------LGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF 70 (318)
T ss_pred chhhhhhh-----------hcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc
Confidence 45777777 9999999999999999999999999998766544455678999999999999999999999
Q ss_pred eccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 210 TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
.. ...+.||+|||+.+|...+......|+..+++.|+.++++||+|||++.|+||||||.|+||+++|.+||+|||+|
T Consensus 71 ~~--~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 71 PH--KSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred cC--CCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccch
Confidence 76 6679999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 290 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 290 ~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
+.+.+.. ...+..+.|.||+|||+|.|...|+..+||||+|||++||+.|.|+|+|.++.+|+..|+..+|+|.++.|.
T Consensus 149 r~f~~p~-~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 149 RFFGSPN-RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred hccCCCC-cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 9886543 344555899999999999999999999999999999999999999999999999999999999999999998
Q ss_pred h-cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCCCC
Q 004999 370 K-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKY 442 (720)
Q Consensus 370 ~-~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~ 442 (720)
+ ..++....+. ..|.. .....|...++++.||+.+||.+||.+|+|+.|+|+|+||+..|.|+.|..+|..
T Consensus 228 ~~~~lpdY~~~~-~~P~~-~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p 299 (318)
T KOG0659|consen 228 EMTSLPDYVKIQ-QFPKP-PLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP 299 (318)
T ss_pred cccccccHHHHh-cCCCC-ccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence 7 4566555444 11111 1233778889999999999999999999999999999999999999999888754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-57 Score=459.52 Aligned_cols=285 Identities=35% Similarity=0.597 Sum_probs=249.5
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
+.||+|.+ +|+|+||+||+|++++||+.||||++.....++...+-.+|||++|++|.|+|+|.|+++|
T Consensus 2 ekYE~Lgk-----------vGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF 70 (396)
T KOG0593|consen 2 EKYEKLGK-----------VGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF 70 (396)
T ss_pred cHHhhhhc-----------cccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH
Confidence 57889998 9999999999999999999999999976665566666678999999999999999999999
Q ss_pred eccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 210 TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
.. ...++||||||++..+..+......+++..++.|+.|++.|+.|||++++|||||||+||||+.+|.+||||||+|
T Consensus 71 rr--krklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 71 RR--KRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred Hh--cceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhh
Confidence 66 6789999999999988888776667999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 290 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 290 ~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
+.+.. .....|.++.|.||+|||++.|...|+..+|||++||++.||++|.|+|+|.++++|+..|.+.+|...+....
T Consensus 149 R~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 149 RTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred HhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 98764 45667899999999999999999999999999999999999999999999999999999999999988776422
Q ss_pred h-cCCCCc-cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 370 K-SKLPHA-TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 370 ~-~~l~~~-~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
- .+.+.. ..-.|...-...+...+++++..+.+|+.+||.+||.+|++.+++|.|+||.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1 111111 1112222223445667788999999999999999999999999999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-57 Score=481.14 Aligned_cols=287 Identities=38% Similarity=0.678 Sum_probs=258.4
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeecc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEG 207 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~ 207 (720)
.+.|..+++ ||.|+||.||+|+...++..||||.++......+.+-. +||+..|++|+ |||||+|.+
T Consensus 9 m~RY~~i~k-----------lGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~E 76 (538)
T KOG0661|consen 9 MDRYTVIRK-----------LGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKE 76 (538)
T ss_pred HHHHHHHHH-----------hcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHH
Confidence 456777888 99999999999999999999999999876655444433 68999999998 999999999
Q ss_pred ceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
++.+.+. .+|+|||||+.+|.+++..++..|++..++.||.||+.||+|+|.+|+.||||||+||||..+..|||+|||
T Consensus 77 vi~d~~~-~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFG 155 (538)
T KOG0661|consen 77 VIRDNDR-ILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFG 155 (538)
T ss_pred HhhccCc-eEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccc
Confidence 9988543 899999999999999999999999999999999999999999999999999999999999989999999999
Q ss_pred cceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 288 la~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
+|+... ...+.|.++.|.||+|||+|+....|+.++|||++|||++||++-+|+|+|.++.+++.+|..++|+|..+.
T Consensus 156 LARev~--SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 156 LAREVR--SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred cccccc--cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 999774 456789999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhh-cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 368 WRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 368 w~~-~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
|.. ..+..+..|....--...+...++.++.++.+||..||.+||.+||||.++|+||||+..
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 987 555555555544444445667778899999999999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-55 Score=482.30 Aligned_cols=260 Identities=30% Similarity=0.432 Sum_probs=230.6
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
.+|.+.++||+|+|+.||.+++..+|+.||+|++.+..+ .....+.+.+||+|.+.|.|||||+++++|++ ...+||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED--SNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec--CCceEE
Confidence 345555679999999999999999999999999987654 45667789999999999999999999999988 788999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
|+|+|..+.+..+......++|.+++.|++||+.||.|||+++|+|||||..||||+++.+|||+|||||..+..+.. .
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E-r 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE-R 174 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc-c
Confidence 999999877777777788999999999999999999999999999999999999999999999999999998865433 3
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
..+.||||.|.|||++.... ++..+||||+|||||.||+|+|||...+-.+.+.+|...-+
T Consensus 175 k~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------------------ 235 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------------------ 235 (592)
T ss_pred cceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc------------------
Confidence 45569999999999999776 69999999999999999999999999999999999865322
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
..+..++.++.+||.+||+.||.+|||+.++|.|+||+....|
T Consensus 236 -----------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 236 -----------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred -----------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 2234789999999999999999999999999999999665444
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-55 Score=454.06 Aligned_cols=290 Identities=37% Similarity=0.578 Sum_probs=252.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceec---cCCCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS---RMSCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~---~~~~~lyLV~Ey 223 (720)
+.||.|+||.|+.|.++.+|+.||||++.......-.+++..||+.+|+.++|+||+.+.+++.. ..-..+|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 34999999999999999999999999998555556778889999999999999999999998865 224579999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC-CCCCccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-QNQPLTS 302 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~t~ 302 (720)
|+.+|...+.. +..+++.++..++.||+.||.|+|+.+|+||||||+|||++.++.+||+|||+|+..... ....+|.
T Consensus 108 MetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTe 186 (359)
T KOG0660|consen 108 METDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTE 186 (359)
T ss_pred HhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcccchhc
Confidence 99888777655 435999999999999999999999999999999999999999999999999999987432 3456789
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
++.|.||+|||+++....|+.++||||+||||+|||+|+++|+|.+.++|+..|...+|+|+++.+.......+..+...
T Consensus 187 YVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~s 266 (359)
T KOG0660|consen 187 YVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKS 266 (359)
T ss_pred ceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHh
Confidence 99999999999999998999999999999999999999999999999999999999999999998776543333222221
Q ss_pred Cc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCC
Q 004999 383 QP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 437 (720)
Q Consensus 383 ~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~ 437 (720)
.+ -+..+...++.+++.+.+||++||..||.+|+|++|+|+||||.....|.+.+
T Consensus 267 lp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 267 LPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred CCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 11 12335677889999999999999999999999999999999999887776544
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-52 Score=435.92 Aligned_cols=293 Identities=41% Similarity=0.720 Sum_probs=249.3
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc-eeeecc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN-VIKLEG 207 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Ivkl~~ 207 (720)
.+.|+.+++ ||+|+||+||+|+++.+|+.||||+++....+...-....+|+.+|+.|+|+| ||.|++
T Consensus 10 ~~~~~~~ek-----------lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~d 78 (323)
T KOG0594|consen 10 MFDYEKVEK-----------LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHD 78 (323)
T ss_pred HHHHHHHHH-----------hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEe
Confidence 567999999 99999999999999999999999999976542222234579999999999999 999999
Q ss_pred ceeccC----CCeEEEEEeeccccccccccCCC---CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc
Q 004999 208 LVTSRM----SCSLYLVFEYMEHDLAGLASHPG---LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 280 (720)
Q Consensus 208 ~~~~~~----~~~lyLV~Ey~~g~ll~~~~~~~---~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~ 280 (720)
++.... ...+|+||||++-++...+.... ..++...++.++.||+.||+|||+++|+||||||.||||+++|.
T Consensus 79 v~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~ 158 (323)
T KOG0594|consen 79 VIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV 158 (323)
T ss_pred eeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc
Confidence 987632 13899999999988876655544 35788999999999999999999999999999999999999999
Q ss_pred eeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 004999 281 LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360 (720)
Q Consensus 281 vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~ 360 (720)
+||+|||+|+.+.- .....+..++|.||+|||+|+|...|+..+||||+|||++||++++++|+|.++.+++..|++.+
T Consensus 159 lKlaDFGlAra~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~l 237 (323)
T KOG0594|consen 159 LKLADFGLARAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLL 237 (323)
T ss_pred EeeeccchHHHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHc
Confidence 99999999997642 22346778999999999999999889999999999999999999999999999999999999999
Q ss_pred CCCChhhhhhc-CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 361 GSPSEDYWRKS-KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 361 g~p~~~~w~~~-~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
|+|.++.|... .++......+...-...+....+...+.+.+|+.+||+++|.+|.||..+|.|+||...+.+
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~ 311 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK 311 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence 99999999873 34433322222222344556666777899999999999999999999999999999876543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-53 Score=443.21 Aligned_cols=264 Identities=30% Similarity=0.423 Sum_probs=222.7
Q ss_pred ccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH-----HHHHHHHHHHHHHHhcCCCceeeeccceeccCC
Q 004999 140 SIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 214 (720)
Q Consensus 140 ~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~-----~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~ 214 (720)
..+|-+.+.||+|+||.|.+|..+.||+.||||+++...... .....+.+|++||++|+|||||+++++|.. .
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~--~ 248 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV--P 248 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--C
Confidence 344555556999999999999999999999999998765421 123346799999999999999999999987 5
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC---Cceeeecccccee
Q 004999 215 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASF 291 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~---g~vKL~DFGla~~ 291 (720)
...|+|||||+|+.+......++.+.+...+.+++||+.||.|||+.||+||||||+|||+..+ ..+||+|||+|++
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 6689999999986665555556689999999999999999999999999999999999999876 7899999999998
Q ss_pred cCCCCCCCccccccccCCCChhhhcCCc--CCCccccchhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhh
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~~~~--~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e-~l~~i~~~~g~p~~~~w 368 (720)
.+ ....+.+.||||.|.|||++.+.. .|+.++||||||||||-+|+|.+||.+..... ...+|.+..+..-+..|
T Consensus 329 ~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 329 SG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred cc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 75 456778899999999999997543 35568999999999999999999999866544 66667665444443444
Q ss_pred hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
..+++++++||.+||.+||++|||+.|+|+||||+..+.
T Consensus 407 -------------------------~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 407 -------------------------DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred -------------------------hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 358999999999999999999999999999999997653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-51 Score=424.73 Aligned_cols=283 Identities=38% Similarity=0.617 Sum_probs=238.0
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCC---eEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC---SLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~---~ly 218 (720)
.+...+++|.|+||.||+|...++++.||||++-.+.. .--+|+.+|+.++|||||+|.-+|....+. .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 34555679999999999999999999999999875532 124799999999999999999888765444 456
Q ss_pred EEEeeccccccccccC---CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-CceeeeccccceecCC
Q 004999 219 LVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYDP 294 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~---~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~DFGla~~~~~ 294 (720)
||||||+.++...+.. .+..++.-.++-|+.||++||.|||+.||+||||||.|||||.+ |.+||||||.|+.+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999887766553 46678999999999999999999999999999999999999976 9999999999998854
Q ss_pred CCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 295 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 295 ~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
. .+..++.+|..|+|||+++|.+.|+.++||||.|||++||+-|+|+|+|.+..+|+..|++.+|.|+.+.....+..
T Consensus 179 ~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 179 G--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred C--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 4 44578889999999999999999999999999999999999999999999999999999999999999986654433
Q ss_pred CccccCCCCccchhhhc-ccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 375 HATIFKPQQPYKRCVAE-TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e-~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.. .++.+.-....+.+ .....++++.+|+.++|.++|.+|.++.++|.||||.....+
T Consensus 257 y~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 257 YT-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cc-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 22 12111111111222 556789999999999999999999999999999999865443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=417.32 Aligned_cols=249 Identities=29% Similarity=0.410 Sum_probs=218.6
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|..|+||+++++.|++.+|+|++. -..++...+++.+|+.|++.++|||||++||.|..... .++|+||||+|+.
T Consensus 87 lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEYMDgGS 164 (364)
T KOG0581|consen 87 LGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEYMDGGS 164 (364)
T ss_pred cccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhhcCCCC
Confidence 999999999999999999999999994 34577888999999999999999999999999988433 6999999999998
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
++.+....+.++|...-.++.+|++||.|||+ ++||||||||+||||+..|.|||||||.+..+... ...+.+||.
T Consensus 165 Ld~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a~tfvGT~ 241 (364)
T KOG0581|consen 165 LDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IANTFVGTS 241 (364)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hcccccccc
Confidence 88888777789999999999999999999995 99999999999999999999999999999876433 456789999
Q ss_pred CCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR-----TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 308 ~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~-----~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.|||||.+.+.. |+.++||||||++++|+++|+.||... ...+.+..|.. .|++
T Consensus 242 ~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~ppP----------------- 300 (364)
T KOG0581|consen 242 AYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPPP----------------- 300 (364)
T ss_pred cccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCCC-----------------
Confidence 999999999987 899999999999999999999888774 45555555542 2211
Q ss_pred CccchhhhcccC-CCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 383 QPYKRCVAETFK-DFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 383 ~~~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
..+. .+++++.+||..||++||.+|+|+.|+|+|||++...
T Consensus 301 --------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 301 --------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred --------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 1123 3899999999999999999999999999999998643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=376.46 Aligned_cols=286 Identities=41% Similarity=0.733 Sum_probs=250.6
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
..|.++++ ||+|+||+||+|++.++++.||+|.++.+..+...-...++||.+|+.|.|.|||+++++.
T Consensus 2 ~~ydkmek-----------igegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl 70 (292)
T KOG0662|consen 2 QKYDKMEK-----------IGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL 70 (292)
T ss_pred cchHHHHh-----------hcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh
Confidence 35788888 9999999999999999999999999998765544445678999999999999999999987
Q ss_pred eccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 210 TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
.+ +..+.||+|||..++...+..-++.++.+.++.+|.|+++||.|||+++++||||||.|+||+.+|.+||+|||++
T Consensus 71 hs--dkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 71 HS--DKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred cc--CceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchh
Confidence 66 6789999999999888777777788999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 004999 290 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 290 ~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w 368 (720)
+.++-. .......+.|.||++|.++.|..-|+...|+||.|||++||.. |+|+|+|.+-.+|+.+|++++|.|.++.|
T Consensus 149 rafgip-vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~w 227 (292)
T KOG0662|consen 149 RAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQW 227 (292)
T ss_pred hhcCCc-eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccC
Confidence 977532 2344556789999999999999999999999999999999975 88999999999999999999999999999
Q ss_pred hhc-CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 369 RKS-KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 369 ~~~-~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
... +++.... -|..+....+....+.+....++|++++|.-+|.+|++|+++|+||||...
T Consensus 228 ps~t~lpdyk~-yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 228 PSMTKLPDYKP-YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CccccCCCCcc-cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 763 4443322 223333344667778888999999999999999999999999999999853
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=413.80 Aligned_cols=261 Identities=31% Similarity=0.471 Sum_probs=228.0
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeec
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
..++|+.++. ||+|+||.||.++.++|++.||+|++++... ....++.+..|..||.+++||.||+++
T Consensus 23 ~~~dF~~lkv-----------iGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ 91 (357)
T KOG0598|consen 23 GPDDFEILKV-----------IGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLI 91 (357)
T ss_pred Chhheeeeee-----------eeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeE
Confidence 4566766666 9999999999999999999999999998765 456788899999999999999999998
Q ss_pred cceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
-.|++ ...+|||+||+.|+.+...+...+.|+|..++.|+..|+.||.|||+.|||||||||+|||||.+|+++|+||
T Consensus 92 ysFQt--~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDF 169 (357)
T KOG0598|consen 92 YSFQT--EEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDF 169 (357)
T ss_pred Eeccc--CCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEecc
Confidence 77766 7889999999998766666666779999999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
||++..-.. .....+.|||+.|||||++.+.. |+.++|+|||||++|||++|.+||.+.+....+.+|.+.-
T Consensus 170 gL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------ 241 (357)
T KOG0598|consen 170 GLCKEDLKD-GDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------ 241 (357)
T ss_pred ccchhcccC-CCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc------
Confidence 999854332 22334579999999999999986 8999999999999999999999999999999988887531
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC----CHHHHHhCccCCCCC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG----SAASALRSEFFTMKP 431 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp----Ta~e~L~hp~f~~~~ 431 (720)
+......++.++++||.++|..||++|. .+.++-+||||....
T Consensus 242 ----------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 242 ----------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred ----------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 1112234789999999999999999995 799999999998653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=420.04 Aligned_cols=272 Identities=33% Similarity=0.502 Sum_probs=231.5
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeee
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKL 205 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl 205 (720)
...+|.-.+. ||.|+|++|++|+++.+++.||||++.+..+ ....++-+.+|-.+|.+| .||.|++|
T Consensus 71 ~~~DF~Fg~~-----------lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkL 139 (604)
T KOG0592|consen 71 TPNDFKFGKI-----------LGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKL 139 (604)
T ss_pred Chhhcchhhe-----------eccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEE
Confidence 4456665555 9999999999999999999999999987755 344456678999999999 89999999
Q ss_pred ccceeccCCCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
+-.|.+ ...+|+|+||+++ +|+.++.. -+.|++..++.|+.||+.||+|||++|||||||||+|||||.||++||+
T Consensus 140 y~TFQD--~~sLYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 140 YFTFQD--EESLYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred EEEeec--ccceEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEe
Confidence 877766 7889999999985 56665554 4589999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCCC------------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHH
Q 004999 285 DFGLASFYDPDQNQ------------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 352 (720)
Q Consensus 285 DFGla~~~~~~~~~------------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~ 352 (720)
|||.|+.+.+.... ...+.|||..|.+||+|.... .++.+|||+||||||.|+.|.|||.+.++.-.
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 99999988543221 125689999999999998876 69999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 353 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 353 l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
..+|+++-+ ++.+++++.+.+||+++|..||.+|+|+.+|.+||||....+
T Consensus 296 FqkI~~l~y-----------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 296 FQKIQALDY-----------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred HHHHHHhcc-----------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 999988633 344678999999999999999999999999999999986532
Q ss_pred ----CCCCCCCCCCC
Q 004999 433 ----PCDPSSLPKYP 443 (720)
Q Consensus 433 ----~~~p~~~p~~~ 443 (720)
...|+.+-.|.
T Consensus 347 ~nlw~~~PP~l~py~ 361 (604)
T KOG0592|consen 347 ENLWQQTPPKLQPYK 361 (604)
T ss_pred hhhhhcCCCcccCCC
Confidence 33444444443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=404.98 Aligned_cols=265 Identities=30% Similarity=0.466 Sum_probs=231.4
Q ss_pred CCCCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceee
Q 004999 125 VPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204 (720)
Q Consensus 125 ~p~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvk 204 (720)
......+|+...+ ||.|+|++||+|+++.++..||||.+....+.++.++.+..||+||+.|+|||||.
T Consensus 5 ~~~~~~~y~~~~~-----------iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~ 73 (429)
T KOG0595|consen 5 SMRVVGDYELSRE-----------IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVR 73 (429)
T ss_pred cccccccceehhh-----------ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceee
Confidence 3445667888888 99999999999999999999999999998888889999999999999999999999
Q ss_pred eccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC------
Q 004999 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN------ 278 (720)
Q Consensus 205 l~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~------ 278 (720)
|++++.. .+.+|||||||+|+.+..++...+.++|..++.++.||+.||++||+++||||||||.||||+..
T Consensus 74 l~d~~~~--~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~ 151 (429)
T KOG0595|consen 74 LLDCIED--DDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTS 151 (429)
T ss_pred EEEEEec--CCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCC
Confidence 9999887 67899999999987777777777789999999999999999999999999999999999999765
Q ss_pred CceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 004999 279 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 279 g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~ 358 (720)
-.+||+|||+|+.+.+ .....+.||++-|||||++.... |+.++|+||+|+|||+|++|++||...+..+.+..+.+
T Consensus 152 ~~LKIADFGfAR~L~~--~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k 228 (429)
T KOG0595|consen 152 PVLKIADFGFARFLQP--GSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK 228 (429)
T ss_pred ceEEecccchhhhCCc--hhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 4689999999998863 33456779999999999997665 89999999999999999999999999999888876544
Q ss_pred hcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.... +......++.+..+|+..+|+.+|..|.+..+-+.|+++...+
T Consensus 229 ~~~~--------------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 229 GNEI--------------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cccc--------------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 2111 1122234667788999999999999999999999999998765
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=415.48 Aligned_cols=266 Identities=33% Similarity=0.492 Sum_probs=226.9
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeec
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
..++|+.|.. ||+|+||.||+|+-+.||..+|||++++..+ ....++.+..|-.||...++|+||+||
T Consensus 139 ~~~DFe~Lk~-----------IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy 207 (550)
T KOG0605|consen 139 SLDDFELLKV-----------IGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY 207 (550)
T ss_pred Ccccchhhee-----------eccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence 4567777776 9999999999999999999999999998765 567788899999999999999999998
Q ss_pred cceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
-.|.+ ...+||||||++|+....++..-..|++.+++.|+.+++.|++.||.+|+|||||||+|+|||..|++||+||
T Consensus 208 YsFQD--~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDF 285 (550)
T KOG0605|consen 208 YSFQD--KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDF 285 (550)
T ss_pred EEecC--CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccc
Confidence 87776 7889999999998666555556668999999999999999999999999999999999999999999999999
Q ss_pred ccceecCC-----------------------CCC-----------------------CCccccccccCCCChhhhcCCcC
Q 004999 287 GLASFYDP-----------------------DQN-----------------------QPLTSRVVTLWYRPPELLLGATY 320 (720)
Q Consensus 287 Gla~~~~~-----------------------~~~-----------------------~~~t~~~gT~~Y~APE~l~~~~~ 320 (720)
||+.-+.. +.. ....+.+|||.|+|||+|++..
T Consensus 286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg- 364 (550)
T KOG0605|consen 286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG- 364 (550)
T ss_pred cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-
Confidence 99854311 000 0112458999999999999988
Q ss_pred CCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc-CCCCccccCCCCccchhhhcccCCCCHh
Q 004999 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHATIFKPQQPYKRCVAETFKDFPAP 399 (720)
Q Consensus 321 y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~-~l~~~~~~~~~~~~~~~~~e~~~~~~~~ 399 (720)
|+..+|+|||||||||||.|.|||.+.+..+...+|+. |... +.| .-..++++
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~n---------wr~~l~fP-----------------~~~~~s~e 418 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVN---------WRETLKFP-----------------EEVDLSDE 418 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---------HhhhccCC-----------------CcCcccHH
Confidence 89999999999999999999999999999999999975 3211 000 01246789
Q ss_pred HHHHHHHhcccCCCCCCC---HHHHHhCccCCCCCCCC
Q 004999 400 ALALMETLLSIDPADRGS---AASALRSEFFTMKPLPC 434 (720)
Q Consensus 400 ~~dLI~~mL~~DP~kRpT---a~e~L~hp~f~~~~~~~ 434 (720)
+.|||.+||. ||++|.. +.||.+||||+...+-.
T Consensus 419 A~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 419 AKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 9999999999 9999975 99999999999876543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=395.89 Aligned_cols=293 Identities=37% Similarity=0.627 Sum_probs=236.3
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeee
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
+.|+.+.+ ||+|+||.||+|....++. .+|||+++.+......-....||+.+++.|+||||+.|
T Consensus 24 ~~ye~ig~-----------Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~L 92 (438)
T KOG0666|consen 24 FEYEGIGK-----------IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISL 92 (438)
T ss_pred HHhhccce-----------ecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhH
Confidence 45666666 9999999999996654432 68999998663211122334689999999999999999
Q ss_pred ccceeccCCCeEEEEEeeccccccccccC----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC---
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN--- 278 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~--- 278 (720)
..+|... +..++|++||.+++|+..+.. ....++...++.|+.||+.|+.|||++-|+||||||.||||..+
T Consensus 93 v~Vfl~~-d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 93 VKVFLSH-DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred HHHHhcc-CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCc
Confidence 9998875 678999999999999887654 23468999999999999999999999999999999999999888
Q ss_pred -CceeeeccccceecCCCCCC--CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-------
Q 004999 279 -GILKIADFGLASFYDPDQNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------- 348 (720)
Q Consensus 279 -g~vKL~DFGla~~~~~~~~~--~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~------- 348 (720)
|.|||+|||+++.+...-.. .....+.|.||+|||+|+|...|++++|||++|||++||||-.|+|.|.+
T Consensus 172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~ 251 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN 251 (438)
T ss_pred cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCC
Confidence 89999999999987532221 22345789999999999999999999999999999999999999999865
Q ss_pred --hHHHHHHHHHhcCCCChhhhhhc-CCCCcc-cc-CCC-Cccchh----hhcccCCCCHhHHHHHHHhcccCCCCCCCH
Q 004999 349 --EVEQLHKIFKLCGSPSEDYWRKS-KLPHAT-IF-KPQ-QPYKRC----VAETFKDFPAPALALMETLLSIDPADRGSA 418 (720)
Q Consensus 349 --~~e~l~~i~~~~g~p~~~~w~~~-~l~~~~-~~-~~~-~~~~~~----~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa 418 (720)
..+|+.+|++++|.|.++.|.+. +.|... .+ ..+ ..|..+ +....+.-++.+.+||.+||++||.+|+|+
T Consensus 252 Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta 331 (438)
T KOG0666|consen 252 PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA 331 (438)
T ss_pred CchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH
Confidence 45899999999999999999874 344331 11 011 111111 223334456679999999999999999999
Q ss_pred HHHHhCccCCCCCCCC
Q 004999 419 ASALRSEFFTMKPLPC 434 (720)
Q Consensus 419 ~e~L~hp~f~~~~~~~ 434 (720)
+++|+|+||+..+.|.
T Consensus 332 ~qAleh~yF~~d~lpp 347 (438)
T KOG0666|consen 332 EQALEHPYFTEDPLPP 347 (438)
T ss_pred HHHhcccccccCCCCC
Confidence 9999999999887763
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=395.66 Aligned_cols=276 Identities=39% Similarity=0.696 Sum_probs=228.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||.|+||.||+|++..++..||+|+++..... .....+.+|+.+++.++||||+++++++.. ...+|+||||+.+
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~ 87 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTLVFEYLDS 87 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEEeCCCc
Confidence 3499999999999999999999999999754322 223456789999999999999999998876 5679999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
++...+...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ........+|
T Consensus 88 ~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~~~~~~~~~ 166 (288)
T cd07871 88 DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVVT 166 (288)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC-CccccCceec
Confidence 877766655666899999999999999999999999999999999999999999999999999764322 2223445779
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC--ccccCCCCc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH--ATIFKPQQP 384 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~--~~~~~~~~~ 384 (720)
+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|..+.|....... .....+...
T Consensus 167 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T cd07871 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYR 246 (288)
T ss_pred ccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccC
Confidence 999999999876668999999999999999999999999999999999999999999999887532111 111111111
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
..........++.++.+||.+||++||.+|||+.|+|+||||
T Consensus 247 -~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 247 -AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred -CCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111223345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=385.04 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=229.4
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeec
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
..++|+.+.. ||.|+||.|.+++++.+|..+|+|++++... .-..++...+|..+|+.+.||++++++
T Consensus 42 ~l~dfe~~~t-----------lGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~ 110 (355)
T KOG0616|consen 42 SLQDFERLKT-----------LGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLY 110 (355)
T ss_pred chhhhhheee-----------eccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEE
Confidence 4467777777 9999999999999999999999999987654 556778899999999999999999999
Q ss_pred cceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
+.+.+ ...+|+||||++|+.+.-++...+.|++..++.|+.||+.||+|||+++|++|||||+|||||.+|.+||+||
T Consensus 111 ~t~~d--~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 111 GTFKD--NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred Eeecc--CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEec
Confidence 87766 7889999999999888888888889999999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
|+|+..... ..+.||||.|+|||++...+ |+.++|.|+|||++|||++|.+||.+.+....+++|+..-
T Consensus 189 GFAK~v~~r----T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~------ 257 (355)
T KOG0616|consen 189 GFAKRVSGR----TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK------ 257 (355)
T ss_pred cceEEecCc----EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc------
Confidence 999976432 35679999999999999877 7999999999999999999999999999999999997631
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCC-----CCHHHHHhCccCCCCC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFFTMKP 431 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kR-----pTa~e~L~hp~f~~~~ 431 (720)
..++..++..+++||.++|++|-.+| ....++..||||+...
T Consensus 258 -----------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 258 -----------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred -----------------------ccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 12345688999999999999999999 3467999999998643
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=385.37 Aligned_cols=295 Identities=44% Similarity=0.750 Sum_probs=246.8
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecc
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~ 207 (720)
....|+++.+ ||+|.||.||+|+...+|+.||+|++-.++.....-...++|+.+|..|.|+|++.+++
T Consensus 15 ~~~~yek~~k-----------igqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliE 83 (376)
T KOG0669|consen 15 EVSKYEKLAK-----------IGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83 (376)
T ss_pred cchHHHHHHh-----------cCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHH
Confidence 3467888888 99999999999999999999999987664432222233578999999999999999998
Q ss_pred ceecc------CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCce
Q 004999 208 LVTSR------MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 281 (720)
Q Consensus 208 ~~~~~------~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~v 281 (720)
+|... ....+|+||.+|+++|..++......|+..+++.+|++++.||.|+|+..|+|||+|++|+||+.+|.+
T Consensus 84 ic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 84 ICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGIL 163 (376)
T ss_pred HHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceE
Confidence 87532 234699999999999999998888899999999999999999999999999999999999999999999
Q ss_pred eeeccccceecCCCC---CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 004999 282 KIADFGLASFYDPDQ---NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 282 KL~DFGla~~~~~~~---~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~ 358 (720)
||+|||+++.+.... ....+.++.|+||++||+++|...|+++.|||+.||||+||+|+.|+|.|.++..+++.|..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 999999997664222 23456788999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCChhhhhh-cCCCCccccCCC-Cc--cchhhhcccC--CCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 359 LCGSPSEDYWRK-SKLPHATIFKPQ-QP--YKRCVAETFK--DFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 359 ~~g~p~~~~w~~-~~l~~~~~~~~~-~~--~~~~~~e~~~--~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
+||+...+.|.. .+++....+.-. .+ -.+.+....+ .-.+++.+||++||.+||.+|+++.++|.|.||...|.
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 999999999976 344443333111 11 1111222222 23568999999999999999999999999999998765
Q ss_pred C
Q 004999 433 P 433 (720)
Q Consensus 433 ~ 433 (720)
|
T Consensus 324 p 324 (376)
T KOG0669|consen 324 P 324 (376)
T ss_pred c
Confidence 5
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=416.71 Aligned_cols=255 Identities=28% Similarity=0.404 Sum_probs=227.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecC-CCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.||.|+.|.|-+|++..||+.+|||++... .+.......+.+||.||+.|.||||++||++|+. ...+|||.||++|
T Consensus 19 TLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~~~lylvlEyv~g 96 (786)
T KOG0588|consen 19 TLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--KQHLYLVLEYVPG 96 (786)
T ss_pred cccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc--CceEEEEEEecCC
Confidence 499999999999999999999999999876 4444455668899999999999999999999987 7889999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+-+..++...++|++.++.+++.||+.|+.|||..+|+||||||+|+|||..+.+||+|||+|..-. ....+.+.||.
T Consensus 97 GELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklLeTSCGS 174 (786)
T KOG0588|consen 97 GELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLLETSCGS 174 (786)
T ss_pred chhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc--CCccccccCCC
Confidence 7777777777799999999999999999999999999999999999999999999999999998643 34456778999
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
|.|.|||++.|.++.+.++||||+|||||.||||+.||.+.+-...+.++.+.
T Consensus 175 PHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G--------------------------- 227 (786)
T KOG0588|consen 175 PHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRG--------------------------- 227 (786)
T ss_pred cccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcC---------------------------
Confidence 99999999999998899999999999999999999999988888888887653
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 435 (720)
..+.+..++.++.+||.+||.+||++|+|.+++++|||+....-+..
T Consensus 228 --~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 228 --VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred --cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 22344689999999999999999999999999999999987654433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=387.31 Aligned_cols=249 Identities=30% Similarity=0.497 Sum_probs=215.5
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
.+|+++++ ||.|+||.||++.+..+|..||+|.+.+..++......+..|+.+|++|+|||||+++++-
T Consensus 19 ~~y~Il~~-----------IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~ 87 (375)
T KOG0591|consen 19 ADYQILKK-----------IGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS 87 (375)
T ss_pred HHHHHHHH-----------HcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh
Confidence 57888888 9999999999999999999999999998888888889999999999999999999999854
Q ss_pred eccCCCeEEEEEeeccc-ccccccc---CCCCCCCHHHHHHHHHhhhhccccccc--cC--cccccCcceeEEEcCCCce
Q 004999 210 TSRMSCSLYLVFEYMEH-DLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHS--RG--VLHRDIKGSNLLIDNNGIL 281 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g-~ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH~--~g--IvHrDIKP~NILld~~g~v 281 (720)
..+....++||||||++ +|...+. .....++|..++.++.|++.||.+||+ .. |+||||||.||+|+.+|.|
T Consensus 88 f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvv 167 (375)
T KOG0591|consen 88 FIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVV 167 (375)
T ss_pred hhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCce
Confidence 44435569999999995 4444333 356679999999999999999999999 44 9999999999999999999
Q ss_pred eeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 004999 282 KIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 282 KL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g 361 (720)
||+||||++++... .....+.+|||.||+||++.+.+ |+.++|||||||++|||..-.+||.|++-.+.-.+|.+.-.
T Consensus 168 KLGDfGL~r~l~s~-~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 168 KLGDFGLGRFLSSK-TTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred eeccchhHhHhcch-hHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 99999999988653 44567889999999999999887 89999999999999999999999999987777777765432
Q ss_pred CCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH
Q 004999 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418 (720)
Q Consensus 362 ~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa 418 (720)
+|.+. ..++..+..||.-|+.+||+.||+.
T Consensus 246 ~~~p~---------------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 PPLPD---------------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcH---------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 22211 2367889999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=407.62 Aligned_cols=248 Identities=32% Similarity=0.496 Sum_probs=223.7
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||||+.+.+.+.||||.+.+.......++.+.+|++|++.|+|||||.+++.|+. ..++|+|+||+.|+|
T Consensus 10 iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~~~~~vVte~a~g~L 87 (808)
T KOG0597|consen 10 IGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET--SAHLWVVTEYAVGDL 87 (808)
T ss_pred hcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--cceEEEEehhhhhhH
Confidence 999999999999999999999999999887777888999999999999999999999999987 788999999999977
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
...+.. +..++|++++.++.|++.||.|||+++|+|||+||.|||++..|++|+||||+|+.+.. .....+...|||.
T Consensus 88 ~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vltsikGtPl 165 (808)
T KOG0597|consen 88 FTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLTSIKGTPL 165 (808)
T ss_pred HHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-CceeeeeccCccc
Confidence 666555 55899999999999999999999999999999999999999999999999999998764 4456677789999
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|||||++.+.. |+..+|+||||||+|||++|+|||...+-.+....|.+.--.
T Consensus 166 YmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-------------------------- 218 (808)
T KOG0597|consen 166 YMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-------------------------- 218 (808)
T ss_pred ccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC--------------------------
Confidence 99999999776 899999999999999999999999998888887777652111
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.+..++..+.+||+.+|.+||.+|.|..++|.|||++..
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 123678899999999999999999999999999999764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=414.54 Aligned_cols=284 Identities=31% Similarity=0.520 Sum_probs=233.1
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-C-----CceeeeccceeccCC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-H-----INVIKLEGLVTSRMS 214 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pnIvkl~~~~~~~~~ 214 (720)
-.|.+..+||+|+||.|.+|.|..|++.||||+++.. +....+...|+.||..|+ | -|||+++++|.. .
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r 260 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--R 260 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--c
Confidence 3667788899999999999999999999999999854 466677789999999996 3 499999999988 6
Q ss_pred CeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC--Cceeeecccccee
Q 004999 215 CSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN--GILKIADFGLASF 291 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~--g~vKL~DFGla~~ 291 (720)
+++|||+|+++-+|.+++.... ..|+...++.|+.||+.||.+||+.||||+||||+||||.+- ..|||+|||.+..
T Consensus 261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 8999999999999888776543 459999999999999999999999999999999999999754 3799999999987
Q ss_pred cCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
.. +....++.+..|+|||+|+|.+ |+.++||||||||++||++|.|+|+|.++.+|+..|.+.+|.|+..++...
T Consensus 341 ~~----q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ES----QRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cC----CcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 43 2334778899999999999988 899999999999999999999999999999999999999999999875543
Q ss_pred CCCCccccC----CC----------------------------Cc-cchhhhcccC-CCCHhHHHHHHHhcccCCCCCCC
Q 004999 372 KLPHATIFK----PQ----------------------------QP-YKRCVAETFK-DFPAPALALMETLLSIDPADRGS 417 (720)
Q Consensus 372 ~l~~~~~~~----~~----------------------------~~-~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~kRpT 417 (720)
+..+.-.-. +. .| ....+...+. .-...+.+||.+||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 222110000 00 00 0000111111 12345899999999999999999
Q ss_pred HHHHHhCccCCCCCCCC
Q 004999 418 AASALRSEFFTMKPLPC 434 (720)
Q Consensus 418 a~e~L~hp~f~~~~~~~ 434 (720)
+.++|+||||+......
T Consensus 496 p~qal~Hpfl~~~~~~~ 512 (586)
T KOG0667|consen 496 PAQALNHPFLTGTSLER 512 (586)
T ss_pred HHHHhcCcccccccccc
Confidence 99999999999765443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=389.41 Aligned_cols=282 Identities=35% Similarity=0.600 Sum_probs=229.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|.+.+.||+|+||.||+|++..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 80 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLVFE 80 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEEEe
Confidence 444556999999999999999999999999998765444556678899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.++++..+......+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 99998877766555679999999999999999999999999999999999999999999999999998764333333345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC-C--Ccccc
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL-P--HATIF 379 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l-~--~~~~~ 379 (720)
..+|+.|+|||++.+.. ++.++|||||||++|||++|++||.+.+..+.+..+....+..+...+..... + ....+
T Consensus 161 ~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 161 YVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred cccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 57899999999998766 79999999999999999999999999988888888887777766655432110 0 00000
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
................++..+.+||.+||++||++|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000000111122334578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=406.54 Aligned_cols=255 Identities=31% Similarity=0.468 Sum_probs=219.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~l 217 (720)
.|...+.||+|+||.|+.|.+..++..||+|++...... ....+.+.+|+.++++++ ||||+++++++.. ...+
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~~~~ 95 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--PTKI 95 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--CCeE
Confidence 344445599999999999999999999999988765321 134566779999999998 9999999999987 5669
Q ss_pred EEEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-CceeeeccccceecCCC
Q 004999 218 YLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYDPD 295 (720)
Q Consensus 218 yLV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~DFGla~~~~~~ 295 (720)
|+|||||.| +|+..+.. .+.+.|.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||++.... .
T Consensus 96 ~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~-~ 173 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP-G 173 (370)
T ss_pred EEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-C
Confidence 999999997 66666655 7789999999999999999999999999999999999999999 999999999999764 3
Q ss_pred CCCCccccccccCCCChhhhcCCc-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~-~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
....+...+||+.|+|||++.+.. +-+.++||||+|||||.|++|..||...+......+|.+..
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~-------------- 239 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE-------------- 239 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC--------------
Confidence 345667789999999999999877 55799999999999999999999999988777777765421
Q ss_pred CccccCCCCccchhhhcccCCC-CHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDF-PAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~-~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
...+..+ ++++.+||.+||..||.+|+|+.+++.||||+.
T Consensus 240 ---------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 ---------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ---------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 1122345 899999999999999999999999999999997
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=381.66 Aligned_cols=252 Identities=28% Similarity=0.416 Sum_probs=221.2
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|.|+.||++.+..||+.+|+|++....+.....+.+.+|+.|.+.|+|||||+|++.+.+ ....|||||+|.|+.
T Consensus 19 igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~--~~~~ylvFe~m~G~d 96 (355)
T KOG0033|consen 19 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGE 96 (355)
T ss_pred HccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc--cceeEEEEecccchH
Confidence 999999999999999999999999998877766677889999999999999999999998876 678999999999854
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC---CceeeeccccceecCCCCCCCcccccc
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~---g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
+..-......++|..+-.+++||+++|.|||.+||||||+||+|+|+.+. .-+||+|||+|..+. ........+|
T Consensus 97 l~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~--~g~~~~G~~G 174 (355)
T KOG0033|consen 97 LFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN--DGEAWHGFAG 174 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--CccccccccC
Confidence 43322223468999999999999999999999999999999999999543 469999999999876 4445567799
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
||.|||||++...+ |+..+|||+.|+|||.||.|.+||.|.+....+++|.+.....+..+|
T Consensus 175 tP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w----------------- 236 (355)
T KOG0033|consen 175 TPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEW----------------- 236 (355)
T ss_pred CCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCccc-----------------
Confidence 99999999998877 899999999999999999999999999998999999876544443333
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..+++++++||++||..||.+|+|+.|+|.|||+.+.
T Consensus 237 --------~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 237 --------DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred --------CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 5799999999999999999999999999999999854
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=398.76 Aligned_cols=264 Identities=31% Similarity=0.445 Sum_probs=223.5
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH------------HHHHHHHHHHHHHHh
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP------------ESVRFMAREIHILRR 196 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~------------~~~~~~~~Ei~iL~~ 196 (720)
.+.|+.+.+ ||+|.||.|.+|++..+++.||||++.+..+.. ..++.+.+||.||++
T Consensus 96 lNqy~l~~e-----------iG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKk 164 (576)
T KOG0585|consen 96 LNQYELIKE-----------IGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKK 164 (576)
T ss_pred hhheehhhh-----------hcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHh
Confidence 456777776 999999999999999999999999997543211 123578999999999
Q ss_pred cCCCceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc
Q 004999 197 LDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID 276 (720)
Q Consensus 197 L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld 276 (720)
|.|||||+|+++..+.....+|||+|||..+-....-.....+++.+++.|+++++.||+|||.+|||||||||+|+||+
T Consensus 165 l~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred cCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 99999999999998888899999999999776655555444499999999999999999999999999999999999999
Q ss_pred CCCceeeeccccceecCC----CCCCCccccccccCCCChhhhcC---CcCCCccccchhhHHHHHHHHhCCCCCCCCCh
Q 004999 277 NNGILKIADFGLASFYDP----DQNQPLTSRVVTLWYRPPELLLG---ATYYGTAVDLWSTGCILAELYAGKPIMPGRTE 349 (720)
Q Consensus 277 ~~g~vKL~DFGla~~~~~----~~~~~~t~~~gT~~Y~APE~l~~---~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~ 349 (720)
++|+|||+|||.+..+.. +....+...+|||.|+|||++.+ ....+.+.|||||||+||.|+.|+.||.+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 999999999999986621 11223344689999999999987 33457899999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 350 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 350 ~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.+...+|...-- .....+++.+.+++||.+||.+||++|++..++..|||.+.
T Consensus 325 ~~l~~KIvn~pL---------------------------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 325 LELFDKIVNDPL---------------------------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred HHHHHHHhcCcc---------------------------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 999999975310 11122367889999999999999999999999999999986
Q ss_pred C
Q 004999 430 K 430 (720)
Q Consensus 430 ~ 430 (720)
.
T Consensus 378 ~ 378 (576)
T KOG0585|consen 378 D 378 (576)
T ss_pred C
Confidence 4
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=389.36 Aligned_cols=295 Identities=49% Similarity=0.818 Sum_probs=244.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||.|+||.||+|.+..+|+.||+|+++...........+.+|+.++++++|+||+++++++.......+|+||||+++
T Consensus 13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 92 (309)
T cd07845 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92 (309)
T ss_pred eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC
Confidence 34999999999999999999999999998654333333345689999999999999999999876545678999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
++...+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++....... ...+...++
T Consensus 93 ~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~ 171 (309)
T cd07845 93 DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVVT 171 (309)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-CCCCccccc
Confidence 7766665545679999999999999999999999999999999999999999999999999998764322 223344568
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccccC-CCCc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIFK-PQQP 384 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~~~-~~~~ 384 (720)
+.|+|||++.+...++.++|||||||++|||++|.++|.+.+..+.+..+...++.+....|.... .+....+. +..+
T Consensus 172 ~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (309)
T cd07845 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQP 251 (309)
T ss_pred ccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCC
Confidence 899999999876668999999999999999999999999999999999999999999888876532 22212221 1112
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP 443 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~~ 443 (720)
+. .+...+..+++.+.+||.+||+.||++|||+.++|.||||...++|+.|..+|.+|
T Consensus 252 ~~-~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~ 309 (309)
T cd07845 252 YN-NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP 309 (309)
T ss_pred CC-chHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence 11 22333455788999999999999999999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=389.01 Aligned_cols=277 Identities=37% Similarity=0.634 Sum_probs=222.6
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.. ...+|+||||+.++
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~ 88 (303)
T cd07869 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLVFEYVHTD 88 (303)
T ss_pred eEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEEEECCCcC
Confidence 399999999999999999999999999754322 222346789999999999999999999876 56899999999998
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
+...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ........+|+
T Consensus 89 l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~ 167 (303)
T cd07869 89 LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTL 167 (303)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC-CccCCCCcccC
Confidence 88777666667899999999999999999999999999999999999999999999999999754322 22334557899
Q ss_pred CCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC---
Q 004999 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ--- 383 (720)
Q Consensus 308 ~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~-~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~--- 383 (720)
.|+|||++.+...++.++||||||||+|+|++|.+||.+..+ .+++..++...+.+....|....... .+.+..
T Consensus 168 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 245 (303)
T cd07869 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP--HFKPERFTL 245 (303)
T ss_pred CCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc--ccccccccc
Confidence 999999998776689999999999999999999999988644 46777888888888877775432110 011000
Q ss_pred ccchhhhccc--CCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 384 PYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~--~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+...+ ..+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 246 YSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred cCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0000011111 1356789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=389.98 Aligned_cols=287 Identities=34% Similarity=0.521 Sum_probs=228.7
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC---CeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS---CSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~---~~lyL 219 (720)
|++.+.||+|+||.||+|++..++..||||++............+.+|+.+++.++||||+++++++..... ..+|+
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 344566999999999999999999999999987543333445568899999999999999999998754322 35899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 297 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-- 297 (720)
|||||++++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 82 VFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 999999877665543 44699999999999999999999999999999999999999999999999999975432211
Q ss_pred CCccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 QPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......++|+.|+|||++.+. ..++.++||||||||+|||++|++||.+.+...++..+....+.|....+........
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 122345789999999998752 3479999999999999999999999999999888888888888888776543211110
Q ss_pred c----ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 377 T----IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 377 ~----~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
. .+....+ ......++.+++.+.+||.+||+.||++|||+.++|+||||+....
T Consensus 241 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 241 RRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHhhcccCC--CchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0 0000000 1123445678889999999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=400.84 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=220.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+|..+..||+|+.|.||.|+...+++.||||.+....... .+.+.+|+.+|+.++|+|||.+++-|.. ...+|+||
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv--~deLWVVM 349 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLV--GDELWVVM 349 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcc--cceeEEEE
Confidence 3444445999999999999999999999999998776433 3457899999999999999999988766 57799999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|||+|+.+..+.... .++|.++.+|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+..... ..+
T Consensus 350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~ 427 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRS 427 (550)
T ss_pred eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-ccc
Confidence 999988776665543 599999999999999999999999999999999999999999999999999998765443 456
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
+.+|||+|||||++.... |++++||||||+++.||+-|.|||...+....+..|.. .|.|.-
T Consensus 428 TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~l---------------- 489 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKL---------------- 489 (550)
T ss_pred cccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCc----------------
Confidence 779999999999998776 89999999999999999999999998888777777654 344421
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
.....+++.+++||.+||+.|+.+|++|.|+|+||||.
T Consensus 490 ---------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 490 ---------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred ---------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 22357899999999999999999999999999999995
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=380.27 Aligned_cols=280 Identities=40% Similarity=0.644 Sum_probs=223.6
Q ss_pred cccceeecccCceEEEEEEECC-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc---CCCceeeeccceec---cCCC
Q 004999 143 SRSFYLIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTS---RMSC 215 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~-tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIvkl~~~~~~---~~~~ 215 (720)
|++.+.||+|+||.||+|++.. ++..||||+++...........+.+|+.+++.+ +||||+++++++.. ....
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 3444559999999999999854 578899999986544333334556788877766 69999999998752 1245
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCC
Q 004999 216 SLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~ 294 (720)
.+|+||||+.+++...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T cd07862 83 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 162 (290)
T ss_pred cEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccC
Confidence 6899999999877666543 234589999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 295 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 295 ~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
. .......+|+.|+|||++.+.. ++.++||||||||+|||++|.+||.+.+..+.+..+...++.|.+..|......
T Consensus 163 ~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 163 Q--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred C--cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 2 2334557899999999997765 799999999999999999999999999999999999999988887777543211
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
....+.... ...+....+++++.+.+||.+||+.||++|||+.++|+||||
T Consensus 240 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchhccCCC--CCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 111111111 112233446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=387.59 Aligned_cols=254 Identities=30% Similarity=0.465 Sum_probs=207.3
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|.+|+|||||+++|.........++|+|||+.++
T Consensus 24 ~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 24 LLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred cccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 3999999999999999999999999998763222 67789999999999999999999975443223689999999986
Q ss_pred ccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-CCceeeeccccceecCC--CCCCCcccc
Q 004999 228 LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDP--DQNQPLTSR 303 (720)
Q Consensus 228 ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~~~~--~~~~~~t~~ 303 (720)
.+..+... +..|+|..++.+.+||++||.|||++|||||||||+||||+. ++.+||+|||++..... .........
T Consensus 102 sL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~ 181 (313)
T KOG0198|consen 102 SLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSV 181 (313)
T ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccc
Confidence 66555543 338999999999999999999999999999999999999999 79999999999987653 222334467
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR-TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~-~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.||+.|||||++........++|||||||++.||+||.+||... ...+.+..+....
T Consensus 182 ~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~---------------------- 239 (313)
T KOG0198|consen 182 QGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED---------------------- 239 (313)
T ss_pred cCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC----------------------
Confidence 89999999999986332245999999999999999999999773 3333333322110
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+..+++.+.+||.+||.+||++||||.++|.|||.+..
T Consensus 240 -----~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 240 -----SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred -----CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 0113345689999999999999999999999999999999764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=397.01 Aligned_cols=284 Identities=34% Similarity=0.510 Sum_probs=231.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC---CeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS---CSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~---~~lyLV~Ey 223 (720)
+.||+|+||.||+|.+..+++.||||++.....+....+.+.+|+.+|+.++|+||+++++++..... ..+|+||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 85 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence 34999999999999999999999999987654444556778899999999999999999998875321 268999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.+++...+.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...........+..
T Consensus 86 ~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~ 164 (372)
T cd07853 86 MQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164 (372)
T ss_pred cccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCC
Confidence 99877765544 44799999999999999999999999999999999999999999999999999987654444444556
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc-cc--C
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT-IF--K 380 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~-~~--~ 380 (720)
++|+.|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..+.+.+|.+..+.+......... .. .
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 244 (372)
T cd07853 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGP 244 (372)
T ss_pred CcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCC
Confidence 78999999999988776899999999999999999999999999999999999999999887665331100000 00 0
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
...+............++.+.+||.+||++||.+|||+.++|+||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 245 HKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred CCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 000111111223345688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=406.25 Aligned_cols=282 Identities=34% Similarity=0.499 Sum_probs=224.1
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc------CCCe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR------MSCS 216 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~------~~~~ 216 (720)
|++.++||+|+||.||+|.+..+++.||||++.... ....+|+.+|+.++|||||++++++... ....
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 344445999999999999999999999999986432 2235799999999999999998876431 1235
Q ss_pred EEEEEeecccccccccc---CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceec
Q 004999 217 LYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFY 292 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~ 292 (720)
+|+||||+++++...+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|..+
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 78999999987654432 3456799999999999999999999999999999999999998665 7999999999865
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
... ......++|+.|+|||++.+...|+.++||||||||||||++|.+||.+....+++.++.+.++.|..+.+....
T Consensus 222 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 222 LAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred cCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 432 223456789999999999887668999999999999999999999999999999999999999999887765432
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
........+...............++++.+||.+||++||.+|+|+.++|+||||.....
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 111111111111111112233457889999999999999999999999999999986543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=403.05 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=223.1
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEe
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+++||+|.||+|+++..+.+++.||||++++..+ ..+.++..+.|.+|+.... ||.+++|+..|.+ ..++|+|||
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~l~fvme 449 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEHLFFVME 449 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CCeEEEEEE
Confidence 34459999999999999999999999999998875 6778899999999999885 9999999999987 789999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.|+.+.++... ..|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++..-. .....++
T Consensus 450 y~~Ggdm~~~~~~-~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~-~g~~TsT 527 (694)
T KOG0694|consen 450 YVAGGDLMHHIHT-DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG-QGDRTST 527 (694)
T ss_pred ecCCCcEEEEEec-ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC-CCCcccc
Confidence 9998776555543 4799999999999999999999999999999999999999999999999999986432 2234567
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.||||.|||||+|.+.. |+.++|.|||||+|||||.|.+||+|.++.+....|+..-
T Consensus 528 fCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~---------------------- 584 (694)
T KOG0694|consen 528 FCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE---------------------- 584 (694)
T ss_pred ccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------------------
Confidence 89999999999999877 8999999999999999999999999999999998886421
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMKP 431 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~~ 431 (720)
...+..++.++.+||++||.+||++|.. +.++..||||+...
T Consensus 585 -------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 585 -------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred -------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 1123468999999999999999999975 58999999998653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=392.99 Aligned_cols=289 Identities=29% Similarity=0.498 Sum_probs=230.1
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~ly 218 (720)
|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 44445599999999999999999999999999865544555667889999999999999999998875422 24589
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 106 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--~ 180 (364)
T cd07875 106 IVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 180 (364)
T ss_pred EEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC--C
Confidence 9999999887765532 5789999999999999999999999999999999999999999999999999865322 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......+|+.|+|||++.+.. ++.++||||||||||+|++|+.||.+.+..+.+.++....+.|.++++..........
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 181 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred cccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 234557899999999998765 7999999999999999999999999999999999999999998887755422110000
Q ss_pred cCCCCc---------cch----hhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCC
Q 004999 379 FKPQQP---------YKR----CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 437 (720)
Q Consensus 379 ~~~~~~---------~~~----~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~ 437 (720)
...... +.. ...+.....+..+++||.+||+.||.+|||+.++|+||||..+..+....
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~ 331 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCC
Confidence 000000 000 00111223457899999999999999999999999999998765555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=383.69 Aligned_cols=282 Identities=35% Similarity=0.652 Sum_probs=230.3
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||+|+||.||+|++..++..||||+++..... .....+.+|+.++++++||||+++++++.. ...+|+||||++
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 87 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVFEYLD 87 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEEeCCC
Confidence 33499999999999999999999999999765432 223346789999999999999999999876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
+++...+...+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .......+
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~ 166 (309)
T cd07872 88 KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVV 166 (309)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc-cccccccc
Confidence 98877766666678999999999999999999999999999999999999999999999999997643222 22234467
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc-cccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA-TIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~-~~~~~~~~ 384 (720)
|+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+.+..+++.++.|..+.|........ ..+.....
T Consensus 167 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (309)
T cd07872 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKY 246 (309)
T ss_pred cccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCcc
Confidence 99999999998766689999999999999999999999999999999999999999999888865322110 00000000
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
....+......++.++.+||.+||+.||.+|||+.++|+||||+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 247 KPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00111223456889999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=390.25 Aligned_cols=286 Identities=32% Similarity=0.516 Sum_probs=228.1
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC----CeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----CSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~----~~ly 218 (720)
|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+++.++||||+++++++..... ..+|
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 445556999999999999999999999999998665555556778899999999999999999998764321 3589
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
+||||+++++...+. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..... ..
T Consensus 103 lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~--~~ 177 (359)
T cd07876 103 LVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NF 177 (359)
T ss_pred EEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc--Cc
Confidence 999999988766553 2579999999999999999999999999999999999999999999999999975432 22
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......+|+.|+|||++.+.. |+.++|||||||++|+|++|..||.+.+..+.+..+.+..+.|..+++..........
T Consensus 178 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred cCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 334567899999999998766 7999999999999999999999999999999999999999988877654321000000
Q ss_pred c--CC---CCccchh--------hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 379 F--KP---QQPYKRC--------VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 379 ~--~~---~~~~~~~--------~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
. .+ ...+... ........++.+.+||.+||+.||++|||+.|+|+||||..+..+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 0 00 0000000 0111223567899999999999999999999999999998654443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=373.18 Aligned_cols=279 Identities=39% Similarity=0.648 Sum_probs=223.3
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc---CCCceeeeccceecc---CCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTSR---MSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIvkl~~~~~~~---~~~~l 217 (720)
++.+.||+|+||.||+|.+..+++.||||.++...........+.+|+.+++.+ +||||+++++++... ....+
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 344559999999999999999999999999976533222223455677777665 799999999987542 13468
Q ss_pred EEEEeeccccccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 218 YLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
++||||+.+++...+... ...+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 83 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~- 161 (288)
T cd07863 83 TLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ- 161 (288)
T ss_pred EEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc-
Confidence 999999998776655432 345899999999999999999999999999999999999999999999999999865422
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++|.++|.+....+.+.+++...+.+....|........
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 162 -MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred -ccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 2234456799999999998765 79999999999999999999999999999999999999888887777754221111
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
..+.+.. ...+....+.++..+.+||.+||++||++|||+.++|.||||
T Consensus 240 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRG--PRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCC--CCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 1111111 122344556788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=397.44 Aligned_cols=279 Identities=23% Similarity=0.317 Sum_probs=216.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|.+.+.||+|+||.||+|.+..+++.||||+... ..+.+|+.+|++|+|||||++++++.. ....|+|||
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e 163 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLILP 163 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEEEe
Confidence 3444459999999999999999999999997542 245789999999999999999999876 677999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
++.+++...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 164 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 999877665544 3468999999999999999999999999999999999999999999999999997543322233345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR-------TEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~-------~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.+||+.|+|||++.+.. |+.++||||||||||||++|..+|.+. ....++..+++..|.++.+++.+.....
T Consensus 243 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 67999999999998765 799999999999999999999766543 2345777788877876655421110000
Q ss_pred cccc------CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 376 ATIF------KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 376 ~~~~------~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
...+ ....+...........++.++.+||.+||++||.+|||+.|+|+||||+..+.+
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 0000 000011111112223467789999999999999999999999999999876544
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=385.48 Aligned_cols=250 Identities=26% Similarity=0.362 Sum_probs=211.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+|++++||||+++++++.. ...+||||||+.+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~ 79 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYANG 79 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCCCC
Confidence 49999999999999999999999999986532 34455677899999999999999999998876 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+.+.........+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... ........+||
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~~gt 158 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGT 158 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccceecC
Confidence 77666555666899999999999999999999999999999999999999999999999999875322 12233456789
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
+.|+|||++.+.. |+.++||||||||+|||++|..||.+.+.......+....
T Consensus 159 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~-------------------------- 211 (323)
T cd05571 159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-------------------------- 211 (323)
T ss_pred ccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------------------------
Confidence 9999999998765 7999999999999999999999998877666555543210
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||++|| ++.++++|+||...
T Consensus 212 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 212 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 011235788999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=377.52 Aligned_cols=276 Identities=35% Similarity=0.637 Sum_probs=216.2
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~--~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|++. .+++.||||.+...... ..+.+|+.+|++++||||+++++++.......+|+||||++
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 3999999999999965 46788999998755332 33578999999999999999999887655678999999999
Q ss_pred ccccccccC--------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE----cCCCceeeeccccceecC
Q 004999 226 HDLAGLASH--------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYD 293 (720)
Q Consensus 226 g~ll~~~~~--------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl----d~~g~vKL~DFGla~~~~ 293 (720)
+++...+.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence 876554321 12358999999999999999999999999999999999999 456799999999998764
Q ss_pred CCCC--CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCC
Q 004999 294 PDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLCGS 362 (720)
Q Consensus 294 ~~~~--~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---------~e~l~~i~~~~g~ 362 (720)
.... ......++|+.|+|||++.+...|+.++||||||||+|||++|++||.+... ..++..++..+|.
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 3221 1233557899999999998876689999999999999999999999976543 4678889999999
Q ss_pred CChhhhhhcCC-CCcccc----C----CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 363 PSEDYWRKSKL-PHATIF----K----PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 363 p~~~~w~~~~l-~~~~~~----~----~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
|....|..... +..... . ........+.......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 98888876321 111000 0 00000011111122345679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=383.10 Aligned_cols=283 Identities=35% Similarity=0.561 Sum_probs=227.0
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLYLV 220 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~lyLV 220 (720)
+...||.|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ...+|++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 19 NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEE
Confidence 333499999999999999999999999999765444445566789999999999999999999875421 2457999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
||++.+++...+. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ..
T Consensus 99 ~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~----~~ 172 (343)
T cd07878 99 TNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EM 172 (343)
T ss_pred eecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC----Cc
Confidence 9999776654443 34699999999999999999999999999999999999999999999999999986532 23
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...++|+.|+|||++.+...++.++||||||||+|+|++|.+||.+....+.+..+....+.+..+.+..........+.
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07878 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252 (343)
T ss_pred CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHh
Confidence 45578999999999988666899999999999999999999999999999999999988888877765432211111110
Q ss_pred CCCc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 381 PQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 381 ~~~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
...+ ....+...+...++.+.+||.+||++||.+|||+.++|.||||.....+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~ 307 (343)
T cd07878 253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307 (343)
T ss_pred hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence 0000 0111233445677889999999999999999999999999999875444
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=385.47 Aligned_cols=286 Identities=31% Similarity=0.506 Sum_probs=228.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~ly 218 (720)
|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 45555699999999999999999999999999866555556677889999999999999999999876422 23579
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
+||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .
T Consensus 99 lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~--~ 173 (355)
T cd07874 99 LVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--F 173 (355)
T ss_pred EEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc--c
Confidence 9999999887665532 5899999999999999999999999999999999999999999999999999865322 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......+|+.|+|||++.+.. |+.++||||||||+|+|++|+.||.+....+.+..+.+.++.+..+++..........
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 174 MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred ccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 234557899999999998765 7999999999999999999999999999999999999999988887765422110000
Q ss_pred cCCCCcc-------------chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 379 FKPQQPY-------------KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 379 ~~~~~~~-------------~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
......+ ...........+..+.+||.+||+.||++|||+.|+|+||||.....++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~ 321 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPA 321 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChh
Confidence 0000000 0001112233567889999999999999999999999999998665443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=371.39 Aligned_cols=280 Identities=40% Similarity=0.689 Sum_probs=229.1
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
.+.+.||.|+||.||+|++..+|+.||+|+++...........+.+|+.++++++||||+++++++.+ ...+|+|+||
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 80 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVFEY 80 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEEec
Confidence 34455999999999999999999999999998654433344567789999999999999999999876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
++++++..+......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.... ......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 159 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RCYSAE 159 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CCcCCC
Confidence 9998877666555679999999999999999999999999999999999999999999999999998654322 223345
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccccCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP-IMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIFKP 381 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~p-pf~g~~~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~~~~ 381 (720)
.+++.|+|||++.+...++.++|||||||++|+|++|.. +|.+.+..+.+..+++.++.+....|.... .+.. ...+
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY-KPYP 238 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc-cccC
Confidence 678999999999887667999999999999999999875 467777888888999988888877775421 1111 1111
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
..+....+.+..+.+++.+.+||.+||+.||.+|||++++|.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1222222334556789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=369.37 Aligned_cols=280 Identities=40% Similarity=0.679 Sum_probs=227.2
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||+|++|.||+|++..++..||||+++....+......+.+|+.++++++||||+++++++.. ...+|+||||+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~ 81 (285)
T cd07861 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIFEFL 81 (285)
T ss_pred EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEEecC
Confidence 3445999999999999999999999999997654444444667889999999999999999999876 67899999999
Q ss_pred cccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 225 EHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 225 ~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
.+++...+.. .+..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .....
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 160 (285)
T cd07861 82 SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTH 160 (285)
T ss_pred CCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-ccccC
Confidence 9876655433 23578999999999999999999999999999999999999999999999999997653321 22234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+++.|+|||++.+...++.++||||||||+|+|+||++||.+.+..+.+..++...+.+....|..............
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (285)
T cd07861 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFP 240 (285)
T ss_pred CcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcc
Confidence 46789999999998766678999999999999999999999999999888888888888888777754221111000000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......+......+++++.+||.+||+.||.+|||+.++|.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 241 KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 011112233445689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=362.17 Aligned_cols=262 Identities=29% Similarity=0.402 Sum_probs=225.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC------CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL------EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~------~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
||.|..++|.++.++.+|..+|+|++..... .....+...+|+.||+++ .||||+++.++|.+ ...+++|+
T Consensus 25 lgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~sF~FlVF 102 (411)
T KOG0599|consen 25 LGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--DAFVFLVF 102 (411)
T ss_pred hcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--cchhhhhh
Confidence 9999999999999999999999999875422 123345567899999998 69999999999987 77899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|.|..+.+..++...-.++|.+.+.||+||++|++|||.++||||||||+|||++++.++||+|||++..+.+ ...+.
T Consensus 103 dl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~--GekLr 180 (411)
T KOG0599|consen 103 DLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP--GEKLR 180 (411)
T ss_pred hhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC--chhHH
Confidence 9999777777777777899999999999999999999999999999999999999999999999999998754 44567
Q ss_pred ccccccCCCChhhhc-----CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 302 SRVVTLWYRPPELLL-----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~-----~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
..||||.|+|||.+. +.+.|+..+|+|++|+|||.||.|.|||.-+...-.+..|++.-+....+.|
T Consensus 181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW-------- 252 (411)
T KOG0599|consen 181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW-------- 252 (411)
T ss_pred HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch--------
Confidence 889999999999985 4556899999999999999999999999888888888888776555444344
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~ 439 (720)
.+++..+++||.+||++||.+|.|++|+|+||||.+......+...
T Consensus 253 -----------------adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r~ms 298 (411)
T KOG0599|consen 253 -----------------ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQARQMS 298 (411)
T ss_pred -----------------hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcccccC
Confidence 5789999999999999999999999999999999755444444333
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=373.24 Aligned_cols=279 Identities=37% Similarity=0.676 Sum_probs=228.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||.|+||.||+|++..+++.||||.++..... .....+.+|+.+++.|+||||+++++++.. ...+|+||||+.+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv~e~~~~ 88 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVFEYLDK 88 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEEEEecccc
Confidence 3499999999999999999999999998765432 223356789999999999999999999876 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......++
T Consensus 89 ~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~ 167 (301)
T cd07873 89 DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVT 167 (301)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-Cccccccee
Confidence 8777666656678999999999999999999999999999999999999999999999999997543221 222334678
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC-CccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP-HATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~-~~~~~~~~~~~ 385 (720)
+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+++..+....+.+....|...... ....+......
T Consensus 168 ~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (301)
T cd07873 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYR 247 (301)
T ss_pred ecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccc
Confidence 99999999987766889999999999999999999999999999999999999999888887642111 00000101111
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..++......+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 248 ~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 248 ADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 11222334568889999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=376.18 Aligned_cols=273 Identities=24% Similarity=0.385 Sum_probs=224.1
Q ss_pred CCCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeee
Q 004999 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 126 p~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
|.....|+..+. ||.|..++||+|+...+++.||||++..+..+.+ +..+.+|+..|+.++||||+++
T Consensus 22 p~n~~~YeL~e~-----------IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~ 89 (516)
T KOG0582|consen 22 PLNAKDYELQEV-----------IGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTY 89 (516)
T ss_pred CCCccceeEEEE-----------EeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceE
Confidence 456788888888 9999999999999999999999999998876555 7889999999999999999999
Q ss_pred ccceeccCCCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceee
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 283 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL 283 (720)
+..|.. +..+|+||.||.++.+..+.. -...|.|..+..|++++++||.|||.+|.||||||+.||||+.+|.|||
T Consensus 90 ~~sFvv--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkL 167 (516)
T KOG0582|consen 90 HCSFVV--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKL 167 (516)
T ss_pred EEEEEe--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEE
Confidence 988877 778999999999755443332 1234899999999999999999999999999999999999999999999
Q ss_pred eccccceecCCCCCC---CccccccccCCCChhhh-cCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 004999 284 ADFGLASFYDPDQNQ---PLTSRVVTLWYRPPELL-LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 359 (720)
Q Consensus 284 ~DFGla~~~~~~~~~---~~t~~~gT~~Y~APE~l-~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~ 359 (720)
+|||....+...... .....+||++|||||++ .....|+.++||||||++..||.+|..||........+..-++
T Consensus 168 adFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq- 246 (516)
T KOG0582|consen 168 ADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ- 246 (516)
T ss_pred cCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-
Confidence 999987665332211 11455899999999995 4445599999999999999999999999999888776654433
Q ss_pred cCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 360 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 360 ~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
+.|+.-. .. ..-.+..+.++..++.+|..||++||.+||||+++|.|+||+...
T Consensus 247 -n~pp~~~------------t~-----~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 247 -NDPPTLL------------TS-----GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred -CCCCCcc------------cc-----cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 3332110 00 001123346778999999999999999999999999999998653
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=375.80 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=212.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+ ...+|+|||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e 81 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYMLME 81 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEEEEe
Confidence 334459999999999999999999999999976433 23445678899999999999999999998876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~~~ 157 (291)
T cd05612 82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWT 157 (291)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC----ccc
Confidence 9998766555555567999999999999999999999999999999999999999999999999999865321 223
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+.. ++.++||||||||+|+|++|..||.+.+..+.+..+....
T Consensus 158 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------------------- 214 (291)
T cd05612 158 LCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---------------------- 214 (291)
T ss_pred ccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------------
Confidence 56899999999998766 7999999999999999999999999988777766664320
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.||.+|++ +.++++|+||+..
T Consensus 215 -------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 215 -------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred -------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 0112346788999999999999999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=382.75 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=209.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|++++||||+++++++.. ...+|+||||+.|
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~ 102 (329)
T PTZ00263 25 TLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYFLLEFVVG 102 (329)
T ss_pred EEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEEEEEcCCCC
Confidence 39999999999999999999999999976432 23445678899999999999999999998876 6789999999987
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....+||
T Consensus 103 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----~~~~~gt 178 (329)
T PTZ00263 103 GELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGT 178 (329)
T ss_pred ChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC----cceecCC
Confidence 665555555567899999999999999999999999999999999999999999999999999865332 1235789
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
+.|+|||++.+.. ++.++|||||||++|||++|.+||.+....+.+..+... .+
T Consensus 179 ~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~----------------------- 232 (329)
T PTZ00263 179 PEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RL----------------------- 232 (329)
T ss_pred hhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--Cc-----------------------
Confidence 9999999998766 699999999999999999999999988877666665431 00
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTM 429 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~ 429 (720)
.....++..+.+||.+||+.||.+|++ +.+++.||||..
T Consensus 233 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 233 ----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred ----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 112246788999999999999999997 799999999985
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=373.32 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=231.5
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeecc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEG 207 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~ 207 (720)
...|+..+. ||+|+||.|-+|++...|+.||||.++++.+ +...+-.+.+||+||..|+||||+.+|.
T Consensus 52 kHRyE~~et-----------LGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyE 120 (668)
T KOG0611|consen 52 KHRYEITET-----------LGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYE 120 (668)
T ss_pred hhHHHHHHH-----------hcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhh
Confidence 357888888 9999999999999999999999999999877 5566778999999999999999999999
Q ss_pred ceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
+|.. ...+.|||||..++.+..+......|+|.+++.|++||.+|+.|||.++|+|||||.+|||+|.++++||+|||
T Consensus 121 VFEN--kdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 121 VFEN--KDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred hhcC--CceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccc
Confidence 9987 67899999999988888888888899999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 288 la~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
|+..+. ....++++||+|-|.+||++.|.++-++.+|-||||++||.|+.|..||.|.+....+.+|-...+.-
T Consensus 199 LSNly~--~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE---- 272 (668)
T KOG0611|consen 199 LSNLYA--DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE---- 272 (668)
T ss_pred hhhhhc--cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC----
Confidence 999874 34567889999999999999999988999999999999999999999999999888887775432211
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
+.-|..+.-||+.||.+||++|.|+.++-.|=|+.-.
T Consensus 273 --------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 273 --------------------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred --------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 2346678999999999999999999999999998643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=384.53 Aligned_cols=255 Identities=34% Similarity=0.469 Sum_probs=220.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.||.|.||.||+|+++.||+.+|+|++.+... .......+.+|+.||++|. |||||.++++|.+ ...+|||||+|
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~~~lvmEL~ 118 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDSVYLVMELC 118 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCeEEEEEEec
Confidence 449999999999999999999999999987765 2335567899999999998 9999999999988 66899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC----CceeeeccccceecCCCCCCCc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN----GILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~----g~vKL~DFGla~~~~~~~~~~~ 300 (720)
.|+.+....... .++|..+..++.||+.++.|||+.||+||||||+|||+... +.+|++|||++..... ....
T Consensus 119 ~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~--~~~~ 195 (382)
T KOG0032|consen 119 EGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP--GERL 195 (382)
T ss_pred CCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC--CceE
Confidence 975544333332 49999999999999999999999999999999999999643 5799999999998755 4456
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+||+.|+|||++.... |+..+||||+||++|.|++|.+||.+.+..+...+|...-....
T Consensus 196 ~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~---------------- 258 (382)
T KOG0032|consen 196 HTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFT---------------- 258 (382)
T ss_pred eeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCC----------------
Confidence 7789999999999998765 89999999999999999999999999999888888766433222
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
.+.+.+++..+.+||..||..||.+|+|+.++|+|||++....
T Consensus 259 ---------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 259 ---------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred ---------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 2345678999999999999999999999999999999987533
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=369.51 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=209.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++|+||+++++++.. ...+|+|||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv~e 80 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLVLT 80 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEEEE
Confidence 4455699999999999999999999999998765432 2334457899999999999999999998876 568999999
Q ss_pred ecccccccccc--CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLAGLAS--HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll~~~~--~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.++.+.... .....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~ 158 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--ETV 158 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--Cee
Confidence 99976554332 23346899999999999999999999999999999999999999999999999999865322 222
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+||+.|+|||++.+.. |+.++|||||||+||||++|++||.+.........+.......
T Consensus 159 ~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 220 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------------- 220 (285)
T ss_pred cCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------------
Confidence 4457899999999998765 7999999999999999999999998876544333333221111
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||+.||.+|+| ++++++||||...
T Consensus 221 --------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 221 --------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred --------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 01223467889999999999999999997 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=375.89 Aligned_cols=248 Identities=29% Similarity=0.441 Sum_probs=209.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|++++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCCC
Confidence 7999999999999999999999999975432 34456678899999999999999999998876 67899999999987
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+||+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~ 157 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGTP 157 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCCc
Confidence 665555556679999999999999999999999999999999999999999999999999997543222 2234457899
Q ss_pred CCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccch
Q 004999 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKR 387 (720)
Q Consensus 308 ~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~ 387 (720)
.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+..+....
T Consensus 158 ~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------------------------- 209 (312)
T cd05585 158 EYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--------------------------- 209 (312)
T ss_pred ccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------------------------
Confidence 999999998765 7999999999999999999999999887766655553210
Q ss_pred hhhcccCCCCHhHHHHHHHhcccCCCCCC---CHHHHHhCccCCC
Q 004999 388 CVAETFKDFPAPALALMETLLSIDPADRG---SAASALRSEFFTM 429 (720)
Q Consensus 388 ~~~e~~~~~~~~~~dLI~~mL~~DP~kRp---Ta~e~L~hp~f~~ 429 (720)
......+++.+.+||.+||..||.+|| ++.++|.||||..
T Consensus 210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCC
Confidence 112245788999999999999999997 5899999999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=377.97 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=210.6
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+||+|+||.||++.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+||||||+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~~~ 79 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYVNG 79 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCCCC
Confidence 49999999999999999999999999986533 34456678899999999999999999988876 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+||
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~gt 158 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGT 158 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccCC
Confidence 766655555667999999999999999999999999999999999999999999999999998753221 2223445789
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
+.|+|||++.+.. ++.++|||||||+||+|++|..||.+.+..+....+... .
T Consensus 159 ~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~--~------------------------ 211 (328)
T cd05593 159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--D------------------------ 211 (328)
T ss_pred cCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--C------------------------
Confidence 9999999998765 799999999999999999999999887766555544211 0
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTM 429 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~ 429 (720)
......+++.+.+||.+||+.||.+|+ ++.++++|+||..
T Consensus 212 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 212 ---IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred ---ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 012245788999999999999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=384.33 Aligned_cols=258 Identities=29% Similarity=0.405 Sum_probs=211.3
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.++||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+|||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~E 81 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYLIME 81 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEEEEC
Confidence 344559999999999999999999999999986432 33455678899999999999999999998877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC----
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---- 298 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~---- 298 (720)
|+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+......
T Consensus 82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (364)
T cd05599 82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161 (364)
T ss_pred CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccc
Confidence 9987665555555567999999999999999999999999999999999999999999999999998754321100
Q ss_pred ---------------------------------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCC
Q 004999 299 ---------------------------------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP 345 (720)
Q Consensus 299 ---------------------------------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~ 345 (720)
.....+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred cccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCCCC
Confidence 111346899999999997765 7999999999999999999999999
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC---HHHHH
Q 004999 346 GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASAL 422 (720)
Q Consensus 346 g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L 422 (720)
+.+..+.+..+....... .+ + ....+++.+.+||.+||. +|.+|++ +.++|
T Consensus 241 ~~~~~~~~~~i~~~~~~~--------------~~----~-------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 241 SDNPQETYRKIINWKETL--------------QF----P-------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred CCCHHHHHHHHHcCCCcc--------------CC----C-------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 988777766664311000 00 0 011468899999999996 9999998 99999
Q ss_pred hCccCCCC
Q 004999 423 RSEFFTMK 430 (720)
Q Consensus 423 ~hp~f~~~ 430 (720)
.||||...
T Consensus 295 ~h~~~~~~ 302 (364)
T cd05599 295 SHPFFKGV 302 (364)
T ss_pred cCCCcCCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=378.24 Aligned_cols=259 Identities=29% Similarity=0.397 Sum_probs=215.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.+.||+|+||.||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++++.. ...+|||||
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e 81 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYLAME 81 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEEEEe
Confidence 344559999999999999999999999999986533 23445678899999999999999999998876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ....
T Consensus 82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~~~ 157 (333)
T cd05600 82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YANS 157 (333)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----ccCC
Confidence 999876666666566799999999999999999999999999999999999999999999999999976532 2345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+.+..+........ .+.
T Consensus 158 ~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---------------~~~ 221 (333)
T cd05600 158 VVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---------------RPV 221 (333)
T ss_pred cccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---------------CCC
Confidence 57899999999998775 79999999999999999999999999887777666543211000 000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......+++++.+||.+||..+|.+|||+.++++||||...
T Consensus 222 ------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 222 ------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred ------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 000013578899999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=368.72 Aligned_cols=275 Identities=26% Similarity=0.333 Sum_probs=230.6
Q ss_pred CCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeee
Q 004999 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 127 ~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
.....|+.++. ||.|.-|+||+|....++..+|||++.+..+ ..+.+.+...|-.||..++||.++.|
T Consensus 74 l~l~~f~llk~-----------LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTL 142 (459)
T KOG0610|consen 74 LGLRHFRLLKR-----------LGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTL 142 (459)
T ss_pred cCHHHHHHHHH-----------cCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchh
Confidence 34568888888 9999999999999999999999999988765 35667788899999999999999999
Q ss_pred ccceeccCCCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceee
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 283 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL 283 (720)
|..|+. +..+|||||||.|+.+..+.+ .+..|++..++.|+..|+.||+|||-.|||+|||||+||||-++|+|.|
T Consensus 143 Ya~fet--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIML 220 (459)
T KOG0610|consen 143 YASFET--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIML 220 (459)
T ss_pred hheeec--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEe
Confidence 999987 788999999999865554443 5567999999999999999999999999999999999999999999999
Q ss_pred eccccceecCC---------------------------------C-C---------------------CCCccccccccC
Q 004999 284 ADFGLASFYDP---------------------------------D-Q---------------------NQPLTSRVVTLW 308 (720)
Q Consensus 284 ~DFGla~~~~~---------------------------------~-~---------------------~~~~t~~~gT~~ 308 (720)
+||.|+..... . . .....+.|||-.
T Consensus 221 sDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThE 300 (459)
T KOG0610|consen 221 SDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHE 300 (459)
T ss_pred eeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccc
Confidence 99998743210 0 0 011224588999
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|+|||++.|..+ +.++|+|+|||+|||||.|..||.|.+..+.+..|+..--..
T Consensus 301 YlAPEvI~G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~F------------------------- 354 (459)
T KOG0610|consen 301 YLAPEVIRGEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKF------------------------- 354 (459)
T ss_pred cccceeeecCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcC-------------------------
Confidence 999999999885 999999999999999999999999999999998886421111
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCC----HHHHHhCccCCCCCCCCCCCCCCCC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGS----AASALRSEFFTMKPLPCDPSSLPKY 442 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpT----a~e~L~hp~f~~~~~~~~p~~~p~~ 442 (720)
...+.++..++|||+++|.+||.+|.. |+||-+||||....|+-.-...|.+
T Consensus 355 --p~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 355 --PEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred --CCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 011256789999999999999999998 9999999999988776443333433
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=383.36 Aligned_cols=260 Identities=27% Similarity=0.363 Sum_probs=209.5
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.+++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+ ...+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv~ 80 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFVM 80 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEEE
Confidence 3445569999999999999999999999999986543 34556778999999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC----
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN---- 297 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~---- 297 (720)
||++|+.+..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9998766555555556799999999999999999999999999999999999999999999999999754311000
Q ss_pred ------------------------------------------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHH
Q 004999 298 ------------------------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILA 335 (720)
Q Consensus 298 ------------------------------------------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ 335 (720)
......+||+.|+|||++.+.. |+.++||||||||+|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHHH
Confidence 0012357899999999998765 799999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcc--cCCC
Q 004999 336 ELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLS--IDPA 413 (720)
Q Consensus 336 ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~--~DP~ 413 (720)
||++|.+||.+.+..+....+....... .......+++++.+||.+||. .+|.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~dli~~ll~~~~~~~ 294 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTL-------------------------HIPPQVKLSPEAVDLITKLCCSAEERL 294 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHcccccc-------------------------CCCCCCCCCHHHHHHHHHHccCccccc
Confidence 9999999999887766655554211000 000112578999999999665 4555
Q ss_pred CCCCHHHHHhCccCCCC
Q 004999 414 DRGSAASALRSEFFTMK 430 (720)
Q Consensus 414 kRpTa~e~L~hp~f~~~ 430 (720)
.|+|+.+++.||||+..
T Consensus 295 ~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 295 GRNGADDIKAHPFFSEV 311 (381)
T ss_pred CCCCHHHHhcCcccCCC
Confidence 69999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=362.08 Aligned_cols=283 Identities=40% Similarity=0.649 Sum_probs=233.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||.|+||.||+|.+..+|..||||++............+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 80 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVMEY 80 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEecc
Confidence 34456999999999999999999999999998766545556778899999999999999999999876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.+++...+......+++.+++.++.||+.+|.|||+.||+|+||||+||+++.++.++|+|||++..............
T Consensus 81 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (286)
T cd07832 81 MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160 (286)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccc
Confidence 95566555544456799999999999999999999999999999999999999999999999999987654332234455
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC-CccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP-HATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~-~~~~~~~~ 382 (720)
.++.+|+|||.+.+...++.++|||||||++|||++|.++|.+....+.+..+...++.+....|...... ........
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07832 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFP 240 (286)
T ss_pred cCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCC
Confidence 78999999999887666799999999999999999999999999999999999999998888777652211 11111000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
......+...+++++..+.+||.+||..||.+|||++++|.||||.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 241 ESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0111113345567789999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=376.32 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=211.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+||+|+||.||++++..+|..||+|+++.... .......+.+|+.+++.++||||+++++++.. ...+||||||+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~~~ 79 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYANG 79 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCCCC
Confidence 49999999999999999999999999986532 34455677899999999999999999998876 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+||
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~gt 158 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGT 158 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCccccccCC
Confidence 776655555667999999999999999999999999999999999999999999999999998753222 1223345789
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+.......+....
T Consensus 159 ~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-------------------------- 211 (323)
T cd05595 159 PEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-------------------------- 211 (323)
T ss_pred cCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------------------
Confidence 9999999998765 7999999999999999999999998887766655553210
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+|+ ++.++++|+||...
T Consensus 212 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 212 ---IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 011235789999999999999999998 89999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=381.37 Aligned_cols=257 Identities=26% Similarity=0.384 Sum_probs=209.4
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..++|+||+++++.+.+ ...+||||||
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~lv~E~ 82 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYLIMEF 82 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEEEEcC
Confidence 34459999999999999999999999999976432 33455678899999999999999999998876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC------
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN------ 297 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~------ 297 (720)
|+|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~ 162 (363)
T cd05628 83 LPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN 162 (363)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccccc
Confidence 99866655555566899999999999999999999999999999999999999999999999999875432110
Q ss_pred ----------------------------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh
Q 004999 298 ----------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE 349 (720)
Q Consensus 298 ----------------------------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~ 349 (720)
......+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~~~~ 241 (363)
T cd05628 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETP 241 (363)
T ss_pred ccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 0112457999999999998766 79999999999999999999999999888
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCC---CCCCHHHHHhCcc
Q 004999 350 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA---DRGSAASALRSEF 426 (720)
Q Consensus 350 ~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~---kRpTa~e~L~hp~ 426 (720)
.+.+.++....... .+.+ ...+++.+.+||.+|+. +|. .||++.++++|||
T Consensus 242 ~~~~~~i~~~~~~~--------------~~p~-----------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~ 295 (363)
T cd05628 242 QETYKKVMNWKETL--------------IFPP-----------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPF 295 (363)
T ss_pred HHHHHHHHcCcCcc--------------cCCC-----------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCC
Confidence 77777765421110 0000 12468899999999875 454 4589999999999
Q ss_pred CCCC
Q 004999 427 FTMK 430 (720)
Q Consensus 427 f~~~ 430 (720)
|...
T Consensus 296 f~~~ 299 (363)
T cd05628 296 FEGV 299 (363)
T ss_pred CCCC
Confidence 9864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=378.07 Aligned_cols=259 Identities=31% Similarity=0.418 Sum_probs=214.5
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|.+.+.||+|+||.||+|++..+++.||||+++.... .......+.+|+.++..++||||+++++++.. ...+|+||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 80 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYLVM 80 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEEEE
Confidence 3444559999999999999999999999999986533 22455678899999999999999999998876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-----
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ----- 296 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~----- 296 (720)
||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999876555555445689999999999999999999999999999999999999999999999999998664332
Q ss_pred -----------------------CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHH
Q 004999 297 -----------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 353 (720)
Q Consensus 297 -----------------------~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l 353 (720)
.......+||+.|+|||++.+.. ++.++||||||||||||++|+.||.+....+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCC-CCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 11233457899999999998875 799999999999999999999999998877776
Q ss_pred HHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-HHHHHhCccCCCC
Q 004999 354 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-AASALRSEFFTMK 430 (720)
Q Consensus 354 ~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-a~e~L~hp~f~~~ 430 (720)
.++....... .......+++.+.+||..||. ||.+|++ +.++|+||||...
T Consensus 240 ~~i~~~~~~~-------------------------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESL-------------------------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcc-------------------------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 6665411000 000112378999999999997 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=382.86 Aligned_cols=259 Identities=29% Similarity=0.394 Sum_probs=210.1
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.+++.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++.+.. ...+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv~ 80 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFVM 80 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEEE
Confidence 3445569999999999999999999999999976432 33456678899999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-----
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ----- 296 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~----- 296 (720)
|||+++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 999976555444445578999999999999999999999999999999999999999999999999975321000
Q ss_pred -----------------------------------------CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHH
Q 004999 297 -----------------------------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILA 335 (720)
Q Consensus 297 -----------------------------------------~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ 335 (720)
.......+||+.|+|||++.+.. |+.++||||||||||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHH
Confidence 00012347899999999998766 799999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCC
Q 004999 336 ELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415 (720)
Q Consensus 336 ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kR 415 (720)
||++|.+||.+.+..+...++........ ......+++++.+||.+|+ .+|.+|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLH-------------------------IPPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcC-------------------------CCCcccCCHHHHHHHHHHc-cCHhHc
Confidence 99999999999887776666543111000 0011357899999999987 599999
Q ss_pred CC---HHHHHhCccCCCC
Q 004999 416 GS---AASALRSEFFTMK 430 (720)
Q Consensus 416 pT---a~e~L~hp~f~~~ 430 (720)
++ +.+++.||||...
T Consensus 294 ~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 294 LGKNGADEIKAHPFFKTI 311 (382)
T ss_pred CCCCCHHHHhcCCCcCCc
Confidence 97 9999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=378.04 Aligned_cols=247 Identities=26% Similarity=0.337 Sum_probs=209.9
Q ss_pred eecccCceEEEEEEECCCC-eEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQK-KIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg-~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|.+..++ ..||||++..... .......+.+|+.+++.++||||+++++++.. ...+|+||||+.
T Consensus 37 ~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lv~Ey~~ 114 (340)
T PTZ00426 37 TLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVI 114 (340)
T ss_pred EEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCEEEEEEeCCC
Confidence 3999999999999876655 6899999875432 33455678899999999999999999999877 678999999998
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
++.+..+......+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...... ....+|
T Consensus 115 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~----~~~~~g 190 (340)
T PTZ00426 115 GGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCG 190 (340)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----cceecC
Confidence 7766656555667999999999999999999999999999999999999999999999999999865322 234578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. ++.++||||||||+|||++|.+||.+.+.......+....
T Consensus 191 t~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~------------------------- 244 (340)
T PTZ00426 191 TPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI------------------------- 244 (340)
T ss_pred ChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-------------------------
Confidence 99999999998765 7999999999999999999999999988777666664321
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||++|+ |+.++++||||...
T Consensus 245 ----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 245 ----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 011235788899999999999999995 89999999999854
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=358.59 Aligned_cols=287 Identities=26% Similarity=0.374 Sum_probs=239.3
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeec
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
..++|+-|+. ||+|+||.|.+++.+.+++.||||+++++.+ ..+.+...+.|-++|+..+||.+..|.
T Consensus 166 Tm~dFdfLKv-----------LGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LK 234 (516)
T KOG0690|consen 166 TMEDFDFLKV-----------LGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLK 234 (516)
T ss_pred ccchhhHHHH-----------hcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhh
Confidence 3466666666 9999999999999999999999999998865 677888889999999999999999887
Q ss_pred cceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
-.|.. ...+|+||||..|+.+...+.....|+|..++.|...|+.||.|||+++||+||||.+|+|+|+||++||+||
T Consensus 235 YsFQt--~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 235 YSFQT--QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred hhhcc--CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeec
Confidence 66665 6789999999998777766676778999999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
||++.-- .....+...||||.|+|||+|.... |+.++|.|.+|||||||+||+.||...+.......|+-.
T Consensus 313 GLCKE~I-~~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------- 383 (516)
T KOG0690|consen 313 GLCKEEI-KYGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------- 383 (516)
T ss_pred ccchhcc-cccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------
Confidence 9998532 2334556789999999999998776 899999999999999999999999988776665555321
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCCCCCC--CCCCC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMKPLPC--DPSSL 439 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~~~~~--~p~~~ 439 (720)
-..++..++++++.||..+|.+||.+|.. |.|+.+|+||....+.. .....
T Consensus 384 ----------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~ 441 (516)
T KOG0690|consen 384 ----------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIE 441 (516)
T ss_pred ----------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccC
Confidence 12334578999999999999999999964 89999999998765432 12333
Q ss_pred CCCCC--ChHHHHhhHHHHHH
Q 004999 440 PKYPP--SKEFDAKIRDEEAR 458 (720)
Q Consensus 440 p~~~p--~~~~~~~~~~~~~~ 458 (720)
|.+.| ..+.|.+.-++|..
T Consensus 442 PPfKPqVtSetDTryFD~EFT 462 (516)
T KOG0690|consen 442 PPFKPQVTSETDTRYFDEEFT 462 (516)
T ss_pred CCCCCCcccccchhhhhhhhh
Confidence 44433 24567777777664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=374.10 Aligned_cols=244 Identities=30% Similarity=0.404 Sum_probs=208.5
Q ss_pred ecccCceEEEEEEECCCCeE-EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~-VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||.|+||+||++.+.. .. ||||++.....+....+.|.+|+.+|.+|+|||||+++|++.... ..++||||||+++
T Consensus 49 iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 49 LGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCIVTEYMPGG 125 (362)
T ss_pred cccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEEEEeCCCC
Confidence 9999999999999854 44 999999877665555888999999999999999999999998742 2689999999988
Q ss_pred ccccccCC--CCCCCHHHHHHHHHhhhhccccccccC-cccccCcceeEEEcCCC-ceeeeccccceecCCCCCCCcccc
Q 004999 228 LAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRG-VLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 228 ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~g-IvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
.+..++.. ...++...+..|+.||++||.|||+++ ||||||||+||||+.++ ++||+|||+++...... ..++..
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~~ 204 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTSV 204 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccCC
Confidence 77776655 678999999999999999999999999 99999999999999998 99999999998764322 455667
Q ss_pred ccccCCCChhhhcC-CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~-~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.||+.|||||++.+ ...|+.++||||||+|||||+||+.||.+.........+......|
T Consensus 205 ~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp------------------- 265 (362)
T KOG0192|consen 205 AGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP------------------- 265 (362)
T ss_pred CCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Confidence 89999999999995 2458999999999999999999999999999866555554322222
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+..||..||..||.+||+..+++.
T Consensus 266 --------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 --------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred --------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 222348899999999999999999999998876
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=375.00 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=210.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+||||||+++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~~ 79 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYANG 79 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCCCC
Confidence 49999999999999999999999999986533 33445667889999999999999999988876 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
+.+.........+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~g 158 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-CcccccccC
Confidence 7766665556679999999999999999999997 79999999999999999999999999998754222 222334578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++||||||||||||++|..||.+.+..+....+....
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~------------------------- 212 (325)
T cd05594 159 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------------------------- 212 (325)
T ss_pred CcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC-------------------------
Confidence 99999999998765 7999999999999999999999998877665555543210
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+|+ ++.++|+|+||...
T Consensus 213 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 213 ----IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 011235788999999999999999997 99999999999853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=381.19 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=208.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.+ ...+|||||
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~E 81 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYLIME 81 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEEEEe
Confidence 344559999999999999999999999999875432 34456778899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-----
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN----- 297 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~----- 297 (720)
|+.|+.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 161 (377)
T cd05629 82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161 (377)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 998765555555556799999999999999999999999999999999999999999999999999863311000
Q ss_pred --------C---------------------------------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHH
Q 004999 298 --------Q---------------------------------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAE 336 (720)
Q Consensus 298 --------~---------------------------------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~E 336 (720)
. .....+||+.|+|||++.+.. |+.++|||||||||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~e 240 (377)
T cd05629 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFE 240 (377)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhhhh
Confidence 0 001246899999999998765 7999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCC-
Q 004999 337 LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR- 415 (720)
Q Consensus 337 LltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kR- 415 (720)
|++|.+||.+....+.+..+....... .+ .....++..+.+||.+||. +|.+|
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~--------------~~-----------p~~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETL--------------YF-----------PDDIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCcc--------------CC-----------CCCCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999988777766664311000 00 0012468899999999997 77776
Q ss_pred --CCHHHHHhCccCCCC
Q 004999 416 --GSAASALRSEFFTMK 430 (720)
Q Consensus 416 --pTa~e~L~hp~f~~~ 430 (720)
+|+.++|.||||+..
T Consensus 295 ~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 295 GRGGAHEIKSHPFFRGV 311 (377)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 599999999999853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=366.08 Aligned_cols=276 Identities=35% Similarity=0.631 Sum_probs=214.4
Q ss_pred eecccCceEEEEEEECC--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLD--QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~--tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|++.. ++..||+|.+...... ..+.+|+.+|+.++||||+++++++.......+|+||||++
T Consensus 8 ~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred EeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 49999999999999654 6688999998754322 34678999999999999999999887655678999999999
Q ss_pred ccccccccC--------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE----cCCCceeeeccccceecC
Q 004999 226 HDLAGLASH--------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYD 293 (720)
Q Consensus 226 g~ll~~~~~--------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl----d~~g~vKL~DFGla~~~~ 293 (720)
+++...+.. ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..+.
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~ 163 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence 876654321 22358999999999999999999999999999999999999 566799999999998764
Q ss_pred CCCC--CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCC
Q 004999 294 PDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLCGS 362 (720)
Q Consensus 294 ~~~~--~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---------~e~l~~i~~~~g~ 362 (720)
.... ......++|+.|+|||++.+...++.++||||||||+|||+||.+||.+..+ ..++..++..++.
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07867 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243 (317)
T ss_pred CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence 3222 1233457899999999998866689999999999999999999999976442 4567788888898
Q ss_pred CChhhhhhcCCCC-ccc----c----CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 363 PSEDYWRKSKLPH-ATI----F----KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 363 p~~~~w~~~~l~~-~~~----~----~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+..+.|....... ... + .................+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8888886532110 000 0 000000011111122345679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=389.85 Aligned_cols=281 Identities=24% Similarity=0.336 Sum_probs=215.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC------CceeeeccceeccCCC
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH------INVIKLEGLVTSRMSC 215 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H------pnIvkl~~~~~~~~~~ 215 (720)
.|++.++||+|+||.||+|.+..+++.||||+++.. ....+.+..|+.++..+.| .+|+++++++... ..
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~ 205 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TG 205 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cc
Confidence 345556699999999999999999999999999643 1223445667777777754 4588888887653 46
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCC---------------
Q 004999 216 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNG--------------- 279 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g--------------- 279 (720)
.+|||||++.++++..+... ..+++.+++.|+.||+.||.|||+ .|||||||||+||||+.++
T Consensus 206 ~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred eEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 79999999988877766543 479999999999999999999997 5999999999999998765
Q ss_pred -ceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 004999 280 -ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 280 -~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~ 358 (720)
.+||+|||++... ....+..+||+.|+|||++.+.. |+.++||||||||||||++|++||.+....+++..+.+
T Consensus 285 ~~vkl~DfG~~~~~----~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~ 359 (467)
T PTZ00284 285 CRVRICDLGGCCDE----RHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEK 359 (467)
T ss_pred ceEEECCCCccccC----ccccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 4999999988642 22334568899999999998876 79999999999999999999999999999999999999
Q ss_pred hcCCCChhhhhhcCCCCcc-------ccCCCCc---cchhh-hcccC--CCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 359 LCGSPSEDYWRKSKLPHAT-------IFKPQQP---YKRCV-AETFK--DFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~-------~~~~~~~---~~~~~-~e~~~--~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
.+|.++..++......... .+.+... ..... ...+. ...+.+.+||.+||++||.+|||+.|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 9998876654322111100 0000000 00000 00000 1245688999999999999999999999999
Q ss_pred cCCCCCC
Q 004999 426 FFTMKPL 432 (720)
Q Consensus 426 ~f~~~~~ 432 (720)
||.....
T Consensus 440 ~~~~~~~ 446 (467)
T PTZ00284 440 YVLKYYP 446 (467)
T ss_pred cccccCC
Confidence 9987543
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=361.40 Aligned_cols=286 Identities=40% Similarity=0.708 Sum_probs=232.5
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.||.|+||.||+|.+..+++.||||+++..... ......+..|+.++++++|+||+++++++.. ...+|+|||
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e 82 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNINLVFE 82 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEEEEEc
Confidence 34599999999999999999999999999866443 3334567789999999999999999999877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.+++...+......+++..++.++.||+.||.|||++||+|+||+|+|||++.++.+||+|||++....... .....
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~ 161 (298)
T cd07841 83 FMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTH 161 (298)
T ss_pred ccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC-ccccc
Confidence 99665555544433479999999999999999999999999999999999999999999999999998764322 22333
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~~~~ 381 (720)
..+++.|+|||.+.+...++.++|||||||++|||++|.++|.+....+.+.+++..++.+....|.... ++.......
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T cd07841 162 QVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKP 241 (298)
T ss_pred cccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccc
Confidence 4568899999998776667999999999999999999999999999999999998888888777775422 111111111
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 436 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p 436 (720)
.. .......+..++..+.+||.+||+.||.+|||+.++|.|+||+..+.+..+
T Consensus 242 ~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~ 294 (298)
T cd07841 242 FP--PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP 294 (298)
T ss_pred cC--CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence 11 111233456678899999999999999999999999999999998877643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=349.99 Aligned_cols=256 Identities=31% Similarity=0.442 Sum_probs=223.0
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeec
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
..++|+.-+. ||.|-||.||+|+.+.++-.||+|++.+..+. .....++.+|++|...|+||||+++|
T Consensus 20 ~l~dfeigr~-----------LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 20 TLDDFEIGRP-----------LGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred chhhcccccc-----------ccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhh
Confidence 3467777777 99999999999999999999999999876553 23345788999999999999999999
Q ss_pred cceeccCCCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
++|.+ ...+||++||...+.+...+. ....|++..+..|+.|++.||.|||..+|+||||||+|+|++.+|.+||+
T Consensus 89 ~~fhd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiA 166 (281)
T KOG0580|consen 89 GYFHD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIA 166 (281)
T ss_pred hheec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeecc
Confidence 99987 788999999998654433333 56679999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 285 DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 285 DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
|||++.... .....+.|||..|.+||...+.. ++..+|+|++|++.||+|.|.+||...+..+.+.+|.+.-.
T Consensus 167 dfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~--- 239 (281)
T KOG0580|consen 167 DFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDL--- 239 (281)
T ss_pred CCCceeecC---CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccc---
Confidence 999998643 23345679999999999999877 69999999999999999999999999999999999876421
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..+..++..+.|||.+||.++|.+|.+..|++.|||+..
T Consensus 240 --------------------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 240 --------------------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --------------------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 122478999999999999999999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=375.12 Aligned_cols=259 Identities=26% Similarity=0.338 Sum_probs=213.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.+.||+|+||.||+|.+..+++.||||+++.... ..+....+.+|+.+++.++|+||+++++++.. ...+|||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~lv~e 81 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYLVME 81 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEEEEC
Confidence 344559999999999999999999999999986543 34456678899999999999999999998876 678999999
Q ss_pred eccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 223 YMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~ 161 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSK 161 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeee
Confidence 998755544443 3367999999999999999999999999999999999999999999999999999876543333333
Q ss_pred ccccccCCCChhhhcC-----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 302 SRVVTLWYRPPELLLG-----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~-----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
...+|+.|+|||++.. ...++.++||||||||+|||++|..||.+.+....+.++.......
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------- 228 (330)
T cd05601 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL------------- 228 (330)
T ss_pred cccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCcc-------------
Confidence 4578999999999873 3347899999999999999999999999888777776665321000
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
. ......++..+.+||..||. ||.+|||+.+++.||||...
T Consensus 229 -~-----------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 229 -K-----------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred -C-----------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 0 00113578899999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=361.72 Aligned_cols=287 Identities=45% Similarity=0.753 Sum_probs=233.9
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~ 208 (720)
.+.|+.+.. ||.|+||.||+|.+..+++.||||.++...........+.+|+.++++++||||++++++
T Consensus 4 ~~~y~~~~~-----------lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~ 72 (293)
T cd07843 4 VDEYEKLNR-----------IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72 (293)
T ss_pred hhhhhhhhh-----------hcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEE
Confidence 356777777 999999999999999999999999998665444444556789999999999999999998
Q ss_pred eeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+.......+||||||+.+++...+......+++.+++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||+
T Consensus 73 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 73 VVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred EEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence 87644478999999999876666555445699999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w 368 (720)
+..+.... .......+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+....+.+.+++..++.|....|
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 153 AREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred eeeccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 98764322 22334567889999999987665789999999999999999999999999999999999999999988887
Q ss_pred hhcC-CCCccccCCCCccchhhhcccCC--CCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 369 RKSK-LPHATIFKPQQPYKRCVAETFKD--FPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 369 ~~~~-l~~~~~~~~~~~~~~~~~e~~~~--~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.... ++..............+...++. +++.+.+||.+||+.||++|||+.|+|.|+||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 6532 22211111111111112233343 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=372.41 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=210.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||++..... .......+..|+.++..+ +||||+++++++.. ...+||||||++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~~ 79 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFVN 79 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCCC
Confidence 49999999999999999999999999986432 234456678899999877 69999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 158 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCG 158 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccccccc
Confidence 8666555555567999999999999999999999999999999999999999999999999998754322 222344578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. ++.++||||||||+|||++|++||.+.+..+.+..+.....
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~------------------------ 213 (320)
T cd05590 159 TPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV------------------------ 213 (320)
T ss_pred CccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC------------------------
Confidence 99999999998765 79999999999999999999999999888777776643110
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH------HHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA------ASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa------~e~L~hp~f~~ 429 (720)
.....++..+.+||.+||+.||.+|+++ .+++.||||..
T Consensus 214 -----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 214 -----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred -----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 1123468889999999999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=378.31 Aligned_cols=256 Identities=26% Similarity=0.362 Sum_probs=211.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.. ...+||||||+.
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~~lv~Ey~~ 126 (370)
T cd05596 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYLYMVMEYMP 126 (370)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEEEEEEcCCC
Confidence 349999999999999999999999999975432 23344567899999999999999999988876 678999999998
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+..+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..............+|
T Consensus 127 gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~g 205 (370)
T cd05596 127 GGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205 (370)
T ss_pred CCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCC
Confidence 7666555443 368999999999999999999999999999999999999999999999999998764433323345678
Q ss_pred ccCCCChhhhcCCc---CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 306 TLWYRPPELLLGAT---YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 306 T~~Y~APE~l~~~~---~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
|+.|+|||++.+.. .++.++|||||||+||||++|.+||.+.+....+.++........
T Consensus 206 t~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 267 (370)
T cd05596 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT------------------ 267 (370)
T ss_pred CcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC------------------
Confidence 99999999987542 378999999999999999999999999888777777654211000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCC--CCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.+|.+ |+|+.+++.||||+..
T Consensus 268 -------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 268 -------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred -------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0011257899999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=368.54 Aligned_cols=259 Identities=28% Similarity=0.399 Sum_probs=206.6
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~ 208 (720)
..+|+.++. ||+|+||.||+|++..+++.||||++.... .......+.+|+.+|+.++|+||++++++
T Consensus 73 ~~~~~~~~~-----------lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 140 (353)
T PLN00034 73 LSELERVNR-----------IGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDM 140 (353)
T ss_pred HHHHhhhhh-----------ccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeE
Confidence 456777777 999999999999999999999999986543 34455678899999999999999999999
Q ss_pred eeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+.. ...+|+||||+.++.+... ..+.+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 141 ~~~--~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 141 FDH--NGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred ecc--CCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 876 6789999999998765432 2457888999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
+..+... .......+||..|+|||++.. ...++.++||||||||||||++|+.||......+....+.......
T Consensus 215 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~- 292 (353)
T PLN00034 215 SRILAQT-MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ- 292 (353)
T ss_pred ceecccc-cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-
Confidence 9875432 122344578999999998743 2234678999999999999999999997433222211111110000
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.......++..+.+||.+||+.||++|||+.|+|+||||....
T Consensus 293 ------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 293 ------------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred ------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 0112246788999999999999999999999999999998754
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=370.45 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=210.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||++..... .......+..|+.++..+ +||||+++++++.. ...+||||||++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~~ 79 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYVN 79 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCCC
Confidence 49999999999999999999999999986532 334556678899999876 79999999999876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~g 158 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTTTFCG 158 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccccccc
Confidence 86665555555679999999999999999999999999999999999999999999999999997543222 22344578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+.....
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~------------------------ 213 (321)
T cd05591 159 TPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV------------------------ 213 (321)
T ss_pred CccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 99999999998765 79999999999999999999999999988877776653110
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCC-------CHHHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRG-------SAASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-------Ta~e~L~hp~f~~ 429 (720)
.....++.++.+||.+||+.||.+|+ ++.++++||||..
T Consensus 214 -----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 214 -----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred -----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 01124678999999999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=372.56 Aligned_cols=260 Identities=25% Similarity=0.362 Sum_probs=206.5
Q ss_pred ccceeecccCceEEEEEEEC---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
++.+.||+|+||.||++++. .+++.||+|++..... .....+.+.+|+.+++.+ +|+||+++++++.. ...+
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~ 80 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EAKL 80 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CCEE
Confidence 34455999999999999864 5789999999975432 223456678999999999 59999999988866 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|+||||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999866655555556799999999999999999999999999999999999999999999999999986544333
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......+||+.|+|||++.+...++.++||||||||||||++|..||.+.........+.+.....
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------------- 226 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-------------- 226 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC--------------
Confidence 333456789999999999876657899999999999999999999997543221111111100000
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.......+++.+.+||.+||+.||++|| ++.++++||||+..
T Consensus 227 -----------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 227 -----------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0011235788999999999999999999 88999999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=380.55 Aligned_cols=258 Identities=28% Similarity=0.371 Sum_probs=208.7
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|+.++||||+++++.+.. ...+|||||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~E 81 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFVMD 81 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEEEe
Confidence 444559999999999999999999999999875432 22345668899999999999999999998876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC------
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ------ 296 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~------ 296 (720)
||+|+.+..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 99876665555555678999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhC
Q 004999 297 ------------------------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG 340 (720)
Q Consensus 297 ------------------------------------~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG 340 (720)
.......+||+.|+|||++.+.. ++.++||||||||||||++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred cccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehhhC
Confidence 00112347899999999998766 79999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC---C
Q 004999 341 KPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG---S 417 (720)
Q Consensus 341 ~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp---T 417 (720)
++||.+....+....+....... .......+++.+.+||.+|+ .+|.+|+ |
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTL-------------------------HIPSQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccc-------------------------cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 99999988776665553211000 00111357889999999987 5999999 9
Q ss_pred HHHHHhCccCCCC
Q 004999 418 AASALRSEFFTMK 430 (720)
Q Consensus 418 a~e~L~hp~f~~~ 430 (720)
+.+++.||||...
T Consensus 295 ~~ell~h~~~~~~ 307 (376)
T cd05598 295 ADEIKAHPFFKGI 307 (376)
T ss_pred HHHHhCCCCcCCC
Confidence 9999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=369.05 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=209.7
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHH---HhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHIL---RRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL---~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
++.++||+|+||.||+|.+..+++.||||+++.... .....+.+.+|+.++ +.++||||+++++++.. ...+|+
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~l 79 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVCF 79 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEEE
Confidence 445669999999999999999999999999986432 233455677777665 45679999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
||||+.|+.+...... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ...
T Consensus 80 v~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~ 157 (324)
T cd05589 80 VMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDR 157 (324)
T ss_pred EEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-CCc
Confidence 9999998766555443 47999999999999999999999999999999999999999999999999998753221 222
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+||+.|+|||++.+.. ++.++||||||||+|||++|..||.+.+..+.+..+.....
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~------------------ 218 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV------------------ 218 (324)
T ss_pred ccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC------------------
Confidence 34567899999999998765 79999999999999999999999999888777766643210
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.....++..+.+||.+||+.||.+|| ++.++++|+||...
T Consensus 219 -----------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 219 -----------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred -----------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 11235788999999999999999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=359.42 Aligned_cols=279 Identities=40% Similarity=0.690 Sum_probs=225.1
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
..+.||.|++|.||+|++..++..||||++............+.+|+.++++++||||+++++++.. ...+|+||||+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~ 81 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFL 81 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEEeecc
Confidence 3445999999999999999999999999987654444444568899999999999999999999876 67899999999
Q ss_pred cccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 225 EHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 225 ~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
.+++...+.. ....+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++....... ......
T Consensus 82 ~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 160 (284)
T cd07860 82 HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHE 160 (284)
T ss_pred ccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-cccccc
Confidence 8766554433 34568999999999999999999999999999999999999999999999999987654322 223344
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC-CCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL-PHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l-~~~~~~~~~ 382 (720)
.+++.|+|||++.+...++.++|||||||++|+|+||+.||.+.++.+.+.++++..+.+....|..... +......+.
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07860 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240 (284)
T ss_pred cccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccc
Confidence 5688999999988766578899999999999999999999999999999999999888887766643111 000000000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.....+....+.++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 241 -~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 241 -WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -ccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00111223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=368.45 Aligned_cols=249 Identities=27% Similarity=0.429 Sum_probs=206.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||+++.... .......+..|..++..+ +||||+++++++.. ...+|+||||++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~~ 79 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYLN 79 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCCC
Confidence 49999999999999999999999999986532 233445566777777754 89999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~g 158 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-CccccccC
Confidence 87666555555679999999999999999999999999999999999999999999999999997643222 23345578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++|||||||++|||++|..||.+.+..+.+..+.... +
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--~---------------------- 213 (316)
T cd05592 159 TPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR--P---------------------- 213 (316)
T ss_pred CccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C----------------------
Confidence 99999999998766 7999999999999999999999999988766666553210 0
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH-HHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA-ASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-~e~L~hp~f~~ 429 (720)
.....++..+.+||.+||+.||.+|+++ .++++|+||..
T Consensus 214 -----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 214 -----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCC
Confidence 1123478889999999999999999986 58889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=368.60 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=209.6
Q ss_pred eeecccCceEEEEEEEC---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 147 YLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.||+|+||.||+|++. .+++.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 35999999999999864 5788999999976432 22334567899999999999999999998876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTH 158 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-Cccc
Confidence 999987666665556678999999999999999999999999999999999999999999999999987543222 2223
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||+.|+|||++.+.. ++.++||||||||||||++|.+||.+.+....+..+....
T Consensus 159 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~--------------------- 216 (323)
T cd05584 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK--------------------- 216 (323)
T ss_pred ccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence 457899999999998765 6899999999999999999999999988777666654310
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||++|+ ++.+++.||||...
T Consensus 217 --------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 217 --------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred --------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 012235788999999999999999999 89999999999753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.75 Aligned_cols=280 Identities=36% Similarity=0.582 Sum_probs=224.6
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||+|+||.||+|.+..+++.||+|+++......... ...+|+.++.++. |+||+++++++.+.....+|+|||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 34456999999999999999999999999987653332322 3457999999985 999999999988744478999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+||+++. +.+||+|||++...... .....
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--~~~~~ 157 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--PPYTE 157 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC--CCcCC
Confidence 9999888776655567899999999999999999999999999999999999999 99999999999865322 22234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..++..|+|||++.+...++.++|||||||++|||++|.+||.+.+..+.+..+....+.+....+..........+...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 56789999999887666578999999999999999999999999999998888888888887755332211111111111
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......+......++..+.+||.+||++||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 111111233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=368.29 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=210.5
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCC-ceeeeccceeccCCCeEEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHI-NVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~Hp-nIvkl~~~~~~~~~~~lyLV~ 221 (720)
.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+..|+.++..+.|+ +|+++++++.. ...+|+||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~ 80 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVM 80 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEEEE
Confidence 344559999999999999999999999999986532 334566788999999999765 58888888766 56899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||++|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CCcee
Confidence 99998666555555567899999999999999999999999999999999999999999999999998753221 12233
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||+.|+|||++.+.. ++.++||||||||+|||++|++||.+....+.+..+....
T Consensus 160 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------------------- 217 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------------------- 217 (324)
T ss_pred eecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------------------
Confidence 457899999999998766 7999999999999999999999999988877776664321
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH-----HHHHhCccCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFFTM 429 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hp~f~~ 429 (720)
......++..+.+||.+||..||.+|+++ .++++||||..
T Consensus 218 --------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 218 --------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred --------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 01123578899999999999999999986 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.25 Aligned_cols=283 Identities=54% Similarity=0.952 Sum_probs=236.1
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.......+|+||||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 44559999999999999999999999999987643344456678999999999999999999998763237899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
++++...+......+++.+++.++.||+.||.|||+.|++|+||+|+|||+++++.+||+|||++...........+...
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 162 (287)
T cd07840 83 DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162 (287)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccc
Confidence 98877776665568999999999999999999999999999999999999999999999999999876544332334456
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc-CCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~-~l~~~~~~~~~~ 383 (720)
++..|+|||.+.+...++.++|||||||++|||++|++||.+.+....+..+++.++.+....|... .+.....+.+..
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07840 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKK 242 (287)
T ss_pred cccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccc
Confidence 7889999998887666799999999999999999999999999998999999999998888777542 222222333333
Q ss_pred ccchhhhcccCCC-CHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 384 PYKRCVAETFKDF-PAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 384 ~~~~~~~e~~~~~-~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.....+...+..+ +..+.++|.+||..||.+|||+.++++|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 3334444555554 9999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=374.33 Aligned_cols=260 Identities=26% Similarity=0.339 Sum_probs=211.6
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~lv~ 122 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLYMVM 122 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEE
Confidence 4445569999999999999999999999999975332 23345567899999999999999999998876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|||.|+.+..+.... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~ 201 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecc
Confidence 999876555444433 6899999999999999999999999999999999999999999999999999876433332334
Q ss_pred ccccccCCCChhhhcCCc---CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 302 SRVVTLWYRPPELLLGAT---YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~---~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
..+||+.|+|||++.+.. .++.++|||||||+||||++|.+||.+.+....+.++........
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 267 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN-------------- 267 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC--------------
Confidence 567999999999997642 378899999999999999999999999888777777654211110
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCC--CCCHHHHHhCccCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 430 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||..||..++.+ |+|+.++++||||+..
T Consensus 268 -----------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 268 -----------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -----------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 0011246888999999999865543 8899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=376.89 Aligned_cols=248 Identities=29% Similarity=0.466 Sum_probs=214.8
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|.+..+++.||||++..+... +.++.+.+|+.+|..++++||.++|+.+.. +..++++||||.|+.
T Consensus 21 IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~--g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 21 IGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLK--GTKLWIIMEYCGGGS 97 (467)
T ss_pred ccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheee--cccHHHHHHHhcCcc
Confidence 99999999999999999999999999987643 456778999999999999999999999887 678999999999987
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
...++..+..+.|.++..++++++.||.|||..+.+|||||+.||||..+|.+||+|||.+..+....... ...+|||.
T Consensus 98 v~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfvGTPf 176 (467)
T KOG0201|consen 98 VLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFVGTPF 176 (467)
T ss_pred hhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccccccc
Confidence 77777777777999999999999999999999999999999999999999999999999998776544433 66799999
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|||||++.+.. |+.++||||||++.+||++|.||+......-.+..|-+ ...|
T Consensus 177 wMAPEVI~~~~-Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk----------------------~~PP---- 229 (467)
T KOG0201|consen 177 WMAPEVIKQSG-YDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK----------------------SAPP---- 229 (467)
T ss_pred ccchhhhcccc-ccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC----------------------CCCC----
Confidence 99999999655 89999999999999999999999988766333222211 0000
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..-..+++.+++||..||.+||+.||+|.++|+|+|++.
T Consensus 230 --~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 230 --RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred --ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 111268899999999999999999999999999999986
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=358.84 Aligned_cols=280 Identities=49% Similarity=0.886 Sum_probs=229.3
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC--------CCeEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM--------SCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~--------~~~lyL 219 (720)
.||+|+||.||+|.+..+++.||||+++...........+.+|+.++++++||||+++++++.+.. ...+|+
T Consensus 14 ~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~l 93 (302)
T cd07864 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYL 93 (302)
T ss_pred eecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEE
Confidence 399999999999999999999999999865433333456678999999999999999999886532 237899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
||||++++++..+......+++.+++.++.||+.||.|||+.||+|+||||+||++++++.+||+|||++..+.......
T Consensus 94 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 173 (302)
T cd07864 94 VFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173 (302)
T ss_pred EEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccc
Confidence 99999998777666555579999999999999999999999999999999999999999999999999998764433233
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~ 378 (720)
.....++..|+|||.+.+...++.++|||||||++|||++|+++|...+..+.+..+.+.++.+....|.... .+....
T Consensus 174 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T cd07864 174 YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNT 253 (302)
T ss_pred cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccc
Confidence 3334568889999998766557899999999999999999999999999999999999999988877765422 111111
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
..........+...+..++..+.+||..||+.||.+|||+.++|.||||
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 254 MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 1122222223344555689999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=368.66 Aligned_cols=286 Identities=30% Similarity=0.498 Sum_probs=227.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~l 217 (720)
.|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++.... ...+
T Consensus 17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 355556699999999999999999999999998765444555667789999999999999999999876432 2357
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|+||||+.+++...+.. .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 97 ~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-- 171 (353)
T cd07850 97 YLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 171 (353)
T ss_pred EEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC--
Confidence 99999999877665543 2899999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+....+..+.+.++.|..+++.........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 2233456789999999998765 799999999999999999999999999999999999999999988765432111100
Q ss_pred ccCCC-----Cccch---------hhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 378 IFKPQ-----QPYKR---------CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 378 ~~~~~-----~~~~~---------~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.+... .++.. .........++.+.+||.+||+.||.+|||+.++|.||||..+-.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 00000 00000 0011122356779999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=370.09 Aligned_cols=251 Identities=27% Similarity=0.476 Sum_probs=227.6
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|-|.+|.+|++.-||..||||++.+..++.-...++..|++.|+.++|||||+||+++.. ...+|||+|+-++
T Consensus 24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QTKlyLiLELGD~ 101 (864)
T KOG4717|consen 24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QTKLYLILELGDG 101 (864)
T ss_pred hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cceEEEEEEecCC
Confidence 35999999999999999999999999999999888888899999999999999999999999876 5679999999986
Q ss_pred -cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE-cCCCceeeeccccceecCCCCCCCccccc
Q 004999 227 -DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI-DNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 227 -~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl-d~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
++.+.++.....+.|..+++|+.||+.|+.|||...||||||||+||++ .+-|-|||+|||++..+.+. +.++..|
T Consensus 102 GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG--~kL~TsC 179 (864)
T KOG4717|consen 102 GDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG--KKLTTSC 179 (864)
T ss_pred chHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc--chhhccc
Confidence 7777777777789999999999999999999999999999999999876 46689999999999987654 4567889
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
|++.|.|||+|+|..+..+++||||||||||.|+||++||...++.|.+.+|+..-+
T Consensus 180 GSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY----------------------- 236 (864)
T KOG4717|consen 180 GSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY----------------------- 236 (864)
T ss_pred chhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-----------------------
Confidence 999999999999999778899999999999999999999999999999999976322
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..+..++.+.++||..||..||.+|.+.++|..|+|++..
T Consensus 237 ------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 237 ------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred ------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 2334688999999999999999999999999999999864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=360.23 Aligned_cols=283 Identities=45% Similarity=0.808 Sum_probs=227.7
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC------CCeEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM------SCSLY 218 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~------~~~ly 218 (720)
+.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 334499999999999999999999999998765433323345678999999999999999999875432 23589
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN- 297 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~- 297 (720)
+||||+.+++...+......+++.+++.++.||+.||.|||+.||+|+||||+|||+++++.+||+|||++........
T Consensus 92 lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 171 (311)
T cd07866 92 MVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171 (311)
T ss_pred EEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcc
Confidence 9999999988777766666899999999999999999999999999999999999999999999999999976532211
Q ss_pred ---------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 004999 298 ---------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 298 ---------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w 368 (720)
...+...+++.|+|||++.+...++.++||||||||+|||++|+++|.+.+.......++..++.+.+..|
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (311)
T cd07866 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW 251 (311)
T ss_pred cccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 11233467899999999887666799999999999999999999999999999999999999988877766
Q ss_pred hhcC-CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 369 RKSK-LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 369 ~~~~-l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.... ++..............+...+..+.+.+.+||.+||+.||.+|||+.++|.||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 252 PGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 5422 1111110111111122334455677889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.40 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=205.2
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||+|+||.||++.+..+++.||+|++...... ......+..|+.+++.++|+||+++++++.. ...+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCCC
Confidence 79999999999999999999999999765432 2334567889999999999999999988876 56799999999986
Q ss_pred cccccc----CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 228 LAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 228 ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
.+.... .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... .....
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 654332 2345689999999999999999999999999999999999999999999999999976543222 22345
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
.+|+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+.......
T Consensus 158 ~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------- 216 (280)
T cd05608 158 AGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-------------------- 216 (280)
T ss_pred CCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--------------------
Confidence 7899999999998765 7999999999999999999999998754432222222111000
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMKP 431 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~~ 431 (720)
.......++..+.+||.+||+.||++|+ |++++++||||+...
T Consensus 217 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 217 -----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred -----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 0012235788999999999999999999 899999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=366.65 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=206.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||+++.... .......+..|+.++..+ +||||+++++++.. ...+||||||+.
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~~ 79 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFLN 79 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCCC
Confidence 49999999999999999999999999986432 123445567788888765 89999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+.........+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... ........+|
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~g 158 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRASTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc-CCCceeccCC
Confidence 866655555556799999999999999999999999999999999999999999999999999875322 1223345678
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++|||||||++|||++|..||.+.+..+.+..+... .+
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~~---------------------- 213 (316)
T cd05620 159 TPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--TP---------------------- 213 (316)
T ss_pred CcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC----------------------
Confidence 99999999998766 799999999999999999999999988776665554321 00
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH-HHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA-ASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-~e~L~hp~f~~ 429 (720)
.....++.++.+||.+||+.||.+|+++ .+++.||||..
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 214 -----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCC
Confidence 1122467889999999999999999998 58889999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=352.28 Aligned_cols=280 Identities=32% Similarity=0.582 Sum_probs=221.7
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++...||+|+||.||+|++..+++.||+|++..........+.+.+|+.+++.++|+||+++++++.. ...+|+||||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e~ 81 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLVFEY 81 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEEEec
Confidence 34445999999999999999999999999987654333334567899999999999999999999876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
++++++..+......+++.+++.++.||+.+|.|||+.||+|+||||+||+|+.++.+||+|||++........ .....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 160 (286)
T cd07847 82 CDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDY 160 (286)
T ss_pred cCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-cccCc
Confidence 99988877766666799999999999999999999999999999999999999999999999999987643221 22334
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh---hhhcCCCCccccC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY---WRKSKLPHATIFK 380 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~---w~~~~l~~~~~~~ 380 (720)
.++..|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+.+..+...... |............
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIP 240 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCC
Confidence 5788999999998766678999999999999999999999999888887777666554433221 1111000000000
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.. .....+...+..++..+.+||.+||+.||++|||+.++|.||||
T Consensus 241 ~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 241 EP-ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred Cc-ccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 00011223345778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=366.23 Aligned_cols=273 Identities=23% Similarity=0.319 Sum_probs=209.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||++++..++..||+|++.... .......+.+|+.+|+.++||||+++++++.. ...+|+||||+++
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 87 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDG 87 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEeecCCC
Confidence 34999999999999999999999999998643 34556778999999999999999999999876 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
+.+..+......+++..+..++.||+.||.|||+. +|+|+||||+||||+.++.+||+|||++...... ......+
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~g 164 (331)
T cd06649 88 GSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVG 164 (331)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc---ccccCCC
Confidence 76666665556799999999999999999999986 6999999999999999999999999999765322 2234578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh----hhhhcC-CCC-----
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED----YWRKSK-LPH----- 375 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~----~w~~~~-l~~----- 375 (720)
|+.|+|||++.+.. ++.++||||||||+|||++|+.||......+... ++ +.+... .+.... ...
T Consensus 165 ~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 165 TRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-IF---GRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred CcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-Hh---cccccccccCCccccCccccccccc
Confidence 99999999998765 7999999999999999999999998776544332 22 211110 000000 000
Q ss_pred ----ccccCCCCccch----hhhcc-----cCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 376 ----ATIFKPQQPYKR----CVAET-----FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 376 ----~~~~~~~~~~~~----~~~e~-----~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+...... ..... ...+++++.+||.+||++||++|||+.++|+||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 000000000000 00000 12467889999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=375.35 Aligned_cols=258 Identities=27% Similarity=0.375 Sum_probs=210.7
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
..+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..++||||+++++.+.. ...+||||||
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv~E~ 82 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYLIMEF 82 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEEeC
Confidence 34459999999999999999999999999975432 34456678899999999999999999998876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC------
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN------ 297 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~------ 297 (720)
|.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 83 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~ 162 (360)
T cd05627 83 LPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162 (360)
T ss_pred CCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccc
Confidence 99876665555566799999999999999999999999999999999999999999999999999875422110
Q ss_pred ----------------------------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh
Q 004999 298 ----------------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE 349 (720)
Q Consensus 298 ----------------------------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~ 349 (720)
......+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~~~~ 241 (360)
T cd05627 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETP 241 (360)
T ss_pred cccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCCCCH
Confidence 0112357899999999998766 79999999999999999999999999888
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC---CHHHHHhCcc
Q 004999 350 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG---SAASALRSEF 426 (720)
Q Consensus 350 ~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp---Ta~e~L~hp~ 426 (720)
.+.+.++....... .+. ....+++.+.+||.+|+ .||.+|+ ++.++++|||
T Consensus 242 ~~~~~~i~~~~~~~--------------~~p-----------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 242 QETYRKVMNWKETL--------------VFP-----------PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred HHHHHHHHcCCCce--------------ecC-----------CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence 77776664310000 000 01236889999999987 4999998 4899999999
Q ss_pred CCCCC
Q 004999 427 FTMKP 431 (720)
Q Consensus 427 f~~~~ 431 (720)
|....
T Consensus 296 f~~~~ 300 (360)
T cd05627 296 FEGVD 300 (360)
T ss_pred CCCCC
Confidence 98643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=367.52 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=206.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIH-ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||++..... .......+..|.. +++.++||||+++++++.. ...+|+||||+.
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~ 79 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDYVN 79 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcCCC
Confidence 49999999999999999999999999976432 2233344555555 5678999999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ........+|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~g 158 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTSTFCG 158 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCccccccC
Confidence 876665555566899999999999999999999999999999999999999999999999999875322 2223344578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..+.+..+....
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------------------- 212 (323)
T cd05575 159 TPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP------------------------- 212 (323)
T ss_pred ChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 99999999998765 7999999999999999999999999887766666654310
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH----HHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.||.+||++ .+++.||||...
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 213 ----LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 11224578899999999999999999997 699999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=367.66 Aligned_cols=261 Identities=23% Similarity=0.311 Sum_probs=209.6
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.+.||+|+||.||++++..+++.||||++.... ........+.+|+.++..++|+||+++++++.. ...+|+|||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 81 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYLVMD 81 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEEEEe
Confidence 34445999999999999999999999999997532 233445668899999999999999999998876 678999999
Q ss_pred ecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 223 YMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|+.|+.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcccc
Confidence 99875544433 33567999999999999999999999999999999999999999999999999999766443332333
Q ss_pred ccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 302 SRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
..+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+....+.+..+.......
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 227 (331)
T cd05597 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF-------------- 227 (331)
T ss_pred ceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc--------------
Confidence 4568999999999973 3347889999999999999999999999887777766664321000
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCC--CCCHHHHHhCccCCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 430 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hp~f~~~ 430 (720)
. +......+++.+.+||.+||..++.+ |+++.++|.||||...
T Consensus 228 ------~----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 228 ------Q----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ------c----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 0 11122347899999999999764443 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=374.09 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=229.2
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~ 208 (720)
.+.|+.++. ||+|+||.+++++++..++.|+||.+..........+...+|+.+++++.|||||.+++.
T Consensus 3 m~~Ye~~~~-----------iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds 71 (426)
T KOG0589|consen 3 MDNYEVLRQ-----------VGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS 71 (426)
T ss_pred cchhhhhhh-----------cCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc
Confidence 356777777 999999999999999999999999999988766666678899999999999999999999
Q ss_pred eeccCCCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
|... ++.+||||+||+|+.+...+. .+..|+|..+..|+.||+.||.|||++.|+|||||+.||+++.++.|||+||
T Consensus 72 ~~~~-~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDf 150 (426)
T KOG0589|consen 72 FEED-GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDF 150 (426)
T ss_pred hhcC-CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecch
Confidence 9872 445999999999876654443 3467999999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
|+|+.+.+.. ....+.+||+.|++||++.+.+ |+.++|||||||++|||++-++.|.+.+....+.+|++....|.+
T Consensus 151 GlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp- 227 (426)
T KOG0589|consen 151 GLAKILNPED-SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP- 227 (426)
T ss_pred hhhhhcCCch-hhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-
Confidence 9999887654 2446679999999999998877 899999999999999999999999999999999999887655532
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
..++.++..||..||..+|+.||++.++|.+|.+.
T Consensus 228 ---------------------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 228 ---------------------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred ---------------------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 35678899999999999999999999999998776
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=365.68 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=210.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.+ +||||+++++++.. ...+|+||||+.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~ 79 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYVN 79 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCCC
Confidence 49999999999999999999999999986532 234456678899999988 69999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+.........+++.++..++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++...... .......++
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g 158 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTFCG 158 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccceec
Confidence 8766655555668999999999999999999999999999999999999999999999999998753221 122234578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. ++.++||||||||+|+|++|..||.+.+..+....+....
T Consensus 159 ~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~------------------------- 212 (318)
T cd05570 159 TPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE------------------------- 212 (318)
T ss_pred CccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 99999999998766 7999999999999999999999999887766665553210
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH-----HHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.||.+|||+ .+++.||||...
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 213 ----VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred ----CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 01123578899999999999999999999 999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=366.67 Aligned_cols=250 Identities=22% Similarity=0.396 Sum_probs=203.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||+++.... .......+.+|+.++..+ +||||+++++++.. ...+|||||||+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~~ 79 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFVS 79 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCCC
Confidence 49999999999999999999999999986543 334566788999999998 79999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ........+|
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~g 158 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTSTFCG 158 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCccccccC
Confidence 866655555556899999999999999999999999999999999999999999999999999874321 1222344578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--------VEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~--------~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
|+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+.+....
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~------------------ 219 (329)
T cd05588 159 TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE------------------ 219 (329)
T ss_pred CccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc------------------
Confidence 99999999998765 79999999999999999999999963211 1111111100
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC------HHHHHhCccCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS------AASALRSEFFTM 429 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT------a~e~L~hp~f~~ 429 (720)
........++..+.+||.+||+.||.+|+| +.++++||||..
T Consensus 220 ----------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 220 ----------KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 001122357888999999999999999987 799999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=353.36 Aligned_cols=279 Identities=37% Similarity=0.669 Sum_probs=227.4
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||.|++|.||+|++..++..||||+++..... .....+.+|+.++++++|+||+++++++.. ...+||||||+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 80 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFEYM 80 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEecC
Confidence 344599999999999999999999999999865432 223556789999999999999999999877 57799999999
Q ss_pred cccccccccCCC--CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 225 EHDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 225 ~g~ll~~~~~~~--~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
.+++...+.... ..+++..+..++.||+.||.|||+.||+|+||||+||++++++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~ 159 (284)
T cd07836 81 DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV-NTFSN 159 (284)
T ss_pred CccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-ccccc
Confidence 987766554433 468999999999999999999999999999999999999999999999999997653322 12234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+++.|++||++.+...++.++|||||||++|+|++|.++|.+.+..+.+.+++.....|....|..............
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence 56789999999988766678999999999999999999999999999999999999999998888765432211111100
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
...........+.++..+.++|.+||+.||.+|||+.++|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000111233345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=367.42 Aligned_cols=251 Identities=26% Similarity=0.407 Sum_probs=209.7
Q ss_pred eeecccCceEEEEEEE---CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARD---LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~---~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.||+|+||.||++++ ..+|+.||+|++............+.+|+.+|++++||||+++++++.. ...+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEEcC
Confidence 3599999999999986 3678999999998654433344567789999999999999999999876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 158 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAYSF 158 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cceecc
Confidence 9876555555555679999999999999999999999999999999999999999999999999997653321 223345
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+||+.|+|||++.+.. ++.++||||||||+|||++|+.||.+.+..+.+..+.+..
T Consensus 159 ~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~----------------------- 214 (318)
T cd05582 159 CGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK----------------------- 214 (318)
T ss_pred cCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-----------------------
Confidence 7899999999998765 6899999999999999999999999988777776664311
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+||| +.+++.|+||...
T Consensus 215 ------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 215 ------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 0112357889999999999999999999 7889999999853
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=364.26 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=210.1
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEe
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+.++||+|+||.||+|++..+++.||||+++.... .......+..|+.++..+ .|++|+++++++.. ...+|||||
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E 81 (323)
T cd05616 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYFVME 81 (323)
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEEEEc
Confidence 34559999999999999999999999999986533 233455677888888887 58999999988876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .....
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~~~~ 160 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VTTKT 160 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Ccccc
Confidence 99976655555555579999999999999999999999999999999999999999999999999997543221 22334
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+..+....
T Consensus 161 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------------------- 217 (323)
T cd05616 161 FCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------------------- 217 (323)
T ss_pred CCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------------
Confidence 57899999999998765 7999999999999999999999999988877776664321
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
......++.++.+||.+||++||.+|++ ..++++|+||...
T Consensus 218 -------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 218 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred -------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 0112357889999999999999999998 4899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=355.58 Aligned_cols=279 Identities=37% Similarity=0.650 Sum_probs=221.3
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+...||.|++|.||+|.+..+++.||||.+...... .....+.+|+.+++.++|+||+++++++.. ....|+||||+
T Consensus 9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 85 (291)
T cd07844 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTLVFEYL 85 (291)
T ss_pred EEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEEEEecC
Confidence 334599999999999999999999999998764322 122345689999999999999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
.+++...+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... .......
T Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~ 164 (291)
T cd07844 86 DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEV 164 (291)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC-ccccccc
Confidence 987776665555578999999999999999999999999999999999999999999999999987543211 1122335
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhcCCCC-ccccCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKSKLPH-ATIFKPQ 382 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~-~~e~l~~i~~~~g~p~~~~w~~~~l~~-~~~~~~~ 382 (720)
++..|+|||++.+...++.++|||||||++|+|++|.++|.+.. ..+++..+.+..+.+....|....... .......
T Consensus 165 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (291)
T cd07844 165 VTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP 244 (291)
T ss_pred cccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccccc
Confidence 68889999998876657899999999999999999999998776 667888888888988888876532111 0100000
Q ss_pred CccchhhhcccCCCC--HhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 383 QPYKRCVAETFKDFP--APALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~--~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......+......++ ..+.+||.+||+.||++|||+.++|.|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000111222333444 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=355.94 Aligned_cols=258 Identities=24% Similarity=0.394 Sum_probs=209.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.++||+|+||.||++.+..+++.||||++...... ......+.+|+.+++.++||||+++++.+.. ...+|+||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEEE
Confidence 34556699999999999999999999999999765432 2334557789999999999999999998876 56899999
Q ss_pred eecccccccccc-C-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 222 EYMEHDLAGLAS-H-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 222 Ey~~g~ll~~~~-~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
||+.++.+.... . ....+++..+..++.||+.||.|||+.||+|+||||+|||+++++.++|+|||++...... ..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~ 157 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--ET 157 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC--Cc
Confidence 999976554332 2 2346899999999999999999999999999999999999999999999999999865322 22
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....++++.|+|||++.+.. ++.++|||||||++|||++|..||.+.........+.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 220 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED---------------- 220 (285)
T ss_pred cccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------------
Confidence 23457899999999998765 7999999999999999999999999876654444433211100
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||..||.+|| ++.++++|+||...
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 221 ---------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ---------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 0112235788899999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=364.58 Aligned_cols=249 Identities=24% Similarity=0.427 Sum_probs=203.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||+|+++.... .......+.+|+.++.++ +||||+++++++.. ...+||||||+.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~~ 79 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYVN 79 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCCC
Confidence 49999999999999999999999999986533 344566788999998877 79999999999876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
++.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g 158 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCG 158 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccccccC
Confidence 8766555555567999999999999999999999999999999999999999999999999998753221 122344578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC--------hHHHH-HHHHHhcCCCChhhhhhcCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT--------EVEQL-HKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~--------~~e~l-~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
|+.|+|||++.+.. ++.++|||||||++|||++|..||.... ....+ ..+...
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------------- 220 (329)
T cd05618 159 TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------------- 220 (329)
T ss_pred CccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC-----------------
Confidence 99999999998765 7999999999999999999999995311 01111 111110
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC------HHHHHhCccCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS------AASALRSEFFTM 429 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT------a~e~L~hp~f~~ 429 (720)
....+..++..+.+||.+||+.||.+|+| +.++++||||..
T Consensus 221 ------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 221 ------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 01123457888999999999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=352.60 Aligned_cols=282 Identities=34% Similarity=0.609 Sum_probs=224.2
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 80 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR--KKRLYLVFE 80 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc--CCeEEEEEe
Confidence 344456999999999999999999999999987654433445667899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD 159 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cccCc
Confidence 99998777666555568999999999999999999999999999999999999999999999999998654322 23344
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc-CCC-CccccC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS-KLP-HATIFK 380 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~-~l~-~~~~~~ 380 (720)
..++.+|+|||++.+...++.++|||||||++|||++|.++|.+....+.+..+....+......-... ..+ ......
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 567899999999987665788999999999999999999999998888888887766554432211000 000 000011
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+...........++.++..+.+||.+||..||.+|||+.++|+|+||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 11111122233456789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=355.97 Aligned_cols=281 Identities=45% Similarity=0.711 Sum_probs=220.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC------CCeEEEE
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM------SCSLYLV 220 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~------~~~lyLV 220 (720)
..||+|+||.||+|.+..+++.||||++............+.+|+.++++++||||+++++++.... ....|+|
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 97 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence 3499999999999999999999999998765433333345678999999999999999999875432 2457999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC---
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--- 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~--- 297 (720)
|||+.+++...+......+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 98 ~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 177 (310)
T cd07865 98 FEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177 (310)
T ss_pred EcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCC
Confidence 99999988777666656799999999999999999999999999999999999999999999999999986643221
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC-c
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH-A 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~-~ 376 (720)
.......++..|+|||++.+...++.++|||||||++|||++|.++|.+.+....+..+.+.++..+...|....... .
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T cd07865 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELF 257 (310)
T ss_pred CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhh
Confidence 122344678899999998876657899999999999999999999999998888888888888887776654421110 0
Q ss_pred cccCCCCccchhhhcc--cCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 377 TIFKPQQPYKRCVAET--FKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~--~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
..+............. ....+..+.+||.+||..||.+|||++++|+||||
T Consensus 258 ~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 258 KKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0000000000001111 11245678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=361.04 Aligned_cols=289 Identities=43% Similarity=0.764 Sum_probs=234.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHH------------HHHHHHHHHHHHHhcCCCceeeeccceeccCC
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE------------SVRFMAREIHILRRLDHINVIKLEGLVTSRMS 214 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~------------~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~ 214 (720)
++||.|+||.||+|.+..+++.||||+++....... ....+.+|+.+++.++|+||+++++++.. .
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 92 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE--G 92 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec--C
Confidence 369999999999999999999999999876533210 01246789999999999999999999876 6
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCC
Q 004999 215 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~ 294 (720)
..+|+||||+.+++...+.. ...+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++.....
T Consensus 93 ~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~ 171 (335)
T PTZ00024 93 DFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGY 171 (335)
T ss_pred CcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeeccc
Confidence 78999999999877665543 44689999999999999999999999999999999999999999999999999976541
Q ss_pred C-------------CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 004999 295 D-------------QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 295 ~-------------~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g 361 (720)
. .........+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+..++..++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~ 251 (335)
T PTZ00024 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251 (335)
T ss_pred ccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 1 111223345688999999998766679999999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCC
Q 004999 362 SPSEDYWRKSK-LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440 (720)
Q Consensus 362 ~p~~~~w~~~~-l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p 440 (720)
.|....|.... ++....+....+ ......+...+..+.+||.+||+.||++|||++++|.||||+..+.++.+..+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~~~~~~~ 329 (335)
T PTZ00024 252 TPNEDNWPQAKKLPLYTEFTPRKP--KDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQLP 329 (335)
T ss_pred CCchhhCcchhhcccccccCcCCc--ccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCCCcccCC
Confidence 88877665432 111111111111 122344556788999999999999999999999999999999998888776655
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=354.83 Aligned_cols=281 Identities=40% Similarity=0.716 Sum_probs=227.4
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
...||.|++|.||+|.+..+++.||||++..........+.+.+|+.++++++||||+++++++.. ...+|+||||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 84 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLVFEYLD 84 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEEEeccc
Confidence 344999999999999999999999999987654444445667899999999999999999999876 678999999999
Q ss_pred ccccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-CCceeeeccccceecCCCCCCCcccc
Q 004999 226 HDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 226 g~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+++...+... ...+++..++.++.||+.||.|||++||+|+||+|+||+++. ++.+||+|||++...... ....+..
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~~~~~~~ 163 (294)
T PLN00009 85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-VRTFTHE 163 (294)
T ss_pred ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC-ccccccC
Confidence 8776665442 334688999999999999999999999999999999999985 567999999999765332 2223345
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~~~~~ 382 (720)
.+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+..+.+.+++...+.|....|.... ++......+.
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T PLN00009 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK 243 (294)
T ss_pred ceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhccc
Confidence 678999999998876667899999999999999999999999999989999999999999888886421 1211111111
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.+ ........+.+++.+.+||.+||+.||++||++.++|+||||...
T Consensus 244 ~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 244 WP-PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred CC-CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 11 011223345688999999999999999999999999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=362.39 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=206.1
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||+++.... .......+..|..++..+ +||||+++++++.. ...+||||||+.
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~~ 79 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYLN 79 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCCC
Confidence 49999999999999999999999999986532 123345567788888764 89999999999876 668999999998
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+|
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 158 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCG 158 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-CceeeecC
Confidence 76665555555678999999999999999999999999999999999999999999999999987532211 22334578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++|||||||++|||++|..||.+.+..+.+..+... .+
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~---------------------- 213 (316)
T cd05619 159 TPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NP---------------------- 213 (316)
T ss_pred CccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CC----------------------
Confidence 99999999998765 799999999999999999999999988776665554321 00
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHH-HHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAA-SALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~-e~L~hp~f~~~ 430 (720)
.....++..+.+||.+||+.||.+|+++. ++++||||...
T Consensus 214 -----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 214 -----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred -----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 01124678899999999999999999996 89999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.57 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=206.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIH-ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+|+.||||++..... .......+..|.. +++.++||||+++++++.. ...+||||||+.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~~~ 79 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDFVN 79 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcCCC
Confidence 49999999999999999999999999976432 2333445556655 4677899999999988876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ........+|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~~~~g 158 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCG 158 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCcccccC
Confidence 876665555566899999999999999999999999999999999999999999999999999875322 1222345578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+..+....
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~------------------------- 212 (325)
T cd05604 159 TPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP------------------------- 212 (325)
T ss_pred ChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 99999999998766 7999999999999999999999999887766666554310
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH----HHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hp~f~~~ 430 (720)
....+.++..+.+||.+||+.||.+||++ .+++.||||...
T Consensus 213 ----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 213 ----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred ----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 01123578889999999999999999976 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=350.74 Aligned_cols=279 Identities=41% Similarity=0.709 Sum_probs=225.7
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||.|++|.||+|.+..+|..||||++............+.+|+.+++.++||||+++++++.. ....|+||||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~e~~ 80 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVFEFL 80 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEEecc
Confidence 3445999999999999999999999999998765444444567889999999999999999999876 67899999999
Q ss_pred cccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 225 EHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 225 ~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
++.+...+.... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~~ 159 (283)
T cd07835 81 DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RTYTHE 159 (283)
T ss_pred CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cccCcc
Confidence 876655443322 368999999999999999999999999999999999999999999999999997653222 222334
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC-CccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP-HATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~-~~~~~~~~ 382 (720)
.++..|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+.++.+..+.|....|...... ....-.+.
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 56889999999877655789999999999999999999999999998888889988888888777543211 11100011
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.. ..........++..+.+||.+||+.||.+|||+.+++.|+||
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00 011223356788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=361.82 Aligned_cols=289 Identities=34% Similarity=0.545 Sum_probs=232.6
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc--CCCeEEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSLYLVF 221 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~--~~~~lyLV~ 221 (720)
.+.+.||.|+||.||+|.+..++..||+|++............+.+|+.+|++++||||+++++++... ....+|+||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 334459999999999999999999999999986544444566778899999999999999999987542 235789999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC---C
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN---Q 298 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~---~ 298 (720)
||+.+++...+.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........ .
T Consensus 88 e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 166 (334)
T cd07855 88 DLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166 (334)
T ss_pred ehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCc
Confidence 9999876665544 44699999999999999999999999999999999999999999999999999976533221 1
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc-
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT- 377 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~- 377 (720)
.....+++.+|+|||.+.+...++.++|||||||++|||++|++||.+.+...++..+....|.|+...+.........
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~ 246 (334)
T cd07855 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRK 246 (334)
T ss_pred ccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHH
Confidence 2234578999999999877555899999999999999999999999999999999999999999887765432111100
Q ss_pred ---ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCC
Q 004999 378 ---IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435 (720)
Q Consensus 378 ---~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 435 (720)
.+..... ..+...++.++..+.+||.+||+.||.+|||+.++|.||||...+.+..
T Consensus 247 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 247 YIQNLPRKQP--VPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred HHhhcccCCC--CCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 0110101 1123345667999999999999999999999999999999987766543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=353.39 Aligned_cols=283 Identities=41% Similarity=0.700 Sum_probs=223.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCC---CeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMS---CSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~---~~lyL 219 (720)
.+.++||+|+||.||+|.+..+++.||||+++...........+.+|+.+++.+. ||||+++++++..... ..+|+
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 3445599999999999999999999999998765433333456788999999995 6999999998765321 23899
Q ss_pred EEeeccccccccccCC----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-CCceeeeccccceecCC
Q 004999 220 VFEYMEHDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDP 294 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~~~~ 294 (720)
||||+++++...+... +..+++..++.++.||+.||.|||++||+|+||+|+|||++. ++.+||+|||++..+..
T Consensus 84 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~ 163 (295)
T cd07837 84 VFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163 (295)
T ss_pred EeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence 9999998776654432 346899999999999999999999999999999999999998 89999999999986533
Q ss_pred CCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 295 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 295 ~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
.. .......++++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+.++++..+.|....|......
T Consensus 164 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T cd07837 164 PV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242 (295)
T ss_pred Cc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhc
Confidence 21 12233456889999999987666799999999999999999999999999999999999888888877766432111
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
......+... ...+....+.++..+.+||.+||..||.+|||+.++|.||||.
T Consensus 243 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 243 RDWHEFPQWK-PQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhcCccc-chhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 1100001100 0112333457899999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=363.51 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=205.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIH-ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||+|++..... .......+..|.. +++.++||||+++++++.. ...+|+||||+.
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~~~ 79 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYIN 79 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeCCC
Confidence 49999999999999999999999999975432 1222334444444 5678899999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ........+|
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~-~~~~~~~~~g 158 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTSTFCG 158 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc-CCCCcccccC
Confidence 876666665566789999999999999999999999999999999999999999999999999975422 1222345578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..+....
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~------------------------- 212 (325)
T cd05602 159 TPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------- 212 (325)
T ss_pred CccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-------------------------
Confidence 99999999998765 7999999999999999999999999988777766664310
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHH----HHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAA----SALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~----e~L~hp~f~~ 429 (720)
......++..+.+||.+||+.||.+|+++. ++++|+||..
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 213 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred ----cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 012246788999999999999999999876 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=368.83 Aligned_cols=259 Identities=26% Similarity=0.354 Sum_probs=210.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~lv~E 123 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLYMVME 123 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEEEEEc
Confidence 333449999999999999999999999999875322 23344567899999999999999999998876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++|+.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..........
T Consensus 124 y~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~ 202 (371)
T cd05622 124 YMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202 (371)
T ss_pred CCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccC
Confidence 9987665555443 358999999999999999999999999999999999999999999999999998764433333345
Q ss_pred cccccCCCChhhhcCCc---CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 303 RVVTLWYRPPELLLGAT---YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~---~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
.+||+.|+|||++.+.. .|+.++||||||||||||++|.+||.+.+......+|........
T Consensus 203 ~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--------------- 267 (371)
T cd05622 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--------------- 267 (371)
T ss_pred cccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---------------
Confidence 67999999999997542 378999999999999999999999999888777766653211100
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCC--CCCHHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||..||..++.+ |+++.++++|+||...
T Consensus 268 ----------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 268 ----------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred ----------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 0112368899999999999844433 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=362.49 Aligned_cols=249 Identities=23% Similarity=0.350 Sum_probs=204.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHH-HHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIH-ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~-iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||++..... .......+..|+. +++.++||||+++++++.. ...+||||||++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~~~ 79 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDYVN 79 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcCCC
Confidence 49999999999999999999999999975432 2233344555554 6788999999999988876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... .......+|
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g 158 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFCG 158 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccccccC
Confidence 8766555555567899999999999999999999999999999999999999999999999998753221 122344578
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+.......+... +
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~---------------------- 212 (321)
T cd05603 159 TPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P---------------------- 212 (321)
T ss_pred CcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C----------------------
Confidence 99999999998765 799999999999999999999999988766655554321 0
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH----HHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hp~f~~ 429 (720)
.......+..+.+||.+||+.||.+|+++ .++++|+||..
T Consensus 213 ----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 213 ----LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 01223567889999999999999999875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=346.96 Aligned_cols=281 Identities=35% Similarity=0.543 Sum_probs=236.4
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC---CeEEEEEeecc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS---CSLYLVFEYME 225 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~---~~lyLV~Ey~~ 225 (720)
||-|+||.||.++|..+|+.||+|++..-...-...+.+.+|+.+|.-++|.||+..+++.....- ..+|+|+|+|.
T Consensus 61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ 140 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ 140 (449)
T ss_pred ccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH
Confidence 999999999999999999999999986544344566788899999999999999999887654322 24789999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+|...+.... .++...++-+++||++||.|||+.+|+||||||.|+||++|+.+||||||+|+..+.++...++..+.
T Consensus 141 SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVV 219 (449)
T KOG0664|consen 141 SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVV 219 (449)
T ss_pred hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHH
Confidence 99888777665 78999999999999999999999999999999999999999999999999999998888889999999
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC-CCcccc--CCC
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL-PHATIF--KPQ 382 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l-~~~~~~--~~~ 382 (720)
|.+|+|||++.|...|+.++||||+|||+.|||..+.+|.....++++..|..++|+|+.+.+..... ....+. ...
T Consensus 220 TQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k 299 (449)
T KOG0664|consen 220 TQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLR 299 (449)
T ss_pred HHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999987653211 111111 111
Q ss_pred Cccchhhhc--ccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAE--TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e--~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.|....+.. ...+...+...++..||..||.+|.+.++++.|+|+...
T Consensus 300 ~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 300 APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111111111 112345678999999999999999999999999998654
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.23 Aligned_cols=283 Identities=34% Similarity=0.608 Sum_probs=228.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|.+..+++.||||+++...........+.+|+.++++++|+||+++++++.. ...+|+|||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~e 80 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVFE 80 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEEe
Confidence 344455999999999999999999999999987655444555778999999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++++++..+......+++.+++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 99998887766666679999999999999999999999999999999999999999999999999998765443334455
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC-CCccccC-
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL-PHATIFK- 380 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l-~~~~~~~- 380 (720)
..++.+|+|||++.+...++.++|||||||++|+|++|.++|.+....+.+..+...++......+..... .......
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF 240 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccccc
Confidence 67899999999998874589999999999999999999999999888888888877777666654432211 0000000
Q ss_pred CCCccchhhhcc-cCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAET-FKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~-~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+.......+... ...++..+.+||.+||..||++|||+.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000000111112 23358999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=359.66 Aligned_cols=291 Identities=37% Similarity=0.568 Sum_probs=231.2
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC---CeEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS---CSLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~---~~ly 218 (720)
.|.+.+.||+|+||.||+|++..+++.||||.+............+.+|+.+++.++|+||+++++++..... ..+|
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 85 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY 85 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence 4556667999999999999999999999999987654334445567789999999999999999998764321 4589
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
|||||+.+++...+.. ...+++..++.++.||+.||.|||+++++|+||||+|||++.++.+||+|||++....... .
T Consensus 86 lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 163 (337)
T cd07858 86 IVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-D 163 (337)
T ss_pred EEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc-c
Confidence 9999999877665543 4579999999999999999999999999999999999999999999999999998654322 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......++..|+|||.+.+...++.++|||||||++|+|++|++||.+.+....+..+....+.+..+.|..........
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 33455678999999998765457999999999999999999999999998888888888888888776653211111110
Q ss_pred cCCCCcc--chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 379 FKPQQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 379 ~~~~~~~--~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
+....+. ........+.+++.+.+||.+||+.||++|||+.++|+||||.....+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 0000000 0011233457899999999999999999999999999999998765544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=360.30 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=209.5
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEe
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
..++||+|+||.||+|.+..+++.||||++..... .......+..|+.++..+. |++|+++++++.. ...+|+|||
T Consensus 4 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E 81 (323)
T cd05615 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYFVME 81 (323)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEEEEc
Confidence 34569999999999999999999999999986532 2344566788999998886 5778888888766 568999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++|+.+..+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-~~~~~ 160 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-VTTRT 160 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-ccccC
Confidence 99976665555555679999999999999999999999999999999999999999999999999987543221 12234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+......+..+....
T Consensus 161 ~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------------------- 217 (323)
T cd05615 161 FCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------------------- 217 (323)
T ss_pred ccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------------------
Confidence 56899999999998765 7999999999999999999999999988777666664321
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
...+..++..+.+||.+||+.||.+|++ ..++++|+||...
T Consensus 218 -------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 218 -------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred -------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 0112357888999999999999999997 5799999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=362.80 Aligned_cols=260 Identities=23% Similarity=0.302 Sum_probs=209.1
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.+.||+|+||.||++++..+++.||+|++..... .......+..|+.++..++|+||+++++++.. ...+||||||
T Consensus 5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ey 82 (332)
T cd05623 5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYLVMDY 82 (332)
T ss_pred EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEEEEec
Confidence 34459999999999999999999999999865322 23344567889999999999999999998876 6789999999
Q ss_pred cccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 224 MEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 224 ~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
+.++.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~ 162 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 162 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecc
Confidence 9865554444 335578999999999999999999999999999999999999999999999999997654333323334
Q ss_pred cccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 303 RVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.+||+.|+|||++.+ ...|+.++|||||||+||||++|+.||.+.+..+.+.++.......
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------- 227 (332)
T cd05623 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--------------- 227 (332)
T ss_pred cccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc---------------
Confidence 578999999999863 3347899999999999999999999999988777777664321000
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCC--CCCHHHHHhCccCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMK 430 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hp~f~~~ 430 (720)
.+......+++.+.+||.+||..++.. |+++.++++||||...
T Consensus 228 ---------~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 228 ---------QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 011223467899999999999765544 6899999999999853
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.46 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=204.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc---CCCceeeeccceeccCCCeEEEEEeec
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL---DHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L---~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
||+|+||.||+|++..+++.||||++..... .......+..|..++..+ .||||+++++++.. ...+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 7999999999999999999999999975432 223344556777777766 69999999998876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCccCcc
Confidence 876655555556679999999999999999999999999999999999999999999999999987542222 2234557
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
||+.|+|||++.+...++.++||||||||||+|++|..||.+.+..+.+..+.... . ..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~------------------~~- 216 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK--V------------------RF- 216 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC--C------------------CC-
Confidence 89999999999876668999999999999999999999999887666555543210 0 00
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCC----CHHHHHhCccCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRG----SAASALRSEFFTM 429 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp----Ta~e~L~hp~f~~ 429 (720)
....+++.+.+||.+||+.||.+|| ++.++++||||..
T Consensus 217 -------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 217 -------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred -------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 0123688899999999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=357.88 Aligned_cols=288 Identities=34% Similarity=0.542 Sum_probs=228.0
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC---CCeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~---~~~lyL 219 (720)
|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.++++++||||+++++++.... ...+|+
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 344455999999999999999999999999986432 2234556788999999999999999998765422 246899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 297 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-- 297 (720)
||||+.+++...+. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 86 v~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 163 (336)
T cd07849 86 VQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163 (336)
T ss_pred EehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccccc
Confidence 99999987766553 34689999999999999999999999999999999999999999999999999976533221
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.......+|+.|+|||.+.+...++.++|||||||++|+|++|++||.+.....++..+...++.+..+.|.........
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (336)
T cd07849 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR 243 (336)
T ss_pred CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhh
Confidence 12233567999999999877655799999999999999999999999999888888889888888877766543221111
Q ss_pred ccCCCCc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 378 IFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 378 ~~~~~~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.+....+ ....+....+.+++.+.+||.+||+.||++|||+.++|+||||.....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 1110000 0111223345678899999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=367.27 Aligned_cols=274 Identities=24% Similarity=0.306 Sum_probs=207.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++..++..||+|+..... ...|+.++++++||||+++++++.. ....|+|||
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 137 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMVLP 137 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEe--CCeeEEEEE
Confidence 455556999999999999999999999999854322 3569999999999999999999877 567899999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.+++...+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ......
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~~~~~ 215 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--APAFLG 215 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc--Cccccc
Confidence 999988887776667899999999999999999999999999999999999999999999999999975322 122234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCC---------hHHHHHHHHHhcCCCChhhhhhcC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRT---------EVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~---------~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
..||+.|+|||++.+.. |+.++||||||||||||+++. ++|.+.. ....+..++..++..+..+..+..
T Consensus 216 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 56899999999998766 799999999999999999855 5554321 123444555555544333221100
Q ss_pred CCCcccc-----CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 373 LPHATIF-----KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 373 l~~~~~~-----~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+ ....++..........++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0000000 00011111001112357788999999999999999999999999999974
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=345.74 Aligned_cols=259 Identities=31% Similarity=0.447 Sum_probs=210.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+..+.||+|+||.||++.+..+++.||+|++..............+|+.++++++||||+++++++.. ...+|+||||
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~~ 79 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--cccccccccc
Confidence 45566999999999999999999999999999876544444455679999999999999999999877 7789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.++.+..+......+++.+++.++.||+.||.+||++||+|+||||+|||++.++.++|+|||++.... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~ 158 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFNPF 158 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 9985554444455678999999999999999999999999999999999999999999999999998642 223344556
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
.+|..|+|||++.....++.++|||||||++|+|++|..||...........+.+.........+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 223 (260)
T PF00069_consen 159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS--------------- 223 (260)
T ss_dssp SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT---------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc---------------
Confidence 78999999999883344799999999999999999999999987544444444333221111110
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......+..+.+||..||+.||++|||+.++++||||
T Consensus 224 -------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 224 -------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 0001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=346.43 Aligned_cols=280 Identities=42% Similarity=0.710 Sum_probs=231.9
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||.|++|.||+|.+..+++.+++|.+............+.+|+.++++++|+||+++++++.. ...+|+||||+
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~ 80 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVFEFM 80 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEEecc
Confidence 4455999999999999999999999999998765554556778899999999999999999999876 57899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
++++...+......+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||.+....... .......
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~~ 159 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYV 159 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccccCcc
Confidence 998877776655689999999999999999999999999999999999999999999999999998765433 2233456
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC-CccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP-HATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~-~~~~~~~~~ 383 (720)
++..|+|||.+.+...++.++|||||||++|+|++|+++|.+.+..+.+.++...++.+....|...... ....+....
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcc
Confidence 7889999999987745799999999999999999999999999999999999998888887776553220 000000000
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
............++..+.+||.+||+.||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 240 KAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01111223345678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=375.90 Aligned_cols=275 Identities=24% Similarity=0.298 Sum_probs=207.3
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|++|+|+|||++++++.. ....||||
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv~ 239 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLVL 239 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 35556669999999999999999999999996432 235689999999999999999998876 67789999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-Cc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PL 300 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~ 300 (720)
|++.++++..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...... ..
T Consensus 240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 99998887776665557999999999999999999999999999999999999999999999999999866432221 12
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCC-CCCCCC------hHHHHHHHHHhcCCCChhhh-----
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP-IMPGRT------EVEQLHKIFKLCGSPSEDYW----- 368 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~p-pf~g~~------~~e~l~~i~~~~g~p~~~~w----- 368 (720)
...+||+.|+|||++.+.. ++.++||||||||||||++|.. +|.+.. ...++.++++..+....++-
T Consensus 320 ~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 2356899999999998876 7999999999999999999874 444321 12445555544332211110
Q ss_pred ---hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 369 ---RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 369 ---~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
............+ .+.......+..++..+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 399 ~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 399 RLVSQYRHRAARNRRP--AYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHhhhhcccCC--ccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000000 0000001112356778999999999999999999999999999975
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.52 Aligned_cols=260 Identities=23% Similarity=0.300 Sum_probs=209.7
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.+.||+|+||.||++++..+++.||||++.... ........+.+|+.++..++|+||+++++++.. ...+|||||
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~lv~E 81 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYLVMD 81 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEEEe
Confidence 34455999999999999999999999999987532 223345567889999999999999999998876 678999999
Q ss_pred eccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 223 YMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|+.|+.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 161 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeec
Confidence 998765554443 3457899999999999999999999999999999999999999999999999999876443332233
Q ss_pred ccccccCCCChhhhcCC----cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 302 SRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~----~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
..+||+.|+|||++.+. ..++.++|||||||+||||++|+.||.+....+.+.++.......
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 227 (331)
T cd05624 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF-------------- 227 (331)
T ss_pred cccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc--------------
Confidence 45789999999998752 347889999999999999999999999888777666664311000
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCC--CCCHHHHHhCccCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTM 429 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hp~f~~ 429 (720)
+ +...+.++++.+.+||.+||..++.+ |+++.++++|+||..
T Consensus 228 ------~----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 228 ------Q----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred ------c----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 0 11223467899999999999976654 469999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.97 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=204.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++.++ +||||+++++++.. ...+|+||||+.
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~ 79 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYVN 79 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCCC
Confidence 49999999999999999999999999987543 345567788999999988 69999999998876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......+|
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~g 158 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCG 158 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceecccC
Confidence 8666555545557999999999999999999999999999999999999999999999999998753221 122344678
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE------VEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~------~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
|+.|+|||++.+.. |+.++||||||||||||++|..||..... .+.+.++... .+
T Consensus 159 t~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~---------------- 219 (327)
T cd05617 159 TPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--KP---------------- 219 (327)
T ss_pred CcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--CC----------------
Confidence 99999999998765 79999999999999999999999964321 1222222110 00
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC------HHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS------AASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT------a~e~L~hp~f~~~ 430 (720)
...+..++..+.+||.+||+.||.+|++ ..+++.|+||...
T Consensus 220 ----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 220 ----------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred ----------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 1122357888999999999999999998 5799999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=368.06 Aligned_cols=276 Identities=24% Similarity=0.320 Sum_probs=212.1
Q ss_pred ccceeecccCceEEEEEEEC--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~--~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.+...||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.|+||||+++++++.. ...+|+||
T Consensus 95 ~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv~ 165 (392)
T PHA03207 95 NILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRW--KSTVCMVM 165 (392)
T ss_pred EEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEee--CCEEEEEe
Confidence 33344999999999999764 456789999886432 24689999999999999999998876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-Cc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PL 300 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~ 300 (720)
|++.+++...+ .....+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...... ..
T Consensus 166 e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccccc
Confidence 99998877766 34457999999999999999999999999999999999999999999999999999765433222 22
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhhhhhcCCC---
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKIFKLCGSPSEDYWRKSKLP--- 374 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~---~~e~l~~i~~~~g~p~~~~w~~~~l~--- 374 (720)
...+||+.|+|||++.+.. |+.++||||||||||||++|..||.+.. ...++..+.+.++..+.++.......
T Consensus 245 ~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 245 YGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred cccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 3457899999999998766 7999999999999999999999997754 45667777776665544432111000
Q ss_pred ----CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 375 ----HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 375 ----~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
......+.......+ .-..++.++.+||.+||.+||++|||+.++|.||||...|.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVI--RKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred HHHhhcccccCCccccchh--hccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 000000100000000 01246778999999999999999999999999999987653
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=347.40 Aligned_cols=281 Identities=37% Similarity=0.583 Sum_probs=218.0
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|.+..++..||||++...... .....+.+|+.+++.++|+||+++++++.. ....|+|||
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv~e 83 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTFVFE 83 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEEEEe
Confidence 44455699999999999999999999999998754322 222346789999999999999999999876 568999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.++++..+......+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...... ......
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~ 162 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSS 162 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC-CCCCCC
Confidence 9998887766555556889999999999999999999999999999999999999999999999998754321 122234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhcC-CCCccccC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKSK-LPHATIFK 380 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~-~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~~~ 380 (720)
..+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.. ..+.+.++....+.|.+..|.... ++......
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW 242 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence 4578999999999876557889999999999999999999998754 456777777777877776654321 11110000
Q ss_pred CCCccchhhhcccC--CCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFK--DFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~--~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
........+..... ..+..+.+||.+||..||.+|||+.++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00000000111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.67 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=207.7
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.++||+|++|.||+|.+..+++.||||++...... ......+.+|+.++++++||||+++++++.. ...+|+|||
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e 84 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETLSIFME 84 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeEEEEEE
Confidence 34599999999999999999999999998765432 2335678899999999999999999999877 568999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc--
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL-- 300 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~-- 300 (720)
|+.++.+..+......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...........
T Consensus 85 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 164 (263)
T cd06625 85 YMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM 164 (263)
T ss_pred ECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccc
Confidence 999866655555555789999999999999999999999999999999999999999999999999976543221111
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....++..|+|||++.+.. ++.++||||||||+|||++|++||...+..+....+.....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------------------- 224 (263)
T cd06625 165 KSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT------------------- 224 (263)
T ss_pred cCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC-------------------
Confidence 2345788999999998866 79999999999999999999999987665555444322100
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......++..+.+||.+||..+|.+|||+.++|+|+||
T Consensus 225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 225 --------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 011234578899999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=367.44 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=221.2
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccc
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGL 208 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~ 208 (720)
..|..|.. ||.|+||.||.|++..+.+.||||++....- ..+....++.|+.+|++|+|||+|.+.|+
T Consensus 26 klf~dLrE-----------IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgC 94 (948)
T KOG0577|consen 26 KLFSDLRE-----------IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGC 94 (948)
T ss_pred HHHHHHHH-----------hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccce
Confidence 45777888 9999999999999999999999999987653 45566789999999999999999999999
Q ss_pred eeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
|.. +...|||||||-|.-.+++.....++-+.++..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.
T Consensus 95 yLr--e~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 95 YLR--EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred eec--cchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccc
Confidence 887 677899999999976666666667899999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
|.+..+ ..+++|||+|||||+++. ...|+-++||||||++..||.-.+||+...+....+.-|.+. .+|...
T Consensus 173 Asi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPtLq 246 (948)
T KOG0577|consen 173 ASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPTLQ 246 (948)
T ss_pred hhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCCCC
Confidence 987644 356799999999999973 455899999999999999999999998888877776666432 222100
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
-...+..++.||..||++-|.+|||.+++|.|+|....
T Consensus 247 --------------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 247 --------------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred --------------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 12456789999999999999999999999999999754
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=354.77 Aligned_cols=290 Identities=36% Similarity=0.558 Sum_probs=235.7
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC---CCeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~---~~~lyL 219 (720)
|++.+.||.|++|.||+|++..+++.||||++..........+.+.+|+.+++.++|+||+++++++.... ...+|+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 34455699999999999999999999999998765444555677899999999999999999999887632 136899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 297 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-- 297 (720)
||||+++++...+.. ...+++..++.++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++........
T Consensus 82 v~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 82 VTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 999999876655544 34899999999999999999999999999999999999999999999999999987644321
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.......+|++|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.|.........
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKAR 240 (330)
T ss_pred ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchh
Confidence 12344567999999999988745799999999999999999999999999999999999999999988776532222221
Q ss_pred ccCCC--CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 378 IFKPQ--QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 378 ~~~~~--~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.+... ......+......++..+.+||..||++||.+|||+.++|.||||.....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 11110 001112334455689999999999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=350.69 Aligned_cols=284 Identities=37% Similarity=0.610 Sum_probs=221.1
Q ss_pred ccceeecccCceEEEEEEECC--CCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLD--QKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~--tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
++...||+|+||.||+|.+.. ++..||||.+..... .......+.+|+.+++.++||||+++++++.......+|+|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 344569999999999999988 899999999986431 22334556789999999999999999999987544789999
Q ss_pred EeeccccccccccC----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC----CCceeeeccccceec
Q 004999 221 FEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN----NGILKIADFGLASFY 292 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~----~g~vKL~DFGla~~~ 292 (720)
|||++++++..+.. ....+++..++.++.||+.||.|||+.+|+|+||||+|||++. ++.+||+|||++..+
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~ 162 (316)
T cd07842 83 FDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162 (316)
T ss_pred EeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccccc
Confidence 99999877654432 2236899999999999999999999999999999999999999 999999999999865
Q ss_pred CCCCC--CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcC
Q 004999 293 DPDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLCG 361 (720)
Q Consensus 293 ~~~~~--~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---------~e~l~~i~~~~g 361 (720)
..... .......+|++|+|||++.+...++.++|||||||+||+|++|.+||.+... ...+..++..++
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (316)
T cd07842 163 NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLG 242 (316)
T ss_pred CCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhC
Confidence 43222 1122346789999999988766679999999999999999999999987653 246777888888
Q ss_pred CCChhhhhhcC-CCCccc---cCCCCccc----hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 362 SPSEDYWRKSK-LPHATI---FKPQQPYK----RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 362 ~p~~~~w~~~~-l~~~~~---~~~~~~~~----~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.+....|.... ++.... ......+. ....+.....+..+.+||.+||+.||++|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 243 TPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 88777664311 111111 00001111 01112223678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=354.60 Aligned_cols=283 Identities=35% Similarity=0.566 Sum_probs=225.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~ly 218 (720)
|.+...||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... ...+|
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 34455699999999999999999999999998765443444456789999999999999999999876432 13579
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
+||||+...+.... +..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 97 lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---- 169 (342)
T cd07879 97 LVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---- 169 (342)
T ss_pred EEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC----
Confidence 99999987544332 23689999999999999999999999999999999999999999999999999875422
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......+|+.|+|||++.+...++.++|||||||++|||++|+.||.+......+..+....+.+.+.++..........
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 22345678999999998875557999999999999999999999999998888999999888888777655432221111
Q ss_pred cCCCCc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 379 FKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 379 ~~~~~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
+....+ ....+...++.++..+.+||.+||+.||.+|||+.++|.||||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 110000 011123334567889999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=343.04 Aligned_cols=278 Identities=41% Similarity=0.699 Sum_probs=230.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
..||+|.||.||+|.+..+++.||+|++............+..|+.++++++|+||+++++++.. ...+|+||||+++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 82 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFEYCDM 82 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEecCcCc
Confidence 44999999999999999999999999998765334445667889999999999999999999876 5789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
++...+......+++..++.++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....... ........+
T Consensus 83 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 161 (282)
T cd07829 83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTYTHEVVT 161 (282)
T ss_pred CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-cccCccccC
Confidence 7666655543579999999999999999999999999999999999999999999999999998654322 123344567
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
..|+|||.+.+...++.++|||||||++|||++|.++|.+.+..+.+.++...++.+.+..|..................
T Consensus 162 ~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (282)
T cd07829 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPP 241 (282)
T ss_pred cCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCc
Confidence 88999999987755799999999999999999999999999999999999999999998888654322111111111111
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......++.++..+.++|.+||..||++||++.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 242 KDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 22334556678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=354.13 Aligned_cols=296 Identities=34% Similarity=0.556 Sum_probs=230.3
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC----CeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----CSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~----~~ly 218 (720)
|++.+.||+|+||.||+|.+..++..||||++............+.+|+.+|+.++||||+++++++..... ..+|
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 444555999999999999999999999999987554444445667899999999999999999998765321 2469
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
+||||+++++..... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++......
T Consensus 97 lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--- 171 (343)
T cd07880 97 LVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--- 171 (343)
T ss_pred EEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC---
Confidence 999999665554443 246899999999999999999999999999999999999999999999999999765321
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+++.|+|||.+.+...++.++|+|||||++|+|++|.+||.+......+.++++..+.++..++..........
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07880 172 -MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN 250 (343)
T ss_pred -ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence 2334668999999999875557899999999999999999999999998888888888877777766554322211111
Q ss_pred cCCCCc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCCCCCC
Q 004999 379 FKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPP 444 (720)
Q Consensus 379 ~~~~~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~~p 444 (720)
+....+ ....+......+++.+.+||.+||+.||.+|||+.++|.||||+...........++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~~ 318 (343)
T cd07880 251 YVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYDD 318 (343)
T ss_pred HHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCccc
Confidence 100000 001122334678889999999999999999999999999999987655444334444443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=389.16 Aligned_cols=278 Identities=28% Similarity=0.375 Sum_probs=236.2
Q ss_pred CCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeee
Q 004999 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 127 ~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
.+.++|++++- ||+|+||.|.+++++.|++.||+|++++-.+ .......|..|-.||.--+.+-||.|
T Consensus 72 l~~~DfeilKv-----------IGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~L 140 (1317)
T KOG0612|consen 72 LKAEDFEILKV-----------IGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQL 140 (1317)
T ss_pred CCHHhhHHHHH-----------hcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence 45678888887 9999999999999999999999999986433 23445678999999999999999999
Q ss_pred ccceeccCCCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
+-.|.+ ..++|+|||||.| +++.++...+ .++|..++.|+..|+.||.-||+.|+|||||||+|||||..|+|||+
T Consensus 141 hyAFQD--~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 141 HYAFQD--ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred HHHhcC--ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeec
Confidence 888876 7899999999986 6777766666 89999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCCCCccccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 004999 285 DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360 (720)
Q Consensus 285 DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~ 360 (720)
|||.|..+..+........+|||.|.+||+|.. ...|++.+|+|||||++||||.|..||...+-++.+.+|+..-
T Consensus 218 DFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk 297 (1317)
T KOG0612|consen 218 DFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK 297 (1317)
T ss_pred cchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh
Confidence 999999888777777778899999999999952 2558999999999999999999999999999999999997641
Q ss_pred CCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC---HHHHHhCccCCCCCCCCCCC
Q 004999 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFTMKPLPCDPS 437 (720)
Q Consensus 361 g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hp~f~~~~~~~~p~ 437 (720)
- .+. +. ...++|+.+.+||+++| .+|+.|.. ++++-.||||....|..--.
T Consensus 298 ~----------------~l~--------FP-~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~ 351 (1317)
T KOG0612|consen 298 E----------------SLS--------FP-DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRE 351 (1317)
T ss_pred h----------------hcC--------CC-cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhh
Confidence 0 000 00 11358999999999998 68899998 99999999999877754334
Q ss_pred CCCCCCC
Q 004999 438 SLPKYPP 444 (720)
Q Consensus 438 ~~p~~~p 444 (720)
..|++.|
T Consensus 352 ~~pP~vP 358 (1317)
T KOG0612|consen 352 SVPPVVP 358 (1317)
T ss_pred cCCCCCC
Confidence 4444433
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=354.46 Aligned_cols=290 Identities=37% Similarity=0.588 Sum_probs=231.3
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccc
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGL 208 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~ 208 (720)
+.|+..+. ||+|+||.||+|.+..++..||||++............+.+|+.+++++ +||||++++++
T Consensus 7 ~~y~~~~~-----------lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~ 75 (337)
T cd07852 7 RKYEILQK-----------LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV 75 (337)
T ss_pred hHHHHhHh-----------hcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence 45666666 9999999999999999999999999865443444455677899999999 99999999998
Q ss_pred eeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+.......+|+||||+.+++...+.. + .+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~L~~~~~~-~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 76 IKAENDKDIYLVFEYMETDLHAVIRA-N-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred eccCCCceEEEEecccccCHHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 86644567899999999876655443 2 789999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCC----CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 289 ASFYDPDQN----QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 289 a~~~~~~~~----~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
+..+..... .......+|.+|+|||++.+...++.++|||||||++|+|++|++||.+....+.+.++....+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 986643322 1233456899999999987766678999999999999999999999999999899999888888877
Q ss_pred hhhhhhcCCCCccccCCC--CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 365 EDYWRKSKLPHATIFKPQ--QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~--~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
.+.|..........+... ..-.......++.++..+.+||.+||+.||.+|||+.++|+|+||+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 665543211111000000 00011123445568999999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=355.93 Aligned_cols=287 Identities=35% Similarity=0.577 Sum_probs=231.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC----CeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----CSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~----~~lyL 219 (720)
.+...||+|+||.||+|++..++..||||++............+.+|+.+++.+.||||+++++++..... ..+|+
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 44455999999999999999999999999987654444555677899999999999999999987765321 34899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
|+||+++++...+.. ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 98 v~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---- 171 (343)
T cd07851 98 VTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---- 171 (343)
T ss_pred EEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc----
Confidence 999998766555443 46899999999999999999999999999999999999999999999999999865322
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
.....++..|+|||++.+...++.++|||||||++|+|++|++||.+....+.+..+...++.+.+..|.+........+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 251 (343)
T cd07851 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNY 251 (343)
T ss_pred ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHH
Confidence 33456789999999987655578999999999999999999999999999999999999888888877654332222111
Q ss_pred CCCCcc--chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCC
Q 004999 380 KPQQPY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 436 (720)
Q Consensus 380 ~~~~~~--~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p 436 (720)
....+. .......+..++..+.+||.+||+.||.+|||+.++|.||||.....+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~ 310 (343)
T cd07851 252 IQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDE 310 (343)
T ss_pred HHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccc
Confidence 111000 011223345678999999999999999999999999999999977665543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=345.41 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=200.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||+|+||.||++.+..+|+.||+|++...... ......+..|+.++++++||||+++++++.. ...+|+||||+.|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCCC
Confidence 79999999999999999999999999754332 1223445679999999999999999988876 67899999999876
Q ss_pred cccccc-C-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 228 LAGLAS-H-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 ll~~~~-~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+.... . ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...... .......+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~ 156 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRAG 156 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccCC
Confidence 554332 2 2335899999999999999999999999999999999999999999999999999866432 22234568
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. ++.++|||||||++|||++|..||.+.........+....-.. .
T Consensus 157 ~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~--- 214 (277)
T cd05607 157 TNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED------------------E--- 214 (277)
T ss_pred CCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc------------------c---
Confidence 99999999998776 7999999999999999999999997654322111221110000 0
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH----HHHHhCccCCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTMKP 431 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hp~f~~~~ 431 (720)
.......+++++.+||.+||+.||.+|||+ .+++.|+||....
T Consensus 215 ---~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 215 ---VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred ---cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 001123578899999999999999999999 7788999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=373.28 Aligned_cols=259 Identities=23% Similarity=0.326 Sum_probs=214.1
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC------C
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS------C 215 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~------~ 215 (720)
.|++.++||+|+||.||+|++..+++.||||++............+.+|+.++..++|+||++++..+..... .
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 4455556999999999999999999999999998877666777788999999999999999999877653221 2
Q ss_pred eEEEEEeeccccccccccC----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 216 SLYLVFEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
.+++||||+.++.+..+.. ....+++..+..++.||+.||.|||+.||+||||||+||||+.++.+||+|||+++.
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~ 192 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence 4789999999755443322 235689999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 292 YDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 292 ~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
+..... ......+||+.|+|||++.+.. |+.++||||||||||||++|+.||.+.+..+.+..+.....
T Consensus 193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~--------- 262 (496)
T PTZ00283 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY--------- 262 (496)
T ss_pred ccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 543221 2233457899999999998766 79999999999999999999999998877766666543211
Q ss_pred cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+++.+.+||.+||+.||.+|||+.++|.|||+..
T Consensus 263 -------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 263 -------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 1123467889999999999999999999999999999864
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=345.87 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=205.5
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+..++||+|+||.||++.+..+++.||||.+...... ......+.+|+.++++++|+||+.+++.+.. ...+|+|||
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e 80 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLT 80 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEEE
Confidence 3445699999999999999999999999998765432 3334567789999999999999999988876 568999999
Q ss_pred eccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.|+.+..... ....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~ 158 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--TI 158 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--cc
Confidence 998765543332 23468999999999999999999999999999999999999999999999999987653222 22
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.................
T Consensus 159 ~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~----------------- 220 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV----------------- 220 (285)
T ss_pred cCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----------------
Confidence 3457899999999998766 7999999999999999999999998754322111111100000
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
.......+++.+.+||.+||+.||++|+| +.++++||||...
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 221 --------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred --------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 01122457888999999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.70 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=210.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+..++||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+|+.++|+||+.+++++.. ...+|+|||
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e 80 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVLT 80 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEEE
Confidence 3455699999999999999999999999999765432 2334567889999999999999999988876 668999999
Q ss_pred ecccccccccc-C-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLAGLAS-H-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll~~~~-~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.++.+.... . ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~ 158 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESI 158 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC--Ccc
Confidence 99976554333 2 2346999999999999999999999999999999999999999999999999999765322 222
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+........
T Consensus 159 ~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~---------------- 221 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE---------------- 221 (285)
T ss_pred cCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------------
Confidence 3457899999999998765 79999999999999999999999998776655555433221110
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
......++..+.+||..||+.||++||| +.+++.|+||+..
T Consensus 222 ---------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 222 ---------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ---------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 0112457888999999999999999999 8999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=354.24 Aligned_cols=274 Identities=23% Similarity=0.343 Sum_probs=205.8
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||++.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.. ...+||||||+.++.
T Consensus 13 lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~ 89 (333)
T cd06650 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGS 89 (333)
T ss_pred ccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEEEecCCCCc
Confidence 999999999999999999999999987653 34455678999999999999999999999887 678999999999866
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
+..+......+++..+..++.||+.||.|||+. +|+|+||||+||||+.++.+||+|||++..+... ......+|+
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~ 166 (333)
T cd06650 90 LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTR 166 (333)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---ccccCCCCc
Confidence 665555555789999999999999999999975 7999999999999999999999999998755321 123346899
Q ss_pred CCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh--cCCCChhhhhhcCCCCc---cccCCC
Q 004999 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL--CGSPSEDYWRKSKLPHA---TIFKPQ 382 (720)
Q Consensus 308 ~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~--~g~p~~~~w~~~~l~~~---~~~~~~ 382 (720)
.|+|||++.+.. ++.++|||||||++|+|++|+.||......+. ..++.. .+.+............. ..+.+.
T Consensus 167 ~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (333)
T cd06650 167 SYMSPERLQGTH-YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL-ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPD 244 (333)
T ss_pred cccCHHHhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH-HHHhcCcccCCccccccCcccCCccchhhhhccc
Confidence 999999998765 79999999999999999999999987654332 222211 11111100000000000 000000
Q ss_pred -Ccc-------chhhhcc-----cCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 -QPY-------KRCVAET-----FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 -~~~-------~~~~~e~-----~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.+. ...+... ...++.++.+||.+||++||.+|||+.++|.|+||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 245 SRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 0000000 01357889999999999999999999999999999854
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.99 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=208.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||.|++|.||++.+..+++.||+|++..........+.+.+|+.++++++|+||+++++.+... ...+|+||||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e~ 81 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DGLLYIVMGF 81 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CCEEEEEecc
Confidence 445569999999999999999999999999987655555667788999999999999999999876532 4568999999
Q ss_pred ccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+.++.+..+.. ....+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... ....
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~ 160 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-DMAS 160 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC-Cccc
Confidence 98755543332 24468999999999999999999999999999999999999999999999999998764322 2333
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
...+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 161 ~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--------------------- 218 (257)
T cd08223 161 TLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--------------------- 218 (257)
T ss_pred cccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC---------------------
Confidence 456789999999988765 6899999999999999999999998876655444433210
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......+++.+.+||.+||+.||.+|||+.++++||||
T Consensus 219 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 219 -------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 001123578889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=370.55 Aligned_cols=254 Identities=27% Similarity=0.374 Sum_probs=210.0
Q ss_pred cccceeecccCceEEEEEEECCC-CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~t-g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|.+.++||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+|+.++|||||++++++.. ...+||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~ 144 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIM 144 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEE
Confidence 44455699999999999998877 7889999875432 3444567889999999999999999999877 67899999
Q ss_pred eecccccccccc----CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 222 EYMEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 222 Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
||+.|+.+...+ .....+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999876554322 2345689999999999999999999999999999999999999999999999999987643222
Q ss_pred -CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 -QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 -~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......+||+.|+|||++.+.. |+.++||||||||+|||++|..||.+....+.+..+......
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-------------- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-------------- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------
Confidence 1234457899999999998765 799999999999999999999999988877776666432111
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.....++..+.+||.+||..||++|||+.++|.|+|+..
T Consensus 290 --------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 290 --------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred --------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 112357788999999999999999999999999999863
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.37 Aligned_cols=280 Identities=22% Similarity=0.285 Sum_probs=205.5
Q ss_pred eeccc--CceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G--~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+| +|++||++.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+||||++
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~ 82 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSFMA 82 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEEEeccC
Confidence 49999 77899999999999999999998766556667788899999999999999999999877 678999999999
Q ss_pred ccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC------
Q 004999 226 HDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN------ 297 (720)
Q Consensus 226 g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~------ 297 (720)
++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+||+.+........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 162 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH 162 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccc
Confidence 765554432 234589999999999999999999999999999999999999999999999987543321110
Q ss_pred CCccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--------CCChhhh
Q 004999 298 QPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG--------SPSEDYW 368 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g--------~p~~~~w 368 (720)
.......++..|+|||++.+. ..|+.++||||||||+|||++|..||.+..............- .+.++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (327)
T cd08227 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELT 242 (327)
T ss_pred cccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcc
Confidence 011123467789999999764 3479999999999999999999999987655443333221100 0000000
Q ss_pred hhc-------CCCCccccCCCCc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 369 RKS-------KLPHATIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 369 ~~~-------~l~~~~~~~~~~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
... ............+ ...........+++.+.+||.+||++||++|||+.++|+||||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 243 MKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred cCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000 0000000000000 000011122346788999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=356.26 Aligned_cols=239 Identities=26% Similarity=0.444 Sum_probs=204.7
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc-c
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-D 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g-~ 227 (720)
||+|-||.||.|.+..+. .||+|.++...+.. ..|.+|+.||++|+|+|||+|++++.. +..+|||||||.. .
T Consensus 214 LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~--~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTK--QEPIYIVTEYMPKGS 287 (468)
T ss_pred hcCCccceEEEEEEcCCC-cccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEec--CCceEEEEEecccCc
Confidence 999999999999986543 59999998765433 346799999999999999999999987 4579999999985 5
Q ss_pred ccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
|++.+.. .+..+...+.+.++.||++|++||+++++|||||...||||++++.+||+|||||+....+...........
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfP 367 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFP 367 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCC
Confidence 6665554 567899999999999999999999999999999999999999999999999999996655554444444456
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
..|.|||.+.... |+.++|||||||+||||+| |+.|+++.+..+.+..+.+..--
T Consensus 368 IkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl----------------------- 423 (468)
T KOG0197|consen 368 IKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL----------------------- 423 (468)
T ss_pred ceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC-----------------------
Confidence 7799999998877 7999999999999999999 88999999999999988654222
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 422 (720)
..+..+|+.+.+|+..||..+|++|||.+.+.
T Consensus 424 -----p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 424 -----PRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -----CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 23457999999999999999999999998655
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=364.33 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=218.7
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
+-|+++.. ||.|+||.||+|.++.++-..|.|+|... ..+.++.++-||.||..++||+||+|++.|
T Consensus 32 d~WeIiGE-----------LGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ay 98 (1187)
T KOG0579|consen 32 DHWEIIGE-----------LGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAY 98 (1187)
T ss_pred HHHHHHhh-----------hcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHH
Confidence 45677777 99999999999999999988899998654 356678889999999999999999999988
Q ss_pred eccCCCeEEEEEeeccccccccc-cCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 210 TSRMSCSLYLVFEYMEHDLAGLA-SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+. .+.++|+.|||.|+-.+.+ +.-+..|++.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.
T Consensus 99 y~--enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGV 176 (1187)
T KOG0579|consen 99 YF--ENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGV 176 (1187)
T ss_pred hc--cCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccc
Confidence 76 6789999999998765543 34566899999999999999999999999999999999999999999999999998
Q ss_pred ceecCCCCCCCccccccccCCCChhhhc----CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLL----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~----~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
+.... ...+...+++|||+|||||++. ...+|+.++||||||++|.||..+.||-...+..-.+-+|.+. -+
T Consensus 177 SAKn~-~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---eP 252 (1187)
T KOG0579|consen 177 SAKNK-STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EP 252 (1187)
T ss_pred cccch-hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CC
Confidence 86532 2334556789999999999985 3456999999999999999999999999888887777777542 11
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
+. . ..+...+..+.|||..||.+||..||+++++|+||||+..
T Consensus 253 PT-----------L------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 253 PT-----------L------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred Cc-----------c------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 11 1 1122446679999999999999999999999999999854
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=332.07 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=210.2
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++.. ...+|+||||+.
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 82 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVMEYAE 82 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEEEeCC
Confidence 345999999999999999999999999998766666667788999999999999999999999876 578999999998
Q ss_pred ccccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 226 HDLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 226 g~ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
|..+..+... ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++..+.... ......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~~~~~ 161 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NFANTI 161 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc-chhhcc
Confidence 7655444332 4578999999999999999999999999999999999999999999999999998764332 222344
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
.+++.|+|||++.+.. ++.++|||||||++|+|++|..||......+....+.....
T Consensus 162 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------- 218 (256)
T cd08529 162 VGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF---------------------- 218 (256)
T ss_pred ccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----------------------
Confidence 6789999999998766 78999999999999999999999988876665555433110
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......++..+.++|.+||+.+|++||++.++++|||+
T Consensus 219 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 ------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 01112567889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=350.28 Aligned_cols=286 Identities=36% Similarity=0.570 Sum_probs=219.5
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC-------
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS------- 214 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~------- 214 (720)
.|++.+.||.|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 34555569999999999999999999999999876543 345667899999999999999999987654321
Q ss_pred -----CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-CCceeeecccc
Q 004999 215 -----CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGL 288 (720)
Q Consensus 215 -----~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-~g~vKL~DFGl 288 (720)
..+|+||||+++++...+. ...+++..++.++.||+.||.|||+.||+|+||||+||||+. ++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 3579999999986654443 236899999999999999999999999999999999999974 56789999999
Q ss_pred ceecCCCCC--CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 289 ASFYDPDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 289 a~~~~~~~~--~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
+..+..... .......++..|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 976532211 111233578899999988765567899999999999999999999999998888888877665544443
Q ss_pred hhhhc--CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 367 YWRKS--KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 367 ~w~~~--~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
.+... ..+... ...............+.++.++.+||.+||+.||.+|||+.++|.|+||+....
T Consensus 242 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~ 308 (342)
T cd07854 242 DRNELLNVIPSFV-RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSC 308 (342)
T ss_pred Hhhhhhhhhhhhh-hhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccC
Confidence 22211 000000 000111111233345578899999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.05 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=205.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
...++||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++.......+|++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 344459999999999999999999999999876532 23445678899999999999999999998876445678999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC--CC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ--NQ 298 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~--~~ 298 (720)
|||+.++.+..+......+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++..+.... ..
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGT 164 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCC
Confidence 9999976665555545568999999999999999999999999999999999999999999999999987653211 11
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......++..|+|||++.+.. ++.++|||||||++|||++|++||........+.++.. .+.
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~~-------------- 226 (266)
T cd06651 165 GIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT-------------- 226 (266)
T ss_pred ccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CCC--------------
Confidence 122345788999999998765 78999999999999999999999987655554443321 110
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
.......+++.+.+|| .||..+|++|||+.++++||||+
T Consensus 227 ----------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ----------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0111234677888998 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=350.38 Aligned_cols=286 Identities=34% Similarity=0.519 Sum_probs=223.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~ly 218 (720)
|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++++++.... ...+|
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 33444599999999999999999999999999765444444567889999999999999999999875421 24578
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
++++++.+++...+.. ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 99 lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~---- 172 (345)
T cd07877 99 LVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---- 172 (345)
T ss_pred EEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc----
Confidence 9999987766544332 3589999999999999999999999999999999999999999999999999875422
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......++++|+|||++.+...++.++|||||||++|+|++|.+||.+......+..+....+.+....+..........
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T cd07877 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 252 (345)
T ss_pred cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence 22345678999999998875557999999999999999999999999988888888888888877766654321110000
Q ss_pred cCCC--CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 379 FKPQ--QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 379 ~~~~--~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
+... ..........+...++.+.+||..||+.||.+|+|+.++|.||||.....|.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 253 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred HHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 0000 0000011222335688899999999999999999999999999998765544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=350.89 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=193.6
Q ss_pred ccceeecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
++.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+|..+ +||||+++++++... ...+
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~ 87 (338)
T cd05102 10 RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKP-NGPL 87 (338)
T ss_pred eeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-CCce
Confidence 33445999999999999752 445789999987543 334456789999999999 899999999987643 4568
Q ss_pred EEEEeeccccccccccCC--------------------------------------------------------------
Q 004999 218 YLVFEYMEHDLAGLASHP-------------------------------------------------------------- 235 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~-------------------------------------------------------------- 235 (720)
|+||||++++.+..+...
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 999999997544322211
Q ss_pred CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-CccccccccCCCChhh
Q 004999 236 GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPEL 314 (720)
Q Consensus 236 ~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~ 314 (720)
...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++......... ......+++.|+|||+
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 247 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence 124788999999999999999999999999999999999999999999999999865322111 1122345678999999
Q ss_pred hcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhccc
Q 004999 315 LLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETF 393 (720)
Q Consensus 315 l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~ 393 (720)
+.+.. |+.++||||||||||||++ |.+||.+....+.+...+.. +.. ....
T Consensus 248 ~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~--------------------------~~~~ 299 (338)
T cd05102 248 IFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTR--------------------------MRAP 299 (338)
T ss_pred hhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCC--------------------------CCCC
Confidence 98765 7999999999999999997 99999886544443333221 000 0112
Q ss_pred CCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 394 KDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 394 ~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
..+++.+.+||.+||+.||.+|||+.++++
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 300 ENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 357888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.52 Aligned_cols=262 Identities=27% Similarity=0.348 Sum_probs=213.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||+|+||.||+|.+..+++.||||.+...... ....+.+..|+.+++.++|+||+++++.+.. ...+|+|||
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 81 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCLVMD 81 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEEEEE
Confidence 3344599999999999999999999999999876543 2456778999999999999999999998876 678999999
Q ss_pred eccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC--
Q 004999 223 YMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-- 298 (720)
Q Consensus 223 y~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-- 298 (720)
|+.|+.+..+.. .+..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++.........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccc
Confidence 998765554443 2357999999999999999999999999999999999999999999999999998754322110
Q ss_pred --------------------------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHH
Q 004999 299 --------------------------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 352 (720)
Q Consensus 299 --------------------------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~ 352 (720)
.....+||..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred cccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 111236788999999998765 69999999999999999999999998887766
Q ss_pred HHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC----HHHHHhCccCC
Q 004999 353 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS----AASALRSEFFT 428 (720)
Q Consensus 353 l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT----a~e~L~hp~f~ 428 (720)
+..+...-.. ......++..+.+||.+||..||++||| +.++|.|+||+
T Consensus 241 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~ 293 (316)
T cd05574 241 FSNILKKEVT---------------------------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293 (316)
T ss_pred HHHHhcCCcc---------------------------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhh
Confidence 6555321000 0011237889999999999999999999 99999999999
Q ss_pred CCCCCCC
Q 004999 429 MKPLPCD 435 (720)
Q Consensus 429 ~~~~~~~ 435 (720)
...++.-
T Consensus 294 ~~~~~~~ 300 (316)
T cd05574 294 GVNWALI 300 (316)
T ss_pred cCChhhc
Confidence 8765543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=384.83 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=208.2
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
..||.|+||.||+|.+..++..||+|++............+..|+.+|+.|+|||||+++++|.......+||||||+.+
T Consensus 19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 33999999999999999999999999998776666667788999999999999999999998876556789999999997
Q ss_pred cccccccC----CCCCCCHHHHHHHHHhhhhcccccccc-------CcccccCcceeEEEcC-----------------C
Q 004999 227 DLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSR-------GVLHRDIKGSNLLIDN-----------------N 278 (720)
Q Consensus 227 ~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~-------gIvHrDIKP~NILld~-----------------~ 278 (720)
+.|..++. ....+++..++.|+.||+.||.|||+. +|||+||||+||||+. .
T Consensus 99 GSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~ 178 (1021)
T PTZ00266 99 GDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178 (1021)
T ss_pred CcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCC
Confidence 55443332 235799999999999999999999985 4999999999999964 3
Q ss_pred CceeeeccccceecCCCCCCCccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 004999 279 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357 (720)
Q Consensus 279 g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~ 357 (720)
+.+||+|||++..+.... .....++|+.|+|||++.+. ..|+.++||||||||||||++|..||........+..++
T Consensus 179 ~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~l 256 (1021)
T PTZ00266 179 PIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISEL 256 (1021)
T ss_pred CceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHH
Confidence 458999999998653321 22345789999999998753 347899999999999999999999998776655554443
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
... | . ..+..++..+.+||..||.++|.+|||+.++|.|+||....
T Consensus 257 k~~--p------------------~--------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 257 KRG--P------------------D--------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred hcC--C------------------C--------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 211 0 0 01134678899999999999999999999999999997543
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=347.11 Aligned_cols=288 Identities=35% Similarity=0.565 Sum_probs=227.5
Q ss_pred ccceeecccCceEEEEEEECCC--CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceecc--CCCeEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQ--KKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSR--MSCSLY 218 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~t--g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~--~~~~ly 218 (720)
.+.++||+|+||.||++.+..+ +..||||++............+.+|+.+++++ +||||+++++++... ....+|
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 4455699999999999999888 89999999875433334456678999999999 599999999865321 134689
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN- 297 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~- 297 (720)
++|||+++++...+. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 83 ~~~e~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 161 (332)
T cd07857 83 LYEELMEADLHQIIR-SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161 (332)
T ss_pred EEEecccCCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccc
Confidence 999999987666554 345799999999999999999999999999999999999999999999999999986543221
Q ss_pred --CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 298 --QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 298 --~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+......+..++..+|.|..+.+.....+.
T Consensus 162 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (332)
T cd07857 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241 (332)
T ss_pred ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhh
Confidence 112335689999999998775557999999999999999999999999999999999999999988876655432221
Q ss_pred ccccCC---CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 376 ATIFKP---QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 376 ~~~~~~---~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
...+.. ..+ ...+....+.++..+.+||.+||+.||.+|||+.++|.||||+.+..+
T Consensus 242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 242 AQNYIRSLPNIP-KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred HHHHHHhccccC-CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 111000 000 011222334568899999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=336.09 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=206.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccC--CCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM--SCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~--~~~lyLV~Ey 223 (720)
++||-|-.|.|..+.++.|++.+|+|++... ....+|+++.-.. .|||||.++++|.... ...+.+|||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 3699999999999999999999999998632 2346788876665 6999999999987533 3468899999
Q ss_pred ccccccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeeccccceecCCCCCC
Q 004999 224 MEHDLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 224 ~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~~~~~~~~ 298 (720)
|+|+.+...... ...|+|.++..|++||..|+.|||+.+|.||||||+|+|... |..+||+|||+|+... ...
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~--~~~ 218 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ--EPG 218 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC--CCc
Confidence 998655444333 345999999999999999999999999999999999999964 5579999999998653 244
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCChhhhhhcCCC
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV----EQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~----e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
.+.+.|.||.|.|||++-... |+...|+||+|||+|.||||.|||...... ....+|....+..+.+.|
T Consensus 219 ~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW------ 291 (400)
T KOG0604|consen 219 DLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW------ 291 (400)
T ss_pred cccCCcccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH------
Confidence 567778999999999887666 899999999999999999999999876543 234455554445555555
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
..+++.+++||++||..+|++|.|+.+++.|||+.+..
T Consensus 292 -------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 292 -------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred -------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 35889999999999999999999999999999998754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=334.42 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=206.6
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
+.|..++. ||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++
T Consensus 9 ~~~~~~~~-----------lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~ 75 (267)
T cd06645 9 EDFELIQR-----------IGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75 (267)
T ss_pred HHHHHHHH-----------hCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 46777777 999999999999999999999999987653 23345578899999999999999999988
Q ss_pred eccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 210 TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
.. ...+|+||||++++.+..+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++
T Consensus 76 ~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 76 LR--RDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred Ee--CCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceee
Confidence 76 6789999999998666555555567999999999999999999999999999999999999999999999999998
Q ss_pred eecCCCCCCCccccccccCCCChhhhc--CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFYDPDQNQPLTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~~~~~~~~~t~~~gT~~Y~APE~l~--~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
...... ........+++.|+|||++. ....++.++|||||||++|+|++|.+||........+..+......+
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~---- 228 (267)
T cd06645 154 AQITAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP---- 228 (267)
T ss_pred eEccCc-ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC----
Confidence 765422 22233457899999999974 23347889999999999999999999887655443333221110000
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
. .......++..+.+||.+||+.||++|||+.++|+|||
T Consensus 229 --------------~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 229 --------------P------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --------------C------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 00011246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=336.62 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=207.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++.. ....|+||||+.++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~~~~~ 87 (282)
T cd06643 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGG 87 (282)
T ss_pred hcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEecCCC
Confidence 4999999999999999999999999986432 4556678899999999999999999998876 57899999999987
Q ss_pred cccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
++..+. .....+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...... ........+|
T Consensus 88 ~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~ 166 (282)
T cd06643 88 AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGT 166 (282)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-cccccccccc
Confidence 665443 33457899999999999999999999999999999999999999999999999998754322 2222345679
Q ss_pred cCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 307 LWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 307 ~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
+.|+|||++.. ...++.++|||||||++|+|++|.+||...+..+....+.......
T Consensus 167 ~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 227 (282)
T cd06643 167 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------------------- 227 (282)
T ss_pred ccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-------------------
Confidence 99999999852 2346789999999999999999999998877666655553321000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.||.+|||+.++++||||...
T Consensus 228 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 228 -------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred -------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 01123467889999999999999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=343.75 Aligned_cols=279 Identities=32% Similarity=0.541 Sum_probs=232.4
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC----CeEEEEEeec
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----CSLYLVFEYM 224 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~----~~lyLV~Ey~ 224 (720)
+|.|+- .|..|.|..+++.||+|++..........++..+|..++..+.|+||++++.+|+.... ..+|+|||||
T Consensus 25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m 103 (369)
T KOG0665|consen 25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM 103 (369)
T ss_pred cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh
Confidence 899998 89999999999999999987765556677888999999999999999999999875322 3589999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
.+++-..... .++...+..++.|++.|+.|||+.||+||||||+||+|..++.+||.|||+|+..+.+ ..++.++
T Consensus 104 ~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~mtpyV 178 (369)
T KOG0665|consen 104 DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FMMTPYV 178 (369)
T ss_pred hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc--cccCchh
Confidence 9988776663 5688999999999999999999999999999999999999999999999999875443 5678899
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+|..|+|||++.+-. |...+||||+|||+.||++|+.+|+|....+++.++...+|.|.+.|..+..-..+..+.+...
T Consensus 179 vtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~ 257 (369)
T KOG0665|consen 179 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQ 257 (369)
T ss_pred heeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChH
Confidence 999999999999988 8999999999999999999999999999999999999999999999976633222221111111
Q ss_pred cc-hhhhcccC------------CCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 385 YK-RCVAETFK------------DFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 385 ~~-~~~~e~~~------------~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
|. ....+.++ .-...+++|+.+||..||++|.++.++|+||||+.+..+.
T Consensus 258 y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ 320 (369)
T KOG0665|consen 258 YQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPD 320 (369)
T ss_pred hhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccc
Confidence 11 11111121 2234589999999999999999999999999998654433
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=335.36 Aligned_cols=279 Identities=40% Similarity=0.660 Sum_probs=221.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc---CCCceeeeccceeccCC---CeE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTSRMS---CSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIvkl~~~~~~~~~---~~l 217 (720)
++.+.||.|+||.||+|.+..+++.||||+++...........+.+|+.+++++ +|+||+++++++..... ..+
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 345569999999999999998899999999986544333345566788887776 59999999999876322 248
Q ss_pred EEEEeeccccccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 218 YLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
|++|||+.+++...+... ...+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++..+....
T Consensus 82 ~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~ 161 (287)
T cd07838 82 TLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161 (287)
T ss_pred EEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc
Confidence 999999998765544332 2368999999999999999999999999999999999999999999999999998764322
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......++..|+|||++.+.. ++.++|||||||++|+|++|.++|.+.+..+.+.+++...+.+....|........
T Consensus 162 --~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07838 162 --ALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238 (287)
T ss_pred --ccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence 223345788999999998766 79999999999999999999999999999999999988877766655543221111
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
..+.. ..........+.++..+.+||..||+.||.+||++.++|.||||
T Consensus 239 ~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 SSFPS--YTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhccc--ccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 11111 11112234445678889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.58 Aligned_cols=256 Identities=24% Similarity=0.435 Sum_probs=214.3
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
+-|..+++ ||+|+||.||+|.++++|..||||.+..+ ..+..+..||.||++++.|+||++||-|
T Consensus 33 EVFDi~~K-----------LGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSY 97 (502)
T KOG0574|consen 33 EVFDIVGK-----------LGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSY 97 (502)
T ss_pred HHHHHHHH-----------hcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhh
Confidence 45778888 99999999999999999999999998754 3567789999999999999999999977
Q ss_pred eccCCCeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 210 TSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
.. ...+|||||||+.+ ..+.+..++..|+|.++..+++..+.||+|||...-+|||||..|||++-+|..||+|||.
T Consensus 98 FK--~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 98 FK--HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred cc--CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccc
Confidence 66 56799999999954 4455556778999999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w 368 (720)
|.-+... -....+.+|||.|||||++..-. |+..+||||||++..||..|+|||........+..| -..|++.|
T Consensus 176 AGQLTDT-MAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPTF- 249 (502)
T KOG0574|consen 176 AGQLTDT-MAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPTF- 249 (502)
T ss_pred cchhhhh-HHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCCC-
Confidence 9766432 22334568999999999998765 899999999999999999999999776554333222 11221111
Q ss_pred hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..+...+.++.|||++||.++|++|-||.++++|+|++..
T Consensus 250 ----------------------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 250 ----------------------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred ----------------------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 1123457789999999999999999999999999999864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=333.01 Aligned_cols=251 Identities=29% Similarity=0.525 Sum_probs=206.9
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-------HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-------PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-------~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
..+||.|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.++++++||||+++++++.. ...++
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 82 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--ADHLN 82 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCccE
Confidence 34699999999999999989999999998754331 1234568899999999999999999998876 67889
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN- 297 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~- 297 (720)
+||||+.+..+..+......+++..+..++.||+.||.|||++|++|+||+|+||||+.++.+||+|||++........
T Consensus 83 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS 162 (267)
T ss_pred EEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccccc
Confidence 9999999876666665556789999999999999999999999999999999999999999999999999986642211
Q ss_pred ----CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 298 ----QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 298 ----~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
.......++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 163 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 228 (267)
T cd06628 163 TKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA------------- 228 (267)
T ss_pred CCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-------------
Confidence 1112345788999999988765 6899999999999999999999998876655444432210
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......++..+.+||.+||+.||.+||++.++++|+||
T Consensus 229 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 229 ---------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ---------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 111224578899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.93 Aligned_cols=264 Identities=30% Similarity=0.481 Sum_probs=213.8
Q ss_pred CCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeee
Q 004999 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 205 (720)
Q Consensus 127 ~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl 205 (720)
.+...|+++++ ||.||.+.||++... ....||+|++.....+...+.-+.+||..|.+| .|.+||+|
T Consensus 358 Vkg~~Yeilk~-----------iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL 425 (677)
T KOG0596|consen 358 VKGREYEILKQ-----------IGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQL 425 (677)
T ss_pred ECcchhhHHHh-----------hcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEE
Confidence 34567888888 999999999999864 456688888887777889999999999999999 59999999
Q ss_pred ccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeec
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 285 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~D 285 (720)
++|-.. ++.+|+||||-+.+|...+......++.-.++.|..|++.++.++|.+||||.||||.|+|+ -.|.+||+|
T Consensus 426 ~DYEv~--d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLID 502 (677)
T KOG0596|consen 426 YDYEVT--DGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLID 502 (677)
T ss_pred eeeecc--CceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeee
Confidence 998666 78999999999999988887766666666999999999999999999999999999999998 578999999
Q ss_pred cccceecCCCCCC-CccccccccCCCChhhhcCCc----------CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHH
Q 004999 286 FGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGAT----------YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLH 354 (720)
Q Consensus 286 FGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~----------~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~ 354 (720)
||+|..+..+... ...+.+||+.||+||.+.... ..+.++||||||||||+|+.|++||..-. .++.
T Consensus 503 FGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~a 580 (677)
T KOG0596|consen 503 FGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIA 580 (677)
T ss_pred echhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHH
Confidence 9999988665543 334679999999999986322 14679999999999999999999995432 2333
Q ss_pred HHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCC--HhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 355 KIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFP--APALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 355 ~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~--~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
++..+ ..|. . .-.|+.++ .++.++++.||..||.+|||+.++|+|||++..+.
T Consensus 581 Kl~aI-~~P~------------------~------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i 635 (677)
T KOG0596|consen 581 KLHAI-TDPN------------------H------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPI 635 (677)
T ss_pred HHHhh-cCCC------------------c------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccc
Confidence 33322 1111 0 01122232 23899999999999999999999999999985443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=336.23 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=212.5
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
+.|+.+++ ||.|+||.||++.+..++..||+|++... .......+.+|+.++++++||||+++++++
T Consensus 5 ~~~~i~~~-----------l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (280)
T cd06611 5 DIWEIIGE-----------LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAY 71 (280)
T ss_pred hHHHHHHH-----------hcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence 46778888 99999999999999889999999998754 345566788999999999999999999998
Q ss_pred eccCCCeEEEEEeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 210 TSRMSCSLYLVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
.. ...+|+||||++++.+..+. ..+..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||+
T Consensus 72 ~~--~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~ 149 (280)
T cd06611 72 FY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGV 149 (280)
T ss_pred ec--CCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCcc
Confidence 76 67899999999986665444 3345799999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
+...... ........+|+.|+|||++.. ...++.++|||||||++|+|++|++||.+......+..+.... .+
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~- 226 (280)
T cd06611 150 SAKNKST-LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-PP- 226 (280)
T ss_pred chhhccc-ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC-CC-
Confidence 8754322 222234567999999999853 2336789999999999999999999998877666555543210 00
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......++..+.+||..||+.||.+||++.++|+|+||...
T Consensus 227 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 ------------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ------------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 001123567889999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=336.82 Aligned_cols=252 Identities=20% Similarity=0.339 Sum_probs=204.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|.+..++..||+|.++.. ........+.+|+.++++++|+||+++++.+.. ...+|+||||++++.
T Consensus 9 ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~ 85 (286)
T cd06622 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGS 85 (286)
T ss_pred hcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEEeecCCCC
Confidence 99999999999999999999999998754 234445678899999999999999999998876 678999999999876
Q ss_pred cccccCC---CCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 229 AGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 229 l~~~~~~---~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+..+... ...+++..+..++.||+.||.|||+ .||+|+||||+|||++.++.+||+|||++..+... ......
T Consensus 86 l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 162 (286)
T cd06622 86 LDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNI 162 (286)
T ss_pred HHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC---ccccCC
Confidence 6555443 2378999999999999999999996 59999999999999999999999999998765321 122345
Q ss_pred cccCCCChhhhcCCc-----CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 305 VTLWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 305 gT~~Y~APE~l~~~~-----~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
+++.|+|||++.+.. .++.++|||||||++|+|++|..||...........+.......
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 226 (286)
T cd06622 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD---------------- 226 (286)
T ss_pred CccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC----------------
Confidence 788999999986532 25789999999999999999999997655444333332221111
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.......++..+.+||.+||+.+|.+||++.+++.||||....
T Consensus 227 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 227 ---------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ---------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 0112345788999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=339.15 Aligned_cols=252 Identities=27% Similarity=0.390 Sum_probs=210.8
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+..+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.++++++||||+++++++.. ...+|+|||
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e 81 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYLVME 81 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEEEEe
Confidence 344569999999999999999999999999876433 33456778899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.++.+..+......+++..+..++.||+.||.|||+.||+|+||+|+||||+.++.+||+|||++...... ...
T Consensus 82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~~~ 157 (290)
T cd05580 82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYT 157 (290)
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----CCC
Confidence 9976655555555568999999999999999999999999999999999999999999999999999865432 233
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+++.|+|||.+.+.. ++.++|||||||++|+|++|..||...........+... .+
T Consensus 158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------------------- 215 (290)
T cd05580 158 LCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--KV------------------- 215 (290)
T ss_pred CCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc-------------------
Confidence 46789999999987765 689999999999999999999999887755555544321 00
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMKP 431 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~~ 431 (720)
.....++..+.+||.+||..||.+|+ ++++++.||||....
T Consensus 216 --------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 216 --------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred --------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 11234688899999999999999999 999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=334.83 Aligned_cols=249 Identities=27% Similarity=0.427 Sum_probs=199.5
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|++..+++.||+|++..... .....+.+|+.++++++||||+++++++.. ...+|+||||++++.
T Consensus 17 lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv~e~~~~~~ 92 (267)
T cd06646 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWICMEYCGGGS 92 (267)
T ss_pred eecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEEEeCCCCCc
Confidence 9999999999999999999999999975432 234567899999999999999999998876 578999999999876
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
+..+......+++.++..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++..+.... .......+++.
T Consensus 93 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~ 171 (267)
T cd06646 93 LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-AKRKSFIGTPY 171 (267)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc-cccCccccCcc
Confidence 66555555678999999999999999999999999999999999999999999999999998653221 12234467889
Q ss_pred CCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 309 YRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 309 Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
|+|||.+.+ ...++.++|||||||++|||++|.+||......+....+.+.. +.+.
T Consensus 172 y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~------------------~~~~---- 229 (267)
T cd06646 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSN------------------FQPP---- 229 (267)
T ss_pred ccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCC------------------CCCC----
Confidence 999998853 3336889999999999999999999886554333222111100 0000
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
.......++..+.+||.+||..||++|||++++|+|.|
T Consensus 230 --~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 230 --KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00112356789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=347.15 Aligned_cols=268 Identities=26% Similarity=0.405 Sum_probs=222.7
Q ss_pred hhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH-HHHHHHHHHHHHHHhcCCCceeeeccceeccCC
Q 004999 136 DKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 214 (720)
Q Consensus 136 ~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~ 214 (720)
...+.+.++..++||+|+||.||-++-..||+.||+|.+.+..+.. ......++|-.||.+++.+.||.+--.|.+ .
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--k 257 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET--K 257 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--C
Confidence 4456678888899999999999999999999999999987655422 223345789999999999999999777766 6
Q ss_pred CeEEEEEeeccc-cccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 215 CSLYLVFEYMEH-DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 215 ~~lyLV~Ey~~g-~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
..+||||..|+| +|..++..- ++.|+|..++.|+.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|||..+
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence 789999999997 555555443 357999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
. ..++.+..+||..|||||++.+.. |+...|.|||||+||||+.|+.||....+..-...+-+..-.-+
T Consensus 338 ~--~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~-------- 406 (591)
T KOG0986|consen 338 P--EGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP-------- 406 (591)
T ss_pred C--CCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--------
Confidence 4 455667789999999999999888 89999999999999999999999987665444433332211111
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCCCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMKPLP 433 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~~~~ 433 (720)
.+....+++++++|.+.+|++||.+|. .+.++.+||||+...+.
T Consensus 407 -----------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~ 455 (591)
T KOG0986|consen 407 -----------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR 455 (591)
T ss_pred -----------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence 122357899999999999999999996 47899999999986654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.41 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=210.1
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
+.|+.++. ||.|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++
T Consensus 12 ~~y~i~~~-----------lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 78 (292)
T cd06644 12 EVWEIIGE-----------LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAF 78 (292)
T ss_pred hhhhhhhe-----------ecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence 45666666 99999999999999999999999998754 345567788999999999999999999988
Q ss_pred eccCCCeEEEEEeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 210 TSRMSCSLYLVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
.. ...+|+||||++++++..+. .....+++..++.++.||+.+|.|||++||+|+||||+||+++.++.+||+|||+
T Consensus 79 ~~--~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 156 (292)
T cd06644 79 YW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV 156 (292)
T ss_pred Ee--CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcc
Confidence 76 56899999999987665433 3345689999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
+...... ........+++.|+|||++.+ ...++.++|||||||++|+|++|.+||.+.+....+.++.+.. .+
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~- 233 (292)
T cd06644 157 SAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PP- 233 (292)
T ss_pred ceecccc-ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCC-Cc-
Confidence 8754321 222234567889999999853 2336889999999999999999999998776555444442210 00
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||..||++||++.++|+||||...
T Consensus 234 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 234 ------------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred ------------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 001123567889999999999999999999999999999743
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=344.15 Aligned_cols=280 Identities=25% Similarity=0.409 Sum_probs=217.6
Q ss_pred ccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC--C----ceeeeccceeccC
Q 004999 140 SIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--I----NVIKLEGLVTSRM 213 (720)
Q Consensus 140 ~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H--p----nIvkl~~~~~~~~ 213 (720)
.+.|.++.+||+|+||.|..+.|..++..||||+++.- ....+..+-||.+|.+|.+ | -+|.+.++|.-
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-- 162 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-- 162 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--
Confidence 34444444599999999999999999999999998743 2334455679999999942 2 36777777765
Q ss_pred CCeEEEEEeeccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---------------
Q 004999 214 SCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--------------- 277 (720)
Q Consensus 214 ~~~lyLV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~--------------- 277 (720)
.+++|||+|.++-++.+.+.. .-.+|+..+++.+++||++++.|||+.+++|.||||+|||+.+
T Consensus 163 rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 163 RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 688999999999777766655 3457999999999999999999999999999999999999942
Q ss_pred -----CCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHH
Q 004999 278 -----NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ 352 (720)
Q Consensus 278 -----~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~ 352 (720)
+..|||+|||.|..... ..+..+.|..|+|||++++-+ ++..+||||+||||+||.||..+|.+.++.|+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 33689999999986432 236678899999999999987 89999999999999999999999999999999
Q ss_pred HHHHHHhcCCCChhhhhhc---------CCCCccccC---------CCCccchhhhcccCCCCHhHHHHHHHhcccCCCC
Q 004999 353 LHKIFKLCGSPSEDYWRKS---------KLPHATIFK---------PQQPYKRCVAETFKDFPAPALALMETLLSIDPAD 414 (720)
Q Consensus 353 l~~i~~~~g~p~~~~w~~~---------~l~~~~~~~---------~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k 414 (720)
+..+...+|..+.....+. .+.+..... +..|....... -...-..+.|||++||.+||.+
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~-~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ-DDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc-CcHHHhHHHHHHHHHHccCccc
Confidence 9999999997666553332 222111111 11111111000 0011235889999999999999
Q ss_pred CCCHHHHHhCccCCCC
Q 004999 415 RGSAASALRSEFFTMK 430 (720)
Q Consensus 415 RpTa~e~L~hp~f~~~ 430 (720)
|+|+.|+|.||||+..
T Consensus 397 RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 397 RITLREALSHPFFARL 412 (415)
T ss_pred cccHHHHhcCHHhhcC
Confidence 9999999999999853
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.11 Aligned_cols=277 Identities=36% Similarity=0.648 Sum_probs=223.3
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.+.||.|++|.||+|.+..+++.||||++........ .....+|+..+++++ |+||+++++++.. ....|+||||
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~ 79 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFEY 79 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEec
Confidence 34459999999999999999999999999875433222 223457999999999 9999999999877 6789999999
Q ss_pred ccccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 224 MEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 224 ~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
+.+++...+.... ..+++.+++.++.||+.+|.|||++||+|+||+|+||+|+.++.++|+|||++...... .....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~~~~~ 157 (283)
T cd07830 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--PPYTD 157 (283)
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC--CCcCC
Confidence 9877766555433 47899999999999999999999999999999999999999999999999999865432 22234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..++..|+|||++.+...++.++|+|||||+++||++|+++|++....+.+.++....+.+....|......... +...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 236 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK-LGFR 236 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc-cccc
Confidence 567889999999876666799999999999999999999999999999999999999998887776543211110 0000
Q ss_pred Cc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 383 QP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 383 ~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.+ ....+...+...+..+.+||.+||+.||.+|||+.|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 0011223344557889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=322.03 Aligned_cols=281 Identities=31% Similarity=0.566 Sum_probs=231.7
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeec
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLE 206 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~ 206 (720)
..++|+.+.+ +|+|.|+.||.|.+..+++.++||+++. ...+.+.+|+.||..|. ||||++|+
T Consensus 36 ~~ddYeivrk-----------~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~ 99 (338)
T KOG0668|consen 36 NQDDYEIVRK-----------VGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLL 99 (338)
T ss_pred ccchHHHHHH-----------HcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehh
Confidence 5688999999 9999999999999999999999999874 44567899999999996 99999999
Q ss_pred cceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-Cceeeec
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIAD 285 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~D 285 (720)
++..+..+....||+||++......+. ..|+.-.++.++.+|+.||.|||+.||+|||+||.|++||.. -.++|+|
T Consensus 100 DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlID 176 (338)
T KOG0668|consen 100 DIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLID 176 (338)
T ss_pred hhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeee
Confidence 999988888899999999974433332 257889999999999999999999999999999999999865 4699999
Q ss_pred cccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCC
Q 004999 286 FGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 286 FGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
+|+|.++.+.. ....++.+..|--||+|..-..|+...|+|||||+|+.|+..+ |.|.|.++.+|+.+|.+.+|+..
T Consensus 177 WGLAEFYHp~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~e 254 (338)
T KOG0668|consen 177 WGLAEFYHPGK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDE 254 (338)
T ss_pred cchHhhcCCCc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHH
Confidence 99999886543 3455677899999999999888999999999999999998866 77889999999999999999754
Q ss_pred hh-hhhhcCCCCcccc------CCCCccchhhhcccC-CCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 365 ED-YWRKSKLPHATIF------KPQQPYKRCVAETFK-DFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 365 ~~-~w~~~~l~~~~~~------~~~~~~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.. +..+..+.....+ -...++...+...-. -+++++.|||.++|.+|-.+|+||.|++.||||..
T Consensus 255 l~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 255 LYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 32 2333222211111 122333333332222 35699999999999999999999999999999974
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.15 Aligned_cols=243 Identities=21% Similarity=0.208 Sum_probs=202.6
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceec--cCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTS--RMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~--~~~~~lyLV~Ey~ 224 (720)
.||+|+++.||+|.+ +|+.||||+++.... .....+.+.+|+.+|++++||||+++++++.+ .....+++||||+
T Consensus 27 ~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 27 LIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred EEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 599999999999987 688999999986544 33445778899999999999999999998866 3345789999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
.++.+..+......+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..+... ....
T Consensus 105 ~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~----~~~~ 180 (283)
T PHA02988 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP----PFKN 180 (283)
T ss_pred CCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc----cccc
Confidence 9877766666666899999999999999999999984 9999999999999999999999999999865321 1234
Q ss_pred ccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
++|..|+|||++.+. ..|+.++|||||||++|||++|..||.+.+..+.+..+......+
T Consensus 181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------------- 241 (283)
T PHA02988 181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL------------------- 241 (283)
T ss_pred cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-------------------
Confidence 678999999998762 347999999999999999999999999887776666654321111
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||.+||+.||.+|||+.++|+
T Consensus 242 --------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 --------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred --------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 011257889999999999999999999999986
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=342.75 Aligned_cols=277 Identities=22% Similarity=0.289 Sum_probs=208.3
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||++.+..++..||+|.+.... .......+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ey 80 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICMEH 80 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEeec
Confidence 34445999999999999999999999999987542 34455678899999999999999999999876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
++++.+..+......+++..+..++.||+.||.|||+ .+|+|+||||+|||++.++.+||+|||++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 157 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 157 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---cccc
Confidence 9987666665555678999999999999999999997 59999999999999999999999999998754322 1234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.++++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+... ...++........ +..............
T Consensus 158 ~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 233 (308)
T cd06615 158 FVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGE--AKESHRPVSGHPPDS 233 (308)
T ss_pred CCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCcccccc--ccCCcccccCCCCCc
Confidence 57789999999987765 7999999999999999999999998765333 2222221110000 000000000000000
Q ss_pred ---Ccc----chhhhc-----ccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 ---QPY----KRCVAE-----TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ---~~~----~~~~~e-----~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
... .....+ ....++.++.+||.+||..||++|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000 000000 011367889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=334.07 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=212.7
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+||+|+|+.|-.+....+|..||||++.+. ......++.+|++++.++ .|+||++|+++|++ +..+|||||-|.|
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~G 160 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMRG 160 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEecccC
Confidence 599999999999999999999999999865 334566788999999999 59999999999987 7789999999997
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC---ceeeeccccceecC------CCCC
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASFYD------PDQN 297 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g---~vKL~DFGla~~~~------~~~~ 297 (720)
+.+-..+.....|+|.++..++++|+.||.|||.+||.||||||+|||..+.. -||||||.|..-.. +...
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 64433344566899999999999999999999999999999999999996554 48999999886432 1222
Q ss_pred CCccccccccCCCChhhhc----CCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---------------HHHHHHHHH
Q 004999 298 QPLTSRVVTLWYRPPELLL----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------------VEQLHKIFK 358 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~----~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---------------~e~l~~i~~ 358 (720)
..+.+.+|+..|||||+.. ....|+.+.|+||||+|||.||+|.+||.|... ....+.|..
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE 320 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE 320 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence 3345668899999999874 355699999999999999999999999998653 234455555
Q ss_pred hcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.-+..+++.| ..++.++.+||..+|..|+..|.++.++|.|||++...
T Consensus 321 GkYeFPdkdW-------------------------ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 321 GKYEFPDKDW-------------------------AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA 368 (463)
T ss_pred cCCcCChhhh-------------------------HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence 5555555555 46899999999999999999999999999999998643
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.68 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=213.5
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|+.+++||.|+||.||.+++..+++.|++|.+............+.+|+.++++++|+||+++++++.. ...+++|||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~e 79 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEME 79 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEEE
Confidence 455667999999999999999999999999998776666667778899999999999999999999877 678999999
Q ss_pred eccccccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.++.+..+... ...+++.++..++.|++.+|.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~ 158 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY-SMA 158 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc-ccc
Confidence 9987554433332 3568999999999999999999999999999999999999999999999999998664322 123
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+++.|+|||++.+.. ++.++|||||||++|+|++|..+|.+....+....+... ..
T Consensus 159 ~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~----------------- 218 (256)
T cd08221 159 ETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NY----------------- 218 (256)
T ss_pred cccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CC-----------------
Confidence 3456899999999998766 689999999999999999999999888777766665431 11
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......++..+.+||.+||..+|.+|||+.++|+|+|+
T Consensus 219 ---------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 219 ---------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ---------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 01113578889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.27 Aligned_cols=285 Identities=35% Similarity=0.534 Sum_probs=227.1
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.|.+.+.||.|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++... ...+|+|
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~lv 88 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYFV 88 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEEE
Confidence 445566669999999999999999999999999876544444556778999999999999999999987642 4568999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|||+++++...+. ...+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..... ..
T Consensus 89 ~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----~~ 162 (328)
T cd07856 89 TELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----QM 162 (328)
T ss_pred eehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----Cc
Confidence 9999876654443 23578999999999999999999999999999999999999999999999999875432 22
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+++.|+|||.+.+...++.++|||||||++|+|++|.++|.+.........+.+.++.++++.+..........+.
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 34467889999999877555899999999999999999999999999888888888888888887765432111111110
Q ss_pred CCCc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 381 PQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 381 ~~~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
...+ ......+.++.++..+.+||.+||+.+|++|||+.++|.|+||.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 0000 001123344578899999999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=339.34 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=209.2
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||++.+..++..||||++.... ....+.+.+|+.+++.++|+||+++++.+.. ....|+||||+.+++
T Consensus 30 lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e~~~~~~ 105 (292)
T cd06658 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVMEFLEGGA 105 (292)
T ss_pred ccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEeCCCCCc
Confidence 999999999999999999999999986533 3445668899999999999999999998876 678999999999877
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
+..+... ..+++.++..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... .......++..
T Consensus 106 L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~ 183 (292)
T cd06658 106 LTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPY 183 (292)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCceeecCcc
Confidence 6655543 368999999999999999999999999999999999999999999999999987553222 22234568999
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|+|||.+.+.. ++.++|||||||++|||++|..||.+......+..+.......
T Consensus 184 y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------- 237 (292)
T cd06658 184 WMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------------------- 237 (292)
T ss_pred ccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-------------------------
Confidence 99999987665 7999999999999999999999998877666555443211000
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
......++..+.+||.+||..||.+|||+.++|+|+||...+.|.
T Consensus 238 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 238 -VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred -cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 001124678899999999999999999999999999999765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.63 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=202.6
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.++||+|+||.||+|.+..+++.||||++.... .......+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 81 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISICTEFM 81 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEEEecC
Confidence 3345999999999999999999999999987643 34455678899999999999999999999877 57789999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+++.+... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...... .....+
T Consensus 82 ~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (279)
T cd06619 82 DGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYV 154 (279)
T ss_pred CCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cccCCC
Confidence 98776543 25789999999999999999999999999999999999999999999999999865322 223457
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ---LHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~---l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
+|..|+|||++.+.. ++.++|||||||++|+|++|..||......+. ...+.+...... .+
T Consensus 155 ~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------~~ 218 (279)
T cd06619 155 GTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------------PP 218 (279)
T ss_pred CChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------------CC
Confidence 899999999998765 79999999999999999999999865322110 011111000000 00
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
. .....+++.+.+||.+||+.||++||++.++++||||...
T Consensus 219 ~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 219 V--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred C--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 0 0112467889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.60 Aligned_cols=248 Identities=27% Similarity=0.475 Sum_probs=206.7
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++|+||+++++++.. ...+|+|+||+.++.
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~~ 85 (274)
T cd06609 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIMEYCGGGS 85 (274)
T ss_pred hcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEEEeeCCCc
Confidence 9999999999999999999999999986542 3345667899999999999999999998876 578999999999866
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
+..+.... .+++..++.++.||+.||.|||+.+|+|+||+|+||++++++.++|+|||++..+.... .......+++.
T Consensus 86 L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~ 163 (274)
T cd06609 86 CLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SKRNTFVGTPF 163 (274)
T ss_pred HHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc-cccccccCCcc
Confidence 55554444 78999999999999999999999999999999999999999999999999998765332 22234467889
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.... + +
T Consensus 164 y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~-----------------~------- 216 (274)
T cd06609 164 WMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--P-----------------P------- 216 (274)
T ss_pred ccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--C-----------------C-------
Confidence 99999998766 7999999999999999999999998776554444332210 0 0
Q ss_pred hhcccC-CCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 389 VAETFK-DFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 389 ~~e~~~-~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.... .++..+.+||.+||..||++|||+.++++|+||...
T Consensus 217 --~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 217 --SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred --CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 0011 268889999999999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.97 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=198.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccC----CCeEEEEEee
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM----SCSLYLVFEY 223 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~----~~~lyLV~Ey 223 (720)
||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++++ +|+||+++++++.... ...+|+||||
T Consensus 14 lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred eeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 9999999999999999999999999875432 234577899999998 7999999999886532 2468999999
Q ss_pred ccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+.++.+..+.. ....+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+|||++....... ....
T Consensus 91 ~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~-~~~~ 169 (272)
T cd06637 91 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRRN 169 (272)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc-ccCC
Confidence 99755544333 23468999999999999999999999999999999999999999999999999998653322 2234
Q ss_pred ccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 302 SRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
...+++.|+|||++.+ ...|+.++|||||||++|||++|.+||...........+... +
T Consensus 170 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~-------------- 232 (272)
T cd06637 170 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P-------------- 232 (272)
T ss_pred cccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C--------------
Confidence 4578999999999863 224788999999999999999999999765544333322110 0
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
. .......++..+.+||.+||..||.+|||+.+++.||||
T Consensus 233 --~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 233 --A--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred --C--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 001113467889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.20 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=209.5
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||.|+||.||+|.+..++..||+|++....... ....+.+|+.+++.++|+||+++++.+.. ...+|+||||+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~e~~ 81 (267)
T cd06610 5 LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVMPYL 81 (267)
T ss_pred eeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEEecc
Confidence 3445999999999999999899999999997655433 56778999999999999999999998876 67899999999
Q ss_pred cccccccccCC---CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC---
Q 004999 225 EHDLAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--- 298 (720)
Q Consensus 225 ~g~ll~~~~~~---~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~--- 298 (720)
.++.+..+... ...+++..++.++.||+.||.|||+.||+|+||+|+||++++++.+||+|||++..+......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 97655544432 246899999999999999999999999999999999999999999999999999766433222
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+++..|+|||.+.....++.++|+|||||++|+|++|+.||...+....+.++.... + ..
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~-~~------------ 226 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--P-PS------------ 226 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC--C-CC------------
Confidence 12334678999999999876457999999999999999999999998877665555543310 0 00
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+. .......+++.+.+||.+||..||.+|||+.+++.||||
T Consensus 227 ~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 LE--------TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cC--------CccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00 001134678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.58 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=205.5
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.++||+|+||.||+|.+..++..||||++..... .......+.+|+.++++++||||+++++++.+.....+|+||
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 34559999999999999999999999999875432 234567888999999999999999999988765456789999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--CC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--QP 299 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~--~~ 299 (720)
||++++.+..+......+++..+..++.||+.+|.|||+.+|+|+||||+|||++.++.+||+|||++........ ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 165 (265)
T cd06652 86 EHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165 (265)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccccccc
Confidence 9999766655554445689999999999999999999999999999999999999999999999999876532111 11
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
.....++..|+|||++.+.. ++.++|||||||++|||++|++||.+......+..+.. .+.
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--------------- 226 (265)
T cd06652 166 MKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--------------- 226 (265)
T ss_pred cccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---------------
Confidence 23345788999999998765 79999999999999999999999987655554433321 110
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
.......++..+.++|.+|| .+|.+|||++++++|||+.
T Consensus 227 ---------~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ---------NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTFVH 265 (265)
T ss_pred ---------CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcccC
Confidence 00112346778999999999 5999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=327.13 Aligned_cols=253 Identities=28% Similarity=0.472 Sum_probs=209.5
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+...||.|+||.||+|.+..++..||+|++............+..|+.+++.++||||+++++++.......+|++|||+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~ 83 (265)
T cd08217 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC 83 (265)
T ss_pred eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence 33459999999999999999999999999987766666677889999999999999999999987765567789999999
Q ss_pred cccccccccC----CCCCCCHHHHHHHHHhhhhcccccc-----ccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 225 EHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCH-----SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 225 ~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH-----~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
.++.+..+.. ....+++..++.++.||+.||.||| +.+|+|+||+|+||+++.++.+||+|||++......
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 8755443332 2457899999999999999999999 899999999999999999999999999999876433
Q ss_pred CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.. ......+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+....+....+... .
T Consensus 164 ~~-~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~------------- 226 (265)
T cd08217 164 SS-FAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG--K------------- 226 (265)
T ss_pred cc-cccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC--C-------------
Confidence 21 123456899999999998765 789999999999999999999999887754443333211 0
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......++..+.+||.+||+.+|.+|||+.++|+|||+
T Consensus 227 -------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 -------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred -------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 011223567889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=339.81 Aligned_cols=258 Identities=27% Similarity=0.342 Sum_probs=209.0
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.+.||+|+||.||++.+..+++.||||.+..... .......+.+|+.+++.++||||+++++.+.. ...+|+||||
T Consensus 5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 82 (305)
T cd05609 5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMVMEY 82 (305)
T ss_pred EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEEEec
Confidence 34459999999999999999999999999876543 23445678899999999999999999998876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-----
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ----- 298 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~----- 298 (720)
++|+.+..+......+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccccc
Confidence 998766655555567999999999999999999999999999999999999999999999999998642111000
Q ss_pred ---------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 299 ---------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 299 ---------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
......++..|+|||.+.+.. ++.++|||||||++|||++|..||.+....+.+..+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~------ 235 (305)
T cd05609 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW------ 235 (305)
T ss_pred ccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC------
Confidence 111235688899999987765 7999999999999999999999999887666555543321000
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC---HHHHHhCccCCCCC
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFTMKP 431 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hp~f~~~~ 431 (720)
......++..+.+||.+||+.||++||+ +.++|+||||....
T Consensus 236 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 236 --------------------PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred --------------------CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 0011247888999999999999999998 79999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.37 Aligned_cols=254 Identities=27% Similarity=0.447 Sum_probs=206.5
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC----CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
++...||.|+||.||+|.+ .+++.+|||.+..... .......+.+|+.+++.++|+||+++++++.. ...+|+
T Consensus 3 ~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 79 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTISI 79 (265)
T ss_pred cccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEEE
Confidence 3445599999999999986 5788999999876432 22344678899999999999999999999876 578999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC----
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD---- 295 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~---- 295 (720)
||||+.++.+..+......+++..+..++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999998776666555567899999999999999999999999999999999999999999999999998754211
Q ss_pred -CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 296 -QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 296 -~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
.........++..|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 226 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL------------ 226 (265)
T ss_pred cccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC------------
Confidence 111223346789999999988765 689999999999999999999999877655544333221110
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......++..+.+||.+||..+|.+|||+.++|.||||
T Consensus 227 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 --------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.33 Aligned_cols=257 Identities=29% Similarity=0.495 Sum_probs=206.0
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC----CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
..++||+|+||.||++.+..+++.||||++..... .......+.+|+.++++++|+||+++++++.. ...+++|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~~v 81 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHFNLF 81 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeEEEE
Confidence 34459999999999999999999999999975432 12345778999999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceecCCCCC--
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQN-- 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~~~-- 297 (720)
|||+.|.++..+......+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++..+.....
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~ 161 (268)
T cd06630 82 VEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA 161 (268)
T ss_pred EeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccC
Confidence 99999877766655556789999999999999999999999999999999999998776 599999999876643211
Q ss_pred -CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 -QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 -~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.......+|..|+|||.+.+.. ++.++|||||||++|+|++|..||...........+.+.....
T Consensus 162 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 227 (268)
T cd06630 162 GEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT------------- 227 (268)
T ss_pred CccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC-------------
Confidence 1112345788999999987755 6899999999999999999999997654333333222210000
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
. .......+++.+.++|.+||..||.+|||+.++|.||||+
T Consensus 228 --~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 --T---------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --C---------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0 0112235788899999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=325.86 Aligned_cols=252 Identities=30% Similarity=0.466 Sum_probs=209.0
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
..++||+|+||.||+|.+..++..|+||.+..... ..+..+.+.+|+.+++.++|+||+++++++.. ...+|+||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~ 81 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLYIFL 81 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEEEEE
Confidence 44569999999999999998999999999876432 34566788999999999999999999998876 57899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||+++..+..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~~~ 159 (258)
T cd06632 82 ELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAK 159 (258)
T ss_pred EecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--ccc
Confidence 999986666555555578999999999999999999999999999999999999999999999999988654322 223
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
...++..|+|||.+.....++.++|+|||||++|+|++|.+||......+....+.....
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------- 219 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-------------------- 219 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc--------------------
Confidence 456789999999987654478999999999999999999999987765554444322100
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......+++.+.+||.+||+.+|.+|||+.++|.||||
T Consensus 220 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 -------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 011223578889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.72 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=199.5
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHH-HHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI-LRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~i-L~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+...||+|+||.||+|.+..+|+.||||+++........ ..+..|+.+ ++.++||||+++++++.. ...+|+||||
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv~e~ 81 (283)
T cd06617 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWICMEV 81 (283)
T ss_pred EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEEhhh
Confidence 334599999999999999999999999999865443333 344556665 566799999999999876 5679999999
Q ss_pred ccccccccc---cCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 224 MEHDLAGLA---SHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 224 ~~g~ll~~~---~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
+++.+...+ ......+++..++.++.||+.||.|||++ +++|+||||+|||++.++.+||+|||++..+... ..
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~--~~ 159 (283)
T cd06617 82 MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VA 159 (283)
T ss_pred hcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc--cc
Confidence 998654433 22345799999999999999999999997 9999999999999999999999999999765322 12
Q ss_pred ccccccccCCCChhhhcCC---cCCCccccchhhHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 300 LTSRVVTLWYRPPELLLGA---TYYGTAVDLWSTGCILAELYAGKPIMPGR-TEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~---~~y~~~sDIWSLG~iL~ELltG~ppf~g~-~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.+...++..|+|||++.+. ..++.++|+|||||++|+|++|..||... ...+.+..+.... .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------------ 225 (283)
T cd06617 160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S------------ 225 (283)
T ss_pred cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C------------
Confidence 2334678899999988652 33688999999999999999999998642 3334444332210 0
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
+.. ....++..+.+||.+||..+|.+|||+.+++.|+||...
T Consensus 226 -----~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 226 -----PQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -----CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 000 012368889999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.75 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=207.6
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
.+.+.||+|+||.||+|++..++..||+|.+...... ....+.+|+.+++.+.|+||+++++.+.. ...+|+||||
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~lv~e~ 98 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEY 98 (296)
T ss_pred eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEEeecc
Confidence 3444599999999999999999999999999865432 24567899999999999999999998876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++........ .....
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 176 (296)
T cd06654 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTM 176 (296)
T ss_pred cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-ccCcc
Confidence 998766555443 3589999999999999999999999999999999999999999999999999876533221 22334
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
.+++.|+|||.+.+.. ++.++|||||||++|+|++|++||.+......+..+... +.+.
T Consensus 177 ~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~------------------- 235 (296)
T cd06654 177 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPE------------------- 235 (296)
T ss_pred cCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCCC-------------------
Confidence 6789999999988765 689999999999999999999999887665444332211 1110
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||..||++|||+.+++.|+||...
T Consensus 236 ------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 236 ------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 01123577889999999999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=326.50 Aligned_cols=253 Identities=24% Similarity=0.440 Sum_probs=208.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||++.+..+++.||||.+............+.+|+.++++++||||+++++++.. ...+|+|||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 79 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIVMD 79 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEEEe
Confidence 344556999999999999999999999999998765555556678999999999999999999998876 678999999
Q ss_pred ecccccc-ccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll-~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.+..+ ..+.. ....+++.++..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....... ...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~ 158 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-ELA 158 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-hhh
Confidence 9987544 33332 23357999999999999999999999999999999999999999999999999998654321 112
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||......+....+.... .
T Consensus 159 ~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------------- 218 (256)
T cd08218 159 RTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--Y----------------- 218 (256)
T ss_pred hhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--C-----------------
Confidence 2345788899999988765 6899999999999999999999998776666655553211 0
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......++..+.+||.+||+.+|.+||++.++|+|+||
T Consensus 219 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 ---------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred ---------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 11223578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=366.07 Aligned_cols=284 Identities=23% Similarity=0.307 Sum_probs=203.3
Q ss_pred ccccceeecccCceEEEEEEECCCC-eEEEEEEe--------------ec-CCCCHHHHHHHHHHHHHHHhcCCCceeee
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQK-KIVALKKV--------------RF-DNLEPESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg-~~VAIK~l--------------~~-~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
.|++...||+|+||.||+|..+... ..+++|.+ .. ..........+.+|+.+|++|+|||||++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 3555666999999999998764332 22222211 10 11122345568899999999999999999
Q ss_pred ccceeccCCCeEEEEEeeccccccccccCC----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCce
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 281 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~v 281 (720)
++++.. ....|+|+|++.++++..+... .......+++.|+.||+.||.|||++||+||||||+||||+.++.+
T Consensus 229 ~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 229 EEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred eEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 999877 5678999999988776654332 2234567888999999999999999999999999999999999999
Q ss_pred eeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCC-CCC--CChHHHHHHHHH
Q 004999 282 KIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI-MPG--RTEVEQLHKIFK 358 (720)
Q Consensus 282 KL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~pp-f~g--~~~~e~l~~i~~ 358 (720)
||+|||++..+...........+||+.|+|||++.+.. |+.++||||||||||||++|..+ +.+ .....++.+++.
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~ 385 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID 385 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHH
Confidence 99999999876543333334567899999999998766 79999999999999999998844 332 345566666666
Q ss_pred hcCCCChhhhhhc-----CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 359 LCGSPSEDYWRKS-----KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 359 ~~g~p~~~~w~~~-----~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.++.+..++.... .+...............+. ...++..+.++|.+||++||.+|||+.|+|.||||...
T Consensus 386 ~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR--NLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH--hcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 6554433321100 0000000000001011111 12467789999999999999999999999999999754
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=335.19 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=211.2
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||.|+||.||+|.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 96 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFVVME 96 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEEEEE
Confidence 3444559999999999999999999999999876543 234567899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.++.+..+... ..+++.++..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++........ ....
T Consensus 97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 174 (296)
T cd06655 97 YLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (296)
T ss_pred ecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-cCCC
Confidence 9998777665543 3689999999999999999999999999999999999999999999999999876543322 2233
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..++..|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+....+..+... +.+.
T Consensus 175 ~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~------------------ 234 (296)
T cd06655 175 MVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE------------------ 234 (296)
T ss_pred cCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc------------------
Confidence 46788999999987765 689999999999999999999999988776665554321 1110
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||..||.+|||+.+++.||||...
T Consensus 235 -------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 235 -------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 11123578889999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.48 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=197.5
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCH-HHHHHHHHHHHHHHh---cCCCceeeeccceeccCCCeEEEEEeec
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRR---LDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~---L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
||+|+||.||++.+..+++.||+|.+....... .....+.+|..+++. .+||||+.+++++.. .+.+|+||||+
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDLM 79 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEecC
Confidence 899999999999999999999999997654322 222333445444443 479999999988876 56799999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
.++.+..+......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....... .....
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 156 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASV 156 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---ccCcC
Confidence 987776555555679999999999999999999999999999999999999999999999999987543221 22346
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~--~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
+|+.|+|||.+.+...++.++|||||||++|+|++|..||.+... ...+..... .
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~-------------------- 213 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T-------------------- 213 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---c--------------------
Confidence 899999999987555578999999999999999999999976432 122211110 0
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
........++..+.+||.+||..||.+|+ |+.++++||||+..
T Consensus 214 -----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 214 -----VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred -----CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 00112345788999999999999999999 69999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=326.41 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=207.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||.|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+|+||||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 6899999999999999999999999986543 33455778999999999999999999998876 67799999999976
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
.+..+......+++..+..++.||+.||.|||++|++|+||+|+||+|+.++.++|+|||++....... ......+++
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~ 156 (262)
T cd05572 79 ELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGTP 156 (262)
T ss_pred cHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCCc
Confidence 666555555578999999999999999999999999999999999999999999999999998764322 223346789
Q ss_pred CCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT--EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 308 ~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~--~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
.|+|||.+.+.. ++.++|+|||||++|+|++|..||.... ..+.+..+......
T Consensus 157 ~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------- 212 (262)
T cd05572 157 EYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK----------------------- 212 (262)
T ss_pred CccChhHhcCCC-CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC-----------------------
Confidence 999999987655 7899999999999999999999998776 44444443321000
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+|+| +.|+++||||...
T Consensus 213 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 213 ----LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ----CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 0111234788999999999999999999 9999999999853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.55 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=206.3
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.++++++||||+++++++.. ...+|++|||+
T Consensus 7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~~e~~ 82 (262)
T cd06613 7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIVMEYC 82 (262)
T ss_pred EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEEEeCC
Confidence 33459999999999999999999999999986542 355778899999999999999999998876 67899999999
Q ss_pred cccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 225 EHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 225 ~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+++.+..+.... ..+++.+++.++.||+.||.|||++||+|+||+|+||+|+.++.+||+|||++....... ......
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~ 161 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AKRKSF 161 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh-hccccc
Confidence 987766555433 679999999999999999999999999999999999999999999999999987654321 122344
Q ss_pred ccccCCCChhhhcCC--cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 304 VVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~--~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
.++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.........+......+.
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~----------------- 224 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP----------------- 224 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc-----------------
Confidence 678899999998765 2368899999999999999999999988776655544432110000
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
.......++.++.+||.+||..||.+|||+.+++.|+|
T Consensus 225 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 -------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred -------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00011235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=350.14 Aligned_cols=251 Identities=23% Similarity=0.397 Sum_probs=217.1
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+||.|.||+||-|+++.+|+.||||++.+-.........+.+|+.||+.+.||.||.|...|+. ...+++|||-+.|+
T Consensus 571 vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 571 VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET--PERVFVVMEKLHGD 648 (888)
T ss_pred hccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEEehhhcch
Confidence 7999999999999999999999999999887766666889999999999999999999988877 67899999999999
Q ss_pred ccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC---ceeeeccccceecCCCCCCCcccc
Q 004999 228 LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 228 ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g---~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
.+..++. ..+.+++...+.++.||+.||.|||..+|+|+||||+|||+.+.. ++||||||+|++++. .....+.
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE--ksFRrsV 726 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE--KSFRRSV 726 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--hhhhhhh
Confidence 9987775 556899999999999999999999999999999999999997543 799999999999864 3455678
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+|||.|+|||+|.... |....||||+|+|+|--|+|..||...++. -.+|.. +..+-|..
T Consensus 727 VGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQN-----------------AaFMyPp~ 786 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQN-----------------AAFMYPPN 786 (888)
T ss_pred cCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccch--hHHhhc-----------------cccccCCC
Confidence 9999999999999877 899999999999999999999999765443 222322 22222333
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
|| ..+++.+.|||..+|++.-.+|.|....|.|+|++..
T Consensus 787 PW--------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 787 PW--------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ch--------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 33 4689999999999999999999999999999999853
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=323.84 Aligned_cols=258 Identities=29% Similarity=0.480 Sum_probs=209.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|.+.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+++.++|+||+++++++.. ...+++|+|
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~lv~e 79 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH--REKVYIFME 79 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec--CCEEEEEEe
Confidence 344456999999999999999999999999998776555677889999999999999999999998765 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc-
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT- 301 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t- 301 (720)
|+.++++..+...+..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++............
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9998777766666667899999999999999999999999999999999999999999999999999876433222111
Q ss_pred --ccccccCCCChhhhcCCc--CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 302 --SRVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 302 --~~~gT~~Y~APE~l~~~~--~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
...+++.|+|||++.+.. .++.++|||||||++|+|++|..||.+............. +..
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~-------------- 224 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK-------------- 224 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC--------------
Confidence 245688999999987653 2688999999999999999999999765432222211111 100
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+..+ ....++..+.+||.+||+.||.+|||+.+++.|||+
T Consensus 225 ---~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 ---PPIP-------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ---CCCC-------cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000 112458889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=336.47 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=207.5
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|.+.+.||+|+||.||+|.+..+++.||||.+...... ..+.+.+|+.+++.++|+||+++++++.. ...+|+|||
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e 96 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVME 96 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEeec
Confidence 34445599999999999999999999999999765432 33567899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++++++..+... ..+++.++..++.||+.+|.|||+.||+|+||||+||||+.++.+||+|||++........ ....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~ 174 (297)
T cd06656 97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (297)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-CcCc
Confidence 9998766655543 3589999999999999999999999999999999999999999999999999986543322 2234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+....+..+.. .+.+.
T Consensus 175 ~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~------------------ 234 (297)
T cd06656 175 MVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE------------------ 234 (297)
T ss_pred ccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC------------------
Confidence 46789999999998765 68999999999999999999999977655433322211 01110
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||..||.+|||+.++|+||||...
T Consensus 235 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 235 -------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred -------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 11123567889999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=328.62 Aligned_cols=257 Identities=30% Similarity=0.527 Sum_probs=205.1
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCC--------CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeE
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--------EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~--------~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~l 217 (720)
.+.||.|+||.||+|.+..+++.||||.++.... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 83 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--EEYL 83 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--CCce
Confidence 3459999999999999999999999999865321 11234567889999999999999999998876 5789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
++||||+.++.+..+......+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 163 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD 163 (272)
T ss_pred EEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccccc
Confidence 99999999876665555556899999999999999999999999999999999999999999999999999976432211
Q ss_pred -CCccccccccCCCChhhhcCCc-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 298 -QPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 298 -~~~t~~~gT~~Y~APE~l~~~~-~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.......++..|+|||.+.... .++.++|+||||||+|+|++|..||......+.+..+......+
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 231 (272)
T cd06629 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP------------ 231 (272)
T ss_pred ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC------------
Confidence 1123345788999999987654 46899999999999999999999997665544443322110000
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.+ .......++..+.+||.+||..||.+|||+.++|+||||
T Consensus 232 --~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 --PI---------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred --cC---------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00 012234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=323.50 Aligned_cols=251 Identities=24% Similarity=0.394 Sum_probs=207.8
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+..+.||+|+||.||+|.+..++..||||.+............+.+|+.+++.++||||+++++.+.. ...+++||||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 80 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIVMEY 80 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEEEec
Confidence 34456999999999999999999999999998776656667788999999999999999999998866 6789999999
Q ss_pred ccccccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-CceeeeccccceecCCCCCCCc
Q 004999 224 MEHDLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 224 ~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~ 300 (720)
++++.+..+... +..+++..++.++.||+.+|.|||++||+|+||+|+||+++.+ +.+||+|||++....... ..
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~ 158 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--KA 158 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--cc
Confidence 987655444432 3458999999999999999999999999999999999999855 468999999998764322 22
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....++..|+|||.+.+.. ++.++|||||||++|+|++|..+|.+.+.......+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------------- 218 (256)
T cd08220 159 YTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------------- 218 (256)
T ss_pred cccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------------
Confidence 2346788999999998765 68999999999999999999999988766555544432110
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......++..+.+||..||..||.+|||+.++|+||||
T Consensus 219 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 ---------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 01123478889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=330.06 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=199.1
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceecc----CCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSR----MSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~----~~~~lyLV~E 222 (720)
.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +|+||+++++++... ....+|+|||
T Consensus 23 ~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 4999999999999999999999999986542 3345678899999998 799999999987532 2457899999
Q ss_pred eccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.++.+..+.. ....+++..++.++.||+.||.|||+.||+|+||+|+||+|+.++.++|+|||++....... ...
T Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 178 (282)
T cd06636 100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV-GRR 178 (282)
T ss_pred eCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc-cCC
Confidence 998754443332 23458899999999999999999999999999999999999999999999999987553221 122
Q ss_pred cccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 301 TSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
....+++.|+|||++.. ...++.++|||||||++|||++|.+||........+..+.....
T Consensus 179 ~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--------------- 243 (282)
T cd06636 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--------------- 243 (282)
T ss_pred CcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC---------------
Confidence 34568999999999863 23478899999999999999999999977665444433221100
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......++..+.+||.+||+.||.+|||+.++|+||||
T Consensus 244 ------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 ------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.90 Aligned_cols=253 Identities=25% Similarity=0.433 Sum_probs=209.6
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.. ...+|+||||++++.
T Consensus 29 ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e~~~~~~ 104 (297)
T cd06659 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLMEFLQGGA 104 (297)
T ss_pred cCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEecCCCCC
Confidence 9999999999999999999999999875432 234567899999999999999999998876 678999999999876
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
+..+... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.... .......++..
T Consensus 105 L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~~~~~~ 182 (297)
T cd06659 105 LTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPY 182 (297)
T ss_pred HHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccceecCcc
Confidence 6554433 468999999999999999999999999999999999999999999999999987553322 22234568999
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|+|||++.+.. ++.++|||||||++|||++|++||......+.+..+... +. .
T Consensus 183 y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-~---------------------- 235 (297)
T cd06659 183 WMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-P---------------------- 235 (297)
T ss_pred ccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-C----------------------
Confidence 99999998765 799999999999999999999999887776665544211 00 0
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
.......++..+.++|.+||+.+|.+|||+.++++|+||....++.
T Consensus 236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~ 281 (297)
T cd06659 236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPE 281 (297)
T ss_pred CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCcc
Confidence 0111235678899999999999999999999999999998776554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=327.97 Aligned_cols=251 Identities=29% Similarity=0.419 Sum_probs=208.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||.|+||.||+|.+..++..||+|++..... .....+.+.+|+.++++++||||+++++++.. ...+|+|||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 80 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EENMYLVVD 80 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CCeEEEEEe
Confidence 445569999999999999999999999999986543 33567788999999999999999999998866 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.|..+.........+++..+..++.||+.||.|||++||+|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~ 158 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTS 158 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cccc
Confidence 99987666555545689999999999999999999999999999999999999999999999999987654322 2233
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--VEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~--~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
..++..|+|||++.+.. ++.++|+|||||++|+|++|..||..... .+.+...... .
T Consensus 159 ~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~----------------- 217 (258)
T cd05578 159 TSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET---A----------------- 217 (258)
T ss_pred cCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc---c-----------------
Confidence 45788899999988766 79999999999999999999999987664 2222222110 0
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH--HHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA--ASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa--~e~L~hp~f 427 (720)
.......++..+.++|.+||..||.+||++ .+++.||||
T Consensus 218 --------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 --------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred --------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 011223567899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=324.92 Aligned_cols=253 Identities=26% Similarity=0.457 Sum_probs=206.8
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccce
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
+.|+..+. ||.|+||.||+|.+..++..|++|.+.... ....+.+|+.+++.++|+||+++++++
T Consensus 3 ~~y~~~~~-----------i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~ 67 (256)
T cd06612 3 EVFDILEK-----------LGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSY 67 (256)
T ss_pred ccchhhhh-----------hcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeee
Confidence 35666666 999999999999999889999999987542 256789999999999999999999998
Q ss_pred eccCCCeEEEEEeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 210 TSRMSCSLYLVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
.. ...+|+++||+.+..+..+. .....+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.+||+|||+
T Consensus 68 ~~--~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~ 145 (256)
T cd06612 68 FK--NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGV 145 (256)
T ss_pred ec--CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEccccc
Confidence 77 57899999999986655444 3456789999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w 368 (720)
+........ ......++..|+|||++.+.. ++.++||||||||+|+|++|++||...........+... ..
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~---- 216 (256)
T cd06612 146 SGQLTDTMA-KRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP---- 216 (256)
T ss_pred chhcccCcc-ccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC----
Confidence 986543221 223345788999999987765 799999999999999999999999876554433322110 00
Q ss_pred hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+ .......++..+.+||.+||+.||.+|||+.++|.||||
T Consensus 217 ------------~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 217 ------------P-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------C-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0 011123467889999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=332.16 Aligned_cols=261 Identities=20% Similarity=0.297 Sum_probs=205.4
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccc
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGL 208 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~ 208 (720)
++|+.+.. ||+|+||.||++.+..+++.||||.+...... .....+.+|+.++.++. |+||++++++
T Consensus 4 ~~~~~~~~-----------lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~ 71 (288)
T cd06616 4 EDLKDLGE-----------IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGA 71 (288)
T ss_pred HHhHHHHH-----------hCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeE
Confidence 35666666 99999999999999999999999998765433 44567889999999996 9999999998
Q ss_pred eeccCCCeEEEEEeeccccccccc----cCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceee
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAGLA----SHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKI 283 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~~~----~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL 283 (720)
+.. ....|++|||+...+.... ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||
T Consensus 72 ~~~--~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl 149 (288)
T cd06616 72 LFR--EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKL 149 (288)
T ss_pred Eec--CCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEE
Confidence 876 5678999999987543322 12345799999999999999999999974 9999999999999999999999
Q ss_pred eccccceecCCCCCCCccccccccCCCChhhhcCC--cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 004999 284 ADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 284 ~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~--~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g 361 (720)
+|||++..+.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||..... ....+.+...
T Consensus 150 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~ 225 (288)
T cd06616 150 CDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVK 225 (288)
T ss_pred eecchhHHhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcC
Confidence 9999997653221 12334678899999999876 3579999999999999999999999976542 2222222111
Q ss_pred CCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 362 ~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.... .. .......++..+.+||.+||+.||.+|||+.+++.||||..
T Consensus 226 ~~~~----------------~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 226 GDPP----------------IL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CCCC----------------cC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 1100 00 01111357889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.01 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=202.2
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++.. ...+|+||||+.+..
T Consensus 9 ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~ 85 (265)
T cd06605 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGS 85 (265)
T ss_pred hcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEEEecCCCc
Confidence 9999999999999999999999999876543 3555678899999999999999999998877 578999999999655
Q ss_pred cccccCCC-CCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 229 AGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 229 l~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+..+.... ..+++..+..++.||+.+|.|||+ .|++|+||||+||+++.++.++|+|||++........ ....++
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~ 162 (265)
T cd06605 86 LDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---KTFVGT 162 (265)
T ss_pred HHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh---hcccCC
Confidence 55444433 678999999999999999999999 9999999999999999999999999999876532211 125678
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-----EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~-----~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..|+|||.+.+.. ++.++|||||||++|+|++|..||.... ..+.+..+.. ... +
T Consensus 163 ~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~----------------~ 222 (265)
T cd06605 163 SSYMAPERIQGND-YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EPP----------------P 222 (265)
T ss_pred hhccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CCC----------------C
Confidence 8999999997765 7999999999999999999999986542 2222222211 000 0
Q ss_pred CCccchhhhcccC-CCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFK-DFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.... .++..+.+||.+||..||.+|||+.+++.||||+..
T Consensus 223 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 223 ---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 0111 178889999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=328.87 Aligned_cols=248 Identities=17% Similarity=0.249 Sum_probs=199.5
Q ss_pred ccceeecccCceEEEEEEEC---CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
++.++||+|+||.||+|.+. ..+..||+|+++... .......+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 8 ~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 84 (266)
T cd05064 8 KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNTMMIV 84 (266)
T ss_pred EEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCCcEEE
Confidence 44456999999999999865 456789999987643 23445678899999999999999999999876 6789999
Q ss_pred EeeccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 221 FEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
|||++++++..+.. ....+++.+++.++.||+.||+|||++|++||||||+||||+.++.+||+|||.+..........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYT 164 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchhc
Confidence 99999876665443 34578999999999999999999999999999999999999999999999999876532221111
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+.+..+......
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 227 (266)
T cd05064 165 TMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL---------------- 227 (266)
T ss_pred ccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC----------------
Confidence 11223467899999988765 7999999999999999775 99999988877666655321110
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||..||+.+|.+|||+.++++
T Consensus 228 ------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 228 ------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 112457889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=325.68 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=202.5
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccC----CCeEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM----SCSLYL 219 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~----~~~lyL 219 (720)
+.+.||+|++|.||+|.+..+++.|++|++..... ....+.+|+.+++++ .|+||+++++++.... ...+|+
T Consensus 10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred heeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 33449999999999999999999999999876532 345688999999999 7999999999886532 346899
Q ss_pred EEeeccccccccccC----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 220 VFEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
||||++++.+..+.. .+..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 999999865544332 2457899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccccccCCCChhhhcCC----cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~----~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
. .......++..|+|||++... ..++.++||||||||||+|++|.+||........+.++... +.
T Consensus 167 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~------- 235 (275)
T cd06608 167 L-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP------- 235 (275)
T ss_pred h-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC-------
Confidence 2 223345678999999988542 34678999999999999999999999876655555444321 00
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+. ......++..+.+||.+||..||.+|||+.++++|||+
T Consensus 236 ---------~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 ---------PT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------CC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00 00112367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=333.78 Aligned_cols=250 Identities=30% Similarity=0.455 Sum_probs=207.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+.||+|+||.||+|.+..+++.||||++..... ..+....+.+|+.+++.++||||+++++++.. ....|+||||+.
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 98 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTAWLVMEYCL 98 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeEEEEHHhhC
Confidence 349999999999999999999999999875433 44555678899999999999999999999876 667899999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|.+...+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++...... ....+
T Consensus 99 g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-----~~~~~ 173 (307)
T cd06607 99 GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-----NSFVG 173 (307)
T ss_pred CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----CCccC
Confidence 8877766554557899999999999999999999999999999999999999999999999999765322 23467
Q ss_pred ccCCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 306 TLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 306 T~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
++.|+|||++.+ ...++.++|||||||++|||++|.+||.+.........+... ..+ .
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~------------------~- 233 (307)
T cd06607 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP------------------T- 233 (307)
T ss_pred CccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CCC------------------C-
Confidence 888999998853 344788999999999999999999999887665544433210 000 0
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....++..+.+||.+||+.||.+|||+.+++.|+||...
T Consensus 234 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 234 -------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred -------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0012357789999999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=353.54 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=225.0
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+|.+...||+|.|+.|.+|++..++..||||++.+...+......+.+|+++|+.|+|||||+++.++.. ...+|+||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t--~~~lylV~ 134 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET--EATLYLVM 134 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee--cceeEEEE
Confidence 3444445999999999999999999999999999998888888889999999999999999999999887 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||+.++.+..+...+..+.+..++.++.|++++++|||+++|||||||++||||+.+.++||+|||++.++. ......
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~lq 212 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLMLQ 212 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--cccccc
Confidence 999987777777777788889999999999999999999999999999999999999999999999999885 345567
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
+.||++.|.|||++.+..+.++.+|+||+|+|||-|++|..||.|.+-.+.-...+...
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk--------------------- 271 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK--------------------- 271 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee---------------------
Confidence 88999999999999999988999999999999999999999999977655443332110
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.....-++.+..+||+++|..+|.+|++..+++.|.|.....
T Consensus 272 --------~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 272 --------YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred --------ecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 111224677899999999999999999999999999997643
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=328.74 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=203.6
Q ss_pred CCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeee
Q 004999 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKL 205 (720)
Q Consensus 127 ~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl 205 (720)
.-.++|+.++. ||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.+ +||||+++
T Consensus 15 ~~~~~~~~~~~-----------lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~ 80 (286)
T cd06638 15 DPSDTWEIIET-----------IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKF 80 (286)
T ss_pred Ccccceeeeee-----------eccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeee
Confidence 33455666655 9999999999999999999999999865322 224567899999999 69999999
Q ss_pred ccceec---cCCCeEEEEEeecccccccccc----CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC
Q 004999 206 EGLVTS---RMSCSLYLVFEYMEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 278 (720)
Q Consensus 206 ~~~~~~---~~~~~lyLV~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~ 278 (720)
++++.. .....+|+||||++|+.+..+. .....+++..++.++.||+.||.|||+.+|+|+||||+||+++.+
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCC
Confidence 998743 2245799999999986654332 234568999999999999999999999999999999999999999
Q ss_pred CceeeeccccceecCCCCCCCccccccccCCCChhhhcCC----cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHH
Q 004999 279 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLH 354 (720)
Q Consensus 279 g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~----~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~ 354 (720)
+.+||+|||++....... .......+++.|+|||++... ..|+.++|||||||++|||++|..||........+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~ 239 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239 (286)
T ss_pred CCEEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence 999999999998654322 222344689999999998532 337889999999999999999999998766544443
Q ss_pred HHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 355 KIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 355 ~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.+... .+ +. ......++..+.+||.+||+.||.+|||+.++|+|+||
T Consensus 240 ~~~~~--~~-----------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 240 KIPRN--PP-----------------PT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred hcccc--CC-----------------Cc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 32110 00 00 00112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=329.07 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=198.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCH-HHHHHHHHHH---HHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREI---HILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~-~~~~~~~~Ei---~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+||+|+||.||+|.+..+++.||||++....... .....+..|. .+++...||||+++++++.. ...+|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 3899999999999999999999999998654321 1112233343 34445689999999998876 5689999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.|+.+..+......+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++..+.... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~~~ 155 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHAS 155 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---CcCc
Confidence 9987666555556679999999999999999999999999999999999999999999999999987553221 1234
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE--QLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e--~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
.++..|+|||++.+...++.++|||||||++|+|++|..||.+..... ....... ..
T Consensus 156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~------------------ 214 (278)
T cd05606 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TM------------------ 214 (278)
T ss_pred CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh---cc------------------
Confidence 689999999999866557999999999999999999999998763221 1111110 00
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMKP 431 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~~ 431 (720)
.......++..+.+||.+||..||.+|+ ++.++++||||....
T Consensus 215 -------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 215 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred -------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 0112234688999999999999999999 999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.48 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=208.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|++|.||++.+..+++.|+||++.... ....+.+.+|+.+++.++||||+++++++.. ....|+|+||+.+
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e~~~~ 100 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVMEFLEG 100 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEeccCC
Confidence 45999999999999999999999999986433 3344567899999999999999999998876 6779999999988
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
..+..+... ..+++.++..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 101 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 178 (285)
T cd06648 101 GALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGT 178 (285)
T ss_pred CCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cccccccCC
Confidence 666655544 468999999999999999999999999999999999999999999999999887543222 122334688
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+... ..+
T Consensus 179 ~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~----------------------- 233 (285)
T cd06648 179 PYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPP----------------------- 233 (285)
T ss_pred ccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCC-----------------------
Confidence 9999999987765 799999999999999999999999887776666554331 000
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.......++..+.+||.+||+.+|.+|||+.++|+|+||....
T Consensus 234 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 234 --KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred --CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0011124778899999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.26 Aligned_cols=247 Identities=28% Similarity=0.437 Sum_probs=203.2
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|.+..++..||||.+..... ......+.+|+.++++++||||+++++++.. ...+|+||||++++.
T Consensus 12 l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~ 88 (277)
T cd06642 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIMEYLGGGS 88 (277)
T ss_pred hcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEEEccCCCc
Confidence 9999999999999999999999999875543 3345678899999999999999999999876 678999999999866
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
+..+... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.... .......++..
T Consensus 89 L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~ 166 (277)
T cd06642 89 ALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPF 166 (277)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc-hhhhcccCccc
Confidence 6555443 468999999999999999999999999999999999999999999999999997654322 12223457889
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|+|||.+.+.. ++.++|+|||||++|||++|.+||...........+... .
T Consensus 167 y~aPE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~-------------------------- 217 (277)
T cd06642 167 WMAPEVIKQSA-YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--S-------------------------- 217 (277)
T ss_pred ccCHHHhCcCC-CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--C--------------------------
Confidence 99999998765 789999999999999999999998765544333222110 0
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.......++..+.+||.+||+.+|.+|||+.++|.|+||..
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 00112246788999999999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=328.99 Aligned_cols=244 Identities=24% Similarity=0.357 Sum_probs=198.2
Q ss_pred ecccCceEEEEEEECCCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 149 IGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.. ....|++|||
T Consensus 13 lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~ 89 (283)
T cd05048 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQPTCMLFEY 89 (283)
T ss_pred ccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CCceEEEEec
Confidence 999999999999976555 679999987543 34455678899999999999999999998876 5678999999
Q ss_pred ccccccccccCCC----------------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 224 MEHDLAGLASHPG----------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 224 ~~g~ll~~~~~~~----------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
++++.+..+.... ..+++..++.++.||+.||.|||++||+|+||||+||||++++.+||+|||
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg 169 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFG 169 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCc
Confidence 9875544332211 458899999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 288 LASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 288 la~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
++........ .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+....+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~----- 243 (283)
T cd05048 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ----- 243 (283)
T ss_pred ceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 9976532221 2223345688999999987765 7999999999999999998 999999887766655543211
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......++..+.+|+.+||+.||.+|||+.+++++
T Consensus 244 -----------------------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 244 -----------------------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred -----------------------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011224678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.27 Aligned_cols=250 Identities=28% Similarity=0.445 Sum_probs=207.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||+++++++.. ...+|+||||++|
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 86 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIMEYLGG 86 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEecCCC
Confidence 349999999999999999999999999876533 3445678899999999999999999999877 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+.+..+... ..+++.++..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus 87 ~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~ 164 (277)
T cd06640 87 GSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGT 164 (277)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cccccccCc
Confidence 766555443 368999999999999999999999999999999999999999999999999997664322 222334678
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
..|+|||++.+.. ++.++|+|||||++|||++|.+||.+.........+... .+
T Consensus 165 ~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~----------------------- 218 (277)
T cd06640 165 PFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--NP----------------------- 218 (277)
T ss_pred ccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--CC-----------------------
Confidence 8999999988765 699999999999999999999999877655443332110 00
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.+|.+|||+.+++.|+||...
T Consensus 219 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 219 ---PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ---CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 11223467889999999999999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=327.65 Aligned_cols=254 Identities=28% Similarity=0.487 Sum_probs=206.7
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC---CCceeeeccceeccCCCeEEEEEe
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.||.|+||.||+|.+..+++.||+|.++... .......+.+|+.+++.+. ||||+++++++.. ...+|+|||
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~lv~e 82 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWIIME 82 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEEEEe
Confidence 344999999999999999999999999987643 2344566889999999996 9999999998876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.++.+..+...+ .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... .....
T Consensus 83 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~ 160 (277)
T cd06917 83 YAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRST 160 (277)
T ss_pred cCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-ccccc
Confidence 99886665555443 78999999999999999999999999999999999999999999999999998765433 22334
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.........+... ..+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-------------------~~~~ 221 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-------------------KPPR 221 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC-------------------CCCC
Confidence 468899999999876655789999999999999999999999876544332221110 0000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.+ ...++..+.+||..||+.||.+|||+.+++.|+||+...
T Consensus 222 ~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 222 LE--------DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CC--------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00 012678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.24 Aligned_cols=253 Identities=28% Similarity=0.397 Sum_probs=202.6
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+|++++||||+++++++.. ...+|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCCC
Confidence 68999999999999999999999998764332 2334556789999999999999999998876 56899999999976
Q ss_pred ccccccCCC--CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 228 LAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 ll~~~~~~~--~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+..+.... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||++..... ........+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~ 156 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRAG 156 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccccC
Confidence 555443322 3689999999999999999999999999999999999999999999999999876532 222234467
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
+..|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.........+.+..-.
T Consensus 157 ~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------------------- 212 (277)
T cd05577 157 TPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE----------------------- 212 (277)
T ss_pred CCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----------------------
Confidence 88999999988766 799999999999999999999999776542222222111000
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMKP 431 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~~ 431 (720)
........+++.+.+||.+||+.||.+|| ++.+++.||||....
T Consensus 213 --~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 213 --MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred --ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 01112345788999999999999999999 999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=352.01 Aligned_cols=253 Identities=30% Similarity=0.495 Sum_probs=206.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+||+|+||+||.|+|..|...+|||.+.... ...+.-+..||.+.++|+|.|||+++|.+.. ++.+-|+||-++|+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 6999999999999999999999999987543 4556678899999999999999999999766 67889999999987
Q ss_pred ccccccC-CCCCC--CHHHHHHHHHhhhhccccccccCcccccCcceeEEEc-CCCceeeeccccceecCCCCCCCcccc
Q 004999 228 LAGLASH-PGLKF--SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 228 ll~~~~~-~~~~l--se~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
.+..++. .=+++ .|..+-.|-+||++||.|||++.|||||||.+||||+ -.|.+||.|||.++.+.. -+....+.
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETF 736 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETF 736 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccccc
Confidence 6655443 33456 7889999999999999999999999999999999996 579999999999987642 22233456
Q ss_pred ccccCCCChhhhc-CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLL-GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~-~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.||+.|||||++. |...|+.++|||||||++.||.||+|||....... ..+|++ | +|+-
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--AAMFkV-G----------------myKv- 796 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--AAMFKV-G----------------MYKV- 796 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--Hhhhhh-c----------------ceec-
Confidence 7999999999995 44569999999999999999999999997543321 112221 0 1110
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
-...+..++.++++||.+|+..||.+||+|.++|+.||++..+
T Consensus 797 ------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 797 ------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred ------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 1122345778899999999999999999999999999998764
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.31 Aligned_cols=265 Identities=22% Similarity=0.333 Sum_probs=209.6
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecc
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~ 207 (720)
+.++|+.++. ||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++
T Consensus 3 ~~~~~~~~~~-----------ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 70 (284)
T cd06620 3 RNEDLETISD-----------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYG 70 (284)
T ss_pred cHHHHHHHHH-----------cCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEee
Confidence 3467788887 999999999999999999999999987543 2344567889999999999999999999
Q ss_pred ceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeecc
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
++.. ...+||||||++++.+..+......+++..+..++.||+.+|.|||+ .+|+|+||+|+||+++.++.++|+||
T Consensus 71 ~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~ 148 (284)
T cd06620 71 AFLN--ENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDF 148 (284)
T ss_pred eEec--CCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccC
Confidence 9877 57899999999987776665555678999999999999999999997 68999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHH----HHHHHHhcCC
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ----LHKIFKLCGS 362 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~----l~~i~~~~g~ 362 (720)
|++....... ....+++..|+|||++.+.. ++.++|||||||++|+|++|..||......+. ...++...
T Consensus 149 gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 222 (284)
T cd06620 149 GVSGELINSI---ADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL-- 222 (284)
T ss_pred Ccccchhhhc---cCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHH--
Confidence 9987542211 12346799999999987764 78999999999999999999999986544211 01110000
Q ss_pred CChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 363 p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
...+.. ..+..+ ...++..+.+||.+||+.||.+|||+.++++|+||...
T Consensus 223 --~~~~~~--------~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 223 --QQIVQE--------PPPRLP--------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred --HHHhhc--------cCCCCC--------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000000 000000 01367889999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=327.71 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=202.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccC---CCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM---SCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~---~~~lyL 219 (720)
.+...||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++ +||||+++++++.... ...+|+
T Consensus 25 ~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 33445999999999999999999999999986542 2234567899999999 8999999999886532 246899
Q ss_pred EEeecccccccccc----CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 220 VFEYMEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 220 V~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
||||++++.+..+. ..+..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 99999886554332 23457899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCccccccccCCCChhhhcCCc----CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGAT----YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~----~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
.. ......++..|+|||.+.... .++.++||||||||+|||++|++||........+..+.+. +...
T Consensus 182 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~~----- 252 (291)
T cd06639 182 RL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPPT----- 252 (291)
T ss_pred cc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCCC-----
Confidence 21 122346788999999986432 2578999999999999999999999887765555444221 0000
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
......++..+.+||.+||+.||++||++.++|+||||+
T Consensus 253 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 ------------------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ------------------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 001124567799999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.68 Aligned_cols=252 Identities=27% Similarity=0.477 Sum_probs=206.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
...+.||.|+||.||++.+..++..||+|.+..........+.+.+|+.+++.++|+||+++++.+.. ...+|+|+||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~ 80 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIVMEY 80 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEEEec
Confidence 34456999999999999999999999999998765444455677899999999999999999998876 6789999999
Q ss_pred ccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceecCCCCCCCc
Q 004999 224 MEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 224 ~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~ 300 (720)
+.+..+..+.. .+..+++..++.++.||+.||.|||+.+|+|+||||+||+++.++ .+||+|||++....... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~ 159 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-ELA 159 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-ccc
Confidence 98755544333 233579999999999999999999999999999999999999886 46999999998664322 222
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 160 ~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------- 218 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------------- 218 (257)
T ss_pred cccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc--------------------
Confidence 3345788999999987765 7899999999999999999999998776555544432210
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+......++..+.++|.+||..+|++|||+.+++.||||
T Consensus 219 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 --------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred --------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 111223577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.73 Aligned_cols=256 Identities=22% Similarity=0.241 Sum_probs=194.8
Q ss_pred cccceeecccCceEEEEEEECC----------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeec
Q 004999 143 SRSFYLIGQGTYSNVYRARDLD----------------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~----------------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
+++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|.+++||||++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 3444559999999999998532 34579999987543 344556789999999999999999999
Q ss_pred cceeccCCCeEEEEEeeccccccccccC-------------------CCCCCCHHHHHHHHHhhhhccccccccCccccc
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASH-------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~-------------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrD 267 (720)
+++.. ...+||||||+.++.+..+.. ....+++..+..++.||+.||.|||+.||+|+|
T Consensus 86 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 86 GVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 99876 567999999998754433221 113478889999999999999999999999999
Q ss_pred CcceeEEEcCCCceeeeccccceecCCCCCCC-ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh--CCCCC
Q 004999 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIM 344 (720)
Q Consensus 268 IKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt--G~ppf 344 (720)
|||+||||+.++.+||+|||++..+....... .....++..|+|||++.+.. ++.++|||||||++|||++ +..||
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999998653322211 12234578899999988765 7999999999999999987 55778
Q ss_pred CCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 345 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 345 ~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.+.+..+.+..+......... .. .......++..+.+||.+||+.||.+|||+.++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~-----------~~----------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 243 GELTDEQVIENAGEFFRDQGR-----------QV----------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CcCCHHHHHHHHHHHhhhccc-----------cc----------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 777665555444321100000 00 00112357889999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.15 Aligned_cols=249 Identities=28% Similarity=0.438 Sum_probs=198.1
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.+||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.. ...+|+||||+.+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 89 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFMEQVPG 89 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEEecCCC
Confidence 35999999999999999999999999887543 3445678899999999999999999999876 6789999999997
Q ss_pred cccccccC-CCCCC--CHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-CCceeeeccccceecCCCCCCCccc
Q 004999 227 DLAGLASH-PGLKF--SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 227 ~ll~~~~~-~~~~l--se~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
+.+..+.. ....+ ++..+..++.||+.||.|||+.||+|+||||+||+|+. ++.+||+|||++....... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~ 168 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTET 168 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC-Ccccc
Confidence 66554443 22345 88899999999999999999999999999999999976 6799999999997653222 22233
Q ss_pred cccccCCCChhhhcCCc-CCCccccchhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 303 RVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~-~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~-l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
..+++.|+|||++.+.. .++.++|||||||++|+|++|.+||........ +..+ ...
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~-------------------- 227 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMF-------------------- 227 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhh--------------------
Confidence 45789999999986542 378899999999999999999999875432211 1111 000
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.........+++.+.+||.+||+.+|.+|||+.+++.||||
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00111234578889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=345.13 Aligned_cols=287 Identities=32% Similarity=0.531 Sum_probs=232.8
Q ss_pred hhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC------CCceeeecc
Q 004999 134 KLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD------HINVIKLEG 207 (720)
Q Consensus 134 ~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~------HpnIvkl~~ 207 (720)
.+.+.+...|.+....|+|-|++|..|.|..-|..||||+|+.+.+ ..+.=+.|+.||++|+ --|+++|+.
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 3456688899999999999999999999999999999999987643 2233468999999994 458899988
Q ss_pred ceeccCCCeEEEEEeeccccccccccCCC--CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-Cceeee
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIA 284 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~ 284 (720)
.|.. .+++|||||-+.-+|..++...+ ..|....++.|++||+.||..|-..||+|.||||+||||+.. ..+|||
T Consensus 502 ~F~h--knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 502 HFKH--KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred Hhhh--cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeec
Confidence 8876 78999999999887777666533 457888999999999999999999999999999999999865 578999
Q ss_pred ccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 285 DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 285 DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
|||.|.....+ ..+.+.++..|+|||+++|.+ |+...|+||+||+||||+||+.+|+|.++...+.-.+.+-|..+
T Consensus 580 DfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 580 DFGSASFASEN---EITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred cCccccccccc---cccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 99999887543 357788899999999999988 89999999999999999999999999999999998888888888
Q ss_pred hhhhhhcCCCC-----c-----------------cccCCCCccchhhhcccC--CCC-------HhHHHHHHHhcccCCC
Q 004999 365 EDYWRKSKLPH-----A-----------------TIFKPQQPYKRCVAETFK--DFP-------APALALMETLLSIDPA 413 (720)
Q Consensus 365 ~~~w~~~~l~~-----~-----------------~~~~~~~~~~~~~~e~~~--~~~-------~~~~dLI~~mL~~DP~ 413 (720)
..+..+..+.. . ..+....|.+....++.. .++ ..+.+||.+||..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 77754432211 0 111122232222222221 133 3588999999999999
Q ss_pred CCCCHHHHHhCccCCC
Q 004999 414 DRGSAASALRSEFFTM 429 (720)
Q Consensus 414 kRpTa~e~L~hp~f~~ 429 (720)
+|.|..++|.||||+.
T Consensus 736 KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 736 KRITVNQALKHPFITE 751 (752)
T ss_pred hcCCHHHHhcCCcccC
Confidence 9999999999999974
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=331.47 Aligned_cols=250 Identities=29% Similarity=0.440 Sum_probs=208.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
..||+|+||.||+|++..++..||||++..... .......+.+|+.+++.++||||+++++++.. ....|+||||+.
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 104 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWLVMEYCL 104 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEEecCC
Confidence 349999999999999999999999999976543 34455678899999999999999999999877 577999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
++++..+......+++.+++.++.||+.+|.|||++||+|+||+|+||+++.++.+||+|||++.... ......+
T Consensus 105 ~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~~~~~~~ 179 (313)
T cd06633 105 GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVG 179 (313)
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----CCCCccc
Confidence 88777766656679999999999999999999999999999999999999999999999999986432 1234467
Q ss_pred ccCCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 306 TLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 306 T~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+..|+|||++.+ ...++.++|||||||++|+|++|.+||.+......+..+... ..+
T Consensus 180 ~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~~-------------------- 238 (313)
T cd06633 180 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DSP-------------------- 238 (313)
T ss_pred cccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CCC--------------------
Confidence 889999999853 234788999999999999999999999887766665554321 000
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.+|.+|||+.++|.||||...
T Consensus 239 ------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 239 ------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred ------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 00113467789999999999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=321.14 Aligned_cols=251 Identities=32% Similarity=0.437 Sum_probs=208.1
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||.|++|.||+|.+..+++.|+||++...... .....+.+|+.++.+++|+||+++++++.. ...+|+||||++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~ 82 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVLEYMD 82 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEEEecC
Confidence 34599999999999999999999999998866432 456778999999999999999999999876 578999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
++.+..+......+++..++.++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-~~~~~~ 161 (264)
T cd06623 83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFV 161 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-ccccee
Confidence 76666555555689999999999999999999999 9999999999999999999999999999987643222 223446
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~---~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.... ..+....+.. ..
T Consensus 162 ~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~------------------ 219 (264)
T cd06623 162 GTVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP------------------ 219 (264)
T ss_pred ecccccCHhhhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC------------------
Confidence 789999999987764 7999999999999999999999998774 2222222221 00
Q ss_pred CCccchhhhcccCC-CCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 382 QQPYKRCVAETFKD-FPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 382 ~~~~~~~~~e~~~~-~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
....... ++..+.+||..||..+|.+|||+.++|+||||+.
T Consensus 220 -------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 220 -------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred -------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 0011123 7889999999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.60 Aligned_cols=251 Identities=30% Similarity=0.425 Sum_probs=206.5
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||.|+||.||++.+..+++.||||++..... .......+.+|+.++++++||||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEecCCCC
Confidence 6899999999999999999999999976543 33456678899999999999999999998876 67899999999876
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-------CCc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-------QPL 300 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-------~~~ 300 (720)
.+..+......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........ ...
T Consensus 79 ~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 158 (265)
T cd05579 79 DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158 (265)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence 5555444444789999999999999999999999999999999999999999999999999875432211 122
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....++..|+|||.+.+.. ++.++|||||||++|+|++|..||......+....+......+
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 220 (265)
T cd05579 159 KRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEW----------------- 220 (265)
T ss_pred cCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCC-----------------
Confidence 3345788999999988766 6899999999999999999999998877666555543210000
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH---HHHHhCccCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA---ASALRSEFFTM 429 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa---~e~L~hp~f~~ 429 (720)
.. ...++..+.+||.+||+.+|.+|||+ .++|.||||+.
T Consensus 221 ---------~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 221 ---------PE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred ---------Cc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 00 01258889999999999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=320.71 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=206.8
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN---LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
++.++||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.++++++|+||+++++++.......+++|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 44456999999999999999999999999986432 134456778899999999999999999998876545678999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC--CC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ--NQ 298 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~--~~ 298 (720)
|||+.+..+.........+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (264)
T cd06653 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164 (264)
T ss_pred EEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccccCc
Confidence 9999876655444444568999999999999999999999999999999999999999999999999997653211 11
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......++..|+|||++.+.. ++.++|+|||||++|+|++|++||........+.++. ..+..
T Consensus 165 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~------------- 227 (264)
T cd06653 165 GIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQPTK------------- 227 (264)
T ss_pred cccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCCCC-------------
Confidence 223346789999999998765 6899999999999999999999998776555544432 11110
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......+++.+.++|.+||. +|..|||+.++|.|||.
T Consensus 228 -----------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 228 -----------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -----------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 11234678899999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=321.51 Aligned_cols=250 Identities=29% Similarity=0.399 Sum_probs=201.6
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHH-HhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHIL-RRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL-~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||.|+||.||+|.+..+++.||||+++.... .......+..|..++ ..++|+||+++++++.. ...+|+||||+.
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~ 80 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYLN 80 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEeccC
Confidence 49999999999999999999999999876533 222333445555544 44589999999999876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
++.+..+......+++.++..++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++..... .....+
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~~~ 155 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVG 155 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cccCCC
Confidence 876666665556789999999999999999999999999999999999999999999999999875432 123457
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
++.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+.......+...... |
T Consensus 156 ~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~----------------- 212 (260)
T cd05611 156 TPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-----W----------------- 212 (260)
T ss_pred CcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC-----C-----------------
Confidence 88999999998776 799999999999999999999999887766555544321100 0
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCC---HHHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||+.||++||| +.|+|.||||...
T Consensus 213 ---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 213 ---PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ---CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 00112357889999999999999999995 5899999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=338.87 Aligned_cols=273 Identities=26% Similarity=0.357 Sum_probs=203.5
Q ss_pred CCCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeee
Q 004999 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 126 p~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
+.+.++|.++.+++++|+.. .+||+|+||.||+|.... +..||||++....... .+.|.+|+.+|.+++|||||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~-~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSES-NLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchh-cceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccE
Confidence 45678999999999999953 349999999999999754 4889999887654322 3459999999999999999999
Q ss_pred ccceeccCCC-eEEEEEeecccccccccc-CCCC-CCCHHHHHHHHHhhhhccccccccC---cccccCcceeEEEcCCC
Q 004999 206 EGLVTSRMSC-SLYLVFEYMEHDLAGLAS-HPGL-KFSEAQVKCYMQQLLCGLDHCHSRG---VLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 206 ~~~~~~~~~~-~lyLV~Ey~~g~ll~~~~-~~~~-~lse~~~~~i~~QIl~gL~yLH~~g---IvHrDIKP~NILld~~g 279 (720)
+|||.+ .. ..+||+|||..+.+...+ .... .++|.....|+.+++.||+|||... |||||||++|||||.++
T Consensus 137 lGyC~e--~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~ 214 (361)
T KOG1187|consen 137 LGYCLE--GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF 214 (361)
T ss_pred EEEEec--CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence 999987 44 699999999965554444 4333 8999999999999999999999864 99999999999999999
Q ss_pred ceeeeccccceecCCCCCCCcccc-ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChH--HHHHHH
Q 004999 280 ILKIADFGLASFYDPDQNQPLTSR-VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV--EQLHKI 356 (720)
Q Consensus 280 ~vKL~DFGla~~~~~~~~~~~t~~-~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~--e~l~~i 356 (720)
++||+|||+|...... ....... .||..|+|||++.... .+.++||||||++|+||+||+++....... ..+...
T Consensus 215 ~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 215 NAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999999999654321 1112222 7899999999998754 799999999999999999999877643211 101110
Q ss_pred HHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCC-----HhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 357 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFP-----APALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 357 ~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~-----~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
. ...|.+. ....++.+.... ...+ ..+..+...|++.+|.+||++.++++
T Consensus 293 ~-------~~~~~~~--~~~eiiD~~l~~--------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 293 A-------KPLLEEG--KLREIVDPRLKE--------GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred H-------HHHHHCc--chhheeCCCccC--------CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0 0011111 111112222110 0111 22667778999999999999999754
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.28 Aligned_cols=277 Identities=23% Similarity=0.310 Sum_probs=204.4
Q ss_pred eccc--CceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G--~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||.| +||+||+|.+..+++.||||++..........+.+.+|+.+++.++||||+++++++.. ...+|+||||+.+
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~~~ 83 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFMAY 83 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecccC
Confidence 6766 99999999999999999999998766666667889999999999999999999999977 6679999999997
Q ss_pred cccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-----
Q 004999 227 DLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP----- 299 (720)
Q Consensus 227 ~ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~----- 299 (720)
+.+..+... ...+++..++.++.||+.||+|||+.||+||||||+||||+.++.+||+||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 555444332 2358999999999999999999999999999999999999999999999998654331111100
Q ss_pred -ccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 300 -LTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 300 -~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.....++..|+|||++.+. ..++.++|||||||++|+|++|.+||.+......+..++......+ |.....+...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 240 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSP---LDITTFPCEE 240 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCC---ccccccchhh
Confidence 0112345679999999764 3378999999999999999999999988766555444433211110 1000000000
Q ss_pred -----------------ccC----CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 378 -----------------IFK----PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 378 -----------------~~~----~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
... ...............+++.+.+||.+||+.||++|||+.++|+|+||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 000 00000000011123467789999999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.02 Aligned_cols=247 Identities=29% Similarity=0.445 Sum_probs=207.0
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||+|+||.||++++..++..||||++..... ..+....+.+|+.+++.++||||+++++++.. ....|+||||+.|.
T Consensus 33 lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~g~ 110 (317)
T cd06635 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWLVMEYCLGS 110 (317)
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEEEEeCCCCC
Confidence 9999999999999999999999999876533 34555678899999999999999999999876 56789999999998
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
++..+......+++.++..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++..... .....+++
T Consensus 111 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----~~~~~~~~ 185 (317)
T cd06635 111 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-----ANSFVGTP 185 (317)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----cccccCCc
Confidence 7776655566799999999999999999999999999999999999999999999999999875432 22346788
Q ss_pred CCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 308 WYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 308 ~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
.|+|||++.+ ...++.++|||||||++|+|++|.+||.+......+..+......+
T Consensus 186 ~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------------------- 243 (317)
T cd06635 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------------------- 243 (317)
T ss_pred cccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC----------------------
Confidence 9999999853 2347899999999999999999999998876666555554321100
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.....+++.+.+||.+||+.+|.+|||+.++++|+|+..
T Consensus 244 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 244 -----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 011246778999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.00 Aligned_cols=252 Identities=31% Similarity=0.474 Sum_probs=210.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
.+.+.||.|+||.||++.+..++..||+|++............+.+|+.+++.++|+||+++++.+.. ...+++||||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv~e~ 80 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIVMEY 80 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEEEEe
Confidence 44456999999999999999999999999998776666667788999999999999999999998876 5789999999
Q ss_pred ccccccccccCC----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 224 MEHDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 224 ~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
+++..+...... +..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 997555433322 3679999999999999999999999999999999999999999999999999998764432 12
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
.....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 219 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ------------------- 219 (258)
T ss_pred ecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------------
Confidence 23346788999999987766 7899999999999999999999998776544444432210
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......++..+.++|..||..+|++|||+.++|+||||
T Consensus 220 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 ---------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.36 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=208.7
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.++..+.||.|+||.||+|.+..++..||||++..... ......+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEE
Confidence 34445559999999999999999999999999875433 3445678899999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||++++++..+... ..+++..+..++.||+.+|.|||+.|++|+||+|+||+++.++.++|+|||++..+.... ....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~ 159 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRN 159 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhhc
Confidence 99998766555443 368999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
...++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||...........+... .
T Consensus 160 ~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~-------------------- 217 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-N-------------------- 217 (277)
T ss_pred cccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-C--------------------
Confidence 346788999999987655 688999999999999999999999876654444433211 0
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......++..+.++|..||+.+|.+||++.++++|+||...
T Consensus 218 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 218 -------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred -------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 001123578889999999999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.94 Aligned_cols=251 Identities=33% Similarity=0.510 Sum_probs=207.9
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEe
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
..+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++++. ||||+++++++.. ...+|+|||
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e 82 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLYFVLE 82 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEEEEEc
Confidence 34459999999999999999999999999876433 3344567889999999998 9999999998866 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-----
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN----- 297 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~----- 297 (720)
|+.++.+..+......+++..++.++.||+.||.|||++|++|+||+|+||+|+.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~ 162 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCC
Confidence 997655554554555799999999999999999999999999999999999999999999999999986643221
Q ss_pred --------------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 004999 298 --------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 363 (720)
Q Consensus 298 --------------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p 363 (720)
.......++..|+|||++.+.. ++.++|||||||++++|++|..||........+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--- 238 (280)
T cd05581 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE--- 238 (280)
T ss_pred CCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC---
Confidence 1122345688999999988765 6899999999999999999999999887655555543211
Q ss_pred ChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH----HHHHhCccC
Q 004999 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFF 427 (720)
Q Consensus 364 ~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hp~f 427 (720)
......+++.+.+||.+||+.||.+|||+ .++|.||||
T Consensus 239 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 --------------------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred --------------------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 11223568889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.57 Aligned_cols=277 Identities=22% Similarity=0.287 Sum_probs=203.4
Q ss_pred eccc--CceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G--~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||+| +++.||++++..+++.||||++............+.+|+.+++.++|+||+++++++.. ...+|++|||+.+
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCC
Confidence 4444 55667777777799999999998775566677889999999999999999999998876 6779999999997
Q ss_pred cccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC------C
Q 004999 227 DLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN------Q 298 (720)
Q Consensus 227 ~ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~------~ 298 (720)
+++..+... ...+++..++.++.||+.||.|||+++|+|+||||+||||+.++.+||+|||.+..+..... .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 666544432 34689999999999999999999999999999999999999999999999998875532111 1
Q ss_pred CccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 299 PLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......++..|+|||++.+. ..|+.++|||||||++|||++|..||........+..... +.... .+.....+...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~ 240 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPC-LLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcc-ccccCchhhhc
Confidence 12233567889999998764 3478999999999999999999999987665544332222 11110 01000000000
Q ss_pred c--------cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 378 I--------FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 378 ~--------~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
. .................++..+.+||..||+.||++|||+.++|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0 0000000000111122456789999999999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=321.23 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=197.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+||+++++++.. ...+|+||||+.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 86 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTY 86 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEEEEeCCC
Confidence 34999999999999999999999999987542 335568899999999999999999998876 6678999999987
Q ss_pred cccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 227 DLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 227 ~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...............
T Consensus 87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 166 (263)
T cd05052 87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 166 (263)
T ss_pred CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCC
Confidence 55544332 2346899999999999999999999999999999999999999999999999999876432221111223
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+....+.... .
T Consensus 167 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------------~--- 223 (263)
T cd05052 167 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------------R--- 223 (263)
T ss_pred CccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------------C---
Confidence 356799999987765 6899999999999999998 999998876655544442210 0
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......++..+.+||.+||..||++|||+.++++.
T Consensus 224 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 224 ------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 01224578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=326.04 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=208.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||++.+..++..||||++.... ......+.+|+.+++.++|+||+++++++.. ....|+||||+.++.
T Consensus 28 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~ 103 (292)
T cd06657 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGGA 103 (292)
T ss_pred cCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecCCCCc
Confidence 999999999999999999999999986432 3345668899999999999999999999876 678999999999876
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
+..+... ..+++..++.++.||+.+|.|||+.||+|+||+|+||+|+.++.++|+|||++....... .......+++.
T Consensus 104 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~ 181 (292)
T cd06657 104 LTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPY 181 (292)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccccCcc
Confidence 6655543 368999999999999999999999999999999999999999999999999987654322 22234567899
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+....+.+..+......
T Consensus 182 y~~pE~~~~~~-~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~-------------------------- 234 (292)
T cd06657 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-------------------------- 234 (292)
T ss_pred ccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc--------------------------
Confidence 99999887655 689999999999999999999999887766655544321100
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
.......++..+.+||.+||..||.+||++.++|.|+||.....
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 235 KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 00112346888999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=319.41 Aligned_cols=251 Identities=20% Similarity=0.251 Sum_probs=198.6
Q ss_pred cceeecccCceEEEEEEECC---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC----CeE
Q 004999 145 SFYLIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----CSL 217 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~---tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~----~~l 217 (720)
+.++||+|+||.||+|.+.. ++..||||+++...........+.+|+.+++.++||||+++++++..... ...
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 34459999999999998764 34789999998765556667788999999999999999999998755221 247
Q ss_pred EEEEeecccccccccc------CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 218 YLVFEYMEHDLAGLAS------HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~------~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
++||||+.++.+..+. .....+++..+..++.||+.||.|||+.+|+|+||||+||++++++.+||+|||++..
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 162 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccceee
Confidence 9999999975543332 1224689999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 292 YDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 292 ~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
....... .......+..|+|||.+.+.. ++.++||||||||+|||++ |.+||.+....+.+..+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--------- 232 (273)
T cd05035 163 IYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN--------- 232 (273)
T ss_pred ccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---------
Confidence 5432221 111223467899999987655 7999999999999999999 889998877666554443210
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus 233 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 -------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=317.37 Aligned_cols=247 Identities=25% Similarity=0.442 Sum_probs=202.7
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||.|+||.||++.+..++..||+|.++.... ....+.+.+|+.+++.++|+||+++++.+.. ...+|+||||+
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 80 (255)
T cd08219 4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIVMEYC 80 (255)
T ss_pred EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEEeeC
Confidence 44569999999999999999999999999876533 3445678899999999999999999998876 67899999999
Q ss_pred ccc-ccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 225 EHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 225 ~g~-ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
.++ +...+.. .+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~ 159 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GAYACT 159 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-cccccc
Confidence 864 4443332 3446899999999999999999999999999999999999999999999999999765432 222234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+++.|+|||++.+.. ++.++|+|||||++|+|++|.+||...+.......+......
T Consensus 160 ~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 218 (255)
T cd08219 160 YVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-------------------- 218 (255)
T ss_pred ccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--------------------
Confidence 56889999999987765 799999999999999999999999887765555544321110
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||.+||+.||++|||+.++|.-
T Consensus 219 --------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1123467789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=326.99 Aligned_cols=248 Identities=29% Similarity=0.458 Sum_probs=205.8
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||.|+||.||+|++..++..||||.+..... .......+.+|+.+++.++|+||+++++++.. ....|+||||+.|.
T Consensus 23 lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 100 (308)
T cd06634 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGS 100 (308)
T ss_pred eeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCeeEEEEEccCCC
Confidence 9999999999999999999999999875432 34455678899999999999999999998876 56789999999987
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
+...+......+++.++..++.||+.||.|||+.+++|+||+|+|||++.++.+||+|||++...... ....+++
T Consensus 101 l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~ 175 (308)
T cd06634 101 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTP 175 (308)
T ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-----ccccCCc
Confidence 77666555567899999999999999999999999999999999999999999999999998765432 2346788
Q ss_pred CCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 308 WYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 308 ~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
.|+|||.+.+ ...++.++|||||||++|+|++|..||......+.+..+.... .+
T Consensus 176 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------- 232 (308)
T cd06634 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SP---------------------- 232 (308)
T ss_pred cccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-CC----------------------
Confidence 9999999853 2336889999999999999999999987766555444432210 00
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||..+|.+|||+.+++.|+||...
T Consensus 233 ----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00113567889999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=325.21 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=200.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++.....+.+|+||||+++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 349999999999999999999999999876533 2455678899999999999999999998876556689999999987
Q ss_pred cccccc----cCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 227 DLAGLA----SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 227 ~ll~~~----~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
+.+..+ ......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 162 (287)
T cd06621 86 GSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGT 162 (287)
T ss_pred CCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc---ccc
Confidence 544322 2234568999999999999999999999999999999999999999999999999987543221 123
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-----EVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~-----~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
..++..|+|||.+.+.. ++.++||||||||+|+|++|..||.... ..+....+... .... .
T Consensus 163 ~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~-~--------- 228 (287)
T cd06621 163 FTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM---PNPE-L--------- 228 (287)
T ss_pred ccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC---Cchh-h---------
Confidence 45688899999987765 7999999999999999999999997652 12222222110 0000 0
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
+.. ...-...++.+.+||.+||..||.+|||+.++++|+||..
T Consensus 229 ---~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 271 (287)
T cd06621 229 ---KDE------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271 (287)
T ss_pred ---ccC------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccc
Confidence 000 0000134677999999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=317.45 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=195.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++..+++.||+|.+... ...+....+.+|+.+++.++||||+++++++.. ...+||||||+.++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGG 78 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCC
Confidence 399999999999999999999999988643 334556778999999999999999999998876 56799999999876
Q ss_pred cccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-cccccc
Q 004999 228 LAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-LTSRVV 305 (720)
Q Consensus 228 ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~t~~~g 305 (720)
.+..+. ..+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......... ......
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 555443 344568999999999999999999999999999999999999999999999999987543211110 011122
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+..|+|||.+.+.. ++.++||||||||+|||++ |.+||...........+.....
T Consensus 159 ~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~----------------------- 214 (252)
T cd05084 159 PVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR----------------------- 214 (252)
T ss_pred ceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------------------
Confidence 45699999987765 7999999999999999998 8888877665544443322100
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||.+||+.||++|||+.++++
T Consensus 215 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 215 -----LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred -----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112346788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=313.80 Aligned_cols=251 Identities=29% Similarity=0.487 Sum_probs=210.8
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||+|++|.||++.+..+++.||+|.+............+.+|+.++++++|+||+++++++.. ...+|+||||+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~ 81 (254)
T cd06627 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIILEYA 81 (254)
T ss_pred eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEEecC
Confidence 3455999999999999999999999999998776555667789999999999999999999998876 57899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
++..+..+......+++..+..++.||+.+|.|||+.||+|+||+|+||+++.++.++|+|||++........ ......
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 160 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVV 160 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-cccccc
Confidence 9866665555556899999999999999999999999999999999999999999999999999987644322 123346
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
++..|+|||.+.+.. ++.++|||+||+++|+|++|.+||........+.++... .
T Consensus 161 ~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~----------------------- 215 (254)
T cd06627 161 GTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-D----------------------- 215 (254)
T ss_pred cchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-C-----------------------
Confidence 788999999987765 789999999999999999999999876655444443210 0
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......++..+.++|.+||..+|++|||+.+++.|+||
T Consensus 216 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 216 ----HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 011223568899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=312.67 Aligned_cols=257 Identities=30% Similarity=0.493 Sum_probs=209.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|++|.||+|.+..++..|++|++............+.+|+.++++++|+||+++++.+.......+|+||||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34456999999999999999999999999998766555667889999999999999999999998876322789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-Cccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTS 302 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~t~ 302 (720)
+.+..+..+......+++.+++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......... ....
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 162 (260)
T cd06606 83 VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162 (260)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccC
Confidence 987666655555558999999999999999999999999999999999999999999999999999876543221 1234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..++..|+|||.+.+.. ++.++|||||||++|+|++|..||..... ....+.+....
T Consensus 163 ~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~-------------------- 219 (260)
T cd06606 163 VRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSS-------------------- 219 (260)
T ss_pred CCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhcccc--------------------
Confidence 46788999999987766 69999999999999999999999987662 11122111100
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.........++..+.+||.+||+.||.+||++.++|.||||
T Consensus 220 ----~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 220 ----GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ----CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 00112223568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.80 Aligned_cols=245 Identities=22% Similarity=0.338 Sum_probs=191.4
Q ss_pred eecccCceEEEEEEECCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~t-----g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.||+|+||.||+|++..+ +..||||+++.... ......+.+|+.+++.+ +|+|||++++++.. ...+|+||
T Consensus 45 ~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--~~~~~lv~ 121 (374)
T cd05106 45 TLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTH--GGPVLVIT 121 (374)
T ss_pred eecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecC--CCCeEEeH
Confidence 399999999999986443 35799999976543 34456788999999999 89999999999876 56899999
Q ss_pred eeccccccccccC-------------------------------------------------------------------
Q 004999 222 EYMEHDLAGLASH------------------------------------------------------------------- 234 (720)
Q Consensus 222 Ey~~g~ll~~~~~------------------------------------------------------------------- 234 (720)
|||.++.+..+..
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 9998654432211
Q ss_pred ---CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-ccccccccCCC
Q 004999 235 ---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-LTSRVVTLWYR 310 (720)
Q Consensus 235 ---~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~t~~~gT~~Y~ 310 (720)
....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....... .....+++.|+
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~ 281 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWM 281 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcccee
Confidence 11347889999999999999999999999999999999999999999999999997653322111 11223456799
Q ss_pred ChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhh
Q 004999 311 PPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCV 389 (720)
Q Consensus 311 APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~ 389 (720)
|||++.+.. |+.++|||||||++|||++ |..||........+..+.+....+
T Consensus 282 aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-------------------------- 334 (374)
T cd05106 282 APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-------------------------- 334 (374)
T ss_pred CHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc--------------------------
Confidence 999997765 7999999999999999997 999998765544443333211000
Q ss_pred hcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 390 AETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 390 ~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++++.+||.+||+.||.+|||+.++++
T Consensus 335 -~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 -SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011235789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.46 Aligned_cols=243 Identities=23% Similarity=0.368 Sum_probs=196.7
Q ss_pred ecccCceEEEEEEECC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 149 IGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~-----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
||+|+||.||+|.+.. ++..||||+++... ..+....+.+|+.+|+.++|+||+++++++.. ...+|+||||
T Consensus 13 lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~ 89 (280)
T cd05049 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTE--GDPPIMVFEY 89 (280)
T ss_pred ccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CCCeEEEEec
Confidence 9999999999998743 46789999987543 23345778999999999999999999999877 5789999999
Q ss_pred ccccccccccC--------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 224 MEHDLAGLASH--------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 224 ~~g~ll~~~~~--------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
+.++.+..+.. ....+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~ 169 (280)
T cd05049 90 MEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169 (280)
T ss_pred CCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccc
Confidence 98765544332 1235889999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
........ .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+....+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~------- 241 (280)
T cd05049 170 RDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR------- 241 (280)
T ss_pred eecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------
Confidence 75432221 1122334578899999998766 7999999999999999998 999998877666555543211
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......++..+.+||.+||+.||.+|||+.|+++
T Consensus 242 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 242 ---------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred ---------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 01112357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.60 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=213.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+|-+||+|.|..+|..||.-.++...+ .+...++|..|+.+|+.|+|||||++|..|.+.....+.+|+|+|.
T Consensus 47 vLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 47 VLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred hcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 59999999999999999999999877666544 5666789999999999999999999999999877778999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCC-CceeeeccccceecCCCCCCCccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNN-GILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
.++|..+......++...++.|++||+.||.|||++. |+|||||.+||+|+.+ |.|||+|+|||..+... ....
T Consensus 127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---~aks 203 (632)
T KOG0584|consen 127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---HAKS 203 (632)
T ss_pred CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---ccce
Confidence 9999999988889999999999999999999999996 9999999999999865 89999999999986432 3345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+|||.|||||++.. .|+..+||||||+.|+||+|+.-||..-....++.+-+- .|..+.-+
T Consensus 204 vIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~sl--------------- 265 (632)
T KOG0584|consen 204 VIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPAAL--------------- 265 (632)
T ss_pred eccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHHHh---------------
Confidence 799999999999974 389999999999999999999988877655544433322 12222111
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.+--.+++++||.+||.. ..+|+|+.|+|.|+||...
T Consensus 266 ----------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 266 ----------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 122367899999999999 9999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=364.80 Aligned_cols=262 Identities=29% Similarity=0.455 Sum_probs=208.0
Q ss_pred CCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeec
Q 004999 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 127 ~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
+...+||++.- ||+||||.||+++++-+|+.||||+|.... .......+.+|+.+|++|+|||||+++
T Consensus 476 RY~~DFEEL~l-----------LGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYy 543 (1351)
T KOG1035|consen 476 RYLNDFEELEL-----------LGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYY 543 (1351)
T ss_pred hHhhhhHHHHH-----------hcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 34678999998 999999999999999999999999998776 566778899999999999999999998
Q ss_pred cceeccC-------------------------------------------------------------------------
Q 004999 207 GLVTSRM------------------------------------------------------------------------- 213 (720)
Q Consensus 207 ~~~~~~~------------------------------------------------------------------------- 213 (720)
..|.+..
T Consensus 544 sAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~ 623 (1351)
T KOG1035|consen 544 SAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDS 623 (1351)
T ss_pred hhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccc
Confidence 6442100
Q ss_pred ------------------------------------C--------CeEEEEEeeccccccccccCCCCCC-CHHHHHHHH
Q 004999 214 ------------------------------------S--------CSLYLVFEYMEHDLAGLASHPGLKF-SEAQVKCYM 248 (720)
Q Consensus 214 ------------------------------------~--------~~lyLV~Ey~~g~ll~~~~~~~~~l-se~~~~~i~ 248 (720)
+ ..+||-||||+..++..+...+... ....+++++
T Consensus 624 dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLF 703 (1351)
T KOG1035|consen 624 DEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLF 703 (1351)
T ss_pred cccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHH
Confidence 0 1379999999999998888776544 478899999
Q ss_pred HhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecC-----------------CCCCCCccccccccCCCC
Q 004999 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD-----------------PDQNQPLTSRVVTLWYRP 311 (720)
Q Consensus 249 ~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~-----------------~~~~~~~t~~~gT~~Y~A 311 (720)
+||++||.|+|+.|||||||||.||++++++.|||+|||+|.... .......|..+||.-|+|
T Consensus 704 reIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 704 REILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeec
Confidence 999999999999999999999999999999999999999998721 112235678899999999
Q ss_pred hhhhcCCc--CCCccccchhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 312 PELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 312 PE~l~~~~--~y~~~sDIWSLG~iL~ELltG~ppf~g-~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
||++.+.. .|+.++||||||+||+||+.- |.. ++....+..+.+ |. +|..
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~--g~----------iP~~------------ 836 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRK--GS----------IPEP------------ 836 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhccc--CC----------CCCC------------
Confidence 99998766 699999999999999999863 543 233333333321 11 1110
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
..++.+--+.-..+|..||+.||.+||||.|+|.+.||-
T Consensus 837 -~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 837 -ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred -cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 011112223467899999999999999999999999986
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=318.83 Aligned_cols=243 Identities=22% Similarity=0.309 Sum_probs=198.9
Q ss_pred ecccCceEEEEEEE--CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYSNVYRARD--LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~--~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||+|+||.||+|.+ ..++..||||+++....+....+.+.+|+.+++.++||||+++++++.. ...++||||+.+
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~ 79 (257)
T cd05116 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAEL 79 (257)
T ss_pred CCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCCC
Confidence 99999999999965 4678899999998665556667788999999999999999999998743 457999999997
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC--Cccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLTSRV 304 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~--~~t~~~ 304 (720)
+.+..+......+++..+..++.||+.||.|||++||+|+||||.|||++.++.+||+|||++..+...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 766555555557999999999999999999999999999999999999999999999999999866433221 112223
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
++..|+|||.+.... ++.++|||||||++|||++ |.+||.+....+....+.+...
T Consensus 160 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~---------------------- 216 (257)
T cd05116 160 WPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER---------------------- 216 (257)
T ss_pred CCccccCHhHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC----------------------
Confidence 357899999887654 7899999999999999998 9999988777666665532110
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||..||+.||.+||++.++.+
T Consensus 217 ------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 217 ------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 0122357889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.16 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=216.8
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEee
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.+||+|+||.|.+|..+.+.+.||||+++++.+ ..+.++..+.|-++|+.. +-|.+++|+..|.. -..+|+||||
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRLyFVMEy 431 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRLYFVMEY 431 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhheeeEEEE
Confidence 3469999999999999999999999999998865 556667778899999877 57888999998877 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.|+.+-..++.-++|.|+.+..|+..|+-||-|||++||++||||.+|||++.+|++||+|||+++.--- ......+.
T Consensus 432 vnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~~~TTkTF 510 (683)
T KOG0696|consen 432 VNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-DGVTTKTF 510 (683)
T ss_pred ecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-CCcceeee
Confidence 99754444444455899999999999999999999999999999999999999999999999999985322 22334567
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
||||.|+|||++.-.+ |+.++|.||+||+|||||.|++||.|.++.+....|....
T Consensus 511 CGTPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------------------- 566 (683)
T KOG0696|consen 511 CGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------------------- 566 (683)
T ss_pred cCCCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----------------------
Confidence 9999999999998877 8999999999999999999999999999999998887532
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH-----HHHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hp~f~~~ 430 (720)
...++.++.++.+++..+|.+.|.+|..+ .++-.||||+..
T Consensus 567 ------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 567 ------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred ------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 22346789999999999999999999753 688999999854
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=341.72 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=201.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|.||+||+|++..+ ||||++......++.++.|.+|+.++++-+|.||+-+.|++... .+.||+-||+|.
T Consensus 399 rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~AIiTqwCeGs 472 (678)
T KOG0193|consen 399 RIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLAIITQWCEGS 472 (678)
T ss_pred eeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---ceeeeehhccCc
Confidence 499999999999998543 99999999988889999999999999999999999999999862 349999999997
Q ss_pred ccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCC-CCCCCcccccc
Q 004999 228 LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP-DQNQPLTSRVV 305 (720)
Q Consensus 228 ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~-~~~~~~t~~~g 305 (720)
.|+..++ ...+|.....+.|++||+.|+.|||.++|||||||..||+|.+++.|||+||||+..-.. .........-|
T Consensus 473 SLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~g 552 (678)
T KOG0193|consen 473 SLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHG 552 (678)
T ss_pred hhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCcc
Confidence 6665544 557899999999999999999999999999999999999999999999999999975421 11222233345
Q ss_pred ccCCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 306 TLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 306 T~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
...|||||++.. ...|++.+||||||||+|||+||..||........+.++=+..+.|.
T Consensus 553 silwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd------------------- 613 (678)
T KOG0193|consen 553 SLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD------------------- 613 (678)
T ss_pred chhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc-------------------
Confidence 677999999964 34589999999999999999999999984443333333211111111
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
+.....+.+.++++|+..||.+++++||+..++|.
T Consensus 614 -----~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 -----LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred -----chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 23344578889999999999999999999999997
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.19 Aligned_cols=246 Identities=23% Similarity=0.354 Sum_probs=191.8
Q ss_pred eecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.||+|+||.||+|++ ..++..||||+++.... ....+.+.+|+.+|+.+ +||||+++++++.. ....|+||
T Consensus 42 ~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~~~~~lv~ 118 (375)
T cd05104 42 TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTV--GGPTLVIT 118 (375)
T ss_pred eecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--CCcceeee
Confidence 399999999999974 35677899999975432 23456788999999999 89999999999876 66799999
Q ss_pred eecccccc-ccccC------------------------------------------------------------------
Q 004999 222 EYMEHDLA-GLASH------------------------------------------------------------------ 234 (720)
Q Consensus 222 Ey~~g~ll-~~~~~------------------------------------------------------------------ 234 (720)
|||+++.+ ..+..
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 99986433 22211
Q ss_pred --------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-cccccc
Q 004999 235 --------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-LTSRVV 305 (720)
Q Consensus 235 --------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~t~~~g 305 (720)
....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......... .....+
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 278 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCC
Confidence 11257889999999999999999999999999999999999999999999999998654322211 112234
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+..|+|||++.+.. ++.++|||||||++|||++ |.+||.+......+.+++.....
T Consensus 279 ~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~---------------------- 335 (375)
T cd05104 279 PVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR---------------------- 335 (375)
T ss_pred CcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCcc----------------------
Confidence 56799999998766 7999999999999999998 88999876554443333221000
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......+.++.+||..||+.||++|||+.++++.
T Consensus 336 -----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 336 -----MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 00112357789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=314.15 Aligned_cols=245 Identities=26% Similarity=0.401 Sum_probs=202.4
Q ss_pred eecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.||+|+||.||+|.+... +..||+|++....... ..+.+.+|+.++..++|+||+++++++.. ...+|+||||+
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 499999999999999865 8889999998664433 56778999999999999999999998876 67899999999
Q ss_pred cccccccccCC---------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 225 EHDLAGLASHP---------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 225 ~g~ll~~~~~~---------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
.++.+..+... ...+++.+++.++.||+.||.|||++||+|+||+|+||+|+.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 76555444433 367999999999999999999999999999999999999999999999999999876433
Q ss_pred CC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 296 QN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 296 ~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
.. .......+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--~----------- 224 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--Y----------- 224 (262)
T ss_pred cccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--C-----------
Confidence 21 1223345688999999988764 7999999999999999999 69999888766655554321 0
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......++..+.++|.+||..||.+|||+.+++.+
T Consensus 225 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ---------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ---------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 011223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=318.28 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=196.9
Q ss_pred eeecccCceEEEEEEECCCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEEEE
Q 004999 147 YLIGQGTYSNVYRARDLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLYLV 220 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~--~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~lyLV 220 (720)
++||+|+||.||+|.+..++. .||+|.++.........+.+.+|+.+++.++|+||+++++++.... ....++|
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 84 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence 459999999999999877765 5999998876555666788899999999999999999998764321 2357899
Q ss_pred Eeecccccccccc------CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCC
Q 004999 221 FEYMEHDLAGLAS------HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294 (720)
Q Consensus 221 ~Ey~~g~ll~~~~------~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~ 294 (720)
|||+.++.+..+. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+..
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 164 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCc
Confidence 9999865443222 1234589999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCC-ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 295 DQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 295 ~~~~~-~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
..... .....+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+....+.... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~---------- 232 (272)
T cd05075 165 GDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-R---------- 232 (272)
T ss_pred ccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-C----------
Confidence 22111 11223567899999987765 7999999999999999999 889998877655544442210 0
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......++..+.+||.+||+.||++|||+.+++++
T Consensus 233 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 -----------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=317.04 Aligned_cols=250 Identities=30% Similarity=0.440 Sum_probs=199.1
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.+.||+|+||.||+|++..+++.||||.+.... .+......+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~ 83 (267)
T cd08228 6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNIVLEL 83 (267)
T ss_pred eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEEEEEe
Confidence 3344999999999999999999999999987543 345556678899999999999999999998876 5689999999
Q ss_pred cccccccccc----CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 224 MEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 224 ~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
++++.+..+. .....+++..++.++.||+.||.|||++||+|+||||+||||+.++.++|+|||++..+.... ..
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-~~ 162 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TA 162 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-HH
Confidence 9975544332 233458999999999999999999999999999999999999999999999999998764322 11
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~-~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+++.|+|||.+.+.. ++.++|||||||++|||++|..||.... ....+...+...+.++
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 227 (267)
T cd08228 163 AHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP-------------- 227 (267)
T ss_pred HhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC--------------
Confidence 22346788999999998765 6899999999999999999998886543 2222222222211111
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||.+||..+|++|||+.++|+.
T Consensus 228 ------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 ------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred ------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 0112467889999999999999999999999973
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.60 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=193.4
Q ss_pred eecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.++.++ +|+||+++++++... ...+|+||
T Consensus 14 ~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~~~~~~v~ 91 (337)
T cd05054 14 PLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKP-GGPLMVIV 91 (337)
T ss_pred ccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-CCCEEEEE
Confidence 3999999999999754 345789999987543 234456778999999999 899999999987643 56789999
Q ss_pred eeccccccccccCC-------------------------------------------------------------CCCCC
Q 004999 222 EYMEHDLAGLASHP-------------------------------------------------------------GLKFS 240 (720)
Q Consensus 222 Ey~~g~ll~~~~~~-------------------------------------------------------------~~~ls 240 (720)
||+.++.+..+... ...++
T Consensus 92 ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 171 (337)
T cd05054 92 EYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLT 171 (337)
T ss_pred ecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCC
Confidence 99997554432211 12578
Q ss_pred HHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-CccccccccCCCChhhhcCCc
Q 004999 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGAT 319 (720)
Q Consensus 241 e~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~ 319 (720)
+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...... ......++..|+|||++.+..
T Consensus 172 ~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 251 (337)
T cd05054 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251 (337)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCC
Confidence 9999999999999999999999999999999999999999999999999865332211 122334567899999998866
Q ss_pred CCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCH
Q 004999 320 YYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPA 398 (720)
Q Consensus 320 ~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~ 398 (720)
++.++|||||||+||||++ |..||.+....+.+...+...-. ......+++
T Consensus 252 -~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~ 303 (337)
T cd05054 252 -YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR---------------------------MRAPEYATP 303 (337)
T ss_pred -CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC---------------------------CCCCccCCH
Confidence 7999999999999999998 99999876544444333221000 011234678
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 399 PALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 399 ~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.+.+|+.+||+.+|++|||+.++++|
T Consensus 304 ~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 304 EIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=317.80 Aligned_cols=240 Identities=21% Similarity=0.348 Sum_probs=194.5
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...+|+||||+.++.
T Consensus 14 lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~ 87 (261)
T cd05072 14 LGAGQFGEVWMGYYN-NSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPIYIITEYMAKGS 87 (261)
T ss_pred cCCcCCceEEEEEec-CCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEEEEecCCCCc
Confidence 999999999999965 45679999986543 235678899999999999999999988766 567899999998654
Q ss_pred ccccc-C-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 229 AGLAS-H-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 229 l~~~~-~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+..+. . ....+++..++.++.||+.||.|||+.+++|+||||+||+++.++.+||+|||++...............++
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccc
Confidence 43333 2 345689999999999999999999999999999999999999999999999999987643322222233456
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+.....
T Consensus 168 ~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------------------ 222 (261)
T cd05072 168 IKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR------------------------ 222 (261)
T ss_pred eecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 7899999987765 7899999999999999998 9999988777666555532110
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||.+||..+|++|||+.++++
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 ----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=375.38 Aligned_cols=260 Identities=29% Similarity=0.443 Sum_probs=217.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.-..||.|.||.||.|.+.+||...|+|.++...........+.+|+.+|..|+|||+|++||+-.. ...+||.|||
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Rekv~IFMEy 1315 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--REKVYIFMEY 1315 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec--HHHHHHHHHH
Confidence 33446999999999999999999999999998876666667778999999999999999999998665 5668999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC---CCCc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ---NQPL 300 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~---~~~~ 300 (720)
|+|+.+..+...+...+|...+-|-.|++.||.|||++|||||||||+|||++.+|.+|++|||.|..+.... ....
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 9999888888888888999999999999999999999999999999999999999999999999998775432 1223
Q ss_pred cccccccCCCChhhhcCCc--CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 301 TSRVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~--~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
...+||+.|||||++.+.. .-+-+.||||||||+.||+||+.||...+..-++.-.+.. .
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~------------------g 1457 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA------------------G 1457 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc------------------c
Confidence 4568999999999998743 2466899999999999999999999775543333222221 1
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
.+|+. +..++.+.++||..||..||++|+++.|+|+|.|-+....
T Consensus 1458 h~Pq~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1458 HKPQI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred CCCCC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 12222 2348899999999999999999999999999999876543
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.35 Aligned_cols=248 Identities=29% Similarity=0.480 Sum_probs=204.8
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||+|++|.||++.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++.. ....|+++||++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~ 80 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIVMEFCS 80 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEecCC
Confidence 3459999999999999998999999999976543 355678899999999999999999998876 577999999999
Q ss_pred ccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 226 HDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 226 g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+..+..+.... ..+++..+..++.||+.+|.|||.+|++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 158 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMV 158 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cccee
Confidence 76665554433 5789999999999999999999999999999999999999999999999999987644321 23456
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
++..|+|||.+.+.. ++.++|||||||++|+|++|..||...+....+..+... ..+. .
T Consensus 159 ~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~------------------~- 217 (253)
T cd05122 159 GTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPPG------------------L- 217 (253)
T ss_pred cCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCCC------------------c-
Confidence 788999999998766 689999999999999999999999877655554443221 0000 0
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
.....++..+.+||..||+.||.+|||+.++|+|||
T Consensus 218 ------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 218 ------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000124788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.36 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=194.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||++.+.. +..+|+|.+...... ...+.+|+.+|++++||||+++++++.. ...+|+||||+++
T Consensus 10 ~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~e~~~~ 83 (256)
T cd05114 10 KELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIVTEFMEN 83 (256)
T ss_pred eEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEEEEcCCC
Confidence 349999999999998754 557999988754332 3457889999999999999999998876 5679999999986
Q ss_pred ccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 227 DLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
+.+..+. .....+++..++.++.||+.||.|||++||+|+||||+||+|+.++.+||+|||++...............+
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05114 84 GCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF 163 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCC
Confidence 5444333 334468999999999999999999999999999999999999999999999999987653322222222334
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+..|+|||.+.+.. ++.++|||||||++|||++ |++||.+.+..+.+..+.+....
T Consensus 164 ~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~---------------------- 220 (256)
T cd05114 164 PVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL---------------------- 220 (256)
T ss_pred chhhCChhhcccCc-cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC----------------------
Confidence 66799999987665 7999999999999999999 89999888877766665432100
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+..+.+||.+||+.||.+|||+.++++
T Consensus 221 ------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 221 ------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=313.83 Aligned_cols=260 Identities=23% Similarity=0.352 Sum_probs=217.1
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeecc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEG 207 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~ 207 (720)
.++.+.+.. ||.|+.|.|++++.+.+|..+|||.++... +.+..+++++.+.++... ++|+||+.+|
T Consensus 91 indl~~l~d-----------lGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~G 158 (391)
T KOG0983|consen 91 INDLENLGD-----------LGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFG 158 (391)
T ss_pred hHHhhhHHh-----------hcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeee
Confidence 455666666 999999999999999999999999998653 466778888888877666 5999999999
Q ss_pred ceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeecc
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
+|.. +..++|.||.|......++.....+++|..+-.+...++.||.||-+ +||+|||+||+|||+|..|++|||||
T Consensus 159 yFi~--n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDF 236 (391)
T KOG0983|consen 159 YFIT--NTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDF 236 (391)
T ss_pred EEee--CchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecc
Confidence 9988 56788999999865545555555579999999999999999999996 48999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCC
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSP 363 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g-~~~~e~l~~i~~~~g~p 363 (720)
|++..+... ...+...|.+.|||||.+.- ...|+..+||||||++|+||.||.-||.+ .++.+.+.+|+.... |
T Consensus 237 GIsGrlvdS--kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P 313 (391)
T KOG0983|consen 237 GISGRLVDS--KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-P 313 (391)
T ss_pred cccceeecc--cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-C
Confidence 999877433 23355578899999999853 45589999999999999999999999998 568888888876211 1
Q ss_pred ChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 364 ~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..+ . -..+++.+.+|+..||++|+.+||...++|+|||+...
T Consensus 314 ------------------~L~------~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 314 ------------------LLP------G-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred ------------------CCC------c-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 111 1 12489999999999999999999999999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=323.04 Aligned_cols=260 Identities=24% Similarity=0.386 Sum_probs=204.2
Q ss_pred ccceeecccCceEEEEEEEC---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
++.+.||.|+||.||+|.+. .+|..||+|+++.... .....+.+.+|+.++.++ +|+||+++++.+.. ...+
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~~ 80 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DTKL 80 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CCeE
Confidence 44556999999999999875 4789999999875432 223346678899999999 59999999988866 5689
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|+||||+.++.+..+......+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999765555544455789999999999999999999999999999999999999999999999999987644333
Q ss_pred CCccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 QPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.......++..|+|||.+.+. ..++.++|||||||++|+|++|..||...........+.+.....
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------- 227 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS------------- 227 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-------------
Confidence 333345688999999998753 236789999999999999999999986543322222222111000
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||+.||.+|+ ++.+++.||||...
T Consensus 228 ------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 228 ------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred ------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 0011235778899999999999999997 89999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=328.45 Aligned_cols=247 Identities=21% Similarity=0.311 Sum_probs=194.3
Q ss_pred cceeecccCceEEEEEEECCCCeE----EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKI----VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~----VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
..+.||+|+||.||+|++..++.. ||||+++.. ......+.+.+|+.+++.++||||+++++++.. ...++|
T Consensus 11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~~~~v 86 (316)
T cd05108 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLI 86 (316)
T ss_pred eeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CCceee
Confidence 334499999999999998766654 899998743 234455678899999999999999999998865 347899
Q ss_pred Eeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 221 FEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 221 ~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
+||+.++ +.+.+......+++..+..++.||+.||+|||+.||+||||||+||||+.++.+||+|||++..+.......
T Consensus 87 ~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 166 (316)
T cd05108 87 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166 (316)
T ss_pred eecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcce
Confidence 9999865 444444444568999999999999999999999999999999999999999999999999998764332211
Q ss_pred -ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 300 -LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 300 -~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.....++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+. ..+......+
T Consensus 167 ~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-------------- 230 (316)
T cd05108 167 HAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL-------------- 230 (316)
T ss_pred eccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC--------------
Confidence 11223467899999998765 7999999999999999998 9999987765443 3332211000
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||.+||..||.+|||+.+++.+
T Consensus 231 -------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 231 -------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0113466789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=324.80 Aligned_cols=251 Identities=27% Similarity=0.448 Sum_probs=204.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||++.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....|+||||+.+
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~~ 100 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWVVMEYLAG 100 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEEEEecCCC
Confidence 349999999999999988999999999865432 234567899999999999999999999876 5679999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+.+..+... ..+++.++..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........ ......++
T Consensus 101 ~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 178 (293)
T cd06647 101 GSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRSTMVGT 178 (293)
T ss_pred CcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-ccccccCC
Confidence 666555443 3588999999999999999999999999999999999999999999999999876543322 22334678
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
+.|+|||.+.+.. ++.++|+|||||++|+|++|.+||...+..+.+..+.. .+.+ .
T Consensus 179 ~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~------------------~---- 234 (293)
T cd06647 179 PYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP------------------E---- 234 (293)
T ss_pred hhhcCchhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC------------------C----
Confidence 8999999987765 78999999999999999999999987765544332211 0000 0
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||..+|.+||++.+++.|+||+..
T Consensus 235 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 235 ---LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 01123467889999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.07 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=201.0
Q ss_pred cchhhhhhhhccccccceeecccCceEEEEEEECCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceee
Q 004999 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204 (720)
Q Consensus 130 ~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~t-----g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvk 204 (720)
.+|..+++ ||.|+||.||+|.+..+ +..||||+++... .......+.+|+.++..++||||++
T Consensus 5 ~~~~~~~~-----------lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~ 72 (283)
T cd05091 5 STVRFMEE-----------LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVC 72 (283)
T ss_pred HHHHHHHH-----------hCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCe
Confidence 35666676 99999999999987543 5789999997543 2344567889999999999999999
Q ss_pred eccceeccCCCeEEEEEeeccccccccccC----------------CCCCCCHHHHHHHHHhhhhccccccccCcccccC
Q 004999 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASH----------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI 268 (720)
Q Consensus 205 l~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~----------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDI 268 (720)
+++++.. ...+++++||+.+..+..+.. ....+++..+..++.||+.||.|||++||+||||
T Consensus 73 ~~~~~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dl 150 (283)
T cd05091 73 LLGVVTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDL 150 (283)
T ss_pred EEEEEcC--CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 9999876 567899999998654433221 1235888999999999999999999999999999
Q ss_pred cceeEEEcCCCceeeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCC
Q 004999 269 KGSNLLIDNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPG 346 (720)
Q Consensus 269 KP~NILld~~g~vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g 346 (720)
||+|||++.++.+||+|||++........ .......+++.|+|||.+.+.. ++.++|||||||++|||++ |.++|.+
T Consensus 151 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 151 ATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred chhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999876532221 1122334578899999998766 7999999999999999998 8889988
Q ss_pred CChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 347 RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 347 ~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
....+.+..+..... .....+++..+.+||..||+.+|.+||++.+++..
T Consensus 230 ~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 230 YSNQDVIEMIRNRQV----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 877666666543210 01124678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.39 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=207.2
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||.|+||.||++.+..+++.+|||++............+.+|+.+++.++|+||+++++++.. ....|+||||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~ 81 (256)
T cd08530 4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVMEYA 81 (256)
T ss_pred EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEehhc
Confidence 3445999999999999999999999999998766555566778899999999999999999998876 57899999999
Q ss_pred cccccccccCC----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 225 EHDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 225 ~g~ll~~~~~~----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
.+..+..+... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---~~ 158 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MA 158 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---Cc
Confidence 87655443322 356899999999999999999999999999999999999999999999999999876443 22
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+++.|+|||.+.+.. ++.++|+||||+++|+|++|++||...+..+....+....
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------- 217 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-------------------- 217 (256)
T ss_pred ccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------------
Confidence 2346788999999997765 7899999999999999999999998877655444432210
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
.......++..+.++|.+||+.+|.+|||+.++|+||++
T Consensus 218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 218 --------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 011122567889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=359.46 Aligned_cols=145 Identities=28% Similarity=0.410 Sum_probs=127.3
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.+++.++||||+++++++.. ...+|||||
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lVmE 84 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNVYLVME 84 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEEEEEEe
Confidence 344459999999999999999999999999986543 45556788999999999999999999988766 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
|+.|+.+..++.....+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||++.
T Consensus 85 y~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 85 YLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99876665555545578999999999999999999999999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=340.11 Aligned_cols=234 Identities=24% Similarity=0.353 Sum_probs=198.0
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||.|+.|.||+|+. .++.||||+++.- -..+|+-|++|+||||+.+.|+|+. ...+|||||||..+-
T Consensus 132 lGSGaQGAVF~Grl--~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtq--sPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRL--HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQ--SPCYCIIMEFCAQGQ 198 (904)
T ss_pred hccCcccceeeeec--cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecC--CceeEEeeecccccc
Confidence 99999999999986 4678999998632 1468999999999999999999987 677999999999877
Q ss_pred cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccC
Q 004999 229 AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308 (720)
Q Consensus 229 l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~ 308 (720)
|..++..+..++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.+... ..+-+++||..
T Consensus 199 L~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVa 276 (904)
T KOG4721|consen 199 LYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVA 276 (904)
T ss_pred HHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHh
Confidence 7777777889999999999999999999999999999999999999999999999999999876432 44567899999
Q ss_pred CCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 309 Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
|||||++...+ .+.++|||||||||||||||..||........+.. .|... .
T Consensus 277 WMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG----VGsNs-----------------------L 328 (904)
T KOG4721|consen 277 WMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG----VGSNS-----------------------L 328 (904)
T ss_pred hhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEEe----ccCCc-----------------------c
Confidence 99999999887 69999999999999999999999976544332211 11110 0
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
-...+..+|+.++=||+.||+-.|..||++.++|.|-
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 1122346888999999999999999999999999984
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.79 Aligned_cols=246 Identities=21% Similarity=0.341 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEEC----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 147 YLIGQGTYSNVYRARDL----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.. ....|+|||
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 87 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQPVCMLFE 87 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CCceEEEEE
Confidence 34999999999999853 456789999987543 34455678899999999999999999998876 567899999
Q ss_pred eccccccccccC-C----------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeec
Q 004999 223 YMEHDLAGLASH-P----------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 285 (720)
Q Consensus 223 y~~g~ll~~~~~-~----------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~D 285 (720)
|+.++.+..+.. . ...+++.++..++.||+.||.|||++||+|+||||+||||+.++.+||+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEecc
Confidence 998754433321 1 12478999999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 004999 286 FGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSP 363 (720)
Q Consensus 286 FGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p 363 (720)
||++........ .......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+.+..+....
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--- 243 (283)
T cd05090 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ--- 243 (283)
T ss_pred ccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC---
Confidence 999986533221 1122334567899999998765 7999999999999999998 999998877665555543211
Q ss_pred ChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 364 ~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......+++.+.+||..||+.||.+||++.+++++
T Consensus 244 -------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 244 -------------------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred -------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 001223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.18 Aligned_cols=283 Identities=27% Similarity=0.403 Sum_probs=223.5
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC--------CCceeeeccceec-
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD--------HINVIKLEGLVTS- 211 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIvkl~~~~~~- 211 (720)
..|-+++.||.|-|++||+|.|..+.+.||||+++-. ....+..+.||++|++++ -.+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 5666777799999999999999999999999999854 345566789999999983 2479999998864
Q ss_pred -cCCCeEEEEEeeccccccccccCC-CCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCC----------
Q 004999 212 -RMSCSLYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNN---------- 278 (720)
Q Consensus 212 -~~~~~lyLV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~---------- 278 (720)
..+.++|+|+|+++..||.++... ...++...++.|++|||.||.|||.. ||||.||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~ 234 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDARE 234 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhh
Confidence 335689999999999999887763 35699999999999999999999965 99999999999999100
Q ss_pred --------------------------------------------------------------------------------
Q 004999 279 -------------------------------------------------------------------------------- 278 (720)
Q Consensus 279 -------------------------------------------------------------------------------- 278 (720)
T Consensus 235 a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~ 314 (590)
T KOG1290|consen 235 AGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNES 314 (590)
T ss_pred hccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcccc
Confidence
Q ss_pred ----------------------------------------------------------------------------Ccee
Q 004999 279 ----------------------------------------------------------------------------GILK 282 (720)
Q Consensus 279 ----------------------------------------------------------------------------g~vK 282 (720)
-.||
T Consensus 315 ~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vK 394 (590)
T KOG1290|consen 315 TVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVK 394 (590)
T ss_pred chhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEE
Confidence 0256
Q ss_pred eeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCC------ChHHHHHHH
Q 004999 283 IADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR------TEVEQLHKI 356 (720)
Q Consensus 283 L~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~------~~~e~l~~i 356 (720)
|+|||.|..+. ...|..+.|..|+|||+|+|.. |++.+||||++||+|||+||..+|... .+.+.++.|
T Consensus 395 IaDlGNACW~~----khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 395 IADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred Eeeccchhhhh----hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 77777776532 2345567799999999999998 899999999999999999999998643 266889999
Q ss_pred HHhcCCCChhhhhh-----------cCCCCccccCCCCccchhhhcccCCCC----HhHHHHHHHhcccCCCCCCCHHHH
Q 004999 357 FKLCGSPSEDYWRK-----------SKLPHATIFKPQQPYKRCVAETFKDFP----APALALMETLLSIDPADRGSAASA 421 (720)
Q Consensus 357 ~~~~g~p~~~~w~~-----------~~l~~~~~~~~~~~~~~~~~e~~~~~~----~~~~dLI~~mL~~DP~kRpTa~e~ 421 (720)
++++|..+...... ..|.+...+++..- ...+.+.+ .++ .++.+||.-||+++|++|+||.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL-~~VL~eKY-~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPL-YEVLIEKY-EWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcH-HHHHHHHh-CCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 99999887765332 33334333333222 22233322 233 458899999999999999999999
Q ss_pred HhCccCCCCCCC
Q 004999 422 LRSEFFTMKPLP 433 (720)
Q Consensus 422 L~hp~f~~~~~~ 433 (720)
|+|||+...+.+
T Consensus 548 l~hPwLn~~~~~ 559 (590)
T KOG1290|consen 548 LKHPWLNPVAGP 559 (590)
T ss_pred hcCccccCCCCC
Confidence 999999977665
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.00 Aligned_cols=250 Identities=18% Similarity=0.240 Sum_probs=194.9
Q ss_pred cccceeecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeE
Q 004999 143 SRSFYLIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~l 217 (720)
++..+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~ 84 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQPT 84 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCe
Confidence 334445999999999999864 345679999986533 22344568899999999999999999998865 5679
Q ss_pred EEEEeeccccccccccCC----------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 218 YLVFEYMEHDLAGLASHP----------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~----------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
|+||||+.++.+..+... ...+++..+..++.||+.||.|||+.|++|+||||+||||+.++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCC
Confidence 999999997655443321 1236788899999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 288 LASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 288 la~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
++......... ......+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+.+..+.... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~--- 239 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG-L--- 239 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-c---
Confidence 98754322211 112234577899999998765 7999999999999999999 788998877655554443210 0
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......++..+.+||.+||+.||++|||+.+++++
T Consensus 240 ------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 ------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.80 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=198.4
Q ss_pred cceeecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.+.||+|+||.||+|.+..+ ...||||+++... .......+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv~ 84 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPVMIIT 84 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCceEEEE
Confidence 344599999999999998654 4579999987543 33445668899999999999999999998876 56799999
Q ss_pred eecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-C
Q 004999 222 EYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-P 299 (720)
Q Consensus 222 Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~ 299 (720)
||+.++.+..+. .....+++..+..++.||+.||.|||+++|+|+||||+||||+.++.+||+|||++..+...... .
T Consensus 85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (266)
T cd05033 85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT 164 (266)
T ss_pred EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccccee
Confidence 999986555443 33457899999999999999999999999999999999999999999999999999876421111 1
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.+....
T Consensus 165 ~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 227 (266)
T cd05033 165 TKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL---------------- 227 (266)
T ss_pred ccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------------
Confidence 11223467899999987765 7999999999999999998 99999877766655555321100
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||..||+.+|++||++.+++++
T Consensus 228 ------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 228 ------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0113568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=313.92 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=192.7
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|.+. ++..||+|.++...... ..+.+|+.++++++|+||+++++++.. ...|+||||+.++
T Consensus 13 ~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~---~~~~lv~e~~~~~ 85 (260)
T cd05070 13 KLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVSE---EPIYIVTEYMSKG 85 (260)
T ss_pred eeccccCceEEEEEec-CCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEECC---CCcEEEEEecCCC
Confidence 3999999999999875 45669999998655433 357899999999999999999988743 4589999999875
Q ss_pred ccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 228 LAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+............+
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 165 (260)
T cd05070 86 SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF 165 (260)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCC
Confidence 5544332 23468999999999999999999999999999999999999999999999999998764322222222234
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 166 ~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 221 (260)
T cd05070 166 PIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR----------------------- 221 (260)
T ss_pred CccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 66799999987665 7999999999999999999 8899988777666655532110
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||.+||..||.+|||+.++++
T Consensus 222 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 222 -----MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112357888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.24 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=193.3
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|.+. ++..+|+|++...... ...+.+|+.+++.++||||+++++++.. ...+|+||||++|+
T Consensus 11 ~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 84 (256)
T cd05059 11 ELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTK--QRPIFIVTEYMANG 84 (256)
T ss_pred hhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCceEEEEecCCCC
Confidence 3999999999999886 4567999998754432 2346789999999999999999998866 56799999999875
Q ss_pred ccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
.+. .+......+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++...............++
T Consensus 85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05059 85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP 164 (256)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCC
Confidence 444 3333344789999999999999999999999999999999999999999999999999976533222111122234
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
..|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus 165 ~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------------ 219 (256)
T cd05059 165 VKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------------------ 219 (256)
T ss_pred ccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------------------
Confidence 5799999998765 7999999999999999999 7899988776665555432110
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......++..+.+|+.+||..+|++|||+.++++.
T Consensus 220 ----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 ----LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01123478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=318.55 Aligned_cols=249 Identities=29% Similarity=0.473 Sum_probs=205.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|.+..++..|++|++..... ....+.+|+.+++.++|+||+++++++.. ...+|+|+||+++.
T Consensus 26 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~ 100 (286)
T cd06614 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWVVMEYMDGG 100 (286)
T ss_pred hccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEE--CCEEEEEEeccCCC
Confidence 39999999999999998899999999986543 45667899999999999999999999877 57899999999975
Q ss_pred ccccccCCCC-CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAGLASHPGL-KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~~~~~~~~-~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
.+..+..... .+++..+..++.||+.||.|||+.||+|+||+|+||+|+.++.++|+|||++....... .......++
T Consensus 101 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~ 179 (286)
T cd06614 101 SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-SKRNSVVGT 179 (286)
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch-hhhccccCC
Confidence 5555444433 79999999999999999999999999999999999999999999999999987653322 122233568
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
..|+|||++.+.. ++.++|+||||||+|+|++|..||.+.........+... +.+.
T Consensus 180 ~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---------------------- 235 (286)
T cd06614 180 PYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP---------------------- 235 (286)
T ss_pred cccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC----------------------
Confidence 8999999988765 799999999999999999999999877665554443221 0000
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......++..+.+||..||+.+|.+|||+.++|+|+||..
T Consensus 236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 236 ---LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ---CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 0112246788999999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.04 Aligned_cols=249 Identities=23% Similarity=0.345 Sum_probs=202.9
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~ 208 (720)
..+|+.++. ||.|+||.||+|.+.. +..||+|++.... ......+.+|+.+++.++|+||++++++
T Consensus 5 ~~~y~~~~~-----------ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 70 (261)
T cd05148 5 REEFTLERK-----------LGSGYFGEVWEGLWKN-RVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAV 70 (261)
T ss_pred HHHHHHhhh-----------hccCCCccEEEeEecC-CCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeee
Confidence 456777777 9999999999999987 8889999987653 2234568899999999999999999998
Q ss_pred eeccCCCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
+.. ...+|+||||++++.+..+.. .+..+++.++..++.||+.||.|||++||+|+||+|+||||+.++.+||+||
T Consensus 71 ~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~ 148 (261)
T cd05148 71 CSV--GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADF 148 (261)
T ss_pred Eec--CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccc
Confidence 876 567999999998754443332 3456899999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
|++........ ......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.+..+......
T Consensus 149 g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--- 223 (261)
T cd05148 149 GLARLIKEDVY-LSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM--- 223 (261)
T ss_pred cchhhcCCccc-cccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC---
Confidence 99976533221 122334567899999987765 7899999999999999998 89999888776666655421100
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.++|.+||+.||.+|||+.++++
T Consensus 224 -------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112357889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=354.04 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=198.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeecc-ceecc---C-CCeE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEG-LVTSR---M-SCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~-~~~~~---~-~~~l 217 (720)
++.++|.+|||+.||+|.+...|..||+|++-.. +...++.+.+||.+|++|. |+|||.+++ ..... . ...+
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 5666899999999999999988899999998655 5778899999999999996 999999999 33222 1 2467
Q ss_pred EEEEeecc-ccccccccC-CCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCCCceeeeccccceecC
Q 004999 218 YLVFEYME-HDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYD 293 (720)
Q Consensus 218 yLV~Ey~~-g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~g~vKL~DFGla~~~~ 293 (720)
+|+||||. |+|++.+.. ....|+|.++++|+.|+++|+.+||... |||||||-+||||+.+|..||||||.|....
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 89999999 577766553 2334999999999999999999999998 9999999999999999999999999997432
Q ss_pred CCCCCCcc--------ccccccCCCChhhhc--CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCC
Q 004999 294 PDQNQPLT--------SRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 363 (720)
Q Consensus 294 ~~~~~~~t--------~~~gT~~Y~APE~l~--~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p 363 (720)
........ ...-|+.|+|||.+. .....+.++|||+|||+||-|+....||.+......++.-+. .
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~----~ 273 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS----F 273 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc----C
Confidence 11111000 112389999999974 233469999999999999999999999977644333222111 0
Q ss_pred ChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 364 ~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
..++.++..+.+||..||+.||.+||++.+++.+-+-
T Consensus 274 ---------------------------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 274 ---------------------------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred ---------------------------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 1124577889999999999999999999999986654
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.81 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 147 YLIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.||+|+||.||++.+ ..++..||+|.+... .......+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 11 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 86 (288)
T cd05093 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVF 86 (288)
T ss_pred cccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCccEEEE
Confidence 3499999999999985 345667999988643 24456678999999999999999999999876 67899999
Q ss_pred eeccccccccccCC-------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 222 EYMEHDLAGLASHP-------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 222 Ey~~g~ll~~~~~~-------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
||+.++.+..+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 166 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGM 166 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCc
Confidence 99987655433321 12489999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 289 ASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 289 a~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
+........ .......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+.+..+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~--~--- 240 (288)
T cd05093 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR--V--- 240 (288)
T ss_pred cccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--c---
Confidence 976532221 1112234577899999988755 7999999999999999998 899998887766665553311 0
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++.++.+||.+||+.||.+|||+.+++.
T Consensus 241 -----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 -----------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0111346788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=313.30 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=195.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|.+.. +..||||.++..... .+.+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 82 (261)
T cd05068 9 QLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIYIVTEL 82 (261)
T ss_pred eeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEec--CCCeeeeeec
Confidence 344559999999999999754 567999998765432 3457889999999999999999998876 5678999999
Q ss_pred ccccccc-cccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHDLAG-LASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~ll~-~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+.++.+. .+.. .+..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 9755444 3332 2346899999999999999999999999999999999999999999999999999876432211111
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+..|+|||++.+.. ++.++|||||||++|||++ |+.||.+......+..+......
T Consensus 163 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------------------ 223 (261)
T cd05068 163 GAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM------------------ 223 (261)
T ss_pred CCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC------------------
Confidence 122245799999887765 7999999999999999999 99999988776666555321100
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||.+||+.+|.+||++.++++
T Consensus 224 ----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 224 ----------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ----------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 011356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=312.77 Aligned_cols=243 Identities=20% Similarity=0.279 Sum_probs=195.6
Q ss_pred eecccCceEEEEEEECCCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++|+||+++++++.. ...++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELA 77 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeC
Confidence 3999999999999876554 78999998866543 455678899999999999999999997653 4689999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc--
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS-- 302 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~-- 302 (720)
.++.+..+......+++..+..++.||+.+|.|||..+|+|+||||+||||+.++.+||+|||++.............
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 876555555555579999999999999999999999999999999999999999999999999998664333221111
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..++..|+|||.+.+.. ++.++|||||||++|+|++ |.+||......+....+.... +
T Consensus 158 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~--~------------------ 216 (257)
T cd05060 158 GRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--R------------------ 216 (257)
T ss_pred ccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC--c------------------
Confidence 12246799999987665 7999999999999999998 999998776655444432210 0
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||.+||..||.+|||+.++++
T Consensus 217 --------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 --------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0122357788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=319.99 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEECCCC----------------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecccee
Q 004999 147 YLIGQGTYSNVYRARDLDQK----------------KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVT 210 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg----------------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~ 210 (720)
+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.++++++||||+++++++.
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 89 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIARLLGVCT 89 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34999999999999876544 568999987653 2355677899999999999999999999887
Q ss_pred ccCCCeEEEEEeeccccccccccCCCC-----------CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 211 SRMSCSLYLVFEYMEHDLAGLASHPGL-----------KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 211 ~~~~~~lyLV~Ey~~g~ll~~~~~~~~-----------~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
. ...+++||||+.++.+..+..... .+++..++.++.||+.||.|||++||+|+||||+||||+.++
T Consensus 90 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05051 90 V--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred c--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCC
Confidence 6 578999999998765544433222 689999999999999999999999999999999999999999
Q ss_pred ceeeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh--CCCCCCCCChHHHHHHH
Q 004999 280 ILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIMPGRTEVEQLHKI 356 (720)
Q Consensus 280 ~vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt--G~ppf~g~~~~e~l~~i 356 (720)
.++|+|||++........ .......+++.|+|||.+.+.. ++.++|||||||++|||++ |..||......+.+..+
T Consensus 168 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~ 246 (296)
T cd05051 168 TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENA 246 (296)
T ss_pred ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHH
Confidence 999999999876532221 1222334578899999988755 7999999999999999998 66788776665555544
Q ss_pred HHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 357 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 357 ~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
........ . .........++.++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~--------~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 247 GHFFRDDG--------R-------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred Hhcccccc--------c-------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 32110000 0 0001112356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.85 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=194.7
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+++.+.||+|+||.||+|.+..+. .||||+++..... ...+.+|+.+++.++||||+++++++. ....|+|||
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv~e 80 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS---EEPIYIVTE 80 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC---CCCcEEEEE
Confidence 344445999999999999987664 5999999864432 245788999999999999999998764 345799999
Q ss_pred eccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.++.+..+.. .+..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++..+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 999755444433 234689999999999999999999999999999999999999999999999999986643322222
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+.+..+......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~----------------- 222 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------- 222 (262)
T ss_pred cCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCC-----------------
Confidence 2334567899999887665 7999999999999999999 88899888766665554321000
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||.+||+.||++|||+.++++
T Consensus 223 -----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 012357888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.02 Aligned_cols=243 Identities=22% Similarity=0.345 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||+|.+.. +..||||.+...... ...+.+|+.++++++||||+++++++.. ...+|+||||+.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 83 (256)
T cd05113 10 KELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIVTEYMSN 83 (256)
T ss_pred eEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEEEEcCCC
Confidence 349999999999998754 445999998754432 2457899999999999999999999876 5678999999987
Q ss_pred ccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 227 DLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
+.+..+. .....+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++...............+
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCcc
Confidence 6544433 334478999999999999999999999999999999999999999999999999987653322111112234
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+......
T Consensus 164 ~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---------------------- 220 (256)
T cd05113 164 PVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL---------------------- 220 (256)
T ss_pred ChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC----------------------
Confidence 67799999997765 7999999999999999998 99999877765555554331100
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+..+.+||..||+.||.+|||+.+++.+
T Consensus 221 ------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112357889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=313.61 Aligned_cols=245 Identities=31% Similarity=0.433 Sum_probs=196.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.||.|+||.||+|.+..++..||||.+..... +......+.+|+.+++.++|+||+++++++.. ...+|+||||+.+
T Consensus 9 ~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 86 (267)
T cd08229 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADA 86 (267)
T ss_pred hhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEEEEEecCC
Confidence 39999999999999999999999998875433 34455678899999999999999999999876 6689999999997
Q ss_pred cccccccC----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 227 DLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 227 ~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
+.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+.... .....
T Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 165 (267)
T cd08229 87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHS 165 (267)
T ss_pred CCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-ccccc
Confidence 65543322 34568999999999999999999999999999999999999999999999999987654322 22234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV--EQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~--e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
..++..|+|||.+.+.. ++.++|||||||++|+|++|..||.+.... +....+... ..+
T Consensus 166 ~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~----------------- 226 (267)
T cd08229 166 LVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYP----------------- 226 (267)
T ss_pred ccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-CCC-----------------
Confidence 46789999999997765 689999999999999999999998765321 111111110 000
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
. .....+++.+.+||.+||..||.+|||+.++++
T Consensus 227 -~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 227 -P--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -C--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 011347788999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=318.33 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=195.5
Q ss_pred ceeecccCceEEEEEEECCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEE
Q 004999 146 FYLIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~t-----g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyL 219 (720)
.+.||+|+||.||++.+... ...||+|.+..... ......+.+|+.+++++ +|+||+++++++.. ...+|+
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~l 93 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--EGPLYV 93 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--CCCeEE
Confidence 34499999999999987643 37899999876533 34456688999999999 89999999998876 567999
Q ss_pred EEeecccccccccc----------------CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceee
Q 004999 220 VFEYMEHDLAGLAS----------------HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 283 (720)
Q Consensus 220 V~Ey~~g~ll~~~~----------------~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL 283 (720)
||||+.++.+..+. .....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEe
Confidence 99999875544333 23456899999999999999999999999999999999999999999999
Q ss_pred eccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 004999 284 ADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 284 ~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g 361 (720)
+|||++..+..... .......++..|+|||++.+.. ++.++||||||||+|||++ |..||.+....+....+....
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 251 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGY- 251 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-
Confidence 99999986543221 1112223456799999987665 7999999999999999998 889998876655444332110
Q ss_pred CCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 362 ~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......++..+.+||.+||..||.+|||+.+++++
T Consensus 252 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 252 ---------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ---------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 001123567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.56 Aligned_cols=249 Identities=22% Similarity=0.340 Sum_probs=195.7
Q ss_pred ccceeecccCceEEEEEEECC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~-----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.. ....|
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 85 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--RLPRF 85 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCcE
Confidence 344559999999999999987 77889999886543 23344568889999999999999999998876 55689
Q ss_pred EEEeeccccccccccC-C------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC---ceeeecccc
Q 004999 219 LVFEYMEHDLAGLASH-P------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGL 288 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~-~------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g---~vKL~DFGl 288 (720)
+||||+.|+.+..+.. . ...+++..+..++.||+.||.|||+++++|+||||+|||++.++ .+||+|||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999998755443332 1 12589999999999999999999999999999999999998765 599999999
Q ss_pred ceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 289 ASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 289 a~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
+..+...... .......+..|+|||++.+.. ++.++||||||||+|||++ |..||.+.+..+.+..+... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~---- 239 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GR---- 239 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-Cc----
Confidence 9865321111 111223356799999998766 7999999999999999997 99999887766554443221 00
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......++..+.+||.+||+.||++|||+.++|+|
T Consensus 240 -----------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 -----------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=317.64 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=196.6
Q ss_pred cceeecccCceEEEEEEECC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~-----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
+.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.. ....|+
T Consensus 10 i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 86 (288)
T cd05061 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSK--GQPTLV 86 (288)
T ss_pred eeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCcEE
Confidence 33449999999999997642 355799999875432 2334457889999999999999999998876 567899
Q ss_pred EEeeccccccccccCC----------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 220 VFEYMEHDLAGLASHP----------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~----------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
||||+.++.+..+... ...++...+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 87 VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred EEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCcc
Confidence 9999986555433321 134567889999999999999999999999999999999999999999999998
Q ss_pred eecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
......... ......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+.+..+.... .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~----- 239 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-Y----- 239 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-----
Confidence 755322211 112224467899999988765 7999999999999999998 788998877655544443210 0
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh------CccCCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR------SEFFTM 429 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~------hp~f~~ 429 (720)
......+++.+.+||.+||+.||.+|||+.++++ ||||..
T Consensus 240 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 240 ----------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 0112346788999999999999999999999987 898875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.82 Aligned_cols=239 Identities=24% Similarity=0.322 Sum_probs=190.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||.|+||.||++.+..++..+|+|++....... .|+.+...+ +||||+++++.+.. ...+|+||||+.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e~~~~~ 94 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMDYIKDG 94 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEEcCCCC
Confidence 699999999999999999999999987543221 122222222 79999999999877 56899999999876
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
.+..+......+++.+++.++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++...... ....++
T Consensus 95 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~~~ 169 (267)
T PHA03390 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGT 169 (267)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCCCC
Confidence 5555544445899999999999999999999999999999999999999998 9999999999865322 223578
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~-l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
..|+|||++.+.. ++.++|||||||++|+|++|..||.+....+. ...+......
T Consensus 170 ~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------- 225 (267)
T PHA03390 170 LDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----------------------- 225 (267)
T ss_pred CcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc-----------------------
Confidence 8999999998765 79999999999999999999999986543321 1111111000
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCC-HHHHHhCccCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGS-AASALRSEFFT 428 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-a~e~L~hp~f~ 428 (720)
....++.+++.+.+||.+||+.||.+|++ ++++|+||||.
T Consensus 226 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 226 ---KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ---cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 01122368899999999999999999996 59999999996
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.83 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=199.7
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.||+|+||.||+|.+..+++.||||.++..... .....+.+|+.++.++ .||||+++++++.. ...+|+||||+.+
T Consensus 22 ~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 98 (296)
T cd06618 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFICMELMST 98 (296)
T ss_pred EeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEEEeeccCc
Confidence 399999999999999999999999999765432 2344566788777666 59999999999876 6789999999988
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+..........+++..+..++.||+.||.|||+ .||+|+||+|+||++++++.+||+|||++..+.... ......+
T Consensus 99 ~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~ 176 (296)
T cd06618 99 CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--AKTRSAG 176 (296)
T ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC--cccCCCC
Confidence 6665555545578999999999999999999997 599999999999999999999999999987653222 1223356
Q ss_pred ccCCCChhhhcCC---cCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 306 TLWYRPPELLLGA---TYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 306 T~~Y~APE~l~~~---~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~-~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
+..|+|||.+.+. ..++.++|||||||++|+|++|+.||..... .+.+..+..... +
T Consensus 177 ~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~------------------ 237 (296)
T cd06618 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-P------------------ 237 (296)
T ss_pred CccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC-C------------------
Confidence 7889999998754 2368899999999999999999999976432 333333322100 0
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.. .....++.++.+||.+||..||.+|||+.++++|+||...
T Consensus 238 ~~-------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 238 SL-------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CC-------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 00 0011467889999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=341.00 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=203.6
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeec
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 206 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~ 206 (720)
..++|+...+ +|.|+|+.|-.+.+..+++..++|++..... ...+|+.++... +||||+++.
T Consensus 320 ~~~~y~~~~~-----------~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~ 382 (612)
T KOG0603|consen 320 FTESYEFREE-----------LGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSH 382 (612)
T ss_pred cchhhccccc-----------cCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeec
Confidence 3466766666 9999999999999999999999999986622 234677666666 799999999
Q ss_pred cceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE-cCCCceeeec
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI-DNNGILKIAD 285 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl-d~~g~vKL~D 285 (720)
+.+.+ ....|+|||++.|+.+-........+. .++..|+.+|+.++.|||++|||||||||+|||+ ++.|+++|+|
T Consensus 383 ~v~~~--~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrlty 459 (612)
T KOG0603|consen 383 DVYED--GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTY 459 (612)
T ss_pred ceecC--CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEE
Confidence 99877 788999999999865544333333344 7888999999999999999999999999999999 6999999999
Q ss_pred cccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 286 FGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 286 FGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
||.+...... +...+.|..|.|||++.... |+.++||||||++||+||+|+.||........+... ++.+..
T Consensus 460 FG~a~~~~~~----~~tp~~t~~y~APEvl~~~~-yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~---i~~~~~ 531 (612)
T KOG0603|consen 460 FGFWSELERS----CDTPALTLQYVAPEVLAIQE-YTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR---IQMPKF 531 (612)
T ss_pred echhhhCchh----hcccchhhcccChhhhccCC-CCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh---hcCCcc
Confidence 9999876433 34457799999999998655 899999999999999999999999887665333222 222211
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
-..+|+.+++||.+||++||.+|+++.+++.|+||...
T Consensus 532 ---------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~ 569 (612)
T KOG0603|consen 532 ---------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWFLSH 569 (612)
T ss_pred ---------------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcchhcC
Confidence 14689999999999999999999999999999999444
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=313.68 Aligned_cols=247 Identities=19% Similarity=0.259 Sum_probs=195.9
Q ss_pred cceeecccCceEEEEEEECCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~t-----g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
+.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~ 86 (277)
T cd05032 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST--GQPTLV 86 (277)
T ss_pred EEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--CCCcEE
Confidence 344599999999999988643 4789999986543 23344567899999999999999999999876 577999
Q ss_pred EEeeccccccccccC----------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 220 VFEYMEHDLAGLASH----------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~----------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
||||+.++.+..+.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccc
Confidence 999998655543332 1234788999999999999999999999999999999999999999999999998
Q ss_pred eecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
........ .......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+....+... +.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~----- 239 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG-GH----- 239 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC-CC-----
Confidence 76533221 1223345678899999987665 7999999999999999998 99999887766555444210 00
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||.+||+.+|.+|||+.+++.
T Consensus 240 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 ----------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0112345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=309.29 Aligned_cols=246 Identities=31% Similarity=0.468 Sum_probs=204.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
||.|+||.||++.+..+++.||+|+++.... .......+..|+.++++++|+||+++++.+.. ...+|+||||+.++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEecCCCC
Confidence 6899999999999998999999999987644 33456678899999999999999999998876 67899999999765
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
.+..+......+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......++.
T Consensus 79 ~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 157 (250)
T cd05123 79 ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGTP 157 (250)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCCc
Confidence 554444444478999999999999999999999999999999999999999999999999998654321 2233456788
Q ss_pred CCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccch
Q 004999 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKR 387 (720)
Q Consensus 308 ~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~ 387 (720)
.|+|||.+.+.. ++.++|+|||||++|+|++|..||...........+... .
T Consensus 158 ~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~------------------------- 209 (250)
T cd05123 158 EYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD--P------------------------- 209 (250)
T ss_pred cccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC--C-------------------------
Confidence 999999987765 688999999999999999999999877664444444320 0
Q ss_pred hhhcccCCCCHhHHHHHHHhcccCCCCCCCH---HHHHhCccC
Q 004999 388 CVAETFKDFPAPALALMETLLSIDPADRGSA---ASALRSEFF 427 (720)
Q Consensus 388 ~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa---~e~L~hp~f 427 (720)
......++..+.+||.+||..||++|||+ .+++.||||
T Consensus 210 --~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 210 --LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 01123458889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=321.55 Aligned_cols=245 Identities=27% Similarity=0.317 Sum_probs=191.3
Q ss_pred ceeecccCceEEEEEEECCCCeE--EEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEe
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKI--VALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~--VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
...||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +|+||+++++++.. ...+|+|||
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e 88 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIE 88 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCceEEEE
Confidence 34499999999999998877764 577766532 2345567788999999999 89999999999876 567999999
Q ss_pred eccccccccccC----------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 223 YMEHDLAGLASH----------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 223 y~~g~ll~~~~~----------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
|+.++.+..+.. ....+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCcc
Confidence 998654433222 1235899999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
|++...... ........+..|+|||++.+.. ++.++|||||||++|||+| |.+||.+.+..+....+....
T Consensus 169 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----- 240 (303)
T cd05088 169 GLSRGQEVY--VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY----- 240 (303)
T ss_pred ccCcccchh--hhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC-----
Confidence 998642111 1111122356799999887665 7999999999999999998 999998776655444331100
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......+++.+.+||.+||+.+|.+||++.++|++
T Consensus 241 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 -----------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -----------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001112467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=307.96 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=194.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+||+|+||.||+|... ++..||+|+++... .......+.+|+.+++.++||||+++++++.. ....|+||||+.++
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 77 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGG 77 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCC
Confidence 4999999999999864 67889999987543 33444568899999999999999999998876 56789999999875
Q ss_pred ccccc-cCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAGLA-SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~~~-~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
.+..+ ......+++..+..++.||+.+|.|||++|++|+||||+||+++.++.+||+|||++...............++
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 54433 33345689999999999999999999999999999999999999999999999999975432221111222335
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
..|+|||++.+.. ++.++|||||||++|+|++ |..||.+.........+....
T Consensus 158 ~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~------------------------- 211 (250)
T cd05085 158 IKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY------------------------- 211 (250)
T ss_pred ccccCHHHhccCC-CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-------------------------
Confidence 6799999987665 7899999999999999998 999998877665544442210
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......++..+.+||.+||+.+|++|||+.++++.
T Consensus 212 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 212 ---RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 001123578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=319.27 Aligned_cols=247 Identities=24% Similarity=0.262 Sum_probs=193.5
Q ss_pred ccceeecccCceEEEEEEECCCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~--~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
++.++||+|+||.||+|.+..++. .+++|.++.. ......+.+.+|+.++.++ +||||+++++++.. ...+|+|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv 81 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLYIA 81 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcceEE
Confidence 344569999999999999877764 4688887632 2334456788999999999 79999999998876 5679999
Q ss_pred EeeccccccccccCC----------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 221 FEYMEHDLAGLASHP----------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
|||+.++.+..+... ...+++..++.++.||+.||+|||++||+|+||||+||||+.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 999986544333221 1358899999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 004999 285 DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSP 363 (720)
Q Consensus 285 DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p 363 (720)
|||++...... ........+..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+...++.....
T Consensus 162 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~-- 236 (297)
T cd05089 162 DFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-- 236 (297)
T ss_pred CcCCCccccce--eccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--
Confidence 99998643211 1111112245699999987765 7999999999999999997 9999988877665554432100
Q ss_pred ChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 364 ~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......++..+.+||.+||+.||.+|||++++++.
T Consensus 237 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 --------------------------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=309.27 Aligned_cols=243 Identities=24% Similarity=0.342 Sum_probs=196.5
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||.|+||.||+|.+. .+..||||.+...... ...+.+|+.++++++|+||+++++++.. ...+|+||||+.
T Consensus 11 ~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~~~ 84 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIYIVTEYMS 84 (261)
T ss_pred eeeeccCcceEEEEEEEc-CCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceEEEEeccC
Confidence 344999999999999975 4577999998865433 3457899999999999999999998865 567999999998
Q ss_pred ccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 226 HDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 226 g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
++.+..+.. .+..+++..+..++.||+.||.|||++||+|+||||+||+|+.++.+||+|||++..+...........
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 765544433 234689999999999999999999999999999999999999999999999999987643222212222
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+..|+|||.+.+.. ++.++|||||||++|+|++ |+.||.+.+....+..+......
T Consensus 165 ~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~-------------------- 223 (261)
T cd05034 165 KFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------------------- 223 (261)
T ss_pred CCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--------------------
Confidence 3456899999998765 7999999999999999998 99999988877766665432111
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.++|.+||..+|.+|||+.++++
T Consensus 224 --------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 224 --------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred --------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 111345788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=310.75 Aligned_cols=242 Identities=22% Similarity=0.282 Sum_probs=194.5
Q ss_pred ecccCceEEEEEEEC--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~--~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ..+|+||||+++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~lv~e~~~~ 78 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALMLVMEMASG 78 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEEEEEeCCC
Confidence 999999999999765 456679999987543 34455678999999999999999999998743 468999999987
Q ss_pred cccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC--cccc
Q 004999 227 DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSR 303 (720)
Q Consensus 227 ~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~--~t~~ 303 (720)
+.+..+.. ....+++..++.++.||+.||.|||++|++|+||||+|||++.++.+||+|||++..+....... .+..
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 65554443 45578999999999999999999999999999999999999999999999999997654332211 1122
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+.+..+.+.. .
T Consensus 159 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~-------------------- 216 (257)
T cd05115 159 KWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK-R-------------------- 216 (257)
T ss_pred CCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC-C--------------------
Confidence 2357899999988765 7899999999999999996 999998887766655443210 0
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......++++.+||..||..||++||++.++++
T Consensus 217 -------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 -------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=309.23 Aligned_cols=244 Identities=26% Similarity=0.331 Sum_probs=197.4
Q ss_pred eecccCceEEEEEEECC-CC--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLD-QK--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~-tg--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+||+|++|.||+|.+.. ++ ..||||.++..... ...+.+.+|+.++++++||||+++++++.. ..+++||||+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 49999999999999865 33 36999999876544 566788999999999999999999998765 6789999999
Q ss_pred ccccccccc-CCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC--Cc
Q 004999 225 EHDLAGLAS-HPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PL 300 (720)
Q Consensus 225 ~g~ll~~~~-~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~--~~ 300 (720)
+++.+.... ... ..+++..++.++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++..+...... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 865544333 322 46899999999999999999999999999999999999999999999999999876432211 11
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+..+.+..+......
T Consensus 158 ~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------- 219 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER----------------- 219 (257)
T ss_pred cCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc-----------------
Confidence 1234577899999987765 7999999999999999999 99999887777666655431000
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||..||+.+|++|||+.++++
T Consensus 220 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 220 ----------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ----------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0011346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=315.52 Aligned_cols=269 Identities=22% Similarity=0.312 Sum_probs=197.6
Q ss_pred cccccceeecccCceEEEEEEE----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCe
Q 004999 141 IFSRSFYLIGQGTYSNVYRARD----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ 216 (720)
.++++++.||+|+||.||+|.. ..++..||+|.++... .......+.+|+.+++.+.||||+++++++.......
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3556666799999999999974 4678899999987543 3444567899999999999999999999887654467
Q ss_pred EEEEEeeccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 217 LYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
+|+||||++|+.+..+.. ....+++.++..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 899999998766655543 3346899999999999999999999999999999999999999999999999999866432
Q ss_pred CCC--CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 296 QNQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 296 ~~~--~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
... ......++..|+|||.+.+.. ++.++|||||||++|||+++..++..... . ..+..+....+......
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~- 235 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--L---FLKMIGPTHGQMTVTRL- 235 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--h---hhhhcccccccccHHHH-
Confidence 211 112334577899999988765 79999999999999999998765432111 1 11111111110000000
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
....... ........++..+.+||.+||+.||.+|||+.++++.
T Consensus 236 --~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 --VRVLEEG-----KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred --HHHHHcC-----ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0000000 0011234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.86 Aligned_cols=249 Identities=30% Similarity=0.441 Sum_probs=197.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||+|+||.||+|.+..+++.||+|.++.... +......+.+|+.++++++|+||+++++++.. ....++|||
T Consensus 5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 82 (267)
T cd08224 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNIVLE 82 (267)
T ss_pred eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEEEEe
Confidence 344459999999999999999999999999875433 44456778999999999999999999999876 578999999
Q ss_pred ecccccccccc----CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 223 YMEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 223 y~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
|++++.+..+. .....+++.+++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+.... .
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~-~ 161 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-T 161 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-c
Confidence 99975444332 234568999999999999999999999999999999999999999999999999987654322 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--VEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~--~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+... .+....+....
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------------- 224 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD---------------- 224 (267)
T ss_pred ccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC----------------
Confidence 223446788999999988765 79999999999999999999999865431 11111111100
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.+..+ ...++..+.++|.+||..+|.+|||+.++++
T Consensus 225 ---~~~~~--------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 ---YPPLP--------ADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---CCCCC--------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00000 1256788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=356.02 Aligned_cols=254 Identities=26% Similarity=0.318 Sum_probs=198.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+.+|+.++++++||||+++++++.. ....|+||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~lyLVM 81 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPVYYTM 81 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEEEEEE
Confidence 4455569999999999999999999999999976543 33445678999999999999999999998876 67899999
Q ss_pred eeccccccccccC-----------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 222 EYMEHDLAGLASH-----------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 222 Ey~~g~ll~~~~~-----------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
||++|+.+..+.. ....++...+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999865543322 12345677889999999999999999999999999999999999999999999998
Q ss_pred ecCCCC-----------------CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHH
Q 004999 291 FYDPDQ-----------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 353 (720)
Q Consensus 291 ~~~~~~-----------------~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l 353 (720)
...... .......+||+.|+|||++.+.. ++.++||||||||+|||+||.+||.+.......
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence 652111 01112346899999999998776 699999999999999999999999875443322
Q ss_pred HHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 354 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 354 ~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
... ....|. .......+++.+.+++.+||+.||.+|++..+.|...
T Consensus 241 ~~~--~i~~P~------------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 241 YRD--VILSPI------------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred hhh--hccChh------------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 111 000100 0011236788999999999999999999887777653
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.88 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=194.3
Q ss_pred eeecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 147 YLIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.||+|+||.||+|.+. .++..|++|.+.... ....+.+.+|+.++++++|+||+++++++.. ...+++||
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 86 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGD--GDPLIMVF 86 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--CCceEEEE
Confidence 45999999999999853 345678999886433 3344668899999999999999999999876 56799999
Q ss_pred eeccccccccccCC----------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeec
Q 004999 222 EYMEHDLAGLASHP----------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 285 (720)
Q Consensus 222 Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~D 285 (720)
||+.++.+..+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~d 166 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGD 166 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECC
Confidence 99987655443321 23489999999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 004999 286 FGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSP 363 (720)
Q Consensus 286 FGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p 363 (720)
||++........ .......++..|+|||.+.+.. ++.++||||||||+|||+| |.+||......+.+..+....
T Consensus 167 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--- 242 (291)
T cd05094 167 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR--- 242 (291)
T ss_pred CCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC---
Confidence 999976533221 1122345578899999988765 7999999999999999999 999998877665554432210
Q ss_pred ChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 364 ~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......++..+.+||.+||+.||.+|||+.++++
T Consensus 243 -------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 243 -------------------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred -------------------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 00112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=309.04 Aligned_cols=243 Identities=22% Similarity=0.376 Sum_probs=194.4
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||+|+||.||+|.+. +++.||+|.+...... ...+.+|+.++++++|+||+++++++. ...+|+||||+
T Consensus 10 ~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~~ 82 (260)
T cd05067 10 LVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYIITEYM 82 (260)
T ss_pred eeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEEEEcC
Confidence 3344999999999999864 5678999998765443 345788999999999999999998764 34689999999
Q ss_pred ccccc-ccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 225 EHDLA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 225 ~g~ll-~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
.++.+ ..+.. .+..+++.++..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.............
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 86544 43332 34578999999999999999999999999999999999999999999999999998764322222223
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..++..|+|||++.+.. ++.++|||||||++|||++ |++||.+.+..+....+......
T Consensus 163 ~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 222 (260)
T cd05067 163 AKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM------------------- 222 (260)
T ss_pred CcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-------------------
Confidence 34567899999987765 6899999999999999999 99999888766555544221110
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||.+||..+|++|||+.+++.
T Consensus 223 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 ---------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=313.79 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEECCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 147 YLIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+++.+.||||+++++++.. ...+++||
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~l~~~ 88 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT---STVQLVTQ 88 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CCcEEEEE
Confidence 349999999999999877776 48999987543 34445678899999999999999999998764 34789999
Q ss_pred ecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-c
Q 004999 223 YMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-L 300 (720)
Q Consensus 223 y~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~ 300 (720)
|++++ +...+......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+....... .
T Consensus 89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~ 168 (279)
T cd05109 89 LMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168 (279)
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccceeec
Confidence 99864 444444444578999999999999999999999999999999999999999999999999998764322211 1
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||...........+ .....+
T Consensus 169 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~---------------- 230 (279)
T cd05109 169 DGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL-EKGERL---------------- 230 (279)
T ss_pred CCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC----------------
Confidence 1223467899999998765 7999999999999999998 88998776554433322 211110
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||.+||..||++|||+.+++.
T Consensus 231 -----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 -----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112346788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=307.31 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=195.3
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|.+.. ++.||+|++...... .....+.+|+.++++++|+||+++++++.. ....|+||||+.++
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~ 77 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGG 77 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCCC
Confidence 39999999999999877 999999998765443 456678999999999999999999998876 56799999999876
Q ss_pred cccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc-ccccc
Q 004999 228 LAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL-TSRVV 305 (720)
Q Consensus 228 ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~-t~~~g 305 (720)
.+..+. .....+++..+..++.|++.+|.|||+++++|+||+|+||||+.++.+||+|||++........... .....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 554333 3345689999999999999999999999999999999999999999999999999976532111111 11223
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+..|+|||.+.+.. ++.++|||||||++|||++ |..||.+.........+.....
T Consensus 158 ~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~----------------------- 213 (251)
T cd05041 158 PIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYR----------------------- 213 (251)
T ss_pred eeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCC-----------------------
Confidence 56799999987765 7999999999999999999 8888888766544443321100
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||.+||..+|.+|||+.++|+
T Consensus 214 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 214 -----MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -----CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0012356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=304.34 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=199.0
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc---CCCeE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR---MSCSL 217 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~---~~~~l 217 (720)
+.|++.+.||+|||+.||++....++..||+|++.... .+..+..++|+...++++||||++++++.... .....
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 46777778999999999999999999999999998765 56677789999999999999999999876532 13468
Q ss_pred EEEEeecccc-cccccc---CCCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCCCceeeecccccee
Q 004999 218 YLVFEYMEHD-LAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 218 yLV~Ey~~g~-ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
||++.|...+ +++.+. ..+..++|.+++.|+.+|++||++||+.. +.||||||.|||+.+++.++|.|||.+..
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999754 554433 35668999999999999999999999998 99999999999999999999999999875
Q ss_pred cCCC---CC-----CCccccccccCCCChhhhcC---CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc
Q 004999 292 YDPD---QN-----QPLTSRVVTLWYRPPELLLG---ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360 (720)
Q Consensus 292 ~~~~---~~-----~~~t~~~gT~~Y~APE~l~~---~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~ 360 (720)
..-. .. +.-+...+|.-|+|||++.- .. .+.++|||||||+||+|+.|.-||. .+++..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~t-i~ertDIWSLGCtLYa~mf~~sPfe---------~~~~~G 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCT-ITERTDIWSLGCTLYAMMFGESPFE---------RIYQQG 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcc-cccccchhhhhHHHHHHHHcCCcch---------HHhhcC
Confidence 4211 10 11223456899999998853 33 5889999999999999999999983 222222
Q ss_pred CCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 361 g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
|+-.. ....+.+..|+. ..+++.+.+||+.||++||.+||++.++|.+
T Consensus 249 gSlaL------Av~n~q~s~P~~----------~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLAL------AVQNAQISIPNS----------SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEE------eeeccccccCCC----------CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 21100 000111111111 1278899999999999999999999999864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.98 Aligned_cols=245 Identities=29% Similarity=0.398 Sum_probs=193.5
Q ss_pred eeecccCceEEEEEEEC----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 147 YLIGQGTYSNVYRARDL----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
..||.|.||.||+|... ..+..|+||++... ...+..+.+.+|+.++++++||||++++|++.. ...+++|||
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~lv~e 81 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFLVME 81 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEEEEE
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccc--ccccccccc
Confidence 45999999999999987 45678999999653 345557889999999999999999999999985 566999999
Q ss_pred ecccccccc-ccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-CC
Q 004999 223 YMEHDLAGL-ASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-QP 299 (720)
Q Consensus 223 y~~g~ll~~-~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-~~ 299 (720)
|+.++.+.. +... ...+++.++..|+.||+.||.|||+++|+|++|+++||||+.++.+||+|||++........ ..
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~ 161 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKN 161 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999655544 3333 46799999999999999999999999999999999999999999999999999987622111 11
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.........|+|||.+.+.. ++.++||||||+++|||++ |+.||.+....+.+.++.+..
T Consensus 162 ~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~------------------ 222 (259)
T PF07714_consen 162 DSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ------------------ 222 (259)
T ss_dssp STTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE------------------
T ss_pred cccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc------------------
Confidence 22234577899999998776 7999999999999999999 779998887777666663321
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......++..+.+||..||..||.+|||+.++++
T Consensus 223 ----------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 ----------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ----------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ----------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01123457889999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.37 Aligned_cols=245 Identities=27% Similarity=0.402 Sum_probs=198.4
Q ss_pred eeecccCceEEEEEEECCCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 147 YLIGQGTYSNVYRARDLDQK----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+.||.|+||.||++.+..++ ..||+|++..... ......+..|+.++..++|+||+++++++.. ....|+|||
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~i~e 81 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMIVME 81 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEEEEe
Confidence 45999999999999998766 8899999975533 2356778899999999999999999998876 578999999
Q ss_pred eccccccccccCC-CCC-CCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLAGLASHP-GLK-FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll~~~~~~-~~~-lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.++.+..+... ... +++.++..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKK 161 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccccc
Confidence 9987555444432 223 89999999999999999999999999999999999999999999999999987643322221
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+++.|+|||.+.+.. ++.++|||||||++|+|++ |.+||.+.+....+..+.....
T Consensus 162 ~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------------ 222 (258)
T smart00219 162 KGGKLPIRWMAPESLKDGK-FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR------------------ 222 (258)
T ss_pred ccCCCcccccChHHhccCC-CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC------------------
Confidence 1223678899999986544 7999999999999999998 7899988766666555432110
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.++|.+||..||++|||+.++++
T Consensus 223 ----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 ----------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0112247889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=315.90 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=201.2
Q ss_pred ccceeecccCceEEEEEEEC---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
++.+.||+|+||.||++.+. .+++.||||+++.... .......+.+|+.++.++ +||||+++++.+.. ...+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~~~ 80 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DTKL 80 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CCEE
Confidence 34456999999999999864 4678899999875432 223445678999999999 69999999988866 6679
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|+||||+.++.+.........+++..++.++.||+.+|.|||+.|++|+||+|.||+++.++.++|+|||++..+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999765555554455789999999999999999999999999999999999999999999999999876543322
Q ss_pred CCccccccccCCCChhhhcCCc-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 QPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~-~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.......++..|+|||.+.+.. .++.++|||||||++|+|++|..||...........+.+..-. .
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~-------~------ 227 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK-------S------ 227 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc-------c------
Confidence 2222345789999999987643 3578999999999999999999998643322111111111000 0
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC---HHHHHhCccCCCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFTMKP 431 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hp~f~~~~ 431 (720)
.......++..+.+||.+||+.||++||| +.++|.|+||+..-
T Consensus 228 ------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 228 ------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred ------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 01112346788999999999999999998 57789999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=332.37 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=190.3
Q ss_pred eecccCceEEEEEEECC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~-----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|+++. ||||+++++++.. ...+||||
T Consensus 44 ~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~ 120 (400)
T cd05105 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--SGPIYIIT 120 (400)
T ss_pred eecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCceEEEE
Confidence 39999999999998743 34579999997543 2344567899999999996 9999999999876 67899999
Q ss_pred eeccccccccccC-------------------------------------------------------------------
Q 004999 222 EYMEHDLAGLASH------------------------------------------------------------------- 234 (720)
Q Consensus 222 Ey~~g~ll~~~~~------------------------------------------------------------------- 234 (720)
|||.++.+..++.
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 9998654432211
Q ss_pred -----------------------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeec
Q 004999 235 -----------------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 285 (720)
Q Consensus 235 -----------------------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~D 285 (720)
....+++.++..++.||+.||.|||+.+|+|+||||+|||++.++.+||+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~D 280 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICD 280 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEe
Confidence 012478889999999999999999999999999999999999999999999
Q ss_pred cccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCC
Q 004999 286 FGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSP 363 (720)
Q Consensus 286 FGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p 363 (720)
||++..+...... ......+++.|+|||++.+.. ++.++|||||||++|||++ |..||.+......+.........
T Consensus 281 fGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~- 358 (400)
T cd05105 281 FGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR- 358 (400)
T ss_pred CCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC-
Confidence 9999865332211 122334678899999998765 7999999999999999997 88888876443333222221000
Q ss_pred ChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 364 ~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||.+||+.||++|||+.++.+
T Consensus 359 --------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 359 --------------------------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred --------------------------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 0112357888999999999999999999988876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.38 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=192.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
..||+|+||.||+|.+..+. .||||.+..... ..+.+.+|+.++++++|+||+++++++. ....|+||||+.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v~e~~~~ 84 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIVTEFMGK 84 (260)
T ss_pred eeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEEEEcCCC
Confidence 34999999999999986654 599998875432 2345788999999999999999998764 3457999999987
Q ss_pred c-ccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 227 D-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 227 ~-ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+ +...+.. ....+++..+..++.||+.||.|||+.||+|+||||+||||++++.+||+|||++...............
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 164 (260)
T cd05069 85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAK 164 (260)
T ss_pred CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCc
Confidence 4 4444433 2345899999999999999999999999999999999999999999999999999866433222222334
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+.+..+.... .+
T Consensus 165 ~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~-------------------- 222 (260)
T cd05069 165 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-RM-------------------- 222 (260)
T ss_pred cchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC--------------------
Confidence 567899999887765 6999999999999999999 899999887766665543210 00
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||.+||..||.+||++.++++
T Consensus 223 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 112357888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.43 Aligned_cols=246 Identities=24% Similarity=0.346 Sum_probs=198.2
Q ss_pred ceeecccCceEEEEEEECCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 146 FYLIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~---~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.||+|+||.||+|.+..++. .||||+++... .......+..|+.+++.++||||+++.+++.. ...+|+|||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 86 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPAMIITE 86 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCcEEEEE
Confidence 4459999999999999876554 79999987543 23445678899999999999999999999876 567899999
Q ss_pred eccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 223 YMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|++++.+..+.. ....+++.++..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++...........+
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 166 (268)
T cd05063 87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166 (268)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccccee
Confidence 999866654443 3457899999999999999999999999999999999999999999999999999866432222111
Q ss_pred c--cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 302 S--RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 302 ~--~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
. ...+..|+|||++.+.. ++.++|||||||++|||++ |..||...+..+....+......|
T Consensus 167 ~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--------------- 230 (268)
T cd05063 167 TSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--------------- 230 (268)
T ss_pred ccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---------------
Confidence 1 12245799999987765 7999999999999999997 999998877766666554321111
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...+++..+.+||.+||+.+|.+||++.++++
T Consensus 231 -------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11256788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.13 Aligned_cols=254 Identities=23% Similarity=0.278 Sum_probs=194.5
Q ss_pred cceeecccCceEEEEEEECCC--------------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecccee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQ--------------KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVT 210 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~t--------------g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~ 210 (720)
+.+.||+|+||.||+|++..+ ...||||+++... .......+.+|+.++++++|+||+++++++.
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 87 (295)
T cd05097 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87 (295)
T ss_pred ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 334499999999999987543 2359999987543 3455567899999999999999999999987
Q ss_pred ccCCCeEEEEEeeccccccccccCC------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC
Q 004999 211 SRMSCSLYLVFEYMEHDLAGLASHP------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 278 (720)
Q Consensus 211 ~~~~~~lyLV~Ey~~g~ll~~~~~~------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~ 278 (720)
. ...+|+||||+.+..+..+... ...+++..+..++.||+.||.|||++|++|+||||+||||+.+
T Consensus 88 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~ 165 (295)
T cd05097 88 S--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNH 165 (295)
T ss_pred C--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCC
Confidence 6 5679999999997554433221 1247889999999999999999999999999999999999999
Q ss_pred CceeeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh--CCCCCCCCChHHHHHH
Q 004999 279 GILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIMPGRTEVEQLHK 355 (720)
Q Consensus 279 g~vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt--G~ppf~g~~~~e~l~~ 355 (720)
+.+||+|||++..+..... .......++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+.+..
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~ 244 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHH
Confidence 9999999999976532221 1112234467899999988766 7999999999999999988 5678887766555554
Q ss_pred HHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 356 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 356 i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
+.+...... . .........+++.+.+||.+||+.||.+|||+.++++
T Consensus 245 ~~~~~~~~~-------~--------------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 245 TGEFFRNQG-------R--------------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHhhhhcc-------c--------------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 432110000 0 0001122356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=310.68 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=197.6
Q ss_pred ccceeecccCceEEEEEEECCCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
++.+.||+|+||.||+|.+..++ ..||+|.++.... ......+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPVMIV 83 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCccEEE
Confidence 34456999999999999986444 3799999875432 3456678999999999999999999999876 5679999
Q ss_pred Eeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 221 FEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 221 ~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
|||++++.+..+. .....+++.++..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 9999876554443 334568999999999999999999999999999999999999999999999999998764322211
Q ss_pred cc--ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 300 LT--SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 300 ~t--~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.+ ...++..|+|||.+.+.. ++.++|+|||||++|||++ |..||.+....+....+.+....
T Consensus 164 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 228 (267)
T cd05066 164 YTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL-------------- 228 (267)
T ss_pred eecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC--------------
Confidence 11 122356799999998765 7999999999999999886 99999887766555544321110
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||.+||+.+|.+|||+.++++
T Consensus 229 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 --------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred --------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 011356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=314.28 Aligned_cols=238 Identities=23% Similarity=0.282 Sum_probs=186.9
Q ss_pred eecccCceEEEEEEECC------------------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCcee
Q 004999 148 LIGQGTYSNVYRARDLD------------------------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~------------------------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIv 203 (720)
.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 39999999999997432 12458899886432 23445678899999999999999
Q ss_pred eeccceeccCCCeEEEEEeeccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC---
Q 004999 204 KLEGLVTSRMSCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG--- 279 (720)
Q Consensus 204 kl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g--- 279 (720)
++++++.. ....||||||++++.+..+.. ....+++.++..++.||+.||+|||+.||+||||||+||||+..+
T Consensus 80 ~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 80 FVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999876 567899999999877665553 355789999999999999999999999999999999999997654
Q ss_pred ----ceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHH-hCCCCCCCCChHHHHH
Q 004999 280 ----ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLH 354 (720)
Q Consensus 280 ----~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELl-tG~ppf~g~~~~e~l~ 354 (720)
.+||+|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|.+||.+....+...
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 4899999988643221 22356788999999977566899999999999999984 7899998766544322
Q ss_pred HHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 355 KIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 355 ~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.+.... ......++.+.+||.+||+.+|++|||+.++|++
T Consensus 233 ~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FYEKKH------------------------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHhcc------------------------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 111100 0111245678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.92 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=198.3
Q ss_pred ccceeecccCceEEEEEEECCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~---~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
++.+.||+|+||.||+|.+..+++ .||||++.... .......+..|+.+++.++||||+++++++.. ...+|+|
T Consensus 7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv 83 (269)
T cd05065 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRPVMII 83 (269)
T ss_pred EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCceEEE
Confidence 445569999999999999877664 59999987542 34556778999999999999999999998866 6678999
Q ss_pred Eeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-
Q 004999 221 FEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ- 298 (720)
Q Consensus 221 ~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~- 298 (720)
|||+.++.+..+. .....+++.+++.++.|++.||.|||++|++|+||||+||||+.++.+||+|||++.........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 9999986555443 33456899999999999999999999999999999999999999999999999998765332211
Q ss_pred Cccccc---cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 299 PLTSRV---VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 299 ~~t~~~---gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
...... .+..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+....+......
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~------------ 230 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL------------ 230 (269)
T ss_pred ccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC------------
Confidence 111111 245799999987765 7999999999999999886 99999887766655555321110
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
....+++..+.+||..||..+|.+||++.+++.
T Consensus 231 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 231 ----------------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 012356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.41 Aligned_cols=243 Identities=19% Similarity=0.282 Sum_probs=190.6
Q ss_pred eecccCceEEEEEEECCCCeE----EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 148 LIGQGTYSNVYRARDLDQKKI----VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~----VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
.||+|+||.||+|.+..++.. |++|.+... ........+..|+.++++++||||+++++++.. ..+++|+||
T Consensus 14 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~~~~i~e~ 89 (279)
T cd05111 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---ASLQLVTQL 89 (279)
T ss_pred ccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---CccEEEEEe
Confidence 399999999999999877763 677776532 223445667889999999999999999998643 457899999
Q ss_pred cccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-Ccc
Q 004999 224 MEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLT 301 (720)
Q Consensus 224 ~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~t 301 (720)
+.++ +...+......+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++......... ..+
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T cd05111 90 SPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169 (279)
T ss_pred CCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccC
Confidence 9864 44444444567899999999999999999999999999999999999999999999999999866433221 122
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...++..|+|||.+.+.. |+.++|||||||++|||++ |..||.+.........+ .....+
T Consensus 170 ~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~----------------- 230 (279)
T cd05111 170 EHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-EKGERL----------------- 230 (279)
T ss_pred CCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCcC-----------------
Confidence 334577899999998765 7999999999999999998 99999887654433222 211000
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+++..||..||.+|||+.++++
T Consensus 231 ----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 ----------AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 011235677899999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=311.05 Aligned_cols=238 Identities=19% Similarity=0.245 Sum_probs=186.4
Q ss_pred eecccCceEEEEEEECC------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCC
Q 004999 148 LIGQGTYSNVYRARDLD------------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 215 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~------------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~ 215 (720)
.||+|+||.||+|+... ....|++|++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~--~~ 77 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVR--DV 77 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CC
Confidence 39999999999998532 23358889876432 3344567889999999999999999999876 56
Q ss_pred eEEEEEeeccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc-------eeeeccc
Q 004999 216 SLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-------LKIADFG 287 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~-------vKL~DFG 287 (720)
..++||||++++.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 7899999999877665554 3456899999999999999999999999999999999999987664 8999999
Q ss_pred cceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 288 la~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELl-tG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
++..... .....++..|+|||++.+...++.++|||||||++|||+ +|..||.+....+.. .+....
T Consensus 158 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~------ 225 (262)
T cd05077 158 IPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQ------ 225 (262)
T ss_pred CCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcC------
Confidence 9875432 123457888999999876556899999999999999998 578888765443321 111100
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......++.+.+||.+||+.||.+||++.++|++
T Consensus 226 -----------------------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 -----------------------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -----------------------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 00112245678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.24 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=194.7
Q ss_pred eeecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 147 YLIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
..||+|+||.||++.. ..++..||+|.+... .......+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 86 (280)
T cd05092 11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRPLLMVF 86 (280)
T ss_pred cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCceEEEE
Confidence 3499999999999974 245678999987643 34455678999999999999999999998876 56789999
Q ss_pred eeccccccccccCCC---------------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 222 EYMEHDLAGLASHPG---------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~---------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
||+.++.+..+.... ..+++..++.++.||+.||.|||++||+|+||||+|||+++++.+||+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~df 166 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDF 166 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCC
Confidence 999876554333221 35889999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 287 GLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 287 Gla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
|++........ .......+++.|+|||.+.+.. ++.++|||||||++|||++ |.+||......+.+..+.... +
T Consensus 167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~- 242 (280)
T cd05092 167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR--E- 242 (280)
T ss_pred CceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc--c-
Confidence 99976532221 1112223467899999998766 7999999999999999998 899998877766655543211 0
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||.+||+.||.+||++.++++
T Consensus 243 -------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 243 -------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0112357888999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.89 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEE
Q 004999 147 YLIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.||+|+||.||+|.+ ..++..||||+++... .....+.+.+|+.+++++ +||||+++++++.. ...+|+|
T Consensus 41 ~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv 117 (302)
T cd05055 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTI--GGPILVI 117 (302)
T ss_pred ceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--CCceEEE
Confidence 3499999999999975 3456689999987543 234456788999999999 79999999998876 5679999
Q ss_pred EeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 221 FEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
|||+.++.+..+.. ....+++.++..++.||+.||.|||+++|+|+||||+|||++.++.+||+|||++..+......
T Consensus 118 ~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 197 (302)
T cd05055 118 TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY 197 (302)
T ss_pred EEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCce
Confidence 99998655544432 2234899999999999999999999999999999999999999999999999999765332211
Q ss_pred -CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 299 -PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 299 -~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+...........
T Consensus 198 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------------- 262 (302)
T cd05055 198 VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR-------------- 262 (302)
T ss_pred eecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc--------------
Confidence 111234577899999998766 7999999999999999998 99999887655544443321000
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||.+||..+|++|||+.++++
T Consensus 263 -------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 263 -------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred -------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.26 Aligned_cols=263 Identities=22% Similarity=0.285 Sum_probs=194.8
Q ss_pred ccceeecccCceEEEEEE----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
++.+.||+|+||.||++. ...++..||+|+++.... ......+.+|+.+|+.++||||+++++++.......+|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 556679999999998865 345788899999876532 334566789999999999999999999877654567899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ- 298 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~- 298 (720)
||||+.++.+..+.... .+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+......
T Consensus 86 v~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 164 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 164 (283)
T ss_pred EecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhh
Confidence 99999987666555433 5899999999999999999999999999999999999999999999999999865432211
Q ss_pred -CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCChhhhhhcCCCCc
Q 004999 299 -PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC-GSPSEDYWRKSKLPHA 376 (720)
Q Consensus 299 -~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~-g~p~~~~w~~~~l~~~ 376 (720)
......++..|+|||.+.+.. ++.++|||||||++|||++|..||...... +..+.... +......+...
T Consensus 165 ~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~----- 236 (283)
T cd05080 165 RVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL----- 236 (283)
T ss_pred ccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh-----
Confidence 111223466799999987655 799999999999999999999887543321 11111100 00000000000
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.... ........++..+.+|+..||+.||++|||+.++++
T Consensus 237 --~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 237 --LERG-----MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred --hhcC-----CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 000112457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.39 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=193.8
Q ss_pred cceeecccCceEEEEEEECC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~-----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
+.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.. ....|+
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 80 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DGPLLL 80 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCCcEE
Confidence 34459999999999998753 33568999887543 33445678899999999999999999998876 567899
Q ss_pred EEeeccccccccccC------------------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE
Q 004999 220 VFEYMEHDLAGLASH------------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 275 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~------------------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl 275 (720)
||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 999999765543321 12358899999999999999999999999999999999999
Q ss_pred cCCCceeeeccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHH
Q 004999 276 DNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 353 (720)
Q Consensus 276 d~~g~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l 353 (720)
++++.+||+|||++......... ......++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+..
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999765322211 112224467899999987765 7999999999999999999 99999887665544
Q ss_pred HHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 354 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 354 ~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
..+.+... ......++..+.+||..||+.||.+||++.++++
T Consensus 240 ~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 240 NLLKTGYR----------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHhCCCC----------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 33321100 0112357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.79 Aligned_cols=242 Identities=27% Similarity=0.323 Sum_probs=189.7
Q ss_pred eecccCceEEEEEEECCCCe--EEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKK--IVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~--~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+||+|+||.||+|++..++. .+|+|.++.. ........+.+|+.++.++ +||||+++++++.. ...+|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 49999999999999988775 4688887632 2345556788999999999 79999999999876 56789999999
Q ss_pred cccccccccCC----------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 225 EHDLAGLASHP----------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 225 ~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
.++.+..+... ...+++.+++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 86544332221 12578999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
+...... ........+..|+|||++.+.. ++.++|||||||++|||++ |..||.+.+..+....+....
T Consensus 159 ~~~~~~~--~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------- 228 (270)
T cd05047 159 SRGQEVY--VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------- 228 (270)
T ss_pred ccccchh--hhccCCCCccccCChHHHccCC-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-------
Confidence 8632211 1111122356799999987655 7999999999999999997 999998876655444432100
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
..+....++..+.+||.+||..||.+|||+.+++.
T Consensus 229 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 229 ---------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ---------------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 00112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.37 Aligned_cols=243 Identities=28% Similarity=0.408 Sum_probs=193.2
Q ss_pred ecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 149 IGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
||+|+||.||+|.+. .++..||||++.... .......+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 13 lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 89 (288)
T cd05050 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAV--GKPMCLLFEY 89 (288)
T ss_pred ccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCccEEEEec
Confidence 999999999999874 367889999987543 34455678899999999999999999998876 5678999999
Q ss_pred ccccccccccC----------------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCce
Q 004999 224 MEHDLAGLASH----------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 281 (720)
Q Consensus 224 ~~g~ll~~~~~----------------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~v 281 (720)
+.++.+..+.. ....+++.+++.++.||+.||.|||+++++|+||||+|||++.++.+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~ 169 (288)
T cd05050 90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 169 (288)
T ss_pred CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCce
Confidence 99754433322 11357889999999999999999999999999999999999999999
Q ss_pred eeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 004999 282 KIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKL 359 (720)
Q Consensus 282 KL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~ 359 (720)
||+|||++..+..... ........+..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+.+..+...
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~ 248 (288)
T cd05050 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG 248 (288)
T ss_pred EECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence 9999999876532211 1112223466799999988765 7999999999999999998 88888887766655544321
Q ss_pred cCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 360 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 360 ~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
. .......++..+.+||.+||+.||.+|||+.|+++
T Consensus 249 ~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 249 N----------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred C----------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0 00112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.90 Aligned_cols=237 Identities=24% Similarity=0.365 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||.|+||.||+|.+ .|+.||||.+..... ..+.+.+|+.+++.++|+||+++++++.. ....|+||||+++
T Consensus 12 ~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 84 (256)
T cd05039 12 ATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIVTEYMAK 84 (256)
T ss_pred eeeecCCCceEEEEEe--cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEEEEecCC
Confidence 3499999999999987 478899999976532 45678899999999999999999999876 6779999999997
Q ss_pred cccccccCCC--CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 227 DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 227 ~ll~~~~~~~--~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
..+..+.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....... ....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----~~~~ 160 (256)
T cd05039 85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----DSGK 160 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc----ccCC
Confidence 5544444322 268999999999999999999999999999999999999999999999999998653211 1223
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
.+..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+.+. . .
T Consensus 161 ~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~------------------~--- 217 (256)
T cd05039 161 LPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-Y------------------R--- 217 (256)
T ss_pred CcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-C------------------C---
Confidence 456799999987655 7899999999999999997 99999877655544333210 0 0
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||.+||..+|++|||+.+++.
T Consensus 218 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 218 ------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0112356889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.38 Aligned_cols=248 Identities=21% Similarity=0.359 Sum_probs=195.4
Q ss_pred ceeecccCceEEEEEEECC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 146 FYLIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~-----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.+.||.|+||.||+|+... +.+.|++|.+.... .......+.+|+.++++++|+||+++++++.. ....|+|
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 86 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AEPHYMI 86 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CCcceEE
Confidence 3449999999999999754 34679999876533 23356678999999999999999999998866 5678999
Q ss_pred EeeccccccccccCCCC---------CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 221 FEYMEHDLAGLASHPGL---------KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~---------~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
|||++++.+..+..... .+++..+..++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++..
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred EEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999765554443222 689999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
.............++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+......+..+... ..
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~------- 236 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KL------- 236 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--Cc-------
Confidence 4322222233445678899999987765 6899999999999999999 77888776655444433210 00
Q ss_pred cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......++..+.+||.+||+.||.+|||+.+++..
T Consensus 237 ------------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 ------------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ------------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 001123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.28 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=191.5
Q ss_pred ccceeecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
++.+.||+|+||.||+|.+ ..+++.||||+++.... ......+.+|+.+|.++ +||||+++++++... ...+
T Consensus 10 ~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~~~~ 87 (343)
T cd05103 10 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPL 87 (343)
T ss_pred cccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecC-CCce
Confidence 3334499999999999985 35678899999975432 34456788999999999 689999999987653 4578
Q ss_pred EEEEeeccccccccccCC--------------------------------------------------------------
Q 004999 218 YLVFEYMEHDLAGLASHP-------------------------------------------------------------- 235 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~-------------------------------------------------------------- 235 (720)
|+||||++++.+..+...
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 999999997554332211
Q ss_pred -----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-CccccccccCC
Q 004999 236 -----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWY 309 (720)
Q Consensus 236 -----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y 309 (720)
...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......... ......++..|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 247 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence 123688889999999999999999999999999999999999999999999999765322111 11122346779
Q ss_pred CChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchh
Q 004999 310 RPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388 (720)
Q Consensus 310 ~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~ 388 (720)
+|||++.+.. ++.++|||||||++|+|++ |..||.+......+.........
T Consensus 248 ~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------- 300 (343)
T cd05103 248 MAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-------------------------- 300 (343)
T ss_pred ECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC--------------------------
Confidence 9999998765 7999999999999999997 88999875443333222211000
Q ss_pred hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 389 VAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 389 ~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+++.+.+++..||+.||.+|||+.++++|
T Consensus 301 -~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 -MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.67 Aligned_cols=251 Identities=28% Similarity=0.435 Sum_probs=199.5
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN---LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.+.+.||+|+||.||++.+..++..+++|+++... ........+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFCII 80 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceEEE
Confidence 34455999999999999998877777777765422 233334456789999999999999999998876 5678999
Q ss_pred Eeecccccccccc----CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 221 FEYMEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 221 ~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
|||+.+..+..+. .....+++.+++.++.||+.||.|||+.|++|+||+|+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 9999976554332 23457899999999999999999999999999999999999974 679999999997654322
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..+|.+.........+... .+
T Consensus 160 ~-~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~------------- 222 (260)
T cd08222 160 D-LATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--PT------------- 222 (260)
T ss_pred c-cccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--CC-------------
Confidence 1 122345688999999987655 688999999999999999999999877665555544321 00
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......++..+.+||.+||..||++||++.++++||||
T Consensus 223 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 -------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 01123567889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.99 Aligned_cols=245 Identities=22% Similarity=0.348 Sum_probs=194.2
Q ss_pred eecccCceEEEEEEEC-------CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~-------~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyL 219 (720)
.||+|+||.||+|++. .++..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.. ...+|+
T Consensus 22 ~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~l 98 (304)
T cd05101 22 PLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGPLYV 98 (304)
T ss_pred eeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec--CCceEE
Confidence 4999999999999753 234579999987542 344557788999999999 89999999998876 567899
Q ss_pred EEeeccccccccccCC----------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceee
Q 004999 220 VFEYMEHDLAGLASHP----------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 283 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL 283 (720)
||||+.++.+..+... ...+++.++..++.||+.||.|||++||+|+||||+||||+.++.+||
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl 178 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKI 178 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEE
Confidence 9999987544433221 235788999999999999999999999999999999999999999999
Q ss_pred eccccceecCCCCCCC-ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 004999 284 ADFGLASFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 284 ~DFGla~~~~~~~~~~-~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g 361 (720)
+|||++..+....... .....+++.|+|||++.+.. |+.++|||||||++|+|++ |..+|.+.+..+....+....
T Consensus 179 ~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~- 256 (304)
T cd05101 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH- 256 (304)
T ss_pred CCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-
Confidence 9999998664322211 12234567899999997765 7999999999999999998 788898877665555442110
Q ss_pred CCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 362 ~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......++..+.+||.+||..+|.+|||+.++++.
T Consensus 257 ---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 257 ---------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ---------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 001123578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.99 Aligned_cols=243 Identities=26% Similarity=0.386 Sum_probs=194.6
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||+|.+. .+..+|+|++....... ..+.+|+.++++++||||+++++++.. ....|+||||+.+
T Consensus 10 ~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 83 (256)
T cd05112 10 QEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLVFEFMEH 83 (256)
T ss_pred eeecCcccceEEEEEEe-CCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEEEEcCCC
Confidence 44999999999999885 46679999987554332 357789999999999999999998866 5678999999998
Q ss_pred cccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 227 DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
+.+..+.. ....+++..++.++.||+.+|.|||+.+++|+||||+||+++.++.+||+|||++...............+
T Consensus 84 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 163 (256)
T cd05112 84 GCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCcc
Confidence 66554443 34568999999999999999999999999999999999999999999999999997653322211122234
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+..|+|||.+.+.. ++.++|||||||++|||++ |.+||......+.+..+.+.. .
T Consensus 164 ~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~---------------------- 219 (256)
T cd05112 164 PVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF-R---------------------- 219 (256)
T ss_pred chhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-C----------------------
Confidence 67899999987655 7999999999999999998 999998877666555543210 0
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......+..+.+|+.+||+.+|++|||+.++++.
T Consensus 220 -----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 220 -----LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 00112357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=309.53 Aligned_cols=265 Identities=24% Similarity=0.332 Sum_probs=193.3
Q ss_pred cccceeecccCceEEEEEE----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
+++.+.||+|+||.||+|. +..++..||||++... .....+.+.+|+.+++.++||||+++++++.......+|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 3444569999999999997 4467889999998754 245567788999999999999999999987654456789
Q ss_pred EEEeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 219 LVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
+||||+.++.+..+. .....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999875554443 3345689999999999999999999999999999999999999999999999999987643222
Q ss_pred CC--ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh-hhhhhcCCC
Q 004999 298 QP--LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE-DYWRKSKLP 374 (720)
Q Consensus 298 ~~--~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~-~~w~~~~l~ 374 (720)
.. .....++..|+|||++.+.. ++.++|||||||++|||++|..++..... ..+..+......+.. ..+..
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---- 237 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPA-EFMRMMGNDKQGQMIVYHLIE---- 237 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcch-hhhhhcccccccccchHHHHH----
Confidence 11 11112345699999997765 79999999999999999998766543321 111111000000000 00000
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...... .......++..+.+||.+||..+|++|||+.++++
T Consensus 238 ---~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 ---LLKNNG-----RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ---HHhcCC-----cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000000 00122467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.88 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=192.8
Q ss_pred eeecccCceEEEEEEEC-------CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEE
Q 004999 147 YLIGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~-------~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~ly 218 (720)
+.||+|+||.||+|.+. .....||+|.++... .......+.+|+.+++.+ +||||+++++++.. ...+|
T Consensus 18 ~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 94 (314)
T cd05099 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQ--EGPLY 94 (314)
T ss_pred eeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc--CCceE
Confidence 34999999999999863 234579999987543 344566788999999999 69999999998876 56799
Q ss_pred EEEeeccccccccccC----------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCcee
Q 004999 219 LVFEYMEHDLAGLASH----------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILK 282 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~----------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vK 282 (720)
+||||+.++.+..+.. ....+++.++..++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~k 174 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMK 174 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEE
Confidence 9999998765443332 123589999999999999999999999999999999999999999999
Q ss_pred eeccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhc
Q 004999 283 IADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLC 360 (720)
Q Consensus 283 L~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~ 360 (720)
|+|||++......... ......++..|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+....
T Consensus 175 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 253 (314)
T cd05099 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGH 253 (314)
T ss_pred EccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999865322111 111222346799999998765 7999999999999999999 889998877655555442210
Q ss_pred CCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 361 g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......++..+.+||.+||..||.+|||+.++++
T Consensus 254 ----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 254 ----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00122356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.27 Aligned_cols=237 Identities=22% Similarity=0.355 Sum_probs=189.2
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
++||+|+||.||++.. .+..||+|.++... ..+.+.+|+.++++++|+||+++++++... ...+|+||||+++
T Consensus 12 ~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~lv~e~~~~ 84 (256)
T cd05082 12 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAK 84 (256)
T ss_pred eeecccCCCeEEEEEE--cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEEEEECCCC
Confidence 4499999999999976 47779999986432 245678999999999999999999876542 4578999999987
Q ss_pred cccc-cccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 227 DLAG-LASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 227 ~ll~-~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+.+. .+... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++....... ....
T Consensus 85 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~ 160 (256)
T cd05082 85 GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGK 160 (256)
T ss_pred CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----CCCc
Confidence 5444 33332 2348999999999999999999999999999999999999999999999999987643221 2223
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
++..|+|||++.+.. ++.++||||||||+|+|++ |++||......+....+.+.. +
T Consensus 161 ~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~--~-------------------- 217 (256)
T cd05082 161 LPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--K-------------------- 217 (256)
T ss_pred cceeecCHHHHccCC-CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC--C--------------------
Confidence 456799999987765 7999999999999999998 999998766555444432210 0
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 218 ------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 218 ------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0112357889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=311.41 Aligned_cols=238 Identities=17% Similarity=0.214 Sum_probs=187.7
Q ss_pred eecccCceEEEEEEECCCCeE-------EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKI-------VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~-------VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.||.|+||.||+|.+..++.. ||+|.+.... ....+.+..|+.+++.++||||+++++++.. ....++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDESIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCcEEE
Confidence 399999999999998665443 8888875432 3445667889999999999999999999876 5678999
Q ss_pred Eeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc--------eeeecccccee
Q 004999 221 FEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--------LKIADFGLASF 291 (720)
Q Consensus 221 ~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~--------vKL~DFGla~~ 291 (720)
|||+.++.+..+. ..+..+++..++.++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999987665544 34456899999999999999999999999999999999999987765 69999998865
Q ss_pred cCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
... .....+++.|+|||++.+...++.++|||||||++|||++|. +||...+........ ...
T Consensus 158 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~---------- 221 (258)
T cd05078 158 VLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-EDR---------- 221 (258)
T ss_pred cCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-Hcc----------
Confidence 432 123457888999999987666799999999999999999985 666655544332211 100
Q ss_pred cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......+..+.+||.+||+.||++|||+.++++.
T Consensus 222 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 222 -------------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -------------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 01112345679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.77 Aligned_cols=249 Identities=20% Similarity=0.272 Sum_probs=189.1
Q ss_pred ecccCceEEEEEEECC--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYSNVYRARDLD--QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~--tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++|+||+++++.+.. ...+|+||||+.+
T Consensus 3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e~~~~ 79 (269)
T cd05042 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLEFCPL 79 (269)
T ss_pred CCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEEeCCC
Confidence 9999999999996432 44568888876433 33445667899999999999999999998876 5679999999997
Q ss_pred cccccccCC-----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-CCc
Q 004999 227 DLAGLASHP-----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-QPL 300 (720)
Q Consensus 227 ~ll~~~~~~-----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-~~~ 300 (720)
+.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ...
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 655443322 12356788999999999999999999999999999999999999999999999865422211 111
Q ss_pred cccccccCCCChhhhcC------CcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 301 TSRVVTLWYRPPELLLG------ATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~------~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
....+++.|+|||++.. ...++.++|||||||++|||++ |.+||......+.+..+........
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~--------- 230 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL--------- 230 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC---------
Confidence 23345678999999753 2346889999999999999999 7888988777666655543211110
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.. ......++..+.+++..|+ .||++|||+.++++-
T Consensus 231 --------~~------~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 231 --------PK------PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred --------CC------CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 00 0112357788899999998 599999999999863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=306.55 Aligned_cols=247 Identities=22% Similarity=0.320 Sum_probs=195.9
Q ss_pred cceeecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.++||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++.. ...|+||
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~lv~ 85 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVWIVM 85 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcEEEE
Confidence 344699999999999987644 3468999886443 34556678999999999999999999998764 4578999
Q ss_pred eecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 222 EYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 222 Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
||+.++.+..+. .....+++..++.++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++...........
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 165 (270)
T cd05056 86 ELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKA 165 (270)
T ss_pred EcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccceec
Confidence 999865444433 3344689999999999999999999999999999999999999999999999999986643322222
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
+...++..|+|||.+.+.. ++.++|||||||++|||++ |.+||.+....+.+..+.+...
T Consensus 166 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~------------------ 226 (270)
T cd05056 166 SKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER------------------ 226 (270)
T ss_pred CCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc------------------
Confidence 2223456799999887655 7999999999999999986 9999988877666555432100
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
...+..++..+.+||.+||..+|.+|||+.+++..
T Consensus 227 ----------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 227 ----------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01124578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.46 Aligned_cols=246 Identities=24% Similarity=0.300 Sum_probs=189.9
Q ss_pred eecccCceEEEEEEECC---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~---tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+||+|+||.||+|.+.. ....||||.+... ........+.+|+.+++.++||||+++++++... +...|+||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~ 79 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM 79 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence 49999999999998653 3457999987532 2344567788999999999999999999976543 45689999999
Q ss_pred ccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC---Cc
Q 004999 225 EHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PL 300 (720)
Q Consensus 225 ~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~---~~ 300 (720)
.++.+..+. .....+++..+..++.||+.||.|||+.+|+|+||||+||||+.++.+||+|||++......... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 875554443 33445678888999999999999999999999999999999999999999999999754322111 11
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....++..|+|||.+.+.. ++.++|||||||++|||++ |.++|......+....+... .+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~---------------- 220 (262)
T cd05058 160 TGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR---------------- 220 (262)
T ss_pred ccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC----------------
Confidence 1224467899999987765 7999999999999999999 56778776655544333211 00
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+++.+.+||..||..+|++||++.+++..
T Consensus 221 ----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 221 ----------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ----------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 00112467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=315.23 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=190.9
Q ss_pred eecccCceEEEEEEECC-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~-------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyL 219 (720)
.||+|+||.||+|.+.. +...||+|.+.... .......+.+|+.+++.+ +||||+++++++.. ...+|+
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~~~~l 101 (307)
T cd05098 25 PLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYV 101 (307)
T ss_pred eeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceEE
Confidence 49999999999998643 23569999998653 234456688899999999 79999999999876 567999
Q ss_pred EEeeccccccc-cccCC---------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceee
Q 004999 220 VFEYMEHDLAG-LASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 283 (720)
Q Consensus 220 V~Ey~~g~ll~-~~~~~---------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL 283 (720)
||||+.++.+. .+... ...+++.+++.++.||+.||+|||++|++|+||||+|||++.++.+||
T Consensus 102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL 181 (307)
T cd05098 102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 181 (307)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEE
Confidence 99999875443 33221 235889999999999999999999999999999999999999999999
Q ss_pred eccccceecCCCCCCC-ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 004999 284 ADFGLASFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 284 ~DFGla~~~~~~~~~~-~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g 361 (720)
+|||++.......... .....+++.|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+....+...
T Consensus 182 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-- 258 (307)
T cd05098 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-- 258 (307)
T ss_pred CCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcC--
Confidence 9999987553211111 11122356899999998765 7999999999999999998 88888776654433333210
Q ss_pred CCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 362 ~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
. ..+....++..+.+||.+||..+|.+|||+.+++++
T Consensus 259 ~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 259 H--------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred C--------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 0 011223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=330.02 Aligned_cols=251 Identities=23% Similarity=0.326 Sum_probs=221.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.||-|+||.|=++........+|+|++++... +....+++..|-+||..++.|.||+||..|.+ +..+|++||-|-|
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd--~kyvYmLmEaClG 504 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD--SKYVYMLMEACLG 504 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc--chhhhhhHHhhcC
Confidence 39999999999998766666699999987654 55667788999999999999999999988866 7899999999987
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+.+..++...+.|++..++.|+..+++|++|||++|||+|||||+|+|++.+|.+||.|||+|+.+.... ..-+.|||
T Consensus 505 GElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KTwTFcGT 582 (732)
T KOG0614|consen 505 GELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KTWTFCGT 582 (732)
T ss_pred chhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC--ceeeecCC
Confidence 7666666677799999999999999999999999999999999999999999999999999999886443 34577999
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
|.|.|||+++...+ +.++|.||||+++||||+|.|||.|.+....++.|++.+.
T Consensus 583 pEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------------------------- 636 (732)
T KOG0614|consen 583 PEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------------------------- 636 (732)
T ss_pred cccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh-------------------------
Confidence 99999999998884 9999999999999999999999999999999999987532
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
..+++..++..+.+||.++...+|.+|.. +.++-+|-||..-
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 12344568889999999999999999976 8999999999754
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=302.97 Aligned_cols=244 Identities=22% Similarity=0.368 Sum_probs=193.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||++.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++.. ...|+||||
T Consensus 9 ~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v~e~ 81 (260)
T cd05073 9 KLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYIITEF 81 (260)
T ss_pred eEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEEEEe
Confidence 44445999999999999865 4556999988753 2345678899999999999999999988765 568999999
Q ss_pred cccc-ccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHD-LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~-ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+.++ +...+.. .+..+++..++.++.||+.||.|||+.|++|+||||+||+|+.++.+||+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 161 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 161 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccccc
Confidence 9864 4444333 3456889999999999999999999999999999999999999999999999999765432222222
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...++..|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.+.......+.....
T Consensus 162 ~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~------------------- 221 (260)
T cd05073 162 GAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------------------- 221 (260)
T ss_pred CCcccccccCHhHhccCC-cCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-------------------
Confidence 234567799999987655 7999999999999999999 8999988776555544422100
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.++|.+||+.+|++||++.+++.
T Consensus 222 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 ---------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112357888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.32 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=195.4
Q ss_pred ccceeecccCceEEEEEEECCC-------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCC
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQ-------KKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 215 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~t-------g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~ 215 (720)
.+.+.||+|+||.||+|++... ...||+|.+... ........+.+|+.+++++ +||||+++++++.. ..
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~ 91 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DG 91 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc--CC
Confidence 4444599999999999986432 336899988743 3345567789999999999 79999999999876 56
Q ss_pred eEEEEEeeccccccccccC----------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 216 SLYLVFEYMEHDLAGLASH----------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~----------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
.+|+||||+.++.+..+.. ....+++.++..++.||+.||.|||++||+|+||||+||||+.++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~ 171 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN 171 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence 7999999998754443322 123478899999999999999999999999999999999999999
Q ss_pred ceeeeccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 004999 280 ILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIF 357 (720)
Q Consensus 280 ~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~ 357 (720)
.+||+|||++......... ......++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 250 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 250 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999865432211 112223356799999998765 7999999999999999998 889998877666555443
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
... .......++..+.+||.+||+.+|.+|||+.+++.+
T Consensus 251 ~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 251 EGH----------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred cCC----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 210 001123567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=303.43 Aligned_cols=245 Identities=24% Similarity=0.431 Sum_probs=197.3
Q ss_pred eecccCceEEEEEEECC-CCeEEEEEEeecCC--------CCHHHHHHHHHHHHHHHh-cCCCceeeeccceeccCCCeE
Q 004999 148 LIGQGTYSNVYRARDLD-QKKIVALKKVRFDN--------LEPESVRFMAREIHILRR-LDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~-tg~~VAIK~l~~~~--------~~~~~~~~~~~Ei~iL~~-L~HpnIvkl~~~~~~~~~~~l 217 (720)
.||+|+||.||+|.+.. +++.+|+|.+.... ........+.+|+.++.+ ++||||+++++++.. ...+
T Consensus 7 ~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~ 84 (269)
T cd08528 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE--NDRL 84 (269)
T ss_pred hhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc--CCeE
Confidence 39999999999999987 78889999986432 223455667889998875 799999999999876 6789
Q ss_pred EEEEeecccccccccc----CCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 218 YLVFEYMEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
|+||||+.+..+..+. .....+++..++.++.||+.+|.|||+ .+|+|+||+|+|||++.++.+||+|||++...
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 164 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeec
Confidence 9999999875443322 344578999999999999999999996 78999999999999999999999999999875
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
.... ......++..|+|||.+.+.. ++.++|||||||++|+|++|.+||...........+......+.
T Consensus 165 ~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 233 (269)
T cd08528 165 QPES--KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL-------- 233 (269)
T ss_pred cccc--ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--------
Confidence 4332 334556789999999998765 79999999999999999999999987665555444432111110
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
....+++.+.+||.+||+.||.+||++.++..+
T Consensus 234 -------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 -------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 012467889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=310.52 Aligned_cols=255 Identities=22% Similarity=0.268 Sum_probs=192.6
Q ss_pred ccceeecccCceEEEEEEECC----------------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecc
Q 004999 144 RSFYLIGQGTYSNVYRARDLD----------------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~----------------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~ 207 (720)
++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++|+||+++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 334459999999999986432 34579999987543 3445567889999999999999999999
Q ss_pred ceeccCCCeEEEEEeeccccccccccCC-----------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASHP-----------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID 276 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~~-----------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld 276 (720)
++.. ...+|+||||+.++.+..+... ...+++..+..++.||+.||.|||+.||+|+||||+||||+
T Consensus 87 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 87 VCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 8876 5678999999986544333221 12477889999999999999999999999999999999999
Q ss_pred CCCceeeeccccceecCCCCCCC-ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh--CCCCCCCCChHHHH
Q 004999 277 NNGILKIADFGLASFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA--GKPIMPGRTEVEQL 353 (720)
Q Consensus 277 ~~g~vKL~DFGla~~~~~~~~~~-~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt--G~ppf~g~~~~e~l 353 (720)
.++.+||+|||++..+....... .....+++.|+|||.+.+.. ++.++|||||||++|||++ |..||...+..+.+
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 99999999999997653322111 12223467899999887765 7999999999999999998 67888776665554
Q ss_pred HHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 354 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 354 ~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
..... ++..... .. .......+++.+.+||..||+.||.+|||+.++++
T Consensus 244 ~~~~~--------~~~~~~~---~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 244 ENTGE--------FFRDQGR---QV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHH--------HHhhccc---cc----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 43321 1100000 00 00112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=325.49 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=193.1
Q ss_pred ecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEe
Q 004999 149 IGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
||+|+||.||+|++. .+++.||||+++.... ......+.+|+.+|.++. |||||++++++.. ...+|||||
T Consensus 45 lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--~~~~~iv~E 121 (401)
T cd05107 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTK--GGPIYIITE 121 (401)
T ss_pred ccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--CCCcEEEEe
Confidence 999999999999864 3557899999976532 333456889999999997 9999999999876 567999999
Q ss_pred eccccccccccC--------------------------------------------------------------------
Q 004999 223 YMEHDLAGLASH-------------------------------------------------------------------- 234 (720)
Q Consensus 223 y~~g~ll~~~~~-------------------------------------------------------------------- 234 (720)
||.++.+..++.
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 998654432221
Q ss_pred ------------------------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 235 ------------------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 235 ------------------------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
....+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~ 281 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEE
Confidence 11246788899999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004999 285 DFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 362 (720)
Q Consensus 285 DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~ 362 (720)
|||++..+..... .......+++.|+|||++.+.. ++.++|||||||++|||++ |..||......+.+...+.....
T Consensus 282 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~ 360 (401)
T cd05107 282 DFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360 (401)
T ss_pred ecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC
Confidence 9999986532221 1122335678899999998765 7999999999999999998 88899876655554443321000
Q ss_pred CChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 363 p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
...+..++..+.+||.+||..+|.+||++.++++.
T Consensus 361 ---------------------------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 361 ---------------------------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01123568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=304.45 Aligned_cols=249 Identities=19% Similarity=0.198 Sum_probs=187.7
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~--~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|.+. .++..+|+|.++.... ......+.+|+.++++++||||+++++++.. ...+|+||||++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEECCC
Confidence 3999999999999864 3567799999876543 2334568889999999999999999998876 566899999999
Q ss_pred ccccccccC-----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-C
Q 004999 226 HDLAGLASH-----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-P 299 (720)
Q Consensus 226 g~ll~~~~~-----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~ 299 (720)
++.+..+.. ....+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++......... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 755544332 1234677888899999999999999999999999999999999999999999998754322111 1
Q ss_pred ccccccccCCCChhhhcCCc------CCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 300 LTSRVVTLWYRPPELLLGAT------YYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~------~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
.....++..|+|||++.+.. .++.++|||||||++|||++ |.+||......+...........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---------- 228 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL---------- 228 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC----------
Confidence 12335678899999986421 25789999999999999996 99999876655443332211000
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
... .......+++.+.+||..|+ .+|++|||+.+++.
T Consensus 229 -------~~~------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 -------KLP------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -------CCC------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00111246778999999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=307.04 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=195.7
Q ss_pred ccceeecccCceEEEEEEECC----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLD----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
.+.++||+|+||.||+|.+.. ++..|++|++... ........+.+|+.++++++|+||+++++++... ....++
T Consensus 9 ~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~~~ 86 (280)
T cd05043 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GEPPFV 86 (280)
T ss_pred EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCCEE
Confidence 344569999999999999876 3578999988643 3455567789999999999999999999987653 467899
Q ss_pred EEeeccccccccccCC--------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 220 VFEYMEHDLAGLASHP--------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~--------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
++||+.++.+..+... +..+++.+++.++.||+.||.|||+++++|+||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 9999986554433321 14689999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCCC-ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 292 YDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 292 ~~~~~~~~-~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
+....... .....++..|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+....+... ..+
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~------ 238 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRL------ 238 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC-CCC------
Confidence 53322211 11223467799999998765 7999999999999999999 99999887665543333211 000
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.++|.+||..||++|||+.++++
T Consensus 239 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 ---------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ---------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 011246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=305.92 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=192.6
Q ss_pred eecccCceEEEEEEECCCC------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQK------KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.||+|+||.||+|.+.... ..||||.+.... .......+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEE
Confidence 4999999999999986544 679999886542 22345668899999999999999999998876 56799999
Q ss_pred eeccccccccccC-------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-----ceeeeccccc
Q 004999 222 EYMEHDLAGLASH-------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-----ILKIADFGLA 289 (720)
Q Consensus 222 Ey~~g~ll~~~~~-------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-----~vKL~DFGla 289 (720)
||+.++.+..+.. ....+++.++..++.||+.||.|||+.+++|+||||+|||++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9998754443322 234578999999999999999999999999999999999999887 8999999999
Q ss_pred eecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
........ .......++..|+|||++.+.. ++.++|||||||++|||++ |..||......+....+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~------ 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G------ 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C------
Confidence 75532211 1112234567899999998766 7999999999999999998 99999887766554443210 0
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......++..+.+||.+||..+|.+||++.++++
T Consensus 231 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 ---------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ---------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00112356788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.91 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=202.6
Q ss_pred eecccCceEEEEEEECCCCe---E-EEEEEeecC-CCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDLDQKK---I-VALKKVRFD-NLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~---~-VAIK~l~~~-~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.||+|+||.||+|.....+. . ||+|..+.. ....+....|++|+++|+.|+|||||++||+... ...+|||||
T Consensus 164 kLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~~Pl~ivmE 241 (474)
T KOG0194|consen 164 KLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--EEPLMLVME 241 (474)
T ss_pred eeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCccEEEEE
Confidence 49999999999998765322 3 899998863 3567888899999999999999999999999877 677999999
Q ss_pred eccccccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 223 YMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+|.|+.+..++.. ...++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||++..-. .......
T Consensus 242 l~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~-~~~~~~~ 320 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS-QYVMKKF 320 (474)
T ss_pred ecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc-ceeeccc
Confidence 9998666555554 4469999999999999999999999999999999999999999999999999987532 1111111
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
.......|+|||.+.... |+.++|||||||++||+++ |..||+|....+...+|.......
T Consensus 321 ~~klPirWLAPEtl~~~~-~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~----------------- 382 (474)
T KOG0194|consen 321 LKKLPIRWLAPETLNTGI-FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM----------------- 382 (474)
T ss_pred cccCcceecChhhhccCc-cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC-----------------
Confidence 123467899999998874 8999999999999999998 889999999999988885432111
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......|..+..++.+|+..||++|||+.++.+
T Consensus 383 ----------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 ----------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ----------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 112256778999999999999999999998876
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=303.95 Aligned_cols=235 Identities=23% Similarity=0.266 Sum_probs=185.3
Q ss_pred eecccCceEEEEEEECCCC----------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeE
Q 004999 148 LIGQGTYSNVYRARDLDQK----------KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg----------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~l 217 (720)
.||+|+||.||+|.+..++ ..|++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 75 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR---DEN 75 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec---CCc
Confidence 4999999999999998776 3578887764432 15678899999999999999999998765 457
Q ss_pred EEEEeeccccccccccCCCC-CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-------ceeeeccccc
Q 004999 218 YLVFEYMEHDLAGLASHPGL-KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-------ILKIADFGLA 289 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~-~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-------~vKL~DFGla 289 (720)
|+||||+.++.+..+..... .+++..+..++.||+.||.|||++||+|+||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999876665554333 789999999999999999999999999999999999999888 7999999999
Q ss_pred eecCCCCCCCccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFYDPDQNQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~~~~~~~~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
..... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||......+........
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~-------- 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQ-------- 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcC--------
Confidence 86532 1233566789999999876 347999999999999999999 46777665432222211100
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
..........+.+||.+||..+|.+|||+.++++
T Consensus 223 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ----------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ----------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000111267899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=304.80 Aligned_cols=251 Identities=21% Similarity=0.271 Sum_probs=195.5
Q ss_pred cceeecccCceEEEEEEEC---CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC----CeE
Q 004999 145 SFYLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----CSL 217 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~----~~l 217 (720)
+.++||+|+||.||+|.+. .+++.||||++..........+.+.+|+.+++.++||||+++++++..... ...
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 3456999999999999864 457899999998765555667778999999999999999999998754322 134
Q ss_pred EEEEeecccccccccc------CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 218 YLVFEYMEHDLAGLAS------HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~------~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
++++||+.++.+..+. .....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~ 162 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccccc
Confidence 7899999865443221 1122578999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 292 YDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 292 ~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
....... ......+++.|++||.+.+.. ++.++|||||||++|||++ |.++|.+....+....+.+.. .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~------- 233 (273)
T cd05074 163 IYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-R------- 233 (273)
T ss_pred ccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-c-------
Confidence 5332211 112223467799999987765 6899999999999999999 889998876655444433210 0
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......++..+.+|+.+||+.+|.+|||+.+++++
T Consensus 234 --------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 234 --------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01113567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=305.21 Aligned_cols=229 Identities=25% Similarity=0.314 Sum_probs=183.8
Q ss_pred cCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccccccc
Q 004999 152 GTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL 231 (720)
Q Consensus 152 G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~ 231 (720)
|.||.||+|++..+++.||+|+++... .+.+|...+....||||+++++++.. ...+|+||||+.|+.+..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHH
Confidence 899999999999999999999997642 12345555566689999999999876 578999999999765554
Q ss_pred ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccCCCC
Q 004999 232 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 311 (720)
Q Consensus 232 ~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~A 311 (720)
+......+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...... .....++..|+|
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 4444456999999999999999999999999999999999999999999999999988654321 223345778999
Q ss_pred hhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhc
Q 004999 312 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAE 391 (720)
Q Consensus 312 PE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e 391 (720)
||.+.+.. ++.++||||+||++|||++|.++|...... + .. . . ...
T Consensus 151 PE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~------------~~----~-----~-------~~~ 196 (237)
T cd05576 151 PEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSG-----I------------NT----H-----T-------TLN 196 (237)
T ss_pred CcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchh-----c------------cc----c-----c-------ccC
Confidence 99887655 689999999999999999999776432110 0 00 0 0 001
Q ss_pred ccCCCCHhHHHHHHHhcccCCCCCCCH-----HHHHhCccC
Q 004999 392 TFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFF 427 (720)
Q Consensus 392 ~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hp~f 427 (720)
....+++.+.+||.+||+.||.+|+|+ .+++.||||
T Consensus 197 ~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 197 IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 223578889999999999999999996 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=340.57 Aligned_cols=242 Identities=27% Similarity=0.449 Sum_probs=203.6
Q ss_pred ecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 149 IGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
||+|+||+||+|+.. .....||||.++... +.+....|.||+.+|..|+|||||+|+|+|.. +..+|+||||
T Consensus 494 LGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~--~~P~~MvFEY 570 (774)
T KOG1026|consen 494 LGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCRE--GDPLCMVFEY 570 (774)
T ss_pred hcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc--CCeeEEEEEe
Confidence 999999999999753 344679999998653 34466789999999999999999999999987 7789999999
Q ss_pred ccc-cccccccC---------CCC----CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 224 MEH-DLAGLASH---------PGL----KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 224 ~~g-~ll~~~~~---------~~~----~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
|.. ||...+.. .+. .|+..+.+.|+.||+.|+.||-++.+|||||-..|+||.++..|||+||||+
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLs 650 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLS 650 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccc
Confidence 985 55443332 122 3889999999999999999999999999999999999999999999999999
Q ss_pred eec-CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFY-DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~-~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
+-. ..+.........-..+|||||.|+... |+.++||||+||||||+++ |+-|+.|.++.|.++.|.+.
T Consensus 651 RdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g-------- 721 (774)
T KOG1026|consen 651 RDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG-------- 721 (774)
T ss_pred hhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC--------
Confidence 854 322222222334478899999999877 7999999999999999998 88999999999999988652
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 422 (720)
.+.+.+.++|.++.+|+..||+.+|.+||++.||-
T Consensus 722 --------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 722 --------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred --------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 23455678999999999999999999999998874
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.10 Aligned_cols=245 Identities=21% Similarity=0.306 Sum_probs=194.2
Q ss_pred ceeecccCceEEEEEEECCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 146 FYLIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.+.||+|+||.||+|.+..++. .||+|.+..... ......+.+|+.++++++||||+++++++.. ...++||
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 87 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS---SQVQLIT 87 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec---CceEEEE
Confidence 3449999999999999876665 589998875533 4455678899999999999999999998865 5789999
Q ss_pred eeccccc-cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 222 EYMEHDL-AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 222 Ey~~g~l-l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
||+.++. ...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++...........
T Consensus 88 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 167 (279)
T cd05057 88 QLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH 167 (279)
T ss_pred ecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccccee
Confidence 9998654 444444455689999999999999999999999999999999999999999999999999987643222111
Q ss_pred -cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 301 -TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 301 -t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
....++..|+|||.+.... ++.++|||||||++|||++ |..||.+....+....+.+.. .
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~---------------- 229 (279)
T cd05057 168 AEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-R---------------- 229 (279)
T ss_pred cCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-C----------------
Confidence 1122356799999887655 7899999999999999998 999998876655444443210 0
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+..+.++|.+||..||.+|||+.++++
T Consensus 230 -----------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 -----------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0112245678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=344.43 Aligned_cols=245 Identities=27% Similarity=0.434 Sum_probs=204.5
Q ss_pred eeecccCceEEEEEEECCCCe-----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 147 YLIGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~-----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.+||+|+||.||.|....... .||||.++.. .+.+....|++|..+|+.++|||||+++|++.+ ....+|++
T Consensus 698 ~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~~~i~l 774 (1025)
T KOG1095|consen 698 RVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGPPLILL 774 (1025)
T ss_pred eeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCCcEEEe
Confidence 369999999999998754332 3899998754 355677889999999999999999999999988 67789999
Q ss_pred eeccc-cccccccCC------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee-cC
Q 004999 222 EYMEH-DLAGLASHP------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF-YD 293 (720)
Q Consensus 222 Ey~~g-~ll~~~~~~------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~-~~ 293 (720)
|||+| +|+..+... ...++..+...++.||+.|+.||+++++|||||...|+||+...+|||+|||+|+. ++
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~ 854 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYD 854 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhh
Confidence 99985 666666555 55689999999999999999999999999999999999999999999999999993 33
Q ss_pred CCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 294 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 294 ~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
.+.........-...|||||.+.... |+.++|||||||+|||++| |..||++..+.+.+....+..
T Consensus 855 ~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg------------ 921 (1025)
T KOG1095|consen 855 KDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG------------ 921 (1025)
T ss_pred chheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC------------
Confidence 22221111112246799999999765 8999999999999999999 889999999999887665431
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
....+..+|+.+.+||..||+.+|++||++..+++
T Consensus 922 ----------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ----------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ----------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 12334578999999999999999999999999998
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.02 Aligned_cols=246 Identities=20% Similarity=0.286 Sum_probs=191.7
Q ss_pred ceeecccCceEEEEEEECCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 146 FYLIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.++||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+++.++||||+++++++.. ...++|+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~~~~v~ 87 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PTIQLVT 87 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CCceeee
Confidence 3449999999999999887776 47888876543 23344567899999999999999999998864 3467999
Q ss_pred eecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-C
Q 004999 222 EYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-P 299 (720)
Q Consensus 222 Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~ 299 (720)
||+.++ +...+......+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+...... .
T Consensus 88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 167 (303)
T cd05110 88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167 (303)
T ss_pred hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccccc
Confidence 999864 44444444456899999999999999999999999999999999999999999999999999876432221 1
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....++..|+|||.+.+.. ++.++|||||||++|||++ |..||.+....+. ..+......+
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--------------- 230 (303)
T cd05110 168 ADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL--------------- 230 (303)
T ss_pred cCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC---------------
Confidence 12234577899999987765 7999999999999999997 8889887654333 2222211000
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||..||..+|++||++.++++.
T Consensus 231 ------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 231 ------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113456789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.54 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=193.1
Q ss_pred ceeecccCceEEEEEEEC----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 146 FYLIGQGTYSNVYRARDL----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.+.||+|+||.||+|... .++..||||++...... .....+.+|+.+++.+.|+||+++++++.......+|+||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence 344999999999999864 34889999999865433 4566789999999999999999999988765566799999
Q ss_pred eecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC--
Q 004999 222 EYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-- 298 (720)
Q Consensus 222 Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-- 298 (720)
||++++.+..+. .....+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.........
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (284)
T cd05038 88 EYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167 (284)
T ss_pred ecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCccee
Confidence 999875544444 33346899999999999999999999999999999999999999999999999999876422211
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC----hhhhhhcCCC
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS----EDYWRKSKLP 374 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~----~~~w~~~~l~ 374 (720)
......++..|+|||.+.+.. ++.++|||||||++|||++|..||........ ...+... ...+...
T Consensus 168 ~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~--- 238 (284)
T cd05038 168 VKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-----RMIGIAQGQMIVTRLLEL--- 238 (284)
T ss_pred ccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeeccCCCcccccchhc-----cccccccccccHHHHHHH---
Confidence 111223456799999987765 78999999999999999999988765322110 0000000 0000000
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
..... .......++..+.+||.+||+.+|.+|||+.++++
T Consensus 239 ----~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 239 ----LKEGE-----RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ----HHcCC-----cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000 00112346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=335.78 Aligned_cols=275 Identities=23% Similarity=0.280 Sum_probs=183.7
Q ss_pred cccceeecccCceEEEEEEECCC----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecccee----ccCC
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQ----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVT----SRMS 214 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~t----g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~----~~~~ 214 (720)
|...+.||+|+||.||+|++..+ +..||||++..... .+....| .++...+.+++.++..+. ....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 34445699999999999999988 89999998764321 1111111 112222333333322211 1235
Q ss_pred CeEEEEEeeccccccccccCCC--------------------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEE
Q 004999 215 CSLYLVFEYMEHDLAGLASHPG--------------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLL 274 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~--------------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NIL 274 (720)
..+||||||++++.+..+.... ....+..+..++.||+.||.|||++||+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 6799999999976554333211 11224457789999999999999999999999999999
Q ss_pred EcC-CCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCc---------------------CCCccccchhhHH
Q 004999 275 IDN-NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT---------------------YYGTAVDLWSTGC 332 (720)
Q Consensus 275 ld~-~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~---------------------~y~~~sDIWSLG~ 332 (720)
|+. ++.+||+|||+|..+...........++|+.|+|||.+.... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 985 589999999999866443334445668899999999765322 1345679999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCC
Q 004999 333 ILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDP 412 (720)
Q Consensus 333 iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP 412 (720)
|||||+++. |........+..++..++... ..|.....+. ..+. .....+.+......+.+||.+||++||
T Consensus 368 iL~el~~~~--~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~---~~~~---~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 368 IFLQMAFPN--LRSDSNLIQFNRQLKRNDYDL-VAWRKLVEPR---ASPD---LRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHhCc--CCCchHHHHHHHHHHhcCCcH-HHHHHhhccc---cchh---hhhhhhhccccchHHHHHHHHHccCCc
Confidence 999999854 455566666666666555432 2343221111 0000 000112222334567799999999999
Q ss_pred CCCCCHHHHHhCccCCCCCC
Q 004999 413 ADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 413 ~kRpTa~e~L~hp~f~~~~~ 432 (720)
.+|||+.++|+||||+....
T Consensus 439 ~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 439 RQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999986543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=300.58 Aligned_cols=249 Identities=19% Similarity=0.266 Sum_probs=187.3
Q ss_pred eecccCceEEEEEEECCC--CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQ--KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~t--g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||++..... ...+++|.+..... ....+.+.+|+.+++.++||||+++++.+.. ...+|+||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCC
Confidence 399999999999975433 33466777665432 3445678999999999999999999998876 567899999999
Q ss_pred ccccccccCC----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC-CCCCc
Q 004999 226 HDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-QNQPL 300 (720)
Q Consensus 226 g~ll~~~~~~----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~ 300 (720)
++.+..+... ...+++..++.++.||+.||.|||+.+|+|+||||+|||++.++.+||+|||++...... .....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 7554433321 234677888999999999999999999999999999999999999999999998643211 11122
Q ss_pred cccccccCCCChhhhcCC------cCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 301 TSRVVTLWYRPPELLLGA------TYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~------~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
...+++..|+|||++... ..++.++|||||||++|||++ |.+||...+..+.+..+.+.....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 228 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK---------- 228 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc----------
Confidence 334678899999988531 125789999999999999997 567888877777666654321100
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.+.+ .....+++.+.+||..|| .+|.+|||+.++++
T Consensus 229 ----~~~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ----LFKP---------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----cCCC---------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0001 112346778999999999 78999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=326.84 Aligned_cols=274 Identities=28% Similarity=0.444 Sum_probs=218.8
Q ss_pred CCccchhhhhhhhcc--ccccceeecccCceEEEEEEECCCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCcee
Q 004999 127 RRADSFEKLDKSLSI--FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVI 203 (720)
Q Consensus 127 ~~~~~ye~l~~~~~~--f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIv 203 (720)
.+...|..|+.+--. .+-+++.||-|+||.|.+++..+|...||+|.+++.. +....+..+..|-.||..-+.+.||
T Consensus 613 QKESnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVV 692 (1034)
T KOG0608|consen 613 QKESNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVV 692 (1034)
T ss_pred hhhhhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceE
Confidence 345667777665433 3456678999999999999999999999999998754 3566677888999999999999999
Q ss_pred eeccceeccCCCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCcee
Q 004999 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILK 282 (720)
Q Consensus 204 kl~~~~~~~~~~~lyLV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vK 282 (720)
+||--|.+ ...+|+||||+.| ++..+++.-+ -|.|..++.|+..|..|+++.|..|+|||||||+|||||.+|+||
T Consensus 693 rLyySFQD--kdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 693 RLYYSFQD--KDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred EEEEEecc--CCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCcee
Confidence 99877766 7789999999986 5555555544 799999999999999999999999999999999999999999999
Q ss_pred eeccccceecC---------CCC--------------------------------CCCccccccccCCCChhhhcCCcCC
Q 004999 283 IADFGLASFYD---------PDQ--------------------------------NQPLTSRVVTLWYRPPELLLGATYY 321 (720)
Q Consensus 283 L~DFGla~~~~---------~~~--------------------------------~~~~t~~~gT~~Y~APE~l~~~~~y 321 (720)
|+|||||.-+. ... .....+.+||+.|+|||+|.... |
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~ 848 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-Y 848 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-c
Confidence 99999996431 000 00112458899999999999876 7
Q ss_pred CccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHH
Q 004999 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPAL 401 (720)
Q Consensus 322 ~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~ 401 (720)
+..+|+||+|||||||+.|++||...+..+.-.+|.. |... .. .....++++++.
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n---------w~~~-----l~-----------~~~~~~ls~e~~ 903 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN---------WRNF-----LH-----------IPYQGNLSKEAL 903 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee---------hhhc-----cc-----------cccccccCHHHH
Confidence 9999999999999999999999998887665444432 2210 00 112247899999
Q ss_pred HHHHHhcccCCCCCCC---HHHHHhCccCCCC
Q 004999 402 ALMETLLSIDPADRGS---AASALRSEFFTMK 430 (720)
Q Consensus 402 dLI~~mL~~DP~kRpT---a~e~L~hp~f~~~ 430 (720)
+||.+++ .+++.|.. +.++-.||||+..
T Consensus 904 ~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 904 DLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred HHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 9999875 67888874 6789999999864
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=298.30 Aligned_cols=238 Identities=24% Similarity=0.374 Sum_probs=189.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
.+.+.||+|+||.||++.. +++.||+|+++... ....+.+|+.++++++||||+++++++.. ..+|+||||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v~e~ 79 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIVMEL 79 (254)
T ss_pred eeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEEEEC
Confidence 3445599999999999964 67889999987542 23567899999999999999999998754 347999999
Q ss_pred cccccccccc-CC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHDLAGLAS-HP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~ll~~~~-~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+.++.+..+. .. ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++...... ..
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----~~ 155 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VD 155 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc----CC
Confidence 9875444333 22 335899999999999999999999999999999999999999999999999999764321 12
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+..|+|||.+.+.. ++.++|+|||||++|+|++ |.+||.+.+..+....+.+.. .
T Consensus 156 ~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~------------------ 215 (254)
T cd05083 156 NSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-R------------------ 215 (254)
T ss_pred CCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC-C------------------
Confidence 223356799999987655 7999999999999999998 999998877655544442210 0
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......++..+.+||..||+.+|.+|||+.++++
T Consensus 216 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 ---------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=303.94 Aligned_cols=259 Identities=19% Similarity=0.181 Sum_probs=185.5
Q ss_pred ccccceeecccCceEEEEEEECCC---CeEEEEEEeecCCCCH--HH-------HHHHHHHHHHHHhcCCCceeeeccce
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEP--ES-------VRFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~--~~-------~~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
.|++.++||+|+||.||+|.+..+ +..+|+|+........ +. ......++..+..+.|+||+++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 445555699999999999998877 6778888755433211 10 01122344455667899999999865
Q ss_pred eccCCC--eEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 210 TSRMSC--SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 210 ~~~~~~--~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
...... ..|+++|++...+...+.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFG 171 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYG 171 (294)
T ss_pred eEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcC
Confidence 543221 3467888876554433322 2346888999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCC------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC
Q 004999 288 LASFYDPDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 288 la~~~~~~~~------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g 361 (720)
+|..+..... .......||+.|+|||++.+.. |+.++|||||||+||||++|.+||.+......+....+.
T Consensus 172 la~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~-- 248 (294)
T PHA02882 172 IASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC-- 248 (294)
T ss_pred CceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH--
Confidence 9987643221 1122346899999999988766 799999999999999999999999887433222211110
Q ss_pred CCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 362 ~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
+++..... -...+...++.+.+++..|+..+|++||+..++++
T Consensus 249 ----~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 ----DFIKRLHE---------------GKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred ----HHHHHhhh---------------hhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 01110000 00112456888999999999999999999999876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.96 Aligned_cols=262 Identities=25% Similarity=0.363 Sum_probs=212.0
Q ss_pred ccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-----CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC
Q 004999 140 SIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-----EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 214 (720)
Q Consensus 140 ~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-----~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~ 214 (720)
+..|-.+.+||+|+|+.||+|.|....+.||+|+-..+.. .....+...+|..|.+.|+||.||++|+||.-. .
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-t 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-T 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-c
Confidence 3455556679999999999999999999999999765532 223456788999999999999999999998753 5
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcC---CCceeeeccccc
Q 004999 215 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDN---NGILKIADFGLA 289 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~---~g~vKL~DFGla 289 (720)
..+|.|+|||+|+.++.++..+..++|.+++.|+.||+.||.||.+.. |||-||||.|||+.+ -|.+||+||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 678999999999999999988889999999999999999999999874 999999999999953 478999999999
Q ss_pred eecCCCCCC------CccccccccCCCChhhhcC---CcCCCccccchhhHHHHHHHHhCCCCCCCCChHH---HHHHHH
Q 004999 290 SFYDPDQNQ------PLTSRVVTLWYRPPELLLG---ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE---QLHKIF 357 (720)
Q Consensus 290 ~~~~~~~~~------~~t~~~gT~~Y~APE~l~~---~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e---~l~~i~ 357 (720)
++++.+... ......||.||++||.+.- .+..+.++||||+|||+|..|.|+.||....... +.+.|+
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 998654332 2223478999999999853 3346889999999999999999999996543322 222222
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
+. +... ...-+.++.++.+||++||++--++|....++..||||.
T Consensus 701 kA-----------------tEVq---------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 701 KA-----------------TEVQ---------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred cc-----------------eecc---------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 21 1110 001135789999999999999999999999999999996
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.10 Aligned_cols=195 Identities=31% Similarity=0.488 Sum_probs=167.8
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEEEEEeec
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLYLVFEYM 224 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~lyLV~Ey~ 224 (720)
||+|+||.||+++++.+|+.||||.++... ....++...+|+++|++|+|+|||+++++-.+.. .....+|||||
T Consensus 21 LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC 99 (732)
T KOG4250|consen 21 LGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYC 99 (732)
T ss_pred hcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeec
Confidence 999999999999999999999999998654 2344567789999999999999999998755543 34568999999
Q ss_pred cccccccccC---CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc--CCC--ceeeeccccceecCCCCC
Q 004999 225 EHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNG--ILKIADFGLASFYDPDQN 297 (720)
Q Consensus 225 ~g~ll~~~~~---~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld--~~g--~vKL~DFGla~~~~~~~~ 297 (720)
.|+.+...+. ....|+|.+++.++.+|..||.|||++||+||||||.||++- .+| .-||+|||.|+.++. .
T Consensus 100 ~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d--~ 177 (732)
T KOG4250|consen 100 SGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDD--N 177 (732)
T ss_pred CCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCC--C
Confidence 9866665554 234699999999999999999999999999999999999984 334 479999999998754 4
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCC
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG 346 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g 346 (720)
...++.+||+.|++||++.....|+..+|.|||||++|+.+||..||--
T Consensus 178 s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 178 SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 4788999999999999998766699999999999999999999988853
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=298.70 Aligned_cols=256 Identities=23% Similarity=0.416 Sum_probs=210.6
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.+++||+|+|..|.+++.+.|.+.||+|+++++-. +.+.+.....|-.+..+- +||.+|.|+.+|.. +..+++|.
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrlffvi 330 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRLFFVI 330 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceEEEEE
Confidence 445569999999999999999999999999998755 456677778888888877 79999999999877 78899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||++|+.+-...+.+.+++|+.++.|-..|+.||.|||++||++||||.+|+|||..|++||+|+|+++.-.. ......
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~-~gd~ts 409 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG-PGDTTS 409 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC-CCcccc
Confidence 9999866666666677999999999999999999999999999999999999999999999999999985422 233446
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCC--CCC-----hHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRT-----EVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~--g~~-----~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
+.||||.|.|||+|.|.. |+..+|.|+||++|+||+.|+.||. |.. ..+.+.+++-
T Consensus 410 tfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil---------------- 472 (593)
T KOG0695|consen 410 TFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL---------------- 472 (593)
T ss_pred cccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh----------------
Confidence 679999999999999887 8999999999999999999999995 221 1122222210
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC------HHHHHhCccCCCCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS------AASALRSEFFTMKP 431 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT------a~e~L~hp~f~~~~ 431 (720)
..+ ...+..++-.+..+|+..|++||.+|.. ..++-.|+||+...
T Consensus 473 -----ekq-------iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 473 -----EKQ-------IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred -----hhc-------ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 000 1122356677888999999999999954 68999999998543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=298.37 Aligned_cols=264 Identities=23% Similarity=0.342 Sum_probs=210.3
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeecc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEG 207 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~ 207 (720)
.+..+.+.. ||.|+||+|++..++.+|+..|||.++..+.+.+ ..+++.|..+..+- +.||||++||
T Consensus 63 ~~~Lqdlg~-----------iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke-q~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 63 SDNLQDLGE-----------IGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE-QKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred cchHHHHHH-----------hcCCcchhhhhhhcCccCcEEEEEEeeeccchHH-HHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 355667777 9999999999999999999999999998776433 45667777765554 7999999999
Q ss_pred ceeccCCCeEEEEEeecccccccccc----CCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCcee
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILK 282 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vK 282 (720)
++.. ++..||.||+|+-++-.++. .....++|..+-.|....+.||.||-.. .|+||||||+||||+..|.+|
T Consensus 131 a~F~--EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vK 208 (361)
T KOG1006|consen 131 ALFS--EGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVK 208 (361)
T ss_pred hhhc--CCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEe
Confidence 9877 67789999999965433222 2445689999999999999999999865 899999999999999999999
Q ss_pred eeccccceecCCCCCCCccccccccCCCChhhhcCCcC-CCccccchhhHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhc
Q 004999 283 IADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY-YGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQLHKIFKLC 360 (720)
Q Consensus 283 L~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~-y~~~sDIWSLG~iL~ELltG~ppf~g~~-~~e~l~~i~~~~ 360 (720)
|||||++..+.. ....+..+|...|||||.+..... |+.++|+||||++|||+.||..|+.+-. ..+|+.++..
T Consensus 209 LCDFGIcGqLv~--SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~-- 284 (361)
T KOG1006|consen 209 LCDFGICGQLVD--SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI-- 284 (361)
T ss_pred eecccchHhHHH--HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc--
Confidence 999999976532 233455678888999999975443 8999999999999999999999888744 4455555543
Q ss_pred CCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 361 g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
|.|+.- ......-.++..+..+|..||.+|-..||...+++.++|++...
T Consensus 285 gdpp~l---------------------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 285 GDPPIL---------------------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred CCCCee---------------------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 333210 01122235788999999999999999999999999999998653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=281.74 Aligned_cols=244 Identities=38% Similarity=0.582 Sum_probs=197.6
Q ss_pred CceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccccccc
Q 004999 153 TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA 232 (720)
Q Consensus 153 ~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~ 232 (720)
+||.||+|.+..+++.||+|++........ .+.+.+|+.++++++|+||+++++++.. ....++||||+.++.+..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 589999999999999999999986543222 5778899999999999999999999876 5789999999998555544
Q ss_pred cCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccCCCCh
Q 004999 233 SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 312 (720)
Q Consensus 233 ~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~AP 312 (720)
......+++..+..++.+|+.+|.|||..+|+|+||+|.||+++.++.++|+|||++....... ......++..|++|
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~p 155 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMAP 155 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCCH
Confidence 4434348999999999999999999999999999999999999999999999999998764322 23445678899999
Q ss_pred hhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcc
Q 004999 313 ELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAET 392 (720)
Q Consensus 313 E~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~ 392 (720)
|.+.+.. ++.++|||+||+++++|++|..+|......+.+........... ...
T Consensus 156 E~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-------------------------~~~ 209 (244)
T smart00220 156 EVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-------------------------PPP 209 (244)
T ss_pred HHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-------------------------ccc
Confidence 9988655 68899999999999999999999987444443333322110000 000
Q ss_pred cCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 393 FKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 393 ~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
...++..+.+++.+||..+|.+||++.++++||||
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 11277889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=321.73 Aligned_cols=264 Identities=27% Similarity=0.430 Sum_probs=214.2
Q ss_pred CCCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceee
Q 004999 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK 204 (720)
Q Consensus 126 p~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvk 204 (720)
|...+.|+..+. ||.|.+|.||+++.+.+++.+|+|++......+ +.+.-|.+||+.+ .|||++.
T Consensus 15 pdp~d~~ei~ev-----------ig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~ 80 (953)
T KOG0587|consen 15 PDPADIFEIIEV-----------IGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVAT 80 (953)
T ss_pred CCCCCccEEEEE-----------EeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcce
Confidence 445566666666 999999999999999999999999988765433 3356789999988 6999999
Q ss_pred eccceeccC---CCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 205 LEGLVTSRM---SCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 205 l~~~~~~~~---~~~lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
+|++|.... .+.+|||||||.|+....+.. .+..+.|+.+.+|++.++.||.+||.+.++|||||..|||++.+|
T Consensus 81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA 160 (953)
T ss_pred EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC
Confidence 999886432 468999999999865443322 267899999999999999999999999999999999999999999
Q ss_pred ceeeeccccceecCCCCCCCccccccccCCCChhhhcCC----cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHH
Q 004999 280 ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 355 (720)
Q Consensus 280 ~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~----~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~ 355 (720)
.|||+|||.+.-++... ....+.+|||.|||||++... ..|+..+|+||||++..||.-|.||+......-.+.+
T Consensus 161 ~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~ 239 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 239 (953)
T ss_pred cEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc
Confidence 99999999998765432 333456899999999999643 2378899999999999999999999988877655544
Q ss_pred HHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 356 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 356 i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
|- ..|++. ...++..+..+.+||..||.+|-++||+..++|+|||++..
T Consensus 240 Ip---RNPPPk-----------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 240 IP---RNPPPK-----------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred CC---CCCCcc-----------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 42 222211 11223456789999999999999999999999999999843
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=319.57 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=214.2
Q ss_pred ccceeecccCceEEEEEEECCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~---~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.+.++||.|.||.||+|+.+..|+ .||||.++.... ....+.|+.|+.||-+++||||++|.|+.+. ...+.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk--s~PvMIi 708 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTK--SKPVMII 708 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEec--CceeEEE
Confidence 456689999999999999887664 599999986554 3445678999999999999999999999987 6789999
Q ss_pred Eeecccccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 221 FEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 221 ~Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
+|||+.+.|+. +....+.|+..+..-+++.|+.|+.||-+.|+|||||...||||+.+-.+||+||||++.+..+....
T Consensus 709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence 99999665554 44456779999999999999999999999999999999999999999999999999999886555444
Q ss_pred cccccc--ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 300 LTSRVV--TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 300 ~t~~~g--T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.++.-| ..+|.|||.+.-.+ ++.++||||+|+||||.++ |..||-..++.+.+..|.+...-|+
T Consensus 789 ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp------------ 855 (996)
T KOG0196|consen 789 YTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP------------ 855 (996)
T ss_pred ccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC------------
Confidence 444433 68899999998776 7999999999999999876 8899999999999999987654443
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
+.++|..+..|+..||++|-..||++.+++.
T Consensus 856 ----------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 856 ----------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred ----------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 2489999999999999999999999999986
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.79 Aligned_cols=243 Identities=23% Similarity=0.381 Sum_probs=202.0
Q ss_pred eecccCceEEEEEEECCC----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 148 LIGQGTYSNVYRARDLDQ----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~t----g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+||.|-||.||+|..... .--||||..+.+.. ++..+.|+.|..+|+.++|||||+|+|+|.+ ...|||||+
T Consensus 396 ~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e---~P~WivmEL 471 (974)
T KOG4257|consen 396 LIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE---QPMWIVMEL 471 (974)
T ss_pred hhcCCcccceeeeEecccccCcceeeeeehhccCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeec---cceeEEEec
Confidence 499999999999986432 33489999876543 4557889999999999999999999999975 568999999
Q ss_pred ccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 224 MEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 224 ~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
+.- .|...+......++......|+.||+.+|.|||+..+|||||...||||.+..-|||+|||+++.+..+.....+.
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhccc
Confidence 984 5555555566789999999999999999999999999999999999999999999999999999886554443333
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..-..-|||||-+.-.. ++.++|||-|||.+||+|. |..||.|..+.+.+-.|.+.-.
T Consensus 552 ~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR-------------------- 610 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER-------------------- 610 (974)
T ss_pred cccceeecCccccchhc-ccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC--------------------
Confidence 33367899999887555 7999999999999999876 8899999888777666543211
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...++++|+.+..|+.+||.+||.+||+..++..
T Consensus 611 --------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 611 --------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred --------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 1234689999999999999999999999988764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=303.66 Aligned_cols=241 Identities=23% Similarity=0.364 Sum_probs=204.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc-cc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME-HD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~-g~ 227 (720)
||-|.||.||.|.++.-...||||.++.+. -.++.|+.|+.+|+.|.|||+|+|+|+|+. +..+|||+|||. |+
T Consensus 275 LGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~--EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 275 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH--EPPFYIITEFMCYGN 349 (1157)
T ss_pred cCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--CCCeEEEEecccCcc
Confidence 999999999999999999999999998654 346779999999999999999999999987 677999999997 67
Q ss_pred ccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
|++.+..- ...++....+.++.||..|++||..+++|||||...|+||..+..|||+||||++++..+...........
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFP 429 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFP 429 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCc
Confidence 77766543 33466777889999999999999999999999999999999999999999999999876655444444457
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
+-|.|||-|.-.+ ++.++|||+|||+|||+.| |..||+|.+-...+..+.+.
T Consensus 430 IKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-------------------------- 482 (1157)
T KOG4278|consen 430 IKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-------------------------- 482 (1157)
T ss_pred ccccCcccccccc-cccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------------------
Confidence 8899999998776 7999999999999999988 77999998765554444321
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...+.+..+|+.+.+|+..||+++|.+||+++|+-+
T Consensus 483 --yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 483 --YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred --ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 112345689999999999999999999999988754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=306.75 Aligned_cols=270 Identities=24% Similarity=0.310 Sum_probs=182.5
Q ss_pred ccceeecccCceEEEEEEEC----------------CCCeEEEEEEeecCCCC--HH----------HHHHHHHHHHHHH
Q 004999 144 RSFYLIGQGTYSNVYRARDL----------------DQKKIVALKKVRFDNLE--PE----------SVRFMAREIHILR 195 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~----------------~tg~~VAIK~l~~~~~~--~~----------~~~~~~~Ei~iL~ 195 (720)
.+.+.||+|+||.||+|.+. ..++.||||++...... .+ ..+....|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 34445999999999999752 23567999998754211 01 1122345788888
Q ss_pred hcCCCce-----eeeccceecc------CCCeEEEEEeeccccccccccCC------------------------CCCCC
Q 004999 196 RLDHINV-----IKLEGLVTSR------MSCSLYLVFEYMEHDLAGLASHP------------------------GLKFS 240 (720)
Q Consensus 196 ~L~HpnI-----vkl~~~~~~~------~~~~lyLV~Ey~~g~ll~~~~~~------------------------~~~ls 240 (720)
++.|.++ ++++++|... .....||||||+.++.+..++.. ...++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 8876654 6677776532 12468999999997555433221 12346
Q ss_pred HHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcC
Q 004999 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320 (720)
Q Consensus 241 e~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~ 320 (720)
+..++.++.||+.+|.|||+.+|+||||||+|||++.++.+||+|||++..+............+|+.|+|||++.....
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~ 387 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQS 387 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCC
Confidence 77899999999999999999999999999999999999999999999997653322222222344899999999864321
Q ss_pred -------------------CC--ccccchhhHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 321 -------------------YG--TAVDLWSTGCILAELYAGKP-IMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 321 -------------------y~--~~sDIWSLG~iL~ELltG~p-pf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
|+ ...||||+|||||+|++|.. +|.+...... .++.+ ......|...+..
T Consensus 388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~-~~~~~~~r~~~~~---- 459 (507)
T PLN03224 388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQY-DNDLNRWRMYKGQ---- 459 (507)
T ss_pred CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhc-cchHHHHHhhccc----
Confidence 12 24799999999999999874 6644322111 11100 0011123221100
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCC---CCCCCHHHHHhCccCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDP---ADRGSAASALRSEFFTM 429 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP---~kRpTa~e~L~hp~f~~ 429 (720)
.+ ....+..+++.+.+||.+||..+| .+|+|+.|+|+||||..
T Consensus 460 -----~~---~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 460 -----KY---DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred -----CC---CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 011244578899999999999876 68999999999999964
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=298.59 Aligned_cols=250 Identities=24% Similarity=0.297 Sum_probs=198.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc-
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH- 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g- 226 (720)
.||+|-||.|.+|.- ..+..||+|+++.... ......|.+||++|.+|+|||||.|+|+|.. +..+++|+|||+.
T Consensus 545 kiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--DePicmI~EYmEnG 620 (807)
T KOG1094|consen 545 KIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DDPLCMITEYMENG 620 (807)
T ss_pred hhcCcccceeEEEEe-cCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CCchHHHHHHHhcC
Confidence 399999999999985 4478999999987643 3445779999999999999999999999987 6779999999985
Q ss_pred cccccccCCCC-CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-Cccccc
Q 004999 227 DLAGLASHPGL-KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRV 304 (720)
Q Consensus 227 ~ll~~~~~~~~-~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~t~~~ 304 (720)
+|.+.+..... .+.......|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-+-..... .-...+
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~v 700 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAV 700 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeeccee
Confidence 45444444322 2356677889999999999999999999999999999999999999999999855332222 222334
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHH--HhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~EL--ltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
-...|||+|.++..+ ++.++|+|+||++|||+ +|...||...++.......-..+..+..
T Consensus 701 lpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~----------------- 762 (807)
T KOG1094|consen 701 LPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR----------------- 762 (807)
T ss_pred eeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc-----------------
Confidence 578999999998877 79999999999999997 4577888887776665554433222211
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+.-+|..+.+||..||..|-++||+.+++-.
T Consensus 763 ----~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 763 ----QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ----ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 1123334568899999999999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=304.10 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=205.1
Q ss_pred ecccCceEEEEEEECCC-C--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 149 IGQGTYSNVYRARDLDQ-K--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~t-g--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
||+|.||.|++|.+... | -.||||.++...... ....|++|+.+|.+|+|+|+++|||++.+ ..+.+|||++.
T Consensus 118 LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~---qp~mMV~ELap 193 (1039)
T KOG0199|consen 118 LGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD---QPAMMVFELAP 193 (1039)
T ss_pred hcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc---chhhHHhhhcc
Confidence 99999999999998743 3 349999999776554 56789999999999999999999999875 45789999999
Q ss_pred c-cccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-Ccc-
Q 004999 226 H-DLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLT- 301 (720)
Q Consensus 226 g-~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~~t- 301 (720)
+ .|++.+.. ....|.......|+.||+.|+.||.++++|||||-..||||...-.|||+||||.+.+..+... .++
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p 273 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAP 273 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecC
Confidence 5 55555444 4567889999999999999999999999999999999999999999999999999987543322 122
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
.......|+|||.|.... ++.++|+|++||++|||++ |..||.|......++.|.+.
T Consensus 274 ~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------------------- 331 (1039)
T KOG0199|consen 274 QRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------------------- 331 (1039)
T ss_pred CCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------------------
Confidence 223467799999998777 7999999999999999998 67999999999888887531
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
......+.+++++.+++..||..+|++|||+..|.+.-++
T Consensus 332 -------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 332 -------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 1223456899999999999999999999999988654444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=291.17 Aligned_cols=276 Identities=32% Similarity=0.513 Sum_probs=206.9
Q ss_pred ccccceeecccCceEEEEEEECC---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~---tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
.|+.+..||+|+|++||++.+.. ..+.||||.+..... ..++..|+++|..+ .+.||+++.+++.. ++..
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v 110 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQV 110 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhcc--CCee
Confidence 33444449999999999999887 788999999876542 34578999999999 59999999998865 7789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-CCceeeeccccceecCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~~~~~~ 296 (720)
.+||||++++....+.. .++..+++.|++.++.||.++|.+|||||||||+|+|.+. .+.-.|+|||+|...+...
T Consensus 111 ~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred EEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999876555544 4689999999999999999999999999999999999975 4678999999997221000
Q ss_pred -------------------------------------------CCCccccccccCCCChhhhcCCcCCCccccchhhHHH
Q 004999 297 -------------------------------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCI 333 (720)
Q Consensus 297 -------------------------------------------~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~i 333 (720)
......+.||++|+|||++...+.-++++||||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0011245689999999999987777999999999999
Q ss_pred HHHHHhCCCCC-CCCChHHHHHHHHHhcCCCChh----------hhhhcCCCCccccCCCCccch-------------hh
Q 004999 334 LAELYAGKPIM-PGRTEVEQLHKIFKLCGSPSED----------YWRKSKLPHATIFKPQQPYKR-------------CV 389 (720)
Q Consensus 334 L~ELltG~ppf-~g~~~~e~l~~i~~~~g~p~~~----------~w~~~~l~~~~~~~~~~~~~~-------------~~ 389 (720)
+.-++++..|| ....+.+.+..|....|...-. .|..+..+-.. .-...|.. +.
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~--e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP--ELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH--HHHhchhccChhhccccccccee
Confidence 99999998554 5566666666666665533221 23321111000 00001111 11
Q ss_pred hcccC-CCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 390 AETFK-DFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 390 ~e~~~-~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
.+... .++..+.+||++||..||.+|+||+++|.||||.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~ 385 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD 385 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence 22222 3455899999999999999999999999999998
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=302.06 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=217.9
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~ 208 (720)
.++|+.+.. +|.|+||.||+|+|+.+++..|+|+++..-. +...-+..||-+++.++|||||.+++-
T Consensus 14 ~ddyellqr-----------vgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gs 80 (829)
T KOG0576|consen 14 QDDYELLQR-----------VGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGS 80 (829)
T ss_pred ccchhheee-----------ecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhh
Confidence 367888877 9999999999999999999999999997643 334557899999999999999999998
Q ss_pred eeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+.. ...++|.||||+|+.++.+.+-.+.++|.++..+++..+.||.|||+.|-+|||||..|||+++.|.+|++|||.
T Consensus 81 ylr--~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 81 YLR--RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred hhh--hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCc
Confidence 876 567999999999998888888778999999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhc--CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~--~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
+.-+.. ......+..||+.|||||+.. ....|...+|||++|++..||---+||.........+..+-+-...|+.
T Consensus 159 saqita-ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~- 236 (829)
T KOG0576|consen 159 SAQITA-TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT- 236 (829)
T ss_pred hhhhhh-hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-
Confidence 876543 223345678999999999863 3344899999999999999998888877666666555555443333321
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.+.-...++.+.+|++.+|.++|.+|||++.+|.|+|...
T Consensus 237 -----------------------lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 237 -----------------------LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -----------------------ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1111234667899999999999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=259.88 Aligned_cols=217 Identities=24% Similarity=0.379 Sum_probs=182.6
Q ss_pred CCCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceee
Q 004999 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK 204 (720)
Q Consensus 126 p~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvk 204 (720)
...+++.+.+.+ ||+|+||.|-+.++..+|...|+|.++... +.+..+++++|+.+..+. .+|.+|+
T Consensus 42 eV~ad~L~~i~e-----------lGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~ 109 (282)
T KOG0984|consen 42 EVPADDLVGIEE-----------LGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVH 109 (282)
T ss_pred ccchhhhhhhhh-----------hcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEE
Confidence 344567777787 999999999999999999999999998653 345567788999988776 7999999
Q ss_pred eccceeccCCCeEEEEEeecccccc---ccccCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCc
Q 004999 205 LEGLVTSRMSCSLYLVFEYMEHDLA---GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGI 280 (720)
Q Consensus 205 l~~~~~~~~~~~lyLV~Ey~~g~ll---~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~ 280 (720)
+||.+.. ...++|.||.|..++- ......+..++|..+-+|+..|+.||.|||++ .|+|||+||+||||+.+|+
T Consensus 110 FyGa~~r--egdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq 187 (282)
T KOG0984|consen 110 FYGALFR--EGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ 187 (282)
T ss_pred eehhhhc--cccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc
Confidence 9998766 6789999999997543 34455778899999999999999999999987 8999999999999999999
Q ss_pred eeeeccccceecCCCCCCCccccccccCCCChhhhcC---CcCCCccccchhhHHHHHHHHhCCCCCC-CCChHHHHHHH
Q 004999 281 LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG---ATYYGTAVDLWSTGCILAELYAGKPIMP-GRTEVEQLHKI 356 (720)
Q Consensus 281 vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~---~~~y~~~sDIWSLG~iL~ELltG~ppf~-g~~~~e~l~~i 356 (720)
+||||||++..+...- ..+...|...|||||.+.. ...|+.++||||||+++.||.+++.||. ..++.+++.++
T Consensus 188 VKiCDFGIsG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 188 VKICDFGISGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred EEEcccccceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 9999999998774322 2344567788999999853 3358999999999999999999997776 47888999888
Q ss_pred HH
Q 004999 357 FK 358 (720)
Q Consensus 357 ~~ 358 (720)
.+
T Consensus 266 Ve 267 (282)
T KOG0984|consen 266 VE 267 (282)
T ss_pred hc
Confidence 65
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=321.11 Aligned_cols=249 Identities=21% Similarity=0.265 Sum_probs=182.0
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
...+||+|+||.||+|++..++..||||++...... ...|+.++++++|||||++++++.. ....|+|||||
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~Ey~ 765 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIHEYI 765 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEEeCC
Confidence 445799999999999999999999999998643221 1346889999999999999999976 56789999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhcccccc---ccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH---SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH---~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+++.+..+.. .+++.++..++.||+.||+||| +.+|+||||||+|||++.++..++. ||....... ..
T Consensus 766 ~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~ 836 (968)
T PLN00113 766 EGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DT 836 (968)
T ss_pred CCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CC
Confidence 9776665554 4799999999999999999999 6699999999999999999888775 665543321 12
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCC-CChhhhhhcCCCCcccc
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGS-PSEDYWRKSKLPHATIF 379 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~-e~l~~i~~~~g~-p~~~~w~~~~l~~~~~~ 379 (720)
...+|+.|+|||++.+.. |+.++|||||||++|||+||+.||...... ..+....+.... .....|.+
T Consensus 837 ~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 906 (968)
T PLN00113 837 KCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID--------- 906 (968)
T ss_pred CccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC---------
Confidence 336789999999988765 799999999999999999999998532110 111111111000 00011111
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
+..... .........++.+|+.+||+.||++|||+.++++.
T Consensus 907 -~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 907 -PSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred -ccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 100000 00000112357789999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=301.10 Aligned_cols=246 Identities=28% Similarity=0.375 Sum_probs=188.4
Q ss_pred eeecccCceE-EEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeec
Q 004999 147 YLIGQGTYSN-VYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~-Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.++|.|+-|+ ||+|.. .|+.||||.+-. +......+||..|+.- .|||||++|+ .+.+...+||..|+|
T Consensus 515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIALELC 585 (903)
T ss_pred HHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEEehHh
Confidence 4599999874 799987 678999998763 4456778999999988 5999999975 455588999999999
Q ss_pred cccccccccCCCCC---CCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CC--ceeeeccccceecCCCC
Q 004999 225 EHDLAGLASHPGLK---FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NG--ILKIADFGLASFYDPDQ 296 (720)
Q Consensus 225 ~g~ll~~~~~~~~~---lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g--~vKL~DFGla~~~~~~~ 296 (720)
...|-+.+...... ......+.++.|+++||++||+.+||||||||.||||+. ++ .++|+|||+++.+..+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 98877766553111 111456889999999999999999999999999999976 34 68999999999886544
Q ss_pred CC--CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 297 NQ--PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 297 ~~--~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG-~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
.. ......||-+|+|||+|..... +.++||||||||+|..++| ..||...-.. -..|+.. ..
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~--~~---------- 730 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTG--NY---------- 730 (903)
T ss_pred chhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcC--cc----------
Confidence 32 2334568999999999988774 7899999999999999997 6777543222 1222221 00
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
++...-.....++.+||.+||++||..||+|.++|.||||...
T Consensus 731 --------------~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 731 --------------TLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred --------------ceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 0111111112279999999999999999999999999999753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=292.60 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=200.6
Q ss_pred chhhhhhhhccccccceeecccCceEEEEEEEC----C---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCce
Q 004999 131 SFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDL----D---QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINV 202 (720)
Q Consensus 131 ~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~----~---tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 202 (720)
.|+...+.+.... .||+|.||.|++|.-. . ....||||.++..... ...+.+..|+.+|+.+ .|+||
T Consensus 290 ~~e~~~~~l~~~~----~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENLKLGK----YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhccccc----eeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcch
Confidence 4555555442222 5999999999999743 1 1456999999866554 6678899999999999 59999
Q ss_pred eeeccceeccCCCeEEEEEeeccc-cccccccCCC---------------CCCCHHHHHHHHHhhhhccccccccCcccc
Q 004999 203 IKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPG---------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266 (720)
Q Consensus 203 vkl~~~~~~~~~~~lyLV~Ey~~g-~ll~~~~~~~---------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHr 266 (720)
+.++|++.. .+.+++|+||+.. +|+..+.... ..++..+...++.||+.|++||++..+|||
T Consensus 365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 999999987 7789999999985 5555444433 248999999999999999999999999999
Q ss_pred cCcceeEEEcCCCceeeeccccceecCCCCCCCccccc--cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCC
Q 004999 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV--VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPI 343 (720)
Q Consensus 267 DIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~--gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~pp 343 (720)
||-..||||..+..+||+|||+|+.............. -...|||||.+.... |+.++||||||++||||++ |..|
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~-ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV-FTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc-ccccchhhHHHHHHHHHhhCCCCC
Confidence 99999999999999999999999854333222211112 234599999999844 8999999999999999998 7799
Q ss_pred CCCCC-hHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 004999 344 MPGRT-EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422 (720)
Q Consensus 344 f~g~~-~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 422 (720)
|+|.. ..+.+..+.+. ...+.+..+++++.+|+..||+.+|++||+..++.
T Consensus 522 Yp~~~~~~~l~~~l~~G----------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 522 YPGIPPTEELLEFLKEG----------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred CCCCCcHHHHHHHHhcC----------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 99855 33443323211 12234456799999999999999999999999887
Q ss_pred h
Q 004999 423 R 423 (720)
Q Consensus 423 ~ 423 (720)
+
T Consensus 574 ~ 574 (609)
T KOG0200|consen 574 E 574 (609)
T ss_pred H
Confidence 5
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=283.33 Aligned_cols=198 Identities=27% Similarity=0.421 Sum_probs=170.3
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHH-----HHHHHHHHHHHHhcC---CCceeeeccceeccC
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPES-----VRFMAREIHILRRLD---HINVIKLEGLVTSRM 213 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~-----~~~~~~Ei~iL~~L~---HpnIvkl~~~~~~~~ 213 (720)
|..++.||.|+||.|++|.++.+...|+||.+.++.. .... +-.+-.||.||..|+ |+||++++++|++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd-- 640 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED-- 640 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec--
Confidence 3444459999999999999999999999999987653 2222 234567999999997 9999999999988
Q ss_pred CCeEEEEEeecc-ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 214 SCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 214 ~~~lyLV~Ey~~-g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
...+||+||--. |--+..+....+.++|.+++.|++||+.|+++||+.||||||||-+|+.|+.+|-+||+|||.|...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 778999999876 3233444555678999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP 345 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~ 345 (720)
...+....+||..|.|||+|.|..+.+..-|||+||++||.++....||.
T Consensus 721 ---ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 ---KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ---cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 33456778999999999999999988999999999999999998887765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=273.46 Aligned_cols=261 Identities=23% Similarity=0.265 Sum_probs=186.6
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc--CCCceeeeccceeccC--CCeEEEEEe
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL--DHINVIKLEGLVTSRM--SCSLYLVFE 222 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIvkl~~~~~~~~--~~~lyLV~E 222 (720)
++||+|.||.||+|.. +++.||||++.. +....+..|-.|.... .|+||++++++-.... ...++||+|
T Consensus 216 eli~~Grfg~V~KaqL--~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQL--DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred HHhhcCccceeehhhc--cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3599999999999976 568999999874 4456678888887754 7999999998643211 337899999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhcccccccc---------CcccccCcceeEEEcCCCceeeeccccceecC
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR---------GVLHRDIKGSNLLIDNNGILKIADFGLASFYD 293 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~---------gIvHrDIKP~NILld~~g~vKL~DFGla~~~~ 293 (720)
|.+.+.|..++..+ .+++....+++..+++||+|||+- .|+|||||..||||.+|+++.|+|||||..+.
T Consensus 289 fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred eccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 99977777766654 689999999999999999999963 59999999999999999999999999999886
Q ss_pred CCCCC-CccccccccCCCChhhhcCCcCCC-----ccccchhhHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCChh
Q 004999 294 PDQNQ-PLTSRVVTLWYRPPELLLGATYYG-----TAVDLWSTGCILAELYAGKPIMP-GRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 294 ~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~-----~~sDIWSLG~iL~ELltG~ppf~-g~~~~e~l~~i~~~~g~p~~~ 366 (720)
+.... .....+||.+|||||+|.|...+. .+.||||+|.|||||++....+. +....-++.--.++.-.|+-+
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 54433 233479999999999999876555 37899999999999999765443 222111111111112233333
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~ 421 (720)
......+..... |.. ...+... .-..-+.+.|+-||..||+.|.||.=+
T Consensus 448 ~mq~~VV~kK~R--P~~--p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 448 EMQELVVRKKQR--PKI--PDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHHHHHHhhccC--CCC--hhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 222211111100 000 0111111 223458899999999999999998543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=241.12 Aligned_cols=213 Identities=38% Similarity=0.605 Sum_probs=180.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|.+|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++.. ....+++|||+.|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 689999999999998889999999998654322 45678899999999999999999998876 478999999999655
Q ss_pred cccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-CCceeeeccccceecCCCCCCCccccccc
Q 004999 229 AGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 229 l~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+..+.... ..+++..++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 44444332 46899999999999999999999999999999999999999 89999999999987643221 12334568
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
..|++||.+.....++.+.|+|+||+++++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 8899999987753478999999999999999
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
..+.++|..||+.||.+||++.++++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2367889999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=281.87 Aligned_cols=246 Identities=21% Similarity=0.273 Sum_probs=200.1
Q ss_pred cceeecccCceEEEEEEECCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
..++||+|+||+||+|.+...|+ .||||++.... ..+.-..++.|+.+|.+|+|||+++|++++.. ..+.||
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~---s~~qlv 775 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCML---STLQLV 775 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhccc---chHHHH
Confidence 34579999999999999876565 48888876543 33445678999999999999999999999976 348899
Q ss_pred Eeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 221 FEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 221 ~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
++||++ .|++.+......+-....+.|..||++|+.|||.+++|||||-..||||..-..+||+|||+++.+..+....
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999995 5666666667789999999999999999999999999999999999999999999999999999887666544
Q ss_pred cccc-ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 300 LTSR-VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 300 ~t~~-~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.+.. ...+-|||=|.+.... |+.++|||||||++|||+| |..|+.|..-.+.-. +++.-.
T Consensus 856 ~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d-lle~ge---------------- 917 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD-LLEKGE---------------- 917 (1177)
T ss_pred cccccccCcHHHHHHHhhccC-CCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH-HHhccc----------------
Confidence 3332 2356788888887766 8999999999999999998 888888886655433 332110
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
....++.++-++.-++.+||..|+..||++.++..
T Consensus 918 -----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 918 -----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 12234567888999999999999999999988765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=239.90 Aligned_cols=209 Identities=36% Similarity=0.533 Sum_probs=171.8
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
...||.|++|.||++.+..+++.+|||.+...... .....+.+|+..+++++|+||+++++++.. ....++++||+.
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~~~ 80 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEYCE 80 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEeccC
Confidence 34599999999999999988999999999865433 256778899999999999999999998766 567999999999
Q ss_pred ccccccccCCCCC-CCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 226 HDLAGLASHPGLK-FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 226 g~ll~~~~~~~~~-lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+..+..+...... +++..+..++.+++.+|.+||..+++|+||+|.||+++.++.++|+|||++...............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVK 160 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccccee
Confidence 8554444443334 899999999999999999999999999999999999999999999999999876443211233456
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCC-CChH-HHHHHHH
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEV-EQLHKIF 357 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g-~~~~-e~l~~i~ 357 (720)
++..|++||.+.+...++.++|+|+|||++++|++|++||.+ .... +....|.
T Consensus 161 ~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 161 GTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred ccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 788899999984444478899999999999999999999988 5555 3444443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=300.29 Aligned_cols=203 Identities=18% Similarity=0.216 Sum_probs=146.4
Q ss_pred hcCC-Cceeeeccceecc-----CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCc
Q 004999 196 RLDH-INVIKLEGLVTSR-----MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIK 269 (720)
Q Consensus 196 ~L~H-pnIvkl~~~~~~~-----~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIK 269 (720)
.+.| .||++++++|... ....++++|||++++|...+......+++.+++.|+.||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 4455 5777777766211 124578899999888777765555679999999999999999999999999999999
Q ss_pred ceeEEEcC-------------------CCceeeeccccceecCCCC---------------CCCccccccccCCCChhhh
Q 004999 270 GSNLLIDN-------------------NGILKIADFGLASFYDPDQ---------------NQPLTSRVVTLWYRPPELL 315 (720)
Q Consensus 270 P~NILld~-------------------~g~vKL~DFGla~~~~~~~---------------~~~~t~~~gT~~Y~APE~l 315 (720)
|+||||+. ++.+||+|||+++...... .......++|++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 99999954 4456666666665321100 0001124689999999999
Q ss_pred cCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCC
Q 004999 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKD 395 (720)
Q Consensus 316 ~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~ 395 (720)
.+.. |+.++||||||||||||++|.+++.... ..+..+.... .|+ . ...
T Consensus 188 ~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~-~--------------------------~~~ 236 (793)
T PLN00181 188 NGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPP-Q--------------------------ILL 236 (793)
T ss_pred ccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cCh-h--------------------------hhh
Confidence 8876 7999999999999999999988765322 1222221110 000 0 001
Q ss_pred CCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 396 FPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 396 ~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+++..||+.||.+|||+.++|+||||..
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 1234678899999999999999999999999975
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=258.42 Aligned_cols=247 Identities=27% Similarity=0.347 Sum_probs=177.7
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHH--hcCCCceeeeccceeccCC--CeEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILR--RLDHINVIKLEGLVTSRMS--CSLYLV 220 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~--~L~HpnIvkl~~~~~~~~~--~~lyLV 220 (720)
..+.||+|-||.||+|.+ .|+.||||++.-.. .+.+.+|.+|.+ .|+|+||+.+++.-....+ ..+|||
T Consensus 215 L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred EEEEecCccccceeeccc--cCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 344699999999999998 56779999987432 233456666665 4699999999876433222 369999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhcccccccc--------CcccccCcceeEEEcCCCceeeeccccceec
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR--------GVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~--------gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
++|.+.+.|..++.. ..++......++..++.||+|||.. .|.|||||..||||.++|.+.|+|+|||...
T Consensus 288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 999998777776665 4789999999999999999999953 4999999999999999999999999999887
Q ss_pred CCCCC---CCccccccccCCCChhhhcCCcC---C--CccccchhhHHHHHHHHhC----------CCCCCCC----ChH
Q 004999 293 DPDQN---QPLTSRVVTLWYRPPELLLGATY---Y--GTAVDLWSTGCILAELYAG----------KPIMPGR----TEV 350 (720)
Q Consensus 293 ~~~~~---~~~t~~~gT~~Y~APE~l~~~~~---y--~~~sDIWSLG~iL~ELltG----------~ppf~g~----~~~ 350 (720)
..+.. ......+||.+|||||+|...-. + -..+||||||.||||++.. .+||.+. ...
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~ 446 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF 446 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence 65432 24456799999999999965321 1 1368999999999999863 2455432 223
Q ss_pred HHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCC--HhHHHHHHHhcccCCCCCCCHHHHH
Q 004999 351 EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFP--APALALMETLLSIDPADRGSAASAL 422 (720)
Q Consensus 351 e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~--~~~~dLI~~mL~~DP~kRpTa~e~L 422 (720)
+.+.+++-. ..+.|..| ..+...+ ..+..|++.||.-||.-|.||-.+-
T Consensus 447 eeMrkVVCv-----------------~~~RP~ip------nrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 447 EEMRKVVCV-----------------QKLRPNIP------NRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHHhcceee-----------------cccCCCCC------cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 333332210 00111111 1111111 2366789999999999999986553
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=231.02 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=182.0
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc-c
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME-H 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~-g 226 (720)
||+|-||.+.+|.++.+...++||.+.... ...+.|.+|..---.| .|.||+.-|++.... .+.+++++||++ |
T Consensus 32 lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 32 LGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVFVQEFAPRG 107 (378)
T ss_pred hcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEEeeccCccc
Confidence 999999999999999999999999987653 3456688888766566 599999888653322 567889999998 5
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc--CCCceeeeccccceecCCCCCCCccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld--~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+|...+... .+-|.-.+.++.|+++||.|||+.++||||||.+||||- +...|||||||+....+.. ....-
T Consensus 108 dL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t----V~~~~ 181 (378)
T KOG1345|consen 108 DLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT----VKYLE 181 (378)
T ss_pred hhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce----ehhhh
Confidence 665555443 478999999999999999999999999999999999994 3347999999998754321 11122
Q ss_pred cccCCCChhhhcCC----cCCCccccchhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 305 VTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 305 gT~~Y~APE~l~~~----~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~-l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
.+..|.+||++... -...+.+|||.||+|+|.+|||.+|+......+. +.... .|.+.+.+
T Consensus 182 ~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~---------~w~~rk~~----- 247 (378)
T KOG1345|consen 182 YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE---------QWLKRKNP----- 247 (378)
T ss_pred hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH---------HHhcccCc-----
Confidence 36679999988642 2257789999999999999999999864321111 11111 12222211
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCC---CCHHHHHhCcc
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR---GSAASALRSEF 426 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kR---pTa~e~L~hp~ 426 (720)
.+...|..+++.+..+.++-|..+|++| .++.......|
T Consensus 248 --------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 248 --------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred --------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 1345667789999999999999999999 44444444444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=222.17 Aligned_cols=165 Identities=23% Similarity=0.311 Sum_probs=125.5
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+|.+.+...+..+++.+++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++...... ...||
T Consensus 2 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~------~~~g~ 67 (176)
T smart00750 2 SLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE------QSRVD 67 (176)
T ss_pred cHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc------cCCCc
Confidence 344444444557999999999999999999999998 999999999999999 9999875432 12679
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e-~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
+.|+|||++.+.. |+.++||||||||+|||++|.+||....... .+..+....... .+.
T Consensus 68 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~~ 127 (176)
T smart00750 68 PYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD-------------------DPR 127 (176)
T ss_pred ccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC-------------------Ccc
Confidence 9999999998776 7999999999999999999999997654432 223332211000 000
Q ss_pred chhhhcccCCCCH--hHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 386 KRCVAETFKDFPA--PALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 386 ~~~~~e~~~~~~~--~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
.. .....++. .+.+||..||..||.+|||+.++++|+|+.
T Consensus 128 ~~---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 128 DR---SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cc---ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00 00112233 689999999999999999999999999985
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=221.25 Aligned_cols=262 Identities=34% Similarity=0.509 Sum_probs=204.0
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH-HHHHHHHHHHHHHHhcCCC-ceeeeccceeccCCCeEEEEEe
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHI-NVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~-~~~~~~~~Ei~iL~~L~Hp-nIvkl~~~~~~~~~~~lyLV~E 222 (720)
....||.|+|+.||++.+. ..+++|.+....... .....+.+|+.++..+.|+ +|+++++++.. ....+++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~~ 78 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSLYLVME 78 (384)
T ss_pred eEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEEEEEEe
Confidence 3455999999999999987 778999998765433 3577889999999999988 79999998854 455899999
Q ss_pred eccccccccccCCCC---CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceecCCCCCC
Q 004999 223 YMEHDLAGLASHPGL---KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 223 y~~g~ll~~~~~~~~---~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~~~~ 298 (720)
|+.+..+..+..... .+++..+..++.|++.+|.|+|..+++||||||+|||++..+ .++++|||++..+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999866654444332 789999999999999999999999999999999999999988 7999999999865433321
Q ss_pred -----CccccccccCCCChhhhcCC--cCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCC-Chhh
Q 004999 299 -----PLTSRVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSP-SEDY 367 (720)
Q Consensus 299 -----~~t~~~gT~~Y~APE~l~~~--~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---~e~l~~i~~~~g~p-~~~~ 367 (720)
.....++|.+|+|||.+.+. ..+....|+|++|++++++++|..||..... .......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 34667899999999999874 4579999999999999999999998887764 33444433332222 0000
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
...... ......+.+++..|+..+|..|.+..+...++|+....
T Consensus 239 -----------~~~~~~---------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 239 -----------LSPSNP---------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred -----------cCcccc---------chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 000000 12235789999999999999999999999997776543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=264.31 Aligned_cols=264 Identities=27% Similarity=0.362 Sum_probs=200.2
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeec----CCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRF----DNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~----~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
...++|.|++|.|+.+......+.++.|..+. ..........+..|+.+-..|.|||++..+..+... ...+-+
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~~~~ 399 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGILQS 399 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccchhh
Confidence 34479999999999998887777777776652 222333344477889999999999998887776653 334445
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC---
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--- 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~--- 297 (720)
||||++++...+.. ...++..++.++++||+.||.|||+.||.|||||++|||+..+|.+||+|||.+..+.-...
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999955555444 45789999999999999999999999999999999999999999999999999987643222
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......+|+..|+|||++.+..+-...+||||.|+|+..|++|+.||.-....+....-.. + ..
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~--------~--------~~ 542 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN--------Y--------SD 542 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc--------c--------cc
Confidence 3445668899999999999888666789999999999999999988865433222110000 0 00
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.+..... ....+..++...+.+|.+||++||.+|.|+.+||+.+||+...
T Consensus 543 ~~~~~~~----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 543 QRNIFEG----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ccccccC----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 0000011 1223346788899999999999999999999999999998654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=230.40 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=193.0
Q ss_pred ceeecccCceEEEEEEECCCC-----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 146 FYLIGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg-----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.-++-+|.||.||.|.+.+.. +.|-+|.++.. ..+-.+..++.|...|..+.|||+..+.++..+. ....+.+
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~-~~~P~V~ 366 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED-YATPFVL 366 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec-cCcceEE
Confidence 346889999999999776432 33666766543 3445567788999999999999999999987763 4567788
Q ss_pred Eeecc-cccccccc-----C--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 221 FEYME-HDLAGLAS-----H--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 221 ~Ey~~-g~ll~~~~-----~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
+.+++ |+|...+. . ....++..+...++.||+.|++|||++||||.||...|.+|++.-++||+|=.+++-+
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhcccc
Confidence 88888 44433222 1 1124778899999999999999999999999999999999999999999999999866
Q ss_pred CCCCCCCcccc-ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 293 DPDQNQPLTSR-VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 293 ~~~~~~~~t~~-~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
-+.....+... .-...||+||.+.... |+.++|+||||++||||+| |+.|+...+..|..+-+.+..
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy---------- 515 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY---------- 515 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc----------
Confidence 54444333322 1256799999998876 8999999999999999988 888888888877766554321
Q ss_pred cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
....+-++|+++..++..||..+|++||+.+++..
T Consensus 516 ------------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 ------------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ------------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11233479999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=231.64 Aligned_cols=168 Identities=21% Similarity=0.249 Sum_probs=127.4
Q ss_pred eecccCceEEEEEEECC-CCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhcCCCceee-eccceeccCCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDLD-QKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIK-LEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~-tg~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIvk-l~~~~~~~~~~~lyLV~E 222 (720)
+||+|+||+||+|++.. +++.||||++..... .......+.+|+.+|++|+|+||+. ++++ ...|||||
T Consensus 25 ~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------~~~~LVmE 98 (365)
T PRK09188 25 VLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------GKDGLVRG 98 (365)
T ss_pred EEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------CCcEEEEE
Confidence 39999999999999876 778889998763311 2344567899999999999999985 4432 34799999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccC-cceeEEEcCCCceeeeccccceecCCCCCC---
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI-KGSNLLIDNNGILKIADFGLASFYDPDQNQ--- 298 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDI-KP~NILld~~g~vKL~DFGla~~~~~~~~~--- 298 (720)
||+|..+..... . . ...++.|++.+|.|||++||+|||| ||+||||+.++.+||+|||+|+.+......
T Consensus 99 ~~~G~~L~~~~~-~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~ 171 (365)
T PRK09188 99 WTEGVPLHLARP-H---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRI 171 (365)
T ss_pred ccCCCCHHHhCc-c---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhh
Confidence 999876653211 1 1 2568899999999999999999999 999999999999999999999976433211
Q ss_pred ----CccccccccCCCChhhhcCC-----cCCCccccch
Q 004999 299 ----PLTSRVVTLWYRPPELLLGA-----TYYGTAVDLW 328 (720)
Q Consensus 299 ----~~t~~~gT~~Y~APE~l~~~-----~~y~~~sDIW 328 (720)
..+...+++.|+|||.+... ...+...|-|
T Consensus 172 ~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 172 AAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred hhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 12345678889999988532 1123446666
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-24 Score=241.51 Aligned_cols=242 Identities=27% Similarity=0.396 Sum_probs=199.9
Q ss_pred eecccCceEEEEEEE---CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEee
Q 004999 148 LIGQGTYSNVYRARD---LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~---~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++|+|+||.|++++- ...+..+|+|++++.............|..++..++ ||.+|+++..+.. ...+|++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhh
Confidence 389999999998753 356778999998876442211125567888999886 9999999888776 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
..|+.+.........+++...+.+...++.+++++|..+|+|||+|++||+++.+|++++.|||+.+..-.... .
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-----~ 153 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-----A 153 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh-----c
Confidence 99877666666677899999999999999999999999999999999999999999999999999987643322 2
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
|||..|||||++.+ ...++|.||||++++||+||..+|.+ +.+..|.+..-..
T Consensus 154 cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~-------------------- 206 (612)
T KOG0603|consen 154 CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEM-------------------- 206 (612)
T ss_pred ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCC--------------------
Confidence 89999999999983 47899999999999999999999988 7777776632211
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMKPL 432 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~~~ 432 (720)
+..++..+.+++..|+..+|..|.- +.++++|+||+..-+
T Consensus 207 ---------p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 207 ---------PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred ---------chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 1345677999999999999999975 579999999986544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=211.29 Aligned_cols=254 Identities=25% Similarity=0.226 Sum_probs=186.8
Q ss_pred cccceeecccCceEEEEEEECCCC-eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC----CceeeeccceeccCCCeE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQK-KIVALKKVRFDNLEPESVRFMAREIHILRRLDH----INVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H----pnIvkl~~~~~~~~~~~l 217 (720)
|.+.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.++..+.. .++..+++... .....-
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~ 96 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFN 96 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCcee
Confidence 444455999999999999998775 67999987764322111 46788999998863 68888887763 225678
Q ss_pred EEEEeeccccccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-----Cceeeeccccce-
Q 004999 218 YLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-----GILKIADFGLAS- 290 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-----g~vKL~DFGla~- 290 (720)
|+||+.++.+|.++.... ...|+...+..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++
T Consensus 97 ~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 97 FIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 999999998888776443 4789999999999999999999999999999999999999755 369999999998
Q ss_pred -ecCCCCCC----C---ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Q 004999 291 -FYDPDQNQ----P---LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 362 (720)
Q Consensus 291 -~~~~~~~~----~---~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~ 362 (720)
.+...... . .....||..|.++.+..+.. .+.+.|+||++.++.+|+.|..|+.+........++.+....
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~ 255 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK 255 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence 33222211 1 22345999999999988877 599999999999999999999998776654443333321100
Q ss_pred CChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 363 p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.. ........+..+..++..+-..+...+|....+...
T Consensus 256 ~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 256 LL------------------------TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hc------------------------cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 00 000122345667777777777788888877665543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-22 Score=232.05 Aligned_cols=218 Identities=30% Similarity=0.399 Sum_probs=162.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
++|..|+||.||.++++.+.+.+|+| +.+.++ +.|- ||.....|.+| |
T Consensus 89 klisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv----------------------g 136 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV----------------------G 136 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee----------------------c
Confidence 34999999999999999999999994 443321 1111 22222333332 4
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC---------
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--------- 297 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~--------- 297 (720)
|....+...+ +++... +.+++|||+.||+|||+||+|+||+.-|++|++|||+.+.......
T Consensus 137 Dc~tllk~~g-~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~ 207 (1205)
T KOG0606|consen 137 DCATLLKNIG-PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIE 207 (1205)
T ss_pred hhhhhcccCC-CCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchH
Confidence 4444444333 333332 7899999999999999999999999999999999999865321110
Q ss_pred ----CCc-cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 298 ----QPL-TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 298 ----~~~-t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
+.. ...||||.|+|||+++... |+..+|+|++|+|+||.+.|..||.|++..+.+.+++......+
T Consensus 208 k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp-------- 278 (1205)
T KOG0606|consen 208 KDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP-------- 278 (1205)
T ss_pred HHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc--------
Confidence 111 2347899999999999877 89999999999999999999999999999998888765332222
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC---CHHHHHhCccCCCCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG---SAASALRSEFFTMKPL 432 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp---Ta~e~L~hp~f~~~~~ 432 (720)
|.-..+++++.++|..+|+.+|..|. .+.++.+|+||+.--+
T Consensus 279 ------------------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 279 ------------------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred ------------------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 22235789999999999999999994 5788899999975433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.2e-22 Score=197.72 Aligned_cols=139 Identities=22% Similarity=0.231 Sum_probs=108.6
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHH------------------------HHHHHHHHHHHHhcCCCcee
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES------------------------VRFMAREIHILRRLDHINVI 203 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~------------------------~~~~~~Ei~iL~~L~HpnIv 203 (720)
+||+|+||.||+|.+. +|+.||||+++........ .....+|+.+|.+|.+++|.
T Consensus 4 ~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 4 CISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred ccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 4999999999999986 8999999999865321110 12334699999999888774
Q ss_pred eeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccc-cccCcccccCcceeEEEcCCCcee
Q 004999 204 KLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC-HSRGVLHRDIKGSNLLIDNNGILK 282 (720)
Q Consensus 204 kl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yL-H~~gIvHrDIKP~NILld~~g~vK 282 (720)
....+... ..||||||++|+.+.........+++..+..++.||+.+|.+| |+.||+||||||+||||+ ++.++
T Consensus 83 ~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 83 CPEPILLK----SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCcEEEec----CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 43322211 2389999999865543322345789999999999999999999 799999999999999998 58899
Q ss_pred eeccccceec
Q 004999 283 IADFGLASFY 292 (720)
Q Consensus 283 L~DFGla~~~ 292 (720)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.7e-22 Score=201.27 Aligned_cols=182 Identities=15% Similarity=0.134 Sum_probs=139.3
Q ss_pred hhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH-HHHHH------HHHHHHHHHhcCCCceee
Q 004999 132 FEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRF------MAREIHILRRLDHINVIK 204 (720)
Q Consensus 132 ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~-~~~~~------~~~Ei~iL~~L~HpnIvk 204 (720)
.+..++.+++.|++.++||.|+||.||++.+ ++..+|||+++...... ..... +.+|+..+.+|.|++|..
T Consensus 22 ~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 22 KEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 4666888999999999999999999999755 46679999998654422 22233 579999999999999999
Q ss_pred eccceeccC------CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC
Q 004999 205 LEGLVTSRM------SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN 278 (720)
Q Consensus 205 l~~~~~~~~------~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~ 278 (720)
+.+++.... .+..+|||||++|..+..+. .+++ ..+.+|+.+|..||..||+|+||||+|||++.+
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCC
Confidence 988765432 24589999999997665542 2333 346699999999999999999999999999999
Q ss_pred CceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHH
Q 004999 279 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELY 338 (720)
Q Consensus 279 g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELl 338 (720)
| ++|+|||.......... -+.+.-...|+.++|+|+||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 9 99999998875422111 111222233678999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-21 Score=189.66 Aligned_cols=141 Identities=23% Similarity=0.290 Sum_probs=110.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCC----------------------H--HHHHHHHHHHHHHHhcCCCce
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----------------------P--ESVRFMAREIHILRRLDHINV 202 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~----------------------~--~~~~~~~~Ei~iL~~L~HpnI 202 (720)
..||+|+||.||+|.+. +|+.||||+++..... . .....+.+|+..+.++.|++|
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35999999999999987 8999999999865321 0 012234689999999999988
Q ss_pred eeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCce
Q 004999 203 IKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGIL 281 (720)
Q Consensus 203 vkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~v 281 (720)
.....+... ..||||||++|+.+.........+++.++..++.|++.+|.+||+ .||+||||||+||||+ ++.+
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 554433322 248999999986332221223467889999999999999999999 9999999999999998 8999
Q ss_pred eeeccccceecC
Q 004999 282 KIADFGLASFYD 293 (720)
Q Consensus 282 KL~DFGla~~~~ 293 (720)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-21 Score=201.63 Aligned_cols=232 Identities=22% Similarity=0.345 Sum_probs=147.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCC----------Cceeeecccee-----
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH----------INVIKLEGLVT----- 210 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~H----------pnIvkl~~~~~----- 210 (720)
..||.|+++.||.++|.+|++.+|||++..... .....+.+.+|.-....+.+ -.++..++...
T Consensus 18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~ 97 (288)
T PF14531_consen 18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKP 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-
T ss_pred cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCC
Confidence 469999999999999999999999999876543 23456677777655544322 12222222111
Q ss_pred ----ccCC-C-----eEEEEEeeccccccccccC----CCCC--CCHHHHHHHHHhhhhccccccccCcccccCcceeEE
Q 004999 211 ----SRMS-C-----SLYLVFEYMEHDLAGLASH----PGLK--FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLL 274 (720)
Q Consensus 211 ----~~~~-~-----~lyLV~Ey~~g~ll~~~~~----~~~~--lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NIL 274 (720)
.... . ..+++|+-+.++|...... .... +.......+-.|++..+++||..||||+||+|+|+|
T Consensus 98 ~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfl 177 (288)
T PF14531_consen 98 PFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFL 177 (288)
T ss_dssp SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEE
T ss_pred cceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEE
Confidence 1100 1 2477888888876554321 1111 122223445589999999999999999999999999
Q ss_pred EcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCC-------cCCCccccchhhHHHHHHHHhCCCCCCCC
Q 004999 275 IDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA-------TYYGTAVDLWSTGCILAELYAGKPIMPGR 347 (720)
Q Consensus 275 ld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~-------~~y~~~sDIWSLG~iL~ELltG~ppf~g~ 347 (720)
++.+|.++|+||+.+...+. .......+..|.+||+.... ..++.+.|.|+||+++|.|+||..||...
T Consensus 178 l~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 178 LDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp E-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred EcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 99999999999998876432 11223456789999987432 34788999999999999999999998765
Q ss_pred ChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCC
Q 004999 348 TEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415 (720)
Q Consensus 348 ~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kR 415 (720)
....... | .+ ..+.++|+.+.+||..||+.||.+|
T Consensus 254 ~~~~~~~-------------~---------------~f-----~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 254 SPEADPE-------------W---------------DF-----SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGGSTSG-------------G---------------GG-----TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred Ccccccc-------------c---------------cc-----hhcCCcCHHHHHHHHHHccCCcccC
Confidence 4311100 0 11 1233789999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.4e-21 Score=222.34 Aligned_cols=242 Identities=26% Similarity=0.369 Sum_probs=176.4
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDN--LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~--~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||.+-|=+|.+|++.+ |. |+||++-... ..-....+-+.|++ ...++|||++.+.-+... ....|||-+|+.+
T Consensus 31 LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 31 LGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAAYLVRQYVKH 105 (1431)
T ss_pred cCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHHHHHHHHHhh
Confidence 9999999999999754 54 8999976543 23333444456666 566799999998776544 5667999999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceec--CCCCCCCccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY--DPDQNQPLTSRV 304 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~--~~~~~~~~t~~~ 304 (720)
+|.+.+.. .+.+.+.+.+-|+.||+.||..||..||+|+|||.+||||++-+.+.|+||..-+.. ..+.....+.+.
T Consensus 106 nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFF 184 (1431)
T KOG1240|consen 106 NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFF 184 (1431)
T ss_pred hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEE
Confidence 88876655 457888999999999999999999999999999999999999999999999866432 122221122111
Q ss_pred c----ccCCCChhhhcCC----------cCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 305 V----TLWYRPPELLLGA----------TYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 305 g----T~~Y~APE~l~~~----------~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
- -..|+|||-+... ...+++-||||+|||++||++ |+|+| ...|+-..... +.-..
T Consensus 185 DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF----~LSQL~aYr~~-~~~~~---- 255 (1431)
T KOG1240|consen 185 DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF----TLSQLLAYRSG-NADDP---- 255 (1431)
T ss_pred ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc----cHHHHHhHhcc-CccCH----
Confidence 1 2459999998642 125789999999999999987 78998 33333222111 00000
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
..+.+... +..++.||..|++.||++|.+|++.|+-
T Consensus 256 -----------------e~~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 -----------------EQLLEKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred -----------------HHHHHhCc--CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11222222 2368999999999999999999999985
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=185.70 Aligned_cols=188 Identities=16% Similarity=0.095 Sum_probs=137.6
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCC--HHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEe
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~--~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
..+|+.|+||+||.+.. .+..++.+.+...... .-....+.+|+.+|++|. |++|++++++ ...|++||
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvme 78 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDRS 78 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEEe
Confidence 34599999999998865 5667777776654321 112235789999999995 5889999875 23699999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccC-cceeEEEcCCCceeeeccccceecCCCCCC---
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI-KGSNLLIDNNGILKIADFGLASFYDPDQNQ--- 298 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDI-KP~NILld~~g~vKL~DFGla~~~~~~~~~--- 298 (720)
|+.|..+..... . ....++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 79 YLAGAAMYQRPP------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eecCccHHhhhh------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 999977653321 1 12457889999999999999999999 799999999999999999999865432210
Q ss_pred -C--------ccccccccCCCChhhhcCCcCCC-ccccchhhHHHHHHHHhCCCCCCCCC
Q 004999 299 -P--------LTSRVVTLWYRPPELLLGATYYG-TAVDLWSTGCILAELYAGKPIMPGRT 348 (720)
Q Consensus 299 -~--------~t~~~gT~~Y~APE~l~~~~~y~-~~sDIWSLG~iL~ELltG~ppf~g~~ 348 (720)
. ..-...++.|+.|+.-......+ ...+.++.|+.+|.++|+..++-++.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 00112478888888654322123 56788899999999999997765543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.7e-20 Score=185.45 Aligned_cols=255 Identities=22% Similarity=0.240 Sum_probs=191.6
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++++.||.|+||.+|.|....+|+.||||+-+..... .++..|..+.+.|+ ...|..+..+..+ ...-.+||
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVM 90 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVM 90 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccc--cccceeee
Confidence 34444499999999999999999999999987654322 23678899999885 5677777766665 55678999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC---CceeeeccccceecCCCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~---g~vKL~DFGla~~~~~~~~~ 298 (720)
++++-.|.+++..-...|+...++.++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||+|+.+......
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 999987777776666789999999999999999999999999999999999998533 46899999999877433222
Q ss_pred ------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCCCChhhhh
Q 004999 299 ------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL---HKIFKLCGSPSEDYWR 369 (720)
Q Consensus 299 ------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l---~~i~~~~g~p~~~~w~ 369 (720)
.-....||..|.+=-...+... +...|+-|+|.+|.....|..||.|....... ++|.+.--+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s------- 242 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS------- 242 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC-------
Confidence 1223468999998777766553 78899999999999999999999997654443 333321111
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC---HHHHHhCccCC
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS---AASALRSEFFT 428 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT---a~e~L~hp~f~ 428 (720)
..+...++.+|.++.-.|.-|-..-=++-|. ..++...-|++
T Consensus 243 -----------------~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 243 -----------------TPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred -----------------CCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 1134456788888888888876665555565 34555555554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-20 Score=194.00 Aligned_cols=199 Identities=25% Similarity=0.315 Sum_probs=143.7
Q ss_pred CCCceeeeccceeccC-------------------------CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhh
Q 004999 198 DHINVIKLEGLVTSRM-------------------------SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLL 252 (720)
Q Consensus 198 ~HpnIvkl~~~~~~~~-------------------------~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl 252 (720)
.|||||++.++|.+.. ...+|+||....+.|...+-... .+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence 5999999998876521 24689999999888776665543 47778888999999
Q ss_pred hccccccccCcccccCcceeEEE--cCCC--ceeeeccccceecCCCCCC-----CccccccccCCCChhhhcCCcC---
Q 004999 253 CGLDHCHSRGVLHRDIKGSNLLI--DNNG--ILKIADFGLASFYDPDQNQ-----PLTSRVVTLWYRPPELLLGATY--- 320 (720)
Q Consensus 253 ~gL~yLH~~gIvHrDIKP~NILl--d~~g--~vKL~DFGla~~~~~~~~~-----~~t~~~gT~~Y~APE~l~~~~~--- 320 (720)
+|+.|||.+||.|||+|.+|||| ++|+ .+.|+|||++-.-+...-+ .....-|.-..||||+....+.
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 3444 5899999988543221111 1112345667899998864321
Q ss_pred --CCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCH
Q 004999 321 --YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPA 398 (720)
Q Consensus 321 --y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~ 398 (720)
.-.++|.|+.|.+.||+++...||.+..+...-..- +..+ .+......+++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-----------Yqe~----------------qLPalp~~vpp 484 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-----------YQES----------------QLPALPSRVPP 484 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhh-----------hhhh----------------hCCCCcccCCh
Confidence 123789999999999999999999885432211110 1111 12233456889
Q ss_pred hHHHHHHHhcccCCCCCCC---HHHHHhCc
Q 004999 399 PALALMETLLSIDPADRGS---AASALRSE 425 (720)
Q Consensus 399 ~~~dLI~~mL~~DP~kRpT---a~e~L~hp 425 (720)
.+++|+..+|+.||.+|++ |+.+|+--
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHHHH
Confidence 9999999999999999998 45566533
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=186.28 Aligned_cols=202 Identities=23% Similarity=0.296 Sum_probs=163.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.||+|+||.++.|.+.-+++.||||.-.... .+-++..|.+..+.| ..++|..+|-+-.. +.+-.||||+++.
T Consensus 35 KIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiLVidLLGP 108 (449)
T KOG1165|consen 35 KIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNILVIDLLGP 108 (449)
T ss_pred ccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhhhhhhhCc
Confidence 3999999999999999999999999755432 234567788888888 57899888654433 5566799999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-----CceeeeccccceecCCCCC-C--
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-----GILKIADFGLASFYDPDQN-Q-- 298 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-----g~vKL~DFGla~~~~~~~~-~-- 298 (720)
.|.+++.--+..|+...+..++.|++.-++|+|++.+|+|||||+|+||..- ..|.|+|||+|+.+....+ +
T Consensus 109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHI 188 (449)
T KOG1165|consen 109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHI 188 (449)
T ss_pred CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccC
Confidence 7777766677799999999999999999999999999999999999999643 4689999999998743322 2
Q ss_pred ---CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHH
Q 004999 299 ---PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKI 356 (720)
Q Consensus 299 ---~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~---~~e~l~~i 356 (720)
...+..||..||+=-.-+|... +...|+=|||-|++..|.|..||.|.. ..+-+++|
T Consensus 189 PYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 189 PYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 1224568999999887788764 889999999999999999999998854 34444444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.7e-19 Score=179.74 Aligned_cols=237 Identities=18% Similarity=0.198 Sum_probs=183.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
|.+.-.|..|+|++..+. ++.|++..........+.|..|.-.|+-+.||||+.+++.|.. ...+.++..||+-+.
T Consensus 198 l~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns--ppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 198 LAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS--PPNLVIISQYMPFGS 273 (448)
T ss_pred hccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC--CCCceEeeeeccchH
Confidence 888899999999996544 7788888766655556778899999999999999999999977 467899999999665
Q ss_pred cccccCCCC--CCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 229 AGLASHPGL--KFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 229 l~~~~~~~~--~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+...+..+. -.+..++.+++.+|++|+.|||+.. |.--.|....++||++.+.+|. .+-+++ ........
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kf-----sfqe~gr~ 347 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKF-----SFQEVGRA 347 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-ccccee-----eeeccccc
Confidence 555555443 3678899999999999999999985 5555689999999999887763 111111 11112334
Q ss_pred cccCCCChhhhcCCcCC--CccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 305 VTLWYRPPELLLGATYY--GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y--~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..|.||+||.+...+.. -.++|+|||.++||||.|...||......|.-.+|.-
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial------------------------ 403 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL------------------------ 403 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh------------------------
Confidence 57899999999875532 3489999999999999999999999888876555521
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 422 (720)
+......++.++.....|+.-|+..||.+||....++
T Consensus 404 ---eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 ---EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ---ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 1112344567888999999999999999999876543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.6e-18 Score=179.50 Aligned_cols=144 Identities=24% Similarity=0.215 Sum_probs=111.8
Q ss_pred ccccceeecccCceEEEEEE-ECCCCeEEEEEEeecCCCC--------------------HH--HHHHHHHHHHHHHhcC
Q 004999 142 FSRSFYLIGQGTYSNVYRAR-DLDQKKIVALKKVRFDNLE--------------------PE--SVRFMAREIHILRRLD 198 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~-~~~tg~~VAIK~l~~~~~~--------------------~~--~~~~~~~Ei~iL~~L~ 198 (720)
+|.+...||+|+||.||+|. +..+|+.||||+++..... .. ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34555679999999999999 6678999999999864321 00 1134678999999997
Q ss_pred CCc--eeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccC-cccccCcceeEEE
Q 004999 199 HIN--VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG-VLHRDIKGSNLLI 275 (720)
Q Consensus 199 Hpn--Ivkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g-IvHrDIKP~NILl 275 (720)
+.+ +.+++++ ...||||||++|+.+.........+.+.++..++.||+.+|.+||..| |+|+||||+||||
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 533 3333332 124899999999766544433445677788999999999999999999 9999999999999
Q ss_pred cCCCceeeeccccceec
Q 004999 276 DNNGILKIADFGLASFY 292 (720)
Q Consensus 276 d~~g~vKL~DFGla~~~ 292 (720)
+ ++.++|+|||++...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 8 889999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.9e-19 Score=194.84 Aligned_cols=177 Identities=30% Similarity=0.461 Sum_probs=135.8
Q ss_pred eEEEEEeeccccccccccCC---CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 216 SLYLVFEYMEHDLAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~~---~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
.+||.|++|.-+.+..|+.. ....+....+.++.|++.+++| +|.+|+|+||.||+...+..+||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 58999999998888777753 3346778899999999999999 99999999999999999999999999999876
Q ss_pred CCCC-----CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChh
Q 004999 293 DPDQ-----NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 293 ~~~~-----~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
.... ....+..+||.|||+||.|.+.. |+.++||||||+|||||+.-. ..| .....+..+.. |..++.
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~--g~ip~~ 480 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRD--GIIPPE 480 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhc--CCCChH
Confidence 5444 33566779999999999999887 899999999999999999821 111 11111222211 222222
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
+|. +. +.-..||.+||...|.+||++.+.-.|.|.
T Consensus 481 ~~~-------------------------d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 481 FLQ-------------------------DY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred Hhh-------------------------cC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 221 22 335689999999999999988887777765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.6e-18 Score=173.44 Aligned_cols=135 Identities=16% Similarity=0.188 Sum_probs=102.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-----CCCceeeeccceeccCC-CeEE-E
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-----DHINVIKLEGLVTSRMS-CSLY-L 219 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIvkl~~~~~~~~~-~~ly-L 219 (720)
.+||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.| +||||+++++++.+..+ +.+| +
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3599999999996 6667665 6999876432 2346689999999999 67999999999987432 2434 7
Q ss_pred EEeecc--ccccccccCCCCCCCHHHHHHHHHhhhhcc-ccccccCcccccCcceeEEEcC----CCceeeeccccc
Q 004999 220 VFEYME--HDLAGLASHPGLKFSEAQVKCYMQQLLCGL-DHCHSRGVLHRDIKGSNLLIDN----NGILKIADFGLA 289 (720)
Q Consensus 220 V~Ey~~--g~ll~~~~~~~~~lse~~~~~i~~QIl~gL-~yLH~~gIvHrDIKP~NILld~----~g~vKL~DFGla 289 (720)
||||++ ++++..+...+ .+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 899944 55555554443 46666 46688888887 9999999999999999999974 347999995544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.3e-19 Score=204.79 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=200.4
Q ss_pred ecccCceEEEEEEEC-CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~-~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||+|+|+.|-.+... .+...+|+|.+............+..|..+-..+. |.|++++++.... ....+++++|..|
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYLLSLSYSDG 105 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--CcccccccCcccc
Confidence 999999999988764 44555777877665444555666778999999997 9999999998766 5678999999887
Q ss_pred ccccccc-CCCC-CCCHHHHHHHHHhhhhcccccc-ccCcccccCcceeEEEcCCC-ceeeeccccceecCC--CCCCCc
Q 004999 227 DLAGLAS-HPGL-KFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDP--DQNQPL 300 (720)
Q Consensus 227 ~ll~~~~-~~~~-~lse~~~~~i~~QIl~gL~yLH-~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~--~~~~~~ 300 (720)
+.+.... ..+. ..+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .+|+.|||+|..+.. ......
T Consensus 106 ~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~ 185 (601)
T KOG0590|consen 106 GSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSL 185 (601)
T ss_pred cccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceee
Confidence 6555544 4443 6788899999999999999999 99999999999999999999 999999999987754 223334
Q ss_pred ccccc-ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~g-T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
...+| ++.|+|||.+.+..+..+..|+||+|+++.-+++|..++......... ...|...+.
T Consensus 186 ~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-----------~~~~~~~~~------ 248 (601)
T KOG0590|consen 186 KDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-----------YSSWKSNKG------ 248 (601)
T ss_pred ecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-----------ceeeccccc------
Confidence 45678 999999999998666789999999999999999999876543322210 001211110
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..-...+..++....+++.++|..+|..|.+..++-.++|+..
T Consensus 249 -------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 249 -------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -------ccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 0011234568888999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.2e-17 Score=164.69 Aligned_cols=136 Identities=21% Similarity=0.248 Sum_probs=108.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHH------HHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE------SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~------~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.||+|++|.||+|.+ +|..|+||+......... ....+.+|+.++..+.|++|+....++.. ....++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEE
Confidence 3499999999999987 667799998664332111 12457899999999999998776666544 4567899
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
|||++|..+..+.... .. ....++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSN---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhc---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999987665554432 22 7889999999999999999999999999999998 88999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.4e-17 Score=163.06 Aligned_cols=138 Identities=23% Similarity=0.194 Sum_probs=105.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHH--------------------HHHHHHHHHHHHHhcCCCc-
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE--------------------SVRFMAREIHILRRLDHIN- 201 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~--------------------~~~~~~~Ei~iL~~L~Hpn- 201 (720)
+.+.+.||+|+||.||++.+. +|+.||||+++....... ......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 445556999999999999874 799999999875431100 1123578999999998874
Q ss_pred -eeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc
Q 004999 202 -VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 280 (720)
Q Consensus 202 -Ivkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~ 280 (720)
++.+++ .+..++||||++|..+..+.. ......++.+|+.+|.++|..||+|+||||+||+|+.++.
T Consensus 96 ~v~~~~~------~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPID------WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceee------cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 333332 234589999999866544322 1346788899999999999999999999999999999999
Q ss_pred eeeeccccceecC
Q 004999 281 LKIADFGLASFYD 293 (720)
Q Consensus 281 vKL~DFGla~~~~ 293 (720)
++|+|||++....
T Consensus 164 ~~liDfg~~~~~~ 176 (198)
T cd05144 164 IYIIDWPQMVSTD 176 (198)
T ss_pred EEEEECCccccCC
Confidence 9999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.5e-17 Score=192.90 Aligned_cols=190 Identities=23% Similarity=0.261 Sum_probs=145.4
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC---CCceeeeccceeccCCCeEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIvkl~~~~~~~~~~~ly 218 (720)
-+.|.+.||+|+||.||+|.+.. |+.||||+-+..+...-+ =-..++.+|+ -+.|..+..++.. .+.-+
T Consensus 699 ~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY-----I~~q~~~RLk~~~~~~~~~~~~a~~~--~~~S~ 770 (974)
T KOG1166|consen 699 KFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY-----ICLQVMERLKPQMLPSIMHISSAHVF--QNASV 770 (974)
T ss_pred eEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeee-----ehHHHHHhhchhhhcchHHHHHHHcc--CCcce
Confidence 34556679999999999999877 999999998876532211 1123334443 2344555554444 34468
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc-------CCCceeeeccccce
Q 004999 219 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-------NNGILKIADFGLAS 290 (720)
Q Consensus 219 LV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld-------~~g~vKL~DFGla~ 290 (720)
||+||.+. .|++++. ....++|..+..+..|++..|++||..+|||+||||+|+||. ..-.++|+|||.+.
T Consensus 771 lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999995 4555544 666899999999999999999999999999999999999994 23469999999986
Q ss_pred ecCC-CCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC
Q 004999 291 FYDP-DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 341 (720)
Q Consensus 291 ~~~~-~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ 341 (720)
-+.. .........+.|-.+-.+|...|.. |+..+|.|.|+.|++-||.|+
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence 5422 1223456667899999999988876 899999999999999999997
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-16 Score=159.63 Aligned_cols=132 Identities=20% Similarity=0.249 Sum_probs=101.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCC-H-----HHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-P-----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~-----~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+||+|+||.||+|.. ++..|++|+....... . .....+.+|+.++..+.|++|.....++.. ....++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 389999999999985 5678999986543221 1 123567899999999998876544433333 34568999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
||++|..+..+..... ..++.||+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 77 e~~~g~~l~~~~~~~~-------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGN-------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcH-------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999866554433221 17899999999999999999999999999998 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-16 Score=154.58 Aligned_cols=136 Identities=25% Similarity=0.233 Sum_probs=98.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHH----------------------HHHHHHHHHhcCCCc--e
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF----------------------MAREIHILRRLDHIN--V 202 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~----------------------~~~Ei~iL~~L~Hpn--I 202 (720)
+.||+|+||.||+|.+. +++.||||+++........... ...|...+.++.+.. +
T Consensus 3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35999999999999986 7899999998764332111111 135666666665433 3
Q ss_pred eeeccceeccCCCeEEEEEeeccccccc-cccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCc
Q 004999 203 IKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGI 280 (720)
Q Consensus 203 vkl~~~~~~~~~~~lyLV~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~ 280 (720)
.+++++ ...+|||||++|+.+. ...... ... .++..++.+++.++.++|. .||+|+||||+||+|+ ++.
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 333332 2358999999984321 111111 111 6788999999999999999 9999999999999999 999
Q ss_pred eeeeccccceec
Q 004999 281 LKIADFGLASFY 292 (720)
Q Consensus 281 vKL~DFGla~~~ 292 (720)
++|+|||++...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.7e-16 Score=173.48 Aligned_cols=206 Identities=27% Similarity=0.397 Sum_probs=153.4
Q ss_pred HHhcCCCceeeeccceeccCCCeEEEEEeecc-ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCc-ccccCcce
Q 004999 194 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV-LHRDIKGS 271 (720)
Q Consensus 194 L~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~-g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gI-vHrDIKP~ 271 (720)
|+.+.|.|+.+++|.+.+ ...+++|.+||. |.+.+.+......+++-....++++|+.||.|||.--| .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~--~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD--GPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEec--CCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 457899999999999988 578999999998 55556666667788999999999999999999998865 99999999
Q ss_pred eEEEcCCCceeeeccccceecCCC-CCCCccccccccCCCChhhhcCCcC------CCccccchhhHHHHHHHHhCCCCC
Q 004999 272 NLLIDNNGILKIADFGLASFYDPD-QNQPLTSRVVTLWYRPPELLLGATY------YGTAVDLWSTGCILAELYAGKPIM 344 (720)
Q Consensus 272 NILld~~g~vKL~DFGla~~~~~~-~~~~~t~~~gT~~Y~APE~l~~~~~------y~~~sDIWSLG~iL~ELltG~ppf 344 (720)
|.+++....+||+|||+....... .........-..-|.|||++.+... .+.+.||||||+|++|+++...||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999998876320 1111111223456999999976421 367899999999999999999998
Q ss_pred CCCChH----HHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHH
Q 004999 345 PGRTEV----EQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420 (720)
Q Consensus 345 ~g~~~~----e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e 420 (720)
...... +.+..+.+ .+.+ .+.|. +.. ...+++++..++..||..+|.+||++++
T Consensus 159 ~~~~~~~~~~eii~~~~~-~~~~--------------~~rP~------i~~-~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK-GGSN--------------PFRPS------IEL-LNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred ccccccCChHHHHHHHHh-cCCC--------------CcCcc------hhh-hhhcchHHHHHHHHhcccChhhCccHHH
Confidence 763322 23333322 1110 01111 111 1145668999999999999999999988
Q ss_pred HHh
Q 004999 421 ALR 423 (720)
Q Consensus 421 ~L~ 423 (720)
+-.
T Consensus 217 i~~ 219 (484)
T KOG1023|consen 217 IRS 219 (484)
T ss_pred HHh
Confidence 764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-15 Score=176.04 Aligned_cols=136 Identities=17% Similarity=0.191 Sum_probs=104.3
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-C-----HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-E-----PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~-----~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~l 217 (720)
...+.||+|+||.||++.+.... +++|+...... . ......+.+|+.+++.++|++|+..+.++.. ....
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~ 411 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEK 411 (535)
T ss_pred CccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCC
Confidence 33456999999999999875443 44444322111 1 1223568899999999999999887665554 3457
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
++||||++|..+..+.. ....++.||+.+|.+||+.||+||||||+|||| .++.++|+|||++...
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 89999999866544332 457899999999999999999999999999999 6789999999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-15 Score=169.85 Aligned_cols=248 Identities=21% Similarity=0.243 Sum_probs=196.4
Q ss_pred eecc--cCceEEEEEEE--CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEe
Q 004999 148 LIGQ--GTYSNVYRARD--LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~--G~~g~Vy~a~~--~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
-+|. |.+|.||.+.. ..++..+|+|.-+.....+..-..=++|+...+.++ |+|.++.+..+.. .+.+|+-+|
T Consensus 121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~lfiqtE 198 (524)
T KOG0601|consen 121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGILFIQTE 198 (524)
T ss_pred ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CCcceeeec
Confidence 4999 99999999998 888999999985443322222223357777777774 9999998888877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhh----ccccccccCcccccCcceeEEEcCC-CceeeeccccceecCCCCC
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLC----GLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYDPDQN 297 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~----gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~DFGla~~~~~~~~ 297 (720)
+|...+..........+++..++.++.+... ||.++|+.+|+|-|+||.||++..+ ...+++|||+...+.....
T Consensus 199 ~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~ 278 (524)
T KOG0601|consen 199 LCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNF 278 (524)
T ss_pred cccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCcc
Confidence 9998888888888878999999999999999 9999999999999999999999999 8899999999987754432
Q ss_pred CC----ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhcCCCChhhhhhc
Q 004999 298 QP----LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR--TEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 298 ~~----~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~--~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
.. .....+...|++||++.+. ++...|||+||.++.+..++..++... ..+.++..++
T Consensus 279 ~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-------------- 342 (524)
T KOG0601|consen 279 SSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-------------- 342 (524)
T ss_pred ccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--------------
Confidence 11 1111457779999998775 689999999999999999988666544 3333332221
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.-.+++...+..+...+..|+..+|..|+++..++.|.++..
T Consensus 343 ----------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 343 ----------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ----------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 112344456666777999999999999999999999999873
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.8e-15 Score=152.66 Aligned_cols=137 Identities=18% Similarity=0.184 Sum_probs=102.4
Q ss_pred eec-ccCceEEEEEEECCCCeEEEEEEeecCCC-----------CHHHHHHHHHHHHHHHhcCCCce--eeeccceeccC
Q 004999 148 LIG-QGTYSNVYRARDLDQKKIVALKKVRFDNL-----------EPESVRFMAREIHILRRLDHINV--IKLEGLVTSRM 213 (720)
Q Consensus 148 ~LG-~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-----------~~~~~~~~~~Ei~iL~~L~HpnI--vkl~~~~~~~~ 213 (720)
+|| .|+.|+||.+... +..++||.+..... .......+.+|+.++.+|.|++| +..+++.....
T Consensus 38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 588 8999999999863 67799998854221 11233567899999999998875 66666543321
Q ss_pred CC--eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 214 SC--SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 214 ~~--~lyLV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
.. ..+|||||++| ..+..+... ..+++.. +.||+.+|.+||++||+|+||||.||||+.++.++|+|||.+.
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~ 190 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGE 190 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcc
Confidence 21 23599999997 444444333 2455543 5789999999999999999999999999999999999999887
Q ss_pred e
Q 004999 291 F 291 (720)
Q Consensus 291 ~ 291 (720)
.
T Consensus 191 ~ 191 (239)
T PRK01723 191 L 191 (239)
T ss_pred c
Confidence 5
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-14 Score=135.83 Aligned_cols=131 Identities=27% Similarity=0.275 Sum_probs=108.1
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC--CceeeeccceeccCCCeEEEEEee
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.||.|.++.||++.+.. ..++||.+..... ...+.+|+.+++.+.| .++++++.+... .+..|++|||
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~ 74 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEW 74 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEe
Confidence 3459999999999999744 6799999865432 3567899999999976 588888877654 4678999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhcccccccc---CcccccCcceeEEEcCCCceeeecccccee
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR---GVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~---gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
+.|..+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++|+|||++..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998655433 5667788899999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.5e-14 Score=165.73 Aligned_cols=255 Identities=23% Similarity=0.238 Sum_probs=186.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+-.|+++.++.+.-..+|...++|+..... +.....+.+..+-.++-...+|-++...--+.. ...++||++|++++
T Consensus 812 ~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~--rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 812 SQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC--RSPLPLVGHYLNGG 889 (1205)
T ss_pred ccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC--CCCcchhhHHhccC
Confidence 888999999999888888777777765432 122223333444444434456666655433222 45689999999875
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCC------C------
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP------D------ 295 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~------~------ 295 (720)
-+.-.++.-+..+++-++.++..+..+++|||...++|+|++|.|+|+..+|..+++|||+...... .
T Consensus 890 ~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~ 969 (1205)
T KOG0606|consen 890 DLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSS 969 (1205)
T ss_pred CchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCccccccc
Confidence 5554444445678888899999999999999999999999999999999999999999984432210 0
Q ss_pred ------------------CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 004999 296 ------------------QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357 (720)
Q Consensus 296 ------------------~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~ 357 (720)
........++|+.|.+||.+++... +..+|+|++|++++|.++|.++|...+.......|.
T Consensus 970 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~ 1048 (1205)
T KOG0606|consen 970 GTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENIL 1048 (1205)
T ss_pred CccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccc
Confidence 0001223467999999999999875 889999999999999999999998877655544443
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHH---HHHhCccCCCCCC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA---SALRSEFFTMKPL 432 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~---e~L~hp~f~~~~~ 432 (720)
..- .+ +..-....+..+.+++..+|..+|.+|..+. ++-.|+||+...+
T Consensus 1049 ~~~----------------------~~----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1049 NRD----------------------IP----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred cCC----------------------CC----CCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 210 00 2223345678899999999999999999887 8899999987654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.4e-13 Score=151.23 Aligned_cols=139 Identities=20% Similarity=0.265 Sum_probs=95.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC---------------------------CH-----HHHHH------HHH
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---------------------------EP-----ESVRF------MAR 189 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~---------------------------~~-----~~~~~------~~~ 189 (720)
-||.|++|.||+|+.+.+|+.||||+++.... +. +..+. +.+
T Consensus 126 PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~ 205 (537)
T PRK04750 126 PLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMR 205 (537)
T ss_pred hhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHH
Confidence 39999999999999988899999999985421 00 11122 334
Q ss_pred HHHHHHhcC----CCceeeeccceeccCCCeEEEEEeeccccccccc---cCCCC---CCCHHHHHHHHHhhhhcccccc
Q 004999 190 EIHILRRLD----HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLA---SHPGL---KFSEAQVKCYMQQLLCGLDHCH 259 (720)
Q Consensus 190 Ei~iL~~L~----HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~---~~~~~---~lse~~~~~i~~QIl~gL~yLH 259 (720)
|+..+.++. +.+.+.+-.++.+- ....+||||||+|..+..+ ...+. .+.+..+..++.||+
T Consensus 206 Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif------- 277 (537)
T PRK04750 206 EAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF------- 277 (537)
T ss_pred HHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 444444442 33333333333221 3456899999998655432 11221 356666777777776
Q ss_pred ccCcccccCcceeEEEcCCC----ceeeeccccceecCC
Q 004999 260 SRGVLHRDIKGSNLLIDNNG----ILKIADFGLASFYDP 294 (720)
Q Consensus 260 ~~gIvHrDIKP~NILld~~g----~vKL~DFGla~~~~~ 294 (720)
..|++|+|+||.||+|+.+| .++++|||++..+..
T Consensus 278 ~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 48999999999999999988 999999999987643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.5e-12 Score=127.98 Aligned_cols=138 Identities=19% Similarity=0.218 Sum_probs=100.4
Q ss_pred eecccCceEEEEEEECC------CCeEEEEEEeecCCC-----------C---------HHHHHHH----HHHHHHHHhc
Q 004999 148 LIGQGTYSNVYRARDLD------QKKIVALKKVRFDNL-----------E---------PESVRFM----AREIHILRRL 197 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~------tg~~VAIK~l~~~~~-----------~---------~~~~~~~----~~Ei~iL~~L 197 (720)
+||.|--+.||.|.... .+..+|||+.+.... + ......+ .+|+..|.+|
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 49999999999998653 357899999863211 0 0112222 3899999999
Q ss_pred C--CCceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccc-cccCcccccCcceeEE
Q 004999 198 D--HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC-HSRGVLHRDIKGSNLL 274 (720)
Q Consensus 198 ~--HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yL-H~~gIvHrDIKP~NIL 274 (720)
. .-++.+++++ ..-+|||||++++.+....-....+++.++..++.+++.+|..| |..||||+||++.|||
T Consensus 84 ~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 84 QKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 5 3456666653 22489999998753322111223456677888899999999998 8999999999999999
Q ss_pred EcCCCceeeeccccceec
Q 004999 275 IDNNGILKIADFGLASFY 292 (720)
Q Consensus 275 ld~~g~vKL~DFGla~~~ 292 (720)
+. ++.+.|+|||.+...
T Consensus 158 ~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred EE-CCcEEEEECCCceeC
Confidence 96 578999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.3e-12 Score=143.78 Aligned_cols=141 Identities=20% Similarity=0.220 Sum_probs=94.6
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCH----------------------------HHH----H------HHHH
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----------------------------ESV----R------FMAR 189 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----------------------------~~~----~------~~~~ 189 (720)
-||.|++|.||+|+.. +|+.||||+.+...... ..+ . .+.+
T Consensus 124 plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 124 PLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred ceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 4999999999999864 68999999987542100 000 0 1445
Q ss_pred HHHHHHhcC----CCceeeeccceeccCCCeEEEEEeeccccccccccCC-CCCCCHHHHHHHHHhhhh-ccccccccCc
Q 004999 190 EIHILRRLD----HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLC-GLDHCHSRGV 263 (720)
Q Consensus 190 Ei~iL~~L~----HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~-gL~yLH~~gI 263 (720)
|+..+.++. |.+-+.+-.++... ....+|||||++|..+..+... ...+ ....++.+++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 666666652 22223333333221 3346899999998665543321 1112 23345555555 4678899999
Q ss_pred ccccCcceeEEEcCCCceeeeccccceecC
Q 004999 264 LHRDIKGSNLLIDNNGILKIADFGLASFYD 293 (720)
Q Consensus 264 vHrDIKP~NILld~~g~vKL~DFGla~~~~ 293 (720)
+|+|++|.||+++.+|.++|+|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.5e-13 Score=148.16 Aligned_cols=243 Identities=21% Similarity=0.193 Sum_probs=178.0
Q ss_pred eecccCceEEEEEEEC-CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~-~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||.|.|+.|+.+... .++..|++|.+.........-.+-..|+-+...+ .|.+++.++..|.. ....||-.|||+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cccccCchhhhc
Confidence 3999999999998755 7788899998876544333333345677777777 58999988776665 455789999998
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-CceeeeccccceecCCCCCCCccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+....+...--..+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||++..+... .....
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~----~~~~~ 425 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS----SGVFH 425 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee----ccccc
Confidence 86665554444467889999999999999999999999999999999999886 78899999998643211 11222
Q ss_pred cccCCC-ChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYR-PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~-APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
.+-++. ..|++.....+..+.|++|||..+.+.+++.++-........ |..
T Consensus 426 ~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~~------------------------- 477 (524)
T KOG0601|consen 426 HIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IRS------------------------- 477 (524)
T ss_pred ccccccccchhhccccccccccccccccccccccccCcccCccccccee---eec-------------------------
Confidence 344455 366666666689999999999999999999865433222111 110
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
............+..+...|+..++..|+.+.++..|.-|.
T Consensus 478 ----~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 478 ----GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00111223346678889999999999999999998887664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-11 Score=139.29 Aligned_cols=169 Identities=20% Similarity=0.294 Sum_probs=128.0
Q ss_pred EEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccccccccCCCCC
Q 004999 159 RARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK 238 (720)
Q Consensus 159 ~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~ 238 (720)
.|..+.++.+|.|.+++.... .......+.+.-|+.|+||||+++++.+.. +..+|||+|-+.-- ..... .
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~Pl--~~~lk---~ 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVRPL--ETVLK---E 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccccH--HHHHH---H
Confidence 466678899999999887654 445667888999999999999999998876 67899999998731 11111 1
Q ss_pred CCHHHHHHHHHhhhhcccccc-ccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcC
Q 004999 239 FSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 317 (720)
Q Consensus 239 lse~~~~~i~~QIl~gL~yLH-~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~ 317 (720)
+....+..-+.||+.||.||| ..+++|+.|.-..|+|+..|..||++|.++........ ......---.|..|+.+..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence 236778888999999999997 56899999999999999999999999999875432211 1111112233677775533
Q ss_pred CcCCCccccchhhHHHHHHHHhC
Q 004999 318 ATYYGTAVDLWSTGCILAELYAG 340 (720)
Q Consensus 318 ~~~y~~~sDIWSLG~iL~ELltG 340 (720)
. +-..|.|.|||+++|++.|
T Consensus 180 s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 S---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c---ccchhhhhHHHHHHHHhCc
Confidence 2 2467999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=9.7e-12 Score=120.77 Aligned_cols=126 Identities=17% Similarity=0.136 Sum_probs=93.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.|+.|.++.||++... +..|+||+...... ....+.+|+.+++.+.+.++ .+++.+. ....++||||++|
T Consensus 5 ~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~----~~~~~lv~e~i~G 75 (170)
T cd05151 5 PLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD----PETGVLITEFIEG 75 (170)
T ss_pred ecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe----CCCCeEEEEecCC
Confidence 3899999999999864 77899998764421 11235689999999865554 3444432 2234899999999
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCc-----ccccCcceeEEEcCCCceeeecccccee
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV-----LHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gI-----vHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
..+... ......++.+|+.+|..||..++ +|+|++|.|||++ ++.++|+|||.+..
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 655432 11123457889999999999985 9999999999998 67899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.6e-12 Score=133.93 Aligned_cols=240 Identities=19% Similarity=0.195 Sum_probs=153.7
Q ss_pred EEEEEEECCCCeEEEEEEeecCCC-CHH-HHHHHHHHHHHHHhcCCCceeeeccceeccC---CCeEEEEEeeccccccc
Q 004999 156 NVYRARDLDQKKIVALKKVRFDNL-EPE-SVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLYLVFEYMEHDLAG 230 (720)
Q Consensus 156 ~Vy~a~~~~tg~~VAIK~l~~~~~-~~~-~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~---~~~lyLV~Ey~~g~ll~ 230 (720)
.||++.+...|..|+.-.+.+... +.. ....+..-...|-.+.|-|||+++.||.+.. .....++.|||..+.+.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 577887777777666544433211 100 0011111233445667999999999987632 24578899999965443
Q ss_pred ccc----CCCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCCCceeeeccccceecCCCCC----CCc
Q 004999 231 LAS----HPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN----QPL 300 (720)
Q Consensus 231 ~~~----~~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~----~~~ 300 (720)
..+ ..+..+.....++|+.||+.||.|||+.. |+|+.+....|++..+|-+||+----.... .... ...
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h-~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-PSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccc-hhhhhhhHhhh
Confidence 333 24556888899999999999999999985 999999999999999999987532111110 0000 011
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCC-CCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI-MPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~pp-f~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+-++|.+||.=.... .+.++|||+||....||..+..- -.+.+..+.-..|....
T Consensus 240 ~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i------------------- 299 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTN-TTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI------------------- 299 (458)
T ss_pred hccccCCccccCCcCcccc-cccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence 1123467899999654433 47789999999999999887732 22222222111111100
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
+..-..--+++|.+||+-.|..||++.++|.||.+-.
T Consensus 300 -------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 300 -------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred -------------eeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 0000112346789999999999999999999998653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.3e-10 Score=112.96 Aligned_cols=142 Identities=20% Similarity=0.237 Sum_probs=104.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC--CceeeeccceeccC-CCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRM-SCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIvkl~~~~~~~~-~~~lyLV~Ey 223 (720)
+.|+.|.++.||++.... |..+++|+....... .....+.+|+.+++.+.+ .++.+++.+..... .+..|+||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 349999999999998643 678999997654321 134457899999999975 34566666544311 1356899999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-------------------------------------------
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS------------------------------------------- 260 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~------------------------------------------- 260 (720)
++|..+...... ..+++.+...++.+++..|..||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999766554322 356777778888888888887773
Q ss_pred -------------cCcccccCcceeEEEcC--CCceeeecccccee
Q 004999 261 -------------RGVLHRDIKGSNLLIDN--NGILKIADFGLASF 291 (720)
Q Consensus 261 -------------~gIvHrDIKP~NILld~--~g~vKL~DFGla~~ 291 (720)
..++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 67789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.3e-10 Score=109.04 Aligned_cols=142 Identities=18% Similarity=0.237 Sum_probs=97.5
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeec-----CCCCH-HHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRF-----DNLEP-ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~-----~~~~~-~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
+.+|-+|+-+.|+++.+ .|+...||.-.. ..++. -...+..+|+++|.++.--.|.-..=++.+ ...-.|
T Consensus 12 l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D--~~~~~i 87 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID--TYGGQI 87 (229)
T ss_pred ceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe--cCCCeE
Confidence 45699999999999987 677777775322 11222 234568899999999864343222223333 233468
Q ss_pred EEeeccc--cccccccCCCCCCCHHH-HHHHHHhhhhccccccccCcccccCcceeEEEcCCC---ceeeecccccee
Q 004999 220 VFEYMEH--DLAGLASHPGLKFSEAQ-VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASF 291 (720)
Q Consensus 220 V~Ey~~g--~ll~~~~~~~~~lse~~-~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g---~vKL~DFGla~~ 291 (720)
+|||++| .+.+.+......-.+.+ ...++.+|-+.|.-||.++|+|+||..+||+|..+| .+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 8999998 44333333222223333 378889999999999999999999999999997765 358999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.2e-09 Score=117.11 Aligned_cols=217 Identities=23% Similarity=0.279 Sum_probs=156.5
Q ss_pred ceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc--CCCeEEEEEeeccc--ccc
Q 004999 154 YSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSLYLVFEYMEH--DLA 229 (720)
Q Consensus 154 ~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~--~~~~lyLV~Ey~~g--~ll 229 (720)
-.+.|++....+|..|++|.+..+.. ........-+++++++.|+|||++.++|... ....++||++|.++ .|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 45789999999999999999954332 1111223457788999999999999987632 24578999999985 333
Q ss_pred ccccC--------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 230 GLASH--------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 230 ~~~~~--------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
+++.. .+.+.+|..+|.|+.||..||.++|+.|+..+-|.+.+||++.+.+++|...|....+..+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 32221 3446789999999999999999999999999999999999999989999888877665443
Q ss_pred CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-hHHH-HHHHHHhcCCCChhhhhhcCC
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-EVEQ-LHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~-~~e~-l~~i~~~~g~p~~~~w~~~~l 373 (720)
.. |.+.+ -.+-|.=.||.+++.|.||..--...+ .... +..|
T Consensus 447 ~~---------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I----------------- 490 (655)
T KOG3741|consen 447 PT---------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI----------------- 490 (655)
T ss_pred CC---------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-----------------
Confidence 21 12222 235788899999999999964211111 1111 2222
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC---ccCC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS---EFFT 428 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h---p~f~ 428 (720)
-..++.+++++|.-+...++++ -++.++|.+ -||.
T Consensus 491 -------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~ 528 (655)
T KOG3741|consen 491 -------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFT 528 (655)
T ss_pred -------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHH
Confidence 2356778899999999999987 678888765 4554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.5e-10 Score=131.45 Aligned_cols=160 Identities=24% Similarity=0.336 Sum_probs=119.6
Q ss_pred HHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc--------ccccccCCCChhhhcCC
Q 004999 248 MQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT--------SRVVTLWYRPPELLLGA 318 (720)
Q Consensus 248 ~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t--------~~~gT~~Y~APE~l~~~ 318 (720)
+.+++.||.|+|.. ++||+.|.|++|.++.+|.+||+.|+++.........+.. ...-...|.|||++.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34455999999966 8999999999999999999999999998765432111111 11226779999999885
Q ss_pred cCCCccccchhhHHHHHHHH-hCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCC
Q 004999 319 TYYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFP 397 (720)
Q Consensus 319 ~~y~~~sDIWSLG~iL~ELl-tG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~ 397 (720)
. .+.++|+|||||++|.+. .|++++.+.........-....+.. ....-..+|
T Consensus 185 ~-~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p 238 (700)
T KOG2137|consen 185 T-NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLP 238 (700)
T ss_pred c-ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCc
Confidence 5 699999999999999999 6778877665444333322211111 001115789
Q ss_pred HhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 398 APALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 398 ~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.++++=|.++|..++..||++.+++..+||.+...+
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~ 274 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK 274 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence 999999999999999999999999999999875443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.4e-10 Score=107.76 Aligned_cols=132 Identities=23% Similarity=0.271 Sum_probs=91.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEe-ecCCCCHH-----HHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKV-RFDNLEPE-----SVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l-~~~~~~~~-----~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
++++|+-+.+|.+.+. |..+++|.= ++....++ ...+..+|+.++.++.--.|...+=+..+ .....|+|
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~m 78 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLIVM 78 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEEE
Confidence 4889999999999763 334566542 22221222 23457899999999864444322222223 34467999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
||++|.++....... ...++..|-.-+.-||..||+|+||.++||++..++ +.++||||+.+
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999998877544433 245566666667779999999999999999996554 99999999974
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.8e-09 Score=106.48 Aligned_cols=127 Identities=25% Similarity=0.281 Sum_probs=82.9
Q ss_pred EEEEEEECCCCeEEEEEEeecCCCC------------------------HHHHHHHHHHHHHHHhcCCC--ceeeeccce
Q 004999 156 NVYRARDLDQKKIVALKKVRFDNLE------------------------PESVRFMAREIHILRRLDHI--NVIKLEGLV 209 (720)
Q Consensus 156 ~Vy~a~~~~tg~~VAIK~l~~~~~~------------------------~~~~~~~~~Ei~iL~~L~Hp--nIvkl~~~~ 209 (720)
.||.|.. ..|..+|||+.+..... ........+|..+|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 55778999998642110 01123467899999999765 566666442
Q ss_pred eccCCCeEEEEEeecc--ccccccccCCCCCCCHHHHHHHHHhhhhcccc-ccccCcccccCcceeEEEcCCCceeeecc
Q 004999 210 TSRMSCSLYLVFEYME--HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH-CHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 210 ~~~~~~~lyLV~Ey~~--g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~y-LH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+||
T Consensus 80 ------~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ------RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ------TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ------CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 1379999999 65554433321 2245567788888885555 679999999999999999877 8999999
Q ss_pred ccceec
Q 004999 287 GLASFY 292 (720)
Q Consensus 287 Gla~~~ 292 (720)
|.+...
T Consensus 151 ~qav~~ 156 (188)
T PF01163_consen 151 GQAVDS 156 (188)
T ss_dssp TTEEET
T ss_pred Ccceec
Confidence 988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=5e-08 Score=102.97 Aligned_cols=140 Identities=15% Similarity=0.084 Sum_probs=94.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHH----------HHHHHHHHHHhcCCCce--eeeccceeccC---
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR----------FMAREIHILRRLDHINV--IKLEGLVTSRM--- 213 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~----------~~~~Ei~iL~~L~HpnI--vkl~~~~~~~~--- 213 (720)
+-.-....|+++.. .|+.|.||........ ...+ .+.+|...+.+|..-+| +.++.+.....
T Consensus 30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EecCCCceEEEEEE--CCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33333344666644 5778999976433211 1111 36789999988843333 33344443221
Q ss_pred CCeEEEEEeecccc-ccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-------CCceee
Q 004999 214 SCSLYLVFEYMEHD-LAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-------NGILKI 283 (720)
Q Consensus 214 ~~~lyLV~Ey~~g~-ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-------~g~vKL 283 (720)
...-|||||++++. .+..+... ....+......++.+|+..+.-||..||+|+|+++.||||+. ++.+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23468999999984 33333221 234567788899999999999999999999999999999975 468999
Q ss_pred ecccccee
Q 004999 284 ADFGLASF 291 (720)
Q Consensus 284 ~DFGla~~ 291 (720)
+||+.+..
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998853
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.2e-08 Score=100.30 Aligned_cols=131 Identities=26% Similarity=0.275 Sum_probs=97.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC------------------C--HHHHHHHHHHHHHHHhcCCC--ceeee
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL------------------E--PESVRFMAREIHILRRLDHI--NVIKL 205 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~------------------~--~~~~~~~~~Ei~iL~~L~Hp--nIvkl 205 (720)
.||-|--+.||.|.+. .|..+|||.-+.... + ........+|..+|.+|.-. .|.+.
T Consensus 98 ~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P 176 (304)
T COG0478 98 KIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKP 176 (304)
T ss_pred ccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCc
Confidence 5999999999999975 688899997653211 1 11223457899999999654 77777
Q ss_pred ccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeec
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 285 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~D 285 (720)
+++ +.-.+||||++|-.+..+. ++...+..++..|+.-+..+-..||||+|+.+-||||+.||.+.|+|
T Consensus 177 ~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vID 245 (304)
T COG0478 177 IAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVID 245 (304)
T ss_pred ccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEe
Confidence 654 3357999999996555433 13444555666666666666689999999999999999999999999
Q ss_pred cccce
Q 004999 286 FGLAS 290 (720)
Q Consensus 286 FGla~ 290 (720)
|--+.
T Consensus 246 wPQ~v 250 (304)
T COG0478 246 WPQAV 250 (304)
T ss_pred Ccccc
Confidence 97554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.2e-08 Score=109.97 Aligned_cols=242 Identities=17% Similarity=0.128 Sum_probs=164.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc-eeeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN-VIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Ivkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+++|+++.++|.+...+...+ .+++... ....-++++|.+++||| .+..++-+. .+...+++|+++.++
T Consensus 250 fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~--~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYD--GEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCC--cccccchhhhhhcCC
Confidence 889999999999987776655 6766543 22345789999999999 444444332 366789999999875
Q ss_pred --ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 228 --LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 --ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
...........|.+-+...+++.-.++|++||+.--+|+| |||.. ++..|..||+...-+.... ......+
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~--~~~t~~~ 392 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTM--KPRTAIG 392 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccc--ccccCCC
Confidence 2222222233455566667777788999999998888999 88764 4789999999887664332 3345678
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.++|||+..... +....|.|++|.-..+|.-|-+|-..- ..... ..|..+ .. +....
T Consensus 393 ~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~----~~g~~p----------~s----~~L~~ 451 (829)
T KOG0576|consen 393 TPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLP----MIGNGP----------NS----PMLTD 451 (829)
T ss_pred CCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCC--ccccC----CCCCCC----------Cc----cccch
Confidence 99999999998877 689999999998777777777664330 00000 000000 00 00000
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
+..+...+. .++...|+...|..+++...++.|.+|...|+-.
T Consensus 452 ~~aw~~~~~------~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i 494 (829)
T KOG0576|consen 452 KSAWSPVFH------RDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRI 494 (829)
T ss_pred hhhcCcccc------cCCcccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence 011111111 1467799999999999999999999999876643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.3e-07 Score=94.21 Aligned_cols=107 Identities=20% Similarity=0.213 Sum_probs=80.4
Q ss_pred HHHHHHHHHHHhcCCCc--eeeeccceeccCC--CeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhcccccc
Q 004999 185 RFMAREIHILRRLDHIN--VIKLEGLVTSRMS--CSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259 (720)
Q Consensus 185 ~~~~~Ei~iL~~L~Hpn--Ivkl~~~~~~~~~--~~lyLV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH 259 (720)
....+|...+.+|..-. +++.+++...... ...|||+|++++. .+..+......++......++.+|+..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 35678888888875333 3445555443222 2458999999973 34444433223677888999999999999999
Q ss_pred ccCcccccCcceeEEEcCCC---ceeeecccccee
Q 004999 260 SRGVLHRDIKGSNLLIDNNG---ILKIADFGLASF 291 (720)
Q Consensus 260 ~~gIvHrDIKP~NILld~~g---~vKL~DFGla~~ 291 (720)
.+||+|+|+++.||||+.++ .+.|+||+.+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=8.4e-07 Score=91.15 Aligned_cols=137 Identities=20% Similarity=0.249 Sum_probs=95.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHH--------------------H--HHHHHHHHHHHhcC--CCcee
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES--------------------V--RFMAREIHILRRLD--HINVI 203 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~--------------------~--~~~~~Ei~iL~~L~--HpnIv 203 (720)
+|..|--+.||+|.. .++..||+|+++.....-.. + .....|...|+++. +=.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 478888889999985 56888999998754221110 0 11346777777774 44445
Q ss_pred eeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCcee
Q 004999 204 KLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILK 282 (720)
Q Consensus 204 kl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vK 282 (720)
+.+.+.. -.|||||++.+..-.-.-....+...++..+..+++..+.-|-. .++||+||..-|||+. ++.+.
T Consensus 134 ~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 134 EPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 5554432 37999999865211111122233444788888999999888877 8999999999999998 88999
Q ss_pred eeccccceec
Q 004999 283 IADFGLASFY 292 (720)
Q Consensus 283 L~DFGla~~~ 292 (720)
|+|||-|...
T Consensus 207 iID~~QaV~~ 216 (268)
T COG1718 207 IIDVSQAVTI 216 (268)
T ss_pred EEECcccccc
Confidence 9999988754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.4e-06 Score=92.67 Aligned_cols=247 Identities=15% Similarity=0.139 Sum_probs=152.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeecc-----ceeccCCCeEEEEEe
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEG-----LVTSRMSCSLYLVFE 222 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~-----~~~~~~~~~lyLV~E 222 (720)
||+|+-+.+|-.-... . .+.|++...--... ..-+..|... .||-+-.=+. .+-.+....+-++|.
T Consensus 19 LgqGgea~ly~l~e~~--d-~VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 19 LGQGGEADLYTLGEVR--D-QVAKIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred ccCCccceeeecchhh--c-hhheeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 9999999999774322 2 24477764321111 1222333333 4665433111 111111233678888
Q ss_pred ecccc--cccccc-----CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 223 YMEHD--LAGLAS-----HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 223 y~~g~--ll~~~~-----~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
.+.|. ...++. ..-..+.+..+.++++.|+.+...||..|.+-+|+.++|+||.+++.|.|.|=..-.+..
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~-- 168 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA-- 168 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc--
Confidence 88763 222111 122457889999999999999999999999999999999999999999999866555432
Q ss_pred CCCCccccccccCCCChhhhc-----CCcCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 296 QNQPLTSRVVTLWYRPPELLL-----GATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~-----~~~~y~~~sDIWSLG~iL~ELltG-~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
........+|...|.+||+-. +.. -+...|.|.||+++|+||.| +.||.|..... -.+.|-+....
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap~p~E~~Ia 240 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAPNPLETDIA 240 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCCCcchhhhh
Confidence 233345668899999999753 222 36789999999999999886 89998753210 00111110100
Q ss_pred h------cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhccc--CCCCCCCHHH
Q 004999 370 K------SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSI--DPADRGSAAS 420 (720)
Q Consensus 370 ~------~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~--DP~kRpTa~e 420 (720)
. .+........| ..-.+.-+++++..|..+|+.. ++.-|||++.
T Consensus 241 ~g~f~ya~~~~~g~~p~P-------~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 241 HGRFAYASDQRRGLKPPP-------RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cceeeechhccCCCCCCC-------CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0 00000011111 1112345788899999999874 4678999753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=9.8e-07 Score=100.78 Aligned_cols=137 Identities=24% Similarity=0.279 Sum_probs=88.1
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCC---------------------------H-HHHH----------HHHH
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---------------------------P-ESVR----------FMAR 189 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~---------------------------~-~~~~----------~~~~ 189 (720)
-|+.++-|.||+|+... |+.||||+.++.-.. . +.++ .+.+
T Consensus 132 PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 132 PIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred chhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 49999999999999754 999999998754210 0 0000 1445
Q ss_pred HHHHHHhcC-----CCceeeeccceeccCCCeEEEEEeecccccccccc-CCCCCCC-----HHHHHHHHHhhhhccccc
Q 004999 190 EIHILRRLD-----HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAS-HPGLKFS-----EAQVKCYMQQLLCGLDHC 258 (720)
Q Consensus 190 Ei~iL~~L~-----HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~-~~~~~ls-----e~~~~~i~~QIl~gL~yL 258 (720)
|...+.++. .++| ++-.+|.+- .+.-.|+|||++|--+..+. .....++ +.-+..++.|++
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------ 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-Eeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH------
Confidence 666666652 3433 222222221 34468999999994333321 1112333 333444444443
Q ss_pred cccCcccccCcceeEEEcCCCceeeeccccceecCC
Q 004999 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294 (720)
Q Consensus 259 H~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~ 294 (720)
..|++|.|.+|.||+|+.+|.+.+.|||+...+.+
T Consensus 283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 37999999999999999999999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=4.5e-06 Score=84.56 Aligned_cols=140 Identities=15% Similarity=0.169 Sum_probs=97.4
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecC---CCC-HHHHHHHHHHHHHHHhcCCCc--eeeecccee---ccCCCeEEE
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFD---NLE-PESVRFMAREIHILRRLDHIN--VIKLEGLVT---SRMSCSLYL 219 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~---~~~-~~~~~~~~~Ei~iL~~L~Hpn--Ivkl~~~~~---~~~~~~lyL 219 (720)
-|.||-+.|+.... .|..+-||.-... .+- +-....|.+|+..|.+|..-+ +.++. ++. ....-.-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 56688888998765 3345778875411 011 334456899999999995333 44444 222 111234689
Q ss_pred EEeeccc--cccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc--eeeecccccee
Q 004999 220 VFEYMEH--DLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--LKIADFGLASF 291 (720)
Q Consensus 220 V~Ey~~g--~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~--vKL~DFGla~~ 291 (720)
|+|-++| +|...+... -...++.+...++.+|+..|.-||..|+.|+|+.+.|||++.+|. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998885 343333221 224577888899999999999999999999999999999987777 99999986653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.2e-06 Score=83.46 Aligned_cols=146 Identities=20% Similarity=0.203 Sum_probs=90.2
Q ss_pred hhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHH-HHHH------HHHHHHHHHhcCC---Ccee
Q 004999 134 KLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE-SVRF------MAREIHILRRLDH---INVI 203 (720)
Q Consensus 134 ~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~-~~~~------~~~Ei~iL~~L~H---pnIv 203 (720)
.+++.+++-+...+++-......|.+.. -+|+.+++|..+......+ .... ..+++..+.++.. -.+.
T Consensus 24 l~~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~ 101 (229)
T PF06176_consen 24 LGEKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPA 101 (229)
T ss_pred HHHHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccc
Confidence 3355566667777777777777676664 3677899999875432111 1111 2344554555432 2222
Q ss_pred eeccceecc---CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc
Q 004999 204 KLEGLVTSR---MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 280 (720)
Q Consensus 204 kl~~~~~~~---~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~ 280 (720)
.++-+..-. .....+|||||++|..+..... +++ .+...|..+|.-||..|++|+|+.|.|++|+.++
T Consensus 102 ~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 102 DPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred cceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-
Confidence 222222111 1234568999999965543321 233 2345566778999999999999999999998555
Q ss_pred eeeeccccce
Q 004999 281 LKIADFGLAS 290 (720)
Q Consensus 281 vKL~DFGla~ 290 (720)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.5e-06 Score=82.46 Aligned_cols=139 Identities=24% Similarity=0.332 Sum_probs=79.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCC--ceeeeccceec-cCCCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI--NVIKLEGLVTS-RMSCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIvkl~~~~~~-~~~~~lyLV~Ey 223 (720)
+.|+.|..+.||++.... ..++||+.... .....+.+|+.+++.|... .+.+++.+... ......|++|++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 459999999999999755 47899987643 4556678899999888533 34566553322 123457999999
Q ss_pred cccccccc--------------------ccC---CCCCCCHHH---------HHHH------------HHhhhh-ccccc
Q 004999 224 MEHDLAGL--------------------ASH---PGLKFSEAQ---------VKCY------------MQQLLC-GLDHC 258 (720)
Q Consensus 224 ~~g~ll~~--------------------~~~---~~~~lse~~---------~~~i------------~~QIl~-gL~yL 258 (720)
++|..+.. +.. ....+.... .... +..+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99864433 000 001111000 0000 001111 22222
Q ss_pred c-------ccCcccccCcceeEEEc-CCCceeeecccccee
Q 004999 259 H-------SRGVLHRDIKGSNLLID-NNGILKIADFGLASF 291 (720)
Q Consensus 259 H-------~~gIvHrDIKP~NILld-~~g~vKL~DFGla~~ 291 (720)
+ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 34699999999999999 667778999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.14 E-value=8.7e-06 Score=83.96 Aligned_cols=130 Identities=18% Similarity=0.208 Sum_probs=78.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc--eeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Ivkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||+|..+.||+.. +..+++|...... . ...+.+|..+++.+..-. +.+++++... .....+|||+++|
T Consensus 9 i~~G~t~~~y~~~----~~~~VlR~~~~~~-~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i~G 78 (226)
T TIGR02172 9 TGEGGNGESYTHK----TGKWMLKLYNPGF-D---KETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELIVG 78 (226)
T ss_pred ecCCCCcceeEec----CCCEEEEeCCCCC-C---HHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeecCC
Confidence 9999999999842 4457888876432 2 233578999999885433 3555555443 5567899999999
Q ss_pred cc-ccccc---------------------C----CCCCCCH----------------HHHHHHHHhhhhccccccccCcc
Q 004999 227 DL-AGLAS---------------------H----PGLKFSE----------------AQVKCYMQQLLCGLDHCHSRGVL 264 (720)
Q Consensus 227 ~l-l~~~~---------------------~----~~~~lse----------------~~~~~i~~QIl~gL~yLH~~gIv 264 (720)
.. ..... + ....++. ...+..+...+..+. -...++
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~--~~~~~~ 156 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVP--DTSTCL 156 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCC--CCCceE
Confidence 52 11000 0 0001110 011111111111111 012478
Q ss_pred cccCcceeEEEcCCCceeeecccccee
Q 004999 265 HRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 265 HrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
|+|+.|.||+++.++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.3e-05 Score=91.50 Aligned_cols=140 Identities=19% Similarity=0.165 Sum_probs=87.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCC-----------------------------HHHHHH------HHHHHH
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-----------------------------PESVRF------MAREIH 192 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-----------------------------~~~~~~------~~~Ei~ 192 (720)
-||.-+.|.||+|+.+. |+.||||+-+..-.. ++..+. |.+|++
T Consensus 168 piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 168 PIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred hhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 49999999999999766 999999997643211 001111 444554
Q ss_pred HHHhc----CCCc------eeeeccceeccCCCeEEEEEeecccccccccc-CCCCCCCHHHHHHHHHhhhhcccccccc
Q 004999 193 ILRRL----DHIN------VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSR 261 (720)
Q Consensus 193 iL~~L----~Hpn------Ivkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~ 261 (720)
...++ .|-+ |.++|..+ ...-.|+||||+|.-...+. .....++...+...+.++.. +.|-..
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhc
Confidence 44443 3555 44444333 33568999999984332221 12223455544433333322 223346
Q ss_pred CcccccCcceeEEEcC----CCceeeeccccceecCC
Q 004999 262 GVLHRDIKGSNLLIDN----NGILKIADFGLASFYDP 294 (720)
Q Consensus 262 gIvHrDIKP~NILld~----~g~vKL~DFGla~~~~~ 294 (720)
|++|+|-+|.||+|.. ++.+.+.|||+...+..
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 8999999999999984 67899999999986543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1e-05 Score=79.13 Aligned_cols=127 Identities=24% Similarity=0.215 Sum_probs=88.0
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEEEeec
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.+.|++|.+|.||++.+ .|..+|+|+-+.+ .....+..|+++|..+.--++ .++|.|-. .++.|||+
T Consensus 27 ~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg~------~~i~me~i 94 (201)
T COG2112 27 EKELAKGTTSVVYLGEW--RGGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYGE------DFIRMEYI 94 (201)
T ss_pred hhhhhcccccEEEEeec--cCceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEech------hhhhhhhh
Confidence 34599999999999987 4567999987654 334567899999999976666 34444322 35669999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCc-ceeEEEcCCCceeeecccccee
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIK-GSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIK-P~NILld~~g~vKL~DFGla~~ 291 (720)
.|--+..+.... + +.-+..+++.-.-|-..||-|..|. |..++|..++.+.|+||..|++
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 985443332211 1 3334455555555777899999986 4555555666999999999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.3e-05 Score=79.16 Aligned_cols=134 Identities=19% Similarity=0.196 Sum_probs=78.4
Q ss_pred ecccCc-eEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTY-SNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~-g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
|..|.+ ..||++... +..+.||+..... ...+.+|+.+++.+. +--+.+++++... ....++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEEEEeeCC
Confidence 444555 789999753 3568888875432 234567999988884 3445566665543 3457899999998
Q ss_pred cccccccC---------------------C--CCCCCHH------HHHHH-------------------HHhhhhccc--
Q 004999 227 DLAGLASH---------------------P--GLKFSEA------QVKCY-------------------MQQLLCGLD-- 256 (720)
Q Consensus 227 ~ll~~~~~---------------------~--~~~lse~------~~~~i-------------------~~QIl~gL~-- 256 (720)
..+..... . ...+... ..... ..++..-|.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 54432110 0 0011100 00000 001111110
Q ss_pred --cccccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 257 --HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 257 --yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
-.....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 01223589999999999999988889999997753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.87 E-value=2e-05 Score=94.85 Aligned_cols=205 Identities=20% Similarity=0.170 Sum_probs=140.0
Q ss_pred HHHHHHHHHHHhcCCCceeeeccceeccCCC--eEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccC
Q 004999 185 RFMAREIHILRRLDHINVIKLEGLVTSRMSC--SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262 (720)
Q Consensus 185 ~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~--~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g 262 (720)
.....|+..+..+.|+|++.++.|-..+... .+.+..|+|....+......-..++...++.+..++++||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3344677778888999999998876543221 22344567776554444455557899999999999999999999997
Q ss_pred cccccCcce---eEEEcCCCceeee--ccccceecCCCCCCCccccccccCCCChhhhcCCcCCCc--cccchhhHHHHH
Q 004999 263 VLHRDIKGS---NLLIDNNGILKIA--DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT--AVDLWSTGCILA 335 (720)
Q Consensus 263 IvHrDIKP~---NILld~~g~vKL~--DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~--~sDIWSLG~iL~ 335 (720)
..|.-|..+ +-.++.++.+.++ ||+....+.... .......+..|.++|.+.... +.. ..|+|.+|..+.
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~--~~~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE--KSFSDLLAEIRNADEDLKENT-AKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcc--cchhhcCcccccccccccccc-chhhhhhHHHHHHHHHh
Confidence 666665555 4445666777777 998887654322 222334456688888776554 333 369999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccC-CCCHhHHHHHHHhcccCCCC
Q 004999 336 ELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFK-DFPAPALALMETLLSIDPAD 414 (720)
Q Consensus 336 ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~-~~~~~~~dLI~~mL~~DP~k 414 (720)
.+..|..+-.-. .... ..+. .......+++.+|+.-++++
T Consensus 384 ~~~~~~~i~~~~---~~~~------------------------------------~~l~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 384 QLSQGEDISEKS---AVPV------------------------------------SLLDVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhcCcccccc---cchh------------------------------------hhhccccchhhhhhhhhhcchhhhh
Confidence 999887432110 0000 0111 11126778899999999999
Q ss_pred CCCHHHHHhCccCCCCC
Q 004999 415 RGSAASALRSEFFTMKP 431 (720)
Q Consensus 415 RpTa~e~L~hp~f~~~~ 431 (720)
|+.+.++|.|+|.+...
T Consensus 425 Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRFPT 441 (1351)
T ss_pred ccchhhhhhchhccccc
Confidence 99999999999997543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.86 E-value=9.3e-05 Score=90.28 Aligned_cols=80 Identities=25% Similarity=0.343 Sum_probs=54.9
Q ss_pred eecccCceEEEEEEECCCC--eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCce--eeeccceecc-CCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINV--IKLEGLVTSR-MSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg--~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnI--vkl~~~~~~~-~~~~lyLV~ 221 (720)
.|+.|.+..+|+......+ ..+++|+....... .....+.+|+.+|+.|. |.+| .+++.++.+. ..+..|+||
T Consensus 45 ~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 45 QFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 3999999999998765432 45778876543221 12345789999999995 6665 6666666542 124578999
Q ss_pred eeccccc
Q 004999 222 EYMEHDL 228 (720)
Q Consensus 222 Ey~~g~l 228 (720)
||++|..
T Consensus 124 E~v~G~~ 130 (822)
T PLN02876 124 EYLEGRI 130 (822)
T ss_pred EecCCcc
Confidence 9999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00018 Score=72.44 Aligned_cols=121 Identities=23% Similarity=0.321 Sum_probs=84.9
Q ss_pred ecccCc-eEEEEEEECCCCeEEEEEEeec---CC-------CC---H------HHHHHHHHHHHHHHhcC---CCce--e
Q 004999 149 IGQGTY-SNVYRARDLDQKKIVALKKVRF---DN-------LE---P------ESVRFMAREIHILRRLD---HINV--I 203 (720)
Q Consensus 149 LG~G~~-g~Vy~a~~~~tg~~VAIK~l~~---~~-------~~---~------~~~~~~~~Ei~iL~~L~---HpnI--v 203 (720)
||.|.- |.||++.. .|+.||||+++. .. .. . ....-|..|.+...+|+ +.++ |
T Consensus 45 Lg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Av 122 (207)
T PF13095_consen 45 LGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAV 122 (207)
T ss_pred cCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEE
Confidence 999999 99999986 678999999432 11 00 0 22345778888888874 4556 8
Q ss_pred eeccceecc----------------CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCccccc
Q 004999 204 KLEGLVTSR----------------MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267 (720)
Q Consensus 204 kl~~~~~~~----------------~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrD 267 (720)
+++||..-. ......||.||+.... .++... +.+|++-|..+|..||+-+|
T Consensus 123 kc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~k~gI~~~D 189 (207)
T PF13095_consen 123 KCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILHKLGIVPRD 189 (207)
T ss_pred EeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHHHCCeeecc
Confidence 999887321 0123467888887543 233333 45666777889999999999
Q ss_pred CcceeEEEcCCCceeeeccccc
Q 004999 268 IKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 268 IKP~NILld~~g~vKL~DFGla 289 (720)
+++.|.. .-||+|||.+
T Consensus 190 v~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 190 VKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred Ccccccc-----CCEEEecccC
Confidence 9999986 3589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00016 Score=74.76 Aligned_cols=31 Identities=26% Similarity=0.455 Sum_probs=26.3
Q ss_pred cCcccccCcceeEEEcCCCceeeecccccee
Q 004999 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 261 ~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
.+++|+|+.+.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4589999999999998766667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00016 Score=72.53 Aligned_cols=99 Identities=23% Similarity=0.179 Sum_probs=78.2
Q ss_pred HHHHHHHHhcCC-CceeeeccceeccCCCeEEEEEeecccc-ccccc--cCCCCCCCHHHHHHHHHhhhhccccccc---
Q 004999 188 AREIHILRRLDH-INVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLA--SHPGLKFSEAQVKCYMQQLLCGLDHCHS--- 260 (720)
Q Consensus 188 ~~Ei~iL~~L~H-pnIvkl~~~~~~~~~~~lyLV~Ey~~g~-ll~~~--~~~~~~lse~~~~~i~~QIl~gL~yLH~--- 260 (720)
..|..+|+.|.+ +++++++|+|-. ++|.||+... +.... ...-...++..+..|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999975 699999998732 5788999953 32110 1111245899999999999999999997
Q ss_pred cCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 261 ~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
..+.-.|++++|+-|+++|.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 35888999999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.52 E-value=1.4e-05 Score=97.81 Aligned_cols=222 Identities=15% Similarity=0.064 Sum_probs=148.8
Q ss_pred CCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccccc-cccC---CCCCCCHHHHHHHHHhhhh
Q 004999 178 NLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASH---PGLKFSEAQVKCYMQQLLC 253 (720)
Q Consensus 178 ~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~-~~~~---~~~~lse~~~~~i~~QIl~ 253 (720)
.+.....+....|...++...|+++...+.-+....+...|.+++|+.++-+. .+.. +...+...-+.+..++.+.
T Consensus 1267 ~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl 1346 (2724)
T KOG1826|consen 1267 NLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVL 1346 (2724)
T ss_pred HHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHh
Confidence 33333445556677777778999999887766665567789999999865443 3332 2334555666666666678
Q ss_pred cccccccc-----CcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccch
Q 004999 254 GLDHCHSR-----GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLW 328 (720)
Q Consensus 254 gL~yLH~~-----gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIW 328 (720)
+..-+|+. -.+|++||+-|.+|..+..+|++++|+.++..+ ........++++.|+.|++...-. ++.++|+|
T Consensus 1347 ~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdil 1424 (2724)
T KOG1826|consen 1347 NRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIK-FTKRSDIL 1424 (2724)
T ss_pred ccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHH
Confidence 88887754 289999999999999999999999999984322 223344557788899999876655 68889999
Q ss_pred hhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhc
Q 004999 329 STGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLL 408 (720)
Q Consensus 329 SLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL 408 (720)
..||-+|++-.|.++| ..++..+.+.. ......+ +...-.|.++-.+...+|
T Consensus 1425 r~s~~ly~rs~~n~~f-----i~flq~~Lkgi------------idn~tf~-----------sIe~l~pgdaNve~~~~L 1476 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYF-----IFFLQPALKGI------------IDNHTFF-----------SIEKLKPGDANVEALHRL 1476 (2724)
T ss_pred HHHHHHHHHhcccHHH-----HHHHHHHHcCc------------ccccccc-----------cccccCCCcccHHHHHHH
Confidence 9999999999888765 23333333210 0011100 111122344444555555
Q ss_pred ccCCCCCCCHHHHHhCccCCC
Q 004999 409 SIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 409 ~~DP~kRpTa~e~L~hp~f~~ 429 (720)
-+.-..||.-...+.-+.|..
T Consensus 1477 l~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1477 LWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHHhhhcchhhhhcccccccc
Confidence 566668899888888877753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.00042 Score=74.96 Aligned_cols=142 Identities=22% Similarity=0.250 Sum_probs=100.5
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC----------------------C-HHHHHH-HHHHHHHHHhcCC
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----------------------E-PESVRF-MAREIHILRRLDH 199 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~----------------------~-~~~~~~-~~~Ei~iL~~L~H 199 (720)
.+-.+|..|--+.||.|.. .+|..+|||+++..-+ + ...++. ...|++-|.+|+.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3444788999999999984 6688899998753210 1 112222 3478889999876
Q ss_pred CceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhcccccc-ccCcccccCcceeEEEcCC
Q 004999 200 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKGSNLLIDNN 278 (720)
Q Consensus 200 pnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH-~~gIvHrDIKP~NILld~~ 278 (720)
..|.-..-+... .-.|||+|++.+-+..-.-....++...+..+-.|++.-+.-|- .+++||.||.-=|+|+ .+
T Consensus 226 aGIP~PePIlLk----~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 226 AGIPCPEPILLK----NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HD 300 (520)
T ss_pred cCCCCCCceeee----cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-EC
Confidence 665433322221 24799999996544433334556888888888888888777765 5689999999999998 77
Q ss_pred Cceeeecccccee
Q 004999 279 GILKIADFGLASF 291 (720)
Q Consensus 279 g~vKL~DFGla~~ 291 (720)
|.+.|+|.+-+..
T Consensus 301 G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 301 GKLYIIDVSQSVE 313 (520)
T ss_pred CEEEEEEcccccc
Confidence 8999999987654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0006 Score=71.31 Aligned_cols=132 Identities=22% Similarity=0.244 Sum_probs=75.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEEEeecccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+..|-.+.+|+.. .++..+++|......... .+ ...+|..+++.+....+ .+++... . -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~-~r~~E~~~l~~l~~~g~~P~~i~~~----~--~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GV-DRQREYQILQALSALGLAPKPILVN----E--HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cC-cHHHHHHHHHHHHhcCCCCceEEEe----C--CEEEEEeccCc
Confidence 6678888999987 356678888755321110 01 13678889988854333 3333322 1 26899999985
Q ss_pred cccccc------------------C---CCCCCCH-HHHHHHHHhhhh---------cccccc--------ccCcccccC
Q 004999 228 LAGLAS------------------H---PGLKFSE-AQVKCYMQQLLC---------GLDHCH--------SRGVLHRDI 268 (720)
Q Consensus 228 ll~~~~------------------~---~~~~lse-~~~~~i~~QIl~---------gL~yLH--------~~gIvHrDI 268 (720)
.+.... . .+..++. ..+..+..++.. .+..+- ...++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 543210 0 0111121 122232222211 011111 125899999
Q ss_pred cceeEEEcCCCceeeecccccee
Q 004999 269 KGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 269 KP~NILld~~g~vKL~DFGla~~ 291 (720)
.|.|||++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0014 Score=66.36 Aligned_cols=128 Identities=22% Similarity=0.282 Sum_probs=86.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCC--------------CCHHHHHHHHHHHHHHHhcC------CCceeeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN--------------LEPESVRFMAREIHILRRLD------HINVIKLEG 207 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~--------------~~~~~~~~~~~Ei~iL~~L~------HpnIvkl~~ 207 (720)
+||+|+.=.||.--+ ....+||++.... ......+...+|+.....+. +.+|.+++|
T Consensus 8 ~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 8 LIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred ccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 499999998888643 3346899988765 11122455667777766665 889999999
Q ss_pred ceeccCCCeEEEEEeeccc---c---ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC--
Q 004999 208 LVTSRMSCSLYLVFEYMEH---D---LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-- 279 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g---~---ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-- 279 (720)
+..+ +.-+-+|+|.+.. . ++..+...+ .+++ .. ...|-+-..||-.++|+.+||+|.||++....
T Consensus 85 ~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 85 FVET--NLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEec--CCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9887 4557899998853 1 233333222 3455 33 33344556677889999999999999996432
Q ss_pred --ceeeec
Q 004999 280 --ILKIAD 285 (720)
Q Consensus 280 --~vKL~D 285 (720)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0021 Score=66.01 Aligned_cols=73 Identities=14% Similarity=0.156 Sum_probs=45.6
Q ss_pred eeecccCceEEEEEEECC-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc-eeeeccceeccCCCeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN-VIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~-tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Ivkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.|..|-...||++.... .+..|++|+....... .-...+|+.+++.+...+ +++++..+. . .+||||+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~i 74 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEFI 74 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEee
Confidence 348889999999997543 3567889977543211 111247888888885333 344443221 1 3799999
Q ss_pred cccc
Q 004999 225 EHDL 228 (720)
Q Consensus 225 ~g~l 228 (720)
+|..
T Consensus 75 ~G~~ 78 (235)
T cd05157 75 PGRT 78 (235)
T ss_pred CCCc
Confidence 9854
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00034 Score=74.53 Aligned_cols=136 Identities=17% Similarity=0.204 Sum_probs=91.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC------------------HHHHH--HHHHHHHHHHhcCC--
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE------------------PESVR--FMAREIHILRRLDH-- 199 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~------------------~~~~~--~~~~Ei~iL~~L~H-- 199 (720)
++.+-..||-|.-+.||.+-+ ..|...++|.-+..... +-.+. ...+|...|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 445566799999999999987 45788999975432211 11111 24578888888843
Q ss_pred CceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 200 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 200 pnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
--|.+.+++ +.-++|||++.|-.+.....-. +. ..+...+..-+--|..+|+||+|+.-=||+|++++
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v~---d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRHVE---DP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeeecC---Ch---HHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 234444443 4568999999985554443211 22 23333444445557789999999999999999999
Q ss_pred ceeeeccccce
Q 004999 280 ILKIADFGLAS 290 (720)
Q Consensus 280 ~vKL~DFGla~ 290 (720)
.++++||--..
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999996443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.004 Score=66.29 Aligned_cols=136 Identities=17% Similarity=0.134 Sum_probs=77.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc--eeeeccce----eccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLV----TSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Ivkl~~~~----~~~~~~~lyLV~ 221 (720)
.|..|....+|+... .+..+++|+... .. ...+..|+.++..|.+.+ +++++... .....+..++||
T Consensus 21 ~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 21 GISAGIENTNYFVTT--DSGRYVLTLFEK--VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred cccCccccceEEEEe--CCCcEEEEEcCC--CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 388888889999864 234688898764 11 234567888888874332 44443311 111134568999
Q ss_pred eecccccccccc---------------C--CC--CC----CCHHHHHH------------HHHhhhhcccccc-------
Q 004999 222 EYMEHDLAGLAS---------------H--PG--LK----FSEAQVKC------------YMQQLLCGLDHCH------- 259 (720)
Q Consensus 222 Ey~~g~ll~~~~---------------~--~~--~~----lse~~~~~------------i~~QIl~gL~yLH------- 259 (720)
+|++|..+.... . .+ .. ........ ....+...+.++.
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 999985432100 0 00 00 00000000 0001112222222
Q ss_pred ccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 260 ~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
..+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2479999999999999988878999999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0037 Score=67.23 Aligned_cols=75 Identities=15% Similarity=0.097 Sum_probs=51.3
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC---Cceeeeccceecc-CCCeEEEEEee
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH---INVIKLEGLVTSR-MSCSLYLVFEY 223 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H---pnIvkl~~~~~~~-~~~~lyLV~Ey 223 (720)
.||.|..+.||...... + .+.+|..+. .. ....+..|...|+.|.- -.|.++++++... ..+..|||||+
T Consensus 21 ~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 21 CISEQPYAALWALYDSQ-G-NPMPLMARS-FS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred ecCCccceeEEEEEcCC-C-CEEEEEecc-cc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 49999999999996532 3 366777432 11 12457889999998853 3577777665432 13557999999
Q ss_pred ccccc
Q 004999 224 MEHDL 228 (720)
Q Consensus 224 ~~g~l 228 (720)
++|..
T Consensus 95 i~G~~ 99 (297)
T PRK10593 95 LRGVS 99 (297)
T ss_pred cCCEe
Confidence 99753
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0037 Score=67.43 Aligned_cols=30 Identities=33% Similarity=0.595 Sum_probs=26.3
Q ss_pred cCcccccCcceeEEEcCCCceeeeccccce
Q 004999 261 RGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 261 ~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 489999999999999876666899999875
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0042 Score=69.31 Aligned_cols=75 Identities=23% Similarity=0.131 Sum_probs=52.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC---C--HHHHHHHHHHHHHHHhcC---CCceeeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---E--PESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~---~--~~~~~~~~~Ei~iL~~L~---HpnIvkl~~~~~~~~~~~lyL 219 (720)
.||.|.+..||++.+...++.|+||.-..... + +-...++..|...|+.+. -.++++++.+. ....++
T Consensus 33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~~l 108 (401)
T PRK09550 33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELAVT 108 (401)
T ss_pred EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCCEE
Confidence 49999999999999865446799998542110 1 223456778888888873 34677777653 234689
Q ss_pred EEeeccc
Q 004999 220 VFEYMEH 226 (720)
Q Consensus 220 V~Ey~~g 226 (720)
||||+++
T Consensus 109 VME~L~~ 115 (401)
T PRK09550 109 VMEDLSD 115 (401)
T ss_pred EEecCCC
Confidence 9999975
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0021 Score=68.85 Aligned_cols=73 Identities=23% Similarity=0.249 Sum_probs=45.7
Q ss_pred eecccCceEEEEEEECC------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEE
Q 004999 148 LIGQGTYSNVYRARDLD------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV 220 (720)
.|..|-...||++.... +++.|++|+..... .......+|+.++..+....+ .++++++.. .+|
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v 75 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN------GRI 75 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC------Cch
Confidence 37778888999997543 25789999965432 111234678888888853333 344444321 358
Q ss_pred Eeecccccc
Q 004999 221 FEYMEHDLA 229 (720)
Q Consensus 221 ~Ey~~g~ll 229 (720)
+||++|..+
T Consensus 76 ~e~i~G~~l 84 (302)
T cd05156 76 EEFIPSRTL 84 (302)
T ss_pred hheeCCCcC
Confidence 999888543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.0045 Score=66.57 Aligned_cols=137 Identities=20% Similarity=0.171 Sum_probs=76.6
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc--eeeeccce----eccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLV----TSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Ivkl~~~~----~~~~~~~lyLV~ 221 (720)
.|+.|....||++.. .++ .+++|+..... .. ..+..|+.++..|.... |++++... .....+..++||
T Consensus 29 ~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 29 GIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccCCccccceEEEEe-CCC-cEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 377888889999864 344 57789875432 12 23455677777774222 34443321 111235678999
Q ss_pred eecccccccc---------------ccCCCCCC--------CHH---H--HH----------HHHHhhhhcccccc----
Q 004999 222 EYMEHDLAGL---------------ASHPGLKF--------SEA---Q--VK----------CYMQQLLCGLDHCH---- 259 (720)
Q Consensus 222 Ey~~g~ll~~---------------~~~~~~~l--------se~---~--~~----------~i~~QIl~gL~yLH---- 259 (720)
||++|..... +......+ ... . .. .....+...++++.
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999843210 00000000 000 0 00 00011122333332
Q ss_pred ---ccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 260 ---SRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 260 ---~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 3589999999999999998877999999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0027 Score=71.32 Aligned_cols=173 Identities=24% Similarity=0.305 Sum_probs=111.6
Q ss_pred HHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCccc
Q 004999 186 FMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265 (720)
Q Consensus 186 ~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvH 265 (720)
++.--..+++.+.|+|...++++.... .....+|||+++-++.+...... +-... ++ .+++.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~--l~~~s----------~~----~~~~~~ 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN--LKDES----------LL----AHGVLH 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc--cchhh----------hc----ccccce
Confidence 355667888999999999998876543 34588999999976654433321 11111 11 222222
Q ss_pred ccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCC
Q 004999 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP 345 (720)
Q Consensus 266 rDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~ 345 (720)
- +.++++| ... +. | | ...++++|||++|.|+.|+.-|..++.
T Consensus 91 ~------------~~~~~td----~~~--------t~------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 L------------NIIYITD----HFL--------TK------Y--P------SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred e------------hhhhccc----ccc--------cc------C--C------CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 1 2233444 110 00 1 1 012359999999999999999999998
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 346 GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 346 g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
.....+++..+.+....+....- ..+.......++.....++.+|+-..|..||...++++++
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~-----------------~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~ 195 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLS-----------------TAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRC 195 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHH-----------------HHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCc
Confidence 88888888888775433321110 0011122234677788999999999999999999999999
Q ss_pred cCCCC
Q 004999 426 FFTMK 430 (720)
Q Consensus 426 ~f~~~ 430 (720)
-|+..
T Consensus 196 i~~ev 200 (725)
T KOG1093|consen 196 SFTEV 200 (725)
T ss_pred cHHHH
Confidence 99754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.015 Score=62.99 Aligned_cols=142 Identities=20% Similarity=0.220 Sum_probs=79.6
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC--CceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+-.|....+|...+. ++.++|. ...............+|..+++.+.- --+...+++|....-...|.||+|++|
T Consensus 33 ~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 33 ISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred ccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 433444455666543 7778888 22222233455667889999988843 233445566655322467999999998
Q ss_pred cccccccCCC--------------------------------CCCCHHHHHHHHHhh--------------hhcccccc-
Q 004999 227 DLAGLASHPG--------------------------------LKFSEAQVKCYMQQL--------------LCGLDHCH- 259 (720)
Q Consensus 227 ~ll~~~~~~~--------------------------------~~lse~~~~~i~~QI--------------l~gL~yLH- 259 (720)
.......... ..+...++..+..+. ..-..+|+
T Consensus 110 e~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~ 189 (321)
T COG3173 110 EVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA 189 (321)
T ss_pred eeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence 4211100000 000111111111111 00111221
Q ss_pred -------ccCcccccCcceeEEEcCCCceeeeccccceecC
Q 004999 260 -------SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 293 (720)
Q Consensus 260 -------~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~ 293 (720)
...++|+|+.+.||+|+..+-+=|+||+++..-+
T Consensus 190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 1248999999999999999889999999997543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.018 Score=61.25 Aligned_cols=30 Identities=23% Similarity=0.409 Sum_probs=25.6
Q ss_pred CcccccCcceeEEEcCCCc-eeeecccccee
Q 004999 262 GVLHRDIKGSNLLIDNNGI-LKIADFGLASF 291 (720)
Q Consensus 262 gIvHrDIKP~NILld~~g~-vKL~DFGla~~ 291 (720)
.++|+|++|.|||++.++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999987565 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.028 Score=61.68 Aligned_cols=134 Identities=16% Similarity=0.205 Sum_probs=79.1
Q ss_pred ecccCceEEEEEEECC----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEEEee
Q 004999 149 IGQGTYSNVYRARDLD----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV~Ey 223 (720)
|-.|-...+|++.... +++.|++|+..... ...+.+ .+|..+++.+..-++ .++++.+.. . .|+||
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~---g---~v~ef 114 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN---G---RVEEF 114 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeech-HHHHHHHHHHHHcCCCCceEEEECC---c---eEEEe
Confidence 6668888999987432 34678999876432 122222 578888888854444 345554422 2 57999
Q ss_pred cccccccccc------------------C---CCC--CCCHHHHHHHHHhhhh------------------------ccc
Q 004999 224 MEHDLAGLAS------------------H---PGL--KFSEAQVKCYMQQLLC------------------------GLD 256 (720)
Q Consensus 224 ~~g~ll~~~~------------------~---~~~--~lse~~~~~i~~QIl~------------------------gL~ 256 (720)
++|..+.... . ... .....++..++.++.. .+.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 9875443110 0 111 1112334344332211 011
Q ss_pred c-ccccCcccccCcceeEEEcC-CCceeeecccccee
Q 004999 257 H-CHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASF 291 (720)
Q Consensus 257 y-LH~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~ 291 (720)
. .+...++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 22346899999999999986 47899999998864
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.029 Score=61.28 Aligned_cols=134 Identities=16% Similarity=0.261 Sum_probs=76.8
Q ss_pred ecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEEEeec
Q 004999 149 IGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
|..|-...+|++..... +..|++|+..... + ..+. -.+|..+++.+..-++ +++++++. .+ +|.+|+
T Consensus 22 l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~-~~Id-R~~E~~il~~l~~~gl~P~~l~~~~---~G---~i~~fi 92 (330)
T PLN02421 22 ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D-YVID-RERELQAIKYLSAAGFGAKLLGVFG---NG---MIQSFI 92 (330)
T ss_pred eCCcccceEEEEEecCCCCCCceEEEEEecCCc-C-eEec-hHHHHHHHHHHHhcCCCCceeEEeC---Cc---Eeehhh
Confidence 66688889999875432 3378899875432 1 1111 1478888888865444 34554442 22 588999
Q ss_pred cccccccc------------------cC---CCC-CC-CHHHHHHHHHhhhh-------------------------ccc
Q 004999 225 EHDLAGLA------------------SH---PGL-KF-SEAQVKCYMQQLLC-------------------------GLD 256 (720)
Q Consensus 225 ~g~ll~~~------------------~~---~~~-~l-se~~~~~i~~QIl~-------------------------gL~ 256 (720)
+|..+... .. ... .+ -...+..++.++.. .+.
T Consensus 93 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 172 (330)
T PLN02421 93 NARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELK 172 (330)
T ss_pred cCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHH
Confidence 87544210 00 000 01 12334444433311 111
Q ss_pred -ccccc----CcccccCcceeEEEcC-CCceeeecccccee
Q 004999 257 -HCHSR----GVLHRDIKGSNLLIDN-NGILKIADFGLASF 291 (720)
Q Consensus 257 -yLH~~----gIvHrDIKP~NILld~-~g~vKL~DFGla~~ 291 (720)
++... -++|.|+.+.|||++. ++.++++||..|..
T Consensus 173 ~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 173 EITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111 2799999999999974 57899999998864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.022 Score=62.64 Aligned_cols=74 Identities=18% Similarity=0.133 Sum_probs=48.6
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecC-----CCCHHHHHHHHHHHHHHHhcC--CC-ceeeeccceeccCCCeEEEE
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFD-----NLEPESVRFMAREIHILRRLD--HI-NVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~-----~~~~~~~~~~~~Ei~iL~~L~--Hp-nIvkl~~~~~~~~~~~lyLV 220 (720)
||-|....||++.+...++.|+||.-... ...+-...+...|...|+... -| .++++|.+- .....+|
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~v 78 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVTV 78 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----cccceeh
Confidence 89999999999998644467999974321 111233455667888887763 33 566666542 3345689
Q ss_pred Eeeccc
Q 004999 221 FEYMEH 226 (720)
Q Consensus 221 ~Ey~~g 226 (720)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.083 Score=59.10 Aligned_cols=73 Identities=16% Similarity=0.104 Sum_probs=48.7
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC--C---HHHHHHHHHHHHHHHhcC---CCceeeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--E---PESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~--~---~~~~~~~~~Ei~iL~~L~---HpnIvkl~~~~~~~~~~~lyL 219 (720)
.||.|....||+..+. +..|+||.-..... . +-...+...|+..|+.+. -.+|++++.++.+ .-++
T Consensus 39 eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~vl 112 (418)
T PLN02756 39 EVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MALI 112 (418)
T ss_pred EcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CCEE
Confidence 3999999999999873 44688997552211 0 113444456677776663 3477888877643 3578
Q ss_pred EEeeccc
Q 004999 220 VFEYMEH 226 (720)
Q Consensus 220 V~Ey~~g 226 (720)
||||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.099 Score=55.92 Aligned_cols=29 Identities=28% Similarity=0.534 Sum_probs=25.6
Q ss_pred cCcccccCcceeEEEcCCCceeeeccccce
Q 004999 261 RGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 261 ~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
.+++|+|+.+.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.032 Score=62.15 Aligned_cols=73 Identities=22% Similarity=0.299 Sum_probs=42.8
Q ss_pred ecccCceEEEEEEECCCC-eE-----EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEEE
Q 004999 149 IGQGTYSNVYRARDLDQK-KI-----VALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg-~~-----VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV~ 221 (720)
|..|-...+|++...... .. |.+++.... ....+. -.+|+.+++.|...++ .++++.+.. ++|.
T Consensus 58 l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~--~~l~Id-R~~E~~i~~~Ls~~glgP~l~~~f~~------g~l~ 128 (383)
T PTZ00384 58 MNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY--NSLVID-NDLQYNIAKLLGDNNFGPKIIGRFGD------FTIQ 128 (383)
T ss_pred eCCcccceEEEEEecCCCCCccccceEEEEeccCC--CceEec-cHHHHHHHHHHHhCCCCCeEEEecCC------EEEE
Confidence 666888999999754321 22 333332111 111111 1468999999965555 556555432 6899
Q ss_pred eeccccccc
Q 004999 222 EYMEHDLAG 230 (720)
Q Consensus 222 Ey~~g~ll~ 230 (720)
||++|..+.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999986543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.049 Score=60.60 Aligned_cols=75 Identities=21% Similarity=0.127 Sum_probs=50.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeec----CCCCHHHHHHHHHHHHHHHhcC--CC-ceeeeccceeccCCCeEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRF----DNLEPESVRFMAREIHILRRLD--HI-NVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~----~~~~~~~~~~~~~Ei~iL~~L~--Hp-nIvkl~~~~~~~~~~~lyLV 220 (720)
.||-|.-..||++.+...++.|+||.-.. ....+-...+..-|..+|+.+. -| +++++|.+- .....+|
T Consensus 36 eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D----~e~~~~v 111 (409)
T PRK12396 36 EIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD----SVMNCCV 111 (409)
T ss_pred EcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC----cHHhhHH
Confidence 49999999999999854456799997432 1111334566677888888763 33 566676542 3345789
Q ss_pred Eeeccc
Q 004999 221 FEYMEH 226 (720)
Q Consensus 221 ~Ey~~g 226 (720)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999863
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.13 Score=55.48 Aligned_cols=30 Identities=27% Similarity=0.282 Sum_probs=27.8
Q ss_pred CcccccCcceeEEEcCCCceeeecccccee
Q 004999 262 GVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 262 gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
++||+|+.+.|||++.++.+-|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.74 E-value=0.096 Score=56.10 Aligned_cols=71 Identities=18% Similarity=0.204 Sum_probs=43.3
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC---CCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
-|+.|....+|+.. .+++.+.||+-... ....|..|..-|+.|. --.|++++++... ...-||||||+
T Consensus 24 ~v~GG~i~~a~~~~--~~~~~~FvK~~~~~-----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~--~~~~fLlle~l 94 (288)
T PF03881_consen 24 PVSGGDINEAYRLD--TDGGSYFVKVNSES-----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEY--DDDAFLLLEFL 94 (288)
T ss_dssp EE--SSSSEEEEEE--TTS-EEEEEEEEGG-----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE---SSCCEEEEE--
T ss_pred ecCCCChhheEEEE--CCCccEEEEecChh-----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee--cCCceEEEEee
Confidence 38999999999987 57778999987622 2245677888888873 4456677776654 33459999998
Q ss_pred ccc
Q 004999 225 EHD 227 (720)
Q Consensus 225 ~g~ 227 (720)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.064 Score=58.51 Aligned_cols=71 Identities=23% Similarity=0.329 Sum_probs=57.0
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeecccccee
Q 004999 215 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
-.+|++|++-.+.+...- .-..+++..|+.+.+..|.-+... ..-||++.-.||||+ +|.|.|+||-+++.
T Consensus 299 ~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 299 LYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred eEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 456788888776544322 236788999999998888777765 688999999999999 99999999999984
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.11 Score=59.12 Aligned_cols=72 Identities=13% Similarity=0.105 Sum_probs=44.3
Q ss_pred eecccCceEEEEEEECCC--------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEE
Q 004999 148 LIGQGTYSNVYRARDLDQ--------KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLY 218 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~t--------g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~ly 218 (720)
.|..|-.-.+|++..... ++.|.+++.-... ...+ .-.+|..+++.+...+| .++++.+. -+
T Consensus 112 ~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t--e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~------gg 182 (442)
T PTZ00296 112 QILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV--DELY-NPISEFEVYKTMSKYRIAPQLLNTFS------GG 182 (442)
T ss_pred EecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc--ccee-CHHHHHHHHHHHHHCCCCCceEEEeC------CC
Confidence 377788889999975421 4678888875432 1111 12468888887764444 34555442 14
Q ss_pred EEEeeccccc
Q 004999 219 LVFEYMEHDL 228 (720)
Q Consensus 219 LV~Ey~~g~l 228 (720)
.|.||++|..
T Consensus 183 ~I~efi~g~~ 192 (442)
T PTZ00296 183 RIEEWLYGDP 192 (442)
T ss_pred EEEEeeCCcc
Confidence 6789998753
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.2 Score=56.52 Aligned_cols=29 Identities=28% Similarity=0.439 Sum_probs=23.4
Q ss_pred cccccCcceeEEEcCCC-----ceeeecccccee
Q 004999 263 VLHRDIKGSNLLIDNNG-----ILKIADFGLASF 291 (720)
Q Consensus 263 IvHrDIKP~NILld~~g-----~vKL~DFGla~~ 291 (720)
++|+||..+|||.+.++ ...|+||-++..
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 79999999999998744 357889877653
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.83 Score=49.93 Aligned_cols=135 Identities=21% Similarity=0.305 Sum_probs=75.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc------eeeeccceeccCCC--eEEEE
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN------VIKLEGLVTSRMSC--SLYLV 220 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Ivkl~~~~~~~~~~--~lyLV 220 (720)
|.+ .-..||+....+ |+ +++|+.+.. .... .+.-|+..|..|.-.. |..+-|-....... ..+-|
T Consensus 34 l~s-~eN~~f~~~~~~-g~-~iLki~~~~-~~~~---~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 34 LNS-EENSNFRVQTED-GR-YILKIYRPG-WTRA---EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred ccc-ccCceEEEEecC-CC-eEEEEecCC-CCHH---HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 555 566899998633 44 499998876 3333 3456777777763221 22222222222233 77889
Q ss_pred Eeecccccccc-ccC-----------------CCCC---------CCHH-----------------H---HHHHHHhhhh
Q 004999 221 FEYMEHDLAGL-ASH-----------------PGLK---------FSEA-----------------Q---VKCYMQQLLC 253 (720)
Q Consensus 221 ~Ey~~g~ll~~-~~~-----------------~~~~---------lse~-----------------~---~~~i~~QIl~ 253 (720)
++|++|..+.. ... .+.+ ..+. . +...+..+..
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99999865551 100 0000 1111 1 1111111122
Q ss_pred ccc-cccccC--cccccCcceeEEEcCCC-ceeeeccccce
Q 004999 254 GLD-HCHSRG--VLHRDIKGSNLLIDNNG-ILKIADFGLAS 290 (720)
Q Consensus 254 gL~-yLH~~g--IvHrDIKP~NILld~~g-~vKL~DFGla~ 290 (720)
.+. .+...+ |||+|+.|.|||++.+. .+-++||+-+.
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 211 122334 99999999999999887 48999999775
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.76 Score=50.00 Aligned_cols=72 Identities=15% Similarity=0.104 Sum_probs=41.2
Q ss_pred cCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc--eeeec---cceeccCCCeEEEEEeeccc
Q 004999 152 GTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLE---GLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 152 G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Ivkl~---~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.-..||+... .++..+++|+.+...... ..+..|+.++..|.... |+... |-.....++..+.|+++++|
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~---~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWSD---AQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCCH---HHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 34557999874 446679999886544332 34556777777663211 22221 21101113567889999987
Q ss_pred c
Q 004999 227 D 227 (720)
Q Consensus 227 ~ 227 (720)
.
T Consensus 112 ~ 112 (325)
T PRK11768 112 R 112 (325)
T ss_pred C
Confidence 4
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.09 E-value=0.64 Score=58.35 Aligned_cols=31 Identities=32% Similarity=0.563 Sum_probs=26.3
Q ss_pred cCcccccCcceeEEEcCCC--cee-eecccccee
Q 004999 261 RGVLHRDIKGSNLLIDNNG--ILK-IADFGLASF 291 (720)
Q Consensus 261 ~gIvHrDIKP~NILld~~g--~vK-L~DFGla~~ 291 (720)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=92.45 E-value=0.31 Score=50.00 Aligned_cols=86 Identities=17% Similarity=0.244 Sum_probs=59.0
Q ss_pred HHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccc--cC
Q 004999 185 RFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS--RG 262 (720)
Q Consensus 185 ~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~--~g 262 (720)
..+..+..+++++. .|++|.. ...-.+-++.|+|..-- .. ...++..=+..|.-.|+ .+
T Consensus 103 ~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~------------i~-~~N~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIK------------IN-FSNFITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcc------------cc-hhHHHHHhHHHHHHhhccCCC
Confidence 34577888988875 5677652 12445678899887310 00 11222222466777884 36
Q ss_pred cccccCcceeEEEcCCCceeeeccccc
Q 004999 263 VLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 263 IvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
.+|+|..|+|||-|+.|.+||.|=+..
T Consensus 164 ~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 164 CLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred eecCCCChhheeecCCCCEEecChhhh
Confidence 999999999999999999999997754
|
The function of this family is unknown. |
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.46 E-value=0.22 Score=53.60 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=91.6
Q ss_pred ccccceeecccCceEEEEEEEC-------C---CCeEEEEEEeecC----------------------CCCHHHHHHH--
Q 004999 142 FSRSFYLIGQGTYSNVYRARDL-------D---QKKIVALKKVRFD----------------------NLEPESVRFM-- 187 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~-------~---tg~~VAIK~l~~~----------------------~~~~~~~~~~-- 187 (720)
+-.+-.+|..|.-+.|+-|+-. . .-..+|||+++.. ..++..+-.+
T Consensus 253 le~i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWA 332 (531)
T KOG2269|consen 253 LESIDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWA 332 (531)
T ss_pred HHhhhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHH
Confidence 3345557899999999888531 1 2234789887521 0111112222
Q ss_pred HHHHHHHHhc-----CCCceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccc-ccc
Q 004999 188 AREIHILRRL-----DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC-HSR 261 (720)
Q Consensus 188 ~~Ei~iL~~L-----~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yL-H~~ 261 (720)
.+|+.-|.++ .+|-+|.|.- -.|||-|++.+-+..-.-....|+..+.+..-.|+...+.-| |+.
T Consensus 333 EkEmhNL~RMq~~GlpcP~vV~lkk---------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec 403 (531)
T KOG2269|consen 333 EKEMHNLSRMQKHGLPCPQVVKLKK---------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKEC 403 (531)
T ss_pred HHHHHHHHHHHhcCCCCCceeeeec---------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhh
Confidence 2566666665 4677776532 369999998643333333344688899998888998887765 466
Q ss_pred CcccccCcceeEEEcCCCceeeeccccce
Q 004999 262 GVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 262 gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
-+||-||.--|||.... .+-++|..-+.
T Consensus 404 ~LVHADlSEyN~Lw~~g-Kvw~IDVsQsv 431 (531)
T KOG2269|consen 404 LLVHADLSEYNLLWTPG-KVWVIDVSQSV 431 (531)
T ss_pred heeecchhhhhheecCC-ceEEEechhcc
Confidence 79999999999999654 88899876543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 720 | ||||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-57 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-57 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-57 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-56 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-53 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-53 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-53 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-52 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-52 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-52 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-52 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-52 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-52 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-52 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-52 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-52 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-52 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-52 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-52 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-52 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-52 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-52 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-52 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-52 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-52 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-52 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-51 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-51 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-51 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-51 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-51 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-51 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-51 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-51 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-51 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-51 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-51 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-51 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-51 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-51 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-51 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-51 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-51 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-51 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-48 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-48 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-48 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-47 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-45 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-45 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-45 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-45 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-45 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-45 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-44 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-44 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-44 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-42 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-42 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-42 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-42 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-42 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-42 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-42 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-42 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-42 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-42 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-42 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-42 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-42 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-42 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-42 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-42 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-42 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-42 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-40 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-40 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-40 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-39 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-39 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-39 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-39 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-39 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-39 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-39 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-39 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-39 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-39 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-39 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-39 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-39 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-39 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-39 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-39 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-39 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-39 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-39 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-39 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-39 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-39 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-39 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-39 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-39 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-39 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-38 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-38 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-38 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-38 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-38 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-38 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-38 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-38 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-37 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-37 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-37 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-36 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-36 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-35 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-35 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-35 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-35 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-35 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-35 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-35 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-35 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-35 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-35 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-35 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-35 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-35 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-35 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-35 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-35 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-35 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-35 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-35 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-35 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-35 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-35 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-35 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-35 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-35 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-35 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-35 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-35 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-35 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-35 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-35 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-35 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-35 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-35 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-35 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-35 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-35 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-35 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-35 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-35 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-35 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-35 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-35 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-35 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-35 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-35 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-35 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-34 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-34 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-34 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-34 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-34 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-34 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-34 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-34 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-34 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-34 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-34 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-34 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-34 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-34 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-33 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-33 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-33 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-33 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-33 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-33 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-32 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-32 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-32 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-32 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-32 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-32 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-32 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-32 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-32 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-32 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-32 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-32 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-32 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-32 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-32 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-32 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-32 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-32 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-31 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-31 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-31 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-31 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-31 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-31 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-31 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-31 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-31 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-30 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-29 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-28 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-27 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-26 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-26 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-26 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-26 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-25 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-25 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-25 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-25 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-25 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-25 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-25 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-25 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-25 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-25 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-25 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-25 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-25 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 9e-25 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-24 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-24 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-24 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-24 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-24 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-24 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-24 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-24 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-24 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-24 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-24 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-24 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-24 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-24 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-24 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-24 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-24 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-24 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-24 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-23 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-23 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-23 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-23 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-22 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-22 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-22 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-21 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-21 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-21 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-20 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-20 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-20 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-20 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-20 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-20 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-20 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-20 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-20 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-20 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-20 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-20 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-20 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-20 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-20 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-20 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-20 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-20 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-20 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-20 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-20 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-19 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-19 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-19 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-19 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-19 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-19 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-19 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-19 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-18 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-17 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-17 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-17 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-17 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-17 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-17 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-17 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-17 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-16 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-16 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-16 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-16 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-16 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-15 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-15 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-15 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-15 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-15 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-15 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-15 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-14 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-14 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-14 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-14 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-14 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-14 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-13 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-13 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-13 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-13 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-13 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-13 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-13 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-13 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-13 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-13 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-13 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-13 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-13 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-13 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-13 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-13 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 9e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-11 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-11 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 4e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 8e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-05 |
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 531 bits (1370), Expect = 0.0
Identities = 135/355 (38%), Positives = 189/355 (53%), Gaps = 25/355 (7%)
Query: 119 EAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN 178
++++ +EKL K IGQGT+ V++AR + VALKKV +N
Sbjct: 6 DSVECPFCDEVSKYEKLAK-----------IGQGTFGEVFKARHRKTGQKVALKKVLMEN 54
Query: 179 LEPESVRFMA-REIHILRRLDHINVIKLEGLVTSRMS------CSLYLVFEYMEHDLAGL 231
E E A REI IL+ L H NV+ L + ++ S S+YLVF++ EHDLAGL
Sbjct: 55 -EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL 113
Query: 232 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291
S+ +KF+ +++K MQ LL GL + H +LHRD+K +N+LI +G+LK+ADFGLA
Sbjct: 114 LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 292 YDP---DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT 348
+ Q T+RVVTLWYRPPELLLG YG +DLW GCI+AE++ PIM G T
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233
Query: 349 EVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAP--ALALME 405
E QL I +LCGS + + W + + KR V + K + AL L++
Sbjct: 234 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 293
Query: 406 TLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 460
LL +DPA R + AL +FF P+P D + + F+
Sbjct: 294 KLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHHH 348
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-164
Identities = 126/360 (35%), Positives = 191/360 (53%), Gaps = 26/360 (7%)
Query: 125 VPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PE 182
V RA +EKLD +G+G ++ VY+ARD + +IVA+KK++ + +
Sbjct: 5 VKSRAKRYEKLDF-----------LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD 53
Query: 183 SVRFMA-REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSE 241
+ A REI +L+ L H N+I L + + + LVF++ME DL + L +
Sbjct: 54 GINRTALREIKLLQELSHPNIIGLLDAFGHKSN--ISLVFDFMETDLEVIIKDNSLVLTP 111
Query: 242 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPL 300
+ +K YM L GL++ H +LHRD+K +NLL+D NG+LK+ADFGLA SF P N+
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAY 169
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
T +VVT WYR PELL GA YG VD+W+ GCILAEL P +PG ++++QL +IF+
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 361 GSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA 419
G+P+E+ W LP FK + F L L++ L +P R +A
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIP--LHHIFSAAGDDLLDLIQGLFLFNPCARITAT 287
Query: 420 SALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESR 479
AL+ ++F+ +P P LP+ E E++ K +R + +G +
Sbjct: 288 QALKMKYFSNRPGPTPGCQLPRPNCPVETL----KEQSNPALAIKRKRTEALEQGGLPKK 343
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-137
Identities = 120/404 (29%), Positives = 184/404 (45%), Gaps = 55/404 (13%)
Query: 122 QGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQK--KIVALKKVRFDNL 179
R D FE +G+GTY +VY+A+ D K K ALK++ +
Sbjct: 12 SSERERVEDLFEYEG----------CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI 61
Query: 180 EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL-------- 231
+ R EI +LR L H NVI L+ + S ++L+F+Y EHDL +
Sbjct: 62 SMSACR----EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK 117
Query: 232 ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFG 287
A+ ++ VK + Q+L G+ + H+ VLHRD+K +N+L+ G +KIAD G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 288 LA-SFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP 345
A F P + L VVT WYR PELLLGA +Y A+D+W+ GCI AEL +PI
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237
Query: 346 GRTEV---------EQLHKIFKLCGSPSEDYWRK-SKLPHATIFKP---QQPYKRCVAET 392
R E +QL +IF + G P++ W K+P + + Y C
Sbjct: 238 CRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIK 297
Query: 393 F--KDFPAP---ALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP---KYPP 444
+ K P A L++ LL++DP R ++ A++ +F PLP YP
Sbjct: 298 YMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPK 357
Query: 445 SKEFDAKIRDEEARRQGGSKGQRMD----LERRGTRESRAIPAP 484
+ + D++ ++ + Q + G ++S P
Sbjct: 358 REFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGP 401
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 400 bits (1029), Expect = e-135
Identities = 111/339 (32%), Positives = 170/339 (50%), Gaps = 20/339 (5%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 189
+++ KLDK +G+GTY+ VY+ + +VALK++R ++ E + R
Sbjct: 2 ETYIKLDK-----------LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-R 49
Query: 190 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 249
E+ +L+ L H N++ L ++ + S L LVFEY++ DL G + VK ++
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKS--LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLF 107
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLW 308
QLL GL +CH + VLHRD+K NLLI+ G LK+ADFGLA + P + + VVTLW
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLW 165
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368
YRPP++LLG+T Y T +D+W GCI E+ G+P+ PG T EQLH IF++ G+P+E+ W
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW 225
Query: 369 RK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+ + + + L+ LL + +R SA A++ FF
Sbjct: 226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285
Query: 428 TMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQ 466
LP +EA +
Sbjct: 286 LSLGERIHK--LPDTTSIFALKEIQLQKEASLRSAHHHH 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 399 bits (1027), Expect = e-135
Identities = 111/333 (33%), Positives = 167/333 (50%), Gaps = 31/333 (9%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+ F++L+K +G GTY+ VY+ + VALK+V+ D+ E E
Sbjct: 3 SSSQFKQLEK-----------LGNGTYATVYKGLNKTTGVYVALKEVKLDS-E-EGTPST 49
Query: 188 A-REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK-----FSE 241
A REI +++ L H N+++L ++ + L LVFE+M++DL +
Sbjct: 50 AIREISLMKELKHENIVRLYDVIHTENK--LTLVFEFMDNDLKKYMDSRTVGNTPRGLEL 107
Query: 242 AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPL 300
VK + QLL GL CH +LHRD+K NLLI+ G LK+ DFGLA +F P
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP--VNTF 165
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
+S VVTLWYR P++L+G+ Y T++D+WS GCILAE+ GKP+ PG + EQL IF +
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 361 GSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAP-----ALALMETLLSIDPAD 414
G+P+E W +KLP Q+P + + + + + + LL ++P
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRD-LRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284
Query: 415 RGSAASALRSEFFTMKPLPCDPSSLPKYPPSKE 447
R SA AL +F +
Sbjct: 285 RLSAKQALHHPWFAEYYHHASMGGSRSHHHHHH 317
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 393 bits (1011), Expect = e-132
Identities = 114/319 (35%), Positives = 158/319 (49%), Gaps = 29/319 (9%)
Query: 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF 186
+E + + IG G Y VY+ARD VALK VR N
Sbjct: 6 MATSRYEPVAE-----------IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL 54
Query: 187 ---MAREIHILRRL---DHINVIKLEGLVTSR---MSCSLYLVFEYMEHDLAG-LASHPG 236
RE+ +LRRL +H NV++L + + + LVFE+++ DL L P
Sbjct: 55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP 114
Query: 237 LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296
+K M+Q L GLD H+ ++HRD+K N+L+ + G +K+ADFGLA Y
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY-- 172
Query: 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
LT VVTLWYR PE+LL +T Y T VD+WS GCI AE++ KP+ G +E +QL KI
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231
Query: 357 FKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
F L G P ED W + LP F P+ P R V + L+ +L+ +P R
Sbjct: 232 FDLIGLPPEDDWPRDVSLPRGA-FPPRGP--RPVQSVVPEMEESGAQLLLEMLTFNPHKR 288
Query: 416 GSAASALRSEFF-TMKPLP 433
SA AL+ + + P
Sbjct: 289 ISAFRALQHSYLHKDEGNP 307
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 392 bits (1009), Expect = e-132
Identities = 124/308 (40%), Positives = 177/308 (57%), Gaps = 21/308 (6%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA- 188
+EKL+K IG+GTY V++A++ + +IVALK+VR D+ + E V A
Sbjct: 2 QKYEKLEK-----------IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSAL 49
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 248
REI +L+ L H N+++L ++ S L LVFE+ + DL VK ++
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKK--LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL 307
QLL GL CHSR VLHRD+K NLLI+ NG LK+A+FGLA +F P + ++ VVTL
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTL 165
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELY-AGKPIMPGRTEVEQLHKIFKLCGSPSED 366
WYRPP++L GA Y T++D+WS GCI AEL AG+P+ PG +QL +IF+L G+P+E+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 367 YWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425
W +KLP + P P + A L++ LL +P R SA AL+
Sbjct: 226 QWPSMTKLPDYKPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 426 FFTMKPLP 433
+F+ P
Sbjct: 285 YFSDFCPP 292
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 391 bits (1008), Expect = e-132
Identities = 119/308 (38%), Positives = 175/308 (56%), Gaps = 20/308 (6%)
Query: 124 WVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES 183
+ + ++KL+K +G+GTY VY+A+D +IVALK++R D E E
Sbjct: 15 YFQGLMEKYQKLEK-----------VGEGTYGVVYKAKDSQ-GRIVALKRIRLDA-EDEG 61
Query: 184 VRFMA-REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEA 242
+ A REI +L+ L H N++ L ++ S L LVFE+ME DL + ++
Sbjct: 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERC--LTLVFEFMEKDLKKVLDENKTGLQDS 119
Query: 243 QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLT 301
Q+K Y+ QLL G+ HCH +LHRD+K NLLI+++G LK+ADFGLA +F P + T
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--VRSYT 177
Query: 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 361
VVTLWYR P++L+G+ Y T+VD+WS GCI AE+ GKP+ PG T+ +QL KIF + G
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILG 237
Query: 362 SPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420
+P+ W + +LP Q K+ + F + L+ +L DP R SA
Sbjct: 238 TPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297
Query: 421 ALRSEFFT 428
A+ +F
Sbjct: 298 AMNHPYFK 305
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-131
Identities = 119/339 (35%), Positives = 170/339 (50%), Gaps = 30/339 (8%)
Query: 124 WVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLEPE 182
+ R +E + + IG+G Y V++ARDL + VALK+VR E
Sbjct: 5 GLCRADQQYECVAE-----------IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEE 52
Query: 183 SVRFMA-REIHILRRL---DHINVIKLEGLVTSRMS---CSLYLVFEYMEHDLAG-LASH 234
+ RE+ +LR L +H NV++L + T + L LVFE+++ DL L
Sbjct: 53 GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV 112
Query: 235 PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294
P +K M QLL GLD HS V+HRD+K N+L+ ++G +K+ADFGLA Y
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 295 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLH 354
LTS VVTLWYR PE+LL ++ Y T VDLWS GCI AE++ KP+ G ++V+QL
Sbjct: 173 --QMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 229
Query: 355 KIFKLCGSPSEDYWRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA 413
KI + G P E+ W + LP + + + D L+ L+ +PA
Sbjct: 230 KILDVIGLPGEEDWPRDVALPRQAFHSKS---AQPIEKFVTDIDELGKDLLLKCLTFNPA 286
Query: 414 DRGSAASALRSEFFTMKPLPCD--PSSLPKYPPSKEFDA 450
R SA SAL +F + S LP + E +
Sbjct: 287 KRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSELNT 325
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 384 bits (990), Expect = e-130
Identities = 109/302 (36%), Positives = 163/302 (53%), Gaps = 21/302 (6%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA- 188
+ + L+K IG+GTY VY+A++ + + ALKK+R + E E +
Sbjct: 2 EKYHGLEK-----------IGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTI 48
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 248
REI IL+ L H N++KL ++ ++ L LVFE+++ DL L K ++
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKR--LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL 106
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL 307
QLL G+ +CH R VLHRD+K NLLI+ G LKIADFGLA +F P + T +VTL
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTL 164
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
WYR P++L+G+ Y T +D+WS GCI AE+ G P+ PG +E +QL +IF++ G+P+
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 368 WRK-SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
W ++LP K + L+ +L +DP R +A AL +
Sbjct: 225 WPNVTELPKYDPNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
Query: 427 FT 428
F
Sbjct: 284 FK 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-129
Identities = 99/323 (30%), Positives = 157/323 (48%), Gaps = 20/323 (6%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA- 188
+ +EK+ K IG+G+Y V++ R+ D +IVA+KK + ++ +A
Sbjct: 3 EKYEKIGK-----------IGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIAL 50
Query: 189 REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM 248
REI +L++L H N++ L + R L+LVFEY +H + E VK
Sbjct: 51 REIRMLKQLKHPNLVNLLEVF--RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT 108
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL 307
Q L ++ CH +HRD+K N+LI + ++K+ DFG A P + V T
Sbjct: 109 WQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATR 166
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
WYR PELL+G T YG VD+W+ GC+ AEL +G P+ PG+++V+QL+ I K G +
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH 226
Query: 368 WRK-SKLPHATIFK-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425
+ S + + K P + F + PAL L++ L +DP +R + L
Sbjct: 227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHP 286
Query: 426 FFTMKPLPCDPSSLPKYPPSKEF 448
+F D + P +
Sbjct: 287 YFENIREIEDLAKEHDKPAENLY 309
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-129
Identities = 93/332 (28%), Positives = 162/332 (48%), Gaps = 20/332 (6%)
Query: 120 AIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL 179
+ + + +E L +G+G+Y V + R+ D +IVA+KK +
Sbjct: 15 GTENLYFQSMEKYENLGL-----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESD- 62
Query: 180 EPESVRFMA-REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK 238
+ + V+ +A REI +L++L H N++ L + + YLVFE+++H +
Sbjct: 63 DDKMVKKIAMREIKLLKQLRHENLVNLLEVC--KKKKRWYLVFEFVDHTILDDLELFPNG 120
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQN 297
V+ Y+ Q++ G+ CHS ++HRDIK N+L+ +G++K+ DFG A + P
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--G 178
Query: 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357
+ V T WYR PELL+G YG AVD+W+ GC++ E++ G+P+ PG ++++QL+ I
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238
Query: 358 KLCGSPSEDYWRK-SKLPHATIFK-PQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
G+ + +K P + P+ + + + + L + L IDP R
Sbjct: 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKR 298
Query: 416 GSAASALRSEFFTMKPLPCDPSSLPKYPPSKE 447
A L +FF M S + K+
Sbjct: 299 PFCAELLHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-129
Identities = 115/353 (32%), Positives = 174/353 (49%), Gaps = 39/353 (11%)
Query: 89 HHPGMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKSLSIFSRSFYL 148
HH G G + P+ D + ++ K
Sbjct: 7 HHMGTLEAQTQGPGSMSVSAAPS--------------ATSIDRYRRITK----------- 41
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLEG 207
+G+GTY VY+A D + VA+K++R ++ E E V A RE+ +L+ L H N+I+L+
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
++ L+L+FEY E+DL S +K ++ QL+ G++ CHSR LHRD
Sbjct: 101 VIHHNHR--LHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRD 157
Query: 268 IKGSNLLID-----NNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
+K NLL+ +LKI DFGLA +F P + T ++TLWYRPPE+LLG+ +Y
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHY 215
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATIFK 380
T+VD+WS CI AE+ P+ PG +E++QL KIF++ G P + W + LP
Sbjct: 216 STSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
P+ K L L+ +L +DP R SA +AL +F+
Sbjct: 276 PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-104
Identities = 113/361 (31%), Positives = 165/361 (45%), Gaps = 30/361 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G++ VY+A+ D ++VA+KKV D RF RE+ I+R+LDH N+++L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYF 115
Query: 209 VTS----RMSCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSR 261
S + L LV +Y+ + +A H VK YM QL L + HS
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 262 GVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
G+ HRDIK NLL+D + +LK+ DFG A + P S + + +YR PEL+ GAT
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATD 233
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
Y +++D+WS GC+LAEL G+PI PG + V+QL +I K+ G+P+ + R+ P+ T FK
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN-PNYTEFK 292
Query: 381 PQQPYKRCVAETF-KDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP-CDPSS 438
Q + F P A+AL LL P R + A FF P +
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN 352
Query: 439 LPKYPPSKEFD-----------AKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDAN 487
P F + AR Q + +A
Sbjct: 353 GRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAA 412
Query: 488 A 488
+
Sbjct: 413 S 413
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = 1e-95
Identities = 107/344 (31%), Positives = 168/344 (48%), Gaps = 35/344 (10%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G++ V++A+ ++ + VA+KKV D RF RE+ I+R + H NV+ L+
Sbjct: 48 IGNGSFGVVFQAKLVESDE-VAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAF 100
Query: 209 VTSRMSCS----LYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSR 261
S L LV EY+ + + H +K YM QLL L + HS
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 262 GVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
G+ HRDIK NLL+D +G+LK+ DFG A +P S + + +YR PEL+ GAT
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA--GEPNVSYICSRYYRAPELIFGATN 218
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
Y T +D+WSTGC++AEL G+P+ PG + ++QL +I K+ G+PS + + + P+ K
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK-TMNPNYMEHK 277
Query: 381 PQQPYKRCVAETF-KDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439
Q ++ F P A+ L+ LL P+ R +A AL FF L + +
Sbjct: 278 FPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF--DELRTGEARM 335
Query: 440 PKYPP--------------SKEFDAKIRDEEARRQGGSKGQRMD 469
P + +++ + A + S+G +
Sbjct: 336 PNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSRGIDVH 379
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 4e-88
Identities = 98/353 (27%), Positives = 149/353 (42%), Gaps = 40/353 (11%)
Query: 116 VAGEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVR 175
A A + D F+ GQGT+ V ++ VA+KKV
Sbjct: 9 NAAAAADERSRKEMDRFQVERM-----------AGQGTFGTVQLGKEKSTGMSVAIKKVI 57
Query: 176 FDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTSRMSCS-----LYLVFEYMEHD 227
D RF RE+ I++ L H N+++L+ + L +V EY+
Sbjct: 58 QD------PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT 111
Query: 228 LAGLASH---PGLKFSEAQVKCYMQQLLCGLD--HCHSRGVLHRDIKGSNLLID-NNGIL 281
L + + +K ++ QL+ + H S V HRDIK N+L++ +G L
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171
Query: 282 KIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 341
K+ DFG A P ++P + + + +YR PEL+ G +Y TAVD+WS GCI AE+ G+
Sbjct: 172 KLCDFGSAKKLSP--SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
Query: 342 PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ---QPYKRCVAETFKDFPA 398
PI G QLH+I ++ G PS + RK H + P+ ++
Sbjct: 230 PIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK 289
Query: 399 PALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP--PSKEFD 449
A L+ LL P +R AL +F L + LP P F
Sbjct: 290 EAYDLLSALLQYLPEERMKPYEALCHPYF--DELHDPATKLPNNKDLPEDLFR 340
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 2e-87
Identities = 90/347 (25%), Positives = 150/347 (43%), Gaps = 53/347 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G++ V D++ K ALKKV D R+ RE+ I++ LDH+N+IKL
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDY 68
Query: 209 VTSRMSCS------------------------------------LYLVFEYMEHDLAGLA 232
+ L ++ EY+ L +
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 233 SHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGL 288
G + Y+ QL + HS G+ HRDIK NLL++ + LK+ DFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGS 188
Query: 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT 348
A P ++P + + + +YR PEL+LGAT Y ++DLWS GC+ EL GKP+ G T
Sbjct: 189 AKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGET 246
Query: 349 EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDF-PAPALALMETL 407
++QL +I ++ G+P+++ + + + P + + + P+ A+ L+E +
Sbjct: 247 SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK-AKDWRKILPEGTPSLAIDLLEQI 305
Query: 408 LSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRD 454
L +P R + A+ FF L + S ++
Sbjct: 306 LRYEPDLRINPYEAMAHPFF--DHLR-NSYESEVKNNSNFPHGVNQN 349
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-87
Identities = 87/291 (29%), Positives = 140/291 (48%), Gaps = 23/291 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEG 207
+G+G YS V+ A ++ + V +K ++ P + + REI IL L N+I L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 208 LVTSRMSCSLYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+V +S + LVFE+ D L ++ ++ YM ++L LD+CHS G++HR
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHR 154
Query: 267 DIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
D+K N++ID + L++ D+GLA FY P Q RV + +++ PELL+ Y ++
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSL 212
Query: 326 DLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPS-EDYWRKSKLPHATIFKPQQ 383
D+WS GC+LA + K P G +QL +I K+ G+ DY K + F
Sbjct: 213 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 272
Query: 384 PYKRCV-------AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+E AL ++ LL D R +A A+ +F
Sbjct: 273 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 2e-82
Identities = 108/309 (34%), Positives = 159/309 (51%), Gaps = 15/309 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G Y V A D K VA+KK+ F++ + REI IL R H N+I +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGIND 92
Query: 208 LVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
++ + +Y+V + ME DL L L S + ++ Q+L GL + HS VL
Sbjct: 93 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHL--SNDHICYFLYQILRGLKYIHSANVL 150
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSRVVTLWYRPPELLLGATYYG 322
HRD+K SNLL++ LKI DFGLA DPD + LT V T WYR PE++L + Y
Sbjct: 151 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 210
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
++D+WS GCILAE+ + +PI PG+ ++QL+ I + GSPS++ A +
Sbjct: 211 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 270
Query: 383 QPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
P+K V F + + AL L++ +L+ +P R AL + + DPS P
Sbjct: 271 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL--EQY-YDPSDEP 327
Query: 441 KYPPSKEFD 449
+FD
Sbjct: 328 IAEAPFKFD 336
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 4e-82
Identities = 101/309 (32%), Positives = 153/309 (49%), Gaps = 20/309 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G Y +V A D + VA+KK+ F + + RE+ +L+ + H NVI L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 207 GLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ T S YLV +M+ DL + FSE +++ + Q+L GL + HS G
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
V+HRD+K NL ++ + LKI DFGLA D + +T VVT WYR PE++L +Y
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYN 202
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
VD+WS GCI+AE+ GK + G+ ++QL +I K+ G P ++ +K A +
Sbjct: 203 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQS 262
Query: 383 QPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
P + F A L+E +L +D R +AA AL FF +P DP
Sbjct: 263 LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF--EPF-RDPEEET 319
Query: 441 KYPPSKEFD 449
+ +
Sbjct: 320 EAQQPFDDS 328
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-81
Identities = 99/321 (30%), Positives = 155/321 (48%), Gaps = 20/321 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G Y V A D VA+KK+ F + + RE+ +L+ + H NVI L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 207 GLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ T + YLV +M DL L H L E +++ + Q+L GL + H+ G
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL--GEDRIQFLVYQMLKGLRYIHAAG 148
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRD+K NL ++ + LKI DFGLA D + +T VVT WYR PE++L Y
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYT 204
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
VD+WS GCI+AE+ GK + G ++QL +I K+ G+P ++ ++ + A +
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264
Query: 383 QPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
P A + A+ L+E +L +D R +A AL +F + L D P
Sbjct: 265 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF--ESL-HDTEDEP 321
Query: 441 KYPP-SKEFDAKIRDEEARRQ 460
+ FD R + ++
Sbjct: 322 QVQKYDDSFDDVDRTLDEWKR 342
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 1e-81
Identities = 94/329 (28%), Positives = 141/329 (42%), Gaps = 24/329 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMA--------REIHILRRLDH 199
I G+Y V D + VA+K+V + +V REI +L H
Sbjct: 30 ISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 200 INVIKLEGLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 256
N++ L + + LYLV E M DLA + + S ++ +M +L GL
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
H GV+HRD+ N+L+ +N + I DF LA D N T V WYR PEL++
Sbjct: 149 VLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVM 206
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376
+ VD+WS GC++AE++ K + G T QL+KI ++ G+P + P A
Sbjct: 207 QFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSA 266
Query: 377 TIF----KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432
+ P R AL L+ +L +P R S ALR +F + L
Sbjct: 267 RDYLRNSLSNVP-ARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF--ESL 323
Query: 433 PCDPSSLPKYPPSK-EFDAKIRDEEARRQ 460
DP L + + FD + D +
Sbjct: 324 -FDPLDLTEGLSERFHFDESVTDVYDMHK 351
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 1e-80
Identities = 112/436 (25%), Positives = 183/436 (41%), Gaps = 73/436 (16%)
Query: 94 GSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKSLSIFS-----RSFYL 148
GS +A+ +Q +G ++ E Q + + + S + +L
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHL 60
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG G+Y +V A D +K++VA+KK+ F++ + R + REI IL RL+H +V+K+
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKR-ILREIAILNRLNHDHVVKVL 118
Query: 207 GLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+V + LY+V E + D L + +E +K + LL G+ + HS G+
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLF-RTPVYLTELHIKTLLYNLLVGVKYVHSAGI 177
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLA--------------------------SFYDPDQN 297
LHRD+K +N L++ + +K+ DFGLA + +
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
Query: 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL-----------YAGKPIMPG 346
+ LT VVT WYR PEL+L Y A+D+WS GCI AEL P+ PG
Sbjct: 238 RQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPG 297
Query: 347 --------------------RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386
R +QL+ IF + G+PSE+ + A + P +
Sbjct: 298 SSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357
Query: 387 RCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD-PSSLPKYP 443
AE F A A+ L++ +L +P R + L FF + ++ K
Sbjct: 358 EGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVR 417
Query: 444 PSKEFDAKIRDEEARR 459
+ + + R
Sbjct: 418 LPFNDWMNMDEPQLRY 433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-80
Identities = 100/295 (33%), Positives = 147/295 (49%), Gaps = 20/295 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G V+ A D D K VA+KK+ + P+SV+ REI I+RRLDH N++K+ +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 209 VTSRMSCS------------LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD 256
+ S +Y+V EYME DLA + L E + +M QLL GL
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL--LEEHARLFMYQLLRGLK 134
Query: 257 HCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQP--LTSRVVTLWYRPPE 313
+ HS VLHRD+K +NL I+ + +LKI DFGLA DP + L+ +VT WYR P
Sbjct: 135 YIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194
Query: 314 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373
LLL Y A+D+W+ GCI AE+ GK + G E+EQ+ I + E+ ++
Sbjct: 195 LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254
Query: 374 PHATIFKPQQPYKRC-VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+ + + A+ +E +L+ P DR +A AL +
Sbjct: 255 VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 3e-80
Identities = 105/318 (33%), Positives = 153/318 (48%), Gaps = 21/318 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G+G Y V A +IVA+KK+ FD P REI IL+ H N+I +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHENIITIFN 76
Query: 208 LVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ + +Y++ E M+ DL + S L S+ ++ ++ Q L + H V+
Sbjct: 77 IQRPDSFENFNEVYIIQELMQTDLHRVISTQML--SDDHIQYFIYQTLRAVKVLHGSNVI 134
Query: 265 HRDIKGSNLLIDNNGILKIADFGLA---------SFYDPDQNQPLTSRVVTLWYRPPELL 315
HRD+K SNLLI++N LK+ DFGLA + Q + V T WYR PE++
Sbjct: 135 HRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVM 194
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP-SEDYWRKSKLP 374
L + Y A+D+WS GCILAEL+ +PI PGR QL IF + G+P S++ R + P
Sbjct: 195 LTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESP 254
Query: 375 HATIFKPQQPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432
A + P + F + L++ +L DPA R +A AL +
Sbjct: 255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314
Query: 433 PCD-PSSLPKYPPSKEFD 449
P D P P P EFD
Sbjct: 315 PNDEPEGEPIPPSFFEFD 332
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 4e-80
Identities = 98/321 (30%), Positives = 152/321 (47%), Gaps = 20/321 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G Y +V A D VA+KK+ F + + RE+ +L+ + H NVI L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 207 GLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ T S +YLV M DL + L ++ V+ + Q+L GL + HS
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHSAD 152
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRD+K SNL ++ + LKI DFGLA + +T V T WYR PE++L +Y
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYN 208
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
VD+WS GCI+AEL G+ + PG ++QL I +L G+P + +K A +
Sbjct: 209 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 268
Query: 383 QPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
+ A F A+ L+E +L +D R +AA AL +F DP P
Sbjct: 269 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF--AQY-HDPDDEP 325
Query: 441 KYPP-SKEFDAKIRDEEARRQ 460
P + +++ + +
Sbjct: 326 VADPYDQSLESRDLLIDEWKS 346
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 1e-77
Identities = 100/353 (28%), Positives = 159/353 (45%), Gaps = 46/353 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRL-DHINVIKL 205
+G+G Y V+++ D ++VA+KK+ F N + REI IL L H N++ L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGHENIVNL 74
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
++ + +YLVF+YME DL + L + + QL+ + + HS G+LH
Sbjct: 75 LNVLRADNDRDVYLVFDYMETDLHAVIRANIL--EPVHKQYVVYQLIKVIKYLHSGGLLH 132
Query: 266 RDIKGSNLLIDNNGILKIADFGLA--------------------SFYDPDQNQPLTSRVV 305
RD+K SN+L++ +K+ADFGL+ + D LT V
Sbjct: 133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVA 192
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365
T WYR PE+LLG+T Y +D+WS GCIL E+ GKPI PG + + QL +I + PS
Sbjct: 193 TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSN 252
Query: 366 D------------YWR----KSKLPHATIFKPQQPYKRCVAETFKDFPAPALA--LMETL 407
+ K ++ + +K + + A L++ L
Sbjct: 253 EDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312
Query: 408 LSIDPADRGSAASALRSEFFTMKPLPCD-PSSLPKYPPSKEFDAKIRDEEARR 459
L +P R SA AL+ F ++ P + P+ + K ++ R
Sbjct: 313 LQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRN 365
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 246 bits (629), Expect = 3e-75
Identities = 92/335 (27%), Positives = 158/335 (47%), Gaps = 35/335 (10%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG G V A D ++ VA+KK+ F N + RE+ +++ ++H N+I L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 207 GLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ T + S +Y+V E M+ +L + ++ + Q+LCG+ H HS G
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAG 147
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRD+K SN+++ ++ LKI DFGLA +T VVT +YR PE++LG Y
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG-MGYK 204
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK---------SKL 373
VD+WS GCI+ E+ G + PG ++Q +K+ + G+P ++ +K
Sbjct: 205 ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 264
Query: 374 PHATIFKPQQPYKR--------CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425
P +++ +E K + A L+ +L ID + R S AL+
Sbjct: 265 PK----YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320
Query: 426 FFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 460
+ + P + + P P K+ D + E ++
Sbjct: 321 YINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 355
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 1e-73
Identities = 94/335 (28%), Positives = 157/335 (46%), Gaps = 35/335 (10%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG G V A D + VA+KK+ F N + RE+ +++ ++H N+I L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 207 GLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ T + + +YLV E M+ +L + ++ + Q+LCG+ H HS G
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAG 184
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRD+K SN+++ ++ LKI DFGLA +T VVT +YR PE++LG Y
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILG-MGYK 241
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK---------SKL 373
VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P ++ +K
Sbjct: 242 ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301
Query: 374 PHATIFKPQQPYKR--------CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425
P + + +E K + A L+ +L IDPA R S AL+
Sbjct: 302 PK----YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 426 FFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 460
+ + P + + P K+ D + E ++
Sbjct: 358 YINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 392
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-73
Identities = 98/357 (27%), Positives = 158/357 (44%), Gaps = 62/357 (17%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
IG+G+Y VY A D + +K VA+KKV F++L + R + REI IL RL +I+L
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI-DCKR-ILREITILNRLKSDYIIRLY 91
Query: 207 GLVTSRMSCS---LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L+ LY+V E + DL L + +E +K + LL G + H G+
Sbjct: 92 DLIIPDDLLKFDELYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGENFIHESGI 150
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLA---------------------SFYDPDQNQPLTS 302
+HRD+K +N L++ + +K+ DFGLA ++ + + LTS
Sbjct: 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-----------KPIMPG----- 346
VVT WYR PEL+L Y ++D+WSTGCI AEL P+ PG
Sbjct: 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFP 270
Query: 347 ------------RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCV--AET 392
++ +QL+ IF + G+P+ED + P + P+++ + +
Sbjct: 271 LSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330
Query: 393 FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFD 449
+ + L+E++L +P R + AL + K +
Sbjct: 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYL--KDV-RKKKLENFSTKKIILP 384
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-64
Identities = 73/308 (23%), Positives = 125/308 (40%), Gaps = 48/308 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKL 205
IG G S V++ + ++K+I A+K V + + +++ EI L +L +I+L
Sbjct: 35 QIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 206 EG-LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+T + +Y+V E DL + K Y + +L + H G++
Sbjct: 94 YDYEITDQ---YIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIV 149
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATY--- 320
H D+K +N LI +G+LK+ DFG+A+ PD + S+V T+ Y PPE + +
Sbjct: 150 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 208
Query: 321 -------YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373
D+WS GCIL + GK P + + Q+ K+
Sbjct: 209 NGKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA--------------- 251
Query: 374 PHATIFKPQQPYKRCVAETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFFTMKPL 432
I P + F D P +++ L DP R S L + ++
Sbjct: 252 ----IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301
Query: 433 PCDPSSLP 440
P + +
Sbjct: 302 PVNQMAKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-62
Identities = 73/326 (22%), Positives = 127/326 (38%), Gaps = 46/326 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKL 205
IG G S V++ + ++K+I A+K V + + +++ EI L +L +I+L
Sbjct: 16 QIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ +Y+V E DL + K Y + +L + H G++H
Sbjct: 75 YDYEITDQY--IYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVH 131
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATY---- 320
D+K +N LI +G+LK+ DFG+A+ PD + S+V T+ Y PPE + +
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 321 ------YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374
D+WS GCIL + GK P + + Q+ K+
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA---------------- 232
Query: 375 HATIFKPQQPYKRCVAETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
I P + F D P +++ L DP R S L + ++ P
Sbjct: 233 ---IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283
Query: 434 CDPSSLPKYPPSKEFDAKIRDEEARR 459
+ + K ++ +
Sbjct: 284 VNQMAKGTTEEMKYVLGQLVGLNSPN 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-60
Identities = 76/329 (23%), Positives = 128/329 (38%), Gaps = 66/329 (20%)
Query: 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF 186
R A FE++ +GQG + V +AR+ + A+KK+R + ++
Sbjct: 3 RYASDFEEIAV-----------LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL- 50
Query: 187 MAREIHILRRLDHINVIKL-----------EGLVTSRMSCSLYLVFEYME-HDLAGLASH 234
E+ +L L+H V++ + + + +L++ EY E L L
Sbjct: 51 --SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS 108
Query: 235 PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD- 293
L + +Q+L L + HS+G++HRD+K N+ ID + +KI DFGLA
Sbjct: 109 ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
Query: 294 ------------PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 341
P + LTS + T Y E+L G +Y +D++S G I E+
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--Y 226
Query: 342 PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPAL 401
P G V L K+ + D+ + K
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDN------------------KMKVEKK------ 262
Query: 402 ALMETLLSIDPADRGSAASALRSEFFTMK 430
++ L+ DP R A + L S + +K
Sbjct: 263 -IIRLLIDHDPNKRPGARTLLNSGWLPVK 290
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-60
Identities = 73/345 (21%), Positives = 129/345 (37%), Gaps = 46/345 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKL 205
IG G S V++ + ++K+I A+K V + + +++ EI L +L +I+L
Sbjct: 63 QIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ +Y+V E DL + K Y + +L + H G++H
Sbjct: 122 YDYEIT--DQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATY---- 320
D+K +N LI +G+LK+ DFG+A+ PD + S+V + Y PPE + +
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 321 ------YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374
D+WS GCIL + GK P + + Q+ K+
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKT--PFQQIINQISKLHA---------------- 279
Query: 375 HATIFKPQQPYKRCVAETFKDFPAP-ALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
I P + F D P +++ L DP R S L + ++ P
Sbjct: 280 ---IIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330
Query: 434 CDPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRES 478
+ + K ++ + + + G
Sbjct: 331 VNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESH 375
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 5e-56
Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 25/289 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
++GQG +NV+R R + A+K + M RE +L++L+H N++KL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFA 74
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ + L+ E+ L + P E++ ++ ++ G++H G++
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 265 HRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT- 319
HR+IK N++ D + K+ DFG A + D + S T Y P++ A
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMYERAVL 192
Query: 320 ------YYGTAVDLWSTGCILAELYAGKP----IMPGRTEVEQLHKIFKLCGSPSEDYWR 369
YG VDLWS G G R E ++KI S + +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
K++ + P ++ + P LA + L D
Sbjct: 253 KAE-NGPIDWSGDMPVSCSLSRGLQVLLTPVLANI---LEADQEKCWGF 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-54
Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR 185
P RA+ +E L IG G+Y + R KI+ K++ + ++ +
Sbjct: 2 PSRAEDYEVLYT-----------IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ 50
Query: 186 FMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGL---ASHPGLKFSE 241
+ E+++LR L H N+++ + R + +LY+V EY E DLA + + E
Sbjct: 51 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 242 AQVKCYMQQLLCGLDHCHSRG-----VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296
V M QL L CH R VLHRD+K +N+ +D +K+ DFGLA + D
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170
Query: 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
+ + V T +Y PE + + Y D+WS GC+L EL A P ++ E KI
Sbjct: 171 SF-AKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228
Query: 357 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG 416
+ G ++P + ++ +L++ R
Sbjct: 229 RE--GKF-------RRIP-------------------YRYSDELNEIITRMLNLKDYHRP 260
Query: 417 SAASALRSEFF 427
S L +
Sbjct: 261 SVEEILENPLI 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 82/316 (25%), Positives = 127/316 (40%), Gaps = 37/316 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHINVIKLE 206
+G+G ++ + D D K++ A K V L R M+ EI I R L H +V+
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G +++V E L L +E + + Y++Q++ G + H V+H
Sbjct: 108 GFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIH 164
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K NL ++ + +KI DFGLA+ + D + T Y PE+L + V
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK-KGHSFEV 222
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
D+WS GCI+ L GKP E +I K +Y +P
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP----------- 261
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD-PSSLPKYPP 444
K A +L++ +L DP R + L EFFT +P P + PP
Sbjct: 262 --------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP 313
Query: 445 SKEFDAKIRDEEARRQ 460
D R+
Sbjct: 314 RFSIAPSSLDPSNRKP 329
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-54
Identities = 64/289 (22%), Positives = 112/289 (38%), Gaps = 25/289 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
++GQG +NV+R R + A+K + M RE +L++L+H N++KL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFA 74
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ + L+ E+ L + P E++ ++ ++ G++H G++
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIV 134
Query: 265 HRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT- 319
HR+IK N++ D + K+ DFG A + D + S T Y P++ A
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD--EQFVSLYGTEEYLHPDMYERAVL 192
Query: 320 ------YYGTAVDLWSTGCILAELYAGKP----IMPGRTEVEQLHKIFKLCGSPSEDYWR 369
YG VDLWS G G R E ++KI S + +
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ 252
Query: 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
K++ + P ++ + P LA + L D
Sbjct: 253 KAE-NGPIDWSGDMPVSCSLSRGLQVLLTPVLANI---LEADQEKCWGF 297
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-54
Identities = 72/321 (22%), Positives = 123/321 (38%), Gaps = 69/321 (21%)
Query: 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR 185
R F++++ IG G + V++A+ K +K+V+++N +
Sbjct: 7 KRFGMDFKEIEL-----------IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK----- 50
Query: 186 FMAREIHILRRLDHINVIKL--------------EGLVTSRMSCSLYLVFEYMEH-DLAG 230
RE+ L +LDH+N++ + + L++ E+ + L
Sbjct: 51 -AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109
Query: 231 -LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
+ G K + +Q+ G+D+ HS+ +++RD+K SN+ + + +KI DFGL
Sbjct: 110 WIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 290 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE 349
+ D T TL Y PE + YG VDL++ G ILAEL + T
Sbjct: 170 TSLKNDGK--RTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAEL-----LHVCDTA 221
Query: 350 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLS 409
E L R + F L++ LLS
Sbjct: 222 FETSKFFTDL---------RDGIIS-------------------DIFDKKEKTLLQKLLS 253
Query: 410 IDPADRGSAASALRSEFFTMK 430
P DR + + LR+ K
Sbjct: 254 KKPEDRPNTSEILRTLTVWKK 274
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-53
Identities = 66/307 (21%), Positives = 113/307 (36%), Gaps = 49/307 (15%)
Query: 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR 185
SF++L + +G G+Y V++ R + ++ A+K+ P+
Sbjct: 53 SFFQQSFQRLSR-----------LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA 101
Query: 186 FMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQV 244
E+ ++ H ++LE LYL E L G EAQV
Sbjct: 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEG--GILYLQTELCGPSLQQHCEAWGASLPEAQV 159
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
Y++ L L H HS+G++H D+K +N+ + G K+ DFGL +
Sbjct: 160 WGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA--GEVQE 217
Query: 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
Y PELL G+ YGTA D++S G + E+ +P E ++ +
Sbjct: 218 GDPRYMAPELLQGS--YGTAADVFSLGLTILEVACNME-LP--HGGEGWQQLRQG----- 267
Query: 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424
P+ + +++ +L DP R +A + L
Sbjct: 268 -------------YLPPEFT---------AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305
Query: 425 EFFTMKP 431
+P
Sbjct: 306 PVLR-QP 311
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-53
Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 37/300 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHINVIKLE 206
+G+G ++ + D D K++ A K V L R M+ EI I R L H +V+
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G +++V E L L +E + + Y++Q++ G + H V+H
Sbjct: 82 GFFEDNDF--VFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIH 138
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K NL ++ + +KI DFGLA+ + D + T Y PE+L + V
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-CGTPNYIAPEVLSK-KGHSFEV 196
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
D+WS GCI+ L GKP E +I K +Y +P
Sbjct: 197 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN------EY----SIP----------- 235
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD-PSSLPKYPP 444
K A +L++ +L DP R + L EFFT +P P + PP
Sbjct: 236 --------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPP 287
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-52
Identities = 75/356 (21%), Positives = 134/356 (37%), Gaps = 40/356 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK-LE 206
IG+G++ + + + +K++ + + RE+ +L + H N+++ E
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ SLY+V +Y E DL + + G+ F E Q+ + Q+ L H H R +L
Sbjct: 91 SFEENG---SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKIL 147
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRDIK N+ + +G +++ DFG+A + + + T +Y PE+ Y
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL-ARACIGTPYYLSPEICENKP-YNNK 205
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+W+ GC+L EL K + + KI P P
Sbjct: 206 SDIWALGCVLYELCTLKHAFEAGSMKNLVLKI------------ISGSFP---------P 244
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPP 444
+ + L+ L +P DR S S L F L
Sbjct: 245 VSLHYSYDLRS-------LVSQLFKRNPRDRPSVNSILEKGFIA----KRIEKFLSPQLI 293
Query: 445 SKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELVLSMQKRQSQ 500
++EF K + + +K ++ I P A + L+ +K +
Sbjct: 294 AEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDK 349
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 5e-52
Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 35/288 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHINVIKLE 206
L+G+G+++ VYRA + VA+K + + + + E+ I +L H ++++L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+YLV E + ++ + FSE + + +M Q++ G+ + HS G+LH
Sbjct: 78 NYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILH 135
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+ SNLL+ N +KIADFGLA+ + T T Y PE+ + +G
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL-CGTPNYISPEIATR-SAHGLES 193
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
D+WS GC+ L G+P T L+K+ DY ++P
Sbjct: 194 DVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------DY----EMP----------- 232
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
A L+ LL +PADR S +S L F +
Sbjct: 233 --------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-51
Identities = 65/291 (22%), Positives = 102/291 (35%), Gaps = 19/291 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL--- 205
+G G + V R D + VA+K+ R + L P++ EI I+++L+H NV+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 206 -EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSR 261
+GL + L EY E DL + E ++ + + L + H
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 262 GVLHRDIKGSNLLIDNNG---ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
++HRD+K N+++ I KI D G A D + T V TL Y PELL
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQK 198
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378
Y VD WS G + E G + Q H + + +
Sbjct: 199 K-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257
Query: 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429
P ++ +L RG+ F
Sbjct: 258 SVLPTPNHLS-----GILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-51
Identities = 66/310 (21%), Positives = 119/310 (38%), Gaps = 56/310 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK--- 204
+G+G + V+ A++ A+K++R N E + M RE+ L +L+H +++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-REVKALAKLEHPGIVRYFN 70
Query: 205 -------LEGLVTSRMSCSLYLVFEYMEH-DLAGL--ASHPGLKFSEAQVKCYMQQLLCG 254
E L S LY+ + +L + + Q+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 255 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-----------SFYDPDQNQPLTSR 303
++ HS+G++HRD+K SN+ + ++K+ DFGL T +
Sbjct: 131 VEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ 190
Query: 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 363
V T Y PE + G + Y VD++S G IL EL + P T++E++ + +
Sbjct: 191 VGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERVRTLTDV---- 240
Query: 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
R K P F +++ +LS P +R A + +
Sbjct: 241 -----RNLKFPP----------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279
Query: 424 SEFFTMKPLP 433
+ F P
Sbjct: 280 NAVFEDLDFP 289
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 79/281 (28%), Positives = 119/281 (42%), Gaps = 34/281 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLE 206
IG+G +S VYRA L VALKKV+ +L R +EI +L++L+H NVIK
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGL---ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L +V E + DL+ + E V Y QL L+H HSR
Sbjct: 99 ASFIED--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
V+HRDIK +N+ I G++K+ D GL F+ + S V T +Y PE + Y
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENG-YN 214
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
D+WS GC+L E+ A + P + L+ + K + + + + P
Sbjct: 215 FKSDIWSLGCLLYEMAALQS--PFYGDKMNLYSLCK----------KIEQCDYPPL--PS 260
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
Y +E + + ++ DP R
Sbjct: 261 DHY----SEELRQL-------VNMCINPDPEKRPDVTYVYD 290
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 8e-50
Identities = 59/321 (18%), Positives = 114/321 (35%), Gaps = 47/321 (14%)
Query: 137 KSLSIFSRSFYL---IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI 193
+ I ++ + +G+G +S V L ALK++ + RE +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--QQDREEAQREADM 79
Query: 194 LRRLDHINVIKLEG--LVTSRMSCSLYLVFEYMEH-DLAGL---ASHPGLKFSEAQVKCY 247
R +H N+++L L +L+ + + L G +E Q+
Sbjct: 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--------QNQP 299
+ + GL+ H++G HRD+K +N+L+ + G + D G + Q
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 300 LTSRVVTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357
++ T+ YR PEL ++ D+WS GC+L + G+ P +
Sbjct: 200 WAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG--P-----------Y 246
Query: 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 417
+ + + PQ P + L+ +++++DP R
Sbjct: 247 DMVFQKGDSVALAV---QNQLSIPQSPR----------HSSALWQLLNSMMTVDPHQRPH 293
Query: 418 AASALRSEFFTMKPLPCDPSS 438
L P P ++
Sbjct: 294 IPLLLSQLEALQPPAPGQHTT 314
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-49
Identities = 57/304 (18%), Positives = 122/304 (40%), Gaps = 39/304 (12%)
Query: 149 IGQGTYSNVYRARD---------LDQKKIVALKKVRFDNLEPESVRFMA----REIHILR 195
+ QG ++ + ++ + + N + S++ E+ I+
Sbjct: 39 LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 196 RLDHINVIKLEGLVTSRMSCSLYLVFEYME--------HDLAGLASHPGLKFSEAQVKCY 247
+ + + EG++T+ +Y+++EYME L + +KC
Sbjct: 99 DIKNEYCLTCEGIITNYDE--VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 248 MQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306
++ +L + H+ + + HRD+K SN+L+D NG +K++DFG + + ++ + T
Sbjct: 157 IKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKGSRGT 213
Query: 307 LWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPS 364
+ PPE ++Y G VD+WS G L ++ P + VE + I
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT------ 267
Query: 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424
++ + P + + + ++ L +PA+R ++ AL+
Sbjct: 268 KNI----EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323
Query: 425 EFFT 428
E+
Sbjct: 324 EWLA 327
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 176 bits (446), Expect = 4e-49
Identities = 48/313 (15%), Positives = 84/313 (26%), Gaps = 56/313 (17%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRRLDHIN----- 201
+ G S V+ RD+++ + ALK S + + RL +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 202 -------------------VIKLEGLVTSRMSCSLYLVFEYMEHDLAGL------ASHPG 236
+L + L+ DL L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 237 LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296
+ QL+ + S+G++H NL I +G L + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW----KV 244
Query: 297 NQPLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 355
+ V + Y P E L + A++ W G + ++ P
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--P---------- 292
Query: 356 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
F L + W++ L + C P L+ L+ D R
Sbjct: 293 -FGLVTPGIKGSWKRPSL--RVPGTDSLAFGSC-----TPLPDFVKTLIGRFLNFDRRRR 344
Query: 416 GSAASALRSEFFT 428
A+ + F
Sbjct: 345 LLPLEAMETPEFL 357
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 8e-49
Identities = 72/354 (20%), Positives = 124/354 (35%), Gaps = 49/354 (13%)
Query: 92 GMGSIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKSLSIFSRSF----- 146
G S +A +A W + A + + EKL +
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62
Query: 147 -YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+G+G++ V+R +D A+KKVR + E E+ L ++ L
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPL 115
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
G R + + E +E L L G E + Y+ Q L GL++ H+R +L
Sbjct: 116 YG--AVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRIL 172
Query: 265 HRDIKGSNLLIDNNGIL-KIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGAT 319
H D+K N+L+ ++G + DFG A PD + + PE+++G
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-K 231
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
VD+WS+ C++ + G P T+ + K+ P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCH--P-WTQYFRGPLCLKIASEP---------------- 272
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
P + A ++ L +P R SA R ++ +
Sbjct: 273 PPIREIPPSCAPLTAQA-------IQEGLRKEPVHRASAMELRRKVGKALQEVG 319
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-48
Identities = 82/283 (28%), Positives = 119/283 (42%), Gaps = 38/283 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRRLDHINVIKLE 206
+G+G + NVY AR+ K I+ALK + LE + RE+ I L H N+++L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G +YL+ EY + KF E + Y+ +L L +CHS+ V+H
Sbjct: 76 GYFHDATR--VYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIH 132
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RDIK NLL+ + G LKIADFG + + T TL Y PPE++ G + V
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGRM-HDEKV 188
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
DLWS G + E GKP T E +I ++ ++ P
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------EF----TFP----------- 227
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
A L+ LL +P+ R L + T
Sbjct: 228 --------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-48
Identities = 99/361 (27%), Positives = 154/361 (42%), Gaps = 90/361 (24%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR----EIHILRRL------ 197
+IG+G++ V +A D + VALK VR + + R EI IL L
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-------NEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 198 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLK------FSEAQVKCYMQQL 251
+ +NVI + T R + + FE + +L L +K FS V+ + +
Sbjct: 157 NTMNVIHMLENFTFRNH--ICMTFELLSMNLYEL-----IKKNKFQGFSLPLVRKFAHSI 209
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLIDNNG--ILKIADFGLASFYDPDQNQPLTSRVVTLWY 309
L LD H ++H D+K N+L+ G +K+ DFG + + ++Q + + + + +Y
Sbjct: 210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRVYTYIQSRFY 265
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369
R PE++LGA Y G +D+WS GCILAEL G P++PG E +QL + +L G PS+
Sbjct: 266 RAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 370 KSK-------------------LPHATIFKPQQPYKR------------------CVAET 392
SK L ++ +R C
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 393 FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKI 452
F DF ++ L DPA R + ALR + + LPK PP+ E +
Sbjct: 385 FLDF-------LKQCLEWDPAVRMTPGQALRHPWLRRR--------LPK-PPTGEKTSVK 428
Query: 453 R 453
R
Sbjct: 429 R 429
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 9e-48
Identities = 83/301 (27%), Positives = 122/301 (40%), Gaps = 41/301 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV-RFMAREIHILRRLDHINVIKLE 206
+G+G + NVY AR+ K I+ALK + LE E V + REI I L H N++++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
R +YL+ E+ +L G +F E + +M++L L +CH R V+H
Sbjct: 81 NYFHDRKR--IYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIH 137
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RDIK NLL+ G LKIADFG + + + TL Y PPE++ G T + V
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRTMCGTLDYLPPEMIEGKT-HDEKV 193
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
DLW G + E G P + E +I + D K P
Sbjct: 194 DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV------DL----KFP----------- 232
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPS 445
+ L+ LL P R + + P P Y +
Sbjct: 233 --------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP---PVYQST 281
Query: 446 K 446
+
Sbjct: 282 Q 282
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-47
Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 46/289 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G Y V RD A+K +R ++ S + E+ +L+ LDH N++KL
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 209 VTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ + YLV E + G + KF+E ++Q+L G+ + H
Sbjct: 105 FEDKRN--YYLVMECYK----GGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 263 VLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
++HRD+K NLL+++ + ++KI DFGL++ ++ + + R+ T +Y PE+L
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIAPEVLRKK- 213
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
Y D+WS G IL L AG P G+T+ E L K+ K + W+
Sbjct: 214 -YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN--------- 263
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
V+E KD ++ +L D R SA AL +
Sbjct: 264 ---------VSEGAKDL-------IKQMLQFDSQRRISAQQALEHPWIK 296
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 2e-47
Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 45/292 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLE 206
++G G + D + VA+K++ PE F RE+ +LR D H NVI+
Sbjct: 31 VLGHGAEGTIVYRGMFDNRD-VAVKRI-----LPECFSFADREVQLLRESDEHPNVIRYF 84
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
R Y+ E L + +QQ GL H HS ++HR
Sbjct: 85 CTEKDRQF--QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHR 142
Query: 267 DIKGSNLLIDNNG-----ILKIADFGLASFYDPDQN--QPLTSRVVTLWYRPPELLLGAT 319
D+K N+LI I+DFGL ++ + T + PE+L
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDC 202
Query: 320 Y--YGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376
VD++S GC+ + + G + + + +
Sbjct: 203 KENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED----- 257
Query: 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
++ L+E ++++DP R SA L+ FF
Sbjct: 258 --------------VIARE-------LIEKMIAMDPQKRPSAKHVLKHPFFW 288
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-47
Identities = 70/290 (24%), Positives = 130/290 (44%), Gaps = 58/290 (20%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G++ V + +D ++ A+K + + + + + RE+ +L++LDH N++KL +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQLLCGLDHC 258
+ S Y+V E G L +FSE ++Q+ G+ +
Sbjct: 90 LEDSSS--FYIVGELYT----------GGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 259 HSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
H ++HRD+K N+L+ + + +KI DFGL++ + + + R+ T +Y PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVL 195
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWRKSKL 373
G Y D+WS G IL L +G P G+ E + L ++ G + WR
Sbjct: 196 RGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYAFDLPQWRT--- 248
Query: 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+++ KD L+ +L+ P+ R +A L
Sbjct: 249 ---------------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 5e-47
Identities = 69/286 (24%), Positives = 131/286 (45%), Gaps = 50/286 (17%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G++ V + +D ++ A+K + + + + + RE+ +L++LDH N++KL +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 209 VTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ S Y+V E G + +FSE ++Q+ G+ + H
Sbjct: 90 LEDSSS--FYIVGELYT----GGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN 141
Query: 263 VLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
++HRD+K N+L+++ + +KI DFGL++ + + + R+ T +Y PE+L G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPEVLRGT- 198
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWRKSKLPHAT 377
Y D+WS G IL L +G P G+ E + L ++ G + WR
Sbjct: 199 -YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQWRT------- 248
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+++ KD L+ +L+ P+ R +A L
Sbjct: 249 -----------ISDDAKD-------LIRKMLTFHPSLRITATQCLE 276
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-46
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 38/292 (13%)
Query: 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN 201
F + IG+G++ VY+ D + VA +++ L + E +L+ L H N
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 202 VIKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+++ T + + LV E M L ++ + +Q+L GL
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFL 145
Query: 259 HSRG--VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
H+R ++HRD+K N+ I G +KI D GLA+ + + + T + PE
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPE-- 200
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375
+ Y +VD+++ G + E+ + P +E + +I++ S
Sbjct: 201 MYEEKYDESVDVYAFGMCMLEMATSEY--PY-SECQNAAQIYRRVTSGV----------- 246
Query: 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
KP K + E K+ +E + + +R S L FF
Sbjct: 247 ----KPASFDKVAIPE-VKEI-------IEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-46
Identities = 79/319 (24%), Positives = 141/319 (44%), Gaps = 55/319 (17%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEG 207
+G+G++ V +D + A+K + ++ + RE+ +L++LDH N++KL
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 208 LVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+ YLV E G + S +FSE ++Q+L G+ + H
Sbjct: 94 FFEDKGY--FYLVGEVYT----GGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN 145
Query: 262 GVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
++HRD+K NLL+++ + ++I DFGL++ ++ ++ + ++ T +Y PE+L G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYYIAPEVLHGT 203
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWRKSKLPHA 376
Y D+WSTG IL L +G P G E + L K+ K G + W+K
Sbjct: 204 --YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQWKK------ 253
Query: 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 436
V+E+ KD + +L+ P+ R SA AL E+
Sbjct: 254 ------------VSESAKDL-------IRKMLTYVPSMRISARDALDHEWIQTYTKEQIS 294
Query: 437 SSLPKYPPS----KEFDAK 451
+P + ++F
Sbjct: 295 VDVPSLDNAILNIRQFQGT 313
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 85/367 (23%), Positives = 142/367 (38%), Gaps = 67/367 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---------- 197
+G G +S V+ A+D+ VA+K VR D + E+ EI +L+R+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82
Query: 198 -DHINVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLA-SHPGLKFSEAQVKCYMQQLLC 253
+++KL + +VFE + +L L + VK +QLL
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 254 GLDHCHSR-GVLHRDIKGSNLLID------NNGILKIADFGLASFYDPDQNQPLTSRVVT 306
GLD+ H R G++H DIK N+L++ N +KIAD G A + ++ T+ + T
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYTNSIQT 198
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHKIFKLC 360
YR PE+LLGA + G D+WST C++ EL G + + + + +I +L
Sbjct: 199 REYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257
Query: 361 GSPSEDYWRKSKL--------------------PHATIFKPQQPYKRCVAETFKDFPAPA 400
G R K P + + + + A+ DF
Sbjct: 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF---- 313
Query: 401 LALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 460
+ +L +DP R A + + + P +E D +
Sbjct: 314 ---LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR-----VPDRELYGSGSDIPGWFE 365
Query: 461 GGSKGQR 467
+R
Sbjct: 366 EVRDHKR 372
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-46
Identities = 76/366 (20%), Positives = 133/366 (36%), Gaps = 81/366 (22%)
Query: 139 LSIFSRSFY-------LIGQGTYSNVYRARDLDQKKIVALKKV------RFDNLEPESVR 185
+S++ ++ +G G V A + K VA+K + E +
Sbjct: 1 MSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL 60
Query: 186 FMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLASHPGLK 238
+ EI IL++L+H +IK++ + Y+V E ME +L +
Sbjct: 61 NVETEIEILKKLNHPCIIKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------R 110
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPD 295
EA K Y Q+L + + H G++HRD+K N+L+ + + ++KI DFG +
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 296 QNQPLTSRVVTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 353
+ + T Y PE+L+ Y AVD WS G I L+ I
Sbjct: 171 --SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI---LF----IC--------- 212
Query: 354 HKIFKLCGSP--SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP--------ALAL 403
L G P SE + + + +F AL L
Sbjct: 213 -----LSGYPPFSEHR------------TQVSLKDQITSGKY-NFIPEVWAEVSEKALDL 254
Query: 404 METLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS 463
++ LL +DP R + ALR + + + L ++ + + +
Sbjct: 255 VKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLAQPSTSRKRP 314
Query: 464 KGQRMD 469
+ +
Sbjct: 315 REGEAE 320
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 3e-46
Identities = 56/403 (13%), Positives = 114/403 (28%), Gaps = 85/403 (21%)
Query: 86 VAQHHPGMGSIPKASEGEQVAAGWPAWLAA-VAGEAIQGWVPRRADSFEKLDKSLSIFSR 144
+ PG I + A A +++ +++ L R
Sbjct: 14 LYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPR 73
Query: 145 SFY---LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRL--- 197
+ ++GQ A D + + + F P +++ M E+ LR L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 198 ----------------------DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGL---- 231
+I++ S + ++ M+ +L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 232 --ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
S Q++ L H G++H ++ ++++D G + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 290 SFYDPDQNQPLTSRVVTLWYRPPELL----------LGATYYGTAVDLWSTGCILAELYA 339
++ V+ + PPEL T + D W+ G ++ ++
Sbjct: 254 V-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 340 GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP 399
+ + IF+ C K+ P P
Sbjct: 309 ADLPITKDAALGGSEWIFRSC---------------------------------KNIPQP 335
Query: 400 ALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKY 442
AL+E L DR A+ + + ++LP Y
Sbjct: 336 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLR-TELSAALPLY 377
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 5e-46
Identities = 81/293 (27%), Positives = 130/293 (44%), Gaps = 54/293 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
++G+GTY VY RDL + +A+K++ + + + EI + + L H N+++ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 208 LVTSRMSCSLYLVFEYME----HDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ + + + E + L L S G LK +E + Y +Q+L GL + H
Sbjct: 87 --SFSENGFIKIFMEQVPGGSLSAL--LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 263 VLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY- 320
++HRDIKG N+LI+ +G+LKI+DFG + N + TL Y PE++
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
YG A D+WS GC + E+ GKP P + + P A +FK
Sbjct: 202 YGKAADIWSLGCTIIEMATGKP--P----------------------FYELGEPQAAMFK 237
Query: 381 -------PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
P+ P ++ K F +++ DP R A L EF
Sbjct: 238 VGMFKVHPEIP--ESMSAEAKAF------ILKC-FEPDPDKRACANDLLVDEF 281
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-46
Identities = 78/382 (20%), Positives = 130/382 (34%), Gaps = 70/382 (18%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
R + ++SL S ++G G+ V + VA+K+ + +
Sbjct: 2 RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRP-VAVKR-----MLIDFCDIA 55
Query: 188 AREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEHDLA------GLASHPGLKFS 240
EI +L D H NVI+ T+ LY+ E +L ++
Sbjct: 56 LMEIKLLTESDDHPNVIRYYCSETTDRF--LYIALELCNLNLQDLVESKNVSDENLKLQK 113
Query: 241 EAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-------------NGILKIADFG 287
E ++Q+ G+ H HS ++HRD+K N+L+ N + I+DFG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 288 LASFYDPDQ---NQPLTSRVVTLWYRPPELLLGAT------YYGTAVDLWSTGCILAELY 338
L D Q L + T +R PELL + ++D++S GC+ +
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 339 -AGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFP 397
GK P + + I + G S D + + + R + D
Sbjct: 234 SKGKH--PFGDKYSRESNIIR--GIFSLD-------------EMKCLHDRSLIAEATD-- 274
Query: 398 APALALMETLLSIDPADRGSAASALRSEFFTMK----PLPCDPSSL----PKYPPSKEFD 449
L+ ++ DP R +A LR F K S + PPS
Sbjct: 275 -----LISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLM 329
Query: 450 AKIRDEEARRQGGSKGQRMDLE 471
+ G + D
Sbjct: 330 KFDAGSDFVIPSGDWTVKFDKT 351
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 73/292 (25%), Positives = 116/292 (39%), Gaps = 61/292 (20%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G +S V R A K + L + + RE I R+L H N+++L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQLLCGLDHC 258
+ YLVF+ + G L +SEA +QQ+L + +C
Sbjct: 74 IQEES--FHYLVFDLVT----------GGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 259 HSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
HS G++HR++K NLL+ +K+ADFGLA + ++ T Y PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVL 179
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPS--EDYWRKS 371
Y VD+W+ G IL L G P P + +I G+ W
Sbjct: 180 KK-DPYSKPVDIWACGVILYILLVGYP--PFWDEDQHRLYAQI--KAGAYDYPSPEWDT- 233
Query: 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
V K L++++L+++P R +A AL+
Sbjct: 234 -----------------VTPEAKS-------LIDSMLTVNPKKRITADQALK 261
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 65/342 (19%), Positives = 120/342 (35%), Gaps = 80/342 (23%)
Query: 148 LIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAR----EIHILRRL----- 197
+G+G + V D + VA+K V+ +V EI +L L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVK-------NVDRYCEAARSEIQVLEHLNTTDP 73
Query: 198 -DHINVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQVKC 246
+++ +V + S Y +++ E+ F ++
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGLSTY---DFIKENGFLP--------FRLDHIRK 122
Query: 247 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-------------------LKIADFG 287
Q+ ++ HS + H D+K N+L + +K+ DFG
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 347
A++ ++ ++ V T YR PE++L + D+WS GCIL E Y G + P
Sbjct: 183 SATY----DDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTH 237
Query: 348 TEVEQLHKIFKLCGSPSEDY----------------WRKSKLPHATIFKPQQPYKRCVAE 391
E L + ++ G + W + + + +P K +
Sbjct: 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS 297
Query: 392 TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
+ L++ +L DPA R + AL+ FF +
Sbjct: 298 QDVEHER-LFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 83/314 (26%), Positives = 132/314 (42%), Gaps = 42/314 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
L+G+G+Y V D + A+K K + + + +EI +LRRL H NVI+
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQ 70
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L ++ + +Y+V EY + + P +F Q Y QL+ GL++ HS+G+
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGI 130
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLGA-TYY 321
+H+DIK NLL+ G LKI+ G+A P + + + ++PPE+ G T+
Sbjct: 131 VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFS 190
Query: 322 GTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
G VD+WS G L + G P G + I K Y +P
Sbjct: 191 GFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGK------GSY----AIP----- 233
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439
D P L++ +L +PA R S + +F K P +
Sbjct: 234 --------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP--AEAP 277
Query: 440 PKYPPSKEFDAKIR 453
PPS + + R
Sbjct: 278 VPIPPSPDTKDRWR 291
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-45
Identities = 54/303 (17%), Positives = 102/303 (33%), Gaps = 62/303 (20%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 206
IG G + +V++ I A+K+ + + RE++ L H +V++
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 207 GLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ + EY D F EA++K + Q+ GL + HS
Sbjct: 78 SAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 263 VLHRDIKGSNLLIDNNGIL-------------------KIADFGLASFYDPDQNQPLTSR 303
++H DIK SN+ I I KI D G + +
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT-----RISSPQVE 190
Query: 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 363
+ E+L + D+++ + +P+ +Q H+I
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL---PRNGDQWHEI------- 240
Query: 364 SEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
R+ +LP + +++ F + L +M + DP R SA + ++
Sbjct: 241 -----RQGRLP---------RIPQVLSQEFTEL----LKVM---IHPDPERRPSAMALVK 279
Query: 424 SEF 426
Sbjct: 280 HSV 282
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-45
Identities = 74/309 (23%), Positives = 122/309 (39%), Gaps = 59/309 (19%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK--------KVRFDNLEPESVRFMA----------- 188
IG+G+Y V A + + A+K + P
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 189 -----REIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEA 242
+EI IL++LDH NV+KL ++ LY+VFE + + + + SE
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSED 137
Query: 243 QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302
Q + Y Q L+ G+++ H + ++HRDIK SNLL+ +G +KIADFG+++ + + L++
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLSN 196
Query: 303 RVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKL 359
V T + PE L + G A+D+W+ G L G+ P M + KI
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-DERIMCLHSKIKS- 254
Query: 360 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA 419
+ + P KD L+ +L +P R
Sbjct: 255 -----QAL----EFPDQPDIAED----------LKD-------LITRMLDKNPESRIVVP 288
Query: 420 SALRSEFFT 428
+ T
Sbjct: 289 EIKLHPWVT 297
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 3e-45
Identities = 75/355 (21%), Positives = 130/355 (36%), Gaps = 81/355 (22%)
Query: 148 LIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLEPESVRFMAR----EIHILRRL----- 197
+G+GT+ V D + K VALK +R +V EI++L+++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIR-------NVGKYREAARLEINVLKKIKEKDK 78
Query: 198 -DHINVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQVKC 246
+ + + + + + + E++ E++ + V+
Sbjct: 79 ENKFLCVLMSDWFNFHGHMCIAFELLGKNTF---EFLKENNFQP--------YPLPHVRH 127
Query: 247 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-------------------LKIADFG 287
QL L H + H D+K N+L N+ +++ADFG
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR 347
A+F ++ T+ V T YRPPE++L + D+WS GCIL E Y G +
Sbjct: 188 SATF----DHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTH 242
Query: 348 TEVEQLHKIFKLCGSPSEDYWRKSKLPH----------------ATIFKPQQPYKRCVAE 391
E L + K+ G +++ + + +P K + +
Sbjct: 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302
Query: 392 TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPPSK 446
+ LM +L DPA R + A AL FF P + S PS+
Sbjct: 303 DSLEHVQ-LFDLMRRMLEFDPAQRITLAEALLHPFFAGLT-PEERSFHTSRNPSR 355
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-45
Identities = 77/327 (23%), Positives = 134/327 (40%), Gaps = 61/327 (18%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVR-----------FDNLEPESVRFMAREIHILRRL 197
+G G Y V ++ + A+K ++ + + + EI +L+ L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 198 DHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQL 251
DH N+IKL + + YLV E+ E G + + KF E M+Q+
Sbjct: 104 DHPNIIKLFDVFEDKKY--FYLVTEFYE----GGELFEQIINRH--KFDECDAANIMKQI 155
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLW 308
L G+ + H ++HRDIK N+L++N +KI DFGL+SF+ D L R+ T +
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTAY 213
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368
Y PE+L Y D+WS G I+ L G P G+ + + + K+ K + W
Sbjct: 214 YIAPEVLKKK--YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
+ +++ K+ ++ +L+ D R +A AL S +
Sbjct: 272 KN------------------ISDEAKEL-------IKLMLTYDYNKRCTAEEALNSRWIK 306
Query: 429 MKPLPCDPSSLPKYPPS----KEFDAK 451
+ S + ++F+
Sbjct: 307 KYANNINKSDQKTLCGALSNMRKFEGS 333
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-45
Identities = 68/213 (31%), Positives = 114/213 (53%), Gaps = 10/213 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL-EG 207
IG+G ++ V AR + + VA+K + L P S++ + RE+ I++ L+H N++KL E
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ T + LYL+ EY ++ L +H +K EA + +Q++ + +CH + ++H
Sbjct: 83 IETEKT---LYLIMEYASGGEVFDYLVAHGRMKEKEA--RSKFRQIVSAVQYCHQKRIVH 137
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K NLL+D + +KIADFG ++ + L + Y PEL G Y G V
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEV 195
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
D+WS G IL L +G G+ E ++ +
Sbjct: 196 DVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-45
Identities = 76/343 (22%), Positives = 134/343 (39%), Gaps = 82/343 (23%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR----EIHILRRL------ 197
LIG+G++ V +A D +++ VA+K ++ + + E+ +L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIK-------NKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 198 DHINVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQVKCY 247
++ L+ LV +S +LY + + + G S + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLY---DLLRNTNFRG--------VSLNLTRKF 162
Query: 248 MQQLLCGLDHCHSR--GVLHRDIKGSNLLIDNNG--ILKIADFGLASFYDPDQNQPLTSR 303
QQ+ L + ++H D+K N+L+ N +KI DFG + Q +
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQY 218
Query: 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 363
+ + +YR PE+LLG Y A+D+WS GCIL E++ G+P+ G EV+Q++KI ++ G P
Sbjct: 219 IQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIP 277
Query: 364 SEDYWRKS---------------------------------KLPHATIFKPQQPYKRCVA 390
++ KL + + P R
Sbjct: 278 PAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337
Query: 391 ETFKDFPAPA--LALMETLLSIDPADRGSAASALRSEFFTMKP 431
E+ L+ +L DP R AL+ FF
Sbjct: 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-45
Identities = 74/287 (25%), Positives = 118/287 (41%), Gaps = 54/287 (18%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEG 207
IG+G++ V A + A KK+ +E + + +EI I++ LDH N+I+L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYE 73
Query: 208 LVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+YLV E G + F E+ M+ +L + +CH
Sbjct: 74 TFEDNTD--IYLVMELCT----GGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL 125
Query: 262 GVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
V HRD+K N L + LK+ DFGLA+ + P + + ++V T +Y P++L G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQVLEGL 183
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWRKSKLPHA 376
YG D WS G ++ L G P T+ E + KI G+ + E W
Sbjct: 184 --YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFPEKDWLN------ 233
Query: 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
V+ + L+ LL+ P R ++ AL
Sbjct: 234 ------------VSPQAES-------LIRRLLTKSPKQRITSLQALE 261
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 49/296 (16%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G Y V A + ++ VA+K R + PE+++ +EI I + L+H NV+K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVK 69
Query: 205 L-EGLVTSRMSCSLYLVFEYMEHDLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+ YL EY G + G+ +AQ + QL+ G+ +
Sbjct: 70 FYGHRREGNI---QYLFLEYCSG---GELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYL 121
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLG 317
H G+ HRDIK NLL+D LKI+DFGLA+ + ++ + L TL Y PELL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377
++ VD+WS G +L + AG+ +P + ++Y +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE---KK 225
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
+ +K + LAL+ +L +P+ R + + ++ KPL
Sbjct: 226 TYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN-KPLK 270
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 9e-45
Identities = 77/301 (25%), Positives = 122/301 (40%), Gaps = 58/301 (19%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVR----FMAREIHILRRLD-HI 200
+G+G S V R K A+K + E V+ +E+ ILR++ H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCG 254
N+I+L+ + +LVF+ M+ L SE + + M+ LL
Sbjct: 85 NIIQLKDTYETNTF--FFLVFDLMK----KGELFDYLTEKV--TLSEKETRKIMRALLEV 136
Query: 255 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 314
+ H ++HRD+K N+L+D++ +K+ DFG + DP + L T Y PE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 194
Query: 315 LLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDY 367
+ + YG VD+WSTG I+ L AG P R ++ L I + G+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGNYQFGSPE 252
Query: 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
W ++T KD L+ L + P R +A AL FF
Sbjct: 253 WDD------------------YSDTVKD-------LVSRFLVVQPQKRYTAEEALAHPFF 287
Query: 428 T 428
Sbjct: 288 Q 288
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 163 bits (413), Expect = 9e-45
Identities = 64/331 (19%), Positives = 120/331 (36%), Gaps = 80/331 (24%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IGQG+Y V A + + I A+K K + + P+ V + E+ ++++L H N+ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 206 EGLVTSRMSCSLYLVFEYME---------------------------------------- 225
+ + LV E
Sbjct: 94 YEVYEDEQY--ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151
Query: 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI--DNNGILKI 283
+ G E + M+Q+ L + H++G+ HRDIK N L + + +K+
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 284 ADFGLASFY---DPDQNQPLTSRVVTLWYRPPELLLGATY-YGTAVDLWSTGCILAELYA 339
DFGL+ + + + +T++ T ++ PE+L YG D WS G +L L
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 340 GKPIMPGRTEVEQLHKIFKLCGSPS--EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFP 397
G PG + + + ++ + ++ +D
Sbjct: 272 GAVPFPGVNDADTISQVLN--KKLCFENPNYNV------------------LSPLARD-- 309
Query: 398 APALALMETLLSIDPADRGSAASALRSEFFT 428
L+ LL+ + +R A AL+ + +
Sbjct: 310 -----LLSNLLNRNVDERFDAMRALQHPWIS 335
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-44
Identities = 74/319 (23%), Positives = 120/319 (37%), Gaps = 74/319 (23%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKV------RFDNLEPESVRFMAREIHILRRLDHINV 202
+G G V A + K VA++ + E + + EI IL++L+H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DL------AGLASHPGLKFSEAQVKCYMQQLLCGL 255
IK++ + Y+V E ME +L + EA K Y Q+L +
Sbjct: 203 IKIKNFFDAE---DYYIVLELMEGGELFDKVVGNK-------RLKEATCKLYFYQMLLAV 252
Query: 256 DHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPP 312
+ H G++HRD+K N+L+ + + ++KI DFG + + + T Y P
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYLAP 310
Query: 313 ELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP--SEDYW 368
E+L+ Y AVD WS G I L+ I L G P SE
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVI---LF----IC--------------LSGYPPFSEHR- 348
Query: 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAP--------ALALMETLLSIDPADRGSAAS 420
+ + + +F AL L++ LL +DP R +
Sbjct: 349 -----------TQVSLKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 396
Query: 421 ALRSEFFTMKPLPCDPSSL 439
ALR + + + L
Sbjct: 397 ALRHPWLQDEDMKRKFQDL 415
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 75/322 (23%), Positives = 125/322 (38%), Gaps = 64/322 (19%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G +S V R A K + L + + RE I R+L H N+++L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQLLCGLDHC 258
+ YLVF+ + G L +SEA +QQ+L + +C
Sbjct: 97 IQEES--FHYLVFDLVT----------GGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 259 HSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
HS G++HR++K NLL+ +K+ADFGLA + ++ T Y PE+L
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVL 202
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS--EDYWRKSKL 373
Y VD+W+ G IL L G P + +I G+ W
Sbjct: 203 KK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDT--- 256
Query: 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK--- 430
V K L++++L+++P R +A AL+ + +
Sbjct: 257 ---------------VTPEAKS-------LIDSMLTVNPKKRITADQALKVPWICNRERV 294
Query: 431 -PLPCDPSSLPKYPPSKEFDAK 451
++ K+F+A+
Sbjct: 295 ASAIHRQDTVDC---LKKFNAR 313
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 77/319 (24%), Positives = 130/319 (40%), Gaps = 49/319 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G Y V A + ++ VA+K R + PE+++ +EI I + L+H NV+K
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC-PENIK---KEICINKMLNHENVVK 69
Query: 205 L-EGLVTSRMSCSLYLVFEYMEHDLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+ YL EY G + G+ +AQ + QL+ G+ +
Sbjct: 70 FYGHRREGNI---QYLFLEYCSG---GELFDRIEPDIGMPEPDAQR--FFHQLMAGVVYL 121
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLG 317
H G+ HRDIK NLL+D LKI+DFGLA+ + ++ + L TL Y PELL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377
++ VD+WS G +L + AG+ +P + ++Y +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE--LP-----------WDQPSDSCQEYSDWKE---KK 225
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 437
+ +K + LAL+ +L +P+ R + + ++ KPL
Sbjct: 226 TYLNP----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN-KPLKKGAK 274
Query: 438 SLPKYPPSKEFDAKIRDEE 456
+
Sbjct: 275 RPRVTSGGVSESPSGFSKH 293
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-44
Identities = 71/341 (20%), Positives = 132/341 (38%), Gaps = 84/341 (24%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR----EIHILRRL-----D 198
+G GT+ V + +D KK A+K VR +++ R E IL+++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVR-------NIKKYTRSAKIEADILKKIQNDDIN 94
Query: 199 HINVIKLEG---------LVTSRMSCSLYLVFEYM-EHDLAGLASHPGLKFSEAQVKCYM 248
+ N++K G L+ + SLY E + ++ G F +K Y
Sbjct: 95 NNNIVKYHGKFMYYDHMCLIFEPLGPSLY---EIITRNNYNG--------FHIEDIKLYC 143
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-------------------------LKI 283
++L L++ + H D+K N+L+D+ +K+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 284 ADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPI 343
DFG A+F ++ S + T YR PE++L + + D+WS GC+LAELY G +
Sbjct: 204 IDFGCATF----KSDYHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLL 258
Query: 344 MPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF--KPQQPYKRCVAETFKDFPAPA- 400
+E L + + ++ ++ + + + K + + +
Sbjct: 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK 318
Query: 401 --------------LALMETLLSIDPADRGSAASALRSEFF 427
+ ++L IDP R S A L+ +F
Sbjct: 319 KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-44
Identities = 82/321 (25%), Positives = 129/321 (40%), Gaps = 61/321 (19%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G +S V R + + A + L + + RE I R L H N+++L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQLLCGLDHC 258
++ YL+F+ + G L +SEA +QQ+L + HC
Sbjct: 79 ISEEG--HHYLIFDLVT----------GGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 259 HSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
H GV+HR++K NLL+ +K+ADFGLA + +Q Q T Y PE+L
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVL 185
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPS--EDYWRKS 371
YG VDLW+ G IL L G P P + +I G+ W
Sbjct: 186 RK-DPYGKPVDLWACGVILYILLVGYP--PFWDEDQHRLYQQI--KAGAYDFPSPEWDT- 239
Query: 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431
V KD L+ +L+I+P+ R +AA AL+ + + +
Sbjct: 240 -----------------VTPEAKD-------LINKMLTINPSKRITAAEALKHPWISHRS 275
Query: 432 LPCDPSSLPKYPPS-KEFDAK 451
+ K+F+A+
Sbjct: 276 TVASCMHRQETVDCLKKFNAR 296
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-44
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 44/284 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + +V+ + +K + D + + + EI +L+ LDH N+IK+ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 209 VTSRMSCSLYLVFEYME-----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ +Y+V E E + + SE V M+Q++ L + HS+ V
Sbjct: 89 FEDYHN--MYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 264 LHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
+H+D+K N+L + + +KI DFGLA + D + T+ T Y PE+
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPEVFKRD-- 201
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS-EDYWRKSKLPHATIF 379
D+WS G ++ L G G + E K P+ R
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA--TYKEPNYAVECRP--------- 250
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+ D ++ +L+ DP R SAA L
Sbjct: 251 ---------LTPQAVDL-------LKQMLTKDPERRPSAAQVLH 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-44
Identities = 61/303 (20%), Positives = 113/303 (37%), Gaps = 50/303 (16%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G + V+R + KK K V+ + V+ +EI IL H N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHLHES 69
Query: 209 VTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
S L ++FE++ G + + + +E ++ Y+ Q+ L HS
Sbjct: 70 FESMEE--LVMIFEFIS----GLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 263 VLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
+ H DI+ N++ + +KI +FG A P Y PE+
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQH-DV 179
Query: 321 YGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378
TA D+WS G ++ L +G P T + + I + E+ +++
Sbjct: 180 VSTATDMWSLGTLVYVLLSGIN--PFLAETNQQIIENIMNAEYTFDEEAFKE-------- 229
Query: 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSS 438
++ DF ++ LL + R +A+ AL+ + K
Sbjct: 230 ----------ISIEAMDF-------VDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
Query: 439 LPK 441
+
Sbjct: 273 IRT 275
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-44
Identities = 81/326 (24%), Positives = 135/326 (41%), Gaps = 56/326 (17%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG+G +S V R + + + A+K +F + S + RE I L H ++++L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 206 EGLVTSRMSCSLYLVFEYME-----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
+S LY+VFE+M+ ++ A G +SEA YM+Q+L L +CH
Sbjct: 92 LETYSSDGM--LYMVFEFMDGADLCFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 261 RGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 317
++HRD+K +L+ +N+ +K+ FG+A RV T + PE++
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKR 207
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPS--EDYWRKSKL 373
YG VD+W G IL L +G G E ++F+ + G W
Sbjct: 208 -EPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWSH--- 258
Query: 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
++E+ KD L+ +L +DPA+R + AL +
Sbjct: 259 ---------------ISESAKD-------LVRRMLMLDPAERITVYEALNHPWL------ 290
Query: 434 CDPSSLPKYPPSKEFDAKIRDEEARR 459
+ E ++R ARR
Sbjct: 291 KERDRYAYKIHLPETVEQLRKFNARR 316
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 69/339 (20%), Positives = 127/339 (37%), Gaps = 61/339 (17%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK-----KVRFDNL-EPESVRFMAREIHILRRLDHINV 202
+G G + V+ A D ++ K V +K KV D E + + EI IL R++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 203 IKL-EGLVTSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGL 255
IK+ + LV ME +G + HP L A +QL+ +
Sbjct: 92 IKVLDIFENQGF---FQLV---MEKHGSGLDLFAFIDRHPRLDEPLA--SYIFRQLVSAV 143
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
+ + ++HRDIK N++I + +K+ DFG A++ + + + T+ Y PE+L
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPEVL 201
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS-PSEDYWRKSKLP 374
+G Y G +++WS G L L + P + +
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTL---------------------VFEENPFCEL---EETV 237
Query: 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434
A I P ++L+ LL P R + + + T +P+
Sbjct: 238 EAAIHPP------------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT-QPVNL 284
Query: 435 DPSSLPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERR 473
+ + + ++ + + G + +
Sbjct: 285 ADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 77/328 (23%), Positives = 124/328 (37%), Gaps = 66/328 (20%)
Query: 144 RSFY----LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD 198
R + ++G G +S V+ + K+ ALK ++ S+ EI +L+++
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64
Query: 199 HINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYM 248
H N++ LE + S YLV + + G L ++E +
Sbjct: 65 HENIVTLEDIYESTTH--YYLVMQLVS----------GGELFDRILERGVYTEKDASLVI 112
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVV 305
QQ+L + + H G++HRD+K NLL + N + I DFGL+ +++
Sbjct: 113 QQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACG 169
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS- 364
T Y PE+L Y AVD WS G I L G P TE + KI + G
Sbjct: 170 TPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE--GYYEF 226
Query: 365 -EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+W ++E+ KDF + LL DP +R + AL
Sbjct: 227 ESPFWDD------------------ISESAKDF-------ICHLLEKDPNERYTCEKALS 261
Query: 424 SEFFTMKPLPCDPSSLPKYPPSKEFDAK 451
+ ++ AK
Sbjct: 262 HPWIDGNTALHRDIYPSVSLQIQKNFAK 289
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 79/384 (20%), Positives = 131/384 (34%), Gaps = 66/384 (17%)
Query: 129 ADSFEKLDKSLSIFSRSFYLIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF 186
+E L IG+G V AR + V ++++ + E V F
Sbjct: 24 GGCYELLTV-----------IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTF 72
Query: 187 MAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEA 242
+ E+H+ + +H N++ + L++V +M DL + +H +E
Sbjct: 73 LQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTSFMAYGSAKDL--ICTHFMDGMNEL 128
Query: 243 QVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG-LASFYDPDQNQ--- 298
+ +Q +L LD+ H G +HR +K S++LI +G + ++ S Q Q
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 299 --PLTSRVVTLWYRPPELLL-GATYYGTAVDLWSTGCILAELYAGKP------------- 342
V L + PE+L Y D++S G EL G
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 248
Query: 343 -----------IMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAE 391
E + + S D S + P PY R +
Sbjct: 249 KLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308
Query: 392 TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPLPCD--PSSLPKYPPSKEF 448
F F +E L +P R SA++ L FF K + P L P F
Sbjct: 309 HFHHF-------VEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNF 361
Query: 449 DAKIRDEEARRQGGSKGQRMDLER 472
+ +++ G G +LE
Sbjct: 362 EGS----QSQDHSGIFGLVTNLEE 381
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 71/335 (21%), Positives = 123/335 (36%), Gaps = 72/335 (21%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK-------KVRFDNLEPESVRFMAREIHILRRLDHIN 201
+G G ++ V + R+ A K + + E + RE+ ILR++ H N
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE---REVSILRQVLHHN 76
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG----------LKFSEAQVKCYMQQL 251
VI L + +R + L+ E + G SE + +++Q+
Sbjct: 77 VITLHDVYENRTD--VVLILELVS----------GGELFDFLAQKESLSEEEATSFIKQI 124
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307
L G+++ H++ + H D+K N+++ +K+ DFGLA + + T
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTP 182
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSE 365
+ PE++ G D+WS G I L +G P G T+ E L I + E
Sbjct: 183 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITSVSYDFDE 239
Query: 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425
+++ +E KDF + LL + R + ALR
Sbjct: 240 EFFSH------------------TSELAKDF-------IRKLLVKETRKRLTIQEALRHP 274
Query: 426 FFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 460
+ T D S R + RR+
Sbjct: 275 WITPV----DNQQAMVRRESVVNLENFRKQYVRRR 305
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 84/306 (27%), Positives = 123/306 (40%), Gaps = 69/306 (22%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK-----KVRFDNLEPESVRFM-AREIHILRRL-DHIN 201
IG+G S V R A+K R + E VR RE HILR++ H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQL 251
+I L S ++LVF+ M L SE + + M+ L
Sbjct: 162 IITLIDSYESSSF--MFLVFDLMR----------KGELFDYLTEKVALSEKETRSIMRSL 209
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 311
L + H+ ++HRD+K N+L+D+N ++++DFG + +P + L T Y
Sbjct: 210 LEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLA 267
Query: 312 PELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPS 364
PE+L + YG VDLW+ G IL L AG P P R ++ L I + G
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP--PFWHRRQILMLRMI--MEGQYQ 323
Query: 365 --EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422
W + T KD L+ LL +DP R +A AL
Sbjct: 324 FSSPEWDD------------------RSSTVKD-------LISRLLQVDPEARLTAEQAL 358
Query: 423 RSEFFT 428
+ FF
Sbjct: 359 QHPFFE 364
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 78/319 (24%), Positives = 121/319 (37%), Gaps = 62/319 (19%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK-----KVRFDNLEPESVRFMAREIHILRRLD---- 198
L+G+G + V+ L + VA+K +V + +SV E+ +L ++
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT-CPLEVALLWKVGAGGG 96
Query: 199 HINVIKL-EGLVTSRMSCSLYLVFEYMEH--DL-AGLASHPGLKFSEAQVKCYMQQLLCG 254
H VI+L + T LV E DL + E +C+ Q++
Sbjct: 97 HPGVIRLLDWFETQEG---FMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAA 151
Query: 255 LDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 313
+ HCHSRGV+HRDIK N+LID G K+ DFG + ++P T T Y PPE
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPPE 208
Query: 314 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS-PSEDYWRKSK 372
+ Y+ +WS G + LY M +CG P E +
Sbjct: 209 WISRHQYHALPATVWSLGIL---LYD----M--------------VCGDIPFERD---QE 244
Query: 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM--K 430
+ A + P AL+ L+ P+ R S L + +
Sbjct: 245 ILEAELHFPAH------------VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292
Query: 431 PLPCDPSSLPKYPPSKEFD 449
+P +PS P +
Sbjct: 293 DVPLNPSKGGPAPLAWSLL 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-42
Identities = 73/310 (23%), Positives = 130/310 (41%), Gaps = 40/310 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEG 207
+G G + V++ + +A K ++ ++ E V+ EI ++ +LDH N+I+L
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYD 153
Query: 208 LVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
S+ + LV EY++ +L +E +M+Q+ G+ H H +LH
Sbjct: 154 AFESKND--IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 267 DIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
D+K N+L N +KI DFGLA Y P + L T + PE++ +
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNFGTPEFLAPEVVNY-DFVSFP 268
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+WS G I L +G G + E L+ I ++ ++
Sbjct: 269 TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD-------------- 314
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPK--- 441
++E K+F + LL + + R SA+ AL+ + + L S+ K
Sbjct: 315 ----ISEEAKEF-------ISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNR 363
Query: 442 YPPSKEFDAK 451
+++F K
Sbjct: 364 GSDAQDFVTK 373
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 61/285 (21%), Positives = 105/285 (36%), Gaps = 44/285 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI-NVIKLEG 207
+G+G ++ V + + A K ++ + + EI +L VI L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 208 LVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ + + L+ EY L SE V ++Q+L G+ + H +
Sbjct: 97 VYENTSE--IILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 264 LHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
+H D+K N+L+ + G +KI DFG++ L + T Y PE+L
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMGTPEYLAPEILNY-DP 209
Query: 321 YGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378
TA D+W+ G I L P G E I ++ SE+ +
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTS--PFVGEDNQETYLNISQVNVDYSEETFSS-------- 259
Query: 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
V++ DF +++LL +P R +A L
Sbjct: 260 ----------VSQLATDF-------IQSLLVKNPEKRPTAEICLS 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 83/337 (24%), Positives = 122/337 (36%), Gaps = 86/337 (25%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLD-HINVIK 204
+G+G++S + + A+K K N + +EI L+ + H N++K
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ--------KEITALKLCEGHPNIVK 70
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAG-------LASHPGLKFSEAQVKCYMQQLLCGLDH 257
L + ++ +LV E + G FSE + M++L+ + H
Sbjct: 71 LHEVFHDQLH--TFLVMELLN----GGELFERIKKKK---HFSETEASYIMRKLVSAVSH 121
Query: 258 CHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 314
H GV+HRD+K NLL ++N +KI DFG A PD NQPL + TL Y PE
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAPE- 179
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374
LL Y + DLWS G I LY M L G P
Sbjct: 180 LLNQNGYDESCDLWSLGVI---LY----TM--------------LSGQV----------P 208
Query: 375 HATIF--KPQQPYKRCVAETFK-------DFPAP--------ALALMETLLSIDPADRGS 417
F + E K F A L++ LL++DP R
Sbjct: 209 ----FQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264
Query: 418 AASALRSEFFTMK-PLPCDPSSLPKYPPSKEFDAKIR 453
+ +E+ L +P P S
Sbjct: 265 MSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTC 301
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 37/279 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEG 207
+G G + V+R + ++ K + +V+ EI I+ +L H +I L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHD 115
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + L+ E++ +L + K SEA+V YM+Q GL H H ++H
Sbjct: 116 AFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 173
Query: 267 DIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
DIK N++ + +KI DFGLA+ +PD + + T + PE++ G
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFY 230
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+W+ G + L +G G ++E L + + ED +
Sbjct: 231 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS-------------- 276
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
V+ KDF ++ LL +P R + AL
Sbjct: 277 ----VSPEAKDF-------IKNLLQKEPRKRLTVHDALE 304
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHINVIKL- 205
+G GT+ V VA+K + + V + REI L+ H ++IKL
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
+ + T ++V EY+ G + H + E + + QQ+L +D+CH
Sbjct: 78 QVISTPTD---FFMVMEYVSG---GELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR 129
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
V+HRD+K N+L+D + KIADFGL++ + L + + Y PE++ G Y
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLY 187
Query: 321 YGTAVDLWSTGCILAELYAGK 341
G VD+WS G IL L G
Sbjct: 188 AGPEVDIWSCGVILYALLCGT 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILRRLDHI--N 201
L+G G + +VY + VA+K V D + E+ +L+++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 202 VIKL-EGLVTSRMSCSLYLVFEYMEH--DL-AGLASHPGLKFSEAQVKCYMQQLLCGLDH 257
VI+L + L+ E E DL + L+ A + + Q+L + H
Sbjct: 110 VIRLLDWFERPDS---FVLILERPEPVQDLFDFITERGALQEELA--RSFFWQVLEAVRH 164
Query: 258 CHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL 316
CH+ GVLHRDIK N+LID N G LK+ DFG + ++ T T Y PPE +
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIR 221
Query: 317 GATYYGTAVDLWSTGCILAELYAGK 341
Y+G + +WS G +L ++ G
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-41
Identities = 83/420 (19%), Positives = 153/420 (36%), Gaps = 63/420 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF-MAREIHILRRLDHINVIKL- 205
+G GT+ V + VA+K + + V + REI L+ H ++IKL
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAG-----LASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
+ + T +++V EY+ G + + L E++ QQ+L G+D+CH
Sbjct: 83 QVISTPSD---IFMVMEYVSG---GELFDYICKNGRLDEKESRR--LFQQILSGVDYCHR 134
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
V+HRD+K N+L+D + KIADFGL++ + L + + Y PE++ G Y
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLY 192
Query: 321 YGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378
G VD+WS+G IL L G +P KI + P
Sbjct: 193 AGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICD------GIF----YTP---- 236
Query: 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSS 438
+ ++L++ +L +DP R + E+F
Sbjct: 237 ---------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPK----- 276
Query: 439 LPKYPPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANAELV---LSMQ 495
+P + + + D+EA ++ ++ + + V L +
Sbjct: 277 -YLFPEDPSYSSTMIDDEALKE---VCEKFECSEEEVLSCLYNRNHQ-DPLAVAYHLIID 331
Query: 496 KRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQSQVTESSAGPQGHNHKRASHSGPLAQR 555
R+ +K +P + P + + P+ + + +
Sbjct: 332 NRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQ 391
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 62/295 (21%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVIK 204
+G G ++ V + R K A K ++ L S + RE++ILR + H N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQLLCG 254
L + ++ + L+ E + G L +E + +++Q+L G
Sbjct: 73 LHDIFENKTD--VVLILELVS----------GGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 255 LDHCHSRGVLHRDIKGSNLLIDN----NGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 310
+ + HS+ + H D+K N+++ + N +K+ DFG+A + + T +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTPEFV 178
Query: 311 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYW 368
PE++ G D+WS G I L +G P G T+ E L I + E+Y+
Sbjct: 179 APEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGETKQETLTNISAVNYDFDEEYF 235
Query: 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+E KDF + LL DP R + A +L
Sbjct: 236 SN------------------TSELAKDF-------IRRLLVKDPKRRMTIAQSLE 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 4e-41
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL-E 206
IG G + RD K++VA+K + E+V+ REI R L H N+++ E
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKE 83
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
++T L ++ EY +L + G +FSE + + + QQLL G+ +CHS + H
Sbjct: 84 VILTPTH---LAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 266 RDIKGSNLLIDNNGI--LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
RD+K N L+D + LKI DFG + S V T Y PE+LL Y G
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGK 197
Query: 324 AVDLWSTGCILAELYAG 340
D+WS G L + G
Sbjct: 198 IADVWSCGVTLYVMLVG 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 76/319 (23%), Positives = 116/319 (36%), Gaps = 62/319 (19%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 206
++G+G ++ V +L + A+K + S + RE+ +L + H NV++L
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEMLYQCQGHRNVLELI 77
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAG--LASHPGLK--FSEAQVKCYMQQLLCGLDHCHSRG 262
YLVFE M G + SH + F+E + +Q + LD H++G
Sbjct: 78 EFFEEEDR--FYLVFEKMR----GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 263 VLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQ------NQPLTSRVVTLWYRPPE 313
+ HRD+K N+L + +KI DF L S + L + + Y PE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 314 LLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP---SED 366
++ A+ Y DLWS G I LY I+ L G P
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVI---LY----IL--------------LSGYPPFVGRC 230
Query: 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAP--------ALALMETLLSIDPADRGSA 418
Q + E +FP A L+ LL D R SA
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 419 ASALRSEFFTM----KPLP 433
A L+ + LP
Sbjct: 291 AQVLQHPWVQGCAPENTLP 309
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-41
Identities = 70/348 (20%), Positives = 126/348 (36%), Gaps = 66/348 (18%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVIK 204
+G G ++ V + R+ A K ++ S + RE+ IL+ + H NVI
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 205 LEGLVTSRMSCSLYLVFEYM----------EHDLAGLASHPGLKFSEAQVKCYMQQLLCG 254
L + ++ + L+ E + E + +E + +++Q+L G
Sbjct: 79 LHEVYENKTD--VILILELVAGGELFDFLAEKE----------SLTEEEATEFLKQILNG 126
Query: 255 LDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYR 310
+ + HS + H D+K N+++ +KI DFGLA D + T +
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFV 184
Query: 311 PPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSEDYW 368
PE++ G D+WS G I L +G P G T+ E L + + ++Y+
Sbjct: 185 APEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
+ KDF + LL DP R + +L+ +
Sbjct: 242 SN------------------TSALAKDF-------IRRLLVKDPKKRMTIQDSLQHPWIK 276
Query: 429 MKPLPCDPSSLPKYPPS---KEFDAKIRDEEARRQGGSK-GQRMDLER 472
K S K+F A+ + G + + +E
Sbjct: 277 PKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGLNDIFEAQKIEW 324
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-41
Identities = 81/369 (21%), Positives = 140/369 (37%), Gaps = 58/369 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLE-PESVRFMAREIHILRRLDHINVI 203
+G+G++ V A ++ VALK + + V REI L+ L H ++I
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHII 72
Query: 204 KL-EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
KL + + T + +V EY +L + +E + + + QQ++C +++CH
Sbjct: 73 KLYDVITTPTD---IVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
++HRD+K NLL+D+N +KIADFGL++ L + + Y PE++ G Y G
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
VD+WS G +L + G+ K+ Y +P
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS------CVY----VMP-------- 228
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKY 442
A +L+ ++ DP R + R +F + +LP Y
Sbjct: 229 -----------DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV--------NLPDY 269
Query: 443 -PPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIPAPDANA---ELVLSMQKRQ 498
P +E D + G+ M E+ + L+ Q Q
Sbjct: 270 LRPMEEVQGSYADSRIVSK---LGEAMGFSEDYIVEALRSDENNEVKEAYNLLHENQVIQ 326
Query: 499 SQYNSKSRS 507
+
Sbjct: 327 EKLEHHHHH 335
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 51/355 (14%), Positives = 98/355 (27%), Gaps = 72/355 (20%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-VRFMAREIHILRRL--------- 197
++GQ A D + + + F P + ++ M E+ LR L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 198 ----------------DHINVIKLEGLVTSRMSCSLYLVFEYMEHDL----AGLASHPGL 237
+I++ S + ++ M+ +L L SH
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 238 K--FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295
Q++ L H G++H ++ ++++D G + + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 296 QNQPLTSRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 351
P+ +L T A D W+ G + ++ +
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324
Query: 352 QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSID 411
IF+ C K+ P P AL+E L
Sbjct: 325 GSEWIFRSC---------------------------------KNIPQPVRALLEGFLRYP 351
Query: 412 PADRGSAASALRSEFFTM---KPLPCDPSSLPKYPPSKEFDAKIRDEEARRQGGS 463
DR A+ + + + P P++E A + G+
Sbjct: 352 KEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGA 406
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 69/335 (20%), Positives = 124/335 (37%), Gaps = 72/335 (21%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALK-------KVRFDNLEPESVRFMAREIHILRRLDHIN 201
+G G ++ V + R+ A K + + E + RE+ ILR++ H N
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE---REVSILRQVLHPN 76
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPG----------LKFSEAQVKCYMQQL 251
+I L + +R + L+ E + G SE + +++Q+
Sbjct: 77 IITLHDVYENRTD--VVLILELVS----------GGELFDFLAQKESLSEEEATSFIKQI 124
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307
L G+++ H++ + H D+K N+++ +K+ DFGLA + + T
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTP 182
Query: 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMP--GRTEVEQLHKIFKLCGSPSE 365
+ PE++ G D+WS G I L +G P G T+ E L I + E
Sbjct: 183 EFVAPEIVNY-EPLGLEADMWSIGVITYILLSGAS--PFLGDTKQETLANITAVSYDFDE 239
Query: 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425
+++ + +E KDF + LL + R + ALR
Sbjct: 240 EFFSQ------------------TSELAKDF-------IRKLLVKETRKRLTIQEALRHP 274
Query: 426 FFTMKPLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 460
+ T D S + + RR+
Sbjct: 275 WITPV----DTQQAMVRRESVVNLENFKKQYVRRR 305
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 59/292 (20%), Positives = 100/292 (34%), Gaps = 56/292 (19%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 206
++G G V + ALK + + R +E+ + +++ +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKAR---QEVDHHWQASGGPHIVCIL 88
Query: 207 GLV--TSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+ L ++ E ME G + F+E + M+ + +
Sbjct: 89 DVYENMHHGKRCLLIIMECME----GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 259 HSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
HS + HRD+K NLL + + +LK+ DFG A L + T +Y PE +
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPCYTPYYVAPE-V 200
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPS--EDYWRKS 371
LG Y + D+WS G I+ L G P T + + G W +
Sbjct: 201 LGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE- 259
Query: 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
V+E K L+ LL DP +R + +
Sbjct: 260 -----------------VSEDAKQ-------LIRLLLKTDPTERLTITQFMN 287
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 73/303 (24%), Positives = 109/303 (35%), Gaps = 73/303 (24%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEG 207
IG G+YS R A+K + +P EI IL R H N+I L+
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT------EEIEILLRYGQHPNIITLKD 83
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPG--L--------KFSEAQVKCYMQQLLCGLDH 257
+ +Y+V E M+ G L FSE + + + +++
Sbjct: 84 VYDDGKY--VYVVTELMK----------GGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 258 CHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE 313
H++GV+HRD+K SN+L N ++I DFG A + N L + T + PE
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTANFVAPE 190
Query: 314 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373
+L Y A D+WS G + LY M L G +
Sbjct: 191 VLER-QGYDAACDIWSLGVL---LY----TM--------------LTGYTP--FANGPDD 226
Query: 374 PHATIFKPQQPYKRCVAETFKDFPAP--------ALALMETLLSIDPADRGSAASALRSE 425
I R + F A L+ +L +DP R +AA LR
Sbjct: 227 TPEEIL------ARIGSGKF-SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279
Query: 426 FFT 428
+
Sbjct: 280 WIV 282
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 26/219 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 206
++ +G ++ VY A+D+ + ALK++ + E R + +E+ +++L H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNE--EEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 207 G---LVTSRMSCSLYLVFEYMEHDLAGLASH-----PGLKFSEAQVKCYMQQLLCGLDHC 258
+ E L S V Q + H
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 259 HSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS-----------RVV 305
H + ++HRD+K NLL+ N G +K+ DFG A+ + ++ R
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 306 TLWYRPPEL--LLGATYYGTAVDLWSTGCILAELYAGKP 342
T YR PE+ L G D+W+ GCIL L +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-39
Identities = 62/282 (21%), Positives = 103/282 (36%), Gaps = 43/282 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+R + A K V + + +EI + L H ++ L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 209 VTSRMSCSLYLVFEYME-----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ +++E+M +A + SE + YM+Q+ GL H H
Sbjct: 223 FEDDNE--MVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 264 LHRDIKGSNLLIDNNG--ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
+H D+K N++ LK+ DFGL + DP Q + T + PE+ G
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEG-KPV 333
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381
G D+WS G + L +G G + E L + + + +
Sbjct: 334 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG----------- 382
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
++E KDF + LL DP R + AL
Sbjct: 383 -------ISEDGKDF-------IRKLLLADPNTRMTIHQALE 410
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 64/293 (21%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G+G S VYR + +K ALK ++ + + VR EI +L RL H N+IKL+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVR---TEIGVLLRLSHPNIIKLKE 115
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGL----------KFSEAQVKCYMQQLLCGLDH 257
+ + + LV E + G +SE ++Q+L + +
Sbjct: 116 IFETPTE--ISLVLELVT----------GGELFDRIVEKGYYSERDAADAVKQILEAVAY 163
Query: 258 CHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 314
H G++HRD+K NLL + LKIADFGL+ + + + T Y PE+
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEI 221
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSPS--EDYWRK 370
L G YG VD+WS G I L G P E +F+ L +W +
Sbjct: 222 LRG-CAYGPEVDMWSVGIITYILLCGFE--PFYDERGD-QFMFRRILNCEYYFISPWWDE 277
Query: 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
V+ KD + L+ +DP R + AL+
Sbjct: 278 ------------------VSLNAKDL-------VRKLIVLDPKKRLTTFQALQ 305
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 71/319 (22%), Positives = 127/319 (39%), Gaps = 53/319 (16%)
Query: 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR 185
D +E + IG G + V A +K+ VA+K++ + + +
Sbjct: 11 SINRDDYELQEV-----------IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MD 58
Query: 186 FMAREIHILRRLDHINVIKLEG--LVTSRMSCSLYLVFEYME----HDL----AGLASHP 235
+ +EI + + H N++ +V L+LV + + D+ H
Sbjct: 59 ELLKEIQAMSQCHHPNIVSYYTSFVVKD----ELWLVMKLLSGGSVLDIIKHIVAKGEHK 114
Query: 236 GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG----LASF 291
E+ + ++++L GL++ H G +HRD+K N+L+ +G ++IADFG LA+
Sbjct: 115 SGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174
Query: 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 351
D +N+ + V T + PE++ Y D+WS G EL G P
Sbjct: 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--P------ 226
Query: 352 QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVA--ETFKDFPAPALALMETLLS 409
HK P + + ++ Q + ++F+ + L
Sbjct: 227 -YHKY-----PPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLC-------LQ 273
Query: 410 IDPADRGSAASALRSEFFT 428
DP R +AA LR +FF
Sbjct: 274 KDPEKRPTAAELLRHKFFQ 292
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-38
Identities = 61/302 (20%), Positives = 107/302 (35%), Gaps = 59/302 (19%)
Query: 142 FSRSFYL----IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 197
+ + +G G V + + ++ ALK ++ + R RE+ + R
Sbjct: 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRA 111
Query: 198 -DHINVIKLEGLV--TSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYM 248
+++++ + L +V E ++ G + F+E + M
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIM 167
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVV 305
+ + + + HS + HRD+K NLL N ILK+ DFG A + LT+
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCY 225
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSP 363
T +Y PE +LG Y + D+WS G I+ L G P + + G
Sbjct: 226 TPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284
Query: 364 S--EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421
W + V+E K L+ LL +P R +
Sbjct: 285 EFPNPEWSE------------------VSEEVKM-------LIRNLLKTEPTQRMTITEF 319
Query: 422 LR 423
+
Sbjct: 320 MN 321
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 48/212 (22%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G + + + +++ +K+ + E+ R +E+ ++R L+H NV+K G+
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKE--LIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
+ L + EY++ L G+ ++ +Q + + + G+ + HS ++HRD
Sbjct: 76 LYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQP-------------LTSRVVTLWYRPPEL 314
+ N L+ N + +ADFGLA ++ QP + V ++ PE+
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKPIMPG 346
+ G + Y VD++S G +L E+ P
Sbjct: 194 INGRS-YDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 36/271 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
++G+G++S V AR+L + A+K + + ++ V ++ RE ++ RLDH +KL
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
T + LY Y ++ +L G F E + Y +++ L++ H +G++H
Sbjct: 97 F--TFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIH 153
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTA 324
RD+K N+L++ + ++I DFG A P+ Q + V T Y PELL +
Sbjct: 154 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KSACKS 212
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
DLW+ GCI+ +L AG P E KI KL + P
Sbjct: 213 SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------EYDFP---------- 252
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADR 415
+ F A L+E LL +D R
Sbjct: 253 ---------EKFFPKARDLVEKLLVLDATKR 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 76/318 (23%), Positives = 137/318 (43%), Gaps = 45/318 (14%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-ESVRFMAREIHILRRLDHINVIKLEG 207
IG G++ VY ARD+ ++VA+KK+ + + E + + +E+ L++L H N I+ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 208 --LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
L +LV EY + L E ++ L GL + HS ++H
Sbjct: 122 CYLREHT----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT--YYGT 323
RD+K N+L+ G++K+ DFG AS P S V T ++ PE++L Y
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSAS-----IMAPANSFVGTPYWMAPEVILAMDEGQYDG 232
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
VD+WS G EL KP P + + ++ + +++ P +
Sbjct: 233 KVDVWSLGITCIELAERKP--P-LFNMNAMSALYHI---------AQNESPA---LQSGH 277
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL-PKY 442
+E F++F +++ L P DR ++ L+ F P+ +
Sbjct: 278 -----WSEYFRNF-------VDSCLQKIPQDRPTSEVLLKHRFVLR---ERPPTVIMDLI 322
Query: 443 PPSKEFDAKIRDEEARRQ 460
+K+ ++ + + R+
Sbjct: 323 QRTKDAVRELDNLQYRKM 340
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 58/349 (16%), Positives = 102/349 (29%), Gaps = 99/349 (28%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK----------------------KVRFDNLEPESVR 185
+G+G + V+ A++ A+K K+ +
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 186 FMAREIHILRRLDHINVIKLEGLVTSRMSCS----------------------------- 216
++ + +K E S S
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 217 ---LYLVFEYMEH-DLAGL--ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKG 270
LY+ + +L Q+ ++ HS+G++HRD+K
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192
Query: 271 SNLLIDNNGILKIADFGLA-----------SFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
SN+ + ++K+ DFGL T +V T Y PE + G
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN 252
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
Y VD++S G IL EL T++E++ I + R K P
Sbjct: 253 -YSHKVDIFSLGLILFELL-----YSFSTQMERVRIITDV---------RNLKFP----- 292
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
F +++ +LS P +R A + + F
Sbjct: 293 -----------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 8e-36
Identities = 46/302 (15%), Positives = 97/302 (32%), Gaps = 62/302 (20%)
Query: 148 LIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 202
L+G+G ++ VY A D K+ LK + N P + + L+
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMF 129
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH----DLAGLASHPGLK-FSEAQVKCYMQQLLCGLDH 257
+K + LV E + + L + K + V + ++L ++
Sbjct: 130 MKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 258 CHSRGVLHRDIKGSNLLI-----------DNNGILKIADFGLASFYDP-DQNQPLTSRVV 305
H ++H DIK N ++ D + L + D G + + T++
Sbjct: 188 VHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365
T ++ E+L + +D + + + L G+ +
Sbjct: 248 TSGFQCVEMLSNKPW-NYQIDYFGVAATVYCM---------------------LFGTYMK 285
Query: 366 DYWRKSKLPHATIFKPQQPYKRCV-AETFKDFPAPALALMETLLSIDPADRGSAASALRS 424
+ KP+ ++R + + +F +L+I + LR
Sbjct: 286 VKNEGGE------CKPEGLFRRLPHLDMWNEF-------FHVMLNIPDCHHLPSLDLLRQ 332
Query: 425 EF 426
+
Sbjct: 333 KL 334
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 83/315 (26%), Positives = 141/315 (44%), Gaps = 65/315 (20%)
Query: 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 188
+ F KL+K IG+G++ V++ D +K+VA+K + + E E + +
Sbjct: 21 EELFTKLEK-----------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQ 68
Query: 189 REIHILRRLDHINVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLASH---PGLKFSEAQ 243
+EI +L + D V K G L ++ L+++ EY+ G A PG E Q
Sbjct: 69 QEITVLSQCDSPYVTKYYGSYLKDTK----LWIIMEYLG---GGSALDLLEPG-PLDETQ 120
Query: 244 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303
+ ++++L GLD+ HS +HRDIK +N+L+ +G +K+ADFG+A Q + T
Sbjct: 121 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF- 179
Query: 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP----IMPGRTEVEQLHKIFKL 359
V T ++ PE++ + Y + D+WS G EL G+P + P + L I K
Sbjct: 180 VGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKV----LFLIPK- 233
Query: 360 CGSPS-EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
P+ E + K K+F +E L+ +P+ R +A
Sbjct: 234 NNPPTLEGNYSKP---------------------LKEF-------VEACLNKEPSFRPTA 265
Query: 419 ASALRSEFFTMKPLP 433
L+ +F
Sbjct: 266 KELLKHKFILRNAKK 280
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 46/296 (15%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG- 207
IGQG VY A D+ + VA++++ + + EI ++R + N++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 208 -LVTSRMSCSLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
LV L++V EY+ G + E Q+ ++ L L+ HS V
Sbjct: 86 YLVGDE----LWVVMEYLA---GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRDIK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++ YG
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKA-YGP 195
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
VD+WS G + E+ G+P + L+ I + P + Q
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------ATNGTP-----ELQN 238
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439
P K ++ F+DF L L +D RGSA L+ +F + SSL
Sbjct: 239 PEK--LSAIFRDF----LNRC---LEMDVEKRGSAKELLQHQFLKI---AKPLSSL 282
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 47/197 (23%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G++ VY+ + VA+K + P+ ++ E+ +LR+ H+N++ G
Sbjct: 32 IGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
T+ L +V ++ E L KF ++ +Q G+D+ H++ ++HRD
Sbjct: 89 STAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 268 IKGSNLLIDNNGILKIADFGLASF-YDPDQNQPLTSRVVTLWYRPPELLLGATY--YGTA 324
+K +N+ + + +KI DFGLA+ + ++ + PE++ Y
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 325 VDLWSTGCILAELYAGK 341
D+++ G +L EL G+
Sbjct: 206 SDVYAFGIVLYELMTGQ 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 54/302 (17%), Positives = 96/302 (31%), Gaps = 80/302 (26%)
Query: 142 FSRSFYL----IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL 197
+ + +G G V + + ++ ALK ++ + R RE+ + R
Sbjct: 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKAR---REVELHWRA 67
Query: 198 -DHINVIKLEGLV--TSRMSCSLYLVFEYMEHDLAG------LASHPGLKFSEAQVKCYM 248
+++++ + L +V E ++ G + F+E + M
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIM 123
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVV 305
+ + + + HS + HRD+K NLL N ILK+ DFG A
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------- 167
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK--LCGSP 363
E Y + D+WS G I+ L G P + + G
Sbjct: 168 ------KETTGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219
Query: 364 S--EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421
W + V+E K L+ LL +P R +
Sbjct: 220 EFPNPEWSE------------------VSEEVKM-------LIRNLLKTEPTQRMTITEF 254
Query: 422 LR 423
+
Sbjct: 255 MN 256
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 31/201 (15%), Positives = 71/201 (35%), Gaps = 18/201 (8%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+ + +++ R Q + +K ++ + R E LR H NV+ + G
Sbjct: 18 LNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 209 VTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG-- 262
S + L+ +M +++ L ++Q + + G+ H+
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY-- 320
+ + +++ID + +I+ + + R+ + PE L
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDT 187
Query: 321 YGTAVDLWSTGCILAELYAGK 341
+ D+WS +L EL +
Sbjct: 188 NRRSADMWSFAVLLWELVTRE 208
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 67/318 (21%), Positives = 132/318 (41%), Gaps = 54/318 (16%)
Query: 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 188
+ +E + + +G G + VY+A++ + + A K + + E +
Sbjct: 18 NEVWEIVGE-----------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYI 64
Query: 189 REIHILRRLDHINVIKLEG--LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVK 245
EI IL DH ++KL G + L+++ E+ + + +E Q++
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGK----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305
+Q+L L+ HS+ ++HRD+K N+L+ G +++ADFG+++ + + +
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-IG 179
Query: 306 TLWYRPPELLLGATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG 361
T ++ PE+++ T Y D+WS G L E+ +P P E+ + + K+
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP--P-HHELNPMRVLLKIAK 236
Query: 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421
S L + + + F+DF ++ L +P R SAA
Sbjct: 237 SDP------PTLLTPSKWSVE----------FRDF-------LKIALDKNPETRPSAAQL 273
Query: 422 LRSEFFTMKPLPCDPSSL 439
L F + +L
Sbjct: 274 LEHPFVSS---ITSNKAL 288
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 73/323 (22%), Positives = 132/323 (40%), Gaps = 49/323 (15%)
Query: 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+G+G+Y +VY+A + +IVA+K+V ++ + + + +EI I+++ D +V+K
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEII---KEISIMQQCDSPHVVKY 89
Query: 206 EG--LVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
G + L++V EY D+ L + +E ++ +Q L GL++ H
Sbjct: 90 YGSYFKNTD----LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLH 142
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
+HRDIK N+L++ G K+ADFG+A + T + T ++ PE++
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-IGTPFWMAPEVIQEIG 201
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
Y D+WS G E+ GKP + + I P ++
Sbjct: 202 -YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPP--------TFRKPELW 251
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439
F DF ++ L P R +A L+ F S L
Sbjct: 252 SDN----------FTDF-------VKQCLVKSPEQRATATQLLQHPFVRS---AKGVSIL 291
Query: 440 -PKYPPSKEFDAKIRDEEARRQG 461
+ + K ++ + R +G
Sbjct: 292 RDLINEAMDVKLKRQESQQREEG 314
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 76/294 (25%), Positives = 137/294 (46%), Gaps = 42/294 (14%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG- 207
IG+G+ V AR+ + VA+K + D + + + E+ I+R H NV+++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 208 -LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
LV L+++ E+++ L + S ++ +E Q+ + +L L + H++GV+H
Sbjct: 111 YLVGEE----LWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIH 164
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RDIK ++L+ +G +K++DFG + D + S V T ++ PE++ + Y T V
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR-KSLVGTPYWMAPEVISRSLY-ATEV 222
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
D+WS G ++ E+ G+P + V+ + ++ R S P K + +
Sbjct: 223 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL------------RDSPPP-----KLKNSH 265
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439
K V+ +DF L M L DP +R +A L F P L
Sbjct: 266 K--VSPVLRDF----LERM---LVRDPQERATAQELLDHPFLLQ---TGLPECL 307
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 45/206 (21%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + VY R + VA++ + + + ++ RE+ R+ H NV+ G
Sbjct: 41 IGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
S L ++ + L + + + + Q+++ G+ + H++G+LH+D
Sbjct: 98 CMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155
Query: 268 IKGSNLLIDNNGILKIADFGLASF----YDPDQNQPLTSRVVTLWYRPPELLLGATY--- 320
+K N+ DN + I DFGL S + L + L + PE++ +
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 321 -----YGTAVDLWSTGCILAELYAGK 341
+ D+++ G I EL+A +
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHARE 240
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 45/207 (21%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-----VRFMAREIHILRRLDHINVI 203
IG+G + V++ R + K +VA+K + + E E+ + RE+ I+ L+H N++
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
KL GL+ + +V E++ DL + M + G+++ ++
Sbjct: 87 KLYGLMHN----PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 263 --VLHRDIKGSNLLIDNNG-----ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
++HRD++ N+ + + K+ADFGL+ ++ + + PE +
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETI 198
Query: 316 LGA-TYYGTAVDLWSTGCILAELYAGK 341
Y D +S IL + G+
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGE 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 73/321 (22%), Positives = 130/321 (40%), Gaps = 67/321 (20%)
Query: 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA 188
A FE ++ +G GTY VY+ R + ++ A+K + ++ + +
Sbjct: 23 AGIFELVEL-----------VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIK 68
Query: 189 REIHILRRL-DHINVIKLEG----LVTSRMSCSLYLVFEYME----HDLAGLASHPGLKF 239
+EI++L++ H N+ G M L+LV E+ DL + + G
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTL 126
Query: 240 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299
E + +++L GL H H V+HRDIKG N+L+ N +K+ DFG+++ Q
Sbjct: 127 KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-----QLDR 181
Query: 300 LTSRVVTLWYRP----PELLLGATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVE 351
R T P PE++ Y DLWS G E+ G P P ++
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP--P-LCDMH 238
Query: 352 QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ-QPYKRCVAETFKDFPAPALALMETLLSI 410
+ +F + +P+ P+ + K + F+ F +E+ L
Sbjct: 239 PMRALFLIPRNPA----------------PRLKSKKWS--KKFQSF-------IESCLVK 273
Query: 411 DPADRGSAASALRSEFFTMKP 431
+ + R + ++ F +P
Sbjct: 274 NHSQRPATEQLMKHPFIRDQP 294
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G++ V+RA VA+K + + E V RE+ I++RL H N++ G
Sbjct: 45 IGAGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGL--ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--V 263
VT + L +V EY+ L L S + E + + G+++ H+R +
Sbjct: 103 VTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HR++K NLL+D +K+ DFGL+ S T + PE+L
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEP-SNE 218
Query: 324 AVDLWSTGCILAELYAGK 341
D++S G IL EL +
Sbjct: 219 KSDVYSFGVILWELATLQ 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 58/223 (26%), Positives = 91/223 (40%), Gaps = 22/223 (9%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G +S V + ++ A+K + + L+ V E +L D + +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 207 GLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
+ LYLV EY DL L S G + + Y+ +++ +D H
Sbjct: 128 --------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG-- 317
G +HRDIK N+L+D G +++ADFG D V T Y PE+L
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 318 ----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
YG D W+ G E++ G+ + E KI
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 84/406 (20%), Positives = 152/406 (37%), Gaps = 69/406 (16%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
IG+G++ V + D KK+ A+K + +E VR + +E+ I++ L+H ++ L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 207 GLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
S +++V + + DL F E VK ++ +L+ LD+
Sbjct: 82 --------YSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ 132
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL--G 317
++ ++HRD+K N+L+D +G + I DF +A+ + +T+ T Y PE+
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTMAGTKPYMAPEMFSSRK 190
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377
Y AVD WS G EL G+ R+ +I
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVH-------------TFETTV 236
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-GSAASALRSEFFT-------- 428
+ P + ++L++ LL +P R + +
Sbjct: 237 VTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVF 284
Query: 429 MKPLPCDPSSLPKYPPSKE---FDAKIRDEEAR---RQGGSKGQRMDLERRGTRESRAIP 482
K L P + P+K D EE + K +R+ + + R+
Sbjct: 285 QKRLI------PGFIPNKGRLNCDPTFELEEMILESKPLHKKKKRLAKKEKDMRKC-DSS 337
Query: 483 APDANAELVLSMQKRQSQYNSKSRSEKFNPHPEEVASGFPIDPPRQ 528
E + S+QK +N + + FN +A DP +
Sbjct: 338 QTCLLQEHLDSVQKEFIIFNREKVNRDFNKRQPNLALEQTKDPQGE 383
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G+G + V +A+ + VA+K++ ++ F+ E+ L R++H N++KL G
Sbjct: 16 VGRGAFGVVCKAKWRAKD--VAIKQIESESERKA---FI-VELRQLSRVNHPNIVKLYGA 69
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGL--ASHPGLKFSEAQVKCYMQQLLCGLDHCHSR---G 262
+ + LV EY E L + + P ++ A + Q G+ + HS
Sbjct: 70 CLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 263 VLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYY 321
++HRD+K NLL+ G +LKI DFG A D +T+ + + PE+ G+ Y
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSN-Y 180
Query: 322 GTAVDLWSTGCILAELYAGK 341
D++S G IL E+ +
Sbjct: 181 SEKCDVFSWGIILWEVITRR 200
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 66/331 (19%), Positives = 122/331 (36%), Gaps = 60/331 (18%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+ D FEK+ + +G G V++ ++A K + + +P +
Sbjct: 31 KDDDFEKISE-----------LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQI 78
Query: 188 AREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKC 246
RE+ +L + ++ G S + + E+M+ L + G + E +
Sbjct: 79 IRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGK 135
Query: 247 YMQQLLCGLDHCHSRG-VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT---- 301
++ GL + + ++HRD+K SN+L+++ G +K+ DFG++ L
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--------QLIDSMA 187
Query: 302 -SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC 360
S V T Y PE L G T+Y D+WS G L E+ G+ +P E
Sbjct: 188 NSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246
Query: 361 GSPSEDYWRKSKL-------------PHATIFK---------PQQPYKRCVAETFKDFPA 398
+ + + + P IF+ P + + F+DF
Sbjct: 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF-- 304
Query: 399 PALALMETLLSIDPADRGSAASALRSEFFTM 429
+ L +PA+R + F
Sbjct: 305 -----VNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 59/288 (20%), Positives = 106/288 (36%), Gaps = 38/288 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEG 207
+G GT V++ R ++A+K++R E + + ++ ++ + D +++ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHR 266
+ + +++ E M L E + ++ L + GV+HR
Sbjct: 92 TFIT--NTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPE----LLLGATYYG 322
D+K SN+L+D G +K+ DFG++ D+ + Y PE Y
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 323 TAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381
D+WS G L EL G+ P +T+ E L K+ + LP F
Sbjct: 208 IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEPP------LLPGHMGFSG 258
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429
F+ F ++ L+ D R L F
Sbjct: 259 D----------FQSF-------VKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 5e-31
Identities = 79/365 (21%), Positives = 133/365 (36%), Gaps = 100/365 (27%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN------- 201
+G G +S V+ + D+ KK VA+K V+ E+ EI +L+ + + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL---DEIRLLKSVRNSDPNDPNRE 101
Query: 202 -VIKL------EGLVTSRMSCSLYLVFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLC 253
V++L G+ + + C +VFE + H L VK +QQ+L
Sbjct: 102 MVVQLLDDFKISGVNGTHI-C---MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQ 157
Query: 254 GLDHCHSR-GVLHRDIKGSNLLI------------------------------------- 275
GLD+ H++ ++H DIK N+L+
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 276 ------------DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+KIAD G A + + + +R YR E+L+G+ Y T
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEVLIGSGY-NT 272
Query: 324 AVDLWSTGCILAELYAGKPIMPGRT------EVEQLHKIFKLCGSPSEDYWRKSK----- 372
D+WST C+ EL G + + + + + I +L G K
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 373 ------LPHATIFKPQQPYKRCVAETFKDFP----APALALMETLLSIDPADRGSAASAL 422
L H T KP ++ V ++ A + +L + P R +AA L
Sbjct: 333 FTKKGDLKHITKLKPWGLFE--VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390
Query: 423 RSEFF 427
R +
Sbjct: 391 RHPWL 395
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 20/221 (9%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G + V + + K+ A+K + ++ L+ E +L D + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 207 GLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
+ LYLV +Y DL L S + E + Y+ +++ +D H
Sbjct: 141 --------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH 192
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL--- 316
+HRDIK N+L+D NG +++ADFG D + V T Y PE+L
Sbjct: 193 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 317 -GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
G YG D WS G + E+ G+ + VE KI
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM--AREIHILRRLDHINVIKLE 206
IG G + VYRA + VA+K R D E S +E + L H N+I L
Sbjct: 15 IGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 207 GLVTSRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
G+ +L LV E+ + + L+ + + + Q+ G+++ H
Sbjct: 73 GVCLKEP--NLCLVMEFARGGPLNRV--LSGK---RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 263 ---VLHRDIKGSNLLIDN--------NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 311
++HRD+K SN+LI N ILKI DFGLA + S +
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMA 182
Query: 312 PELLLGATYYGTAVDLWSTGCILAELYAGK 341
PE++ + + D+WS G +L EL G+
Sbjct: 183 PEVIRASM-FSKGSDVWSYGVLLWELLTGE 211
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 61/280 (21%), Positives = 106/280 (37%), Gaps = 48/280 (17%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
++G+G + V+ + K+ A KK+ + + + E IL ++ ++ L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 207 GLVTSRMSC-----SLYLVFEYME------HDLAGLASHPGLKFSEAQVKCYMQQLLCGL 255
L LV M H + + F E + Y Q++ GL
Sbjct: 252 -------YAFETKTDLCLVMTIMNGGDIRYH-IYNVDEDNP-GFQEPRAIFYTAQIVSGL 302
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
+H H R +++RD+K N+L+D++G ++I+D GLA T + PELL
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAPELL 361
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375
LG Y +VD ++ G L E+ A + R E + ++ +
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---------------- 404
Query: 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
+ + Y F + E LL DP R
Sbjct: 405 --VLEQAVTYPD-------KFSPASKDFCEALLQKDPEKR 435
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 9/214 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVR-FDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+IG+G + V R +K+ A+K + F+ ++ F E I+ + V++L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 207 GLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+ LY+V EYM DL L S+ E + Y +++ LD HS G +H
Sbjct: 136 Y--AFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIH 191
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL---GATYYG 322
RD+K N+L+D +G LK+ADFG + + + V T Y PE+L G YYG
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYG 251
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356
D WS G L E+ G + V KI
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 285
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 56/297 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
++G+G + V + K+ A KK+ + + + E IL +++ V+ L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 207 GLVTSRMSC-----SLYLVFEYME------HDLAGLASHPGLKFSEAQVKCYMQQLLCGL 255
+L LV M H + F EA+ Y ++ CGL
Sbjct: 251 -------YAYETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYAAEICCGL 299
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELL 315
+ H +++RD+K N+L+D++G ++I+D GLA + Q + RV T+ Y PE++
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTVGYMAPEVV 357
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375
Y + D W+ GC+L E+ AG+ R + + ++ +L
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---------------- 400
Query: 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR----GSAASALRS-EFF 427
+ + + Y F A +L LL DPA+R G +A ++ F
Sbjct: 401 --VKEVPEEYSE-------RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 56/241 (23%), Positives = 105/241 (43%), Gaps = 25/241 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+ +G + V++A+ L++ VA+K F + +S + E++ L + H N+++ G
Sbjct: 31 VKARGRFGCVWKAQLLNEY--VAVKI--FPIQDKQSWQN-EYEVYSLPGMKHENILQFIG 85
Query: 208 LVT--SRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR--- 261
+ + L+L+ + E L+ + ++E + GL + H
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAE--TMARGLAYLHEDIPG 143
Query: 262 -------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPE 313
+ HRDIK N+L+ NN IADFGLA ++ ++ T V T Y PE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 314 LLLGATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369
+L GA +D+++ G +L EL + G + L ++ PS + +
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263
Query: 370 K 370
+
Sbjct: 264 E 264
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 32/230 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G Y V+ + +K VA+K E+ F EI+ + H N++
Sbjct: 44 QIGKGRYGEVWMGKWRGEK--VAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 208 LVT--SRMSCSLYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+ LYL+ +Y E +D L S + + GL H H+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDY--LKSTT---LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 262 --------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PLTSRVVTLWYR 310
+ HRD+K N+L+ NG IAD GLA + D N+ P +RV T Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 311 PPELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK 355
PPE+L + D++S G IL E+ E + +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 53/215 (24%), Positives = 80/215 (37%), Gaps = 32/215 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G+G Y V+R + VA+K + + F E++ L H N++
Sbjct: 15 CVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSW---FRETELYNTVMLRHENILGFIA 69
Query: 208 LVTSRMSCS--LYLVFEYME----HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+ S L+L+ Y E +D L + + GL H H
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDY--LQLTT---LDTVSCLRIVLSIASGLAHLHIE 124
Query: 262 --------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PLTSRVVTLWYR 310
+ HRD+K N+L+ NG IAD GLA + NQ RV T Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 311 PPELLLGATY-----YGTAVDLWSTGCILAELYAG 340
PE+L VD+W+ G +L E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 62/312 (19%), Positives = 123/312 (39%), Gaps = 50/312 (16%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
A+ + L + IG+G Y +V + +I+A+K++R ++ + + +
Sbjct: 20 TAEDLKDLGE-----------IGRGAYGSVNKMVHKPSGQIMAVKRIRST-VDEKEQKQL 67
Query: 188 AREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM----EHDLAGLASHPGLKFSEA 242
++ ++ R D +++ G + ++ E M + + S E
Sbjct: 68 LMDLDVVMRSSDCPYIVQFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE 125
Query: 243 QVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301
+ + L+H ++HRDIK SN+L+D +G +K+ DFG++ + T
Sbjct: 126 ILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--T 183
Query: 302 SRVVTLWYRPPELLLGATY---YGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIF 357
Y PE + + Y D+WS G L EL G+ P + +QL ++
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243
Query: 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 417
K G P +L + ++ + + +F +F + L+ D + R
Sbjct: 244 K--GDP-------PQLSN----SEEREF----SPSFINF-------VNLCLTKDESKRPK 279
Query: 418 AASALRSEFFTM 429
L+ F M
Sbjct: 280 YKELLKHPFILM 291
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 52/224 (23%), Positives = 81/224 (36%), Gaps = 32/224 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G + V+R + ++ VA+K F EI+ L H N++
Sbjct: 49 SIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSW---FREAEIYQTVMLRHENILGFIA 103
Query: 208 LVTSRMSCS--LYLVFEYMEH----DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
L+LV +Y EH D L + + + GL H H
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDY--LNRYT---VTVEGMIKLALSTASGLAHLHME 158
Query: 262 --------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PLTSRVVTLWYR 310
+ HRD+K N+L+ NG IAD GLA +D + RV T Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 311 PPELLLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTE 349
PE+L + D+++ G + E+ I +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 68/318 (21%), Positives = 122/318 (38%), Gaps = 66/318 (20%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+AD E + + +G+G Y V + R + +I+A+K++R + + + +
Sbjct: 5 KADDLEPIME-----------LGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRL 52
Query: 188 AREIHI-LRRLDHINVIKLEGLVTSRMSCSLYLVFEYM----EHDLAGLASHPGLKFSEA 242
++ I +R +D + G + +++ E M + + E
Sbjct: 53 LMDLDISMRTVDCPFTVTFYGALFRE--GDVWICMELMDTSLDKFYKQVIDKGQ-TIPED 109
Query: 243 QVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301
+ ++ L+H HS V+HRD+K SN+LI+ G +K+ DFG++ + L
Sbjct: 110 ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY--------LV 161
Query: 302 SRVV------TLWYRPPELLLGATY---YGTAVDLWSTGCILAELYAGK-PIMPGRTEVE 351
V Y PE + Y D+WS G + EL + P T +
Sbjct: 162 DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 352 QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSID 411
QL ++ PS PQ P + AE F DF L +
Sbjct: 222 QLKQV---VEEPS----------------PQLPADKFSAE-FVDF-------TSQCLKKN 254
Query: 412 PADRGSAASALRSEFFTM 429
+R + ++ FFT+
Sbjct: 255 SKERPTYPELMQHPFFTL 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-27
Identities = 72/279 (25%), Positives = 119/279 (42%), Gaps = 49/279 (17%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHIL--RR-LDHINVIK 204
+IG+G + VY R D K+ A+K L+ + ++ E L R L ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKC-----LDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 205 LEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 257
+V MS + L + + M DL S G FSEA ++ Y +++ GL+H
Sbjct: 251 CPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEH 307
Query: 258 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 317
H+R V++RD+K +N+L+D +G ++I+D GLA + + + V T Y PE+L
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQK 364
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKLPHA 376
Y ++ D +S GC+L +L G P R + H+I ++
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHS--PFRQHKTKDKHEIDRM----------------- 405
Query: 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
F +L+E LL D R
Sbjct: 406 -TLTMAVELPDS-------FSPELRSLLEGLLQRDVNRR 436
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 58/233 (24%), Positives = 102/233 (43%), Gaps = 29/233 (12%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + V R + + VA+K ++ ++ +EI ILR L H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYHENIVK 87
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+G+ T + L+ E++ L L + K + Q Y Q+ G+D+ SR
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLA-------SFYDPDQNQPLTSRVVTLWYRPPELL 315
+HRD+ N+L+++ +KI DFGL +Y ++ WY PE L
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF----WY-APECL 201
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368
+ + +Y A D+WS G L EL + ++ + K+ G +
Sbjct: 202 MQSKFY-IASDVWSFGVTLHEL-----LTYCDSDSSPMALFLKMIGPT---HG 245
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESVRFMAREIHILRRLDHINVIKL- 205
L+G+G +VY A D +++IVALK + + +P M RE RL +V+ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 206 -----EGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
+G LY+ + DLA + G + + ++Q+ LD H
Sbjct: 101 DFGEIDGQ--------LYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH 151
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGA 318
+ G HRD+K N+L+ + + DFG+AS D+ V TL+Y PE +
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 319 TYYGTAVDLWSTGCILAELYAGKP 342
D+++ C+L E G P
Sbjct: 211 H-ATYRADIYALTCVLYECLTGSP 233
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA-REIHILRRLDHINVIKLE 206
LIG+G Y VY+ LD++ VA+K F ++ F+ + I+ + ++H N+ +
Sbjct: 20 LIGRGRYGAVYKGS-LDERP-VAVKV--FSFANRQN--FINEKNIYRVPLMEHDNIARFI 73
Query: 207 G---LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-- 260
VT+ LV EY + L S + + + + GL + H+
Sbjct: 74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAH--SVTRGLAYLHTEL 131
Query: 261 -------RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-------QNQPLTSRVVT 306
+ HRD+ N+L+ N+G I+DFGL+ + ++ S V T
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 307 LWYRPPELLLGA------TYYGTAVDLWSTGCILAELYAGK 341
+ Y PE+L GA VD+++ G I E++
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESV-RFMAREIHILRRLDHINVIKL 205
+G G S VY A D VA+K + + E++ RF RE+H +L H N++ +
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRF-EREVHNSSQLSHQNIVSM 76
Query: 206 ------EGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
+ YLV EY+E L+ G S + Q+L G+ H
Sbjct: 77 IDVDEEDDCY--------YLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHA 127
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLG 317
H ++HRDIK N+LID+N LKI DFG+A + + T+ V+ T+ Y PE G
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 318 ATYYGTAVDLWSTGCILAELYAGKP 342
D++S G +L E+ G+P
Sbjct: 187 EA-TDECTDIYSIGIVLYEMLVGEP 210
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + +V R + ++VA+KK++ + E F REI IL+ L H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHDNIVK 75
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+G+ S +L L+ EY+ + L L H + ++ Y Q+ G+++ ++
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLA-------SFYDPDQNQPLTSRVVTLWYRPPELL 315
+HRD+ N+L++N +KI DFGL F+ + WY PE L
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF----WY-APESL 189
Query: 316 LGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ + A D+WS G +L EL Y K P + +
Sbjct: 190 TESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 24/223 (10%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + +V R + ++VA+KK++ + E F REI IL+ L H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFE-REIEILKSLQHDNIVK 106
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+G+ S +L L+ EY+ + L L H + ++ Y Q+ G+++ ++
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLA-------SFYDPDQNQPLTSRVVTLWYRPPELL 315
+HRD+ N+L++N +KI DFGL +Y + WY PE L
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF----WY-APESL 220
Query: 316 LGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ + A D+WS G +L EL Y K P + +
Sbjct: 221 TESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
+G G++ V + + A+K + ++ + + E IL+ ++ ++KLE
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQLLCGLDHCHS 260
+ + + +LY+V EY+ G + SH L +FSE + Y Q++ ++ HS
Sbjct: 108 F--SFKDNSNLYMVMEYVA----GGEMFSH--LRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLL 316
+++RD+K NLLID G +++ DFG A R TL PE++L
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--------GRTWTLCGTPEALAPEIIL 211
Query: 317 GATYYGTAVDLWSTGCILAELYAGKP 342
Y AVD W+ G ++ E+ AG P
Sbjct: 212 SKG-YNKAVDWWALGVLIYEMAAGYP 236
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFD-NLEPESV-RFMAREIHILRRLDHINVIKL 205
++G G S V+ ARDL + VA+K +R D +P RF RE L+H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF-RREAQNAAALNHPAIVAV 77
Query: 206 --EGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
G + Y+V EY++ L + G + + + L+ H G
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNG 136
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT--SRVV-TLWYRPPELLLGAT 319
++HRD+K +N++I +K+ DFG+A D +T + V+ T Y PE G +
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDS 195
Query: 320 YYGTAVDLWSTGCILAELYAGKP 342
D++S GC+L E+ G+P
Sbjct: 196 -VDARSDVYSLGCVLYEVLTGEP 217
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 28/206 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
+G G++ V+ R + A+K ++ + + + V E +L + H +I++
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQLLCGLDHCHS 260
G T + + ++++ +Y+E G L S L +F K Y ++ L++ HS
Sbjct: 73 G--TFQDAQQIFMIMDYIE----GGELFSL--LRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW----YRPPELLL 316
+ +++RD+K N+L+D NG +KI DFG A + + TL Y PE++
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFA--------KYVPDVTYTLCGTPDYIAPEVVS 176
Query: 317 GATYYGTAVDLWSTGCILAELYAGKP 342
Y ++D WS G ++ E+ AG
Sbjct: 177 TKP-YNKSIDWWSFGILIYEMLAGYT 201
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 149 IGQGTYSNVYRAR---DLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + +V R D VA+K+++ P+ R REI IL+ L ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQREIQILKALHSDFIVK 88
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
G+ SL LV EY+ L L H + +++ Y Q+ G+++ SR
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR 147
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGAT 319
+HRD+ N+L+++ +KIADFGLA D++ + WY PE L
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-APESLSDNI 206
Query: 320 YYGTAVDLWSTGCILAEL--YAGKP 342
+ D+WS G +L EL Y K
Sbjct: 207 FS-RQSDVWSFGVVLYELFTYCDKS 230
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-25
Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 11/212 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G Y VY VA+K ++ D +E E F+ E +++ + H N+++L G+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLK-EAAVMKEIKHPNLVQLLGV 284
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
T Y++ E+M + +L L + S + Q+ +++ + +HR
Sbjct: 285 CTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPPELLLGATYYGTAV 325
++ N L+ N ++K+ADFGL+ D + W P L +
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK--FSIKS 400
Query: 326 DLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+W+ G +L E+ G PG + +
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-25
Identities = 44/207 (21%), Positives = 79/207 (38%), Gaps = 19/207 (9%)
Query: 148 LIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
I G +Y A D + + V LK + M E L + H +++++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAM-AERQFLAEVVHPSIVQIF 145
Query: 207 GLV---TSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
V Y+V EY+ L A+ Y+ ++L L + HS G
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIG 202
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYY 321
+++ D+K N+++ + K+ D G S + + T ++ PE++
Sbjct: 203 LVYNDLKPENIMLTEEQL-KLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTGP-- 253
Query: 322 GTAVDLWSTGCILAELYAGKPIMPGRT 348
A D+++ G LA L P GR
Sbjct: 254 TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 66/278 (23%), Positives = 106/278 (38%), Gaps = 52/278 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
L+G+GT+ V R+ + A+K +R + + + V E +L+ H + L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 207 GLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
L V EY +L S F+E + + Y +++ L++ HS
Sbjct: 72 -------YAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHS 123
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLA--SFYDPDQNQPLTSRVV-TLWYRPPELLLG 317
R V++RDIK NL++D +G +KI DFGL D T Y PE+L
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT----MKTFCGTPEYLAPEVLED 179
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377
YG AVD W G ++ E+ G+ + I + + P
Sbjct: 180 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----------EEIRFP--- 225
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
+ A +L+ LL DP R
Sbjct: 226 ----------------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 28/228 (12%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G+G + V + ++VA+K ++ D + +EI ILR L H ++IK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWK-QEIDILRTLYHEHIIK 97
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+G + SL LV EY+ L L H AQ+ + QQ+ G+ + H++
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLA-------SFYDPDQNQPLTSRVVTLWYRPPELL 315
+HRD+ N+L+DN+ ++KI DFGLA +Y ++ WY PE L
Sbjct: 155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF----WY-APECL 209
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSP 363
+Y A D+WS G L EL + + K +L G
Sbjct: 210 KEYKFY-YASDVWSFGVTLYEL-----LTHCDSSQSPPTKFLELIGIA 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G Y VY VA+K ++ D +E E F+ +E +++ + H N+++L G+
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FL-KEAAVMKEIKHPNLVQLLGV 77
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
T Y++ E+M + +L L + S + Q+ +++ + +HR
Sbjct: 78 CTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 135
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGATYYG 322
D+ N L+ N ++K+ADFGL+ D T+ W PE + Y
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWT-APE----SLAYN 187
Query: 323 ---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
D+W+ G +L E+ Y P PG + +
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 66/282 (23%), Positives = 123/282 (43%), Gaps = 48/282 (17%)
Query: 148 LIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHIN- 201
++G G Y V+ R + D K+ A+K ++ + + ++ E +L +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120
Query: 202 VIKLEGLVTSRMSCS------LYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCG 254
++ L + L+L+ +Y+ +L S +F+E +V+ Y+ +++
Sbjct: 121 LVTLH--------YAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLA 171
Query: 255 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 314
L+H H G+++RDIK N+L+D+NG + + DFGL+ + D+ + T+ Y P++
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 315 LLGATY-YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373
+ G + AVD WS G ++ EL G E +I +
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-------------- 277
Query: 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
I K + PY + + A A L++ LL DP R
Sbjct: 278 ----ILKSEPPYPQ-------EMSALAKDLIQRLLMKDPKKR 308
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 46/332 (13%), Positives = 88/332 (26%), Gaps = 78/332 (23%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLE------PESVRFMAREIHILRRL----- 197
IG+G + V++ VA+K + + + ++ + EI I + L
Sbjct: 28 IGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 198 ----DHINVIKLEGLVTSRMSCS----------------------------LYLVFEYME 225
I L + + S L++V E E
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE-FE 144
Query: 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIA 284
L S A K + QL L + HRD+ N+L+ + K+
Sbjct: 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 285 DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM 344
P V++ Y + + ++ + +
Sbjct: 205 YTLNGKSSTI----PSCGLQVSII-----------DYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 345 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH---------ATIFKPQQPYKRCVAETFKD 395
G + + I++L + + W + + K +C K
Sbjct: 250 TG--DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQ 307
Query: 396 FPAPALALMETLLSIDPADRGSAASALRSEFF 427
T+L+ SA L
Sbjct: 308 IKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 62/284 (21%)
Query: 148 LIGQGTYSNVYRAR---DLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVI 203
++GQG++ V+ + D +++ A+K ++ L + VR E IL ++H ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVNHPFIV 89
Query: 204 KLEGLVTSRMSCS------LYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQL 251
KL + LYL+ +++ G L + L F+E VK Y+ +L
Sbjct: 90 KLH--------YAFQTEGKLYLILDFL----RGGDLFTR--LSKEVMFTEEDVKFYLAEL 135
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 311
LDH HS G+++RD+K N+L+D G +K+ DFGL S D + S T+ Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYSFCGTVEYMA 194
Query: 312 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371
PE++ + + D WS G ++ E+ G G+ E + I K K
Sbjct: 195 PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----------AKL 243
Query: 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
+P + A +L+ L +PA+R
Sbjct: 244 GMP-------------------QFLSPEAQSLLRMLFKRNPANR 268
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 61/221 (27%), Positives = 106/221 (47%), Gaps = 23/221 (10%)
Query: 149 IGQGTYSNVYRAR---DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG G V R + VA+K ++ E + F+ E I+ + DH N+I+L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFL-SEASIMGQFDHPNIIRL 115
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
EG+VT +V EYME+ L L +H G +F+ Q+ ++ + G+ + G
Sbjct: 116 EGVVTR--GRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGATY 320
+HRD+ N+L+D+N + K++DFGL+ + D + T+ + W PE A
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-APE----AIA 227
Query: 321 YG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ +A D+WS G ++ E+ Y +P T + + +
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP-YWNMTNRDVISSV 267
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 13/212 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+GQG + V+ + VA+K ++ + PE F+ +E ++++L H +++L +
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHEKLVQLYAV 247
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
V+ +Y+V EYM L L G Q+ Q+ G+ + +HR
Sbjct: 248 VSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPPELLLGATYYGTAV 325
D++ +N+L+ N + K+ADFGLA + ++ + W P L G +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 362
Query: 326 DLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+WS G +L EL G+ PG E L ++
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 23/221 (10%)
Query: 149 IGQGTYSNVYRAR---DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+G G + V R ++ VA+K ++ E + F+ E I+ + DH N+I+L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-GEASIMGQFDHPNIIRL 111
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
EG+VT S + +V EYME+ L L H +F+ Q+ ++ + G+ + G
Sbjct: 112 EGVVTK--SKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGATY 320
+HRD+ N+LI++N + K++DFGL + D T+R + W PE A
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-SPE----AIA 223
Query: 321 YG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
Y +A D+WS G +L E+ Y +P + + + +
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP-YWEMSNQDVIKAV 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 65/284 (22%), Positives = 115/284 (40%), Gaps = 60/284 (21%)
Query: 148 LIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINV 202
++G+G Y V++ R + + KI A+K ++ + + E +IL + H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 203 IKLEGLVTSRMSC-----SLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQL 251
+ L + LYL+ EY+ +G L L F E Y+ ++
Sbjct: 84 VDL-------IYAFQTGGKLYLILEYL----SGGELFMQ--LEREGIFMEDTACFYLAEI 130
Query: 252 LCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 311
L H H +G+++RD+K N+++++ G +K+ DFGL + T+ Y
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMA 189
Query: 312 PELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371
PE+L+ + + AVD WS G ++ ++ G P G + + KI K K
Sbjct: 190 PEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK----------CKL 238
Query: 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
LP A L++ LL + A R
Sbjct: 239 NLP-------------------PYLTQEARDLLKKLLKRNAASR 263
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 21/221 (9%)
Query: 149 IGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG+G + VY D D KKI A+K + E +F+ E I++ H NV+ L
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVLSL 91
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
G+ R S +V YM+H DL + + + + Q+ G+ + S+ +
Sbjct: 92 LGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 265 HRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL---WYRPPELLLGATY 320
HRD+ N ++D +K+ADFGLA YD + L W E +
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM-ALE----SLQ 205
Query: 321 YG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
T D+WS G +L EL P P + +
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 245
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 11/213 (5%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + V+ R +VA+K R +F+ +E IL++ H N+++L G+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFL-QEARILKQYSHPNIVRLIGV 180
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
T + +Y+V E ++ D L + + + + G+++ S+ +HR
Sbjct: 181 CTQKQP--IYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCCIHR 237
Query: 267 DIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL-WYRPPELLLGATYYGTA 324
D+ N L+ +LKI+DFG++ D R V + W PE L Y +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APEALNYGR-YSSE 295
Query: 325 VDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+WS G +L E ++ G P + + +
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 24/222 (10%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
IG G + VY+ ++ VA+K ++ E + V F+ E I+ + H N+I+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHNIIR 110
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
LEG+++ + ++ EYME+ L L G +FS Q+ ++ + G+ + +
Sbjct: 111 LEGVISK--YKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGAT 319
+HRD+ N+L+++N + K++DFGL+ + D T+ + W PE A
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-APE----AI 222
Query: 320 YYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
Y +A D+WS G ++ E+ Y +P + E + I
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP-YWELSNHEVMKAI 263
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 63/276 (22%), Positives = 108/276 (39%), Gaps = 47/276 (17%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLE 206
L+G+GT+ V ++ + A+K ++ + + + V E +L+ H + L+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 207 GLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
L V EY +L S FSE + + Y +++ LD+ HS
Sbjct: 215 -------YSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHS 266
Query: 261 -RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
+ V++RD+K NL++D +G +KI DFGL + + T Y PE+L
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLED-N 324
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
YG AVD W G ++ E+ G+ + + I + + P
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM----------EEIRFP----- 369
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
+ A +L+ LL DP R
Sbjct: 370 --------------RTLGPEAKSLLSGLLKKDPKQR 391
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 50/219 (22%), Positives = 98/219 (44%), Gaps = 22/219 (10%)
Query: 149 IGQGTYSNVYRARDLDQKKI---VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG+G + +V++ + + VA+K + + +F+ +E +R+ DH +++KL
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHIVKL 81
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
G++T ++++ E +L L A + Y QL L + S+
Sbjct: 82 IGVITEN---PVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKRF 137
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
+HRDI N+L+ +N +K+ DFGL+ D + ++ W PE + +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE----SINFR 192
Query: 323 ---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+A D+W G + E+ + KP G + + +I
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 230
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 21/221 (9%)
Query: 149 IGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG+G + VY D D KKI A+K + E +F+ E I++ H NV+ L
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVLSL 155
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
G+ R S +V YM+H DL + + + + Q+ G+ S+ +
Sbjct: 156 LGICL-RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 265 HRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL---WYRPPELLLGATY 320
HRD+ N ++D +K+ADFGLA YD + + L W E +
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM-ALE----SLQ 269
Query: 321 YG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
T D+WS G +L EL P P + +
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYL 309
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 60/219 (27%), Positives = 108/219 (49%), Gaps = 27/219 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ K VA+K ++ ++ P++ F+A E +++++L H +++L +
Sbjct: 21 LGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDA--FLA-EANLMKQLQHQRLVRLYAV 76
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
VT +Y++ EYME+ L L + G+K + ++ Q+ G+ R +HR
Sbjct: 77 VTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGATYYG 322
D++ +N+L+ + KIADFGLA + ++ T+R W PE A YG
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWT-APE----AINYG 185
Query: 323 ---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
D+WS G +L E+ + P PG T E + +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP-YPGMTNPEVIQNL 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 46/221 (20%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G G + VY+ K VA+K++R + + E +++ +D+ +V +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 81
Query: 205 LEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L G+ + ++ L+ + M L + H + + Q+ G+++ R
Sbjct: 82 LLGICLTS---TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPELLLGATY 320
++HRD+ N+L+ +KI DFGLA ++ + +V W E +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE----SIL 192
Query: 321 YG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ D+WS G + EL + KP G E +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-23
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 13/212 (6%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+GQG + V+ + VA+K ++ + PE F+ +E ++++L H +++L +
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPE--AFL-QEAQVMKKLRHEKLVQLYAV 330
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
V+ +Y+V EYM L L G Q+ Q+ G+ + +HR
Sbjct: 331 VSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 387
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL-WYRPPELLLGATYYGTAV 325
D++ +N+L+ N + K+ADFGLA + ++ + W P L G +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTIKS 445
Query: 326 DLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+WS G +L EL G+ PG E L ++
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 149 IGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVR--FMAREIHILRRLDHINVI 203
+G G++ V R K + VA+K ++ D L F+ RE++ + LDH N+I
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHRNLI 84
Query: 204 KLEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
+L G+V + + +V E L L H G F + Y Q+ G+ + S+
Sbjct: 85 RLYGVVLTP---PMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK 140
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGA 318
+HRD+ NLL+ ++KI DFGL + + + + W PE +
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC-APE----S 195
Query: 319 TYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
A D W G L E+ Y +P G + LHKI
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKI 237
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 50/219 (22%), Positives = 90/219 (41%), Gaps = 21/219 (9%)
Query: 149 IGQGTYSNVYRA--RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G + +V + R ++ VA+K ++ + ++ M RE I+ +LD+ +++L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRLI 76
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G+ + +L LV E L + + V + Q+ G+ + + +H
Sbjct: 77 GVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGATYYG 322
RD+ N+L+ N KI+DFGL+ D + WY PE +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APE----CINFR 188
Query: 323 ---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ D+WS G + E Y KP E + I
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 226
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 149 IGQGTYSNVYRARDLDQKKI---VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG+G + +V++ + + VA+K + + +F+ +E +R+ DH +++KL
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHIVKL 456
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
G++T ++++ E +L L A + Y QL L + S+
Sbjct: 457 IGVITEN---PVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLESKRF 512
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322
+HRDI N+L+ +N +K+ DFGL+ D + ++ W P + +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR--FT 570
Query: 323 TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+A D+W G + E+ + KP G + + +I
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP-FQGVKNNDVIGRI 605
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 30/223 (13%)
Query: 149 IGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+G+G + VY + +KI VA+K + D +FM E I++ LDH +++KL
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFM-SEAVIMKNLDHPHIVKL 78
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
G++ +++ E + +L L + + Y Q+ + + S
Sbjct: 79 IGIIEEE---PTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESINC 134
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL----WYRPPELLLGA 318
+HRDI N+L+ + +K+ DFGL+ D D VT W PE +
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY----YKASVTRLPIKWM-SPE----S 185
Query: 319 TYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ TA D+W + E+ + +P + + +
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP-FFWLENKDVIGVL 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 49/216 (22%), Positives = 88/216 (40%), Gaps = 25/216 (11%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + +V K VA+K ++ D F+ E ++ +L H N+++L G+
Sbjct: 29 IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA---FL-AEASVMTQLRHSNLVQLLGV 82
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ LY+V EYM L L S + + + +++ +HR
Sbjct: 83 IV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 141
Query: 267 DIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG--- 322
D+ N+L+ + + K++DFGL L + W PE A
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WT-APE----ALREKKFS 192
Query: 323 TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
T D+WS G +L E+ + P P + + ++
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP-YPRIPLKDVVPRV 227
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 66/279 (23%), Positives = 113/279 (40%), Gaps = 53/279 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLD-HINVIKL 205
++G+G++ V + ++ A+K ++ D ++ + V E +L + +L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 206 EGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
SC LY V EY+ DL G +F E Y ++ GL
Sbjct: 87 H-------SCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ 138
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLA--SFYDPDQNQPLTSRVV-TLWYRPPELLL 316
S+G+++RD+K N+++D+ G +KIADFG+ + +D T T Y PE++
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT----TKTFCGTPDYIAPEIIA 194
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376
YG +VD W+ G +L E+ AG+ G E E I + P
Sbjct: 195 Y-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----------HNVAYP-- 241
Query: 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
K A+A+ + L++ P R
Sbjct: 242 -----------------KSMSKEAVAICKGLMTKHPGKR 263
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 50/237 (21%), Positives = 90/237 (37%), Gaps = 44/237 (18%)
Query: 149 IGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+G+G + +V A + D + VA+K ++ D + + RE ++ DH +V KL
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 206 EGLVT----SRMSCSLYLVFEYMEH-DL-----AGLASHPGLKFSEAQVKCYMQQLLCGL 255
G+ ++ +M+H DL A + +M + CG+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 256 DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYR---- 310
++ SR +HRD+ N ++ + + +ADFGL+ Y D +YR
Sbjct: 151 EYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD------------YYRQGCA 198
Query: 311 --------PPE-LLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
E L Y D+W+ G + E+ P G E + +
Sbjct: 199 SKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYL 252
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 23/220 (10%)
Query: 149 IGQGTYSNVYRA--RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G + V + + K VA+K ++ + +P + E +++++LD+ ++++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
G+ + S LV E E L L + + + + Q+ G+ + +
Sbjct: 85 GICEAE---SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFV 139
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGATYY 321
HRD+ N+L+ KI+DFGL+ D+N WY PE Y
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APE----CINY 194
Query: 322 G---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ D+WS G ++ E Y KP G E +
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP-YRGMKGSEVTAML 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 47/238 (19%), Positives = 89/238 (37%), Gaps = 47/238 (19%)
Query: 149 IGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
+G+G + +V + D + VA+K ++ DN + E ++ H NVI+L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 206 EGLVT---SRMSCSLYLVFEYMEH-DL-----AGLASHPGLKFSEAQVKCYMQQLLCGLD 256
G+ S+ ++ +M++ DL + +M + G++
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 257 HCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYR----- 310
+ +R LHRD+ N ++ ++ + +ADFGL+ Y D +YR
Sbjct: 162 YLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD------------YYRQGRIA 209
Query: 311 -------PPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
E L + D+W+ G + E+ P PG E +
Sbjct: 210 KMPVKWIAIESLA----DRVYTSKSDVWAFGVTMWEIATRGMTP-YPGVQNHEMYDYL 262
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-22
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 27/219 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G + V+ L++ K VA+K +R + E F+ E ++ +L H +++L G+
Sbjct: 16 IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEED--FI-EEAEVMMKLSHPKLVQLYGV 71
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + LV E+MEH L+ L + G F+ + + G+ + V+HR
Sbjct: 72 CLEQAP--ICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGATYYG 322
D+ N L+ N ++K++DFG+ F DQ TS T W PE +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWA-SPE----VFSFS 180
Query: 323 ---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ D+WS G ++ E+ P R+ E + I
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP-YENRSNSEVVEDI 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 8e-22
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 47/276 (17%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHIL-RRLDHINVIKL 205
++G+G++ V + ++ A+K ++ D ++ + V E +L + +L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 206 EGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
SC LY V EY+ DL G +F E Y ++ GL
Sbjct: 408 H-------SCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ 459
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
S+G+++RD+K N+++D+ G +KIADFG+ + + T Y PE++
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIAY-Q 517
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
YG +VD W+ G +L E+ AG+ G E E I + P
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----------HNVAYP----- 562
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
K A+A+ + L++ P R
Sbjct: 563 --------------KSMSKEAVAICKGLMTKHPGKR 584
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 9e-22
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 21/221 (9%)
Query: 149 IGQGTYSNVYRA--RDLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205
IG+G + VY D Q +I A+K + + F+ RE ++R L+H NV+ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REGLLMRGLNHPNVLAL 87
Query: 206 EGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
G++ +++ YM H DL P + + + Q+ G+++ + +
Sbjct: 88 IGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 265 HRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL---WYRPPELLLGATY 320
HRD+ N ++D + +K+ADFGLA D + R L W E +
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-ALE----SLQ 201
Query: 321 YG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
T D+WS G +L EL P + H +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFL 241
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 69/293 (23%), Positives = 115/293 (39%), Gaps = 56/293 (19%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR-LDHINVIKL 205
++G+G++ V+ A + A+K ++ D L + V E +L +H + +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83
Query: 206 EGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
+L+ V EY+ DL KF ++ Y +++ GL H
Sbjct: 84 F-------CTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 135
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELL 315
S+G+++RD+K N+L+D +G +KIADFG+ +N ++ T Y PE+L
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAPEIL 190
Query: 316 LGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375
LG Y +VD WS G +L E+ G+ G+ E E H I P
Sbjct: 191 LG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----------DNPFYP- 238
Query: 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-GSAASALRSEFF 427
+ A L+ L +P R G + F
Sbjct: 239 ------------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 70/278 (25%), Positives = 121/278 (43%), Gaps = 42/278 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR-LDHINVIKL 205
+IG+G+Y+ V R +I A+K V+ + + E + ++ E H+ + +H ++ L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 206 EGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
SC L+ V EY+ DL K E + Y ++ L++ H
Sbjct: 76 H-------SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH 127
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV-TLWYRPPELLLG 317
RG+++RD+K N+L+D+ G +K+ D+G+ P TS T Y PE+L G
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRG 184
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377
YG +VD W+ G ++ E+ AG+ P F + GS
Sbjct: 185 -EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVGSSDNPDQNTEDYLFQV 230
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
I + Q R A +++++ L+ DP +R
Sbjct: 231 ILEKQIRIPRS-------LSVKAASVLKSFLNKDPKER 261
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V + Q VA+K ++ ++ + F +E + +L H ++K G+
Sbjct: 16 LGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSED--EFF-QEAQTMMKLSHPKLVKFYGV 71
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ +Y+V EY+ + L L SH +Q+ + G+ S +HR
Sbjct: 72 CSKEYP--IYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGATYYG 322
D+ N L+D + +K++DFG+ + DQ S V T W PE +Y
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWS-APE----VFHYF 180
Query: 323 ---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ D+W+ G ++ E+ P T E + K+
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSEVVLKV 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 21/214 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + +V K VA+K ++ D F+ E ++ +L H N+++L G+
Sbjct: 201 IGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA---FL-AEASVMTQLRHSNLVQLLGV 254
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ LY+V EYM L L S + + + +++ +HR
Sbjct: 255 IV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 267 DIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYRPPELLLGATY--YGT 323
D+ N+L+ + + K++DFGL L + W PE + T
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WT-APE---ALREKKFST 365
Query: 324 AVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
D+WS G +L E+Y+ G+ P + + ++
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 21/216 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V+ A K VA+K ++ ++ E+ F+ E ++++ L H ++KL +
Sbjct: 196 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEA--FL-AEANVMKTLQHDKLVKLHAV 251
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
VT +Y++ E+M L L S G K ++ + Q+ G+ R +HR
Sbjct: 252 VTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGATYYG 322
D++ +N+L+ + + KIADFGLA + ++ T+R W P + G+ +
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGS--FT 363
Query: 323 TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
D+WS G +L E+ Y P PG + E + +
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRAL 398
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 51/278 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR-LDHINVIKL 205
++G+G++ V AR + + A+K ++ D L+ + V E IL +H + +L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 206 EGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
C L+ V E++ DL +F EA+ + Y +++ L H
Sbjct: 90 F-------CCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH 141
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV-TLWYRPPELLLG 317
+G+++RD+K N+L+D+ G K+ADFG+ T+ T Y PE+L
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCGTPDYIAPEILQE 198
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377
YG AVD W+ G +L E+ G E + I + P
Sbjct: 199 -MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----------DEVVYP--- 244
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
A ++++ ++ +P R
Sbjct: 245 ----------------TWLHEDATGILKSFMTKNPTMR 266
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 44/277 (15%), Positives = 77/277 (27%), Gaps = 60/277 (21%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESV--RFMAREIHILRRLDHINVIKL 205
G ++A D + VAL V + P+ V + L R+D V ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETL-SRTLRLSRIDKPGVARV 96
Query: 206 EGLVTSRMSCSLYLVFEYME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+V +R +V E++ L +A + MQ L D H GV
Sbjct: 97 LDVVHTRAGG--LVVAEWIRGGSLQEVADTSPSPVGAIRA---MQSLAAAADAAHRAGVA 151
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
S + + +G + +A +P
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMPDANP-----------------------------Q 182
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+ G L L + +P L + P +P
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ-----------------PIEP 225
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421
A+ +D P A+ + D R ++
Sbjct: 226 -----ADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-21
Identities = 50/219 (22%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V + + VA+K ++ ++ + F+ E ++ L H +++L G+
Sbjct: 32 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDE--FI-EEAKVMMNLSHEKLVQLYGV 87
Query: 209 VTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
T + ++++ EYM + L L +F Q+ + + +++ S+ LHR
Sbjct: 88 CTKQRP--IFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL----WYRPPELLLGATYYG 322
D+ N L+++ G++K++DFGL+ + D+ TS V + W PPE Y
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWS-PPE----VLMYS 196
Query: 323 ---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ D+W+ G ++ E+ P T E I
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMP-YERFTNSETAEHI 234
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 57/281 (20%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHIL-RRLDHINVIKL 205
+IG+G++ V AR ++ A+K ++ L+ + + + E ++L + + H ++ L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 206 EGLVTSRMSC-----SLYLVFEYMEHDLAG--LASHPGL----KFSEAQVKCYMQQLLCG 254
LY V +Y+ G L H L F E + + Y ++
Sbjct: 105 H-------FSFQTADKLYFVLDYI----NGGELFYH--LQRERCFLEPRARFYAAEIASA 151
Query: 255 LDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPEL 314
L + HS +++RD+K N+L+D+ G + + DFGL + + N ++ T Y PE+
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEV 210
Query: 315 LLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374
L Y VD W G +L E+ G P R E I + +L
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----------KPLQLK 259
Query: 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
+ A L+E LL D R
Sbjct: 260 -------------------PNITNSARHLLEGLLQKDRTKR 281
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 46/221 (20%), Positives = 90/221 (40%), Gaps = 24/221 (10%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G G + VY+ K VA+K++R + + E +++ +D+ +V +
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL-DEAYVMASVDNPHVCR 81
Query: 205 LEGLVTSRMSCSLYLVFEYMEHD--LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L G+ + ++ L+ + M L + H + + Q+ G+++ R
Sbjct: 82 LLGICLTS---TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPELLLGATY 320
++HRD+ N+L+ +KI DFGLA ++ + +V W E +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-ALE----SIL 192
Query: 321 YG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ D+WS G + EL + KP G E +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSIL 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 18/218 (8%)
Query: 149 IGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+G G + V++ K V +K + + + + LDH ++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT-DHMLAIGSLDHAHIVR 79
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
L GL SL LV +Y+ L + H G + + Q+ G+ + G
Sbjct: 80 LLGLCPGS---SLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPELLLGATY 320
++HR++ N+L+ + +++ADFG+A PD Q L S + W E +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-ALESIHFGK- 193
Query: 321 YGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
Y D+WS G + EL + +P G E +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAEP-YAGLRLAEVPDLL 230
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 6e-21
Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 21/219 (9%)
Query: 149 IGQGTYSNVYRAR-DLDQKKI-VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G + +V + + +K+I VA+K ++ + ++ M RE I+ +LD+ +++L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRLI 402
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G+ + +L LV E L + + V + Q+ G+ + + +H
Sbjct: 403 GVCQAE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL---WYRPPELLLGATYYG 322
R++ N+L+ N KI+DFGL+ D + WY PE +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APE----CINFR 514
Query: 323 ---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
+ D+WS G + E Y KP E + I
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKP-YKKMKGPEVMAFI 552
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 9e-21
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 42/278 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR-LDHINVIKL 205
+IG+G+Y+ V R +I A++ V+ + + E + ++ E H+ + +H ++ L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 206 EGLVTSRMSC-----SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
SC L+ V EY+ DL K E + Y ++ L++ H
Sbjct: 119 H-------SCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH 170
Query: 260 SRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVV-TLWYRPPELLLG 317
RG+++RD+K N+L+D+ G +K+ D+G+ P TS T Y PE+L G
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRG 227
Query: 318 ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377
YG +VD W+ G ++ E+ AG+ P F + GS
Sbjct: 228 -EDYGFSVDWWALGVLMFEMMAGRS--P-----------FDIVGSSDNPDQNTEDYLFQV 273
Query: 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
I + Q R A +++++ L+ DP +R
Sbjct: 274 ILEKQIRIPRS-------LSVKAASVLKSFLNKDPKER 304
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 50/239 (20%), Positives = 97/239 (40%), Gaps = 49/239 (20%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+GQG++ VY + + VA+K V E + F+ E +++ + +V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHVV 91
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAG--LASHPGLKFSEAQVKCYMQQLL-------C 253
+L G+V+ ++ E M DL + P + + + +++
Sbjct: 92 RLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 254 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTLWYR-- 310
G+ + ++ +HRD+ N ++ + +KI DFG+ Y+ D +YR
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD------------YYRKG 197
Query: 311 ----------PPE-LLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
PE L G + T D+WS G +L E+ A +P G + + L +
Sbjct: 198 GKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFV 253
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 44/226 (19%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+ + VY+ +Q + VA+K ++ P F E + RL H NV+
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR-HEAMLRARLQHPNVV 75
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASHPGLKFSEAQVKCY 247
L G+VT L ++F Y H DL
Sbjct: 76 CLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 248 MQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA------SFYDPDQNQPLT 301
+ Q+ G+++ S V+H+D+ N+L+ + +KI+D GL +Y N L
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 302 SRVVTLWYRPPELLLGATYYG---TAVDLWSTGCILAEL--YAGKP 342
R W PE A YG D+WS G +L E+ Y +P
Sbjct: 194 IR----WM-APE----AIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 66/235 (28%), Positives = 100/235 (42%), Gaps = 49/235 (20%)
Query: 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR----FMAREIHILRRL 197
F F LIG G + VY+ L VALK+ PES + F EI L
Sbjct: 41 FDHKF-LIGHGVFGKVYKGV-LRDGAKVALKR-----RTPESSQGIEEFET-EIETLSFC 92
Query: 198 DHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYM---QQ 250
H +++ L G C + L+++YME+ L H L + M Q+
Sbjct: 93 RHPHLVSLIGF------CDERNEMILIYKYMENG--NLKRH--L-YGSDLPTMSMSWEQR 141
Query: 251 L-LC-----GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
L +C GL + H+R ++HRD+K N+L+D N + KI DFG++ L++ V
Sbjct: 142 LEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVV 201
Query: 305 V-TLWYRPPELLLGATYYGTA-----VDLWSTGCILAELYAGK-PIMPGRTEVEQ 352
TL Y PE Y+ D++S G +L E+ + I+
Sbjct: 202 KGTLGYIDPE------YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 59/239 (24%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 131 SFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMARE 190
S +L + FS ++G+G + VY+ R L +VA+K+++ + + ++F E
Sbjct: 21 SLRELQVASDNFSNK-NILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQT-E 77
Query: 191 IHILRRLDHINVIKLEGLVTSRMSCS----LYLVFEYMEHDLAGLASH-PGLKFSEAQVK 245
+ ++ H N+++L G C LV+ YM + +AS S+ +
Sbjct: 78 VEMISMAVHRNLLRLRGF------CMTPTERLLVYPYMANG--SVASCLRERPESQPPLD 129
Query: 246 CYMQQLLC-----GL----DHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296
+Q + GL DHC + ++HRD+K +N+L+D + DFGLA +
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYK 187
Query: 297 NQPLTSRVV-TLWYRPPELLLGATYYGTA-VDLWSTGCILAELYAG-KPIMPGRTEVEQ 352
+ +T+ V T+ + PE L T + D++ G +L EL G + R +
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLS--TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 22/161 (13%)
Query: 148 LIGQGTYSNVYRAR--DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK 204
+IG+G + V +AR + A+K+++ + + F E+ +L +L H N+I
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIIN 90
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASHPGLKFSEAQVKCYM 248
L G R LYL EY H +L +A+ S Q+ +
Sbjct: 91 LLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
+ G+D+ + +HRD+ N+L+ N + KIADFGL+
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 40/227 (17%), Positives = 79/227 (34%), Gaps = 30/227 (13%)
Query: 149 IGQGTYSNVYRAR-------DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN 201
+GQGT++ +++ + V LK + + F ++ +L H +
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFF-EAASMMSKLSHKH 73
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
++ G+ LV E+++ L L + + +QL +
Sbjct: 74 LVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLE 130
Query: 260 SRGVLHRDIKGSNLLID--------NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRP 311
++H ++ N+L+ N +K++D G++ P + W P
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----ILQERIPWV-P 185
Query: 312 PELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKI 356
PE + A D WS G L E+ KP + +L
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 60/247 (24%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + V+ A K +VA+K ++ D F RE +L L H +++
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQ-REAELLTNLQHEHIV 80
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DL--------AGLASHPGLKFSEAQVKCYMQQLL-- 252
K G+ L +VFEYM+H DL + +A+ + + Q+L
Sbjct: 81 KFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 253 -----CGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVT 306
G+ + S+ +HRD+ N L+ N ++KI DFG++ Y D
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----------- 187
Query: 307 LWYR------------PPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTE 349
+YR PPE ++ Y T D+WS G IL E+ Y +P +
Sbjct: 188 -YYRVGGHTMLPIRWMPPESIM----YRKFTTESDVWSFGVILWEIFTYGKQP-WFQLSN 241
Query: 350 VEQLHKI 356
E + I
Sbjct: 242 TEVIECI 248
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 50/236 (21%)
Query: 142 FSRSFY-----LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR----FMAREIH 192
F +G+G + VY+ ++ VA+KK+ ++ + F EI
Sbjct: 27 FDERPISVGGNKMGEGGFGVVYKGY-VNNT-TVAVKKLA-AMVDITTEELKQQFDQ-EIK 82
Query: 193 ILRRLDHINVIKLEGLVTSRMSCS----LYLVFEYM-----EHDLAGLASHPGLKFSE-- 241
++ + H N+++L G S L LV+ YM L+ L P L +
Sbjct: 83 VMAKCQHENLVELLGF------SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 242 ------AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295
A G++ H +HRDIK +N+L+D KI+DFGLA +
Sbjct: 137 KIAQGAAN----------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 296 QNQPLTSRVV-TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTE 349
+TSR+V T Y PE L G D++S G +L E+ G + R
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 58/230 (25%), Positives = 92/230 (40%), Gaps = 54/230 (23%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + V+ A K +VA+K ++ + E F RE +L L H +++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQ-REAELLTMLQHQHIV 106
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DL--------------AGLASHPGLKFSEAQVKCYM 248
+ G+ T L +VFEYM H DL AG Q+
Sbjct: 107 RFFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSRVVTL 307
Q+ G+ + +HRD+ N L+ ++KI DFG++ Y D
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD------------ 212
Query: 308 WYR------------PPE-LLLGATYYGTAVDLWSTGCILAEL--YAGKP 342
+YR PPE +L + T D+WS G +L E+ Y +P
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 55/235 (23%), Positives = 90/235 (38%), Gaps = 39/235 (16%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINV 202
+G+G + V A + VA+K ++ E M E+ IL + H+NV
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM-SELKILIHIGHHLNV 93
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASHPGLKFSEAQVKC 246
+ L G T + L ++ E+ + +L + + C
Sbjct: 94 VNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 247 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA------SFYDPDQNQPL 300
Y Q+ G++ SR +HRD+ N+L+ ++KI DFGLA Y + L
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQL 353
+ W PE + Y D+WS G +L E+ P PG E+
Sbjct: 213 PLK----WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 260
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 54/243 (22%), Positives = 88/243 (36%), Gaps = 57/243 (23%)
Query: 149 IGQGTYSNVYR--ARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G G + VY + VA+K + E + + F+ E I+ + +H N++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIV 96
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLL-------CG 254
+ G+ + +++ E M DL L + + M LL CG
Sbjct: 97 RCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLA--MLDLLHVARDIACG 152
Query: 255 LDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLA-SFYDPDQNQPLTSRVVTLWYR 310
+ +HRDI N L+ G + KI DFG+A Y +YR
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS------------YYR 200
Query: 311 ------------PPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQL 353
PPE + G + D WS G +L E+ P P ++ E L
Sbjct: 201 KGGCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVL 255
Query: 354 HKI 356
+
Sbjct: 256 EFV 258
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 58/239 (24%), Positives = 90/239 (37%), Gaps = 42/239 (17%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINV 202
+G G + V A D VA+K ++ E M E+ +L L +H+N+
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLSYLGNHMNI 89
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DL----------AGLASHPGLKFSEAQVKCYMQQL 251
+ L G T ++ EY + DL + + ++ ++ L
Sbjct: 90 VNLLGACTIGGP--TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 252 LC-------GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA------SFYDPDQNQ 298
L G+ S+ +HRD+ N+L+ + I KI DFGLA S Y N
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHK 355
L + W PE + Y D+WS G L EL P PG + +K
Sbjct: 208 RLPVK----WM-APESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFYK 259
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 32/170 (18%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
IG+G + V++AR + +VA+K ++ + F RE ++ D+ N++
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNPNIV 113
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DL-----------------------AGLASHPGLKF 239
KL G+ + + L+FEYM + DL A ++S
Sbjct: 114 KLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 240 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
S A+ C +Q+ G+ + R +HRD+ N L+ N ++KIADFGL+
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 44/225 (19%), Positives = 84/225 (37%), Gaps = 42/225 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---------- 197
IG G + +Y A ++ + A V+ +E + + E+ +R+
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK---VEYQENGPLFSELKFYQRVAKKDCIKKWI 100
Query: 198 -----DHINVIKLEGLVTSRMSCSLY--LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 250
D++ + G + Y +V E + DL ++ G F ++ V +
Sbjct: 101 ERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIR 159
Query: 251 LLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIADFGLASFY-DPDQNQPLTSRVVTL 307
+L L++ H +H DIK +NLL+ N + +AD+GL+ Y ++
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ------ 213
Query: 308 WYRPPELLLGATYY-------GTAV----DLWSTGCILAELYAGK 341
P + G + G A+ D+ G + GK
Sbjct: 214 -ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 36/170 (21%), Positives = 71/170 (41%), Gaps = 32/170 (18%)
Query: 149 IGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G+G + V +A K VA+K ++ + E + E ++L++++H +VI
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLL-SEFNVLKQVNHPHVI 89
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DL-----------------------AGLASHPGLKF 239
KL G + L L+ EY ++ L + L
Sbjct: 90 KLYGACSQDGP--LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 240 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
+ + + Q+ G+ + ++HRD+ N+L+ +KI+DFGL+
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 56/247 (22%), Positives = 96/247 (38%), Gaps = 56/247 (22%)
Query: 149 IGQGTYSNVYRAR-------DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHI 200
+G+G + V A + VA+K ++ D E + + E+ +++ + H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGKHK 101
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASHPGLKFSEAQV 244
N+I L G T LY++ EY +L + P + + +
Sbjct: 102 NIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQPLTSR 303
QL G+++ S+ +HRD+ N+L+ N ++KIADFGLA + D
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID-------- 211
Query: 304 VVTLWYR------------PPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTE 349
+Y+ PE L Y D+WS G ++ E+ G P PG
Sbjct: 212 ----YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP-YPGIPV 265
Query: 350 VEQLHKI 356
E +
Sbjct: 266 EELFKLL 272
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 50/241 (20%), Positives = 86/241 (35%), Gaps = 53/241 (21%)
Query: 149 IGQGTYSNVYR--ARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+G G + VY + VA+K + E + + F+ E I+ + +H N++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL-MEALIISKFNHQNIV 137
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DL------AGLASHPGLKFSEAQVKCYMQQLLCGLD 256
+ G+ + +++ E M DL + + + + CG
Sbjct: 138 RCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 257 HCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLA-SFYDPDQNQPLTSRVVTLWYR-- 310
+ +HRDI N L+ G + KI DFG+A Y +YR
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG------------YYRKG 243
Query: 311 ----------PPELLLGATYYG---TAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHK 355
PPE + G + D WS G +L E+ P P ++ E L
Sbjct: 244 GCAMLPVKWMPPEAFM----EGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEF 298
Query: 356 I 356
+
Sbjct: 299 V 299
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 37/222 (16%)
Query: 149 IGQGTYSNVYRA-----RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINV 202
+G G + V A D VA+K ++ E M E+ I+ L H N+
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM-SELKIMSHLGQHENI 112
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DL-------------AGLASHPGLKFSEAQVKCYM 248
+ L G T + ++ EY + DL + S + +
Sbjct: 113 VNLLGACTHGGP--VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA------SFYDPDQNQPLTS 302
Q+ G+ S+ +HRD+ N+L+ N + KI DFGLA S Y N L
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKP 342
+ W PE + Y D+WS G +L E+ P
Sbjct: 231 K----WM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 56/248 (22%), Positives = 96/248 (38%), Gaps = 58/248 (23%)
Query: 149 IGQGTYSNVYRAR-------DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHI 200
+G+G + V A + VA+K ++ D E + + E+ +++ + H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV-SEMEMMKMIGKHK 147
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASHPGLKFSEAQV 244
N+I L G T LY++ EY +L + P + + +
Sbjct: 148 NIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
QL G+++ S+ +HRD+ N+L+ N ++KIADFGLA R
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA-------------RD 252
Query: 305 V--TLWYR------------PPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRT 348
+ +Y+ PE L Y D+WS G ++ E+ G P PG
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP-YPGIP 310
Query: 349 EVEQLHKI 356
E +
Sbjct: 311 VEELFKLL 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 39/165 (23%), Positives = 74/165 (44%), Gaps = 27/165 (16%)
Query: 149 IGQGTYSNVYRAR-------DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHI 200
+G+G + V A ++ VA+K ++ D E + + E+ +++ + H
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGKHK 135
Query: 201 NVIKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASHPGLKFSEAQV 244
N+I L G T LY++ EY +L + +P + S +
Sbjct: 136 NIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
Q+ G+++ S+ +HRD+ N+L+ + ++KIADFGLA
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 41/170 (24%), Positives = 68/170 (40%), Gaps = 32/170 (18%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINV 202
+G G + V A VA+K ++ E M E+ ++ +L H N+
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQLGSHENI 111
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH-DL---------------AGLASHPGLKFSEAQVKC 246
+ L G T +YL+FEY + DL + L+ E
Sbjct: 112 VNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 247 YMQQLLC-------GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
+ LLC G++ + +HRD+ N+L+ + ++KI DFGLA
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 58/256 (22%), Positives = 94/256 (36%), Gaps = 50/256 (19%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKL 205
IG+G++ ++ +L + VA+K + P+ + E + L I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVYY 73
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G + LV + + L L G KFS V +Q+L + H + +++
Sbjct: 74 FG----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129
Query: 266 RDIKGSNLLI-----DNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPPELLLGAT 319
RDIK N LI N ++ + DFG+ FY DP Q + YR + L G
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-------YREKKNLSGTA 182
Query: 320 YY-------GTAV----DLWSTGCILAELYAGK---PIMPGRTEVEQLHKIFK------- 358
Y G DL + G + G + T ++ +I +
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242
Query: 359 --LC-GSPSE--DYWR 369
LC G P E Y
Sbjct: 243 RELCAGFPEEFYKYMH 258
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 51/215 (23%), Positives = 80/215 (37%), Gaps = 39/215 (18%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRF--MAREIHILRRL---DHINVI 203
IG G + + ++L + VA+K LEP R + E ++L D I +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 204 KLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
G +V E + L L FS V QL+ +++ HS+ +
Sbjct: 71 YYFG----PCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 264 LHRDIKGSNLLI-----DNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPPELLLG 317
++RD+K N LI ++ I DF LA Y DP+ + + YR + L G
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIP-------YREHKSLTG 179
Query: 318 ATYY-------GTAV----DLWSTGCILAELYAGK 341
Y G DL + G + G
Sbjct: 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 60/248 (24%), Positives = 96/248 (38%), Gaps = 46/248 (18%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKL 205
IG G++ ++Y D+ + VA+K P+ + E I + + I I+
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIRW 72
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G +V E + L L + KFS V Q++ +++ HS+ +H
Sbjct: 73 CG----AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128
Query: 266 RDIKGSNLLI---DNNGILKIADFGLASFY-DPDQNQPLTSRVVTLWYRPPELLLGATYY 321
RD+K N L+ ++ I DFGLA Y D +Q + YR + L G Y
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP-------YRENKNLTGTARY 181
Query: 322 -------GTAV----DLWSTGCILAELYAGK---PIMPGRTEVEQLHKIFK--------- 358
G DL S G +L G + T+ ++ +I +
Sbjct: 182 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241
Query: 359 LC-GSPSE 365
LC G PSE
Sbjct: 242 LCKGYPSE 249
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 44/225 (19%), Positives = 73/225 (32%), Gaps = 39/225 (17%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE- 206
IGQG + +Y A + V +EP + E+ +R I+
Sbjct: 42 PIGQGGFGCIYLADMNSSES-VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 207 ----------------GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQ 250
GL +++ + DL + +FS V +
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 251 LLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIADFGLASFY-DPDQNQPLTSRVVTL 307
+L L++ H +H DIK SNLL++ N + + D+GLA Y ++
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA------ 214
Query: 308 WYRPPELLLGATYY-------GTAV----DLWSTGCILAELYAGK 341
P G + G A DL G + + G
Sbjct: 215 -ADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 15/157 (9%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKL 205
IG G++ +Y ++ + VA+K P+ + E I R L I ++
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LLYESKIYRILQGGTGIPNVRW 70
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G LV + + L L + K S V Q++ ++ HS+ LH
Sbjct: 71 FG----VEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
Query: 266 RDIKGSNLLIDNNG---ILKIADFGLASFY-DPDQNQ 298
RDIK N L+ + I DFGLA Y D +Q
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 26/177 (14%), Positives = 52/177 (29%), Gaps = 33/177 (18%)
Query: 149 IGQGTYSNVYRARDLDQKKI--------VALKKVRFDNLEPESVRFMAREIHILRRLDHI 200
+ +Y A +LK L+ + R + E + +R
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK------LDAKDGR-LFNEQNFFQRAAKP 102
Query: 201 NVIKLEG------------LVTSRMSCSLY--LVFEYMEHDLAGL-ASHPGLKFSEAQVK 245
+ + + Y LV + L P SE V
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLI--DNNGILKIADFGLASFY-DPDQNQP 299
+LL L+ H +H ++ N+ + ++ + +A +G A Y ++
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 6e-08
Identities = 60/452 (13%), Positives = 122/452 (26%), Gaps = 131/452 (28%)
Query: 6 FKPSAIED-----SKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLI 60
F+ + +++ ++ P+ LS + + S+ R+ F L+
Sbjct: 25 FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSK---DAVSGTLRL---FW------TLL 72
Query: 61 DKQVN------GSV----------RLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQ 104
KQ V + E Y + Q ++
Sbjct: 73 SKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMY-IEQRDRLYNDNQVFAKYN- 130
Query: 105 VAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKSLSIFSRSFYLI-----GQGTYSNVYR 159
V R + KL ++L + ++ G G
Sbjct: 131 --------------------VSRL-QPYLKLRQALLELRPAKNVLIDGVLGSG------- 162
Query: 160 ARDLDQKKIVALKKVRFDNLEPESVRFMAREIH-I-LRRLDHINVIKLEGLVTSRMSCSL 217
K VAL ++ M +I + L+ + + LE L L
Sbjct: 163 ------KTWVALDVCLSYKVQ----CKMDFKIFWLNLKNCNSPETV-LEMLQK------L 205
Query: 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID- 276
+ + +S+ L+ Q + +++LL + + VL +++ + +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAE--LRRLLKSKPYENCLLVL-LNVQNAK-AWNA 261
Query: 277 -NNG--ILKI-ADFGLASFYDPDQNQPLTSRVVTLWYRPPELL-LGATYYGTAV-DLWST 330
N IL + F ++ ++ P E+ L Y DL
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE 321
Query: 331 GC--------ILAELYAGKPIMPGR---TEVEQLHKIFKLCG---SPSEDYWRKSKLPHA 376
I+AE ++L I + P+E
Sbjct: 322 VLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY---------- 371
Query: 377 TIFKPQQPYKRCVAETF-KDFPAPALALMETL 407
++ + R F P L+ +
Sbjct: 372 -----RKMFDRLS--VFPPSAHIPT-ILLSLI 395
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 1e-07
Identities = 39/319 (12%), Positives = 94/319 (29%), Gaps = 60/319 (18%)
Query: 1 MGCICFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRF--DSNDGRAM 58
+ C P + + + ++ +S S R + R +
Sbjct: 189 LKN-CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 59 LI-----DKQVNGSVRLHGENFD---------RKREKMEYVVAQH--HPGMGSIPKA--- 99
L+ + + F+ R ++ +++ A H +
Sbjct: 248 LVLLNVQNAKA-------WNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 100 SEGEQVAAGWPAWLAAVAGEAIQGWVPRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYR 159
E + + L Q +PR + LSI + S G T+ N
Sbjct: 301 DEVKSL-------LLKYLDCRPQD-LPREVLTTNPR--RLSIIAESIR-DGLATWDNW-- 347
Query: 160 ARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL-- 217
+ ++ K+ + + + LEP R M + + + + + + +
Sbjct: 348 -KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP--PSAH-------IPTILLSLIWF 397
Query: 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLD-HCHSRGVLHRDIKGS-NLL- 274
++ + + L + ++ + + + L + LHR I N+
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPK 457
Query: 275 -IDNNGILKIADFGLASFY 292
D++ ++ FY
Sbjct: 458 TFDSDDLIPPYLDQY--FY 474
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 5e-07
Identities = 53/436 (12%), Positives = 125/436 (28%), Gaps = 136/436 (31%)
Query: 5 CFKPSAIEDSKESPRERLSSKASSDLRGSRATSSRREEVYRVKDRFDSNDGRAMLIDKQV 64
+PS + R+RL + + + SR + ++ R L++ +
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNV---SRLQPYLKL---------RQALLELRP 149
Query: 65 NGSVRLHGENFDRKREKMEYVVAQHHPGMGSIPKASEGEQVAAGWPAWLAA--VAGEAIQ 122
+V + G + G G K W+A +Q
Sbjct: 150 AKNVLIDG---------V--------LGSG---K------------TWVALDVCLSYKVQ 177
Query: 123 G-------WVP-RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKV 174
W+ + +S E + L + + Y I S + ++ K+
Sbjct: 178 CKMDFKIFWLNLKNCNSPETV---LEMLQKLLYQIDPNWTSRSDHSSNI---------KL 225
Query: 175 RFDNLEPESVRFMAREIH-----ILRRLDHINVIK-LEG----LVTSRMSC------SLY 218
R +++ E R + + + +L + + L+T+R +
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQL----------LCGL-------DHCHSR 261
++H L + C Q L +
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345
Query: 262 GVLHRDIKGSNLLIDNN-GILKIADF-----GLASFYDPDQNQPLTSRV-VTLW----YR 310
H + +I+++ +L+ A++ L+ F P + + + + +W
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVF--PP-SAHIPTILLSLIWFDVIKS 402
Query: 311 PPELLLGATYYGTAVDLWSTG--CILAELYAGKPIMPGRTEVE---QLHKIF-------- 357
+++ + + V+ + +Y + + ++E LH+
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIY-----LELKVKLENEYALHRSIVDHYNIPK 457
Query: 358 KLCGS----PSED-YW 368
P D Y+
Sbjct: 458 TFDSDDLIPPYLDQYF 473
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 35/121 (28%), Positives = 52/121 (42%), Gaps = 15/121 (12%)
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA------SFYDPDQNQP 299
CY Q+ G++ SR +HRD+ N+L+ ++KI DFGLA Y +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAEL--YAGKPIMPGRTEVEQLHKIF 357
L + W PE + Y D+WS G +L E+ P PG E+ +
Sbjct: 257 LPLK----WM-APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCRRL 309
Query: 358 K 358
K
Sbjct: 310 K 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 20/84 (23%), Positives = 37/84 (44%), Gaps = 8/84 (9%)
Query: 149 IGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRLD-HINV 202
+G+G + V A K VA+K ++ + R + E+ IL + H+NV
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNV 88
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEH 226
+ L G T + L ++ E+ +
Sbjct: 89 VNLLGACT-KPGGPLMVIVEFCKF 111
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 25/156 (16%), Positives = 53/156 (33%), Gaps = 29/156 (18%)
Query: 149 IGQGTYSNVYRARDLDQ----KKIVALKKVRFDNL----EPESVRFM-------AREIHI 193
+G+G S V+ K + F + + + F E
Sbjct: 98 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157
Query: 194 LRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLC 253
L++L + V K+ + ++ E ++ ++ + +L
Sbjct: 158 LQKLQGLAVPKVYAWEGN------AVLMELIDAK-----ELYRVRVENPD--EVLDMILE 204
Query: 254 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289
+ + RG++H D+ N+L+ GI I DF +
Sbjct: 205 EVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.18 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.99 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.95 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.84 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.4 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.36 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.03 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.92 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.7 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.63 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.57 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.49 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.08 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.76 | |
| 3p34_A | 232 | Serine/threonine-protein kinase PLK1; phosphoprote | 93.76 | |
| 1q4k_B | 259 | Serine/threonine-protein kinase PLK; six-stranded | 93.4 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.08 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-58 Score=505.77 Aligned_cols=290 Identities=32% Similarity=0.483 Sum_probs=241.8
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc----CCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~----~~~~lyL 219 (720)
++.+.||+|+||.||+|+++.+|+.||||+++.........+.+.+|+.+|+.|+|||||++++++... ....+||
T Consensus 57 ~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 57 EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEE
Confidence 333449999999999999999999999999987766667778899999999999999999999987542 2367999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC---C
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD---Q 296 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~---~ 296 (720)
|||||+|+|...+.. ...|++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... .
T Consensus 137 vmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~ 215 (398)
T 4b99_A 137 VLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEH 215 (398)
T ss_dssp EEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------
T ss_pred EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCcccc
Confidence 999999987776654 458999999999999999999999999999999999999999999999999999866322 2
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
....+..+||++|||||++.+..+|+.++||||||||||||++|++||.|.+..+++..|++..|.|+...|........
T Consensus 216 ~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~ 295 (398)
T 4b99_A 216 QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 295 (398)
T ss_dssp CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CH
T ss_pred ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhh
Confidence 23456779999999999999887789999999999999999999999999999999999999999999887754322211
Q ss_pred cccCCCC--ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 377 TIFKPQQ--PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 377 ~~~~~~~--~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
..+.... .....+...++.+++++.+||.+||++||.+|||+.|+|+||||+....|.
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~ 355 (398)
T 4b99_A 296 RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPD 355 (398)
T ss_dssp HHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGG
T ss_pred hhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCc
Confidence 1110000 111124456678999999999999999999999999999999999876654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-58 Score=487.78 Aligned_cols=262 Identities=28% Similarity=0.423 Sum_probs=225.3
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeec
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
+.++|+.++. ||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|++|+|||||+++
T Consensus 30 ~~~dy~i~~~-----------lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~ 98 (311)
T 4aw0_A 30 RPEDFKFGKI-----------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 98 (311)
T ss_dssp CGGGEEEEEE-----------EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CccccEEEEE-----------EecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3456766666 9999999999999999999999999986432 223456789999999999999999999
Q ss_pred cceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
++|.+ ...+|||||||+|+.+..++.....++|.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+||
T Consensus 99 ~~~~~--~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DF 176 (311)
T 4aw0_A 99 FTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 176 (311)
T ss_dssp EEEEC--SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEe--CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEc
Confidence 99987 6789999999998655555555568999999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 287 GLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 287 Gla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
|+|+.+..... ....+.+||+.|||||++.+.. |+.++||||||||||||+||.+||.+.+..+.+.+|.+.-.
T Consensus 177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---- 251 (311)
T 4aw0_A 177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEY---- 251 (311)
T ss_dssp TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred CCceecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----
Confidence 99998754333 3445679999999999998866 79999999999999999999999999999988888875311
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHH------HHhCccCCCCCC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS------ALRSEFFTMKPL 432 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e------~L~hp~f~~~~~ 432 (720)
..+..+++++.+||.+||++||.+|||+.| +++||||+...+
T Consensus 252 -------------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 252 -------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred -------------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 112357899999999999999999999987 589999986544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-57 Score=490.86 Aligned_cols=251 Identities=26% Similarity=0.431 Sum_probs=217.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ ...+|||||||+|+
T Consensus 81 ~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~ivmEy~~gg 156 (346)
T 4fih_A 81 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFLEGG 156 (346)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEECCCTTE
T ss_pred EeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeCCCCC
Confidence 399999999999999999999999999865432 23457899999999999999999999987 67899999999987
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
.+..+... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... ....+..+||+
T Consensus 157 ~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~GTp 234 (346)
T 4fih_A 157 ALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKSLVGTP 234 (346)
T ss_dssp EHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SCCBCCCCSCG
T ss_pred cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC-CCcccccccCc
Confidence 66655544 46999999999999999999999999999999999999999999999999999876533 23456679999
Q ss_pred CCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccch
Q 004999 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKR 387 (720)
Q Consensus 308 ~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~ 387 (720)
+|||||++.+.. |+.++||||||||||||++|.+||.+.+..+.+..|..... +.
T Consensus 235 ~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~----------------------- 289 (346)
T 4fih_A 235 YWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR----------------------- 289 (346)
T ss_dssp GGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CC-----------------------
T ss_pred CcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC-----------------------
Confidence 999999998766 89999999999999999999999999999888888765321 10
Q ss_pred hhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 388 CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 388 ~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
...+..+++++.+||.+||++||++|||+.|+|+||||+...
T Consensus 290 --~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 290 --LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 112346899999999999999999999999999999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-57 Score=492.51 Aligned_cols=251 Identities=24% Similarity=0.438 Sum_probs=214.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|++|+|||||++++++.+ ...+|||||||+|+
T Consensus 31 ~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~yiVmEy~~gg 108 (350)
T 4b9d_A 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGG 108 (350)
T ss_dssp EC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEECCTTC
T ss_pred EEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEEeCCCCC
Confidence 3999999999999999999999999999887777778889999999999999999999999987 67899999999975
Q ss_pred cc-cccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 228 LA-GLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 ll-~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.| ..+. ..+..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+... ....+..+|
T Consensus 109 ~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~G 187 (350)
T 4b9d_A 109 DLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VELARACIG 187 (350)
T ss_dssp BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-HHHHHHHHS
T ss_pred cHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-cccccccCC
Confidence 44 4443 34456899999999999999999999999999999999999999999999999999876421 122345689
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|||||++.+.. |+.++||||||||||||+||++||.+.+..+.+.+|......
T Consensus 188 T~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~----------------------- 243 (350)
T 4b9d_A 188 TPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP----------------------- 243 (350)
T ss_dssp CCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----------------------
T ss_pred CccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-----------------------
Confidence 99999999998866 899999999999999999999999999999988888763211
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 244 -----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 -----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 1123678999999999999999999999999999999753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-57 Score=474.75 Aligned_cols=248 Identities=28% Similarity=0.439 Sum_probs=203.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.||+|+||.||+|++..+|+.||||+++.... .......+.+|+.+|++|+|||||++++++.+ ...+|||||||+|
T Consensus 20 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivmEy~~g 97 (275)
T 3hyh_A 20 TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEIIMVIEYAGN 97 (275)
T ss_dssp EEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEEeCCCC
Confidence 39999999999999999999999999987654 33445678999999999999999999999977 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
+++..+... ..+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.... .......+||
T Consensus 98 ~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~~GT 174 (275)
T 3hyh_A 98 ELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGS 174 (275)
T ss_dssp EHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------------
T ss_pred CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC--CCccCCeeEC
Confidence 888776554 4799999999999999999999999999999999999999999999999999987543 2334567899
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
+.|||||++.+..+++.++||||||||||||+||++||.+.+..+.+..|.... +
T Consensus 175 ~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~----------------------- 229 (275)
T 3hyh_A 175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--Y----------------------- 229 (275)
T ss_dssp CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C-----------------------
T ss_pred cccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--C-----------------------
Confidence 999999999988766789999999999999999999999988887777775421 1
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..+..+++++.+||.+||++||++|||+.|+|+||||+.
T Consensus 230 ----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 230 ----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 112357899999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-56 Score=469.52 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=214.8
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc--CCCeEEEEEee
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSLYLVFEY 223 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~--~~~~lyLV~Ey 223 (720)
...||+|+||.||+|++..++..||||++..........+.|.+|+.+|++|+|||||+++++|.+. ....+||||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 3459999999999999999999999999988777777788899999999999999999999998652 23568999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcC-CCceeeeccccceecCCCCCCCc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+|+.+..++.....+++..++.|+.||+.||.|||++| ||||||||+||||+. +|.+||+|||+|+... ....
T Consensus 111 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~---~~~~ 187 (290)
T 3fpq_A 111 MTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFA 187 (290)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC---TTSB
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC---CCcc
Confidence 998777666666668999999999999999999999998 999999999999985 7999999999998643 2334
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+||+.|||||++.+ . |+.++||||||||||||+||++||.+......+...+.....|
T Consensus 188 ~~~~GTp~YmAPE~~~~-~-y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~----------------- 248 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------------- 248 (290)
T ss_dssp EESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------------
T ss_pred CCcccCccccCHHHcCC-C-CCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-----------------
Confidence 56789999999998865 3 8999999999999999999999998877666554443221111
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 249 ---------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 249 ---------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp ---------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ---------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 11223578899999999999999999999999999999853
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-56 Score=493.10 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=221.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++++.||+|+||.||+|+++.+|+.||||++...... ..+.+.+|+.+|+.|+|||||+++++|.+ ...+||||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~~~~~iVm 227 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVM 227 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEE--CCEEEEEE
Confidence 344555599999999999999999999999999865432 23457899999999999999999999987 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|||+|+.+..+... ..+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+... .....
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~ 305 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRK 305 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CCCBC
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC-Ccccc
Confidence 99998766665543 36999999999999999999999999999999999999999999999999999876543 23456
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||++|||||++.+.. |+.++||||||||||||++|++||.+.+..+.+..|..... +.
T Consensus 306 ~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~----------------- 366 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR----------------- 366 (423)
T ss_dssp CCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC-----------------
T ss_pred ccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC-----------------
Confidence 679999999999998766 89999999999999999999999999999988888765311 10
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
...+..+++++.+||.+||++||.+|||+.|+|+||||+...
T Consensus 367 --------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 367 --------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp --------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 112346899999999999999999999999999999998653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=474.04 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=208.4
Q ss_pred eecccCceEEEEEEEC---CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.||+|+||.||+|++. .+++.||||+++...........+.+|+.+|++|+|||||++++++.+ ...+|||||||
T Consensus 31 ~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ivmEy~ 108 (304)
T 3ubd_A 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKLYLILDFL 108 (304)
T ss_dssp EEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTEEEEEECCC
T ss_pred EEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEEEEcC
Confidence 3999999999999874 578899999997654332223457889999999999999999999987 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+|+.+..++.....+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... .......+
T Consensus 109 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~~~~~~~ 187 (304)
T 3ubd_A 109 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAYSFC 187 (304)
T ss_dssp TTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC------CCCCSCC
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC-Cccccccc
Confidence 98666555555668999999999999999999999999999999999999999999999999999865332 23345678
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
||+.|||||++.+.. |+.++||||||||||||+||++||.+.+..+.+.+|.+...
T Consensus 188 GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~----------------------- 243 (304)
T 3ubd_A 188 GTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL----------------------- 243 (304)
T ss_dssp CCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------------
T ss_pred cCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCC-----------------------
Confidence 999999999998876 89999999999999999999999999999998888865311
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
..+..+++++.+||.+||++||++||| ++|+|+||||+..
T Consensus 244 ------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 244 ------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred ------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 112458899999999999999999998 5899999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=468.55 Aligned_cols=252 Identities=24% Similarity=0.317 Sum_probs=211.6
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||+|+||.||+|+++.+|+.||||+++..... .+|+.+|+.|+|||||++++++.+ ...+|||||||+
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~--~~~~~ivmEy~~ 133 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE--GPWVNIFMELLE 133 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE--TTEEEEEECCCT
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEeccC
Confidence 33499999999999999999999999999875432 479999999999999999999987 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceecCCCCCC----Cc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQ----PL 300 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~~~~----~~ 300 (720)
|+.+..++.....|++.+++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+...... ..
T Consensus 134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~ 213 (336)
T 4g3f_A 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213 (336)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecC
Confidence 866665555556899999999999999999999999999999999999999998 6999999999987543221 12
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+||+.|||||++.+.. |+.++||||||||||||+||++||.+.+..+.+.+|... .++
T Consensus 214 ~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~---------------- 274 (336)
T 4g3f_A 214 DYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP---------------- 274 (336)
T ss_dssp CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG----------------
T ss_pred CccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC----------------
Confidence 2357999999999998876 899999999999999999999999998877777776542 110
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHH-------------HhCccCCCCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA-------------LRSEFFTMKPLP 433 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~-------------L~hp~f~~~~~~ 433 (720)
+.+.++.+++.+.+||.+||++||.+|||+.|+ |+|||+.....|
T Consensus 275 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 275 --------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp --------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred --------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 123446789999999999999999999999997 569999765433
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=465.69 Aligned_cols=283 Identities=28% Similarity=0.364 Sum_probs=220.1
Q ss_pred hccccccceeecccCceEEEEEEEC---CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCC
Q 004999 139 LSIFSRSFYLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMS 214 (720)
Q Consensus 139 ~~~f~r~~~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~ 214 (720)
+.+.|++.+.||+|+||.||+|+++ .+++.||||++..... ...+.+|+.+|+.+ +|||||+++++|.+ .
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~ 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRK--N 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEE--T
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEE--C
Confidence 3455666677999999999999874 5688999999875432 34578999999998 69999999999887 6
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-CceeeeccccceecC
Q 004999 215 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYD 293 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~DFGla~~~~ 293 (720)
..+|||||||+|+.+..+.. .+++.+++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+|+...
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 78999999999755544443 58999999999999999999999999999999999999877 899999999998653
Q ss_pred CCC---------------------------CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCC-C
Q 004999 294 PDQ---------------------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM-P 345 (720)
Q Consensus 294 ~~~---------------------------~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf-~ 345 (720)
... ....+..+||++|+|||++.+...|+.++||||+|||||||++|++|| .
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 221 122345689999999999998877999999999999999999999766 6
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhcCC---------CCc------------cccCC----CCccchhhhcccCCCCHhH
Q 004999 346 GRTEVEQLHKIFKLCGSPSEDYWRKSKL---------PHA------------TIFKP----QQPYKRCVAETFKDFPAPA 400 (720)
Q Consensus 346 g~~~~e~l~~i~~~~g~p~~~~w~~~~l---------~~~------------~~~~~----~~~~~~~~~e~~~~~~~~~ 400 (720)
+.++.+++..|++.+|.+....+..... +.. ....+ .........+.+..+++++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 7788999999999998765444322100 000 00000 0000011223456789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 401 LALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 401 ~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
+|||.+||++||.+|+|++|+|+||||+..
T Consensus 330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-53 Score=448.01 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=192.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC---------
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--------- 214 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~--------- 214 (720)
+++++||+|+||.||+|+++.+|+.||||+++... .....+.+.+|+.+|++|+|||||+++++|.....
T Consensus 8 ~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 34445999999999999999999999999998654 34455778999999999999999999998875322
Q ss_pred -CeEEEEEeeccccccccccCCCCC---CCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 215 -CSLYLVFEYMEHDLAGLASHPGLK---FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 215 -~~lyLV~Ey~~g~ll~~~~~~~~~---lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
..+|||||||.|+.+..+...... .++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~ 166 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC-
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccce
Confidence 247999999998666555443333 4567789999999999999999999999999999999999999999999998
Q ss_pred ecCCCCC-----------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 004999 291 FYDPDQN-----------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 359 (720)
Q Consensus 291 ~~~~~~~-----------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~ 359 (720)
.+..... ...+..+||+.|||||++.+.. |+.++||||||||||||++ ||.+. .+....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~ 240 (299)
T 4g31_A 167 AMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDV 240 (299)
T ss_dssp -------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHH
T ss_pred ecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHH
Confidence 7643321 1234568999999999998866 8999999999999999996 56543 3333333222
Q ss_pred cCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 360 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 360 ~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
.....+ ..+...++.+.+||.+||+.||.+|||+.|+|+||||+...+
T Consensus 241 ~~~~~p-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 241 RNLKFP-------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HTTCCC-------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred hcCCCC-------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 111111 112234567889999999999999999999999999986543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=474.82 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=229.1
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|.+.+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.|+|||||+|+++|.+ ...+||||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iv~ 233 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIY 233 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEE
Confidence 3455556999999999999999999999999997653 3445678899999999999999999999987 78899999
Q ss_pred eeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC--CceeeeccccceecCCCCCC
Q 004999 222 EYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN--GILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~--g~vKL~DFGla~~~~~~~~~ 298 (720)
|||+| +|...+......|++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|+.+... .
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--~ 311 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--Q 311 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--S
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--C
Confidence 99987 4555555556689999999999999999999999999999999999999854 89999999999987543 3
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+||++|||||++.+.. |+.++||||||||||||++|.+||.+.+..+.+..|......+..
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 377 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------------- 377 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCS-------------
T ss_pred ceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCc-------------
Confidence 445678999999999998876 899999999999999999999999999999999888764333322
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~ 439 (720)
..+..+++.+.+||.+||++||.+|||+.|+|+||||+....+.....+
T Consensus 378 ------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~~~~~ 426 (573)
T 3uto_A 378 ------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426 (573)
T ss_dssp ------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTTTCEE
T ss_pred ------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCchhhC
Confidence 2235689999999999999999999999999999999987776655444
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=439.54 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=202.4
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|++.. .||||+++......+..+.|.+|+.+|++|+|||||++++++.. ..+|||||||+|+.
T Consensus 44 iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~~iVmEy~~gGs 117 (307)
T 3omv_A 44 IGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNLAIVTQWCEGSS 117 (307)
T ss_dssp CCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCSSCB
T ss_pred EeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeEEEEEEcCCCCC
Confidence 9999999999998643 49999998776777788899999999999999999999998754 45899999999765
Q ss_pred cc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-CCCccccccc
Q 004999 229 AG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVT 306 (720)
Q Consensus 229 l~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~t~~~gT 306 (720)
+. .+......+++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|+...... ....+..+||
T Consensus 118 L~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT 197 (307)
T 3omv_A 118 LYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS 197 (307)
T ss_dssp HHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCC
T ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccC
Confidence 54 444555679999999999999999999999999999999999999999999999999998764322 2334566899
Q ss_pred cCCCChhhhcCC--cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 307 LWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 307 ~~Y~APE~l~~~--~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+.|||||++.+. ..|+.++||||||||||||+||++||.+.+....+..+......++
T Consensus 198 ~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p-------------------- 257 (307)
T 3omv_A 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP-------------------- 257 (307)
T ss_dssp TTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC--------------------
T ss_pred CCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC--------------------
Confidence 999999999753 3489999999999999999999999999887776666544221110
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
.+.....++|+.+.+||.+||+.||++|||+.+++++-
T Consensus 258 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 258 ---DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp ---CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred ---CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 01233457899999999999999999999999887653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=420.16 Aligned_cols=285 Identities=38% Similarity=0.663 Sum_probs=241.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++..+++.||||++............+.+|+.++++++||||+++++++.. ...+|||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 81 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVFE 81 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEEEe
Confidence 344455999999999999999999999999998776666666788999999999999999999999877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++++++..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ......
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 160 (292)
T 3o0g_A 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CSCCCS
T ss_pred cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc-cccccC
Confidence 9999988887776778999999999999999999999999999999999999999999999999999876432 233455
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
.++|+.|+|||++.+...|+.++||||||||+|+|++|. |+|.+.+..+.+..+++..+.+....|............+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 678999999999988776899999999999999999766 5688888999999999999999988876532211111112
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..+....+....+.+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 2222223345556789999999999999999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=434.28 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=198.7
Q ss_pred eecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.||+|+||.||+|++. .++..||||+++.. .....+.|.+|+.+|++|+|||||++++++.+ ...+|||||
T Consensus 48 ~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~~~~lV~E 123 (329)
T 4aoj_A 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTE--GRPLLMVFE 123 (329)
T ss_dssp EEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSEEEEEE
T ss_pred EEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEE
Confidence 3999999999999865 46889999999753 45667789999999999999999999999987 677999999
Q ss_pred eccccccccccCC---------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 223 YMEHDLAGLASHP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 223 y~~g~ll~~~~~~---------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
||+++.+..++.. ...+++.+++.|+.||+.||.|||+++||||||||+||||+.++.+||+|||
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFG 203 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccc
Confidence 9997655543321 2469999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 288 LASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 288 la~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
+|+.+..... ...+..+||+.|||||++.+.. |+.++||||||||||||+| |++||.+.+..+.+..+.+...
T Consensus 204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~---- 278 (329)
T 4aoj_A 204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE---- 278 (329)
T ss_dssp ----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC----
T ss_pred cceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 9987643322 2334567899999999998876 8999999999999999999 8999999998888877754210
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
...+..+++++.+||.+||+.||++|||+.|++++
T Consensus 279 ------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 279 ------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred ------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 11234688999999999999999999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=433.51 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=204.3
Q ss_pred eecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.||+|+||.||+|++. .++..||||+++.. .....+.|.+|+.+|++|+|||||++++++.+ ...+|||||
T Consensus 20 ~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~~~~lV~E 95 (299)
T 4asz_A 20 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDPLIMVFE 95 (299)
T ss_dssp EEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSEEEEEE
T ss_pred EEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCEEEEEEE
Confidence 3999999999999875 46889999999753 45667789999999999999999999999987 677999999
Q ss_pred eccccccccccC-------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 223 YMEHDLAGLASH-------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 223 y~~g~ll~~~~~-------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
||+++.+..++. ....+++.+++.|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla 175 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 175 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCH
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccc
Confidence 999765544432 2346999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
+........ .....+||+.|||||++.+.. |+.++||||||||||||+| |++||.+.+..+.+..+.+...
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~------ 248 (299)
T 4asz_A 176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV------ 248 (299)
T ss_dssp HHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC------
T ss_pred eecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 865433222 223346899999999998876 8999999999999999998 8999999998888877755210
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
...+..+|+++.+||.+||+.||++|||+.+++ +|++
T Consensus 249 ----------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 249 ----------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred ----------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 112346889999999999999999999999994 4654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=471.19 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=208.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC----CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
|.+.++||+|+||.||+|+++.+|+.||||++.+..+ ..........++.+++.++|||||+++++|.+ ...+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~--~~~ly 268 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLS 268 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE--CCEEE
Confidence 3444559999999999999999999999999975432 12222233344666677899999999999987 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||||||.|+.+..++.....|++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~-- 346 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 346 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCC--
Confidence 999999976665555555689999999999999999999999999999999999999999999999999998764332
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
..+.+||+.|||||++.+...|+.++||||||||||||++|.+||.+.+. .+....+...
T Consensus 347 -~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~---------------- 409 (689)
T 3v5w_A 347 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM---------------- 409 (689)
T ss_dssp -CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC----------------
T ss_pred -CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC----------------
Confidence 34568999999999998665689999999999999999999999987532 2223333221
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMKP 431 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~~ 431 (720)
....+..+++++.+||.+||++||.+|++ +.++++||||+...
T Consensus 410 -------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 410 -------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred -------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 01123468999999999999999999998 79999999998653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=444.67 Aligned_cols=286 Identities=35% Similarity=0.556 Sum_probs=223.3
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC---CCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~---~~~lyLV~Ey~ 224 (720)
+||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.|+|||||++++++.... ...+||||||+
T Consensus 60 ~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~ 139 (458)
T 3rp9_A 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA 139 (458)
T ss_dssp C-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC
T ss_pred EeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc
Confidence 399999999999999999999999999876666677788999999999999999999999885432 25799999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-------
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN------- 297 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~------- 297 (720)
++++...+.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 140 ~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 218 (458)
T 3rp9_A 140 DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218 (458)
T ss_dssp SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-
T ss_pred ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcccccccccc
Confidence 9987776655 44799999999999999999999999999999999999999999999999999987642211
Q ss_pred -------------------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-----------CCCCCCCC
Q 004999 298 -------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-----------GKPIMPGR 347 (720)
Q Consensus 298 -------------------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-----------G~ppf~g~ 347 (720)
...+..+||++|+|||++.....|+.++||||||||||||++ |.++|+|.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~ 298 (458)
T 3rp9_A 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGS 298 (458)
T ss_dssp --------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--
T ss_pred CccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCC
Confidence 234566889999999998766668999999999999999999 88999886
Q ss_pred C--------------------hHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC--CccchhhhcccCCCCHhHHHHHH
Q 004999 348 T--------------------EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ--QPYKRCVAETFKDFPAPALALME 405 (720)
Q Consensus 348 ~--------------------~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~--~~~~~~~~e~~~~~~~~~~dLI~ 405 (720)
. ..+++..|++.+|.|..+.|..........+... ......+.+.++.+++.+.+||.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 378 (458)
T 3rp9_A 299 SCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLK 378 (458)
T ss_dssp ------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHH
T ss_pred ccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHH
Confidence 5 3688999999999999988765332221111111 11112245566788999999999
Q ss_pred HhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 406 TLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 406 ~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
+||.+||.+|||+.|+|+||||+....+.
T Consensus 379 ~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 379 RMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 99999999999999999999999775543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=429.21 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=203.8
Q ss_pred eecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.||+|+||.||+|+.. .+++.||||+++... .....+.|.+|+.+|++|+|||||+++|++.. ...+|||||
T Consensus 33 ~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~~lV~E 109 (308)
T 4gt4_A 33 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--DQPLSMIFS 109 (308)
T ss_dssp EEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEE
T ss_pred EeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--CCEEEEEEE
Confidence 4999999999999863 467899999997543 33445678999999999999999999999977 567999999
Q ss_pred ecccccccccc-CC---------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecc
Q 004999 223 YMEHDLAGLAS-HP---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 223 y~~g~ll~~~~-~~---------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
||+++.+..++ .. ...+++.++..|+.||+.||.|||+++||||||||+||||++++.+||+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DF 189 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDL 189 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCS
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCc
Confidence 99975554333 21 235899999999999999999999999999999999999999999999999
Q ss_pred ccceecCCCC-CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 287 GLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 287 Gla~~~~~~~-~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
|+|+.+.... ....+..+||+.|||||++.+.. |+.++||||||||||||+| |.+||.+.+..+.+..+.....
T Consensus 190 Glar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~--- 265 (308)
T 4gt4_A 190 GLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV--- 265 (308)
T ss_dssp CCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC---
T ss_pred ccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 9998664322 23345568999999999998776 8999999999999999998 8999999998887777653211
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
...+.++|+.+.+||..||+.||++|||+.+++++
T Consensus 266 -------------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 266 -------------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11234688999999999999999999999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=420.97 Aligned_cols=283 Identities=39% Similarity=0.673 Sum_probs=232.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|++. +++.||||++............+.+|+.+|++++||||+++++++.. ...+||||||
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~ 100 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERCLTLVFEF 100 (311)
T ss_dssp EEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSCEEEEEEC
T ss_pred HhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCEEEEEEcC
Confidence 33334999999999999985 58999999998765555556778899999999999999999999876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .......
T Consensus 101 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~ 179 (311)
T 3niz_A 101 MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSYTHE 179 (311)
T ss_dssp CSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC-CC---CC
T ss_pred CCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC-cccccCC
Confidence 999988888777777999999999999999999999999999999999999999999999999999876432 2234456
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc-cccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA-TIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~-~~~~~~ 382 (720)
++|+.|+|||++.+...|+.++|||||||++|+|++|.+||.+....+.+..+...++.+....|........ ......
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccc
Confidence 7899999999998866689999999999999999999999999999999999999999998877754321100 000000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......+......+++++.+||.+||++||.+|||+.++|+||||+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 111122344556789999999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=437.32 Aligned_cols=290 Identities=33% Similarity=0.527 Sum_probs=228.1
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyL 219 (720)
..|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.+. ||||+++++++.......+||
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 3455556699999999999999999999999999766556677788899999999997 999999999987655568999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC----
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD---- 295 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~---- 295 (720)
|||||++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 89 v~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 166 (388)
T 3oz6_A 89 VFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166 (388)
T ss_dssp EEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred EecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence 999999987766554 36899999999999999999999999999999999999999999999999999865321
Q ss_pred ----------------CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 004999 296 ----------------QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 359 (720)
Q Consensus 296 ----------------~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~ 359 (720)
.....+..+||++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++..|+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~ 246 (388)
T 3oz6_A 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246 (388)
T ss_dssp CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 1223455689999999999988666899999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCccccCC---------CCc----c---chhh--hcccCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 004999 360 CGSPSEDYWRKSKLPHATIFKP---------QQP----Y---KRCV--AETFKDFPAPALALMETLLSIDPADRGSAASA 421 (720)
Q Consensus 360 ~g~p~~~~w~~~~l~~~~~~~~---------~~~----~---~~~~--~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~ 421 (720)
++.|..+.+.....+....+.. ... + .... ......+++.+.+||.+||++||.+|||+.++
T Consensus 247 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~ 326 (388)
T 3oz6_A 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDA 326 (388)
T ss_dssp HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHH
Confidence 9999988775433322111100 000 0 0000 01122678999999999999999999999999
Q ss_pred HhCccCCCCCC
Q 004999 422 LRSEFFTMKPL 432 (720)
Q Consensus 422 L~hp~f~~~~~ 432 (720)
|+||||+....
T Consensus 327 l~Hp~~~~~~~ 337 (388)
T 3oz6_A 327 LKHPFVSIFHN 337 (388)
T ss_dssp TTSTTTTTTCC
T ss_pred hCCHHHHHhcC
Confidence 99999986543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=435.25 Aligned_cols=291 Identities=32% Similarity=0.531 Sum_probs=236.3
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC---CeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS---CSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~---~~lyL 219 (720)
|++.++||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.|+||||+++++++..... ..+||
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 344445999999999999999999999999998765566777889999999999999999999998865321 57999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 297 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-- 297 (720)
||||++++|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 108 v~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 186 (432)
T 3n9x_A 108 VLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186 (432)
T ss_dssp EEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------
T ss_pred EEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccc
Confidence 999999987776654 45799999999999999999999999999999999999999999999999999987643321
Q ss_pred -------------------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-----------CCCCCCCC
Q 004999 298 -------------------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-----------GKPIMPGR 347 (720)
Q Consensus 298 -------------------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-----------G~ppf~g~ 347 (720)
...+..+||++|+|||++.....|+.++||||||||||||++ |.++|.|.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~ 266 (432)
T 3n9x_A 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266 (432)
T ss_dssp ------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCS
T ss_pred ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCc
Confidence 234677899999999998776678999999999999999997 67888886
Q ss_pred C-----------------hHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC--CccchhhhcccCCCCHhHHHHHHHhc
Q 004999 348 T-----------------EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ--QPYKRCVAETFKDFPAPALALMETLL 408 (720)
Q Consensus 348 ~-----------------~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~--~~~~~~~~e~~~~~~~~~~dLI~~mL 408 (720)
. ..+++..|+..+|.|+.+.|..........+... ......+...++.+++.+.+||.+||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL 346 (432)
T 3n9x_A 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESML 346 (432)
T ss_dssp CSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHS
T ss_pred cccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHh
Confidence 5 4789999999999999988765332221111100 01111234456789999999999999
Q ss_pred ccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 409 SIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 409 ~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
++||.+|||+.|+|+||||+....+.
T Consensus 347 ~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 347 KFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp CSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred cCCcccCCCHHHHhcChhhhhccCcc
Confidence 99999999999999999999765543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=445.65 Aligned_cols=286 Identities=30% Similarity=0.516 Sum_probs=229.2
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~l 217 (720)
.|++.+.||+|+||.||+|++..+++.||||++..........+.+.+|+.+|+.++||||+++++++.... ...+
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 355566699999999999999999999999999876556677788999999999999999999999986532 2468
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|||||||+++++..+.. .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... .
T Consensus 143 ~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 217 (464)
T 3ttj_A 143 YLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 217 (464)
T ss_dssp EEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-------C
T ss_pred EEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC--C
Confidence 99999999988776643 489999999999999999999999999999999999999999999999999987643 2
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
...+..+||++|+|||++.+.. |+.++||||||||||||++|++||.+.+..+++.+|++.+|.|.+++|.........
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 3456678999999999999875 899999999999999999999999999999999999999999999887543210000
Q ss_pred ccCC-----CCccchhhhcc-c-------CCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 378 IFKP-----QQPYKRCVAET-F-------KDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 378 ~~~~-----~~~~~~~~~e~-~-------~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.+.. ...+....... + ...++.+.+||.+||.+||.+|||+.|+|+||||+....+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 365 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCc
Confidence 0000 00111100000 0 0115679999999999999999999999999999865443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=411.30 Aligned_cols=281 Identities=36% Similarity=0.653 Sum_probs=229.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++ .+++.||||++............+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 80 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVFE 80 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEEE
T ss_pred chhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEEEE
Confidence 34445599999999999998 678999999997654433334567899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+++++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 159 (288)
T 1ob3_A 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTH 159 (288)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc-cccccc
Confidence 9999887777666678999999999999999999999999999999999999999999999999999866432 223345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.++|+.|+|||++.+...|+.++||||||||+|||++|.+||.+....+.+..+++..+.+....|....... .+.+.
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 237 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP--KYDPN 237 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCCTT
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc--ccccc
Confidence 5789999999999876668999999999999999999999999999999999999999988877765421110 01110
Q ss_pred Cc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 383 QP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 383 ~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.. ....+......+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00 011123445678999999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=424.92 Aligned_cols=289 Identities=33% Similarity=0.525 Sum_probs=230.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC----CeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----CSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~----~~ly 218 (720)
|++.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++..... ..+|
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 445555999999999999999999999999997665566677889999999999999999999999875321 4579
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
|||||+++++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 107 lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---- 180 (367)
T 1cm8_A 107 LVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---- 180 (367)
T ss_dssp EEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS----
T ss_pred EEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc----
Confidence 9999997666555443 4689999999999999999999999999999999999999999999999999987543
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
..+..++|++|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|++..|.|+.+++..........
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 260 (367)
T 1cm8_A 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN 260 (367)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence 23556889999999999886668999999999999999999999999999999999999999999988876432211111
Q ss_pred cCCC--CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCC
Q 004999 379 FKPQ--QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPS 437 (720)
Q Consensus 379 ~~~~--~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~ 437 (720)
+... ......+...+..+++.+.+||.+||+.||.+|||+.++|+||||+....+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~ 321 (367)
T 1cm8_A 261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 321 (367)
T ss_dssp HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCC
Confidence 1000 0001123455677899999999999999999999999999999999766554433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=414.69 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=222.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.. ...+|+|||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e 94 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYLIME 94 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEE
Confidence 344445999999999999999999999999998877777778889999999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... .....
T Consensus 95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~ 172 (328)
T 3fe3_A 95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDA 172 (328)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS--CGGGT
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC--Ccccc
Confidence 9987655554444557999999999999999999999999999999999999999999999999999866432 33456
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||++|+|||++.+...++.++||||||||+|+|++|.+||.+.+..+....+.....
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------- 231 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--------------------- 231 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------------
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------------
Confidence 78999999999999887556899999999999999999999999988887777754211
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 232 --------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 232 --------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp --------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred --------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 11234788999999999999999999999999999998654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=426.63 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=202.8
Q ss_pred eeecccCceEEEEEEECCC-----CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC-CceeeeccceeccCCCeEEEE
Q 004999 147 YLIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEPESVRFMAREIHILRRLDH-INVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~t-----g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIvkl~~~~~~~~~~~lyLV 220 (720)
+.||+|+||.||+|.+..+ ++.||||++.... .....+.|.+|+.+|.+|.| ||||+++++|... ...+|||
T Consensus 70 ~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-~~~~~iV 147 (353)
T 4ase_A 70 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVI 147 (353)
T ss_dssp EEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-TSCCEEE
T ss_pred eEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-CCEEEEE
Confidence 3499999999999997654 4689999997653 34556778999999999965 9999999998653 4568999
Q ss_pred EeeccccccccccC----------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 221 FEYMEHDLAGLASH----------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~----------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
||||+++.+..++. ....+++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~ 227 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 227 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEEC
Confidence 99999765544332 12458999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004999 285 DFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 362 (720)
Q Consensus 285 DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~ 362 (720)
|||+|+.+..+... ..+..+||+.|||||++.+.. |+.++||||||||||||+| |.+||.+....+.+.+++.....
T Consensus 228 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~ 306 (353)
T 4ase_A 228 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 306 (353)
T ss_dssp CCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred cchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 99999876443322 233457899999999998876 8999999999999999998 99999997655555444432111
Q ss_pred CChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 363 p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
+ ..+..+++++.+||..||+.||++|||+.++++|
T Consensus 307 ~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 307 M---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 1 1224578999999999999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=414.85 Aligned_cols=280 Identities=36% Similarity=0.658 Sum_probs=224.3
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|.+..+++.||||+++.... ......+.+|+.+|++++||||+++++++.. ...+||||||+++++
T Consensus 13 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~L 89 (317)
T 2pmi_A 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTLVFEFMDNDL 89 (317)
T ss_dssp ------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEEEEECCCCBH
T ss_pred ECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEEEEEecCCCH
Confidence 9999999999999999999999999986542 2223557899999999999999999999876 678999999999877
Q ss_pred cccccC-----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 229 AGLASH-----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 229 l~~~~~-----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
...+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ......
T Consensus 90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 168 (317)
T 2pmi_A 90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV-NTFSSE 168 (317)
T ss_dssp HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC-CCCCCC
T ss_pred HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc-ccCCCC
Confidence 655432 22458999999999999999999999999999999999999999999999999998764322 233456
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccccC--
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIFK-- 380 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~~~-- 380 (720)
++|+.|+|||++.+...|+.++||||||||+|||++|.+||.+.+..+++..+++.++.+....|.... ++......
T Consensus 169 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T 2pmi_A 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQ 248 (317)
T ss_dssp CSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCC
T ss_pred cccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccccccc
Confidence 789999999999876668999999999999999999999999999999999999999999888876532 11111000
Q ss_pred -CCCccchh-hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 381 -PQQPYKRC-VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 381 -~~~~~~~~-~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
+....... .......++..+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp CCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred ccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 01111111 11233468899999999999999999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=420.91 Aligned_cols=287 Identities=34% Similarity=0.527 Sum_probs=223.4
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~l 217 (720)
.|++.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+|+.++||||+++++++.... ...+
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 345555699999999999999999999999999876556667788899999999999999999999886521 2568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|+||||++++|...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 110 ~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~--- 184 (367)
T 2fst_X 110 YLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD--- 184 (367)
T ss_dssp EEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------------
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc---
Confidence 99999998776665543 4699999999999999999999999999999999999999999999999999986532
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
..+..++|++|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++..|++.+|.|..+.|.........
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 2355688999999999988666899999999999999999999999999999999999999999998877543221111
Q ss_pred ccC---CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCC
Q 004999 378 IFK---PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435 (720)
Q Consensus 378 ~~~---~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 435 (720)
.+. +..+ ...+...+..+++.+.+||.+||++||.+|||+.++|+||||+....+..
T Consensus 264 ~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 264 NYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp HHHHTSCCCC-CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGG
T ss_pred HHHhccCCCC-CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCC
Confidence 100 0000 11234456678999999999999999999999999999999998765544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=413.29 Aligned_cols=293 Identities=38% Similarity=0.688 Sum_probs=239.0
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
|++.+.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.. ...+|+
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 89 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISL 89 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CCceEE
Confidence 34444599999999999999999999999999764321 1223467899999999999999999999876 677999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+... ...
T Consensus 90 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~ 168 (346)
T 1ua2_A 90 VFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRA 168 (346)
T ss_dssp EEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCC
T ss_pred EEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-ccc
Confidence 9999999887777766677999999999999999999999999999999999999999999999999999876432 233
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~ 378 (720)
....++|+.|+|||++.+...|+.++||||||||+|||++|.++|.+.+..+.+..++...+.+..+.|.+.. ++....
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 248 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 248 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccc
Confidence 4556789999999999877668999999999999999999999999999999999999999999888876532 222111
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p 440 (720)
+.... ...+...+..+++.+.+||.+||+.||.+|||+.|+|+||||+..+.+.....+|
T Consensus 249 ~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~~~~~~ 308 (346)
T 1ua2_A 249 FKSFP--GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 308 (346)
T ss_dssp CCCCC--CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred ccccC--CCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCCcccCC
Confidence 11110 1113345567899999999999999999999999999999999877666544443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=416.38 Aligned_cols=291 Identities=43% Similarity=0.683 Sum_probs=235.5
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC------CCeEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM------SCSLY 218 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~------~~~ly 218 (720)
+.+.||+|+||.||+|++..+++.||||++............+.+|+.+|+.++||||+++++++.... ...+|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence 333499999999999999999999999999766544444456789999999999999999999887643 34689
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC---
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD--- 295 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~--- 295 (720)
|||||+++++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 101 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (351)
T 3mi9_A 101 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180 (351)
T ss_dssp EEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSS
T ss_pred EEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccc
Confidence 99999999888888777778999999999999999999999999999999999999999999999999999876422
Q ss_pred CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC-
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP- 374 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~- 374 (720)
........++|+.|+|||++.+...|+.++||||||||+|+|++|.+||.+....+++..+.+.++.++.+.|......
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 260 (351)
T 3mi9_A 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260 (351)
T ss_dssp SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccch
Confidence 2223345678999999999988766899999999999999999999999999999999999999999888776542111
Q ss_pred CccccCCCCccchhhhccc--CCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCC
Q 004999 375 HATIFKPQQPYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~--~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 435 (720)
....+.........+...+ ...++.+.+||.+||++||.+|||+.|+|+||||+..+.+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 0000000000000011111 124778999999999999999999999999999998766543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=411.41 Aligned_cols=280 Identities=37% Similarity=0.656 Sum_probs=220.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++..+++.||||+++...........+.+|+.+|++++||||+++++++.. ...+||||||++|+
T Consensus 41 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 118 (329)
T 3gbz_A 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLHLIFEYAEND 118 (329)
T ss_dssp EEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEEEEECCSEE
T ss_pred EEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEEEEEecCCCC
Confidence 3999999999999999999999999998765555556677899999999999999999999877 67899999999997
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc-----CCCceeeeccccceecCCCCCCCccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-----NNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld-----~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
+...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+... ......
T Consensus 119 L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 196 (329)
T 3gbz_A 119 LKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTH 196 (329)
T ss_dssp HHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---------
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc-ccccCC
Confidence 7666554 34699999999999999999999999999999999999994 4556999999999876432 223345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC-CCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK-LPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~-l~~~~~~~~ 381 (720)
.++|+.|+|||++.+...|+.++||||||||+|||++|.+||.+....+.+..++...+.|....|.... .+......+
T Consensus 197 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
T 3gbz_A 197 EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFP 276 (329)
T ss_dssp ---CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred CcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhh
Confidence 5789999999999887768999999999999999999999999999999999999999998887765421 111111111
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
..............+++.+.+||.+||++||.+|||+.++|+||||+...
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 277 KFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp CCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 11111111122234789999999999999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=404.80 Aligned_cols=285 Identities=38% Similarity=0.613 Sum_probs=230.1
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhc---CCCceeeeccceeccCC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRL---DHINVIKLEGLVTSRMS 214 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~L---~HpnIvkl~~~~~~~~~ 214 (720)
..|++.+.||+|+||.||+|++..+++.||||++...... ......+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 3445555699999999999999999999999999754321 11123456777777766 49999999999876322
Q ss_pred C---eEEEEEeeccccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 215 C---SLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 215 ~---~lyLV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
. .+|+||||+++++...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 168 (308)
T 3g33_A 89 DREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168 (308)
T ss_dssp SSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTT
T ss_pred CCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcccc
Confidence 1 589999999997777665533 349999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 291 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 291 ~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
.... .......++|+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+.++++..+.+....|..
T Consensus 169 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (308)
T 3g33_A 169 IYSY--QMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245 (308)
T ss_dssp TSTT--CCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred ccCC--CcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 6543 23345668899999999998876 79999999999999999999999999999999999999999998888765
Q ss_pred cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
........+.+.. ...+....+.+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 246 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 246 DVSLPRGAFPPRG--PRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCGGGSCCCC--CCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hhhccccccCCCC--CCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 3322222222221 122345567899999999999999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=415.26 Aligned_cols=285 Identities=35% Similarity=0.627 Sum_probs=228.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++..+++.||||++..... ......+.+|+.+|+.++||||+++++++.. ...+|||||
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 80 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVFE 80 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEEEE
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEEec
Confidence 4445559999999999999999999999999975432 1112234579999999999999999999876 677999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+++++...+...+..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 159 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDN 159 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC-cccccc
Confidence 9999888877776777999999999999999999999999999999999999999999999999999865432 223345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC-ccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH-ATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~-~~~~~~ 381 (720)
.++|++|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+++..+.+.++.|....|....... ...+..
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 5789999999999886668999999999999999999999999999999999999999999888775421110 000111
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.......+......+++.+.+||.+||++||.+|||+.|+|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence 11111223345567899999999999999999999999999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=414.08 Aligned_cols=259 Identities=23% Similarity=0.306 Sum_probs=223.3
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhcCCCceeeeccceeccCCCe
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ 216 (720)
..|.+.+.||+|+||.||+|++..+|+.||||++....... ...+.+.+|+.+|+.++||||+++++++.. ...
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~ 89 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RTD 89 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CCE
Confidence 44556666999999999999999999999999998754321 134668899999999999999999999876 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC----ceeeeccccceec
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASFY 292 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g----~vKL~DFGla~~~ 292 (720)
+||||||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999998766665666666899999999999999999999999999999999999998877 7999999999876
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
... ......+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..|..........+|
T Consensus 170 ~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~---- 242 (361)
T 2yab_A 170 EDG--VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF---- 242 (361)
T ss_dssp CTT--CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH----
T ss_pred CCC--CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc----
Confidence 432 2345568999999999998765 799999999999999999999999999998888888765444433333
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 243 ---------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 ---------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp ---------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred ---------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 468899999999999999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=398.57 Aligned_cols=286 Identities=31% Similarity=0.525 Sum_probs=230.7
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.++++++||||+++++++.. ...+|+|||
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 82 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHLVFE 82 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEEEEE
Confidence 445556999999999999999999999999998776666667788999999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++++++..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cccCC
Confidence 99998887776666789999999999999999999999999999999999999999999999999998764322 23345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC-ccc-cC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH-ATI-FK 380 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~-~~~-~~ 380 (720)
.++|+.|+|||++.+...|+.++||||||||+|+|++|.+||.+....+.+..+.+..+...+..+....... ... ..
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 5789999999999886668999999999999999999999999999999999998888877665432211000 000 00
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
+.......+...+..++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 111111112334567899999999999999999999999999999998653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=421.00 Aligned_cols=280 Identities=36% Similarity=0.560 Sum_probs=226.8
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~lyL 219 (720)
.+.++||+|+||.||+|++..+++.||||++..... .+.+|+.+|+.|+|||||++++++.... ...++|
T Consensus 57 ~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred EeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 344459999999999999999999999999875431 2347999999999999999999875421 234789
Q ss_pred EEeecccccccccc---CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-CceeeeccccceecCCC
Q 004999 220 VFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASFYDPD 295 (720)
Q Consensus 220 V~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~DFGla~~~~~~ 295 (720)
||||+++++...+. .....+++..++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++.+...
T Consensus 131 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp EEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 99999987665443 345679999999999999999999999999999999999999965 67899999999876432
Q ss_pred CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
......++|++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++.++++.+|.|..+.|......
T Consensus 211 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~- 287 (420)
T 1j1b_A 211 --EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN- 287 (420)
T ss_dssp --CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC-
T ss_pred --CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh-
Confidence 23345688999999999988766899999999999999999999999999999999999999999999888653221
Q ss_pred ccccCCCCccchhhhc-ccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 376 ATIFKPQQPYKRCVAE-TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e-~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
...+.........+.. +...+++.+.+||.+||++||.+|||+.|+|+||||.....
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 1111111100111111 23467899999999999999999999999999999976543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=413.15 Aligned_cols=280 Identities=31% Similarity=0.513 Sum_probs=228.4
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc---------
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--------- 212 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~--------- 212 (720)
.|++.+.||+|+||.||+|++..+|+.||||++...... ..+|+.+|+.++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 345555699999999999999999999999998755321 24799999999999999999988542
Q ss_pred ---------------------------CCCeEEEEEeecccccccccc---CCCCCCCHHHHHHHHHhhhhccccccccC
Q 004999 213 ---------------------------MSCSLYLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262 (720)
Q Consensus 213 ---------------------------~~~~lyLV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH~~g 262 (720)
....+||||||+++++...+. ..+..+++..++.++.||+.||.|||++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 234589999999987544333 45668999999999999999999999999
Q ss_pred cccccCcceeEEEc-CCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC
Q 004999 263 VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 341 (720)
Q Consensus 263 IvHrDIKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ 341 (720)
|+||||||+||||+ .++.+||+|||++..+... ......++|+.|+|||++.+...|+.++||||||||+|||++|.
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 99999999999998 6899999999999876433 23345678999999999988777899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHH
Q 004999 342 PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421 (720)
Q Consensus 342 ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~ 421 (720)
+||.+.+..+++..+.+.+|.|..+.|............+..............+++.+.+||.+||++||.+|||+.|+
T Consensus 240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 319 (383)
T 3eb0_A 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA 319 (383)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99999999999999999999999988765432222211122111121223344689999999999999999999999999
Q ss_pred HhCccCCC
Q 004999 422 LRSEFFTM 429 (720)
Q Consensus 422 L~hp~f~~ 429 (720)
|+||||+.
T Consensus 320 l~hp~f~~ 327 (383)
T 3eb0_A 320 MAHPFFDH 327 (383)
T ss_dssp HTSGGGHH
T ss_pred hcCHHHHH
Confidence 99999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=417.00 Aligned_cols=286 Identities=29% Similarity=0.509 Sum_probs=222.3
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~l 217 (720)
.|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++.... ...+
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 345555699999999999999999999999999876666677788899999999999999999999987532 1378
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
||||||+++++...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 106 ~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-- 180 (371)
T 2xrw_A 106 YIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-- 180 (371)
T ss_dssp EEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---------
T ss_pred EEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc--
Confidence 99999999987776643 5899999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......++|+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+++..+++.++.|.+++|.........
T Consensus 181 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ---------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 2334568899999999998865 799999999999999999999999999999999999999999988876542110000
Q ss_pred cc--CC---CCccchhhhcc--------cCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 378 IF--KP---QQPYKRCVAET--------FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 378 ~~--~~---~~~~~~~~~e~--------~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.+ .+ ...+....... ....+..+.+||.+||++||.+|||+.++|+||||+....+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 328 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence 00 00 00000000000 01125679999999999999999999999999999876544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=409.07 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=221.7
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|.+.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.+|+.|+||||+++++++.. ...+||||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv~ 107 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVF 107 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEE
Confidence 3445556999999999999999999999999999877777777889999999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC---CceeeeccccceecCCCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~---g~vKL~DFGla~~~~~~~~~ 298 (720)
|||.|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++...... .
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~--~ 185 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--E 185 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC--C
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC--c
Confidence 999986665555555679999999999999999999999999999999999999865 45999999999876432 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..+.......+..
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------------ 252 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP------------ 252 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT------------
T ss_pred ccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc------------
Confidence 334568999999999998765 7999999999999999999999999998888887776543222211
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.+..+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 253 -------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 253 -------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp -------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred -------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 12457899999999999999999999999999999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=406.73 Aligned_cols=288 Identities=34% Similarity=0.533 Sum_probs=236.6
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC---CCeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~---~~~lyL 219 (720)
|++.+.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|++++||||+++++++.... ...+|+
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 444455999999999999999999999999997533 3455677899999999999999999999886532 246899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 297 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-- 297 (720)
||||+++++...+.. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 108 v~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 185 (364)
T 3qyz_A 108 VQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185 (364)
T ss_dssp EEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCcc
Confidence 999999987766543 3689999999999999999999999999999999999999999999999999987643222
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......+||++|+|||++.+...|+.++||||||||+|+|++|.+||.+.+..+.+..+...++.|..+.|.........
T Consensus 186 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 265 (364)
T 3qyz_A 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 265 (364)
T ss_dssp CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHH
Confidence 22345688999999999887776899999999999999999999999999999999999999999998876542211110
Q ss_pred cc--CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 378 IF--KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 378 ~~--~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.+ .........+...+..+++.+.+||.+||++||.+|||+.++|+||||+....+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 266 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 00 000111112345567789999999999999999999999999999999876443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=411.11 Aligned_cols=282 Identities=35% Similarity=0.541 Sum_probs=226.9
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~l 217 (720)
.|++.++||+|+||.||+|++..++. ||+|++..... ...+|+.+|+.++||||+++++++.... ...+
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 34555559999999999999988776 88888764431 1237999999999999999999986532 2248
Q ss_pred EEEEeecccccccccc---CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc-CCCceeeeccccceecC
Q 004999 218 YLVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYD 293 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld-~~g~vKL~DFGla~~~~ 293 (720)
||||||++++++..+. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+.
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 8999999997665433 2345799999999999999999999999999999999999999 79999999999998764
Q ss_pred CCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 294 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 294 ~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
.. ......++|++|+|||++.+...|+.++||||||||||||++|++||.+.+..+++..+.+.+|.|..+.|.....
T Consensus 194 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 271 (394)
T 4e7w_A 194 AG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271 (394)
T ss_dssp TT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred CC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence 33 2334567899999999998877789999999999999999999999999999999999999999999887764321
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
.......+..............+++.+.+||.+||++||.+|||+.++|+||||+....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 11111111111111112233458999999999999999999999999999999986543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=400.91 Aligned_cols=258 Identities=23% Similarity=0.328 Sum_probs=221.5
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++||||+++++++.. ...+|+||
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 80 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEEEE
Confidence 445556699999999999999999999999998754 2445568899999999999999999999977 67899999
Q ss_pred eecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC--CCceeeeccccceecCCCCCC
Q 004999 222 EYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~--~g~vKL~DFGla~~~~~~~~~ 298 (720)
|||+|+ +...+......+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~--~ 158 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--D 158 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--C
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC--C
Confidence 999975 44444444557999999999999999999999999999999999999987 789999999999876432 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....++|+.|+|||++.+.. ++.++||||||||+|+|++|.+||.+.+..+.+..+......+....
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----------- 226 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----------- 226 (321)
T ss_dssp EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-----------
T ss_pred ccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhh-----------
Confidence 345567899999999998765 79999999999999999999999999999888888876544433332
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
+..++..+.+||.+||..||.+|||+.++|+||||+....
T Consensus 227 --------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 227 --------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp --------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred --------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 3468999999999999999999999999999999986543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=399.67 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=222.1
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhcCCCceeeeccceeccCCCe
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ 216 (720)
..|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+.+|+.|+||||+++++++.. ...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 34556667999999999999999999999999998654321 135678899999999999999999999876 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC----ceeeeccccceec
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASFY 292 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g----~vKL~DFGla~~~ 292 (720)
+|+||||+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999998766666666666899999999999999999999999999999999999999887 8999999999876
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
... ......+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+....+.+..+..........
T Consensus 169 ~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 239 (326)
T 2y0a_A 169 DFG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE------ 239 (326)
T ss_dssp CTT--SCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH------
T ss_pred CCC--CccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc------
Confidence 432 2334567999999999997765 7999999999999999999999999999888888776643333222
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 240 -------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 240 -------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 234678999999999999999999999999999999843
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=406.19 Aligned_cols=286 Identities=35% Similarity=0.533 Sum_probs=233.2
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCC----e
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC----S 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~----~ 216 (720)
+.|++.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++...... .
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 345556669999999999999999999999999987766667778899999999999999999999998763221 2
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
+|+||||+.+++...+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 122 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-- 196 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-- 196 (371)
T ss_dssp CEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred EEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc--
Confidence 49999999987766553 3589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.....++|++|+|||++.+...++.++||||||||+|+|++|.+||.+.+..+.+..+++..+.+..+++........
T Consensus 197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 274 (371)
T 4exu_A 197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 274 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence 234567899999999998856689999999999999999999999999999999999999999998887654321111
Q ss_pred cccC--CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 377 TIFK--PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 377 ~~~~--~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
..+. ........+...+..+++.+.+||.+||++||.+|||+.++|+||||+....+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 0000 00011112344556789999999999999999999999999999999865443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=412.34 Aligned_cols=284 Identities=35% Similarity=0.645 Sum_probs=215.5
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~--~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++. .+++.||||++...... ..+.+|+.+|++|+||||+++++++.......+||||||++
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 5999999999999965 57889999999765443 34678999999999999999999997655778999999999
Q ss_pred ccccccccC--------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE----cCCCceeeeccccceecC
Q 004999 226 HDLAGLASH--------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYD 293 (720)
Q Consensus 226 g~ll~~~~~--------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl----d~~g~vKL~DFGla~~~~ 293 (720)
++++..+.. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 183 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC---
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecC
Confidence 987765542 22358999999999999999999999999999999999999 678999999999998764
Q ss_pred CCCC--CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHhcCC
Q 004999 294 PDQN--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------VEQLHKIFKLCGS 362 (720)
Q Consensus 294 ~~~~--~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---------~e~l~~i~~~~g~ 362 (720)
.... ......+||++|+|||++.+...|+.++||||||||||||++|.+||.+... .+++..|+..+|.
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~ 263 (405)
T 3rgf_A 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263 (405)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCC
T ss_pred CCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCC
Confidence 3211 2334568899999999999877689999999999999999999999987665 5889999999999
Q ss_pred CChhhhhhcC-CCCcccc----C----CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 363 PSEDYWRKSK-LPHATIF----K----PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 363 p~~~~w~~~~-l~~~~~~----~----~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
|....|.... ++....+ . ........+.......++.+.+||.+||++||.+|||+.|+|+||||+..+.+
T Consensus 264 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 264 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP 343 (405)
T ss_dssp CCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred CChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence 9988876532 1110000 0 00000111112223447889999999999999999999999999999988776
Q ss_pred CC
Q 004999 434 CD 435 (720)
Q Consensus 434 ~~ 435 (720)
..
T Consensus 344 ~~ 345 (405)
T 3rgf_A 344 TS 345 (405)
T ss_dssp CS
T ss_pred cc
Confidence 54
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=419.02 Aligned_cols=259 Identities=28% Similarity=0.389 Sum_probs=221.0
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.+|+.|+||||+++++++.+ ...+||||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv~ 89 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYLIF 89 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEEEE
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEEEE
Confidence 3455556999999999999999999999999998877666667789999999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc---CCCceeeeccccceecCCCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID---NNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld---~~g~vKL~DFGla~~~~~~~~~ 298 (720)
|||.|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++...... ..
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~-~~ 168 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQ 168 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-CC
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-Cc
Confidence 9999865544444455799999999999999999999999999999999999998 4678999999999876432 23
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+..+.+..+.......+..
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------ 235 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP------------ 235 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT------------
T ss_pred eeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc------------
Confidence 344568999999999998765 7999999999999999999999999999888888876643332221
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 236 -------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 236 -------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp -------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred -------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 22467899999999999999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=402.33 Aligned_cols=282 Identities=30% Similarity=0.581 Sum_probs=230.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.++||+|+||.||+|++..+++.||||++..........+.+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 105 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWYLVFEF 105 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEEEEEec
Confidence 33344999999999999999999999999998776666667788899999999999999999999876 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
++++++..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.... ......
T Consensus 106 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 184 (331)
T 4aaa_A 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYDDE 184 (331)
T ss_dssp CSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------------C
T ss_pred CCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-cccCCC
Confidence 9998888776666679999999999999999999999999999999999999999999999999998654322 233455
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh---hcCCCCccccC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR---KSKLPHATIFK 380 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~---~~~l~~~~~~~ 380 (720)
++|+.|+|||++.+...++.++||||||||+|+|++|.+||.+....+.+..+....+...+..+. ...... ....
T Consensus 185 ~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 263 (331)
T 4aaa_A 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA-GVRL 263 (331)
T ss_dssp CCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT-TCCC
T ss_pred cCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc-cccC
Confidence 789999999999887668999999999999999999999999999999999998888877665432 111000 0011
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
+...........++.+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 1111122234455678999999999999999999999999999999974
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=392.44 Aligned_cols=256 Identities=26% Similarity=0.422 Sum_probs=216.4
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 96 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVM 96 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEEEE
Confidence 3455556999999999999999999999999997654322 3567899999999999999999999887 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||++|+.+..+.... .+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ....
T Consensus 97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 174 (297)
T 3fxz_A 97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRS 174 (297)
T ss_dssp ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBC
T ss_pred ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-cccC
Confidence 999876665554433 68999999999999999999999999999999999999999999999999998765433 2344
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+......+..+.... .+.
T Consensus 175 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~----------------- 235 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE----------------- 235 (297)
T ss_dssp CCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC-----------------
T ss_pred CccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC-----------------
Confidence 568999999999998876 7999999999999999999999999988877776665421 110
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 236 --------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 236 --------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp --------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred --------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 01123578899999999999999999999999999999853
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=405.56 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=215.7
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.++||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+|||||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lv~E 85 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVME 85 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEEEEEe
Confidence 334459999999999999999999999999975421 12335668899999999999999999999877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... ......
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~ 164 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 164 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC-CCcccc
Confidence 9998666555555567999999999999999999999999999999999999999999999999999864322 223456
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+....+.....
T Consensus 165 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------------------- 222 (337)
T 1o6l_A 165 FCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI--------------------- 222 (337)
T ss_dssp CEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------------
T ss_pred cccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 68999999999998765 79999999999999999999999999888777776654210
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||+.||.+|| ++.++++||||...
T Consensus 223 --------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 223 --------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 11235789999999999999999999 99999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=411.21 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=211.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
++||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|+.+ +||||+++++++.. ...+|||||||
T Consensus 29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~lv~E~~ 106 (353)
T 3txo_A 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRLFFVMEFV 106 (353)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEEEEEEeCC
Confidence 349999999999999999999999999986432 233456688999999998 79999999999877 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
.|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... .......+
T Consensus 107 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~~~~ 185 (353)
T 3txo_A 107 NGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTATFC 185 (353)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC-CccccccC
Confidence 98666555555567999999999999999999999999999999999999999999999999999854322 23345568
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+..|.....
T Consensus 186 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~----------------------- 241 (353)
T 3txo_A 186 GTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV----------------------- 241 (353)
T ss_dssp CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------------
T ss_pred CCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 999999999998765 79999999999999999999999999999888888865211
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH------HHHHhCccCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSA------ASALRSEFFTMK 430 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa------~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||++||.+||++ .++++||||+..
T Consensus 242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 1123478899999999999999999999 999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=390.55 Aligned_cols=256 Identities=27% Similarity=0.354 Sum_probs=208.8
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH------------------------HHHHHHHHHHHHHHhcCC
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP------------------------ESVRFMAREIHILRRLDH 199 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~------------------------~~~~~~~~Ei~iL~~L~H 199 (720)
++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.+|++|+|
T Consensus 16 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 95 (298)
T 2zv2_A 16 TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDH 95 (298)
T ss_dssp EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCC
T ss_pred EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCC
Confidence 33444999999999999999999999999997654211 124568899999999999
Q ss_pred CceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 200 INVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 200 pnIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
|||+++++++.......+||||||++++.+..+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~ 174 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG 174 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC
Confidence 99999999988755678999999999876665544 34799999999999999999999999999999999999999999
Q ss_pred ceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcC--CCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 004999 280 ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357 (720)
Q Consensus 280 ~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~--y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~ 357 (720)
.+||+|||++..+.... ......+||+.|+|||++.+... ++.++||||||||+|+|++|..||.+.........+.
T Consensus 175 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 253 (298)
T 2zv2_A 175 HIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK 253 (298)
T ss_dssp CEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHh
Confidence 99999999998764322 22345578999999999976542 4788999999999999999999999887766655554
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
...... .....+++.+.+||.+||+.||.+|||+.++|+||||+
T Consensus 254 ~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 254 SQALEF---------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HCCCCC---------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred cccCCC---------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 321100 01246889999999999999999999999999999996
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=397.53 Aligned_cols=284 Identities=36% Similarity=0.569 Sum_probs=231.0
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC----CeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS----CSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~----~~l 217 (720)
.|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+++.++||||+++++++..... ..+
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3455556999999999999999999999999998766666677888999999999999999999999876322 246
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|+||||+.+++...+. ..+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.....
T Consensus 105 ~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--- 178 (353)
T 3coi_A 105 YLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA--- 178 (353)
T ss_dssp EEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC------
T ss_pred EEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC---
Confidence 9999999987665543 3589999999999999999999999999999999999999999999999999986532
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.....++|+.|+|||++.+...++.++||||||||+|+|++|.+||.+.+..+.+..+.+..|.+..+++.........
T Consensus 179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 2345578999999999988566899999999999999999999999999999999999999999988776542211000
Q ss_pred cc---CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 378 IF---KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 378 ~~---~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.+ .+..+ ...+...+..+++.+.+||.+||+.||.+|||+.++|+||||+....+
T Consensus 258 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 258 SYIQSLPQTP-RKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp HHHHTSCBCS-SCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHhCcCCC-CccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 00 00000 111233456789999999999999999999999999999999865443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=398.63 Aligned_cols=287 Identities=30% Similarity=0.463 Sum_probs=223.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC-----CCeEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM-----SCSLY 218 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~-----~~~ly 218 (720)
++.+.||+|+||.||+|++..+++.||||++...... .....+|+..+..++||||+++++++.... ...+|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~ 102 (360)
T 3e3p_A 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN 102 (360)
T ss_dssp EEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence 3334499999999999999999999999998654321 224567888889999999999999986522 22388
Q ss_pred EEEeecccccccccc---CCCCCCCHHHHHHHHHhhhhcccccc--ccCcccccCcceeEEEcC-CCceeeeccccceec
Q 004999 219 LVFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCH--SRGVLHRDIKGSNLLIDN-NGILKIADFGLASFY 292 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH--~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~~ 292 (720)
+||||+++++...+. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|||++..+
T Consensus 103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 999999998655333 35667899999999999999999999 999999999999999996 899999999999876
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
.... .....+||+.|+|||++.+...|+.++||||||||+|+|++|.+||.+....+.+..+.+..+.+..+.|....
T Consensus 183 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 183 SPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 4332 33455789999999999887768999999999999999999999999999999999999999999998876543
Q ss_pred CCCcc---ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCC
Q 004999 373 LPHAT---IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435 (720)
Q Consensus 373 l~~~~---~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 435 (720)
..... ......++...+.......++.+.+||.+||++||.+|||+.++|+||||+....+..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 22111 1112223333333444457789999999999999999999999999999987655543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=398.67 Aligned_cols=278 Identities=25% Similarity=0.386 Sum_probs=224.4
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-----CCceeeeccceeccCCC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-----HINVIKLEGLVTSRMSC 215 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-----HpnIvkl~~~~~~~~~~ 215 (720)
+.|++.+.||+|+||.||+|++..+++.||||+++.. ......+..|+.+++.+. ||||+++++++.. ..
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~~ 109 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--YD 109 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--TT
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--CC
Confidence 3455556699999999999999999999999999742 455566788999999996 9999999999877 67
Q ss_pred eEEEEEeeccccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-----------------
Q 004999 216 SLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN----------------- 277 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~----------------- 277 (720)
.+||||||++++|...+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 899999999777766655433 45999999999999999999999999999999999999975
Q ss_pred --------CCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh
Q 004999 278 --------NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE 349 (720)
Q Consensus 278 --------~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~ 349 (720)
++.+||+|||++..... .....+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.+.
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 78999999999986533 224567899999999998876 79999999999999999999999999999
Q ss_pred HHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc-----------------hhhhcccCCCCHhHHHHHHHhcccCC
Q 004999 350 VEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK-----------------RCVAETFKDFPAPALALMETLLSIDP 412 (720)
Q Consensus 350 ~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~-----------------~~~~e~~~~~~~~~~dLI~~mL~~DP 412 (720)
.+.+..+....+.++...+..........+....... .+........++.+.+||.+||++||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 9999999998888887765443221111110000000 00111112345778899999999999
Q ss_pred CCCCCHHHHHhCccCC
Q 004999 413 ADRGSAASALRSEFFT 428 (720)
Q Consensus 413 ~kRpTa~e~L~hp~f~ 428 (720)
.+|||+.++|+||||+
T Consensus 345 ~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 345 TLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGSCCHHHHTTSGGGC
T ss_pred hhCCCHHHHhcCcccC
Confidence 9999999999999995
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=420.05 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=218.0
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|.+.++||+|+||.||+|++..+++.||||++..... .......+.+|+.++..++||||+++++++.+ ...+||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~lV~ 153 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLYLVM 153 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEEEEE
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEEEEE
Confidence 3445569999999999999999999999999975321 11112337889999999999999999999877 67899999
Q ss_pred eecccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 222 EYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 222 Ey~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|||.|+.+ ..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+........
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 99976544 44444456899999999999999999999999999999999999999999999999999987654444344
Q ss_pred cccccccCCCChhhhc----CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 301 TSRVVTLWYRPPELLL----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~----~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
+..+||++|+|||++. +...|+.++||||||||||||++|++||.+.+..+.+.+|.......
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------- 300 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF------------- 300 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC-------------
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc-------------
Confidence 4568999999999997 23448999999999999999999999999999988888886421100
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCC--CCCHHHHHhCccCCCCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMKPL 432 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hp~f~~~~~ 432 (720)
.+...+..+++.+.+||.+||..+|.+ |+++.++++||||+...+
T Consensus 301 -----------~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w 347 (437)
T 4aw2_A 301 -----------QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDW 347 (437)
T ss_dssp -----------CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCT
T ss_pred -----------cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCH
Confidence 011123468999999999999998888 999999999999986544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=401.02 Aligned_cols=251 Identities=24% Similarity=0.266 Sum_probs=184.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC--CeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--CSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~--~~lyLV~Ey~ 224 (720)
+.||+|+||.||+|++ +|+.||||+++... .....+..|+.++.+|+|||||++++++..... ..+|||||||
T Consensus 9 ~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 3599999999999987 68999999997532 222223456777778999999999999876432 3689999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhcccccccc--------CcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR--------GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~--------gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
+++.+..++.. ..+++.++..++.||+.||.|||++ +||||||||+||||+.++++||+|||+|+......
T Consensus 84 ~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 162 (303)
T 3hmm_A 84 EHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT 162 (303)
T ss_dssp TTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred CCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence 97666555543 3689999999999999999999987 99999999999999999999999999998764332
Q ss_pred C---CCccccccccCCCChhhhcCCc-----CCCccccchhhHHHHHHHHhCCCCCCCCCh--------------HHHHH
Q 004999 297 N---QPLTSRVVTLWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRTE--------------VEQLH 354 (720)
Q Consensus 297 ~---~~~t~~~gT~~Y~APE~l~~~~-----~y~~~sDIWSLG~iL~ELltG~ppf~g~~~--------------~e~l~ 354 (720)
. ......+||++|||||++.+.. .|+.++||||||||||||+||.++|..... .+.+.
T Consensus 163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 242 (303)
T 3hmm_A 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242 (303)
T ss_dssp TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH
T ss_pred CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHH
Confidence 2 1223458999999999997642 367899999999999999999887654322 11111
Q ss_pred HHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 355 KIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 355 ~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
+.... ..+.|..+... .....+..+.+||.+||+.||++|||+.++++.
T Consensus 243 ~~~~~-----------------~~~rp~~p~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 243 KVVCE-----------------QKLRPNIPNRW----QSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHTT-----------------SCCCCCCCGGG----GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHhc-----------------ccCCCCCCccc----cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 11100 00111111000 001233568899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=407.49 Aligned_cols=279 Identities=31% Similarity=0.486 Sum_probs=226.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc------CCCceeeeccceeccCCC
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL------DHINVIKLEGLVTSRMSC 215 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L------~HpnIvkl~~~~~~~~~~ 215 (720)
.|++.++||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.+ +|+||+++++++.. ..
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~ 172 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN 172 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TT
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CC
Confidence 345555699999999999999999999999999753 44556778899999887 57799999999877 67
Q ss_pred eEEEEEeeccccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc--eeeeccccceec
Q 004999 216 SLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--LKIADFGLASFY 292 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~--vKL~DFGla~~~ 292 (720)
.+||||||+.+++...+.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++...
T Consensus 173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 899999999998777665533 45999999999999999999999999999999999999999987 999999999764
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
.. .....++|+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+++..+++.++.|+...+....
T Consensus 253 ~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 253 HQ----RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp TC----CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred CC----cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 32 234568899999999999876 7999999999999999999999999999999999999999999988765432
Q ss_pred CCCccccCCC-----------------------------Cccchhhh-cccCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 004999 373 LPHATIFKPQ-----------------------------QPYKRCVA-ETFKDFPAPALALMETLLSIDPADRGSAASAL 422 (720)
Q Consensus 373 l~~~~~~~~~-----------------------------~~~~~~~~-e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 422 (720)
.......... .+....+. ......++.+.+||.+||++||.+|||+.|+|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 1100000000 00000011 11224578899999999999999999999999
Q ss_pred hCccCCCC
Q 004999 423 RSEFFTMK 430 (720)
Q Consensus 423 ~hp~f~~~ 430 (720)
+||||+..
T Consensus 408 ~Hpw~~~~ 415 (429)
T 3kvw_A 408 RHPWLRRR 415 (429)
T ss_dssp TSTTTC--
T ss_pred CChhhccC
Confidence 99999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=399.17 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=209.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
++||+|+||.||+|++..+++.||||++..... .......+.+|+.++.++ +||||+++++++.. ...+||||||+
T Consensus 15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~lv~e~~ 92 (345)
T 3a8x_A 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 92 (345)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCC
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEEEEEEeCC
Confidence 349999999999999999999999999987654 456677889999999998 89999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... .......+
T Consensus 93 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~~~~~~~~ 171 (345)
T 3a8x_A 93 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFC 171 (345)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-TCCBCCCC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC-CCcccccC
Confidence 87666555544557999999999999999999999999999999999999999999999999999854322 22345568
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC---------hHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---------EVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~---------~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.. .......+...
T Consensus 172 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---------------- 234 (345)
T 3a8x_A 172 GTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------------- 234 (345)
T ss_dssp SCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC----------------
T ss_pred CCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC----------------
Confidence 999999999998866 7999999999999999999999997521 11222222221
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH------HHHHhCccCCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA------ASALRSEFFTMK 430 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa------~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||+.||.+||++ .++++||||+..
T Consensus 235 -------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 235 -------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 001224678999999999999999999995 899999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=397.54 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=214.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.++||+|+||.||+|++..+|+.||||+++.... .....+.+.+|+.+|+.++||||+++++++.+ ...+|+|||
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lv~e 86 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMD 86 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEEEC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEEEEEe
Confidence 334449999999999999999999999999975421 11234567899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..... ....
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----~~~~ 162 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYT 162 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCC
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC----cccc
Confidence 999866655555556799999999999999999999999999999999999999999999999999987532 2234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+.+|.....
T Consensus 163 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------- 220 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL--------------------- 220 (318)
T ss_dssp CCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------------------
T ss_pred ccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------------------
Confidence 57999999999998766 79999999999999999999999999988888887765210
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||..||.+|+ ++.++++||||+..
T Consensus 221 --------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 221 --------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred --------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 11235789999999999999999999 99999999999854
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=393.10 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=210.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.. ...+|||||
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e 85 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFLE 85 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEEEEE
Confidence 3444559999999999999999999999999976533 2233567899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-CCCcc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~t 301 (720)
||+|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.... .....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 165 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccC
Confidence 99987666666666679999999999999999999999999999999999999999999999999998653222 22334
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||+.|+|||++.+...++.++||||||||+|+|++|..||.+................
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~------------------- 226 (323)
T 3tki_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------------- 226 (323)
T ss_dssp SCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-------------------
T ss_pred CCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-------------------
Confidence 5688999999999988775688999999999999999999999876654322222111100
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
....+..+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 227 -------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 227 -------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp -------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 011124578999999999999999999999999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=398.21 Aligned_cols=290 Identities=29% Similarity=0.431 Sum_probs=229.0
Q ss_pred ccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC---------CHHHHHHHHHHHHHHHhcCCCceeeecccee
Q 004999 140 SIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---------EPESVRFMAREIHILRRLDHINVIKLEGLVT 210 (720)
Q Consensus 140 ~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~---------~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~ 210 (720)
...|++.+.||+|+||.||+|.+.. +..||||++..... +....+.+.+|+.+|++++||||+++++++.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 3455666679999999999999865 89999999865432 2344578899999999999999999999885
Q ss_pred cc---CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 211 SR---MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 211 ~~---~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
.. ....+||||||++|+++..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp ECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTT
T ss_pred eccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecC
Confidence 42 234789999999999988888777789999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 288 la~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
++...... .......+|++|+|||++.+...++.++||||||||+|+|++|.+||.+.+..+.+..+....+.|..+.
T Consensus 180 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 180 LAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp C-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 99754322 2334567899999999998856689999999999999999999999999999999999999999988776
Q ss_pred hhhcCCCCccccCC---CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 368 WRKSKLPHATIFKP---QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 368 w~~~~l~~~~~~~~---~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
+.....+....+.. .......+......+++.+.+||.+||+.||.+|||+.++|+||||+....
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 43321111100000 000011234455678999999999999999999999999999999987643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=381.46 Aligned_cols=261 Identities=26% Similarity=0.361 Sum_probs=221.4
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++++++||||+++++++.. ....|+|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 83 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 83 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCEEEEE
Confidence 34455556999999999999999999999999998877777777889999999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc---eeeeccccceecCCCCC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLASFYDPDQN 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~---vKL~DFGla~~~~~~~~ 297 (720)
|||+.++.+.........+++..++.++.||+.||.|||++||+|+||||+||||+.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-- 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-- 161 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS--
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC--
Confidence 999998655444444457999999999999999999999999999999999999987655 999999999876432
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+....+....+.......+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 228 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPS------------ 228 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------------
T ss_pred ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCc------------
Confidence 2334567899999999998766 799999999999999999999999999888877777553222211
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 229 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 229 -------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp -------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred -------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 12246789999999999999999999999999999998643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=398.84 Aligned_cols=259 Identities=27% Similarity=0.392 Sum_probs=211.5
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC---CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~---~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
.|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+++.|+||||+++++++.. ...+|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 102 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGMLY 102 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 45555669999999999999999999999999874321 11134668899999999999999999999877 67899
Q ss_pred EEEeecccccc-ccccC---CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc---eeeecccccee
Q 004999 219 LVFEYMEHDLA-GLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLASF 291 (720)
Q Consensus 219 LV~Ey~~g~ll-~~~~~---~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~---vKL~DFGla~~ 291 (720)
||||||+|+.+ ..+.. .+..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999997544 33322 3346899999999999999999999999999999999999987654 99999999987
Q ss_pred cCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
+.... ......+||+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.. .+.+..+.+........
T Consensus 183 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~----- 254 (351)
T 3c0i_A 183 LGESG-LVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR----- 254 (351)
T ss_dssp CCTTS-CBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH-----
T ss_pred ecCCC-eeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc-----
Confidence 65422 2234568999999999998766 7999999999999999999999998853 34455554432222222
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 255 --------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 --------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp --------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred --------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 224688999999999999999999999999999999853
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=406.87 Aligned_cols=251 Identities=24% Similarity=0.413 Sum_probs=207.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
++||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|.++ +|||||++++++.. ...+|||||||
T Consensus 58 ~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~lV~E~~ 135 (396)
T 4dc2_A 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 135 (396)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEEEEEEEcC
Confidence 349999999999999999999999999987644 334456688999999887 89999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..... ........+
T Consensus 136 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~-~~~~~~~~~ 214 (396)
T 4dc2_A 136 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFC 214 (396)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-TTCCBCCCC
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-CCCcccccc
Confidence 9866655555556799999999999999999999999999999999999999999999999999985322 223345678
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChH---------HHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV---------EQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~---------e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
||+.|+|||++.+.. |+.++||||||||||||++|.+||.+.... .....+...
T Consensus 215 gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------------- 277 (396)
T 4dc2_A 215 GTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------------- 277 (396)
T ss_dssp BCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC----------------
T ss_pred CCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc----------------
Confidence 999999999998876 799999999999999999999999754221 122222211
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH------HHHHhCccCCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA------ASALRSEFFTMK 430 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa------~e~L~hp~f~~~ 430 (720)
....+..++..+.+||.+||+.||.+||++ .++++||||+..
T Consensus 278 -------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 278 -------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp -------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred -------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 011234688999999999999999999985 899999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=413.16 Aligned_cols=275 Identities=25% Similarity=0.353 Sum_probs=220.3
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.++||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|..++||||+++++++.+ ...+||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~lVm 140 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYLYLVM 140 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEEE
Confidence 4455569999999999999999999999999975321 12223457899999999999999999999877 67899999
Q ss_pred eecccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 222 EYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 222 Ey~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|||.|+.+ ..+...+..+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+........
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 99976544 44443345799999999999999999999999999999999999999999999999999987654433333
Q ss_pred cccccccCCCChhhhcC------CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 301 TSRVVTLWYRPPELLLG------ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~------~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
...+||+.|+|||++.+ ...|+.++||||||||+|||++|++||.+.+..+.+.+|....... .
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--------~-- 290 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL--------S-- 290 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC--------C--
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc--------C--
Confidence 45689999999999973 3348999999999999999999999999999888888876421000 0
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCC---CCHHHHHhCccCCCCCCCCCCCCCCCCCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR---GSAASALRSEFFTMKPLPCDPSSLPKYPP 444 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kR---pTa~e~L~hp~f~~~~~~~~p~~~p~~~p 444 (720)
+......+++.+.+||.+||. +|.+| ++++++++||||+...+.......|.+.|
T Consensus 291 --------------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~p 348 (412)
T 2vd5_A 291 --------------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTP 348 (412)
T ss_dssp --------------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCCC
T ss_pred --------------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCC
Confidence 011124689999999999999 99998 59999999999987655443333444433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=401.07 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=213.8
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.++||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+|+.++||||+++++++.+ ...+||||||+
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 123 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYV 123 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEEEEEcCC
Confidence 3349999999999999999999999999975432 12234668899999999999999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... ....+
T Consensus 124 ~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~----~~~~~ 199 (350)
T 1rdq_E 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLC 199 (350)
T ss_dssp TTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----BCCCE
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC----ccccc
Confidence 87655554444457999999999999999999999999999999999999999999999999999876432 23568
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+..|.....
T Consensus 200 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~----------------------- 255 (350)
T 1rdq_E 200 GTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------------------- 255 (350)
T ss_dssp ECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----------------------
T ss_pred CCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCC-----------------------
Confidence 999999999998766 79999999999999999999999999988888877765210
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||+.||.+||+ +.++++||||...
T Consensus 256 ------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 256 ------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 112357899999999999999999998 9999999999854
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=414.36 Aligned_cols=262 Identities=26% Similarity=0.345 Sum_probs=216.5
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|.+.++||+|+||.||+|++..+++.||||++..... .......+.+|+.+++.++|||||++++++.+ ...+||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lV~ 148 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLYMVM 148 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEE
Confidence 4455569999999999999999999999999975311 11112347789999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|||+|+.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.........
T Consensus 149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 99987655544443 36899999999999999999999999999999999999999999999999999876544333344
Q ss_pred ccccccCCCChhhhcCCc---CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 302 SRVVTLWYRPPELLLGAT---YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~---~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
..+||+.|+|||++.+.. .|+.++||||||||||||++|.+||.+.+..+.+.+|.......
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------- 292 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL--------------- 292 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---------------
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc---------------
Confidence 668999999999998654 26899999999999999999999999999988888886531100
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCC--CCCHHHHHhCccCCCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPAD--RGSAASALRSEFFTMKPL 432 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~k--RpTa~e~L~hp~f~~~~~ 432 (720)
.......+++.+.+||.+||+.+|.+ |+++.++++||||+...+
T Consensus 293 ----------~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w 338 (410)
T 3v8s_A 293 ----------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 338 (410)
T ss_dssp ----------CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred ----------cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence 00011368899999999999999988 999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=402.64 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=213.4
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEee
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
.++||+|+||.||+|++..+++.||||+++.... .......+..|..+|..+ +||||+++++++.+ ...+||||||
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~~lv~E~ 99 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLFFVMEY 99 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEEC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEEEEEEeC
Confidence 3349999999999999999999999999976421 112345678899999987 99999999999877 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... .......
T Consensus 100 ~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~~ 178 (345)
T 1xjd_A 100 LNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTF 178 (345)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCC
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC-CCcccCC
Confidence 987666555544457999999999999999999999999999999999999999999999999999864322 2234556
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+..|.... +
T Consensus 179 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~-------------------- 235 (345)
T 1xjd_A 179 CGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--P-------------------- 235 (345)
T ss_dssp CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C--------------------
T ss_pred CCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--C--------------------
Confidence 8999999999998866 7999999999999999999999999998888877775421 0
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHH-HHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA-SALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~-e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||+.||.+||++. ++++||||+..
T Consensus 236 -------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 236 -------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp -------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 11235789999999999999999999998 99999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=386.87 Aligned_cols=286 Identities=36% Similarity=0.599 Sum_probs=223.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc---------
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--------- 212 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~--------- 212 (720)
.|++.+.||+|+||.||+|.+..+++.||||++... +....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 445556699999999999999999999999998754 356677889999999999999999999887431
Q ss_pred ---CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc-CCCceeeecccc
Q 004999 213 ---MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGL 288 (720)
Q Consensus 213 ---~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld-~~g~vKL~DFGl 288 (720)
....+|+||||++|++...+.. ..+++..++.++.||+.||.|||++||+|+||||+||||+ .++.+||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 2467899999999877665533 4689999999999999999999999999999999999997 567999999999
Q ss_pred ceecCCCC--CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 289 ASFYDPDQ--NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 289 a~~~~~~~--~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
+....... ........+|++|+|||++.+...++.++|||||||++|||++|++||.+....+.+..+....+.+..+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 98764321 1223445679999999999876668999999999999999999999999999999999998887777666
Q ss_pred hhhhcCC--CCcc---ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCC
Q 004999 367 YWRKSKL--PHAT---IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435 (720)
Q Consensus 367 ~w~~~~l--~~~~---~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 435 (720)
.+..... +... ...+. ..+......++..+.+||.+||+.||.+|||+.++|+||||+....|..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 248 DRQELLSVIPVYIRNDMTEPH----KPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp HHHHHHTTSCHHHHHHTTSCC----CCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred hhhhhhhcCcccccccccCCC----CChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence 5443111 0000 00011 1123445678999999999999999999999999999999997766543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=391.09 Aligned_cols=290 Identities=33% Similarity=0.532 Sum_probs=229.3
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC---CCeEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~---~~~ly 218 (720)
.|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++.... ...+|
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 3445556999999999999999999999999996432 3455667889999999999999999998875421 26789
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
+||||+.+++...+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 91 lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (353)
T 2b9h_A 91 IIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168 (353)
T ss_dssp EEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccccc
Confidence 9999999877665544 36899999999999999999999999999999999999999999999999999876432211
Q ss_pred ---------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 299 ---------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 299 ---------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
.....+||+.|+|||++.+...++.++||||||||+|+|++|.+||.+.+..+++..+....+.|......
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T 2b9h_A 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248 (353)
T ss_dssp -----------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTT
T ss_pred ccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccc
Confidence 12335789999999998876668999999999999999999999999999999999999988887633211
Q ss_pred hcCC-CCcccc---CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCC
Q 004999 370 KSKL-PHATIF---KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435 (720)
Q Consensus 370 ~~~l-~~~~~~---~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 435 (720)
.... .....+ .+..+ ...+...+..+++.+.+||.+||+.||.+|||+.++|+||||+....+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 249 RCIESPRAREYIKSLPMYP-AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317 (353)
T ss_dssp TTCCCHHHHHHHHTSCCCC-CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTS
T ss_pred cccccchhhHHhhcccCCC-CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCccc
Confidence 1000 000000 00000 11133445678999999999999999999999999999999998765544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=401.10 Aligned_cols=284 Identities=21% Similarity=0.274 Sum_probs=211.8
Q ss_pred ceeeccc--CceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 146 FYLIGQG--TYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 146 ~~~LG~G--~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
.++||+| +||.||+|++..+++.||||++............+.+|+.+|+.++|||||++++++.. ...+||||||
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 107 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVVTSF 107 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCEEEEEEEc
Confidence 3349999 99999999999999999999999877677778889999999999999999999999987 6789999999
Q ss_pred ccccccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-----
Q 004999 224 MEHDLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ----- 296 (720)
Q Consensus 224 ~~g~ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~----- 296 (720)
|+++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~ 187 (389)
T 3gni_B 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187 (389)
T ss_dssp CTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSC
T ss_pred cCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccc
Confidence 997655544432 3569999999999999999999999999999999999999999999999999986542111
Q ss_pred -CCCccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC--------CCChh
Q 004999 297 -NQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCG--------SPSED 366 (720)
Q Consensus 297 -~~~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g--------~p~~~ 366 (720)
.......+||+.|+|||++.+. ..|+.++||||||||+|||++|.+||.+....+.+..+..... .+...
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (389)
T 3gni_B 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEE 267 (389)
T ss_dssp BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------------
T ss_pred cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccc
Confidence 1122334789999999999874 3489999999999999999999999998776665544432111 00000
Q ss_pred hhhhc-------CCCCccccCCCCc--cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 367 YWRKS-------KLPHATIFKPQQP--YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 367 ~w~~~-------~l~~~~~~~~~~~--~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.+... .+..........+ ...........+++.+.+||.+||++||.+|||+.++|+||||+...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 268 LTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp --------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred ccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 00000 0000000000000 00011123456889999999999999999999999999999998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=392.11 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=207.1
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.|++.+.||+|+||.||+|++..+++.||||++............+..|+..+.++ .||||+++++++.. ...+|||
T Consensus 58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~lv 135 (311)
T 3p1a_A 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYLQ 135 (311)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEEE
Confidence 34555569999999999999999999999999877655555555566677666666 89999999999976 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|||+++++...+...+..+++..++.++.||+.||.|||+.||+||||||+||||+.++.+||+|||++...... ...
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~--~~~ 213 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA--GAG 213 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--CCC
Confidence 999998888777766667999999999999999999999999999999999999999999999999999876432 233
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....||+.|+|||++.+ .|+.++||||||||+|||++|..+|.+...... +.. +..+
T Consensus 214 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~~---------------- 270 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYLP---------------- 270 (311)
T ss_dssp -CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCCC----------------
T ss_pred cccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCCC----------------
Confidence 45578999999999886 379999999999999999999877766433222 211 1111
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.+....+++.+.+||.+||+.||.+|||+.++|+||||++
T Consensus 271 ---------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 271 ---------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ---------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ---------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 1223468899999999999999999999999999999974
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=388.45 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=216.1
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+.....||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+++.++||||+++++++.. ...+|||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 122 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVLME 122 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEEEe
Confidence 4445569999999999999999999999999986543 234567899999999999999999999877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++|+.+..+... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... .....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CCBCC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-ccccc
Confidence 9998776666553 469999999999999999999999999999999999999999999999999998765332 22345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+....+.+..+.... .+.
T Consensus 201 ~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~~------------------ 260 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPK------------------ 260 (321)
T ss_dssp CCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CCC------------------
T ss_pred ccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCC------------------
Confidence 67899999999998765 7999999999999999999999999988877776664421 000
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
......+++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus 261 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 261 -------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp -------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred -------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 011235788999999999999999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=398.29 Aligned_cols=258 Identities=24% Similarity=0.387 Sum_probs=217.5
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|+.|+||||+++++++.. ...+||||
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv~ 127 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLIL 127 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEE
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEEEE
Confidence 3455556999999999999999999999999997543 3345578899999999999999999999876 67899999
Q ss_pred eecccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC--CCceeeeccccceecCCCCCC
Q 004999 222 EYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~--~g~vKL~DFGla~~~~~~~~~ 298 (720)
|||.|+.+ ..+......+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+... .
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~--~ 205 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--E 205 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--S
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC--c
Confidence 99987554 444444557999999999999999999999999999999999999974 478999999999876433 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....++|+.|+|||++.+.. ++.++||||||||+|||++|.+||.+.+..+.+..+........
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 270 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD-------------- 270 (387)
T ss_dssp CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred ceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 334557899999999998765 79999999999999999999999999988888877755321111
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
...+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 271 -----------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 271 -----------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp -----------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -----------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 122346899999999999999999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=387.25 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=220.4
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhcCCCceeeeccceeccCCCe
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ 216 (720)
..|++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RTD 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 34566667999999999999999999999999998654321 135668899999999999999999999876 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC----ceeeeccccceec
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASFY 292 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g----~vKL~DFGla~~~ 292 (720)
+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++ .+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999998766655555566799999999999999999999999999999999999999888 7999999999876
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
... .......+|+.|+|||++.+.. ++.++||||||||+|+|++|..||.+....+.+..+.........
T Consensus 170 ~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~------- 239 (321)
T 2a2a_A 170 EDG--VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE------- 239 (321)
T ss_dssp CTT--CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred Ccc--ccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-------
Confidence 432 2234557899999999998765 799999999999999999999999999888888777654332222
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 240 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 240 ------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp ------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 223468899999999999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=399.33 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=211.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
++||+|+||.||+|.+..+|+.||||+++... ....+.+.+|+.+|++|+||||+++++++.. ...+|||||||++
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVDG 170 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECCTT
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeCCCC
Confidence 45999999999999999999999999998653 3455678999999999999999999999877 6789999999987
Q ss_pred c-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE--cCCCceeeeccccceecCCCCCCCcccc
Q 004999 227 D-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI--DNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 227 ~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl--d~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+ |...+......+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.... .....
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~~~~ 248 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVN 248 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BCCCC
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--ccccc
Confidence 4 444444455579999999999999999999999999999999999999 567899999999998765432 33455
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+||+.|+|||++.+.. ++.++||||||||||||++|.+||.+.+..+.+..+......+.
T Consensus 249 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~------------------- 308 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE------------------- 308 (373)
T ss_dssp CSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC-------------------
T ss_pred cCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC-------------------
Confidence 7999999999997765 79999999999999999999999999999988888876432221
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
...+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 309 ------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 309 ------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12335689999999999999999999999999999999853
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=411.06 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=217.3
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+.+.||+|+||.||+|++..+|+.||||++..... ..+....+.+|+.+|+.++||||+++++++.. ...+|||||
T Consensus 19 ~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E 96 (476)
T 2y94_A 19 ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDIFMVME 96 (476)
T ss_dssp EEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEe
Confidence 333449999999999999999999999999975432 11234678899999999999999999999877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... .....
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~~~~~ 174 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRT 174 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT--CCBCC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc--ccccc
Confidence 9987666666666668999999999999999999999999999999999999999999999999999876432 23455
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+...++.++||||||||+|+|++|.+||.+......+.++.....
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------------------- 233 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--------------------- 233 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC---------------------
T ss_pred cCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc---------------------
Confidence 68999999999999877568899999999999999999999999888777777654211
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||+.||.+|||+.++++||||+..
T Consensus 234 --------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 234 --------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 1123578899999999999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=399.96 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=214.0
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEe
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+.++||+|+||.||+|++..+++.||||+++.... .......+.+|+.+|..+ +||||+++++++.. ...+|||||
T Consensus 24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~lv~E 101 (353)
T 2i0e_A 24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFVME 101 (353)
T ss_dssp EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEEEEEEe
Confidence 33449999999999999999999999999986422 122345678999999988 79999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... ......
T Consensus 102 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~~~~~ 180 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKT 180 (353)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCC
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC-Cccccc
Confidence 9987655555444457999999999999999999999999999999999999999999999999999864322 223455
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+..|.....
T Consensus 181 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~--------------------- 238 (353)
T 2i0e_A 181 FCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------------------- 238 (353)
T ss_dssp CCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------------------
T ss_pred ccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC---------------------
Confidence 68999999999998766 79999999999999999999999999988888887765210
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||+.||.+|| ++.++++||||+..
T Consensus 239 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 239 --------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred --------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 11236789999999999999999999 47999999999854
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=385.01 Aligned_cols=284 Identities=39% Similarity=0.620 Sum_probs=229.1
Q ss_pred cccceeecccCceEEEEEEEC-CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc---CCCceeeeccceec---cCCC
Q 004999 143 SRSFYLIGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTS---RMSC 215 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~-~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIvkl~~~~~~---~~~~ 215 (720)
|++.+.||+|+||.||+|++. .+++.||||+++...........+.+|+.+++.+ .||||+++++++.. ....
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 444555999999999999995 7789999999976543222223456777777766 89999999998862 1256
Q ss_pred eEEEEEeeccccccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCC
Q 004999 216 SLYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~ 294 (720)
.+|+||||++|++...+... ...+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.....
T Consensus 93 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (326)
T 1blx_A 93 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172 (326)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccC
Confidence 78999999998776655443 34589999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 295 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 295 ~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
. .......+|+.|+|||++.+.. ++.++||||||||+|+|++|.+||.+....+.+..+.+..+.+....|......
T Consensus 173 ~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 173 Q--MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp G--GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred C--CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 2 2234557899999999998766 799999999999999999999999999999999999999999988887653222
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
....+.... ...+......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 250 ~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 250 PRQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CGGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred chhhhcccC--cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 211111111 1123455678899999999999999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=387.69 Aligned_cols=264 Identities=23% Similarity=0.274 Sum_probs=219.0
Q ss_pred hccccccc-eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCe
Q 004999 139 LSIFSRSF-YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 139 ~~~f~r~~-~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~ 216 (720)
+.++|.+. +.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+ .||||+++++++.. ...
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~ 103 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSE 103 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCe
Confidence 34455555 679999999999999999999999999987655445566788999999999 57999999999876 678
Q ss_pred EEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeecccccee
Q 004999 217 LYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASF 291 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~ 291 (720)
+|+||||+.++.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 999999999865554443 2467999999999999999999999999999999999999987 78999999999987
Q ss_pred cCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
.... ......++|+.|+|||++.+.. ++.++||||||||+|+|++|..||.+....+.+..+.........
T Consensus 184 ~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------ 254 (327)
T 3lm5_A 184 IGHA--CELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------ 254 (327)
T ss_dssp C-----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------
T ss_pred cCCc--cccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc------
Confidence 6432 2234557899999999998766 799999999999999999999999999988887777654332221
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPL 432 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~ 432 (720)
..+..+++.+.+||.+||+.||.+|||+.++|+||||+...+
T Consensus 255 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 255 -------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp -------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred -------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 223467899999999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=405.15 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=209.5
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|.+..+++.||||++...... .+....+.+|+.+|+.++||||+++++++.. ...+|+||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 88 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDIVMVI 88 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEE
Confidence 44445599999999999999999999999999753211 1123467899999999999999999999877 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||++|+++..+... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ....
T Consensus 89 E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~~~~ 165 (336)
T 3h4j_B 89 EYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLK 165 (336)
T ss_dssp CCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--BTTC
T ss_pred ECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--cccc
Confidence 99988877766543 47999999999999999999999999999999999999999999999999999866432 2335
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||+.|+|||++.+...++.++||||||||+|+|++|..||.+....+....+
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------------------------- 220 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV------------------------- 220 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-------------------------
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-------------------------
Confidence 5689999999999988775589999999999999999999999765322111000
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..........+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 221 ----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 ----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ----CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ----HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 001112234578999999999999999999999999999999854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=377.05 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=218.9
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.++++++||||+++++++.. ...+|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEEEE
Confidence 3456666799999999999999999999999999765432 24568899999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE---cCCCceeeeccccceecCCCCC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl---d~~g~vKL~DFGla~~~~~~~~ 297 (720)
|||++++.+..+......+++.+++.++.||+.||.|||++||+|+||||+|||| +.++.+||+|||++..+...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-- 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-- 162 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT--
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc--
Confidence 9999886655444445579999999999999999999999999999999999999 78899999999999876432
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.......+|+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+.......+...|
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 231 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW--------- 231 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---------
T ss_pred cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---------
Confidence 233455789999999998764 799999999999999999999999999988888887665444333322
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 232 ----------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 ----------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ----------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ----------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 357899999999999999999999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=391.50 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=203.1
Q ss_pred eeecccCceEEEEEEEC---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 147 YLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
++||+|+||.||+|++. .+++.||||+++.... .......+.+|+.+|+.++||||+++++++.. ...+||||
T Consensus 23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 100 (327)
T 3a62_A 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--GGKLYLIL 100 (327)
T ss_dssp EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--CCEEEEEE
Confidence 34999999999999985 6899999999986543 22345567899999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||+.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++....... ....
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 179 (327)
T 3a62_A 101 EYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG-TVTH 179 (327)
T ss_dssp ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----------C
T ss_pred eCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC-cccc
Confidence 999976655555445578999999999999999999999999999999999999999999999999997543222 2234
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||+.|+|||++.+.. ++.++||||||||+|+|++|.+||.+.+..+.+..+.+...
T Consensus 180 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~-------------------- 238 (327)
T 3a62_A 180 TFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL-------------------- 238 (327)
T ss_dssp TTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC--------------------
T ss_pred ccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--------------------
Confidence 557899999999998766 79999999999999999999999999988888877765211
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||..||.+|| ++.++|+||||+..
T Consensus 239 ---------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 239 ---------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp ---------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred ---------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 11235789999999999999999999 89999999999854
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=390.90 Aligned_cols=257 Identities=28% Similarity=0.363 Sum_probs=198.5
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
..|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+|++|+||||+++++++.. ...+|||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 126 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISLV 126 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEEE
Confidence 34555666999999999999999999999999998542 23457889999999999999999999876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeeccccceecCCCCC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~~~~~~~ 297 (720)
|||+.++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-- 204 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-- 204 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc--
Confidence 999997666555555667999999999999999999999999999999999999975 889999999999865432
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e-~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......+||+.|+|||++.+.. |+.++||||||||+|||++|..||.+....+ .+..+........
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~------------ 271 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI------------ 271 (349)
T ss_dssp --------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC------------
T ss_pred cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC------------
Confidence 2234567899999999998766 7999999999999999999999998766554 4444433211110
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
...+..++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 272 -------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 272 -------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp -------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred -------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 112346889999999999999999999999999999998653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=403.05 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=205.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHH-HHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHI-LRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~i-L~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||++..... .......+.+|..+ ++.++||||+++++++.. ...+||||||+.
T Consensus 45 ~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~~lv~E~~~ 122 (373)
T 2r5t_A 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDYIN 122 (373)
T ss_dssp EEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSEEEEEEECCC
T ss_pred EEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEEEEEEeCCC
Confidence 39999999999999999999999999987643 33445566778777 567899999999999877 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..... ........+|
T Consensus 123 gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-~~~~~~~~~g 201 (373)
T 2r5t_A 123 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNSTTSTFCG 201 (373)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC-CCCCCCSBSC
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc-CCCccccccC
Confidence 866655555455799999999999999999999999999999999999999999999999999986432 2223456689
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+..|....
T Consensus 202 t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~------------------------- 255 (373)
T 2r5t_A 202 TPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP------------------------- 255 (373)
T ss_dssp CCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-------------------------
T ss_pred CccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------------------------
Confidence 99999999998766 7999999999999999999999999999888888776521
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCH----HHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSA----ASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa----~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.||.+|+++ .++++|+||+..
T Consensus 256 ----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 256 ----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp ----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred ----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 01224688999999999999999999986 699999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=413.82 Aligned_cols=257 Identities=29% Similarity=0.451 Sum_probs=213.1
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.+.||+|+||.||+|++..++..||||++............+.+|+.+|+.++||||+++++++.. ...+||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~ 115 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYLVM 115 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEEE
Confidence 4555556999999999999999999999999998765444445678899999999999999999999976 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeeccccceecCCCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~~~~~~~~ 298 (720)
|||.|+.+.........+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++..+... .
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~--~ 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--K 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT--B
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC--c
Confidence 99997655444444457999999999999999999999999999999999999976 456999999999876432 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+..........
T Consensus 194 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------ 259 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP------------ 259 (494)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG------------
T ss_pred cccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch------------
Confidence 3455689999999999864 38999999999999999999999999999988888887644333222
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 260 -------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 260 -------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp -------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred -------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 23468899999999999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=413.53 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=220.8
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.|++.++||+|+||.||+|++..+++.||||++...... ......+.+|+.+|++|+||||+++++++.. ...+|+|
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 104 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYLV 104 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEE
Confidence 455556699999999999999999999999999766442 3345678899999999999999999999877 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE---cCCCceeeeccccceecCCCCC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl---d~~g~vKL~DFGla~~~~~~~~ 297 (720)
||||.|+.+.........+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+...
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-- 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-- 182 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC--
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc--
Confidence 9999876555444455679999999999999999999999999999999999999 56789999999999876432
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......+||+.|+|||++.+. |+.++||||||||+|+|++|.+||.+.+..+.+..+.+........
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----------- 249 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP----------- 249 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-----------
T ss_pred cccccCCCCccccCceeecCC--CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-----------
Confidence 334566899999999999773 7999999999999999999999999999998888886643322211
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.+..+++.+.+||.+||++||.+|||+.++|+||||+...
T Consensus 250 --------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 250 --------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp --------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred --------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 2245789999999999999999999999999999997543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=400.96 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=211.1
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.++||+|+||.||+|.+..+++.||||++..... .....+.+.+|+.+|+.++|||||++++++.. ...+|+||||
T Consensus 19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~lv~e~ 96 (384)
T 4fr4_A 19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDMFMVVDL 96 (384)
T ss_dssp EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECC
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEEEec
Confidence 33349999999999999999999999999975421 22335678899999999999999999999877 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
+.|+.+..+......+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+... ......
T Consensus 97 ~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~ 174 (384)
T 4fr4_A 97 LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--TQITTM 174 (384)
T ss_dssp CTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT--CCBCCC
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC--Cceecc
Confidence 998777666666678999999999999999999999999999999999999999999999999999876432 334567
Q ss_pred ccccCCCChhhhcCC--cCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 304 VVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~--~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
+||+.|+|||++.+. ..|+.++||||||||+|||++|.+||.+... .+.+..+...
T Consensus 175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------------- 235 (384)
T 4fr4_A 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------------------- 235 (384)
T ss_dssp CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-------------------
T ss_pred CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-------------------
Confidence 899999999999742 3479999999999999999999999986432 2222222211
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-HHHHHhCccCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-AASALRSEFFTMK 430 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-a~e~L~hp~f~~~ 430 (720)
.......+++.+.+||.+||+.||.+||+ +.+++.||||...
T Consensus 236 ----------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 236 ----------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred ----------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 11123467899999999999999999998 9999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=397.15 Aligned_cols=282 Identities=26% Similarity=0.388 Sum_probs=225.4
Q ss_pred ccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC--------CCceeeeccceec
Q 004999 140 SIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD--------HINVIKLEGLVTS 211 (720)
Q Consensus 140 ~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~--------HpnIvkl~~~~~~ 211 (720)
...|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+|+.+. |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 34456666699999999999999999999999999743 455677889999999995 7889999998863
Q ss_pred c--CCCeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCC--------
Q 004999 212 R--MSCSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNG-------- 279 (720)
Q Consensus 212 ~--~~~~lyLV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g-------- 279 (720)
. ....+||||||++++++..+.... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 2 256799999999998887766543 5699999999999999999999998 999999999999998775
Q ss_pred -----------------------------------------ceeeeccccceecCCCCCCCccccccccCCCChhhhcCC
Q 004999 280 -----------------------------------------ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318 (720)
Q Consensus 280 -----------------------------------------~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~ 318 (720)
.+||+|||++...... .+..+||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876432 3455789999999999987
Q ss_pred cCCCccccchhhHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhcCCCChhhhhhcCCCCcccc--------CCCCc
Q 004999 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHKIFKLCGSPSEDYWRKSKLPHATIF--------KPQQP 384 (720)
Q Consensus 319 ~~y~~~sDIWSLG~iL~ELltG~ppf~g~~------~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~--------~~~~~ 384 (720)
. |+.++||||||||||||++|.+||.+.+ ..+.+..+.+.++.++...|........... ....+
T Consensus 269 ~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 269 G-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp C-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred C-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 6 7999999999999999999999998765 6778888999999988877654332211000 00000
Q ss_pred c--chhhhc---ccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 385 Y--KRCVAE---TFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 385 ~--~~~~~e---~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
+ ...+.+ ....++..+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0 000111 11233567889999999999999999999999999973
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=392.06 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=216.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|++++||||+++++++.. ...+||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~ 133 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVM 133 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCeEEEEE
Confidence 3444559999999999999999999999999987643 34456778999999999999999999999877 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||+.|++...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ..
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-----~~ 208 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----AN 208 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BC
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-----CC
Confidence 9999988777665556799999999999999999999999999999999999999999999999999986532 23
Q ss_pred ccccccCCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 302 SRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
..+||+.|+|||++.+ ...|+.++||||||||+|||++|.+||.+.+..+.+..+.... .+.
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~~~--------------- 272 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPA--------------- 272 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCC---------------
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCC---------------
Confidence 4578999999999863 3447999999999999999999999999988877776665421 100
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 273 -----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 -----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred -----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0113578899999999999999999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=410.65 Aligned_cols=254 Identities=25% Similarity=0.352 Sum_probs=206.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.++||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.. ...+|||||
T Consensus 151 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e 228 (446)
T 4ejn_A 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVME 228 (446)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEEEEEEC
T ss_pred EEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEEEEEe
Confidence 344459999999999999999999999999986432 33445667899999999999999999999877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||+++.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.++.+||+|||++..... ......
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~~~~ 307 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMK 307 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC------C
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC-CCcccc
Confidence 99987666555555679999999999999999999998 9999999999999999999999999999975432 223345
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+....+.....
T Consensus 308 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~-------------------- 366 (446)
T 4ejn_A 308 TFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI-------------------- 366 (446)
T ss_dssp CSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------------
T ss_pred cccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC--------------------
Confidence 578999999999998766 79999999999999999999999999888777777654211
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||++||.+|| |+.++|+||||+..
T Consensus 367 ---------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 367 ---------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 11235789999999999999999999 99999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=413.61 Aligned_cols=257 Identities=25% Similarity=0.442 Sum_probs=214.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+|++|+||||+++++++.. ...+|+|||
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e 101 (486)
T 3mwu_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIVGE 101 (486)
T ss_dssp EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEEEEEE
Confidence 444455999999999999999999999999997543222334668899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc---CCCceeeeccccceecCCCCCCC
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID---NNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld---~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
||.|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..+... ..
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~--~~ 179 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TK 179 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC--Cc
Confidence 998765544444445799999999999999999999999999999999999995 4567999999999866432 23
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+||+.|+|||++.+. |+.++||||||||+|+|++|.+||.+.+..+.+..+..........
T Consensus 180 ~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------- 244 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP------------- 244 (486)
T ss_dssp --CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG-------------
T ss_pred cCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc-------------
Confidence 4556899999999999764 8999999999999999999999999999988888876643322211
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 245 ------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 245 ------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp ------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred ------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 224578999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=389.14 Aligned_cols=251 Identities=30% Similarity=0.441 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+ ...+||||||++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e~~~ 89 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLN 89 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEEccC
Confidence 4599999999999999999999999999743 3456779999999997 9999999999876 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC---ceeeeccccceecCCCCCCCccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g---~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++...... ......
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~ 168 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKT 168 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCcccc
Confidence 866555555556899999999999999999999999999999999999998766 8999999999876432 233455
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh-------HHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE-------VEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~-------~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.++|+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+... .+.+..+.........
T Consensus 169 ~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~---------- 237 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG---------- 237 (325)
T ss_dssp ---------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS----------
T ss_pred cCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc----------
Confidence 67899999999998766 79999999999999999999999987543 3344444322111111
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
+.+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 238 ---------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 238 ---------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp ---------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred ---------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 22246889999999999999999999999999999998653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=409.38 Aligned_cols=258 Identities=29% Similarity=0.425 Sum_probs=215.6
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH-----------HHHHHHHHHHHHHHhcCCCceeeecccee
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP-----------ESVRFMAREIHILRRLDHINVIKLEGLVT 210 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~-----------~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~ 210 (720)
.|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+.+|++|+||||+++++++.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3445555999999999999999999999999998654321 23467889999999999999999999997
Q ss_pred ccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC---ceeeeccc
Q 004999 211 SRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFG 287 (720)
Q Consensus 211 ~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g---~vKL~DFG 287 (720)
. ...+|||||||.|+.+.........+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||
T Consensus 117 ~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 117 D--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred c--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 6 678999999998765544444445799999999999999999999999999999999999998876 69999999
Q ss_pred cceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 288 la~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
++..+... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+.+.........
T Consensus 195 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (504)
T 3q5i_A 195 LSSFFSKD--YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFND 270 (504)
T ss_dssp TCEECCTT--SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH
T ss_pred CCEEcCCC--CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 99876433 23455689999999999875 379999999999999999999999999999888888876433333222
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
+..+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 271 -------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 271 -------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp -------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred -------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 24688999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=390.08 Aligned_cols=263 Identities=24% Similarity=0.357 Sum_probs=212.2
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCC---CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN---LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~---~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
.|++.+.||+|+||.||+|.+..++..||||++.... ......+.+.+|+.++++++||||+++++++.. ...+|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 104 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQYIC 104 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCeEE
Confidence 4555666999999999999999999999999997542 234556788999999999999999999999976 67899
Q ss_pred EEEeeccccccccccC----------------------------------------CCCCCCHHHHHHHHHhhhhccccc
Q 004999 219 LVFEYMEHDLAGLASH----------------------------------------PGLKFSEAQVKCYMQQLLCGLDHC 258 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~----------------------------------------~~~~lse~~~~~i~~QIl~gL~yL 258 (720)
||||||+|+.+..+.. ....+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999998755443321 012346888999999999999999
Q ss_pred cccCcccccCcceeEEEcCCC--ceeeeccccceecCCCC---CCCccccccccCCCChhhhcCC-cCCCccccchhhHH
Q 004999 259 HSRGVLHRDIKGSNLLIDNNG--ILKIADFGLASFYDPDQ---NQPLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGC 332 (720)
Q Consensus 259 H~~gIvHrDIKP~NILld~~g--~vKL~DFGla~~~~~~~---~~~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~ 332 (720)
|++||+|+||||+||||+.++ .+||+|||++..+.... ........+|+.|+|||++.+. ..|+.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999998653221 1234456789999999999752 45899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCC
Q 004999 333 ILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDP 412 (720)
Q Consensus 333 iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP 412 (720)
|+|||++|..||.+....+.+..+......... ..+..+++.+.+||.+||+.||
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~l~~~p 319 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSNLLNRNV 319 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHHHSCSCT
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHHHcCCCh
Confidence 999999999999999998888877653222111 1223578999999999999999
Q ss_pred CCCCCHHHHHhCccCCCCC
Q 004999 413 ADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 413 ~kRpTa~e~L~hp~f~~~~ 431 (720)
.+|||+.++|+||||+...
T Consensus 320 ~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 320 DERFDAMRALQHPWISQFS 338 (345)
T ss_dssp TTSCCHHHHHHSHHHHTTS
T ss_pred hHCCCHHHHhcChhhccCh
Confidence 9999999999999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=392.66 Aligned_cols=253 Identities=27% Similarity=0.324 Sum_probs=206.3
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|.+.+.||+|+||.||+|.+..+++.||||++...... ..+|+.+|.++ +||||+++++++.+ ...+||||
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ 95 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVT 95 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEE
Confidence 44445599999999999999999999999999865432 34688888888 79999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC----CceeeeccccceecCCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN----GILKIADFGLASFYDPDQN 297 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~----g~vKL~DFGla~~~~~~~~ 297 (720)
|||.|+.+.........+++.+++.++.||+.||.|||++||+||||||+||||..+ +.+||+|||++..+....
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~- 174 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN- 174 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT-
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC-
Confidence 999875554444445679999999999999999999999999999999999998543 359999999998764332
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCC---ChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR---TEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~---~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
......++|+.|+|||++.+.. |+.++||||||||+|||++|.+||.+. +..+.+..+........
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~---------- 243 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS---------- 243 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC----------
T ss_pred CceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC----------
Confidence 2334568899999999998765 799999999999999999999999863 34445555543211111
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
...+..+++.+.+||.+||..||.+|||+.++|+||||..+
T Consensus 244 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 244 ---------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp ---------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ---------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 11234689999999999999999999999999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=395.23 Aligned_cols=253 Identities=27% Similarity=0.352 Sum_probs=194.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++..+++.||||++....... ..+.+|+.+++.++||||+++++++.. ...+||||||+.|+
T Consensus 27 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIIMEYASGG 101 (361)
T ss_dssp EESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEEECCCSC
T ss_pred EeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEEEEEeCCCC
Confidence 3999999999999999999999999998654322 446799999999999999999999976 67899999999876
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc--eeeeccccceecCCCCCCCcccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--LKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~--vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..... .......+|
T Consensus 102 ~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~g 179 (361)
T 3uc3_A 102 ELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTVG 179 (361)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------------
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--cCCCCCCcC
Confidence 55554444557999999999999999999999999999999999999987765 99999999975322 222345579
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|++|+|||++.+...++.++||||||||+|+|++|.+||.+......+..+........ ..
T Consensus 180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------~~--- 240 (361)
T 3uc3_A 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK----------------YS--- 240 (361)
T ss_dssp -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC----------------CC---
T ss_pred CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC----------------CC---
Confidence 99999999998877545569999999999999999999988654333322222110000 00
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 241 ----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 241 ----IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp ----CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred ----CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 00112578999999999999999999999999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=381.34 Aligned_cols=277 Identities=30% Similarity=0.513 Sum_probs=218.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||+|+||.||+|++..+++.||||++.... .+.+.+|+.+|++|. ||||+++++++.......+|+|||
T Consensus 39 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 39 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 33444999999999999999999999999987432 356789999999997 999999999998765678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceecCCCCCCCcc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~t 301 (720)
|+.++.+..+.. .+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+.... ...
T Consensus 114 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~ 188 (330)
T 3nsz_A 114 HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYN 188 (330)
T ss_dssp CCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC--CCC
T ss_pred ccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC--ccc
Confidence 999876655543 489999999999999999999999999999999999999777 89999999998764332 234
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCChhhh-hhcCCCCcccc
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIM-PGRTEVEQLHKIFKLCGSPSEDYW-RKSKLPHATIF 379 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf-~g~~~~e~l~~i~~~~g~p~~~~w-~~~~l~~~~~~ 379 (720)
..++|+.|+|||++.+...++.++||||||||+|+|++|..|| .+....+++..+.+.++.+....+ ..........+
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 5678999999999988666899999999999999999999777 567777888887777665433222 11111100000
Q ss_pred ------CCCCccchh-hhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 380 ------KPQQPYKRC-VAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 380 ------~~~~~~~~~-~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+... .......+++.+.+||.+||++||.+|||+.++|+||||+..
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 000111110 111223478999999999999999999999999999999854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=388.45 Aligned_cols=258 Identities=30% Similarity=0.423 Sum_probs=217.9
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC--CH----HHHHHHHHHHHHHHhc-CCCceeeeccceeccCC
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EP----ESVRFMAREIHILRRL-DHINVIKLEGLVTSRMS 214 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~--~~----~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~ 214 (720)
.|++...||+|+||.||+|++..+|+.||||+++.... .. ...+.+.+|+.+++++ +||||+++++++.. .
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 172 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--S 172 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--S
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--C
Confidence 35555679999999999999999999999999986542 22 2345678999999999 79999999999876 6
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCC
Q 004999 215 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~ 294 (720)
..+||||||++|+.+..+......+++..++.++.||+.||.|||+.||+|+||||+||||+.+|.+||+|||++..+..
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 78999999999866655555556799999999999999999999999999999999999999999999999999987653
Q ss_pred CCCCCccccccccCCCChhhhcCC-----cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 295 DQNQPLTSRVVTLWYRPPELLLGA-----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 295 ~~~~~~t~~~gT~~Y~APE~l~~~-----~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
. ......+||+.|+|||++.+. ..|+.++||||||||+|+|++|.+||.+......+..+......+....
T Consensus 253 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 328 (365)
T 2y7j_A 253 G--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE-- 328 (365)
T ss_dssp T--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH--
T ss_pred C--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc--
Confidence 3 233456889999999998642 2478999999999999999999999999888887777765433332222
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
+..++..+.+||.+||+.||.+|||+.++|+||||+
T Consensus 329 -----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 329 -----------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp -----------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred -----------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 246788999999999999999999999999999996
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=387.64 Aligned_cols=258 Identities=28% Similarity=0.399 Sum_probs=219.6
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 120 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeEEEEE
Confidence 3444559999999999999999999999999986543 45667788999999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||++++.+..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ....
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 199 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKK 199 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBC
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc-cccc
Confidence 999976665555545679999999999999999999999999999999999999999999999999998764322 2234
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
...+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 200 ~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------- 258 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY-------------------- 258 (335)
T ss_dssp CCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC--------------------
T ss_pred ccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC--------------------
Confidence 557899999999998766 79999999999999999999999999887776666543210
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
.....+++.+.+||.+||+.||.+|||+.++|+|+||+....+
T Consensus 259 ---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 259 ---------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred ---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 1123578889999999999999999999999999999876544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=382.22 Aligned_cols=255 Identities=27% Similarity=0.338 Sum_probs=199.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
++||+|+||.||+|.+..+++.||||++..... .....+.+|+.+|.++ +||||+++++++.. ...+||||||++
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~ 94 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYLVFEKMR 94 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCT
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEEEEEcCC
Confidence 359999999999999999999999999976532 2345678999999995 79999999999877 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc---eeeeccccceecCCCC------
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLASFYDPDQ------ 296 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~---vKL~DFGla~~~~~~~------ 296 (720)
|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.......
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (316)
T 2ac3_A 95 GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174 (316)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence 7555544444457999999999999999999999999999999999999988776 9999999997653221
Q ss_pred CCCccccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCCh---------------HHHHHHHH
Q 004999 297 NQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---------------VEQLHKIF 357 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---------------~e~l~~i~ 357 (720)
.......+||+.|+|||++.+ ...|+.++||||||||+|||++|.+||.+... ......+.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 254 (316)
T 2ac3_A 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254 (316)
T ss_dssp -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH
T ss_pred ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh
Confidence 112234568999999999975 13378999999999999999999999987642 12223332
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......+ ...+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 255 ~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 255 EGKYEFP-------------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HCCCCCC-------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred ccCcccC-------------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 2111111 11224678999999999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=373.73 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=214.1
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc--CCCeEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSLYL 219 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~--~~~~lyL 219 (720)
++++...||+|+||.||+|.+..++..||+|++..........+.+.+|+.+|+.++||||+++++++... ....+|+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 34455569999999999999999999999999988777777788899999999999999999999987643 2356899
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEc-CCCceeeeccccceecCCCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld-~~g~vKL~DFGla~~~~~~~ 296 (720)
||||++++.+..+......+++..++.++.||+.||.|||++| |+|+||||+||||+ .++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~-- 184 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-- 184 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc--
Confidence 9999988666655555567999999999999999999999999 99999999999997 789999999999975432
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.......+|+.|+|||++.+. ++.++|||||||++|+|++|..||.+......+.........+
T Consensus 185 -~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------- 248 (290)
T 1t4h_A 185 -SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------------- 248 (290)
T ss_dssp -TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-------------
T ss_pred -cccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc-------------
Confidence 233456789999999988753 7999999999999999999999998866655554433211111
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 249 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 -------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 11223567889999999999999999999999999999853
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=385.38 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=212.5
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC--CeEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--CSLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~--~~ly 218 (720)
.|++.+.||+|+||.||+|++..+++.||||++..... +......+.+|+.++++++||||+++++++..... ..+|
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 34555569999999999999999999999999987644 45666788999999999999999999998765322 2459
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN- 297 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~- 297 (720)
|||||++|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 172 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccc
Confidence 9999998766665555555799999999999999999999999999999999999999999999999999986643222
Q ss_pred -CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 -QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 -~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......+||+.|+|||++.+.. ++.++||||||||+|+|++|..||.+....+....+......+.
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 239 (311)
T 3ork_A 173 VTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP------------ 239 (311)
T ss_dssp ---------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH------------
T ss_pred cccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc------------
Confidence 2223456899999999998876 79999999999999999999999999988877766655322221
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+++.+.+||.+||+.||.+||++.++|.|+|++.
T Consensus 240 -------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 -------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 1223468999999999999999999999999999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=376.19 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=196.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|++..+++.||||+++.........+.+.++...++.++||||+++++++.. ...+|+||||
T Consensus 10 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~lv~e~ 87 (290)
T 3fme_A 10 EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVWICMEL 87 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEEEEEEC
T ss_pred hhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEEEEEeh
Confidence 33444999999999999999999999999998665444445555566666888899999999999876 6779999999
Q ss_pred cccccccccc---CCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 224 MEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 224 ~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
++|++...+. ..+..+++..++.++.||+.||.|||++ ||+|+||||+||||+.++.+||+|||++....... .
T Consensus 88 ~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 165 (290)
T 3fme_A 88 MDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV--A 165 (290)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred hccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc--c
Confidence 9987654433 3556899999999999999999999998 99999999999999999999999999998764322 2
Q ss_pred ccccccccCCCChhhh---cCCcCCCccccchhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 300 LTSRVVTLWYRPPELL---LGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l---~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g-~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.....+|+.|+|||++ .....++.++||||||||+|+|++|..||.+ ......+..+.......
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 233 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------------ 233 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC------------
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC------------
Confidence 2344789999999997 3444589999999999999999999999987 34444444443321100
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.....+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 234 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 234 ---------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ---------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ---------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 011357889999999999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=375.21 Aligned_cols=259 Identities=28% Similarity=0.400 Sum_probs=219.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 94 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEEEEEE
Confidence 3444559999999999999999999999999986543 45666788999999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||++++.+..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... ....
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~ 173 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-ERKK 173 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-CCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc-cccc
Confidence 999976665555555679999999999999999999999999999999999999999999999999998764322 2334
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
...+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+....
T Consensus 174 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 231 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------------------- 231 (294)
T ss_dssp CCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------------------
T ss_pred cccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc---------------------
Confidence 457899999999998765 7999999999999999999999999988777665553310
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
......+++.+.+||.+||+.||.+|||+.++|+|+||+..+.|.
T Consensus 232 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 232 --------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred --------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 011235788999999999999999999999999999999876554
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=376.96 Aligned_cols=253 Identities=32% Similarity=0.446 Sum_probs=210.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.++++++||||+++++++.. ...+|+|||
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 89 (279)
T 3fdn_A 12 EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYLILE 89 (279)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred EEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEEEEEEe
Confidence 3344599999999999999999999999998754321 1224568899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++++.+.........+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...... ....
T Consensus 90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 166 (279)
T 3fdn_A 90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTD 166 (279)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----------
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc---cccc
Confidence 9997666555544457999999999999999999999999999999999999999999999999998654322 2345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+....+.....
T Consensus 167 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------------- 224 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--------------------- 224 (279)
T ss_dssp -CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------------------
T ss_pred cCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCC---------------------
Confidence 57899999999998765 69999999999999999999999999888777776654211
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.....+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 225 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 225 --------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp --------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred --------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 11234788999999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=397.68 Aligned_cols=249 Identities=22% Similarity=0.311 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh-cCCCceeeeccceec--cCCCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR-LDHINVIKLEGLVTS--RMSCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~-L~HpnIvkl~~~~~~--~~~~~lyLV~Ey 223 (720)
++||+|+||.||+|.+..+++.||||++... ..+.+|+.++.+ ++||||+++++++.. .....+||||||
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~ 140 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 140 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEe
Confidence 5699999999999999999999999999732 345788888754 589999999998754 224578999999
Q ss_pred cccccc-ccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeeccccceecCCCCCC
Q 004999 224 MEHDLA-GLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 224 ~~g~ll-~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~~~~~~~~ 298 (720)
|.|+.+ ..+... ...+++.+++.|+.||+.||.|||++||+||||||+||||+. ++.+||+|||++...... .
T Consensus 141 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~--~ 218 (400)
T 1nxk_A 141 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--N 218 (400)
T ss_dssp CCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC--C
Confidence 987544 444332 246999999999999999999999999999999999999997 789999999999876432 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHH----HHHHHHHhcCCCChhhhhhcCCC
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE----QLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e----~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
.....+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+..... ....+.......+
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~---------- 287 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP---------- 287 (400)
T ss_dssp --------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC----------
T ss_pred ccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC----------
Confidence 345668899999999987765 7999999999999999999999998765422 2222221110000
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
...+..+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 288 ---------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 ---------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ---------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ---------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 01224688999999999999999999999999999999854
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=389.24 Aligned_cols=278 Identities=27% Similarity=0.428 Sum_probs=221.2
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CC-----ceeeeccceeccCC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HI-----NVIKLEGLVTSRMS 214 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----nIvkl~~~~~~~~~ 214 (720)
+.|++.+.||+|+||.||+|++..+++.||||+++.. ......+.+|+.+++.+. |+ +|+++++++.. .
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~ 128 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--R 128 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--T
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--C
Confidence 3455556699999999999999999999999999743 345667788999999885 55 48999998877 6
Q ss_pred CeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHhhhhcccccc--ccCcccccCcceeEEEc--CCCceeeeccccc
Q 004999 215 CSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCH--SRGVLHRDIKGSNLLID--NNGILKIADFGLA 289 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH--~~gIvHrDIKP~NILld--~~g~vKL~DFGla 289 (720)
..+||||||+++++...+.... ..+++..++.++.||+.||.||| ..||+||||||+||||+ .++.+||+|||++
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 7899999999998777665533 46999999999999999999999 46999999999999995 4788999999999
Q ss_pred eecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 290 SFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 290 ~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
..... .....++|+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+++..+.+.++.|+...+.
T Consensus 209 ~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 209 CQLGQ----RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp EETTC----CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eeccc----ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87643 234567899999999998876 7999999999999999999999999999999999999999999887764
Q ss_pred hcCC--------CCcc-----------ccCCCCccchhhhcccC------------------CCCHhHHHHHHHhcccCC
Q 004999 370 KSKL--------PHAT-----------IFKPQQPYKRCVAETFK------------------DFPAPALALMETLLSIDP 412 (720)
Q Consensus 370 ~~~l--------~~~~-----------~~~~~~~~~~~~~e~~~------------------~~~~~~~dLI~~mL~~DP 412 (720)
.... +... .+.+. ....+...+. ...+.+.+||.+||++||
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPP--GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCT--TCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCc--chhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 3210 0000 00000 0000000000 001368999999999999
Q ss_pred CCCCCHHHHHhCccCCCC
Q 004999 413 ADRGSAASALRSEFFTMK 430 (720)
Q Consensus 413 ~kRpTa~e~L~hp~f~~~ 430 (720)
++|||+.|+|+||||+..
T Consensus 362 ~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTSCCHHHHTTSGGGCC-
T ss_pred hhCCCHHHHhcCcccccC
Confidence 999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=372.78 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=214.5
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~l 217 (720)
.|++.+.||+|+||.||+|++..+++.||||++....... ...+.+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 83 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTDV 83 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCeE
Confidence 3555566999999999999999999999999998654321 135678899999999999999999999876 6789
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC----ceeeeccccceecC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASFYD 293 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g----~vKL~DFGla~~~~ 293 (720)
|+||||+++..+..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999998766655554455799999999999999999999999999999999999998877 89999999998764
Q ss_pred CCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 294 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 294 ~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+.+..+........
T Consensus 164 ~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 231 (283)
T 3bhy_A 164 AGN--EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD--------- 231 (283)
T ss_dssp ----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC---------
T ss_pred CCC--cccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc---------
Confidence 322 234457899999999998765 79999999999999999999999999888877777654322221
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
...+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 232 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 232 ----------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp ----------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred ----------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 1223567899999999999999999999999999999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=374.59 Aligned_cols=254 Identities=27% Similarity=0.367 Sum_probs=203.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+.+|+.+|++++||||+++++++.. ...+|+|||
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e 100 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIVME 100 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEEEEE
Confidence 3344459999999999999999999999999986542 2234668899999999999999999999876 678999999
Q ss_pred ecccccc-ccccC---CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE---cCCCceeeeccccceecCCC
Q 004999 223 YMEHDLA-GLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 223 y~~g~ll-~~~~~---~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl---d~~g~vKL~DFGla~~~~~~ 295 (720)
|++++.+ ..+.. .+..+++..++.++.||+.||.|||++||+|+||||+|||| +.++.+||+|||++..+...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 9987444 33322 24579999999999999999999999999999999999999 45688999999999865432
Q ss_pred CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.......+|+.|+|||++.+ .++.++||||||||+|+|++|..||.+....+....+.......
T Consensus 181 --~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------------ 244 (285)
T 3is5_A 181 --EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------------ 244 (285)
T ss_dssp --------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------------
T ss_pred --ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc------------
Confidence 22345678999999999864 37999999999999999999999999988766655543311100
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 245 --------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 --------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred --------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 1112347889999999999999999999999999999974
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=397.19 Aligned_cols=261 Identities=27% Similarity=0.381 Sum_probs=203.1
Q ss_pred hccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC------CHHHHHHHHHHHHHHHhcCCCceeeeccceecc
Q 004999 139 LSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL------EPESVRFMAREIHILRRLDHINVIKLEGLVTSR 212 (720)
Q Consensus 139 ~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~------~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~ 212 (720)
+.+.|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|++|+||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 34456666779999999999999999999999999976432 12223357899999999999999999998753
Q ss_pred CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC---ceeeeccccc
Q 004999 213 MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFGLA 289 (720)
Q Consensus 213 ~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g---~vKL~DFGla 289 (720)
..+|||||||.++.+.........+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 45899999999866665555666899999999999999999999999999999999999997544 5999999999
Q ss_pred eecCCCCCCCccccccccCCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHH-HHHhcCCCChh
Q 004999 290 SFYDPDQNQPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHK-IFKLCGSPSED 366 (720)
Q Consensus 290 ~~~~~~~~~~~t~~~gT~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~-i~~~~g~p~~~ 366 (720)
..... .......+||+.|+|||++.+ ...|+.++||||||||||+|++|.+||.+......+.. +.......
T Consensus 290 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~--- 364 (419)
T 3i6u_A 290 KILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF--- 364 (419)
T ss_dssp TSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC---
T ss_pred eecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC---
Confidence 87643 223345689999999999864 34478899999999999999999999987654333322 22211111
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..+.+..+++.+.+||.+||++||.+|||+.++|+||||+.
T Consensus 365 ----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 365 ----------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 12334568999999999999999999999999999999974
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=384.21 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=205.5
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC--CceeeeccceeccCCCeEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIvkl~~~~~~~~~~~lyL 219 (720)
.|++.+.||+|+||.||+|.+ .+++.||||++..........+.+.+|+.+|+.|.| |||+++++++.. ...+||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~l 86 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYM 86 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred EEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCEEEE
Confidence 345555699999999999998 468899999998877777778889999999999976 999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ- 298 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~- 298 (720)
|||+..+++...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+......
T Consensus 87 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 87 VMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp EECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 999877776665554 45799999999999999999999999999999999999996 688999999999876433322
Q ss_pred CccccccccCCCChhhhcC----------CcCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhh
Q 004999 299 PLTSRVVTLWYRPPELLLG----------ATYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~----------~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~-~e~l~~i~~~~g~p~~~~ 367 (720)
.....+||+.|+|||++.+ ...|+.++||||||||||||++|.+||.+... ...+..+.....
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------ 238 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH------ 238 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS------
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc------
Confidence 2345679999999999864 24479999999999999999999999987543 333333321100
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
........+..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 239 ---------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 239 ---------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp ---------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ---------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 0112234567899999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=375.71 Aligned_cols=263 Identities=29% Similarity=0.434 Sum_probs=215.9
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
.|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.......+||
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 35555669999999999999999999999999975432 1234567899999999999999999999986544668999
Q ss_pred EEeeccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-C
Q 004999 220 VFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-N 297 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~-~ 297 (720)
||||+++++...+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... .
T Consensus 86 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 165 (305)
T 2wtk_C 86 VMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165 (305)
T ss_dssp EEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSS
T ss_pred EehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccc
Confidence 999999886554443 34579999999999999999999999999999999999999999999999999998764322 2
Q ss_pred CCccccccccCCCChhhhcCCc-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 QPLTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~-~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.......+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+....+.+..+.+..
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~---------------- 229 (305)
T 2wtk_C 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS---------------- 229 (305)
T ss_dssp CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC----------------
T ss_pred cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC----------------
Confidence 2233456899999999997643 34789999999999999999999999988777766664321
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
......+++.+.+||.+||+.||.+|||+.++|+||||+....+
T Consensus 230 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 230 -------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp -------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred -------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 01224578899999999999999999999999999999876544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=375.81 Aligned_cols=263 Identities=26% Similarity=0.361 Sum_probs=213.4
Q ss_pred ccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 140 SIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 140 ~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
.+.|++.+.||+|+||.||+|++..++..||||++..... .....+.+.+|+.++++++||||+++++++.. ...+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE--DDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC--SSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee--CCeEE
Confidence 3445556669999999999999999999999999876543 45667889999999999999999999999876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
+||||++|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999998666655555567999999999999999999999999999999999999999999999999999876543333
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+...++.... .+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~-~~--------------- 230 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS-VP--------------- 230 (294)
T ss_dssp -------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC-CC---------------
T ss_pred ccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc-CC---------------
Confidence 344567899999999998876 7999999999999999999999999988877665554321 11
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.........+++.+.+||.+||+.||.+||+..+.|.+.|...
T Consensus 231 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 231 --------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 0112334578999999999999999999998778888877653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=370.62 Aligned_cols=250 Identities=19% Similarity=0.195 Sum_probs=204.2
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++.. ...+||||
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~lv~ 90 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQN 90 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEEEE
Confidence 4445559999999999999999999999999987665556667788999999999 99999999999877 67899999
Q ss_pred eeccccccccccCC----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-------------------
Q 004999 222 EYMEHDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN------------------- 278 (720)
Q Consensus 222 Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~------------------- 278 (720)
||++++.+..+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 99987554444332 2568999999999999999999999999999999999999844
Q ss_pred CceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 004999 279 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 279 g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~ 358 (720)
..+||+|||++...... ....+|+.|+|||++.+...++.++||||||||+|+|++|.+++...... ..+..
T Consensus 171 ~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~ 242 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---HEIRQ 242 (289)
T ss_dssp CCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---HHHHT
T ss_pred eEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---HHHHc
Confidence 47999999999876432 23458999999999988756788999999999999999999887654332 22221
Q ss_pred hcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.. .......+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 243 ~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GR----------------------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TC----------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CC----------------------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 10 112234688999999999999999999999999999999853
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=367.05 Aligned_cols=258 Identities=27% Similarity=0.400 Sum_probs=212.1
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 85 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFLE 85 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEEEE
Confidence 4445569999999999999999999999999976543 2345678899999999999999999999876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-CCCcc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~t 301 (720)
|++++.+..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.... .....
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 99986666666666679999999999999999999999999999999999999999999999999998653222 12234
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~-l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+|+.|+|||++.+...++.++|||||||++|+|++|..||.+...... +..+.... .
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------------------ 226 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-T------------------ 226 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-T------------------
T ss_pred CCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-c------------------
Confidence 557899999999998776557899999999999999999999987654322 22221100 0
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
....+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 227 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 --------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp --------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred --------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 001123578899999999999999999999999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=383.53 Aligned_cols=255 Identities=22% Similarity=0.337 Sum_probs=198.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC--------
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS-------- 214 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~-------- 214 (720)
|++.+.||+|+||.||+|++..+++.||||+++... .....+.+.+|+.+|++|+||||+++++++.....
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 445556999999999999999999999999998654 23455778999999999999999999998755321
Q ss_pred -----------------------------------------------CeEEEEEeeccccccccccCCC---CCCCHHHH
Q 004999 215 -----------------------------------------------CSLYLVFEYMEHDLAGLASHPG---LKFSEAQV 244 (720)
Q Consensus 215 -----------------------------------------------~~lyLV~Ey~~g~ll~~~~~~~---~~lse~~~ 244 (720)
..+|+|||||+|+.+..+.... ...++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 2389999999986655544433 23566779
Q ss_pred HHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-----------CCccccccccCCCChh
Q 004999 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-----------QPLTSRVVTLWYRPPE 313 (720)
Q Consensus 245 ~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-----------~~~t~~~gT~~Y~APE 313 (720)
+.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........ ......+||+.|+|||
T Consensus 167 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 99999999999999999999999999999999999999999999987754321 2234457899999999
Q ss_pred hhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhccc
Q 004999 314 LLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETF 393 (720)
Q Consensus 314 ~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~ 393 (720)
++.+.. |+.++||||||||+|||++|..++.. ....+..+.. .. ....+
T Consensus 247 ~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~---~~-------------------------~~~~~ 295 (332)
T 3qd2_B 247 QIHGNN-YSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRN---LK-------------------------FPLLF 295 (332)
T ss_dssp HHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHT---TC-------------------------CCHHH
T ss_pred HhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhc---cC-------------------------CCccc
Confidence 998876 79999999999999999998765411 1111111111 01 01112
Q ss_pred CCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 394 KDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 394 ~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
...++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 235677899999999999999999999999999974
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=376.24 Aligned_cols=256 Identities=26% Similarity=0.363 Sum_probs=213.3
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|.+.+.||+|+||.||+|++..+|+.||||++..... .....+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 85 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYLVM 85 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEEEE
Confidence 45556679999999999999999999999999986432 223567899999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE---cCCCceeeeccccceecCCCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl---d~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+|||| +.++.+||+|||++..... .
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~ 162 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---G 162 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC---B
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC---C
Confidence 999875554444444578999999999999999999999999999999999999 7889999999999975432 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....++|+.|+|||++.+.. |+.++|||||||++|+|++|.+||.+....+.+..+.+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------------- 227 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE-------------- 227 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC--------------
T ss_pred ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 234557899999999998765 79999999999999999999999999888877777765322111
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
...+..+++.+.+||.+||..||.+|||+.++|+||||+..
T Consensus 228 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 -----------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp -----------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred -----------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 11234688999999999999999999999999999999854
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=374.79 Aligned_cols=251 Identities=29% Similarity=0.420 Sum_probs=211.1
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.+++.++||||+++++++.. ...+|+||||+
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 96 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIYLMLEFA 96 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEECCC
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEEEEEEeC
Confidence 33499999999999999999999999999754221 1123568899999999999999999999876 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...... ......
T Consensus 97 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~ 173 (284)
T 2vgo_A 97 PRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---RRRTMC 173 (284)
T ss_dssp TTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---CBCCCC
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc---cccccc
Confidence 87555444444457999999999999999999999999999999999999999999999999999765332 223457
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+....+....+....
T Consensus 174 ~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------------------ 228 (284)
T 2vgo_A 174 GTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD------------------------ 228 (284)
T ss_dssp SCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------------------
T ss_pred CCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc------------------------
Confidence 899999999998765 7999999999999999999999999988877766664321
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
......++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 229 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 229 -----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 011235788999999999999999999999999999998644
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=373.39 Aligned_cols=264 Identities=28% Similarity=0.440 Sum_probs=217.8
Q ss_pred CCCccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeee
Q 004999 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 126 p~~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
|.+.+.|+.++. ||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++++++||||+++
T Consensus 2 p~~~~~y~~~~~-----------lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 70 (279)
T 2w5a_A 2 PSRAEDYEVLYT-----------IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70 (279)
T ss_dssp -CCGGGEEEEEE-----------EEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCchhheeeehh-----------ccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeE
Confidence 344455655555 999999999999999999999999999877777777889999999999999999999
Q ss_pred ccceeccCCCeEEEEEeeccccccccccC----CCCCCCHHHHHHHHHhhhhccccccccC-----cccccCcceeEEEc
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRG-----VLHRDIKGSNLLID 276 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~g-----IvHrDIKP~NILld 276 (720)
++++.......+|+||||++++.+..+.. ....+++..++.++.||+.||.|||+.| |+|+||||+||||+
T Consensus 71 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~ 150 (279)
T 2w5a_A 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150 (279)
T ss_dssp EEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC
T ss_pred EEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc
Confidence 99886655678999999998754443332 2345899999999999999999999999 99999999999999
Q ss_pred CCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHH
Q 004999 277 NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356 (720)
Q Consensus 277 ~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i 356 (720)
.++.+||+|||++....... .......+|+.|+|||++.+.. ++.++||||||||+|+|++|.+||.+....+....+
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i 228 (279)
T 2w5a_A 151 GKQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 228 (279)
T ss_dssp SSSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEecCchheeecccc-ccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence 99999999999998654321 1123457899999999998765 799999999999999999999999998877666665
Q ss_pred HHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 357 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 357 ~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..... ......+++.+.+||.+||+.||.+|||+.++|+|+|+...
T Consensus 229 ~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 229 REGKF----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred hhccc----------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 44210 01123578999999999999999999999999999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=389.89 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=205.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC--CCceeeeccceeccCCCeEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD--HINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIvkl~~~~~~~~~~~lyLV 220 (720)
|++.+.||+|+||.||+|.+.. ++.||||++............+.+|+.+|++|. ||||+++++++.. ...+|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~~lv 134 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYMV 134 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEEEEE
Confidence 4444559999999999999865 889999999887777777888999999999996 5999999998876 6679999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-C
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-P 299 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~-~ 299 (720)
||+..++|...+.. ...+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||++..+...... .
T Consensus 135 ~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 135 MECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp EECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence 99766666655544 44789999999999999999999999999999999999995 689999999999876433222 2
Q ss_pred ccccccccCCCChhhhcCC----------cCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhhh
Q 004999 300 LTSRVVTLWYRPPELLLGA----------TYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~----------~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~-~e~l~~i~~~~g~p~~~~w 368 (720)
....+||+.|+|||++.+. ..|+.++||||||||||||++|.+||.+... ...+..+......
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~------ 286 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE------ 286 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC------
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc------
Confidence 3456799999999999752 3489999999999999999999999987543 3444443321000
Q ss_pred hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
.......+..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 287 ---------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 287 ---------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp ---------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ---------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 011223477899999999999999999999999999998654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=369.47 Aligned_cols=258 Identities=28% Similarity=0.394 Sum_probs=215.3
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC---C----HHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCC
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---E----PESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSC 215 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~---~----~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~ 215 (720)
++.+.||+|+||.||+|.+..+++.||||++..... . ....+.+.+|+.+++++. ||||+++++++.. ..
T Consensus 20 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~--~~ 97 (298)
T 1phk_A 20 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET--NT 97 (298)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SS
T ss_pred ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc--CC
Confidence 334459999999999999999999999999986542 1 223456889999999995 9999999999876 67
Q ss_pred eEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 216 SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
.+|+||||++++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 177 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCC
Confidence 89999999997655555554567999999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCccccccccCCCChhhhc-----CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 296 QNQPLTSRVVTLWYRPPELLL-----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~-----~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
.......+|+.|+|||++. ....++.++|||||||++|+|++|..||.+....+....+.........
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 250 (298)
T 1phk_A 178 --EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS----- 250 (298)
T ss_dssp --CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT-----
T ss_pred --cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc-----
Confidence 2334557899999999986 2344789999999999999999999999998887777776553222111
Q ss_pred cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..+..++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 --------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 251 --------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp --------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred --------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 1123578899999999999999999999999999999854
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=386.25 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=208.3
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH------HHHHHHHHHHHHHHhcCCCceeeeccceeccCC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP------ESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 214 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~------~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~ 214 (720)
+.|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|++++||||+++++++.. .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~ 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--Q 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--C
Confidence 34555666999999999999999999999999998764321 133456789999999999999999999876 6
Q ss_pred CeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecC
Q 004999 215 CSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYD 293 (720)
Q Consensus 215 ~~lyLV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~ 293 (720)
..+|+||||+.++ .+..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 7899999999654 555555556679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 294 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 294 ~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
.. ......+||+.|+|||++.+...++.++||||||||+|+|++|..||.+.... ..
T Consensus 182 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~--------------- 238 (335)
T 3dls_A 182 RG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------VE--------------- 238 (335)
T ss_dssp TT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------TT---------------
T ss_pred CC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------Hh---------------
Confidence 32 23345678999999999998775689999999999999999999999652210 00
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
........+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 239 --------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 239 --------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp --------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred --------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 001112347899999999999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=375.56 Aligned_cols=279 Identities=24% Similarity=0.384 Sum_probs=222.2
Q ss_pred cccccceeecccCceEEEEEEE-CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc------eeeeccceeccC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARD-LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN------VIKLEGLVTSRM 213 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~-~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Ivkl~~~~~~~~ 213 (720)
..|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+.+++.++|++ |+++++++..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-- 88 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-- 88 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--
Confidence 3455555699999999999998 568999999999743 355667889999999997654 9999998876
Q ss_pred CCeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---------------
Q 004999 214 SCSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--------------- 277 (720)
Q Consensus 214 ~~~lyLV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~--------------- 277 (720)
...+||||||+++++...+...+ ..+++.+++.++.||+.||.|||++||+||||||+||||+.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 67899999999888777665443 36899999999999999999999999999999999999987
Q ss_pred ----CCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHH
Q 004999 278 ----NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 353 (720)
Q Consensus 278 ----~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l 353 (720)
++.+||+|||++...... ....++|+.|+|||++.+.. |+.++||||||||+|||++|.+||.+.+..+.+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999875322 23457899999999998766 799999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhhhhcCCCCccc-----cCCCCccchhh----------hcccCCCCHhHHHHHHHhcccCCCCCCCH
Q 004999 354 HKIFKLCGSPSEDYWRKSKLPHATI-----FKPQQPYKRCV----------AETFKDFPAPALALMETLLSIDPADRGSA 418 (720)
Q Consensus 354 ~~i~~~~g~p~~~~w~~~~l~~~~~-----~~~~~~~~~~~----------~e~~~~~~~~~~dLI~~mL~~DP~kRpTa 418 (720)
..+.+..+..+...+.......... +.......... .......++.+.+||.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 9999988888877765432111000 00000000000 00111235678999999999999999999
Q ss_pred HHHHhCccCCC
Q 004999 419 ASALRSEFFTM 429 (720)
Q Consensus 419 ~e~L~hp~f~~ 429 (720)
.|+|+||||+.
T Consensus 324 ~ell~hp~f~~ 334 (339)
T 1z57_A 324 REALKHPFFDL 334 (339)
T ss_dssp HHHTTSGGGGG
T ss_pred HHHhcCHHHHH
Confidence 99999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=375.79 Aligned_cols=259 Identities=28% Similarity=0.381 Sum_probs=205.2
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC------CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL------EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS 214 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~------~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~ 214 (720)
..|++.+.||+|+||.||+|++..+++.||||++..... .......+.+|+.+|++++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence 345566669999999999999999999999999976432 12233457899999999999999999998865
Q ss_pred CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc---eeeecccccee
Q 004999 215 CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLASF 291 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~---vKL~DFGla~~ 291 (720)
..+|+||||+.++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+.++. +||+|||++..
T Consensus 87 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 87 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 348999999987655555555668999999999999999999999999999999999999987664 99999999987
Q ss_pred cCCCCCCCccccccccCCCChhhhc--CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHH-HHHHHhcCCCChhhh
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL-HKIFKLCGSPSEDYW 368 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~--~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l-~~i~~~~g~p~~~~w 368 (720)
.... .......+|+.|+|||++. +...|+.++||||||||+|+|++|.+||.+......+ ..+.......
T Consensus 167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----- 239 (322)
T 2ycf_A 167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF----- 239 (322)
T ss_dssp CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC-----
T ss_pred cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc-----
Confidence 6422 2223457899999999984 3445799999999999999999999999875443222 2222211111
Q ss_pred hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..+.+..+++.+.+||.+||..||.+|||+.++|+||||+.
T Consensus 240 --------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 240 --------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp --------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred --------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 12233568899999999999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=376.53 Aligned_cols=280 Identities=25% Similarity=0.362 Sum_probs=223.4
Q ss_pred cccccceeecccCceEEEEEEECCCC-eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc------eeeeccceeccC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQK-KIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN------VIKLEGLVTSRM 213 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg-~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn------Ivkl~~~~~~~~ 213 (720)
..|++.+.||+|+||.||+|.+..++ ..||||+++.. ......+.+|+.+++.+.|++ |+.+++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 93 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-- 93 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--
Confidence 34555566999999999999998777 78999999743 345567889999999997766 8888888776
Q ss_pred CCeEEEEEeeccccccccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE-----------------
Q 004999 214 SCSLYLVFEYMEHDLAGLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----------------- 275 (720)
Q Consensus 214 ~~~lyLV~Ey~~g~ll~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl----------------- 275 (720)
...+||||||++++++..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 67899999999988887666543 569999999999999999999999999999999999999
Q ss_pred --cCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHH
Q 004999 276 --DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQL 353 (720)
Q Consensus 276 --d~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l 353 (720)
+.++.+||+|||++..... .....+||+.|+|||++.+.. |+.++||||||||+|||++|.+||.+....+.+
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred cccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 6788999999999986532 224457899999999998766 799999999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhhhhcCCCCcc-----ccCCCCccchhhhc----------ccCCCCHhHHHHHHHhcccCCCCCCCH
Q 004999 354 HKIFKLCGSPSEDYWRKSKLPHAT-----IFKPQQPYKRCVAE----------TFKDFPAPALALMETLLSIDPADRGSA 418 (720)
Q Consensus 354 ~~i~~~~g~p~~~~w~~~~l~~~~-----~~~~~~~~~~~~~e----------~~~~~~~~~~dLI~~mL~~DP~kRpTa 418 (720)
..+.+.++.++...+......... .+...........+ .....+..+.+||.+||+.||.+|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 999999998888776543211100 00000000000000 011124578999999999999999999
Q ss_pred HHHHhCccCCCC
Q 004999 419 ASALRSEFFTMK 430 (720)
Q Consensus 419 ~e~L~hp~f~~~ 430 (720)
.++|+||||+..
T Consensus 329 ~e~l~hp~f~~~ 340 (355)
T 2eu9_A 329 AEALLHPFFAGL 340 (355)
T ss_dssp HHHTTSGGGGGC
T ss_pred HHHhcChhhcCC
Confidence 999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=412.42 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=210.7
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
+.|++.++||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++|||||++++++.+ ...+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~l 261 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCL 261 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCEEEE
Confidence 445666779999999999999999999999999975422 11224567899999999999999999999876 678999
Q ss_pred EEeecccccccc-ccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 220 VFEYMEHDLAGL-ASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 220 V~Ey~~g~ll~~-~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|||||+|+.+.. +... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-- 339 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 339 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC--
Confidence 999998755543 3332 235999999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
......+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+... ...+....... +
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~----------- 405 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--P----------- 405 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--C-----------
T ss_pred ccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--c-----------
Confidence 2344568999999999998766 79999999999999999999999988643 22222221110 0
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+|| ++.++++||||+..
T Consensus 406 ---------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 406 ---------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred ---------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 012246789999999999999999999 89999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=420.37 Aligned_cols=255 Identities=24% Similarity=0.355 Sum_probs=217.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
|.+.++||+|+||.||+|++..+++.||||+++.... .......+..|+.+|..+ +||||+++++++.+ ...+|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~~lV 420 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYFV 420 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEEEEE
Confidence 4455569999999999999999999999999985421 123345678899999988 79999999998876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|||++|+.+..++.....|++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++...... ....
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~~~~ 499 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTT 499 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT-TCCB
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC-Cccc
Confidence 999998666655555557999999999999999999999999999999999999999999999999999864332 2334
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+.+..|.....
T Consensus 500 ~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------------------- 559 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV------------------- 559 (674)
T ss_dssp CCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCC-------------------
T ss_pred ccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCC-------------------
Confidence 5668999999999998766 79999999999999999999999999999888888864211
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCH-----HHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA-----ASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa-----~e~L~hp~f~~~ 430 (720)
.....+++++.+||.+||+.||.+|+++ .++++||||+..
T Consensus 560 ----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 560 ----------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp ----------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred ----------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 1224688999999999999999999997 999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=373.33 Aligned_cols=251 Identities=25% Similarity=0.312 Sum_probs=201.9
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||+|+||.||+|++ ++..||||++..........+.+.+|+.+|++++||||+++++++.. ...+|+||||+.
T Consensus 42 ~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~ 117 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLSIVTEYLS 117 (309)
T ss_dssp EEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCEEEEECCT
T ss_pred eeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceEEEEecCC
Confidence 33499999999999987 68889999998877777778889999999999999999999999876 567999999999
Q ss_pred ccccccccCCCC---CCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 226 HDLAGLASHPGL---KFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 226 g~ll~~~~~~~~---~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
++.+..+..... .+++..++.++.||+.||.|||++| |+||||||+||||+.++.+||+|||++...... ....
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~ 196 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-FLSS 196 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc-cccc
Confidence 865554444332 2899999999999999999999999 999999999999999999999999999764332 2223
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....||+.|+|||++.+.. ++.++||||||||+|+|++|..||.+.+..+....+......
T Consensus 197 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------------------ 257 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------------------ 257 (309)
T ss_dssp -----CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC------------------
T ss_pred ccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------------------
Confidence 4567899999999998776 799999999999999999999999998887766655332111
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh--CccCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFTM 429 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~--hp~f~~ 429 (720)
......+++.+.+||.+||+.||.+|||+.++++ .+++..
T Consensus 258 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 ---------LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1223468899999999999999999999999998 677764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.37 Aligned_cols=255 Identities=26% Similarity=0.358 Sum_probs=204.7
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|.+..+++.||||++..... ..+....+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 90 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFFMVM 90 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEEEEE
Confidence 3444459999999999999999999999999975421 11234578899999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||+.+..+..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...... ....
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 168 (276)
T 2h6d_A 91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLR 168 (276)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------
T ss_pred eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC--ccee
Confidence 99987655554444457899999999999999999999999999999999999999999999999999876432 2234
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
...+|+.|+|||++.+...++.++|||||||++|+|++|..||.+....+.+..+.....
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 228 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF-------------------- 228 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------------------
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--------------------
Confidence 457899999999998876557899999999999999999999998877666665543210
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 229 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 229 ---------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ---------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 1123468899999999999999999999999999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=372.88 Aligned_cols=253 Identities=30% Similarity=0.431 Sum_probs=185.2
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 92 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYVYLVLEM 92 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEEEEEEEC
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeEEEEEec
Confidence 33449999999999999999999999999975321 11224678899999999999999999999876 6789999999
Q ss_pred cccccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 224 MEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 224 ~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
++++.+.. +......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++........ ....
T Consensus 93 ~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 171 (278)
T 3cok_A 93 CHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-KHYT 171 (278)
T ss_dssp CTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---------
T ss_pred CCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-ccee
Confidence 98755544 444446799999999999999999999999999999999999999999999999999987643222 2234
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+....+.+..+.. .
T Consensus 172 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------------------~- 227 (278)
T 3cok_A 172 LCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----------------------A- 227 (278)
T ss_dssp ---------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----------------------S-
T ss_pred ccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----------------------c-
Confidence 57899999999998765 69999999999999999999999987654333322110 0
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus 228 ------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 228 ------DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 001223578899999999999999999999999999999854
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=405.04 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=211.2
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
..|.+.++||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|++++||||+++++++.. ...+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~l 262 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDLCL 262 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEEEE
Confidence 345556679999999999999999999999999975432 11234567899999999999999999999876 678999
Q ss_pred EEeeccccccccccCC----CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 220 VFEYMEHDLAGLASHP----GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~----~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
|||||+|+.+..+... ...+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 9999997655433321 346999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh----HHHHHHHHHhcCCCChhhhhhc
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE----VEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~----~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
.. .....+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+... .+....+....
T Consensus 343 ~~-~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~----------- 409 (543)
T 3c4z_A 343 QT-KTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA----------- 409 (543)
T ss_dssp CC-CBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC-----------
T ss_pred Cc-ccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc-----------
Confidence 22 234458999999999998865 79999999999999999999999988642 33333443210
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+||+ +.++++||||+..
T Consensus 410 ------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 410 ------------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred ------------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 1122467899999999999999999996 5899999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=387.68 Aligned_cols=262 Identities=17% Similarity=0.182 Sum_probs=190.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhc--CCCceeeecc-------ceeccC
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRL--DHINVIKLEG-------LVTSRM 213 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L--~HpnIvkl~~-------~~~~~~ 213 (720)
++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+++.| +||||++++. ++....
T Consensus 65 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~ 144 (371)
T 3q60_A 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQS 144 (371)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETT
T ss_pred eeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCC
Confidence 344459999999999999999999999999998765 345566778886655555 6999888553 222211
Q ss_pred C---------------CeEEEEEeeccccccccccCCCCCCCHHHH------HHHHHhhhhccccccccCcccccCccee
Q 004999 214 S---------------CSLYLVFEYMEHDLAGLASHPGLKFSEAQV------KCYMQQLLCGLDHCHSRGVLHRDIKGSN 272 (720)
Q Consensus 214 ~---------------~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~------~~i~~QIl~gL~yLH~~gIvHrDIKP~N 272 (720)
. ..+|||||||+|+|...+...+..+.+..+ ..++.||+.||.|||++||+||||||+|
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~N 224 (371)
T 3q60_A 145 QPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDN 224 (371)
T ss_dssp SCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred CCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHH
Confidence 1 348999999998877766554444555555 6777999999999999999999999999
Q ss_pred EEEcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcC-CcCCCccccchhhHHHHHHHHhCCCCCCCCChHH
Q 004999 273 LLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE 351 (720)
Q Consensus 273 ILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~-~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e 351 (720)
|||+.+|.+||+|||++..... ......+|+.|+|||++.+ ...|+.++||||||||||||++|++||.+.....
T Consensus 225 Ill~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 225 LFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp EEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred EEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 9999999999999999987532 1224567899999999976 2348999999999999999999999998764310
Q ss_pred HHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 352 QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 352 ~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
. ..|......... . .......+..+++.+.+||.+||+.||++|||+.++|+||||+.
T Consensus 301 ~-------------~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 301 K-------------GSWKRPSLRVPG--T-----DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp T-------------TCCCBCCTTSCC--C-----CSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred c-------------cchhhhhhhhcc--c-----cccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 0 001100000000 0 00111223578999999999999999999999999999999974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=368.69 Aligned_cols=258 Identities=25% Similarity=0.437 Sum_probs=214.2
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.+.||+|+||.||+|++..+++.||||++............+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 100 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYIVG 100 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEEEE
Confidence 4455556999999999999999999999999997654444445678899999999999999999999876 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC---CceeeeccccceecCCCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---GILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~---g~vKL~DFGla~~~~~~~~~ 298 (720)
||+.++.+.........+++.+++.++.||+.||.|||++||+|+||||+||||+.+ +.+||+|||++...... .
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~--~ 178 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--T 178 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC--S
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC--C
Confidence 999875554333334479999999999999999999999999999999999999754 47999999999866432 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......+|+.|+|||++.+. ++.++|||||||++|+|++|.+||.+....+.+..+........
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 242 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD-------------- 242 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred ccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 23445689999999998764 79999999999999999999999999888877776654321111
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
...+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 243 -----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 243 -----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 11224678999999999999999999999999999999743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=376.75 Aligned_cols=277 Identities=20% Similarity=0.292 Sum_probs=208.2
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
..|++.++||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+|++++||||+++++++.......+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 345566669999999999999999999999999975432 1224567899999999999999999999887555689999
Q ss_pred EeeccccccccccCCC---CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE----cCCCceeeeccccceecC
Q 004999 221 FEYMEHDLAGLASHPG---LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYD 293 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~---~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl----d~~g~vKL~DFGla~~~~ 293 (720)
|||++++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999875554443322 238999999999999999999999999999999999999 788899999999998764
Q ss_pred CCCCCCccccccccCCCChhhhcC-------CcCCCccccchhhHHHHHHHHhCCCCCCCCC----hHHHHHHHHHhcCC
Q 004999 294 PDQNQPLTSRVVTLWYRPPELLLG-------ATYYGTAVDLWSTGCILAELYAGKPIMPGRT----EVEQLHKIFKLCGS 362 (720)
Q Consensus 294 ~~~~~~~t~~~gT~~Y~APE~l~~-------~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~----~~e~l~~i~~~~g~ 362 (720)
... .....++|+.|+|||++.. ...|+.++||||||||+|||++|..||.+.. ..+.+.++....
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 243 (319)
T 4euu_A 168 DDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK-- 243 (319)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC--
T ss_pred CCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC--
Confidence 432 3345678999999999862 2448999999999999999999999997533 344555554432
Q ss_pred CChhhhhhcCCCCc--cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 363 PSEDYWRKSKLPHA--TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 363 p~~~~w~~~~l~~~--~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
| ...|........ ..+....+. .......++..+.+||.+||+.||++|||+.|+|+||=
T Consensus 244 p-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 244 P-SGAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp C-TTCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred C-cccchhhhcccCCccccCccCCc---ccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2 111111000000 000000010 00112245667899999999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=378.96 Aligned_cols=280 Identities=29% Similarity=0.458 Sum_probs=217.7
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-----------CCceeeeccceec
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-----------HINVIKLEGLVTS 211 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIvkl~~~~~~ 211 (720)
|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.+++++. ||||+++++++..
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred EEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 34444599999999999999999999999999743 345567789999999886 8999999998875
Q ss_pred cC--CCeEEEEEeeccccccccccC-CCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEc------CCCce
Q 004999 212 RM--SCSLYLVFEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLID------NNGIL 281 (720)
Q Consensus 212 ~~--~~~lyLV~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld------~~g~v 281 (720)
.. ...+++||||+.+++...+.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+ ..+.+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~ 177 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177 (373)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred cCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence 32 237899999997777666554 344699999999999999999999998 999999999999994 34489
Q ss_pred eeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC------hHHHHHH
Q 004999 282 KIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHK 355 (720)
Q Consensus 282 KL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~------~~e~l~~ 355 (720)
||+|||++...... ....++|+.|+|||++.+.. |+.++||||||||||||++|.+||.+.. ..+.+..
T Consensus 178 kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 178 KIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred EEcccccccccCCC----CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 99999999876432 34457899999999998876 7999999999999999999999998765 5678888
Q ss_pred HHHhcCCCChhhhhhcCCCCc-----cccC-----CCCccchhhh---cccCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 004999 356 IFKLCGSPSEDYWRKSKLPHA-----TIFK-----PQQPYKRCVA---ETFKDFPAPALALMETLLSIDPADRGSAASAL 422 (720)
Q Consensus 356 i~~~~g~p~~~~w~~~~l~~~-----~~~~-----~~~~~~~~~~---e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 422 (720)
+.+.++.++...|...+.... ..+. ...+....+. .....++..+.+||.+||+.||.+|||+.++|
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 889999888776654332110 0000 0000111111 11123457789999999999999999999999
Q ss_pred hCccCCCC
Q 004999 423 RSEFFTMK 430 (720)
Q Consensus 423 ~hp~f~~~ 430 (720)
+||||+..
T Consensus 333 ~hp~f~~~ 340 (373)
T 1q8y_A 333 NHPWLKDT 340 (373)
T ss_dssp TCGGGTTC
T ss_pred hChhhhcc
Confidence 99999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=387.87 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=204.4
Q ss_pred cceeecccCceEEEEEEEC---CCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEE
Q 004999 145 SFYLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNL--EPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~ly 218 (720)
+.+.||+|+||.||+|++. .+++.||||+++.... .......+.+|+.+|+.+ +||||+++++++.. ...+|
T Consensus 58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 135 (355)
T 1vzo_A 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--ETKLH 135 (355)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--TTEEE
T ss_pred EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--CceEE
Confidence 3334999999999999984 5899999999875321 112234467899999999 69999999998876 67899
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
|||||++++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~ 215 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC
Confidence 99999998666555544557999999999999999999999999999999999999999999999999999876443333
Q ss_pred CccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCChhhhhhcCC
Q 004999 299 PLTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIMPGRTEV----EQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~----e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
.....+||+.|+|||++.+. ..++.++||||||||||||++|..||...... .....+...
T Consensus 216 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------- 281 (355)
T 1vzo_A 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------------- 281 (355)
T ss_dssp GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--------------
T ss_pred cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc--------------
Confidence 34456799999999999863 34789999999999999999999999764322 222222211
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||..||.+|| |+.++++|+||+..
T Consensus 282 ---------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 282 ---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ---------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 0112246788999999999999999999 99999999999853
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=364.68 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=214.2
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|.+.+.||+|+||.||+|++..+++.||||++...... ...+.+.+|+.+++.++||||+++++++.. ...+|+|||
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 100 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIME 100 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEEE
Confidence 34444599999999999999999999999999866432 345678899999999999999999999877 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|++++.+..+... ..+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++....... .....
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 178 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNT 178 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-CCBCC
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc-cccCc
Confidence 9998666655544 479999999999999999999999999999999999999999999999999998764322 22345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
..+|+.|+|||++.+.. ++.++||||||||+|+|++|.+||.+.........+.+.. +
T Consensus 179 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------------- 236 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN--P------------------- 236 (303)
T ss_dssp CCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C-------------------
T ss_pred cCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC--C-------------------
Confidence 57899999999998765 7999999999999999999999999887766655543311 0
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.||.+|||+.++|+|+||...
T Consensus 237 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 -------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 11224678899999999999999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=392.66 Aligned_cols=249 Identities=17% Similarity=0.239 Sum_probs=193.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHH---HHHHhcCCCceeeec-------cceec
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREI---HILRRLDHINVIKLE-------GLVTS 211 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei---~iL~~L~HpnIvkl~-------~~~~~ 211 (720)
|++.+.||+|+||.||+|++..+|+.||||++..... .....+.+.+|+ .+|++++|||||+++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 3444559999999999999999999999999986533 445667889999 455556899999998 44433
Q ss_pred cC----------CC-----eEEEEEeeccccccccccCCC------CCCCHHHHHHHHHhhhhccccccccCcccccCcc
Q 004999 212 RM----------SC-----SLYLVFEYMEHDLAGLASHPG------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKG 270 (720)
Q Consensus 212 ~~----------~~-----~lyLV~Ey~~g~ll~~~~~~~------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP 270 (720)
.. .. ..||||||++|+|...+...+ ..+++..++.|+.||+.||.|||++||+||||||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp 234 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRP 234 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred cCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 21 01 379999999887766554321 1233588889999999999999999999999999
Q ss_pred eeEEEcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhcCC----------cCCCccccchhhHHHHHHHHhC
Q 004999 271 SNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA----------TYYGTAVDLWSTGCILAELYAG 340 (720)
Q Consensus 271 ~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~----------~~y~~~sDIWSLG~iL~ELltG 340 (720)
+||||+.++.+||+|||++..... .....+| +.|+|||++.+. ..|+.++||||||||||||++|
T Consensus 235 ~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg 309 (377)
T 3byv_A 235 VDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred HHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence 999999999999999999986432 3345567 999999999876 2489999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHH
Q 004999 341 KPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS 420 (720)
Q Consensus 341 ~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e 420 (720)
++||.+......+.. +......+++.+.+||.+||+.||.+|||+.+
T Consensus 310 ~~Pf~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e 356 (377)
T 3byv_A 310 DLPITKDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQ 356 (377)
T ss_dssp SCCC------CCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred CCCCcccccccchhh---------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence 999976543222111 11122578999999999999999999999999
Q ss_pred HHhCccCCC
Q 004999 421 ALRSEFFTM 429 (720)
Q Consensus 421 ~L~hp~f~~ 429 (720)
+|+||||+.
T Consensus 357 ~l~hp~f~~ 365 (377)
T 3byv_A 357 AMETPEYEQ 365 (377)
T ss_dssp HHTSHHHHH
T ss_pred HhhChHHHH
Confidence 999999963
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=380.02 Aligned_cols=281 Identities=21% Similarity=0.273 Sum_probs=209.6
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+.+|+.+|+.++||||+++++++.. ...+|||||
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 111 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICME 111 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEEEEE
Confidence 444445999999999999999999999999998653 45666788999999999999999999999887 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|++|+.+..+......+++..++.++.||+.||.|||+. ||+|+||||+||||+.++.+||+|||++...... ...
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 188 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 188 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C--
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---ccc
Confidence 999866655555555799999999999999999999996 9999999999999999999999999998754221 223
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhc-CCCChhhhhhcCCC-Ccccc
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLC-GSPSEDYWRKSKLP-HATIF 379 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~-g~p~~~~w~~~~l~-~~~~~ 379 (720)
..++|+.|+|||++.+.. |+.++||||||||+|+|++|..||.+....+....+.... +.+....+...... ....+
T Consensus 189 ~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp --CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred CCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence 457899999999998765 7999999999999999999999999877655433221111 11111000000000 00000
Q ss_pred ----CCCCccch----hhh-----cccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 380 ----KPQQPYKR----CVA-----ETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 380 ----~~~~~~~~----~~~-----e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.+...... ... .....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 00000000 000 0112468899999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=368.52 Aligned_cols=259 Identities=25% Similarity=0.341 Sum_probs=207.4
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
..|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 94 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWIM 94 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEEE
Confidence 34555666999999999999999999999999987543 2335678899999999999999999999876 5689999
Q ss_pred EeeccccccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 221 FEYMEHDLAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
|||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...... ...
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 173 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQK 173 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HHC
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-ccc
Confidence 99999866654433 3457999999999999999999999999999999999999999999999999987532111 011
Q ss_pred ccccccccCCCChhhhc----CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 300 LTSRVVTLWYRPPELLL----GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~----~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.....+|+.|+|||++. ....++.++|||||||++|+|++|.+||.+......+..+.+.....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 241 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT------------ 241 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC------------
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc------------
Confidence 23346899999999985 33447999999999999999999999999988777766654421100
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 242 --------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 242 --------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred --------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 01123568889999999999999999999999999999853
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=371.23 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=188.3
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++++++||||+++++++.. ...+|+||||+
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 95 (303)
T 2vwi_A 19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDELWLVMKLL 95 (303)
T ss_dssp EEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEES--SSCEEEEEECC
T ss_pred hhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCcEEEehhc
Confidence 33449999999999999999999999999875432 2345668899999999999999999999877 56799999999
Q ss_pred cccccccccC--------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 225 EHDLAGLASH--------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 225 ~g~ll~~~~~--------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
+++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.......
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 8755443332 34568999999999999999999999999999999999999999999999999997654321
Q ss_pred C----CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 297 N----QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 297 ~----~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
. .......+|+.|+|||++.+...++.++||||||||+|+|++|..||.+......+...........
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------- 247 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL-------- 247 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT--------
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc--------
Confidence 1 1223457899999999997644579999999999999999999999998776655544432111000
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......+....++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 248 -----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 248 -----------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp -----------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred -----------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 00001123345788999999999999999999999999999999854
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.06 Aligned_cols=257 Identities=27% Similarity=0.412 Sum_probs=198.3
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc----------
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR---------- 212 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~---------- 212 (720)
|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++||||+++++++...
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 45555699999999999999999999999999653 45567789999999999999999999987542
Q ss_pred -CCCeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 213 -MSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 213 -~~~~lyLV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
....+|+||||++++ |...+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 135789999999874 444444455578999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCC-------------CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 004999 291 FYDPDQ-------------NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIF 357 (720)
Q Consensus 291 ~~~~~~-------------~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~ 357 (720)
...... ........+|+.|+|||++.+...++.++|||||||++|+|++ +.+.+....+.+..+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--p~~~~~~~~~~~~~~~ 242 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLR 242 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS--CCSSHHHHHHHHHHHH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh--ccCCchhHHHHHHhcc
Confidence 653211 1223455789999999999876568999999999999999998 2222333333333332
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+ .......++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 243 ~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 243 SVSIEFP-------------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp STTCCCC-------------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred ccccccC-------------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 2110000 1122356788999999999999999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=365.67 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=207.8
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 103 (314)
T 3com_A 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWIVM 103 (314)
T ss_dssp CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEe
Confidence 34444559999999999999999999999999986532 3457899999999999999999999876 67899999
Q ss_pred eecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 222 EYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 222 Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
||++++.+..+. .....+++..++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++....... ...
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~ 182 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-AKR 182 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-SCB
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-ccc
Confidence 999985555443 345679999999999999999999999999999999999999999999999999998764322 223
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+......+..+.... .+
T Consensus 183 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~----------------- 243 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP----------------- 243 (314)
T ss_dssp CCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC-----------------
T ss_pred CccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc-----------------
Confidence 4457899999999998765 7999999999999999999999999887766655443211 00
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 244 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 244 --------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 001123468899999999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=368.27 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=203.4
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccC----CCeE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRM----SCSL 217 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~----~~~l 217 (720)
|++.+.||+|+||.||+|++..+++.||||++...... ...+.+|+.+++++ +||||+++++++.... ...+
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 34445599999999999999999999999999765432 34578999999999 7999999999987632 4579
Q ss_pred EEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 218 YLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
||||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999755444332 2357899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCCccccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 004999 296 QNQPLTSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
. .......+|+.|+|||++.+ ...++.++||||||||+|+|++|.+||.+......+..+..... +
T Consensus 183 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-------- 252 (326)
T 2x7f_A 183 V-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA-P-------- 252 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C--------
T ss_pred c-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc-c--------
Confidence 1 22334578999999999973 23479999999999999999999999998887776655543110 0
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......++..+.+||.+||..||.+|||+.++|+||||+..
T Consensus 253 ------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 253 ------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 00123578899999999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.07 Aligned_cols=272 Identities=23% Similarity=0.364 Sum_probs=210.8
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH---------------HHHHHHHHHHHHHHhcCCCceeeec
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP---------------ESVRFMAREIHILRRLDHINVIKLE 206 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~---------------~~~~~~~~Ei~iL~~L~HpnIvkl~ 206 (720)
.|++.+.||+|+||.||+|.+ +++.||||++....... .....+.+|+.++++|+||||++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 445555699999999999998 89999999987542111 1126788999999999999999999
Q ss_pred cceeccCCCeEEEEEeeccccccccc------cCC--CCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcC
Q 004999 207 GLVTSRMSCSLYLVFEYMEHDLAGLA------SHP--GLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDN 277 (720)
Q Consensus 207 ~~~~~~~~~~lyLV~Ey~~g~ll~~~------~~~--~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~ 277 (720)
+++.. ...+|+||||++++.+..+ ... ...+++..++.++.||+.||.|||+ +||+|+||||+||||+.
T Consensus 110 ~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 110 GIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99877 6789999999998555444 333 5679999999999999999999999 99999999999999999
Q ss_pred CCceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCc-cccchhhHHHHHHHHhCCCCCCCCCh-HHHHHH
Q 004999 278 NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT-AVDLWSTGCILAELYAGKPIMPGRTE-VEQLHK 355 (720)
Q Consensus 278 ~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~-~sDIWSLG~iL~ELltG~ppf~g~~~-~e~l~~ 355 (720)
++.+||+|||++...... ......+|+.|+|||++.+...++. ++||||||||+|+|++|.+||.+... .+.+..
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 999999999999876432 3345578999999999988744666 99999999999999999999998777 555555
Q ss_pred HHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 356 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 356 i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
+.......+.. + .....+.. ..........++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 265 i~~~~~~~~~~-~-------~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 265 IRTKNIEYPLD-R-------NHFLYPLT--NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HTSCCCCCCCS-S-------SSSTTTTC--C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HhccCcCCccc-h-------hhhhcccc--ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 53321111000 0 00000000 000112235689999999999999999999999999999999853
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=358.67 Aligned_cols=251 Identities=29% Similarity=0.448 Sum_probs=200.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+||+|+||.||+|.+..++..||||++.... ....+.+.+|+.+++.++||||+++++++.. ...+|+||||++++
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQVPGG 104 (295)
T ss_dssp EEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCSEE
T ss_pred EEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEEeCCCC
Confidence 5999999999999999999999999997653 3445678899999999999999999999876 67899999999875
Q ss_pred ccccccC-C--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-CCceeeeccccceecCCCCCCCcccc
Q 004999 228 LAGLASH-P--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 228 ll~~~~~-~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
.+..+.. . ...+++..++.++.||+.||.|||++||+|+||||+||||+. ++.+||+|||++....... ......
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 183 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETF 183 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cccccc
Confidence 5544433 2 235679999999999999999999999999999999999987 8999999999998764322 223345
Q ss_pred ccccCCCChhhhcCCc-CCCccccchhhHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 304 VVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ-LHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~-~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~-l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
.+|+.|+|||++.+.. .++.++|||||||++|+|++|..||.+...... +..... ...
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~------------------- 243 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-FKV------------------- 243 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-HCC-------------------
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-ccc-------------------
Confidence 7899999999997642 368999999999999999999999976543322 111111 000
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 244 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 244 -------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp -------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred -------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 012234678999999999999999999999999999999854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=364.24 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=191.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||+|.+..+++.||||++..........+.+..+..+++.++||||+++++++.. ...+||||||+++
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 108 (318)
T 2dyl_A 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGT 108 (318)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECCCSE
T ss_pred ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEEEEeccCC
Confidence 34999999999999999999999999998765544444555566667888899999999999877 6789999999965
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+..+.......+++..++.++.||+.||.|||+. ||+|+||||+||||+.++.+||+|||++..+... .......+
T Consensus 109 ~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~ 186 (318)
T 2dyl_A 109 CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD--KAKDRSAG 186 (318)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------------
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC--ccccccCC
Confidence 44444433356799999999999999999999995 9999999999999999999999999999765432 22334578
Q ss_pred ccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 306 TLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 306 T~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g-~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
|+.|+|||++.+ ...++.++||||||||+|+|++|..||.+ ....+.+..+.......
T Consensus 187 ~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 249 (318)
T 2dyl_A 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL----------------- 249 (318)
T ss_dssp CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-----------------
T ss_pred CccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-----------------
Confidence 999999999952 33478999999999999999999999987 44555555554321000
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+++.+.+||.+||+.||.+|||+.++|+||||+.
T Consensus 250 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 250 ---------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp ---------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred ---------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 0112357899999999999999999999999999999974
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=368.85 Aligned_cols=259 Identities=19% Similarity=0.266 Sum_probs=191.3
Q ss_pred cccceeecccCceEEEEEEECCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCC----
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC---- 215 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~---~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~---- 215 (720)
|++.+.||+|+||.||+|.+..++. .||||++..........+.+.+|+.++++++||||+++++++......
T Consensus 25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (323)
T 3qup_A 25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP 104 (323)
T ss_dssp CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence 3444559999999999999887765 799999987665566678899999999999999999999998763221
Q ss_pred eEEEEEeeccccccccccC------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 216 SLYLVFEYMEHDLAGLASH------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
..|+||||+.++.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 105 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a 184 (323)
T 3qup_A 105 IPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184 (323)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred ccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccc
Confidence 2499999999855543332 2226899999999999999999999999999999999999999999999999999
Q ss_pred eecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 290 SFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 290 ~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
........ .......+|+.|+|||++.+.. |+.++||||||||+|+|++ |.+||.+....+....+.....
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~------ 257 (323)
T 3qup_A 185 RKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR------ 257 (323)
T ss_dssp ----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC------
T ss_pred ccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC------
Confidence 86643222 1223345678899999998766 7999999999999999999 9999999888777666643211
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-------HHHHHhCccCCCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-------AASALRSEFFTMK 430 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-------a~e~L~hp~f~~~ 430 (720)
......+++.+.+||.+||+.||.+||| +.+++.|+|+...
T Consensus 258 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 258 ----------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred ----------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 1122467899999999999999999999 7888999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=374.31 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=202.8
Q ss_pred cceeecccCceEEEEEEEC-------CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCe
Q 004999 145 SFYLIGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~-------~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~ 216 (720)
+.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|+++ +||||+++++++.. ...
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~ 161 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGP 161 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS--SSS
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc--CCC
Confidence 3445999999999999874 356789999997653 455667899999999999 89999999999876 667
Q ss_pred EEEEEeeccccccccccC-C---------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc
Q 004999 217 LYLVFEYMEHDLAGLASH-P---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 280 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~-~---------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~ 280 (720)
+||||||+.++.+..+.. . ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 241 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV 241 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCC
Confidence 999999998755443332 1 235899999999999999999999999999999999999999999
Q ss_pred eeeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 004999 281 LKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 281 vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~ 358 (720)
+||+|||++..+..... .......+|+.|+|||++.+.. |+.++||||||||+|||++ |.+||.+....+.+..+..
T Consensus 242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~ 320 (370)
T 2psq_A 242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 320 (370)
T ss_dssp EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 99999999987643322 2233446688999999998766 7999999999999999999 9999998876665554432
Q ss_pred hcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.. .......++..+.+||.+||+.||.+|||+.+++++
T Consensus 321 ~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 321 GH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 011224678899999999999999999999999974
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=355.79 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=203.8
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||+|+||.||+|.+. ++..||||++....... +.+.+|+.++++++||||+++++++.. ...+|+||||++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~ 88 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEFME 88 (269)
T ss_dssp EEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEEEECCT
T ss_pred eheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEEEEEeCC
Confidence 344999999999999986 47779999998665433 457899999999999999999999876 567999999998
Q ss_pred ccccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 226 HDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 226 g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
++.+. .+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...............
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 168 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence 76554 44455567999999999999999999999999999999999999999999999999999866433322333445
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 169 ~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~--------------------- 226 (269)
T 4hcu_A 169 FPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------------------- 226 (269)
T ss_dssp CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---------------------
T ss_pred cccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccC---------------------
Confidence 678899999998766 7999999999999999999 99999998888777766442110
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....+++.+.+||.+||+.||.+|||+.+++++
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 227 -------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1123468899999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=365.81 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=204.5
Q ss_pred cccceeecccCceEEEEEEECCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~---~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
|++.++||+|+||.||+|.+..++. .||||+++... .....+.+.+|+.+|++|+||||+++++++.. ...+||
T Consensus 51 y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 127 (325)
T 3kul_A 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRLAMI 127 (325)
T ss_dssp EEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGCCEE
T ss_pred eEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCccEE
Confidence 3444559999999999999986554 59999997543 45556778999999999999999999999876 667899
Q ss_pred EEeeccccccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 220 VFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 220 V~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||||++++.+. .+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+......
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999875544 44445567999999999999999999999999999999999999999999999999999876543222
Q ss_pred C--ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 299 P--LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 299 ~--~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
. .....+|+.|+|||++.+.. |+.++||||||||+|||++ |..||.+....+.+..+......
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------- 273 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL------------- 273 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-------------
T ss_pred eeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-------------
Confidence 2 22234578899999998766 7999999999999999999 99999998888877776542111
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||..||..||.+|||+.++++
T Consensus 274 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 ---------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112367899999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=370.48 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=202.3
Q ss_pred ccceeecccCceEEEEEE-----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~-----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
++.+.||+|+||.||+|+ +..+++.||||+++... .....+.+.+|+.+|.++ +||||+++++++... ...+
T Consensus 25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~-~~~~ 102 (359)
T 3vhe_A 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPL 102 (359)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TSCC
T ss_pred eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-CCce
Confidence 344459999999999998 56677999999997543 345567789999999999 799999999998763 4558
Q ss_pred EEEEeeccccccccccCCC-------------------------------------------------------------
Q 004999 218 YLVFEYMEHDLAGLASHPG------------------------------------------------------------- 236 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~------------------------------------------------------------- 236 (720)
|+|||||.++.+..+....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 9999999975544333221
Q ss_pred -----CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-CCccccccccCCC
Q 004999 237 -----LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYR 310 (720)
Q Consensus 237 -----~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~ 310 (720)
..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... .......+|+.|+
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~ 262 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGC
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeE
Confidence 1289999999999999999999999999999999999999999999999999986643222 2233456799999
Q ss_pred ChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhh
Q 004999 311 PPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCV 389 (720)
Q Consensus 311 APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~ 389 (720)
|||++.+.. |+.++||||||||+|||++ |.+||.+....+.+.........+
T Consensus 263 aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------- 315 (359)
T 3vhe_A 263 APETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-------------------------- 315 (359)
T ss_dssp CHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC--------------------------
T ss_pred ChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC--------------------------
Confidence 999998765 7999999999999999998 999999877555554444321111
Q ss_pred hcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 390 AETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 390 ~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....+++.+.+||..||+.||.+|||+.++++|
T Consensus 316 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1223578899999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.99 Aligned_cols=247 Identities=21% Similarity=0.339 Sum_probs=199.3
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.++||+|+||.||+|.+..+++.||+|++.. .+....+.+.+|+.++++++||||+++++++.. ...+|+||||+
T Consensus 14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 89 (310)
T 3s95_A 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFITEYI 89 (310)
T ss_dssp EEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECC
T ss_pred ccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEEEEEec
Confidence 34459999999999999999999999999854 346677889999999999999999999999987 67899999999
Q ss_pred ccccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC----
Q 004999 225 EHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP---- 299 (720)
Q Consensus 225 ~g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~---- 299 (720)
+++.+.. +......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.......
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccc
Confidence 8755544 44446679999999999999999999999999999999999999999999999999998764332211
Q ss_pred ---------ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 300 ---------LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 300 ---------~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
....+||+.|+|||++.+.. |+.++||||||||+|||++|..+|..........
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---------------- 232 (310)
T 3s95_A 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---------------- 232 (310)
T ss_dssp ----------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------------
T ss_pred cccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------------
Confidence 11457899999999998765 7999999999999999999998886532210000
Q ss_pred cCCCCccccCCCCccc-hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 371 SKLPHATIFKPQQPYK-RCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~-~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
..... .........+++.+.+||.+||+.||++|||+.++++
T Consensus 233 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 233 -----------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -----------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00000 0011123568889999999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=354.04 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=203.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|.+. ++..||||++....... ..+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 84 (268)
T 3sxs_A 11 TLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSK--EYPIYIVTEY 84 (268)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEEEEEC
T ss_pred eeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEcc--CCceEEEEEc
Confidence 33444999999999999876 56779999998665433 457899999999999999999999876 6779999999
Q ss_pred ccccccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 224 MEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 224 ~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
++++.+. .+...+..+++.+++.++.||+.||.|||+.||+|+||||+||||+.++.+||+|||++.............
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9876444 443344469999999999999999999999999999999999999999999999999998765443333334
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 165 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 224 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL------------------- 224 (268)
T ss_dssp CCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------------------
T ss_pred CCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-------------------
Confidence 45677899999998766 7999999999999999999 99999998887777666432110
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....+++.+.+||..||+.||.+|||+.+++++
T Consensus 225 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 225 ---------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ---------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123467889999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=357.17 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=203.9
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~ 208 (720)
.+.|+.++. ||+|+||.||+|.+. ++..||||++....... +.+.+|+.++++++||||++++++
T Consensus 23 ~~~y~~~~~-----------lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 23 PKDLTFLKE-----------LGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp GGGEEEEEE-----------CC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHHHhHhh-----------cCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEE
Confidence 345666665 999999999999876 57789999998665433 457899999999999999999999
Q ss_pred eeccCCCeEEEEEeeccccccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 209 VTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 209 ~~~~~~~~lyLV~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
+.. ...+|+||||+.++.+. .+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||
T Consensus 88 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 88 CTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp ECS--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred Eec--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccc
Confidence 876 67799999999865444 443435579999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 288 la~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
++...............+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---- 240 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---- 240 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC----
T ss_pred ccccccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCC----
Confidence 99866433222233445678899999998766 7999999999999999998 99999998887777776542111
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....+++.+.+||..||+.||.+|||+.++|+|
T Consensus 241 ------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 241 ------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1123467889999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=353.77 Aligned_cols=251 Identities=19% Similarity=0.212 Sum_probs=205.0
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.+ +|+||+++++++.. ....|+|
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv 84 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLV 84 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEE
Confidence 345555699999999999999999999999998754322 3467899999999 79999999998876 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc-----eeeeccccceecCCC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-----LKIADFGLASFYDPD 295 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~-----vKL~DFGla~~~~~~ 295 (720)
|||+.++|...+...+..+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999966666666555567999999999999999999999999999999999999987776 999999999876543
Q ss_pred CCC------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChh
Q 004999 296 QNQ------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 296 ~~~------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~---~~e~l~~i~~~~g~p~~~ 366 (720)
... ......||+.|+|||++.+.. ++.++||||||||+|||++|..||.+.. ..+.+..+......++
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 241 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-- 241 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC--
T ss_pred cccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc--
Confidence 221 234557899999999998766 7999999999999999999999998843 3444444433211111
Q ss_pred hhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+++.+.+||..||+.||.+|||+.++++
T Consensus 242 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 242 ----------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp ----------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 22334578999999999999999999999999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=374.84 Aligned_cols=255 Identities=20% Similarity=0.314 Sum_probs=205.7
Q ss_pred cccceeecccCceEEEEEE-----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeE
Q 004999 143 SRSFYLIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~-----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~l 217 (720)
+++.+.||+|+||.||+|. +..+++.||||+++... .......+.+|+.++++++||||+++++++.. ....
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 149 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SLPR 149 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCCC
Confidence 3444559999999999999 45678899999997543 34555678899999999999999999999876 5678
Q ss_pred EEEEeeccccccc-cccC------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC---ceeeeccc
Q 004999 218 YLVFEYMEHDLAG-LASH------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG---ILKIADFG 287 (720)
Q Consensus 218 yLV~Ey~~g~ll~-~~~~------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g---~vKL~DFG 287 (720)
|||||||.|+.+. .+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.+| .+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 9999999874443 3322 124589999999999999999999999999999999999999555 59999999
Q ss_pred cceecCCC-CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 288 LASFYDPD-QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 288 la~~~~~~-~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
++..+... .........+|+.|+|||++.+.. |+.++||||||||||||++ |.+||.+....+.+..+.....
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~---- 304 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR---- 304 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC----
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 99754221 122334456799999999998766 7999999999999999998 9999999988777766644211
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......++..+.+||.+||+.||.+|||+.+++++.++..
T Consensus 305 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 ------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1122467889999999999999999999999999988753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=347.49 Aligned_cols=244 Identities=16% Similarity=0.183 Sum_probs=203.9
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.+.||+|+||.||+|++. +..||||++..........+.+.+|+.++++++||||+++++++.......+|+||||+
T Consensus 14 ~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (271)
T 3kmu_A 14 FLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91 (271)
T ss_dssp EEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred HHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence 3344999999999999984 88899999998777777778899999999999999999999998875457899999999
Q ss_pred cccccccccCCCC--CCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 225 EHDLAGLASHPGL--KFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 225 ~g~ll~~~~~~~~--~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
+++.+..+..... .+++.+++.++.||+.||.|||++| |+|+||||+||||+.++.++|+|||++.... .
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~------~ 165 (271)
T 3kmu_A 92 PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------S 165 (271)
T ss_dssp TTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS------C
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec------c
Confidence 9754444443332 5899999999999999999999999 9999999999999999999999999876432 1
Q ss_pred cccccccCCCChhhhcCCcC--CCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 301 TSRVVTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~--y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
....+|+.|+|||++.+... ++.++|||||||++|||++|..||.+....+....+......+
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------- 230 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--------------- 230 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---------------
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC---------------
Confidence 33478999999999987542 2337999999999999999999999988877766664421111
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 231 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 231 ------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 123468899999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=362.93 Aligned_cols=249 Identities=20% Similarity=0.207 Sum_probs=201.0
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.++++| +||||+++++++.. ...+||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~ 84 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVL 84 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEE
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEE
Confidence 44455699999999999999999999999998765332 2467899999999 99999999999877 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc-----eeeeccccceecCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI-----LKIADFGLASFYDPDQ 296 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~-----vKL~DFGla~~~~~~~ 296 (720)
||+.++|...+......+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..+....
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99966666665554568999999999999999999999999999999999999998887 9999999998764332
Q ss_pred CC------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhcCCCChhh
Q 004999 297 NQ------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT---EVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 297 ~~------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~---~~e~l~~i~~~~g~p~~~~ 367 (720)
.. .....+||+.|+|||++.+.. ++.++||||||||||||++|.+||.+.. ..+.+..+.......+
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~--- 240 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP--- 240 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC---
T ss_pred CCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC---
Confidence 21 124567899999999998866 7999999999999999999999998843 3334444432111110
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+| .+.+||..||+.||.+||++.++++
T Consensus 241 ---------------------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 241 ---------------------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ---------------------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ---------------------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111123355 8999999999999999999988876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=359.44 Aligned_cols=248 Identities=23% Similarity=0.312 Sum_probs=193.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+.||+|+||.||+|.+..+++.||||++..... +....+.+.+|+.++++++||||+++++++.. ...+|+||||++
T Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~ 117 (309)
T 2h34_A 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLYVDMRLIN 117 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCC
T ss_pred EEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEEEEEEecC
Confidence 349999999999999999999999999976543 44556788999999999999999999999877 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...............+
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 197 (309)
T 2h34_A 118 GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVG 197 (309)
T ss_dssp CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------------C
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCC
Confidence 86655555545579999999999999999999999999999999999999999999999999998765443334455678
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..... +..........
T Consensus 198 ~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~---------------------- 253 (309)
T 2h34_A 198 TLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPR---------------------- 253 (309)
T ss_dssp CGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-HHHHHHSCCCC----------------------
T ss_pred CcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCCCCchHHH-HHHHhccCCCC----------------------
Confidence 99999999998765 7999999999999999999999998876543 33322211100
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCC-CHHHHHh
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRG-SAASALR 423 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-Ta~e~L~ 423 (720)
.......+++.+.+||.+||+.||.+|| |+.++++
T Consensus 254 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1123357889999999999999999999 6776665
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.58 Aligned_cols=250 Identities=20% Similarity=0.290 Sum_probs=193.4
Q ss_pred ccccceeecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
.|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.++++++||||+++++++. ...+|
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~ 91 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPVW 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSCE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc---cCccE
Confidence 344455599999999999998653 5679999987542 3455677899999999999999999999874 35689
Q ss_pred EEEeecccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 219 LVFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 219 LV~Ey~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
+||||+.++.+ ..+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 99999997544 44444455799999999999999999999999999999999999999999999999999987654333
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.......+|+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+....+.+..+.....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~--------------- 235 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------------- 235 (281)
T ss_dssp -------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---------------
T ss_pred cccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---------------
Confidence 3333445688999999998765 7999999999999999996 9999998887776666543210
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 236 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 236 -------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01224688999999999999999999999999874
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=364.09 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=203.0
Q ss_pred cceeecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 145 SFYLIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
+.+.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.++++++||||+++++++.. ...+||
T Consensus 51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 127 (343)
T 1luf_A 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--GKPMCL 127 (343)
T ss_dssp EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEE
T ss_pred eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc--CCceEE
Confidence 3344999999999999987 456899999997543 45566788999999999999999999999876 667999
Q ss_pred EEeeccccccccccCC------------------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE
Q 004999 220 VFEYMEHDLAGLASHP------------------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI 275 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~------------------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl 275 (720)
||||++++.+..+... ...+++.+++.++.||+.||.|||++||+||||||+||||
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV 207 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE
Confidence 9999987544433321 2579999999999999999999999999999999999999
Q ss_pred cCCCceeeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHH
Q 004999 276 DNNGILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 353 (720)
Q Consensus 276 d~~g~vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l 353 (720)
+.++.+||+|||++........ .......+|+.|+|||++.+.. ++.++||||||||+|||++ |..||.+....+.+
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 286 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH
Confidence 9999999999999976532221 2223456789999999998766 7999999999999999999 99999998877776
Q ss_pred HHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 354 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 354 ~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
..+.... .......+++.+.+||..||+.||.+|||+.+++++
T Consensus 287 ~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 287 YYVRDGN----------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp HHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCCC----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 6654311 011224678899999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=357.29 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=202.9
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC--CCceeeeccceeccCCCeEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD--HINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~--HpnIvkl~~~~~~~~~~~lyL 219 (720)
.|++.+.||+|+||.||+|.+. +++.||||++............+.+|+.+++++. ||||+++++++.. ...+||
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~~l 105 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYIYM 105 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEEEE
T ss_pred eEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEEEE
Confidence 3445555999999999999985 5888999999887777777888999999999997 5999999999876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ- 298 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~- 298 (720)
|||+..++|...+.. ...+++.+++.++.||+.||.|||++||+|+||||+||||+ ++.+||+|||++..+......
T Consensus 106 v~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 106 VMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccccc
Confidence 999777766665544 34789999999999999999999999999999999999996 589999999999876433221
Q ss_pred CccccccccCCCChhhhcCC----------cCCCccccchhhHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCChhh
Q 004999 299 PLTSRVVTLWYRPPELLLGA----------TYYGTAVDLWSTGCILAELYAGKPIMPGRTE-VEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~----------~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~-~e~l~~i~~~~g~p~~~~ 367 (720)
.....++|+.|+|||++.+. ..++.++||||||||+|+|++|..||.+... ...+..+.....
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~------ 257 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH------ 257 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS------
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc------
Confidence 22345789999999999752 3478999999999999999999999987543 333333321100
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
........+..+.+||.+||+.||.+|||+.++|+||||+....+
T Consensus 258 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 258 ---------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp ---------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred ---------------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 001123457889999999999999999999999999999876443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=359.08 Aligned_cols=249 Identities=21% Similarity=0.297 Sum_probs=203.1
Q ss_pred ccceeecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 144 RSFYLIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
.+.+.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+|+.++||||+++++++.. ...+|
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 102 (314)
T 2ivs_A 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--DGPLL 102 (314)
T ss_dssp EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSCE
T ss_pred eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec--CCceE
Confidence 3444599999999999998 3456899999997543 45667789999999999999999999999876 66799
Q ss_pred EEEeeccccccccccCCC------------------------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEE
Q 004999 219 LVFEYMEHDLAGLASHPG------------------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLL 274 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~------------------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NIL 274 (720)
+||||+.++.+..+.... ..+++.+++.++.||+.||.|||++||+|+||||+|||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl 182 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence 999999965544333221 24899999999999999999999999999999999999
Q ss_pred EcCCCceeeeccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHH
Q 004999 275 IDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQ 352 (720)
Q Consensus 275 ld~~g~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~ 352 (720)
|+.++.+||+|||++......... ......+|+.|+|||++.+.. ++.++||||||||+|||++ |..||.+....+.
T Consensus 183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876433221 223345688999999998765 7999999999999999999 9999998877655
Q ss_pred HHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 353 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 353 l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
...+.... .......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 262 ~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 262 FNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54443211 011224678999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=352.21 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=193.6
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|++.. .||||+++.........+.+.+|+.+|++++||||++++++.. ...+++||||
T Consensus 27 ~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~lv~e~ 100 (289)
T 3og7_A 27 TVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLAIVTQW 100 (289)
T ss_dssp EEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEEEC
T ss_pred eeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccEEEEEe
Confidence 334449999999999998643 4999999887777777888999999999999999999999653 4568999999
Q ss_pred cccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC-CCCCcc
Q 004999 224 MEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD-QNQPLT 301 (720)
Q Consensus 224 ~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~-~~~~~t 301 (720)
++++.+ ..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...... ......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE 180 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccccc
Confidence 997555 444445667999999999999999999999999999999999999999999999999999765421 122334
Q ss_pred ccccccCCCChhhhcC--CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 302 SRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
...||+.|+|||++.. ...++.++||||||||+|+|++|..||.+....+.+..+......+.
T Consensus 181 ~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------- 245 (289)
T 3og7_A 181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP--------------- 245 (289)
T ss_dssp ---CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC---------------
T ss_pred ccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc---------------
Confidence 4578999999999862 33478899999999999999999999998777666655544221110
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.+......+++.+.+||.+||+.||.+|||+.++++
T Consensus 246 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 --------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp --------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 012233468899999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=364.12 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=182.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHH-HHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIH-ILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~-iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
.||+|+||.||+|.+..+++.||||++..... ......+.+|+. +++.++||||+++++++.. ...+||||||+++
T Consensus 29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~lv~e~~~~ 105 (327)
T 3aln_A 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCWICMELMST 105 (327)
T ss_dssp EEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEEEEECCCSE
T ss_pred eeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceEEEEeecCC
Confidence 39999999999999999999999999986543 334445556666 6777899999999999876 6789999999999
Q ss_pred cccccccC----CCCCCCHHHHHHHHHhhhhcccccccc-CcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 227 DLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 227 ~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~-gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
++...+.. ....+++..+..++.||+.||.|||+. ||+|+||||+||||+.++.+||+|||++..+... ....
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~ 183 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--IAKT 183 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc--cccc
Confidence 76554432 355789999999999999999999999 9999999999999999999999999999865432 2223
Q ss_pred ccccccCCCChhhhc---CCcCCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 302 SRVVTLWYRPPELLL---GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~---~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~-e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
...||+.|+|||++. ....++.++||||||||+|+|++|..||.+.... +.+..+.. +.
T Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~--------------- 246 (327)
T 3aln_A 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GD--------------- 246 (327)
T ss_dssp ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCC--SC---------------
T ss_pred cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhc--CC---------------
Confidence 447899999999984 2334799999999999999999999999875432 11111100 00
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.+.. .......+++.+.+||.+||+.||.+|||+.++|+||||..
T Consensus 247 --~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 247 --PPQL-----SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp --CCCC-----CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred --CCCC-----CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 0000 01122468899999999999999999999999999999974
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=362.36 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=198.9
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhc----CCCceeeeccceeccC
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRL----DHINVIKLEGLVTSRM 213 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~L----~HpnIvkl~~~~~~~~ 213 (720)
.|++.+.||+|+||.||+|++..+++.||||++....... .....+.+|+.++.++ +||||+++++++..
T Consensus 32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~-- 109 (312)
T 2iwi_A 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET-- 109 (312)
T ss_dssp -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC----
T ss_pred ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec--
Confidence 3444555999999999999999999999999997654322 1233456899999999 89999999999876
Q ss_pred CCeEEEEEee-ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc-CCCceeeecccccee
Q 004999 214 SCSLYLVFEY-MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASF 291 (720)
Q Consensus 214 ~~~lyLV~Ey-~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld-~~g~vKL~DFGla~~ 291 (720)
....|+|||| +.++.+..+......+++..++.++.||+.||.|||++||+|+||||+||||+ .++.+||+|||++..
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 5678999999 66655554444455799999999999999999999999999999999999999 889999999999987
Q ss_pred cCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
.... ......+|+.|+|||++.+...++.++||||||||+|+|++|+.||.+... +...
T Consensus 190 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~------------ 248 (312)
T 2iwi_A 190 LHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------ILEA------------ 248 (312)
T ss_dssp CCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHT------------
T ss_pred cccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hhhh------------
Confidence 6432 234567899999999998766556699999999999999999999975421 1110
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.......++..+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 249 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 249 -----------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp -----------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred -----------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 001224578899999999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=366.77 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=204.5
Q ss_pred ccceeecccCceEEEEEEECC-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCC
Q 004999 144 RSFYLIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 215 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~-------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~ 215 (720)
.+.+.||+|+||.||+|.+.. .+..||||++... ........+.+|+.+++++ +||||+++++++.. ..
T Consensus 72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~ 148 (382)
T 3tt0_A 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--DG 148 (382)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc--CC
Confidence 344459999999999999753 3467999999765 3455667889999999999 89999999999876 66
Q ss_pred eEEEEEeeccccccccccC-C---------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 216 SLYLVFEYMEHDLAGLASH-P---------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~-~---------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
.+||||||++++.+..+.. . ...+++.+++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 228 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 228 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence 7999999998754443332 1 23599999999999999999999999999999999999999999
Q ss_pred ceeeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 004999 280 ILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIF 357 (720)
Q Consensus 280 ~vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~ 357 (720)
.+||+|||++........ .......+|+.|+|||++.+.. ++.++||||||||+|+|++ |..||.+....+....+.
T Consensus 229 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~ 307 (382)
T 3tt0_A 229 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307 (382)
T ss_dssp CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999986643222 2233446789999999998766 7999999999999999999 999999988776665554
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.... ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 308 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 308 EGHR----------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTCC----------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCC----------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3210 11224678999999999999999999999999985
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=366.61 Aligned_cols=266 Identities=22% Similarity=0.248 Sum_probs=196.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC--CCeEEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM--SCSLYLVF 221 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~--~~~lyLV~ 221 (720)
++.++||+|+||.||+|++. ++.||||++.... .......+|+.+|++++||||+++++++.... ...+||||
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred hhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 33444999999999999875 7899999997542 33345567999999999999999999987643 23589999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhcccccccc----------CcccccCcceeEEEcCCCceeeecccccee
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR----------GVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~----------gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
||++++.+..+... ..+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..
T Consensus 102 e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 102 AFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 99988555544443 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CCccccccccCCCChhhhcCC----cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChh
Q 004999 292 YDPDQN-QPLTSRVVTLWYRPPELLLGA----TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSED 366 (720)
Q Consensus 292 ~~~~~~-~~~t~~~gT~~Y~APE~l~~~----~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~ 366 (720)
+..... ......+||+.|+|||++.+. ..++.++||||||||+|||++|++||.+................+...
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 654332 223446789999999999873 235678999999999999999999998754422221122222233332
Q ss_pred hhhhcCCCCccccCCCCccchhhhccc--CCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 367 YWRKSKLPHATIFKPQQPYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 367 ~w~~~~l~~~~~~~~~~~~~~~~~e~~--~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.+......... .+. +...+ ...++.+.+||.+||+.||.+|||+.++++
T Consensus 261 ~~~~~~~~~~~--~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 261 DMQEVVVHKKK--RPV------LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHTTSCC--CCC------CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhhhcccC--CCC------ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22211110000 000 00001 123456999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.60 Aligned_cols=266 Identities=22% Similarity=0.352 Sum_probs=196.4
Q ss_pred cccceeecccCceEEEEEE----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
+++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|++++||||+++++++.......+|
T Consensus 12 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred hhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 4444559999999999998 5678999999998754 356667889999999999999999999988664456789
Q ss_pred EEEeecccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 219 LVFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 219 LV~Ey~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
+||||++++.+ ..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-------
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcc
Confidence 99999987444 44444444699999999999999999999999999999999999999999999999999987643322
Q ss_pred --CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 298 --QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 298 --~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.......+|+.|+|||++.+.. ++.++|||||||++|||++|..+|..... ..... .+......+....+..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 170 FFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRM---IGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHH--HHHHH---HCTTCCTHHHHHHHHH
T ss_pred eeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChH--HHHhh---hcCccccchhHHHHHH
Confidence 1223345678899999998776 79999999999999999999988754321 11111 1111100000000000
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.... .........+++.+.+||..||+.||.+|||+.++++
T Consensus 244 --~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 244 --LLKN-----NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp --HHHT-----TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --HHhc-----cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000 0001123468899999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=366.59 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=203.8
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhcC--CCceeeeccceeccCCC
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLD--HINVIKLEGLVTSRMSC 215 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIvkl~~~~~~~~~~ 215 (720)
.|++.++||+|+||.||+|++..+++.||||++....... .....+.+|+.+++++. |+||+++++++.. ..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~--~~ 121 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--PD 121 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--SS
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--CC
Confidence 3444455999999999999999999999999998654321 12234678999999996 5999999999876 67
Q ss_pred eEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc-CCCceeeeccccceecC
Q 004999 216 SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID-NNGILKIADFGLASFYD 293 (720)
Q Consensus 216 ~lyLV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld-~~g~vKL~DFGla~~~~ 293 (720)
.+|+||||+.+ ..+..+......+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++....
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~ 201 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 201 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred cEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccc
Confidence 89999999974 44443333345799999999999999999999999999999999999999 78999999999998764
Q ss_pred CCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCC
Q 004999 294 PDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373 (720)
Q Consensus 294 ~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l 373 (720)
.. ......+|+.|+|||++.+...++.++||||||||+|||++|..||.+... +... .
T Consensus 202 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~--~----------- 259 (320)
T 3a99_A 202 DT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRG--Q----------- 259 (320)
T ss_dssp SS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHC--C-----------
T ss_pred cc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhcc--c-----------
Confidence 32 234557899999999998776567899999999999999999999965421 1110 0
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
......+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 260 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 ----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 011245789999999999999999999999999999998653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=353.32 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=204.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|.+..++..||||++.... ...+.+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e~ 90 (288)
T 3kfa_A 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEF 90 (288)
T ss_dssp EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSEEEEEEC
T ss_pred eEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCEEEEEEc
Confidence 33445999999999999999999999999997543 345678899999999999999999999876 6679999999
Q ss_pred ccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+.|+.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++............
T Consensus 91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 99654443332 3456999999999999999999999999999999999999999999999999999876544433334
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.........+.....
T Consensus 171 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~------------------- 230 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------------- 230 (288)
T ss_dssp TEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-------------------
T ss_pred CCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-------------------
Confidence 456688999999998766 7999999999999999999 9999998776655554432110
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||..||..||.+|||+.++++
T Consensus 231 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 231 ---------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 1122467899999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=354.44 Aligned_cols=253 Identities=19% Similarity=0.248 Sum_probs=197.3
Q ss_pred cccceeecccCceEEEEEEECC---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCC---e
Q 004999 143 SRSFYLIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC---S 216 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~---tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~---~ 216 (720)
|.+.++||+|+||.||+|.+.. ++..||||++..........+.+.+|+.++++++||||+++++++...... .
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 4455569999999999998765 566899999987776777778899999999999999999999998764322 4
Q ss_pred EEEEEeecccccccccc------CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 217 LYLVFEYMEHDLAGLAS------HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~------~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
.|+||||++++.+..+. .....+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~ 195 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcce
Confidence 69999999975554333 344579999999999999999999999999999999999999999999999999998
Q ss_pred ecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhh
Q 004999 291 FYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 291 ~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w 368 (720)
.+..... .......+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------- 267 (313)
T 3brb_A 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR------- 267 (313)
T ss_dssp ---------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-------
T ss_pred ecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-------
Confidence 6643221 1223345688999999998766 7999999999999999999 8899998877666665543210
Q ss_pred hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+++.+.+||.+||..||.+|||+.+++++
T Consensus 268 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 268 ---------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11234688999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=346.43 Aligned_cols=245 Identities=28% Similarity=0.379 Sum_probs=191.8
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC--HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE--PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~--~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
++.+.||+|+||.||+|.+ ++..||||+++..... ....+.+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 10 ~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 85 (271)
T 3dtc_A 10 TLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNLCLVM 85 (271)
T ss_dssp EEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--CEEEE
T ss_pred eeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceEEEE
Confidence 3444599999999999998 4888999998765332 2335678899999999999999999999876 56789999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccC---cccccCcceeEEEcC--------CCceeeeccccce
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG---VLHRDIKGSNLLIDN--------NGILKIADFGLAS 290 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g---IvHrDIKP~NILld~--------~g~vKL~DFGla~ 290 (720)
||++++.+..+.. ...+++..++.++.||+.||.|||++| |+|+||||+||||+. ++.+||+|||++.
T Consensus 86 e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999877666654 347999999999999999999999999 899999999999986 7789999999998
Q ss_pred ecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 291 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 291 ~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
...... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.........+......
T Consensus 165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 232 (271)
T 3dtc_A 165 EWHRTT---KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA-------- 232 (271)
T ss_dssp --------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--------
T ss_pred cccccc---ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--------
Confidence 654322 23457899999999998765 799999999999999999999999998877666554321100
Q ss_pred cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 233 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 233 -------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 11224678899999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=352.83 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=204.1
Q ss_pred ccccceeecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCC
Q 004999 142 FSRSFYLIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 215 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~ 215 (720)
.|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.++++| +||||+++++++.. ..
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~ 100 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GG 100 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--CC
Confidence 344555699999999999985 4678899999998653 344567789999999999 99999999999876 56
Q ss_pred eEEEEEeeccccccc-cccCCC-----------------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC
Q 004999 216 SLYLVFEYMEHDLAG-LASHPG-----------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 277 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~-~~~~~~-----------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~ 277 (720)
.+|+||||++++.+. .+.... ..+++.+++.++.||+.||.|||++||+|+||||+||||+.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence 789999999874443 333222 24899999999999999999999999999999999999999
Q ss_pred CCceeeeccccceecCCCCCCC-ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 004999 278 NGILKIADFGLASFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHK 355 (720)
Q Consensus 278 ~g~vKL~DFGla~~~~~~~~~~-~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~ 355 (720)
++.+||+|||++.......... .....+|+.|+|||++.+.. ++.++||||||||+|+|++ |.+||.+......+..
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 259 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence 9999999999998765433221 22345688999999998765 7999999999999999999 9999998776555555
Q ss_pred HHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 356 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 356 i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
+......+ .....++..+.+||.+||+.||.+|||+.+++++
T Consensus 260 ~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 260 MIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhccCCCC---------------------------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 44321111 1123578899999999999999999999999974
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=371.82 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=201.9
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||+|++..+++.||||+++.. ........+.+|+.+|++++||||+++++++.. ...+|||||||++
T Consensus 120 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQG 196 (377)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEEECCTT
T ss_pred eEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcEEEEEcCCC
Confidence 3499999999999999999999999998754 345556678899999999999999999999876 5679999999986
Q ss_pred c-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-ccccc
Q 004999 227 D-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-LTSRV 304 (720)
Q Consensus 227 ~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~t~~~ 304 (720)
+ +...+...+..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.......... .....
T Consensus 197 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~ 276 (377)
T 3cbl_A 197 GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQ 276 (377)
T ss_dssp CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCE
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCC
Confidence 4 444444444568999999999999999999999999999999999999999999999999998653221111 11223
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+++.|+|||++.+.. |+.++|||||||+||||++ |.+||.+....+....+.+....
T Consensus 277 ~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------------------- 334 (377)
T 3cbl_A 277 VPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL--------------------- 334 (377)
T ss_dssp EEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCC---------------------
T ss_pred CCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------------------
Confidence 577899999998765 7999999999999999998 99999998877665555331100
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||..||+.||.+|||+.++++
T Consensus 335 -------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 335 -------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112357889999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=353.20 Aligned_cols=267 Identities=24% Similarity=0.338 Sum_probs=197.9
Q ss_pred ccccceeecccCceEEEEEE----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~l 217 (720)
++++.+.||+|+||.||+|+ +..+++.||||++..... ......+.+|+.+|+.++||||+++++++.......+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 34555569999999999999 577899999999976532 2345678899999999999999999999987555779
Q ss_pred EEEEeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 218 YLVFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
|+||||++++.+..+. .....+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.......
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 180 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCCC
Confidence 9999999875544443 445579999999999999999999999999999999999999999999999999998765433
Q ss_pred C--CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 297 N--QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 297 ~--~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
. .......+|..|+|||++.+.. ++.++|||||||++|+|++|..|+... ..... ...+.......... ..
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~--~~~~~---~~~~~~~~~~~~~~-~~ 253 (302)
T 4e5w_A 181 EYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSP--MALFL---KMIGPTHGQMTVTR-LV 253 (302)
T ss_dssp CEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSH--HHHHH---HHHCSCCGGGHHHH-HH
T ss_pred cceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcch--hhHHh---hccCCcccccCHHH-HH
Confidence 2 2233456788899999998766 689999999999999999999875322 11111 11111111000000 00
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
. ... ..........+++.+.+||.+||+.||.+|||+.++++
T Consensus 254 ~--~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 254 N--TLK-----EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp H--HHH-----TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred H--HHh-----ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0 000 00011123468899999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=348.26 Aligned_cols=243 Identities=22% Similarity=0.317 Sum_probs=197.2
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH--HHH---HHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP--ESV---RFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~--~~~---~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
.+.||+|+||.||+|++..+++.||||++....... ... +.+.+|+.++++++||||+++++++... .++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----~~lv 99 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP----PRMV 99 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT----TEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC----CeEE
Confidence 334999999999999999999999999997654322 211 6788999999999999999999988652 2799
Q ss_pred Eeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCCCc-----eeeeccccceec
Q 004999 221 FEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGI-----LKIADFGLASFY 292 (720)
Q Consensus 221 ~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~g~-----vKL~DFGla~~~ 292 (720)
|||+.+ ++...+......+++..++.++.||+.||.|||++| |+|+||||+||||+.++. +||+|||++...
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp EECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCC
T ss_pred EEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccc
Confidence 999985 555666666668999999999999999999999999 999999999999988776 999999999753
Q ss_pred CCCCCCCccccccccCCCChhhhcC-CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCChhhhh
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLG-ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQ--LHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~-~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~--l~~i~~~~g~p~~~~w~ 369 (720)
.. ......+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.+...... ...+... +.
T Consensus 180 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~------- 247 (287)
T 4f0f_A 180 VH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE-GL------- 247 (287)
T ss_dssp SS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS-CC-------
T ss_pred cc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc-CC-------
Confidence 22 3345678999999999843 33478999999999999999999999987553322 3333221 10
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 248 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 -------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01123467899999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=360.64 Aligned_cols=252 Identities=22% Similarity=0.325 Sum_probs=200.0
Q ss_pred ccceeecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
.+.+.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+|++| +||||+++++++.. ...+
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 124 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL--SGPI 124 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--CCcc
Confidence 3344599999999999997 3467789999997543 234456789999999999 89999999999876 5679
Q ss_pred EEEEeecccc-ccccccCCC----------------------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEE
Q 004999 218 YLVFEYMEHD-LAGLASHPG----------------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLL 274 (720)
Q Consensus 218 yLV~Ey~~g~-ll~~~~~~~----------------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NIL 274 (720)
||||||++++ |...+.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 204 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence 9999999874 444433322 23799999999999999999999999999999999999
Q ss_pred EcCCCceeeeccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHH
Q 004999 275 IDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQ 352 (720)
Q Consensus 275 ld~~g~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~ 352 (720)
|+.++.+||+|||++..+...... ......+|+.|+|||++.+.. ++.++||||||||||+|+| |.+||.+......
T Consensus 205 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 283 (344)
T 1rjb_A 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 283 (344)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHH
Confidence 999999999999999866433222 223345688999999998765 7999999999999999998 9999998776555
Q ss_pred HHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 353 LHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 353 l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
+..+...... ......+++.+.+||.+||+.||.+|||+.+++++-.
T Consensus 284 ~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 284 FYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 5554432111 0112357899999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=353.26 Aligned_cols=243 Identities=16% Similarity=0.200 Sum_probs=195.3
Q ss_pred cccceeecccCceEEEEEEECCCC-------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCC
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQK-------KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC 215 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~ 215 (720)
|.+.+.||+|+||.||+|++..++ ..||+|++.... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 85 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVC--GD 85 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--TT
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--CC
Confidence 344445999999999999998777 579999986543 3445678999999999999999999999876 56
Q ss_pred eEEEEEeeccccccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc--------eeeecc
Q 004999 216 SLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI--------LKIADF 286 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~--------vKL~DF 286 (720)
..|+||||+.++.+. .+......+++.+++.++.||+.||.|||++||+||||||+||||+.++. +||+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 789999999965444 44444445999999999999999999999999999999999999998887 999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCCh
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
|++.... ......+|+.|+|||++.+...++.++|||||||++|||++|. ++|.+........ +....
T Consensus 166 g~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~~~----- 234 (289)
T 4fvq_A 166 GISITVL-----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDR----- 234 (289)
T ss_dssp CSCTTTS-----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-HHHTT-----
T ss_pred ccccccc-----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH-Hhhcc-----
Confidence 9986542 1234567999999999988556899999999999999999955 5555554443332 22210
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 235 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 ------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp ------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 01123456779999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=350.81 Aligned_cols=244 Identities=20% Similarity=0.278 Sum_probs=199.7
Q ss_pred eecccCceEEEEEE--ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRAR--DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~--~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|. +..+++.||||+++.........+.+.+|+.+++.++||||+++++++. ...+|+||||+.
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~ 100 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AESWMLVMEMAE 100 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SSSEEEEEECCT
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CCCcEEEEEeCC
Confidence 59999999999995 4567889999999876555566778999999999999999999999883 456899999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC--Ccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLTSR 303 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~--~~t~~ 303 (720)
++.+..+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++......... .....
T Consensus 101 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 180 (291)
T 1xbb_A 101 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180 (291)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccC
Confidence 7666655555567999999999999999999999999999999999999999999999999999876443221 12223
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.... .
T Consensus 181 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~-------------------- 238 (291)
T 1xbb_A 181 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R-------------------- 238 (291)
T ss_dssp CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C--------------------
T ss_pred CCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-C--------------------
Confidence 4578899999998766 7899999999999999999 999999988766655553310 0
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||.+||+.||.+|||+.++++
T Consensus 239 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 239 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122467899999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=348.26 Aligned_cols=252 Identities=21% Similarity=0.227 Sum_probs=201.8
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+.++... ...+|+||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv~ 84 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVM 84 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCC-CCceEEEE
Confidence 445555699999999999999999999999998765432 2478999999999998877777665432 66789999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE---cCCCceeeeccccceecCCCCCC
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl---d~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||+++++...+......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.........
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 999766666665455679999999999999999999999999999999999999 48899999999999876543221
Q ss_pred ------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhhh
Q 004999 299 ------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 299 ------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---~e~l~~i~~~~g~p~~~~w~ 369 (720)
......+|+.|+|||++.+.. ++.++||||||||+|||++|+.||.+... .+.+..+.......+
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 238 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----- 238 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-----
T ss_pred cccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-----
Confidence 224557899999999998876 79999999999999999999999987432 223333322110000
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+++.+.+||..||+.||.+|||+.++++
T Consensus 239 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 239 -------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11233568999999999999999999999999886
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=353.88 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=202.7
Q ss_pred ccccceeecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCC
Q 004999 142 FSRSFYLIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSC 215 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~ 215 (720)
.|++.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~ 105 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GG 105 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-TS
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-CC
Confidence 344555699999999999985 4677899999997653 345567789999999999 799999999988653 45
Q ss_pred eEEEEEeeccccccccccCCCC----------------CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 216 SLYLVFEYMEHDLAGLASHPGL----------------KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~~~~----------------~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
.+|+||||++++.+..+..... .+++..++.++.||+.||.|||++||+|+||||+||||+.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 6899999999755544433222 289999999999999999999999999999999999999999
Q ss_pred ceeeeccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 004999 280 ILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIF 357 (720)
Q Consensus 280 ~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~ 357 (720)
.+||+|||++..+...... ......+|+.|+|||++.+.. ++.++||||||||+|+|++ |..||.+....+.+....
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 264 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence 9999999999866433221 223446789999999998766 7999999999999999998 999998876544443333
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
..... ......+++.+.+||..||+.||.+|||+.++++|
T Consensus 265 ~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 265 KEGTR---------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCcc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22111 01123578899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=356.88 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=184.2
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceec------cCCC
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTS------RMSC 215 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~------~~~~ 215 (720)
|++.++||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++++. ||||+++++++.. ....
T Consensus 30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 44555699999999999999999999999998654 3455677899999999996 9999999998742 2245
Q ss_pred eEEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEcCCCceeeecccccee
Q 004999 216 SLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
.+|+||||++|++...+.. ....+++.+++.++.||+.||.|||++| |+|+||||+||||+.++.+||+|||++..
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred eEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 6899999999987776543 3457999999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCC-----------CccccccccCCCChhhhc--CCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 004999 292 YDPDQNQ-----------PLTSRVVTLWYRPPELLL--GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 292 ~~~~~~~-----------~~t~~~gT~~Y~APE~l~--~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~ 358 (720)
....... ......+|+.|+|||++. ....++.++||||||||+|+|++|..||.+......+.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 267 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------CC
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCccc
Confidence 6432221 112446899999999984 233478999999999999999999999976544332211100
Q ss_pred hcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
.......+..+.+||.+||+.||.+|||+.+++++-+
T Consensus 268 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 268 -------------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred -------------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0112345677999999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=362.46 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=173.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC--CCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM--SCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~--~~~lyLV~Ey~~ 225 (720)
+||+|+||.||+|++..+++.||||++... .... ......++.+.||||+++++++.... ...+|||||||+
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 599999999999999999999999999753 2221 22333456779999999999886522 345899999998
Q ss_pred cccc-ccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeeccccceecCCCCCCCc
Q 004999 226 HDLA-GLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 226 g~ll-~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|+.+ ..+... ...+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++...... ..
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~---~~ 186 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---AL 186 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc---cc
Confidence 7544 444333 246999999999999999999999999999999999999976 456999999999865432 23
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...++|+.|+|||++.+.. |+.++||||||||+|+|++|.+||.+.........+....... .+
T Consensus 187 ~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~- 250 (336)
T 3fhr_A 187 QTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG--------------QY- 250 (336)
T ss_dssp -----------------CH-HHHHHHHHHHHHHHHHHHHSSCCC------------------------------------
T ss_pred ccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc--------------cc-
Confidence 4557899999999987665 7999999999999999999999998765543322211110000 00
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......+..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus 251 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 251 ------GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ------ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 00011234688999999999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.11 Aligned_cols=253 Identities=21% Similarity=0.221 Sum_probs=200.5
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+.++... ....|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEE-TTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCC-CCceEEE
Confidence 3455556699999999999999999999999997654322 2467899999999998888777666442 6678999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE---cCCCceeeeccccceecCCCCC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl---d~~g~vKL~DFGla~~~~~~~~ 297 (720)
|||+.+++...+......+++.+++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++........
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 84 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp EECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred EEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999767766665555679999999999999999999999999999999999999 7899999999999987654322
Q ss_pred ------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCChhhh
Q 004999 298 ------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV---EQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 298 ------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~---e~l~~i~~~~g~p~~~~w 368 (720)
.......+|+.|+|||++.+.. ++.++||||||||+|+|++|..||.+.... ..+..+.......
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----- 237 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST----- 237 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----
T ss_pred CccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-----
Confidence 1223557899999999998876 799999999999999999999999875432 2222222211000
Q ss_pred hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
........+++.+.+||..||+.||.+|||+.++++
T Consensus 238 -------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 -------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 012233568899999999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=365.07 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=193.1
Q ss_pred cccceeecccCceEEEEEEEC---CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDL---DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~---~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
+.+.++||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|++++||||+++++++.. ...+||
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 123 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKPVMI 123 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSCEE
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCceEE
Confidence 344455999999999999886 467789999997643 45566789999999999999999999999876 567999
Q ss_pred EEeecccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 220 VFEYMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 220 V~Ey~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||||++++.+ ..+...+..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 9999986544 444444557999999999999999999999999999999999999999999999999999876433222
Q ss_pred Ccc--ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 299 PLT--SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 299 ~~t--~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
..+ ...+|+.|+|||++.+.. |+.++||||||||||||++ |..||.+....+.+..+......
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~------------- 269 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL------------- 269 (373)
T ss_dssp ----------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-------------
T ss_pred ceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 212 223477899999998765 7999999999999999998 99999998877766665432111
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||..||+.||.+|||+.++++
T Consensus 270 ---------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 270 ---------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ---------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 112357889999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=357.37 Aligned_cols=256 Identities=20% Similarity=0.295 Sum_probs=201.0
Q ss_pred ccccceeecccCceEEEEEE-----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCe
Q 004999 142 FSRSFYLIGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~-----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ 216 (720)
.|++.+.||+|+||.||+|+ +..++..||||++.... .......+.+|+.++++++||||+++++++.. ...
T Consensus 31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 107 (327)
T 2yfx_A 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ--SLP 107 (327)
T ss_dssp GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSS
T ss_pred heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--CCC
Confidence 34445559999999999999 55678899999997443 34556678899999999999999999999876 567
Q ss_pred EEEEEeeccccccccccC-CC------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeecc
Q 004999 217 LYLVFEYMEHDLAGLASH-PG------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADF 286 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~-~~------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DF 286 (720)
+||||||++++.+..+.. .. ..+++.+++.++.||+.||.|||++||+|+||||+||||+. +..+||+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 899999997654443332 21 35899999999999999999999999999999999999984 446999999
Q ss_pred ccceecCCCC-CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 287 GLASFYDPDQ-NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 287 Gla~~~~~~~-~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
|++....... ........+|+.|+|||++.+.. ++.++||||||||+|+|++ |.+||.+....+.+..+.....
T Consensus 188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--- 263 (327)
T 2yfx_A 188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--- 263 (327)
T ss_dssp HHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---
T ss_pred ccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC---
Confidence 9997543222 12233456789999999998765 7999999999999999998 9999998887766665543210
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......++..+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 264 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 264 -------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 0112467889999999999999999999999999988753
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.66 Aligned_cols=246 Identities=22% Similarity=0.258 Sum_probs=203.9
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~--~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+++.++||||+++++++. ...+|+||||++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~ 92 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---AEALMLVMEMAG 92 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---SSSEEEEEECCT
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec---CCCcEEEEEeCC
Confidence 5999999999999864 568889999998653 4566778999999999999999999999984 356899999999
Q ss_pred cccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--CCccc
Q 004999 226 HDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--QPLTS 302 (720)
Q Consensus 226 g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~--~~~t~ 302 (720)
++.+.. +......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++........ .....
T Consensus 93 ~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 172 (287)
T 1u59_A 93 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 172 (287)
T ss_dssp TEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred CCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccc
Confidence 755544 434556799999999999999999999999999999999999999999999999999987643322 11223
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+|+.|+|||++.+.. ++.++||||||||+|+|++ |..||.+....+.+..+....
T Consensus 173 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~--------------------- 230 (287)
T 1u59_A 173 GKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK--------------------- 230 (287)
T ss_dssp SCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC---------------------
T ss_pred ccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC---------------------
Confidence 35688999999998765 7999999999999999998 999999988777666554310
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
.......+++.+.+||..||+.||.+|||+.+++++.+
T Consensus 231 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 231 -------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 01123468899999999999999999999999998643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=374.72 Aligned_cols=275 Identities=22% Similarity=0.329 Sum_probs=205.4
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
..|++.++||+|+||.||+|++..+++.||||++..... ....+.+.+|+.+|++++||||+++++++.......+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 345566669999999999999999999999999975432 1224567899999999999999999999887555688999
Q ss_pred EeeccccccccccCCC---CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE----cCCCceeeeccccceecC
Q 004999 221 FEYMEHDLAGLASHPG---LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI----DNNGILKIADFGLASFYD 293 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~---~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl----d~~g~vKL~DFGla~~~~ 293 (720)
||||.|+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++....
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999875555444432 239999999999999999999999999999999999999 788889999999998764
Q ss_pred CCCCCCccccccccCCCChhhhcCC-------cCCCccccchhhHHHHHHHHhCCCCCCC----CChHHHHHHHHHhcCC
Q 004999 294 PDQNQPLTSRVVTLWYRPPELLLGA-------TYYGTAVDLWSTGCILAELYAGKPIMPG----RTEVEQLHKIFKLCGS 362 (720)
Q Consensus 294 ~~~~~~~t~~~gT~~Y~APE~l~~~-------~~y~~~sDIWSLG~iL~ELltG~ppf~g----~~~~e~l~~i~~~~g~ 362 (720)
.. ......+||+.|+|||++.+. ..|+.++||||||||+|||++|..||.+ ....+.+.++.. +.
T Consensus 168 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~--~~ 243 (396)
T 4eut_A 168 DD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT--GK 243 (396)
T ss_dssp CG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH--SC
T ss_pred CC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc--CC
Confidence 32 223456789999999998752 3478899999999999999999999975 334455555543 22
Q ss_pred CChhhhhhcCCCCc--cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 363 PSEDYWRKSKLPHA--TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 363 p~~~~w~~~~l~~~--~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
|. ..|........ ..+....+. .......++..+.+||.+||+.||++|||+.+++++
T Consensus 244 p~-~~~~~~~~~~~~~~~~~~~~~~---~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 244 PS-GAISGVQKAENGPIDWSGDMPV---SCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CT-TCCEEEECSTTCCEEEESSCCT---TCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred Cc-ccchhheeccCCCcccCccCCc---ccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 22 22111000000 000000010 001112355678999999999999999999998663
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=354.89 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=201.3
Q ss_pred cceeecccCceEEEEEEEC-------CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCe
Q 004999 145 SFYLIGQGTYSNVYRARDL-------DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~-------~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~ 216 (720)
+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++++ +||||+++++++.. ...
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~ 115 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ--DGP 115 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc--CCc
Confidence 3344999999999999986 467789999997543 455667889999999999 89999999999876 667
Q ss_pred EEEEEeeccccccccccCCC----------------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc
Q 004999 217 LYLVFEYMEHDLAGLASHPG----------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI 280 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~----------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~ 280 (720)
+|+||||++++.+..+.... ..+++.+++.++.||+.||.|||++||+|+||||+||||+.++.
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 195 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV 195 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCC
Confidence 99999999875544333222 24899999999999999999999999999999999999999999
Q ss_pred eeeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 004999 281 LKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 281 vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~ 358 (720)
+||+|||++........ .......+|+.|+|||++.+.. ++.++||||||||+|+|++ |..||.+....+....+..
T Consensus 196 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 274 (334)
T 2pvf_A 196 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 274 (334)
T ss_dssp EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH
T ss_pred EEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhc
Confidence 99999999987643322 1123345688999999998765 7999999999999999999 9999999887766655543
Q ss_pred hcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
... ......++..+.+||..||+.||.+|||+.+++++
T Consensus 275 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 275 GHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 210 11224678899999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.86 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=202.5
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|.+. ++..||||++....... +.+.+|+.++++++||||+++++++.. ...+|+||||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~ 84 (267)
T 3t9t_A 11 TFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVTEF 84 (267)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEECC
T ss_pred eeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEEEEeC
Confidence 33445999999999999986 57789999998665433 467899999999999999999999876 5679999999
Q ss_pred ccccccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 224 MEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 224 ~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
++++.+. .+......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.............
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9875444 444444578999999999999999999999999999999999999999999999999998654322222233
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+......
T Consensus 165 ~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~------------------- 224 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL------------------- 224 (267)
T ss_dssp TTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------------
T ss_pred ccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcC-------------------
Confidence 45678899999998765 7999999999999999999 89999998887776666432100
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 225 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 225 ---------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1123468889999999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=355.92 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=199.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ...+|+||||
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~ 116 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMILIYKY 116 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCCEEEEEC
T ss_pred CccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEEEEc
Confidence 34445999999999999964 68899999987653 3446678999999999999999999999876 6679999999
Q ss_pred ccccccccccCCC----CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-CC
Q 004999 224 MEHDLAGLASHPG----LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQ 298 (720)
Q Consensus 224 ~~g~ll~~~~~~~----~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~-~~ 298 (720)
++++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....... ..
T Consensus 117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 196 (321)
T 2qkw_B 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196 (321)
T ss_dssp CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC
T ss_pred CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9975555444322 358999999999999999999999999999999999999999999999999998654322 22
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......||+.|+|||++.+.. ++.++||||||||+|||++|+.||.+....+....+... ........+.. .
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~~--~ 268 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESHNNGQLEQ--I 268 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHHTTTCCCS--S
T ss_pred cccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhccccccHHH--h
Confidence 234456899999999998765 799999999999999999999999775432211111000 00000000000 0
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
..+.. .......++..+.+||.+||+.||++|||+.+++++-
T Consensus 269 ~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 269 VDPNL-----ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSSC-----TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cChhh-----ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 01100 0111223456789999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=364.56 Aligned_cols=259 Identities=19% Similarity=0.178 Sum_probs=194.6
Q ss_pred ccceeecccCceEEEEEEECCC-----CeEEEEEEeecCCCCH-HHH--------HHHHHHHHHHHhcCCCceeeeccce
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQ-----KKIVALKKVRFDNLEP-ESV--------RFMAREIHILRRLDHINVIKLEGLV 209 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~t-----g~~VAIK~l~~~~~~~-~~~--------~~~~~Ei~iL~~L~HpnIvkl~~~~ 209 (720)
++.+.||+|+||.||+|.+..+ ++.||||++....... ..+ ..+..|+..+..++||||+++++++
T Consensus 38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 117 (364)
T 3op5_A 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSG 117 (364)
T ss_dssp EEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEE
T ss_pred EEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeee
Confidence 3334499999999999998765 5789999987653110 000 1234566677778899999999988
Q ss_pred eccCC--CeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc--CCCceeeec
Q 004999 210 TSRMS--CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIAD 285 (720)
Q Consensus 210 ~~~~~--~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld--~~g~vKL~D 285 (720)
..... ..+|||||||+++|...+......+++.+++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|
T Consensus 118 ~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~D 197 (364)
T 3op5_A 118 LHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVD 197 (364)
T ss_dssp EEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECC
T ss_pred eeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEE
Confidence 76322 46899999996566665555556899999999999999999999999999999999999999 889999999
Q ss_pred cccceecCCCCC------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 004999 286 FGLASFYDPDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKL 359 (720)
Q Consensus 286 FGla~~~~~~~~------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~ 359 (720)
||++..+..... ......+||+.|+|||++.+.. |+.++||||||||||||++|..||.+.............
T Consensus 198 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~ 276 (364)
T 3op5_A 198 YGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKI 276 (364)
T ss_dssp CTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHH
T ss_pred CCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHH
Confidence 999987643221 1223456899999999998776 799999999999999999999999874333322222211
Q ss_pred cCCCChhhhhhcCCCCccccCCCCccchhhhcc--cCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 360 CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAET--FKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 360 ~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~--~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...+....+ +... ...+++.+.+||..||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~--------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 277 RYRENIASL--------------------MDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHCHHHH--------------------HHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HhhhhHHHH--------------------HHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 100000000 1111 1468999999999999999999999999886
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.71 Aligned_cols=247 Identities=21% Similarity=0.279 Sum_probs=197.8
Q ss_pred cceeecccCceEEEEEEECC---CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~---tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+.+.||+|+||.||+|.+.. ++..||||++.... .....+.+.+|+.+++.++||||+++++++.. ...|+||
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~ 91 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EPTWIIM 91 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SSCEEEE
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCCEEEE
Confidence 33449999999999998653 44569999987653 34566788999999999999999999998764 3569999
Q ss_pred eecccccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 222 EYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 222 Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
||+.++.+.. +......+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...........
T Consensus 92 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 171 (281)
T 3cc6_A 92 ELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA 171 (281)
T ss_dssp ECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--------
T ss_pred ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccccccc
Confidence 9999755444 434445699999999999999999999999999999999999999999999999999987654333333
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+....+......
T Consensus 172 ~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~----------------- 233 (281)
T 3cc6_A 172 SVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL----------------- 233 (281)
T ss_dssp -CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC-----------------
T ss_pred ccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC-----------------
Confidence 4456688999999997665 7999999999999999998 99999877766665555432111
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 -----------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1123578899999999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=373.51 Aligned_cols=261 Identities=27% Similarity=0.353 Sum_probs=193.2
Q ss_pred hhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCC
Q 004999 136 DKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMS 214 (720)
Q Consensus 136 ~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~ 214 (720)
...+.+++.+.++||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+|+++ +|||||++++++.. .
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~ 81 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETT--D 81 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--S
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec--C
Confidence 34455666666789999999998754 467999999998753 234568999999987 89999999998876 6
Q ss_pred CeEEEEEeeccccccccccCCCCC------CCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC----------
Q 004999 215 CSLYLVFEYMEHDLAGLASHPGLK------FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN---------- 278 (720)
Q Consensus 215 ~~lyLV~Ey~~g~ll~~~~~~~~~------lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~---------- 278 (720)
..+|||||||+|+|...+...... .++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 789999999998766655443211 1334567899999999999999999999999999999754
Q ss_pred ---CceeeeccccceecCCCCCC---CccccccccCCCChhhhcC------CcCCCccccchhhHHHHHHHHh-CCCCCC
Q 004999 279 ---GILKIADFGLASFYDPDQNQ---PLTSRVVTLWYRPPELLLG------ATYYGTAVDLWSTGCILAELYA-GKPIMP 345 (720)
Q Consensus 279 ---g~vKL~DFGla~~~~~~~~~---~~t~~~gT~~Y~APE~l~~------~~~y~~~sDIWSLG~iL~ELlt-G~ppf~ 345 (720)
+.+||+|||++..+...... .....+||+.|+|||++.+ ...++.++||||||||+|||++ |.+||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 48999999999877543221 2234578999999999976 2447999999999999999999 899997
Q ss_pred CCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 346 GRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 346 g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
+....+ ..+........ . .. ......+++.+.+||.+||+.||.+|||+.++|+||
T Consensus 242 ~~~~~~--~~i~~~~~~~~----------~-------~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLD----------E-------MK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp STTTHH--HHHHHTCCCCC----------C-------CT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred CchhhH--HHHhcCCCCcc----------c-------cc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 765433 22322111100 0 00 000113457899999999999999999999999999
Q ss_pred cCC
Q 004999 426 FFT 428 (720)
Q Consensus 426 ~f~ 428 (720)
||.
T Consensus 298 ~f~ 300 (434)
T 2rio_A 298 LFW 300 (434)
T ss_dssp GGS
T ss_pred ccC
Confidence 996
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=355.29 Aligned_cols=265 Identities=23% Similarity=0.307 Sum_probs=201.4
Q ss_pred ccceeecccCceEEEEEE----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.++++++||||+++++++.......+||
T Consensus 26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 444459999999999999 5778999999998754 3556677899999999999999999999887655778999
Q ss_pred EEeecccccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 220 VFEYMEHDLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 220 V~Ey~~g~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||||++++.+..+. .....+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.........
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 183 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY 183 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSE
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCcc
Confidence 99999775554443 33446999999999999999999999999999999999999999999999999999876433221
Q ss_pred --CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 299 --PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 299 --~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......+|+.|+|||++.+.. ++.++||||||||+|+|++|..||.+............ ...+........
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~----- 256 (327)
T 3lxl_A 184 YVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE-RDVPALSRLLEL----- 256 (327)
T ss_dssp EECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHHH-----
T ss_pred ceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccc-cccccHHHHHHH-----
Confidence 223446788899999998766 79999999999999999999999866433211100000 000000000000
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
... .........+++.+.+||.+||+.||.+|||+.+++++
T Consensus 257 --~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 257 --LEE-----GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp --HHT-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --hhc-----ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 00011234688999999999999999999999999654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=342.78 Aligned_cols=244 Identities=22% Similarity=0.353 Sum_probs=200.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+|+.++||||+++++++.. ..+|+||||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~v~e~ 88 (279)
T 1qpc_A 16 KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEY 88 (279)
T ss_dssp EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEEC
T ss_pred hheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEEEEec
Confidence 34445999999999999975 5678999999765433 3567899999999999999999998753 458999999
Q ss_pred ccccccccccCCC--CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHDLAGLASHPG--LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~ll~~~~~~~--~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+.++.+..+.... ..+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++............
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 9876555544432 26899999999999999999999999999999999999999999999999999876543333333
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+|+.|+|||++.+.. ++.++|||||||++|||++ |..||.+....+.+..+.....
T Consensus 169 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------------------- 228 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR------------------- 228 (279)
T ss_dssp TCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------------------
T ss_pred CCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-------------------
Confidence 445688999999998765 7999999999999999999 9999999888776666543210
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||..||..||.+|||+.++++
T Consensus 229 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 ---------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0112367899999999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=355.31 Aligned_cols=250 Identities=18% Similarity=0.247 Sum_probs=203.2
Q ss_pred cccceeecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeE
Q 004999 143 SRSFYLIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~l 217 (720)
|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~ 103 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQPT 103 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--SSSC
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--CCcc
Confidence 344445999999999999876 467889999997543 34455678899999999999999999999876 5678
Q ss_pred EEEEeeccccccccccCC----------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 218 YLVFEYMEHDLAGLASHP----------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~----------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
|+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCc
Confidence 999999987544433321 1457999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCCh
Q 004999 288 LASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSE 365 (720)
Q Consensus 288 la~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~ 365 (720)
++........ .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 257 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG----- 257 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-----
T ss_pred cccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-----
Confidence 9976532221 1122345688999999998766 7999999999999999999 889999888776666554311
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......++..+.+||.+||+.||.+|||+.+++++
T Consensus 258 -----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 258 -----------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 011224678999999999999999999999999987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.69 Aligned_cols=243 Identities=27% Similarity=0.331 Sum_probs=195.8
Q ss_pred eecccCceEEEEEEECCCCeEE--EEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKIV--ALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~V--AIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.||+|+||.||+|++..++..+ |||++.... .....+.+.+|+.+|+++ +||||+++++++.. ...+||||||+
T Consensus 32 ~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~lv~e~~ 108 (327)
T 1fvr_A 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 108 (327)
T ss_dssp EEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEEEEECCC
T ss_pred eeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCceEEEEecC
Confidence 4999999999999999888865 999987432 334456788999999999 89999999999877 67899999999
Q ss_pred cccccccccCCC----------------CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 225 EHDLAGLASHPG----------------LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 225 ~g~ll~~~~~~~----------------~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+++.+..+.... ..+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~ 188 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 188 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCc
Confidence 875444333322 3699999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
+..... ........+|+.|+|||++.+.. ++.++||||||||+|+|++ |.+||.+....+....+....
T Consensus 189 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~------- 258 (327)
T 1fvr_A 189 SRGQEV--YVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------- 258 (327)
T ss_dssp EESSCE--ECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-------
T ss_pred Cccccc--cccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC-------
Confidence 974322 11223345688999999998765 7999999999999999998 999999988776655543210
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 259 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 259 ---------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 011223578899999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=377.90 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=204.0
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
...+.||+|+||.||+|.+..++..||||+++..... .+.+.+|+.+|++|+||||+++++++.. ...+||||||
T Consensus 223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lv~E~ 297 (495)
T 1opk_A 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEF 297 (495)
T ss_dssp EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEEC
T ss_pred eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEEEEEEc
Confidence 3444599999999999999999999999999865433 4568899999999999999999999876 5679999999
Q ss_pred cccccc-ccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHDLA-GLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~ll-~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|.++.+ ..+.. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++............
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 996544 44332 3456899999999999999999999999999999999999999999999999999876443322233
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+|+.|+|||++.+.. |+.++||||||||||||++ |.+||.+.+..+.+..+.+..
T Consensus 378 ~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------------------- 436 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------------------- 436 (495)
T ss_dssp TCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--------------------
T ss_pred CCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------------------
Confidence 345678899999998766 7999999999999999999 999999987666555443211
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 437 --------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 --------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 01123467899999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=345.51 Aligned_cols=250 Identities=23% Similarity=0.284 Sum_probs=199.2
Q ss_pred cccceeecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
|++.++||+|+||.||+|.+..+ ...||+|++... ......+.+.+|+.++++++||||+++++++... ....|+
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~ 104 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLV 104 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC-CCceEE
Confidence 34444599999999999997543 346899998753 3455667889999999999999999999986543 567899
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-
Q 004999 220 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN- 297 (720)
Q Consensus 220 V~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~- 297 (720)
||||++++ |...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 99999984 4444444566789999999999999999999999999999999999999999999999999986543221
Q ss_pred --CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 298 --QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 298 --~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
.......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.++|.+....+....+......
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 251 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL------------ 251 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCC------------
T ss_pred ccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCC------------
Confidence 1223446688999999998766 7999999999999999999 67888887766665555432111
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 252 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 ----------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ----------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112357889999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=355.96 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=193.7
Q ss_pred cccceeecccCceEEEEEEECCCCeEE----EEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIV----ALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~V----AIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
|++.++||+|+||.||+|++..+++.| |+|.++... .....+.+.+|+.++++++||||+++++++.. ...+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~ 92 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQ 92 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---SSEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---CCeE
Confidence 344455999999999999998887765 777765432 23445678899999999999999999999875 3478
Q ss_pred EEEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 219 LVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 219 LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
+|+||+.++ +...+......+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 999999864 4444444556799999999999999999999999999999999999999999999999999987654332
Q ss_pred C-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 298 Q-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 298 ~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
. ......+|+.|+|||++.+.. |+.++||||||||+|||++ |.+||.+....+....+......
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------------- 238 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------------- 238 (327)
T ss_dssp -------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred cccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC-------------
Confidence 2 223345688999999998766 7999999999999999999 99999987766554444321100
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 239 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 239 ---------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ---------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ---------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 1123578889999999999999999999999975
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=358.80 Aligned_cols=249 Identities=20% Similarity=0.272 Sum_probs=198.0
Q ss_pred cccceeecccCceEEEEEEECCCCeE----EEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKI----VALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~----VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
|++.++||+|+||.||+|.+..++.. ||+|++..... ......+.+|+.+++.++||||+++++++.. ..+|
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~ 90 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG---SSLQ 90 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB---SSEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CccE
Confidence 34445599999999999999888876 77777653321 2223456789999999999999999998853 5689
Q ss_pred EEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 219 LVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 219 LV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
+||||+.+ ++...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 99999986 45455544456799999999999999999999999999999999999999999999999999987754433
Q ss_pred C-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 298 Q-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 298 ~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
. ......+|+.|+|||++.+.. |+.++||||||||+|+|++ |..||.+....+....+.....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------------- 235 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-------------- 235 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB--------------
T ss_pred cccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC--------------
Confidence 2 234456788999999998766 7999999999999999999 9999998776665555432110
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......++..+.+||.+||+.||.+|||+.+++++
T Consensus 236 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 236 --------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp --------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred --------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01122467778999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.34 Aligned_cols=256 Identities=17% Similarity=0.123 Sum_probs=190.7
Q ss_pred cceeecccCceEEEEEEECC---CCeEEEEEEeecCCCCHH---------HHHHHHHHHHHHHhcCCCceeeeccceecc
Q 004999 145 SFYLIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPE---------SVRFMAREIHILRRLDHINVIKLEGLVTSR 212 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~---tg~~VAIK~l~~~~~~~~---------~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~ 212 (720)
+.+.||+|+||.||+|.+.. ++..||||++........ ....+.+|+.+++.++||||+++++++...
T Consensus 41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence 33349999999999999987 788999999986532110 112366888999999999999999988662
Q ss_pred --CCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC--ceeeecccc
Q 004999 213 --MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG--ILKIADFGL 288 (720)
Q Consensus 213 --~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g--~vKL~DFGl 288 (720)
....+||||||+ ++.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~ 199 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTT
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCC
Confidence 246799999999 544444444444899999999999999999999999999999999999999887 999999999
Q ss_pred ceecCCCCC------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhc
Q 004999 289 ASFYDPDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGR--TEVEQLHKIFKLC 360 (720)
Q Consensus 289 a~~~~~~~~------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~--~~~e~l~~i~~~~ 360 (720)
+..+..... .......||+.|+|||++.+.. ++.++||||||||+|||++|..||.+. .............
T Consensus 200 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 278 (345)
T 2v62_A 200 SYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLL 278 (345)
T ss_dssp CEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHH
T ss_pred ceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhc
Confidence 987643211 1224557899999999998875 799999999999999999999999653 2222222221111
Q ss_pred CCCChhhhhhcCCCCccccCCCCccchhhhccc--CCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 361 GSPSEDYWRKSKLPHATIFKPQQPYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 361 g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~--~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
...+.. +.... ..+++.+.+||..||..||.+|||+.++++.
T Consensus 279 ~~~~~~----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 279 DELPQS----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HTTTHH----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred ccccHH----------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111111 11111 2688999999999999999999999999873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=347.37 Aligned_cols=251 Identities=30% Similarity=0.432 Sum_probs=190.7
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCC-CCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~-~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|.+..+++.||||++.... .+......+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 111 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVL 111 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEEEEE
Confidence 344445999999999999999999999999998643 355667788999999999999999999999887 67899999
Q ss_pred eeccccccccccC----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 222 EYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 222 Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.......
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~- 190 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 190 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC-
Confidence 9999855544332 35578999999999999999999999999999999999999999999999999998654322
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-h-HHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-E-VEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~-~-~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.......+|+.|+|||++.+.. ++.++||||||||+|+|++|..||.+.. . ......+. ....+.
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~----------- 257 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-QCDYPP----------- 257 (310)
T ss_dssp --------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH-TTCSCC-----------
T ss_pred ccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh-cccCCC-----------
Confidence 2233457899999999998765 7999999999999999999999997643 2 22222221 111110
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....+++.+.+||.+||..||.+|||+.+++++
T Consensus 258 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 258 ---------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp ---------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 0113578899999999999999999999999873
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=343.16 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=199.3
Q ss_pred ceeecccCceEEEEEEECCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 146 FYLIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~---~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.++||+|+||.||+|.+..++. .||+|++... ......+.+.+|+.+++.++||||+++++++... ....|+|||
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~~v~e 103 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP-EGLPHVLLP 103 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS-SSCCEEEEC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC-CCCcEEEEe
Confidence 3569999999999999755444 7999998753 3455677889999999999999999999998763 344589999
Q ss_pred eccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC---CC
Q 004999 223 YMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ---NQ 298 (720)
Q Consensus 223 y~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~---~~ 298 (720)
|+.+ ++...+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++..+.... ..
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSC
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccc
Confidence 9975 5555555556779999999999999999999999999999999999999999999999999997653321 12
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......+|+.|+|||++.+.. ++.++|||||||++|+|++ |.++|.+....+....+......
T Consensus 184 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--------------- 247 (298)
T 3pls_A 184 QHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL--------------- 247 (298)
T ss_dssp CSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC---------------
T ss_pred cCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC---------------
Confidence 223446789999999998766 7999999999999999999 55667766665555554332111
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||..||+.||.+|||+.++++
T Consensus 248 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 -------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 112357889999999999999999999999887
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=353.50 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=200.9
Q ss_pred ccceeecccCceEEEEEEECCCCe-----EEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~-----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~l 217 (720)
++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+|+.+ +||||+++++++.. ...+
T Consensus 49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~ 125 (333)
T 2i1m_A 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTH--GGPV 125 (333)
T ss_dssp EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSC
T ss_pred eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--CCce
Confidence 334459999999999999977664 79999997643 345567789999999999 89999999999876 5679
Q ss_pred EEEEeeccccccccccC--------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceee
Q 004999 218 YLVFEYMEHDLAGLASH--------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 283 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~--------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL 283 (720)
||||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEE
Confidence 99999998754433322 1346899999999999999999999999999999999999999999999
Q ss_pred eccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 004999 284 ADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 284 ~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g 361 (720)
+|||++......... ......+|+.|+|||++.+.. ++.++||||||||+|||++ |.+||.+......+..+.....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 284 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY 284 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTC
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCC
Confidence 999999865432221 122345688999999998766 7999999999999999998 9999988766555555443211
Q ss_pred CCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 362 ~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.+ .....+++.+.+||..||+.||.+|||+.++++
T Consensus 285 ~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 285 QM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 11 112346889999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=373.20 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=189.9
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.+..+||+|+||.||. ....+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.. ...+|||||
T Consensus 27 ~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E 98 (432)
T 3p23_A 27 CPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIE 98 (432)
T ss_dssp EEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred ecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEE
Confidence 3444599999999764 3346789999999975432 2246899999999 79999999998876 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---C--CceeeeccccceecCCCCC
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---N--GILKIADFGLASFYDPDQN 297 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~--g~vKL~DFGla~~~~~~~~ 297 (720)
||+|++...+......+.+.+++.++.||+.||.|||++||+||||||+||||+. + ..+||+|||++..+.....
T Consensus 99 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 99 LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp CCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 9999888877776666777788899999999999999999999999999999953 3 3578999999987643221
Q ss_pred --CCccccccccCCCChhhhcC--CcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 298 --QPLTSRVVTLWYRPPELLLG--ATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 298 --~~~t~~~gT~~Y~APE~l~~--~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
......+||++|+|||++.+ ...++.++||||||||+|||++ |.+||....... ...+.. ......
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~~~---~~~~~~----- 249 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANILLG---ACSLDC----- 249 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHHTT---CCCCTT-----
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHHhc---cCCccc-----
Confidence 23345679999999999975 2346889999999999999999 888886554332 222211 110000
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.......+..+.+||.+||+.||.+|||+.++|+||||..
T Consensus 250 -----------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 250 -----------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp -----------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred -----------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 0001123456889999999999999999999999999974
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=351.41 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=196.7
Q ss_pred ccceeecccCceEEEEEEECCCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQK----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
.+.++||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+++.++||||+++++++.. ...+||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 123 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPMMI 123 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--CCCcEE
Confidence 33455999999999999886553 459999997543 44556678999999999999999999999876 677999
Q ss_pred EEeecccccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 220 VFEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 220 V~Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||||++++.+.. +......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.........
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 999999755444 4344567999999999999999999999999999999999999999999999999999876433221
Q ss_pred C--ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 299 P--LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 299 ~--~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
. .....+|+.|+|||++.+.. ++.++||||||||+|||++ |..||.+....+.+..+......
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~------------- 269 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL------------- 269 (333)
T ss_dssp -------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------
T ss_pred ccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-------------
Confidence 1 12234578899999998766 7999999999999999999 99999988877766665432111
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||.+||+.||.+|||+.+++++
T Consensus 270 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 ---------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ---------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1123578899999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.43 Aligned_cols=271 Identities=18% Similarity=0.229 Sum_probs=198.3
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.++||+|+||.||+|.+ .+++.||||++...... .....+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 31 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 106 (326)
T 3uim_A 31 NFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMT--PTERLLVY 106 (326)
T ss_dssp SSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--SSCCEEEE
T ss_pred ccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEec--CCceEEEE
Confidence 345555699999999999985 46889999999765321 112257899999999999999999999876 56789999
Q ss_pred eeccccccccccC----CCCCCCHHHHHHHHHhhhhcccccccc---CcccccCcceeEEEcCCCceeeeccccceecCC
Q 004999 222 EYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSR---GVLHRDIKGSNLLIDNNGILKIADFGLASFYDP 294 (720)
Q Consensus 222 Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~---gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~ 294 (720)
||+.++.+..+.. ....+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||++.....
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 186 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCS
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCc
Confidence 9998755544333 233599999999999999999999999 999999999999999999999999999988755
Q ss_pred CCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 295 DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 295 ~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
..........||+.|+|||++.+.. ++.++||||||||+|+|++|.+||........ .......|......
T Consensus 187 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 187 KDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLAND--------DDVMLLDWVKGLLK 257 (326)
T ss_dssp SSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT--------SCSBHHHHHTTTTS
T ss_pred ccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccc--------cchhHHHHHHHHhh
Confidence 4444455567899999999998766 79999999999999999999999952110000 00000001110000
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
....... .............+..+.+||..||+.||.+|||+.++++|-.-
T Consensus 258 ~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 258 EKKLEAL--VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SCCSTTS--SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred chhhhhh--cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000000 00000011112334679999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=345.68 Aligned_cols=247 Identities=27% Similarity=0.402 Sum_probs=200.1
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceec---------
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS--------- 211 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~--------- 211 (720)
..|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 34556667999999999999999999999999998653 245789999999999999999998753
Q ss_pred -----cCCCeEEEEEeeccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 212 -----RMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 212 -----~~~~~lyLV~Ey~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
.....+|+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 11345899999999855544432 23579999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Q 004999 285 DFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364 (720)
Q Consensus 285 DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~ 364 (720)
|||++....... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..+|.... .....+..
T Consensus 165 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~------ 233 (284)
T 2a19_B 165 DFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD------ 233 (284)
T ss_dssp CCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT------
T ss_pred cchhheeccccc--cccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc------
Confidence 999998765432 234457899999999998766 7999999999999999999998763211 11111110
Q ss_pred hhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 365 ~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......++..+.+||.+||+.||.+|||+.+++++.+.-.
T Consensus 234 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 -------------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0011347888999999999999999999999999988753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=369.87 Aligned_cols=243 Identities=22% Similarity=0.348 Sum_probs=200.0
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
..+.||+|+||.||+|.+. ++..||||+++.... ..+.+.+|+.+|++|+||||+++++++. ...+|||||||
T Consensus 192 ~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~lv~e~~ 264 (454)
T 1qcf_A 192 LEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYIITEFM 264 (454)
T ss_dssp EEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEEEECCC
T ss_pred EEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEEEEeec
Confidence 3345999999999999985 467899999986543 3567899999999999999999999875 35689999999
Q ss_pred cccccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 225 EHDLAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 225 ~g~ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
.++.+..++.. +..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 87544444332 2368999999999999999999999999999999999999999999999999998764322222233
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+|+.|+|||++.+.. |+.++||||||||||||++ |.+||.+.+..+.+..+......
T Consensus 345 ~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------------- 404 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------------------- 404 (454)
T ss_dssp SSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC-------------------
T ss_pred CcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 34578899999998765 7999999999999999999 99999999888877776542111
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||.+||+.||.+|||+.++++
T Consensus 405 ---------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 ---------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 112467899999999999999999999999876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=384.90 Aligned_cols=245 Identities=20% Similarity=0.277 Sum_probs=202.9
Q ss_pred eeecccCceEEEEEEE--CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARD--LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~--~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+.||+|+||.||+|.+ ..+++.||||+++....+....+.+.+|+.+|++|+|||||++++++.. ..+|||||||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEEcc
Confidence 3599999999999954 4677899999998765555666789999999999999999999998854 4589999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--CCccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--QPLTS 302 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~--~~~t~ 302 (720)
.++.+..++.....+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+..... ...+.
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 9876666555566899999999999999999999999999999999999999999999999999987643322 22233
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+|+.|+|||++.+.. |+.++||||||||||||++ |..||.+....+....+.+...
T Consensus 532 ~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------------------- 590 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------------------- 590 (635)
T ss_dssp ---CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------------------
T ss_pred CCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence 45678999999998766 7999999999999999998 9999999988877776654211
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
......+++.+.+||..||+.||++|||+.++++
T Consensus 591 --------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 --------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1122468899999999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=348.00 Aligned_cols=275 Identities=23% Similarity=0.259 Sum_probs=208.2
Q ss_pred Cccchhhhhhhhcccccc-----ceeecccCceEEEEEEECCCCeEEEEEEeecCC--CCHHHHHHHHHHHHHHHhcCCC
Q 004999 128 RADSFEKLDKSLSIFSRS-----FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDN--LEPESVRFMAREIHILRRLDHI 200 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~-----~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~--~~~~~~~~~~~Ei~iL~~L~Hp 200 (720)
..+.|..+.+.+.+|... .+.||+|+||.||+|.+ ++..||||++.... ......+.+.+|+.+++.++||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 345666777766665533 25699999999999986 67889999987543 2345567789999999999999
Q ss_pred ceeeeccceeccCCCeEEEEEeeccccccccccC---CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC
Q 004999 201 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 277 (720)
Q Consensus 201 nIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~---~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~ 277 (720)
||+++++++.. ...+|+||||++++.+..+.. ....+++..++.++.||+.||.|||++||+|+||||+||||+.
T Consensus 91 ~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 91 NLVELLGFSSD--GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE 168 (307)
T ss_dssp TBCCEEEEECS--SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred CeEEEEEEEec--CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC
Confidence 99999999876 567999999998654433322 2346899999999999999999999999999999999999999
Q ss_pred CCceeeeccccceecCCCCCCC-ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHH
Q 004999 278 NGILKIADFGLASFYDPDQNQP-LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356 (720)
Q Consensus 278 ~g~vKL~DFGla~~~~~~~~~~-~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i 356 (720)
++.+||+|||++.......... .....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+......+..+
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 9999999999998764332221 2334789999999998763 689999999999999999999999876544333333
Q ss_pred HHhcCC--CChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 357 FKLCGS--PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 357 ~~~~g~--p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.+.... +....|.... +.......+..+.+||..||+.||.+|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKK----------------MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHTTSCCHHHHSCSS----------------CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHhhhhhhhhhhhcccc----------------ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 221111 1001110000 011112345678999999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=344.78 Aligned_cols=253 Identities=25% Similarity=0.286 Sum_probs=191.2
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh--cCCCceeeeccceecc--CCCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR--LDHINVIKLEGLVTSR--MSCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIvkl~~~~~~~--~~~~l 217 (720)
.|++.+.||+|+||.||+|++ +++.||||++... ....+.+|..++.. ++||||+++++++... ....+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 445555699999999999987 6899999998643 23445667777777 7999999999986542 23568
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhcccccc--------ccCcccccCcceeEEEcCCCceeeeccccc
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH--------SRGVLHRDIKGSNLLIDNNGILKIADFGLA 289 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH--------~~gIvHrDIKP~NILld~~g~vKL~DFGla 289 (720)
|+||||++++.+..+... ..+++..++.++.||+.||.||| +.||+||||||+||||+.++.+||+|||++
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 999999997655555543 47999999999999999999999 999999999999999999999999999999
Q ss_pred eecCCCCCC---CccccccccCCCChhhhcCCc-----CCCccccchhhHHHHHHHHhC----------CCCCCCCC---
Q 004999 290 SFYDPDQNQ---PLTSRVVTLWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAG----------KPIMPGRT--- 348 (720)
Q Consensus 290 ~~~~~~~~~---~~t~~~gT~~Y~APE~l~~~~-----~y~~~sDIWSLG~iL~ELltG----------~ppf~g~~--- 348 (720)
......... .....+||+.|+|||++.+.. .++.++||||||||+|||++| .+||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 866433221 123347899999999998763 245799999999999999999 77876532
Q ss_pred -hHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 349 -EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 349 -~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
....+..+....+.. +..+. ......+++.+.+||.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQR-----------------PNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCHHHHHHHHTTSCCC-----------------CCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cchhhhhHHHhccCCC-----------------CCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 223333332111100 00000 0011234577999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=350.30 Aligned_cols=260 Identities=24% Similarity=0.299 Sum_probs=198.0
Q ss_pred ccceeecccCceEEEEEE----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
++.+.||+|+||.||++. +..+++.||||++... ........+.+|+.+|++|+||||+++++++.......+||
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 344459999999998875 3458899999999865 34556678899999999999999999999998765678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 297 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-- 297 (720)
||||++++.+..+.... .+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++........
T Consensus 113 v~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 191 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY 191 (318)
T ss_dssp EECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEE
T ss_pred EEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccccc
Confidence 99999876555554433 489999999999999999999999999999999999999999999999999987654322
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh----hhhcCC
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY----WRKSKL 373 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~----w~~~~l 373 (720)
.......+|+.|+|||++.+.. ++.++||||||||+|+|++|..||........ ...+...... +...
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-- 263 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQGQMTVLRLTEL-- 263 (318)
T ss_dssp EC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCCHHHHHHHHHHH--
T ss_pred ccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccccchhHHHHHHH--
Confidence 1223445788899999998766 68999999999999999999998865322110 0000000000 0000
Q ss_pred CCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 374 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
... .........+++.+.+||..||+.||.+|||+.++++
T Consensus 264 -----~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 264 -----LER-----GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -----HHT-----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----Hhc-----ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000 0001123468899999999999999999999999985
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=342.68 Aligned_cols=237 Identities=27% Similarity=0.403 Sum_probs=185.2
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|.+ .++.||||++... ...+.+.+|+.+|++++||||+++++++.+ .+||||||
T Consensus 11 ~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~lv~e~ 80 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN----PVCLVMEY 80 (307)
T ss_dssp EEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTEEEEEC
T ss_pred eeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcEEEEEc
Confidence 3444599999999999987 4788999998643 345678899999999999999999998753 37999999
Q ss_pred ccccccccccCCCC---CCCHHHHHHHHHhhhhccccccc---cCcccccCcceeEEEcCCCc-eeeeccccceecCCCC
Q 004999 224 MEHDLAGLASHPGL---KFSEAQVKCYMQQLLCGLDHCHS---RGVLHRDIKGSNLLIDNNGI-LKIADFGLASFYDPDQ 296 (720)
Q Consensus 224 ~~g~ll~~~~~~~~---~lse~~~~~i~~QIl~gL~yLH~---~gIvHrDIKP~NILld~~g~-vKL~DFGla~~~~~~~ 296 (720)
++++.+..+..... .+++..++.++.||+.||.|||+ +||+||||||+||||+.++. +||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-- 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-- 158 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc--
Confidence 98755544443322 47899999999999999999999 89999999999999998886 79999999976532
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE--VEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~--~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ......+.. +.
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~------------ 221 (307)
T 2eva_A 159 --HMTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT------------ 221 (307)
T ss_dssp --------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC------------
T ss_pred --ccccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC------------
Confidence 223456899999999998765 79999999999999999999999976432 222222211 00
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 222 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 --------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp --------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01223468899999999999999999999999998
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.09 Aligned_cols=249 Identities=22% Similarity=0.353 Sum_probs=198.4
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
..+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++|+||||+++++++.. ..+|||||||
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~iv~e~~ 260 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYM 260 (452)
T ss_dssp EEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCC
T ss_pred eeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEEEehhh
Confidence 33449999999999999865 466999999865443 3467899999999999999999998864 4689999999
Q ss_pred cccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 225 EHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 225 ~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
.++.+..++. .+..+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 8755544443 23468999999999999999999999999999999999999999999999999998764433323334
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+|+.|+|||++.+.. |+.++|||||||+||||++ |.+||.+....+.+..+......
T Consensus 341 ~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------------------- 400 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM------------------- 400 (452)
T ss_dssp --CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------------------
T ss_pred CcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 45678999999998765 7999999999999999999 99999999888777766432110
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh--CccCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFTM 429 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~--hp~f~~ 429 (720)
.....+++.+.+||.+||+.||.+|||+.++++ ..+|..
T Consensus 401 ---------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 401 ---------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 112467899999999999999999999999987 356653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=365.48 Aligned_cols=240 Identities=21% Similarity=0.359 Sum_probs=196.1
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+|++|+||||+++++++... ...+||||||
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~iv~e~ 268 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEY 268 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEEEEEEC
T ss_pred EEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceEEEEEe
Confidence 33445999999999999884 7799999998653 345688999999999999999999987653 3479999999
Q ss_pred cccccc-ccccCCC-CCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 224 MEHDLA-GLASHPG-LKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 224 ~~g~ll-~~~~~~~-~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
|.++.+ ..+...+ ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 344 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QD 344 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----cc
Confidence 987544 4433322 24799999999999999999999999999999999999999999999999999864322 12
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+|+.|+|||++.+.. |+.++|||||||+||||++ |..||.+....+.+..+.+...
T Consensus 345 ~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------------- 404 (450)
T 1k9a_A 345 TGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------------- 404 (450)
T ss_dssp --CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------------------
T ss_pred CCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------------------
Confidence 235688999999998766 7999999999999999998 9999998877666665543210
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...+..+++.+.+||..||+.||.+|||+.++++
T Consensus 405 ---------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 405 ---------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123468899999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=352.35 Aligned_cols=248 Identities=20% Similarity=0.293 Sum_probs=193.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEE----EEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIV----ALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~V----AIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
|++.++||+|+||.||+|.+..+++.| |+|.+.... .......+.+|+.++++++||||+++++++.. ...+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~ 92 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQ 92 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES---SSEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec---CCce
Confidence 444455999999999999998888765 666665332 23345678899999999999999999999875 3478
Q ss_pred EEEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 219 LVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 219 LV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
+||||+.++ +...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 999999864 4444444556799999999999999999999999999999999999999999999999999987643222
Q ss_pred -CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 298 -QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 298 -~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.......+|+.|+|||++.+.. |+.++||||||||+|||++ |.+||.+....+....+......
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~------------- 238 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------------- 238 (327)
T ss_dssp -------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------------
T ss_pred cccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 1223345688999999998766 7999999999999999999 99999988776655554332111
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||.+||+.||.+|||+.++++
T Consensus 239 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 239 ---------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ---------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 112357889999999999999999999999997
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.01 Aligned_cols=255 Identities=20% Similarity=0.299 Sum_probs=196.0
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc--CCCeEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSLYLV 220 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~--~~~~lyLV 220 (720)
|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++... ....+|+|
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 34444599999999999999999999999998764 355667889999999999999999999988632 24578999
Q ss_pred EeeccccccccccC----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 221 FEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
|||+.++.+..+.. .+..+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999854433222 35679999999999999999999999999999999999999999999999999987643211
Q ss_pred CC--------CccccccccCCCChhhhcCCc--CCCccccchhhHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCh
Q 004999 297 NQ--------PLTSRVVTLWYRPPELLLGAT--YYGTAVDLWSTGCILAELYAGKPIMPGRTEV-EQLHKIFKLCGSPSE 365 (720)
Q Consensus 297 ~~--------~~t~~~gT~~Y~APE~l~~~~--~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~-e~l~~i~~~~g~p~~ 365 (720)
.. ......||+.|+|||++.+.. .++.++||||||||+|+|++|..||.+.... ..+.......
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~----- 263 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ----- 263 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-----
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-----
Confidence 10 012335699999999987643 2688999999999999999999998531100 0001111000
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCcc
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~ 426 (720)
. .......++..+.+||.+||+.||.+|||+.+++++-.
T Consensus 264 -------------~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 264 -------------L---------SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp ------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -------------C---------CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 0 00112357889999999999999999999999999743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=355.15 Aligned_cols=251 Identities=16% Similarity=0.155 Sum_probs=192.5
Q ss_pred ccceeecccCceEEEEEEECCC--------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeee----------
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQ--------KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKL---------- 205 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~t--------g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl---------- 205 (720)
++.+.||+|+||.||+|++..+ ++.||||++... ..+.+|+.++++++||||+++
T Consensus 45 ~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 45 KLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred EEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 3344499999999999999874 889999999754 346899999999999999984
Q ss_pred -----ccceeccCCCeEEEEEeeccccccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 206 -----EGLVTSRMSCSLYLVFEYMEHDLAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 206 -----~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
++++.. ....+||||||+.++|...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 118 ~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 118 AIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED 196 (352)
T ss_dssp SCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred Cccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence 444433 25678999999955555544432 35799999999999999999999999999999999999999998
Q ss_pred --ceeeeccccceecCCCCC------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC-hH
Q 004999 280 --ILKIADFGLASFYDPDQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT-EV 350 (720)
Q Consensus 280 --~vKL~DFGla~~~~~~~~------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~-~~ 350 (720)
.+||+|||++..+..... .......||+.|+|||++.+.. ++.++||||||||||||++|..||.+.. ..
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 275 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT 275 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence 999999999986643221 1223457899999999998765 7999999999999999999999998764 33
Q ss_pred HHHHHHHHh-cCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 351 EQLHKIFKL-CGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 351 e~l~~i~~~-~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
+.+...... ...+. .+ .. .......+++.+.+||..||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~-~~------------~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 276 EDIMKQKQKFVDKPG-PF------------VG-------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHHHSCC-CE------------EC-------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhccCChh-hh------------hh-------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 333332221 11110 00 00 00112357899999999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=358.53 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=191.2
Q ss_pred cceeecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
..++||+|+||.||+|.+..+ +..||||+++.. ......+.+.+|+.++++++||||+++++++... ....|+||
T Consensus 93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~lv~ 170 (373)
T 3c1x_A 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVL 170 (373)
T ss_dssp EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCCEEEE
T ss_pred cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCeEEEE
Confidence 344599999999999987543 346899998753 2345667889999999999999999999986543 45789999
Q ss_pred eeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC---
Q 004999 222 EYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--- 297 (720)
Q Consensus 222 Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~--- 297 (720)
||+++ +|...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 250 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccccc
Confidence 99987 45455545556789999999999999999999999999999999999999999999999999986533221
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
...+...+|+.|+|||++.+.. |+.++||||||||+|||++ |.+||.+.+..+....+.....
T Consensus 251 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~--------------- 314 (373)
T 3c1x_A 251 HNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------------- 314 (373)
T ss_dssp -------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC---------------
T ss_pred cccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC---------------
Confidence 1123345688999999998765 7999999999999999999 7788988766555544432110
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 315 -------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 315 -------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123578899999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=342.55 Aligned_cols=250 Identities=27% Similarity=0.355 Sum_probs=192.4
Q ss_pred ccceeecccCceEEEEEEECC-CC--eEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLD-QK--KIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~-tg--~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
++.+.||+|+||.||+|++.. ++ ..||||+++.... .....+.+.+|+.++++++||||+++++++.. ...++
T Consensus 21 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 97 (291)
T 1u46_A 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PPMKM 97 (291)
T ss_dssp EEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred eeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc---CCcee
Confidence 333449999999999998643 33 3699999886543 34566788999999999999999999999875 23899
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 220 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 220 V~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||||+.++ +...+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.........
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 177 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccccc
Confidence 99999864 44444443456899999999999999999999999999999999999999999999999999876433221
Q ss_pred --CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 299 --PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 299 --~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
......+|+.|+|||++.+.. ++.++||||||||+|+|++ |.+||.+....+.+..+......+
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------ 244 (291)
T 1u46_A 178 YVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL------------ 244 (291)
T ss_dssp EEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC------------
T ss_pred hhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC------------
Confidence 122345688899999998765 7999999999999999999 999999988877776664321111
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....++..+.+||.+||..||.+|||+.+++++
T Consensus 245 ---------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 245 ---------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1124678999999999999999999999999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=368.14 Aligned_cols=245 Identities=17% Similarity=0.207 Sum_probs=191.0
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCC-Cceeeecc----------------
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDH-INVIKLEG---------------- 207 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~H-pnIvkl~~---------------- 207 (720)
.++||+|+||.||+|++..+|+.||||++..... .....+.+.+|+.+++.|.| .|+..+..
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 3469999999999999999999999999885432 23345678899999999987 32211111
Q ss_pred -----ceeccC---CCeEEEEEeeccccccccc------cCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeE
Q 004999 208 -----LVTSRM---SCSLYLVFEYMEHDLAGLA------SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNL 273 (720)
Q Consensus 208 -----~~~~~~---~~~lyLV~Ey~~g~ll~~~------~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NI 273 (720)
++.... ...+|++|+++.+++...+ ...+..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NI 242 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242 (413)
T ss_dssp --------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred CccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceE
Confidence 111110 2357899999998877665 23345678889999999999999999999999999999999
Q ss_pred EEcCCCceeeeccccceecCCCCCCCccccccccCCCChhhhc---------CCcCCCccccchhhHHHHHHHHhCCCCC
Q 004999 274 LIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLL---------GATYYGTAVDLWSTGCILAELYAGKPIM 344 (720)
Q Consensus 274 Lld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~---------~~~~y~~~sDIWSLG~iL~ELltG~ppf 344 (720)
||+.++.+||+|||++...... ....+| +.|+|||++. ....|+.++||||||||||||++|+.||
T Consensus 243 Ll~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 243 VLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp EECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred EEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999865432 345567 9999999993 3334789999999999999999999999
Q ss_pred CCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 345 PGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 345 ~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.+....+.... +......+|+.+.+||.+||+.||.+|||+.++|+|
T Consensus 318 ~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 318 TDDAALGGSEW---------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp CTTGGGSCSGG---------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCcchhhhHHH---------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 77653221111 111223678999999999999999999999999999
Q ss_pred ccCC
Q 004999 425 EFFT 428 (720)
Q Consensus 425 p~f~ 428 (720)
|||+
T Consensus 365 ~~~~ 368 (413)
T 3dzo_A 365 PEYE 368 (413)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9996
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.42 Aligned_cols=238 Identities=21% Similarity=0.338 Sum_probs=187.0
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.+.||+|+||.||+|.+ +++.||||+++... ..+.+.+|+.++++++||||+++++++... ...+|+||||++
T Consensus 26 ~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~~ 98 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMA 98 (278)
T ss_dssp EEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCT
T ss_pred EeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEEEEecCC
Confidence 33499999999999987 48899999987543 346688999999999999999999987542 457899999999
Q ss_pred ccccccccCCCC--CCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 226 HDLAGLASHPGL--KFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 226 g~ll~~~~~~~~--~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
++.+..+..... .+++..++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++...... ....
T Consensus 99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----~~~~ 174 (278)
T 1byg_A 99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTG 174 (278)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc----ccCC
Confidence 754443333221 3799999999999999999999999999999999999999999999999999765322 2233
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+++.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+....+....+.+..
T Consensus 175 ~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------------------- 231 (278)
T 1byg_A 175 KLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------------- 231 (278)
T ss_dssp -CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC----------------------
T ss_pred CccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------------
Confidence 5688999999998765 7999999999999999998 999998877655554442210
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 232 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 232 ------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 01122467899999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=365.33 Aligned_cols=251 Identities=22% Similarity=0.245 Sum_probs=199.8
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc-eeeeccceeccCCCeEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN-VIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Ivkl~~~~~~~~~~~lyLV 220 (720)
.|++.++||+|+||.||+|++..+++.||||++....... .+.+|+.+++.|.|++ |+.+..++.. ....|||
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lv 81 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLV 81 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEE
Confidence 3444455999999999999999999999999987654322 3678999999998754 4444444443 6788999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEE---cCCCceeeeccccceecCCCCC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLI---DNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILl---d~~g~vKL~DFGla~~~~~~~~ 297 (720)
|||+.++|..++......+++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||++..+.....
T Consensus 82 me~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 82 MDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred EECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999777777666556689999999999999999999999999999999999999 6889999999999987654322
Q ss_pred C------CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCChhhh
Q 004999 298 Q------PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTE---VEQLHKIFKLCGSPSEDYW 368 (720)
Q Consensus 298 ~------~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~---~e~l~~i~~~~g~p~~~~w 368 (720)
. .....+||+.|+|||++.+.. |+.++||||||||||||++|..||.+... .+.+.++.....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 233 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV------- 233 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-------
T ss_pred ccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-------
Confidence 1 122567899999999998876 79999999999999999999999988543 333333322110
Q ss_pred hhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 369 ~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...+......++.++.+||..||+.||.+||++.++++
T Consensus 234 -----------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 234 -----------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -----------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01122334578999999999999999999999998776
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=370.49 Aligned_cols=250 Identities=23% Similarity=0.353 Sum_probs=203.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+++.+.||+|+||.||+|.+.. +..||||+++..... .+.+.+|+.+|++|+||||+++++++.. ..+|||||
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv~e 341 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTE 341 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEC
T ss_pred hhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEeee
Confidence 3455679999999999999865 466999999865543 3468899999999999999999998854 56899999
Q ss_pred eccccccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 223 YMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 223 y~~g~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
||.++.+..++. .+..+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+........
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 998755544443 234689999999999999999999999999999999999999999999999999986543211122
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....++..|+|||++.+.. |+.++||||||||||||++ |..||.+....+.+..+.+....
T Consensus 422 ~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~----------------- 483 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------------- 483 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC-----------------
T ss_pred cCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-----------------
Confidence 2335678899999998765 7999999999999999999 99999999888777766432110
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC--ccCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS--EFFT 428 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h--p~f~ 428 (720)
.....+++.+.+||.+||+.||++|||+.++++. .+|.
T Consensus 484 -----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 484 -----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp -----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 1124678999999999999999999999999874 5554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.68 Aligned_cols=242 Identities=19% Similarity=0.204 Sum_probs=185.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC------CHHHHHHHHHHHHHHHhcC-----------------------
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL------EPESVRFMAREIHILRRLD----------------------- 198 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~------~~~~~~~~~~Ei~iL~~L~----------------------- 198 (720)
.||+|+||.||+|++ +|+.||||++..... .....+.+.+|+.+|+.|+
T Consensus 27 ~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~ 104 (336)
T 2vuw_A 27 KIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ 104 (336)
T ss_dssp EEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEE
T ss_pred eecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEec
Confidence 399999999999998 789999999987642 2233467889999999986
Q ss_pred ---CCceeeeccceecc-----------CCCeEEEEEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhcccccc-ccC
Q 004999 199 ---HINVIKLEGLVTSR-----------MSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH-SRG 262 (720)
Q Consensus 199 ---HpnIvkl~~~~~~~-----------~~~~lyLV~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH-~~g 262 (720)
||||+++++++... ....+|||||||.++ ++..+.. ..+++.+++.|+.||+.||.||| ++|
T Consensus 105 ~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ 182 (336)
T 2vuw_A 105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLR 182 (336)
T ss_dssp SSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 55555555555431 146799999999865 5665543 46899999999999999999999 999
Q ss_pred cccccCcceeEEEcCCC--------------------ceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCC
Q 004999 263 VLHRDIKGSNLLIDNNG--------------------ILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYG 322 (720)
Q Consensus 263 IvHrDIKP~NILld~~g--------------------~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~ 322 (720)
|+||||||+||||+.++ .+||+|||+|+.... ...+||+.|+|||++.+.. +
T Consensus 183 ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~aPE~~~g~~--~ 254 (336)
T 2vuw_A 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSMDEDLFTGDG--D 254 (336)
T ss_dssp CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTTCSGGGCCCS--S
T ss_pred EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeecccChhhhcCCC--c
Confidence 99999999999999887 899999999987643 2448999999999998764 8
Q ss_pred ccccchhhHHH-HHHHHhCCCCCCCCChHH-HHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhH
Q 004999 323 TAVDLWSTGCI-LAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPA 400 (720)
Q Consensus 323 ~~sDIWSLG~i-L~ELltG~ppf~g~~~~e-~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~ 400 (720)
.++|||||+++ .+++++|..||.+..... ....+....... .. .....+..+++.+
T Consensus 255 ~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------~~-----~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 255 YQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK-----------------TK-----CNTPAMKQIKRKI 312 (336)
T ss_dssp HHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS-----------------SC-----CCSHHHHHHHHHH
T ss_pred cceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC-----------------cc-----cchhhhhhcCHHH
Confidence 89999998877 778899999885432111 222222211000 00 0111233578889
Q ss_pred HHHHHHhcccCCCCCCCHHHHH-hCccCC
Q 004999 401 LALMETLLSIDPADRGSAASAL-RSEFFT 428 (720)
Q Consensus 401 ~dLI~~mL~~DP~kRpTa~e~L-~hp~f~ 428 (720)
.+||.+||++| |+.|+| +||||+
T Consensus 313 ~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 99999999987 999999 999995
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=373.81 Aligned_cols=249 Identities=21% Similarity=0.279 Sum_probs=200.4
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~--~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.+|++|+|||||++++++.. ..+|||||||.
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~~lv~E~~~ 418 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAG 418 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSEEEEEECCT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCeEEEEEeCC
Confidence 5999999999999875 456779999998653 23345678999999999999999999999865 45899999999
Q ss_pred cccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC--Cccc
Q 004999 226 HDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLTS 302 (720)
Q Consensus 226 g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~--~~t~ 302 (720)
++.+.. +......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...... ....
T Consensus 419 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp TCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 765544 4445567999999999999999999999999999999999999999999999999999876433221 1122
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+|+.|+|||++.+.. |+.++||||||||||||++ |..||.+.+..+.+..+.+...
T Consensus 499 ~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------------------- 557 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------------------- 557 (613)
T ss_dssp ---CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC--------------------
T ss_pred CCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence 34568999999998765 7999999999999999998 9999999888877766643210
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHH---hCccCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL---RSEFFTM 429 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L---~hp~f~~ 429 (720)
......+++.+.+||..||+.||.+|||+.+++ ++.|+..
T Consensus 558 --------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 558 --------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp --------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 112346889999999999999999999999874 5555543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=343.68 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=196.8
Q ss_pred ccceeecccCceEEEEEE----ECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRAR----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~----~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyL 219 (720)
++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.++++++||||+++++++.......+|+
T Consensus 44 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp EEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred eeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 444459999999999998 4678999999999764 3455677899999999999999999999887654557899
Q ss_pred EEeecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 220 VFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 220 V~Ey~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
||||++++ |...+......+++.+++.++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.........
T Consensus 122 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~ 201 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY 201 (326)
T ss_dssp EECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSE
T ss_pred EEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccc
Confidence 99999874 44444444456999999999999999999999999999999999999999999999999999876543221
Q ss_pred --CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 299 --PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 299 --~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......+|..|+|||++.+.. ++.++||||||||+|||++|..+|..... .. .+..+......+....+..
T Consensus 202 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~- 274 (326)
T 2w1i_A 202 YKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--EF---MRMIGNDKQGQMIVFHLIE- 274 (326)
T ss_dssp EECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HH---HHHHCTTCCTHHHHHHHHH-
T ss_pred cccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--HH---HHhhccccchhhhHHHHHH-
Confidence 122345678899999998766 79999999999999999999988754211 11 1111111110000000000
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
..... ........+++.+.+||.+||+.||.+|||+.++++
T Consensus 275 -~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 275 -LLKNN-----GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp -HHHTT-----CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -HhhcC-----CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00000 001123467899999999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=351.25 Aligned_cols=243 Identities=18% Similarity=0.219 Sum_probs=188.8
Q ss_pred ccccceeecccCceEEEEE-----EECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC---CCceeeeccceeccC
Q 004999 142 FSRSFYLIGQGTYSNVYRA-----RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRM 213 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a-----~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIvkl~~~~~~~~ 213 (720)
.|++.++||+|+||.||+| .+..+++.||||+++... ...+.+|+.+++.+. |+||+++++++..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-- 138 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-- 138 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC--
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec--
Confidence 3445556999999999999 467889999999997542 345678888888886 9999999999877
Q ss_pred CCeEEEEEeeccccccccccC-----CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-----------
Q 004999 214 SCSLYLVFEYMEHDLAGLASH-----PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN----------- 277 (720)
Q Consensus 214 ~~~lyLV~Ey~~g~ll~~~~~-----~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~----------- 277 (720)
....|||||||+|+.+..+.. ....+++.+++.|+.||+.||.|||++||+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccc
Confidence 667899999999755544432 3557999999999999999999999999999999999999998
Q ss_pred CCceeeeccccceecCC-CCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHH
Q 004999 278 NGILKIADFGLASFYDP-DQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKI 356 (720)
Q Consensus 278 ~g~vKL~DFGla~~~~~-~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i 356 (720)
++.+||+|||++..+.. ......+..+||+.|+|||++.+.. |+.++||||||||||||++|+.||......
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~------ 291 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG------ 291 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT------
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC------
Confidence 89999999999976531 2223345568999999999998876 899999999999999999999988543220
Q ss_pred HHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCc
Q 004999 357 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSE 425 (720)
Q Consensus 357 ~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp 425 (720)
.|. ....+.. ...++.+.+|+..||+.+|.+|++..+.|.+.
T Consensus 292 ----------~~~-----------~~~~~~~------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~ 333 (365)
T 3e7e_A 292 ----------ECK-----------PEGLFRR------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK 333 (365)
T ss_dssp ----------EEE-----------ECSCCTT------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred ----------cee-----------echhccc------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence 000 0000000 02356788999999999999997766655543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=345.37 Aligned_cols=243 Identities=19% Similarity=0.268 Sum_probs=193.4
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
+||+|+||.||+|.+.. .||+|++..........+.+.+|+.++++++||||+++++++.. ...+|+||||+.|+
T Consensus 40 ~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 40 LIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLAIITSLCKGR 114 (319)
T ss_dssp BCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEEEECBCCCSE
T ss_pred EeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceEEEeecccCC
Confidence 39999999999999854 39999998655444444557789999999999999999999876 56799999999875
Q ss_pred ccccccC-CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC----CCCCccc
Q 004999 228 LAGLASH-PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD----QNQPLTS 302 (720)
Q Consensus 228 ll~~~~~-~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~----~~~~~t~ 302 (720)
.+..+.. ....+++.+++.++.||+.||.|||++||+|+||||+||||+ ++.+||+|||++...... .......
T Consensus 115 ~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 193 (319)
T 2y4i_B 115 TLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRI 193 (319)
T ss_dssp EHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBC
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccccccccc
Confidence 5544444 445799999999999999999999999999999999999997 789999999998754321 1122334
Q ss_pred cccccCCCChhhhcC--------CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCC
Q 004999 303 RVVTLWYRPPELLLG--------ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLP 374 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~--------~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~ 374 (720)
..||+.|+|||++.+ ...|+.++||||||||+|||++|..||.+.........+.......
T Consensus 194 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 262 (319)
T 2y4i_B 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN----------- 262 (319)
T ss_dssp CSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC-----------
T ss_pred CCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC-----------
Confidence 568999999999975 2347899999999999999999999999888776665553321000
Q ss_pred CccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 375 HATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 375 ~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....++..+.+||..||..||.+|||+.++++
T Consensus 263 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 263 ----------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ----------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ----------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011257888999999999999999999999997
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.37 Aligned_cols=233 Identities=21% Similarity=0.299 Sum_probs=180.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHH-HhcCCCceeeeccceec--cCCCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHIL-RRLDHINVIKLEGLVTS--RMSCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL-~~L~HpnIvkl~~~~~~--~~~~~lyLV~Ey 223 (720)
++||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.++||||+++++++.. .....+||||||
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 96 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEee
Confidence 5699999999999999999999999999742 3457888888 55699999999998764 224578999999
Q ss_pred cccc-ccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeeccccceecCCCCCC
Q 004999 224 MEHD-LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 224 ~~g~-ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~~~~~~~~ 298 (720)
++|+ |...+... ...+++.+++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---- 172 (299)
T 3m2w_A 97 LDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---- 172 (299)
T ss_dssp CCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence 9874 44444332 346999999999999999999999999999999999999998 78999999999975421
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
..|+.++||||||||+|||++|.+||.+.........+... .
T Consensus 173 --------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~------------------~ 214 (299)
T 3m2w_A 173 --------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR------------------I 214 (299)
T ss_dssp --------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCS------------------S
T ss_pred --------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHH------------------H
Confidence 22688999999999999999999999776543321111000 0
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~ 431 (720)
..... ......+..+++.+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 215 ~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 215 RMGQY---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CTTCC---SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred hhccc---cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 00000 001122356899999999999999999999999999999998643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=341.80 Aligned_cols=254 Identities=25% Similarity=0.301 Sum_probs=186.2
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc--CCCceeeeccceeccCC--Ce
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL--DHINVIKLEGLVTSRMS--CS 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L--~HpnIvkl~~~~~~~~~--~~ 216 (720)
+.|++.+.||+|+||.||+|++. ++.||||++.... ...+.+|..++..+ +||||+++++++..... ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34555566999999999999984 8999999986432 23344555555554 89999999998876422 67
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhcccccccc--------CcccccCcceeEEEcCCCceeeecccc
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR--------GVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~--------gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+|+||||++++.+..+... ..+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999987555444433 3689999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCCC---CccccccccCCCChhhhcCCcCCCcc------ccchhhHHHHHHHHhC----------CCCCCCCC-
Q 004999 289 ASFYDPDQNQ---PLTSRVVTLWYRPPELLLGATYYGTA------VDLWSTGCILAELYAG----------KPIMPGRT- 348 (720)
Q Consensus 289 a~~~~~~~~~---~~t~~~gT~~Y~APE~l~~~~~y~~~------sDIWSLG~iL~ELltG----------~ppf~g~~- 348 (720)
+..+...... .....+||+.|+|||++.+.. ++.. +||||||||+|||++| ..||.+..
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 9876433222 123457899999999998765 3443 9999999999999999 55554422
Q ss_pred ---hHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 349 ---EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 349 ---~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
....+..+..... ..+..+. ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~-----------------~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 268 SDPSYEDMREIVCIKK-----------------LRPSFPN----RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SSCCHHHHHHHHTTSC-----------------CCCCCCG----GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCchhhhHHHHhhhc-----------------cCccccc----cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2222222221100 0000000 00112456779999999999999999999999985
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.93 Aligned_cols=270 Identities=23% Similarity=0.264 Sum_probs=183.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHH--HHhcCCCceeeeccceec---cCCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHI--LRRLDHINVIKLEGLVTS---RMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~i--L~~L~HpnIvkl~~~~~~---~~~~~lyLV~E 222 (720)
.||+|+||.||+|++ +++.||||++.... ...+..|..+ +..++||||+++++.+.. .....+|||||
T Consensus 20 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 92 (336)
T 3g2f_A 20 LIGRGRYGAVYKGSL--DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVME 92 (336)
T ss_dssp EEEECSSEEEEEEEE--TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEEC
T ss_pred ecccCCCeEEEEEEE--CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEe
Confidence 399999999999987 68999999997542 2233344444 455899999999874432 22346899999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhcccccccc---------CcccccCcceeEEEcCCCceeeeccccceecC
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR---------GVLHRDIKGSNLLIDNNGILKIADFGLASFYD 293 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~---------gIvHrDIKP~NILld~~g~vKL~DFGla~~~~ 293 (720)
|++++.+..+.... .+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..+.
T Consensus 93 ~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~ 171 (336)
T 3g2f_A 93 YYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171 (336)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecc
Confidence 99875554444322 458999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC-------CCCccccccccCCCChhhhcCC------cCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHH-
Q 004999 294 PDQ-------NQPLTSRVVTLWYRPPELLLGA------TYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFK- 358 (720)
Q Consensus 294 ~~~-------~~~~t~~~gT~~Y~APE~l~~~------~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~~- 358 (720)
... .......+||+.|+|||++.+. ..++.++||||||||+|||++|. ++|.+....+....+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 251 (336)
T 3g2f_A 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTE 251 (336)
T ss_dssp SSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHH
T ss_pred cccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcc
Confidence 321 1223345789999999999873 23678999999999999999996 45554332111111111
Q ss_pred hcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh------CccCCCC
Q 004999 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR------SEFFTMK 430 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~------hp~f~~~ 430 (720)
....+....+........ ..+..+ . .......+++.+.+||.+||+.||.+|||+.++++ ++|-+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~--~~~~~~--~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 252 VGNHPTFEDMQVLVSREK--QRPKFP--E-AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp HCSSCCHHHHHHHHTTSC--CCCCCC--T-TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred cCCCchHHHHHhhhcccc--cCCCCC--c-ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 111121111111000000 000000 0 00001124457999999999999999999999954 6776654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=380.95 Aligned_cols=273 Identities=23% Similarity=0.281 Sum_probs=203.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceec----cCCCeEEEEEee
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTS----RMSCSLYLVFEY 223 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~----~~~~~lyLV~Ey 223 (720)
.||+|+||.||+|.+..+|+.||||+++.. ......+.+.+|+.+|++++||||+++++++.. ......||||||
T Consensus 21 ~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy 99 (676)
T 3qa8_A 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99 (676)
T ss_dssp CCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEEC
T ss_pred EEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEe
Confidence 399999999999999999999999998764 345667788999999999999999999988654 124678999999
Q ss_pred ccccccccccCC---CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCc---eeeeccccceecCCCCC
Q 004999 224 MEHDLAGLASHP---GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGI---LKIADFGLASFYDPDQN 297 (720)
Q Consensus 224 ~~g~ll~~~~~~---~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~---vKL~DFGla~~~~~~~~ 297 (720)
|+|+.+..+... ...+++..++.++.||+.||.|||+.||+|+||||+||||+.++. +||+|||++......
T Consensus 100 ~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~-- 177 (676)
T 3qa8_A 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-- 177 (676)
T ss_dssp CSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC--
T ss_pred CCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc--
Confidence 987555443332 236899999999999999999999999999999999999997765 999999999876433
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
.......+|+.|+|||++.+.. |+.++|||||||++|+|++|..||.+......+......... ...+.........
T Consensus 178 ~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~l~g~~ 254 (676)
T 3qa8_A 178 ELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN--EHIVVYDDLTGAV 254 (676)
T ss_dssp CCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------CCSCCCCSSSC
T ss_pred cccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc--hhhhhhhhhcccc
Confidence 2334568899999999998765 799999999999999999999999876544332211100000 0000000001111
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.+....+. .......+++.+.+||..||.+||.+|||+.++|+||||+.
T Consensus 255 ~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 255 KFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred ccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 11111110 11222346788999999999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=367.23 Aligned_cols=249 Identities=20% Similarity=0.292 Sum_probs=201.8
Q ss_pred ccccceeecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLY 218 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ly 218 (720)
.+.+.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.+|++++||||+++++++.. ..+|
T Consensus 391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~ 466 (656)
T 2j0j_A 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVW 466 (656)
T ss_dssp GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---CceE
Confidence 345556699999999999998643 5679999987542 44556788999999999999999999998843 4689
Q ss_pred EEEeeccccccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 219 LVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 219 LV~Ey~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|||||++++.+. .+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~ 546 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 546 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence 999999965444 4443455799999999999999999999999999999999999999999999999999987654333
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
.......+|+.|+|||++.+.. |+.++||||||||+|||++ |.+||.+....+.+..+......
T Consensus 547 ~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~-------------- 611 (656)
T 2j0j_A 547 YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------------- 611 (656)
T ss_dssp -------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC--------------
T ss_pred eeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC--------------
Confidence 3333445688999999998765 7999999999999999997 99999999888877776542111
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++.+.+||.+||..||.+|||+.++++
T Consensus 612 --------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 612 --------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 122467899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=334.50 Aligned_cols=255 Identities=23% Similarity=0.246 Sum_probs=192.4
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHh--cCCCceeeeccceeccCC--Ce
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRR--LDHINVIKLEGLVTSRMS--CS 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~--L~HpnIvkl~~~~~~~~~--~~ 216 (720)
..|++.+.||+|+||.||+|.+ +++.||||++... ....+.+|+.++.. ++||||+++++++..... ..
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3455556699999999999998 5899999998643 23557789999988 789999999999876432 27
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhcccccc--------ccCcccccCcceeEEEcCCCceeeecccc
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH--------SRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH--------~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+|+||||+.++.+..+... ..+++.+++.++.||+.||.||| +.||+|+||||+||||+.++.+||+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999998555444433 36899999999999999999999 89999999999999999999999999999
Q ss_pred ceecCCCCCC---CccccccccCCCChhhhcCCcC-----CCccccchhhHHHHHHHHhC----------CCCCCCCC--
Q 004999 289 ASFYDPDQNQ---PLTSRVVTLWYRPPELLLGATY-----YGTAVDLWSTGCILAELYAG----------KPIMPGRT-- 348 (720)
Q Consensus 289 a~~~~~~~~~---~~t~~~gT~~Y~APE~l~~~~~-----y~~~sDIWSLG~iL~ELltG----------~ppf~g~~-- 348 (720)
+......... ......+|+.|+|||++.+... ++.++||||||||+|||++| ..||.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 273 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 273 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence 9876433221 2244578999999999987532 23689999999999999999 66776542
Q ss_pred --hHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 349 --EVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 349 --~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
..+.+........ ..+..+.. -....+++.+.+||..||+.||.+|||+.+++++
T Consensus 274 ~~~~~~~~~~~~~~~-----------------~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 274 DPSVEEMRKVVCEQK-----------------LRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SCCHHHHHHHHTTSC-----------------CCCCCCGG----GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHHH-----------------hCCCCccc----ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 2222222211000 00000000 0011345678999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.85 Aligned_cols=226 Identities=19% Similarity=0.118 Sum_probs=181.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++.+.||+|+||.||+|++..+++.||||++..... .....+.+.+|+.++.+++||||+++++++.. ...+||||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~ 110 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLVVA 110 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEEEE
Confidence 3444459999999999999999999999999987654 45667889999999999999999999999877 67899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
||++|+.+..+...+ ....++..++.||+.||.|||++||+||||||+||||+.+|.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------------
Confidence 999986666555443 4667899999999999999999999999999999999999999998543
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
|++| ++.++||||||||||||++|+.||.+.+..+.+....+ ....
T Consensus 175 -------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-------------------~~~~ 220 (286)
T 3uqc_A 175 -------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-------------------DTAG 220 (286)
T ss_dssp -------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB-------------------CTTS
T ss_pred -------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH-------------------Hhcc
Confidence 3332 68999999999999999999999988654221100000 0000
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
. ..........+++.+.+||.+||+.||.+| |+.++++.
T Consensus 221 ~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 221 Q---PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp C---BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred C---CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 0 001223446789999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=370.69 Aligned_cols=242 Identities=21% Similarity=0.256 Sum_probs=196.3
Q ss_pred cccccceeecccCceEEEEEEECC-CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCC---e
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLD-QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSC---S 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~-tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~---~ 216 (720)
+.|++.++||+|+||.||+|.+.. +++.||||++... ........+.+|+.+|++++||||+++++++...... .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 445666669999999999999976 7899999998754 2455667789999999999999999999998764221 2
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
+|||||||+|+.+..+... .+++.+++.|+.||+.||.|||++||+||||||+||||+.+ .+||+|||++......
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC-
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC-
Confidence 7999999998777665443 79999999999999999999999999999999999999875 8999999999876432
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
...+||+.|+|||++.+. ++.++||||||||||+|++|.++|.+.... +.+
T Consensus 235 ----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~------------- 285 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP------------- 285 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC-------------
T ss_pred ----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------ccc-------------
Confidence 445789999999999765 489999999999999999999888652110 000
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
... ....+++.+.+||.+||+.||.+||++.++|.|+|+.
T Consensus 286 ----~~~--------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ----EDD--------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----TTC--------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----ccc--------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000 0112457899999999999999999999999999874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-31 Score=308.82 Aligned_cols=185 Identities=17% Similarity=0.072 Sum_probs=133.9
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCC----C----HHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEE
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNL----E----PESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~----~----~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyL 219 (720)
++.|+.|.+..++..-.|+.||+|++..... . ....+.|.+|+.+|+++ .|+||+++++++.+ +..+||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~yL 319 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGWL 319 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEEE
Confidence 5567777777777777899999999986532 1 23345689999999999 69999999999987 788999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
|||||+|+.|..++..+..+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...... ..
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~ 395 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SW 395 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----CC
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC-cc
Confidence 99999998887777777778775 478999999999999999999999999999999999999999998765432 34
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK 341 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ 341 (720)
.+..+||+.|+|||++.+. +..++|+||+|+++++|+++.
T Consensus 396 ~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred ccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence 5567899999999999875 477899999999999887764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-26 Score=260.35 Aligned_cols=184 Identities=18% Similarity=0.156 Sum_probs=139.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCC-H-----HHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-P-----ESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-~-----~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
++||+|+||.||+|. ..+..+++|+....... . ...+.+.+|+.+|++++||||+++..++.. ....|||
T Consensus 342 ~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lV 417 (540)
T 3en9_A 342 HLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNKRIM 417 (540)
T ss_dssp ------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTTEEE
T ss_pred CEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCccEEE
Confidence 359999999999994 35778999987654332 1 124558999999999999999955544444 4557999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP- 299 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~- 299 (720)
||||+|+.+..+... ++.++.||+.||.|||++||+||||||+||||+. .+||+|||+++.........
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 999986555554443 6789999999999999999999999999999988 99999999999864322111
Q ss_pred -----ccccccccCCCChhhhcCC-cCCCccccchhhHHHHHHHHhCCCCC
Q 004999 300 -----LTSRVVTLWYRPPELLLGA-TYYGTAVDLWSTGCILAELYAGKPIM 344 (720)
Q Consensus 300 -----~t~~~gT~~Y~APE~l~~~-~~y~~~sDIWSLG~iL~ELltG~ppf 344 (720)
....+||+.|+|||++... ..|+..+|+|+..+-..+.+.++..|
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2356789999999999751 23788899999999888887776544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.9e-23 Score=220.18 Aligned_cols=147 Identities=16% Similarity=0.139 Sum_probs=117.1
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH----------------HHHHHHHHHHHHHHhcCCCceeee
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----------------ESVRFMAREIHILRRLDHINVIKL 205 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----------------~~~~~~~~Ei~iL~~L~HpnIvkl 205 (720)
++.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.+|++++ | +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 444557799999999999999 889999999997542211 23567889999999999 5 677
Q ss_pred ccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeec
Q 004999 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIAD 285 (720)
Q Consensus 206 ~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~D 285 (720)
++++.. +.+|+|||||+|+.+..+.. .....++.||+.||.|||++||+||||||+||||+ +|.+||+|
T Consensus 167 ~~~~~~---~~~~lvmE~~~g~~L~~l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW---EGNAVLMELIDAKELYRVRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE---ETTEEEEECCCCEEGGGCCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec---cceEEEEEecCCCcHHHcch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 776543 45699999999865554321 23567999999999999999999999999999999 99999999
Q ss_pred cccceecCCCCCCCccccccccCCCChhhhcC
Q 004999 286 FGLASFYDPDQNQPLTSRVVTLWYRPPELLLG 317 (720)
Q Consensus 286 FGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~ 317 (720)
||+|.. +..|+|||++..
T Consensus 236 FG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE--------------TTSTTHHHHHHH
T ss_pred CCCCeE--------------CCCCCHHHHHHH
Confidence 999974 344899998854
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.9e-20 Score=191.96 Aligned_cols=139 Identities=17% Similarity=0.199 Sum_probs=105.0
Q ss_pred cccceeecccCceEEEEEEECCCCeE--EEEEEeecCCCCH----------------------HHHHHHHHHHHHHHhcC
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKI--VALKKVRFDNLEP----------------------ESVRFMAREIHILRRLD 198 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~--VAIK~l~~~~~~~----------------------~~~~~~~~Ei~iL~~L~ 198 (720)
+.+...||+|+||.||+|.+..+|+. ||||+++...... .....+.+|+.+|.+|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45556799999999999998778999 9999976542110 11235789999999998
Q ss_pred CCce--eeeccceeccCCCeEEEEEeeccc-c----ccccccCCCCCCCHHHHHHHHHhhhhcccccc-ccCcccccCcc
Q 004999 199 HINV--IKLEGLVTSRMSCSLYLVFEYMEH-D----LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH-SRGVLHRDIKG 270 (720)
Q Consensus 199 HpnI--vkl~~~~~~~~~~~lyLV~Ey~~g-~----ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH-~~gIvHrDIKP 270 (720)
|++| +.++.+ ...||||||+++ + .+..+.. .+++..+..++.||+.+|.||| ++||+||||||
T Consensus 129 ~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGR---ELKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGG---GGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhh---ccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8865 333321 246899999953 1 2222211 1245678899999999999999 99999999999
Q ss_pred eeEEEcCCCceeeeccccceec
Q 004999 271 SNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 271 ~NILld~~g~vKL~DFGla~~~ 292 (720)
+||||+. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999988 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-16 Score=175.09 Aligned_cols=140 Identities=17% Similarity=0.126 Sum_probs=98.4
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-----C----------HHHHH-----HHHHHHHHHHhcCCC
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-----E----------PESVR-----FMAREIHILRRLDHI 200 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-----~----------~~~~~-----~~~~Ei~iL~~L~Hp 200 (720)
..|++...||.|+||.||+|.+. +|+.||||+++.... . ..... ...+|...|.+|.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 35777788999999999999974 689999999864211 0 00000 123466666666444
Q ss_pred ceeeeccceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-
Q 004999 201 NVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG- 279 (720)
Q Consensus 201 nIvkl~~~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g- 279 (720)
+|.-.. .+.. ...+|||||++|..+..+.. ...+..++.||+.+|.+||++|||||||||.||||+.+|
T Consensus 174 gv~vp~-p~~~---~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 174 GFPVPE-PIAQ---SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TCSCCC-EEEE---ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred CCCCCe-eeec---cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 432211 1111 12379999999876654432 224567889999999999999999999999999998877
Q ss_pred ---------ceeeecccccee
Q 004999 280 ---------ILKIADFGLASF 291 (720)
Q Consensus 280 ---------~vKL~DFGla~~ 291 (720)
.+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 389999997764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=1.6e-11 Score=126.19 Aligned_cols=135 Identities=15% Similarity=0.106 Sum_probs=101.8
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEeec
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
...++.|+.+.||++.. .+..++||+....... ....+.+|+.+|+.|. +..+.++++++.. .+..|+||||+
T Consensus 19 ~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~--~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~e~i 92 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEA 92 (263)
T ss_dssp EECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECC
T ss_pred EeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC--CHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEEEec
Confidence 33488888999999975 3678999998753211 1124788999999994 6778888887765 56789999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccc--------------------------------------------
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-------------------------------------------- 260 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-------------------------------------------- 260 (720)
+|..+..... +......++.+++.+|..||+
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9976654321 122345778888888899998
Q ss_pred ---------------cCcccccCcceeEEEcCCCceeeecccccee
Q 004999 261 ---------------RGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 261 ---------------~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998766677999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.07 E-value=2.1e-10 Score=116.78 Aligned_cols=127 Identities=15% Similarity=0.137 Sum_probs=91.0
Q ss_pred ec-ccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc--eeeeccceeccCCCeEEEEEeecc
Q 004999 149 IG-QGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 149 LG-~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Ivkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
++ .|..+.||++.. .+|..++||+..... ...+.+|+.+++.|.+.+ |.+++++... .+..|+||||++
T Consensus 27 ~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~i~ 98 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVP 98 (264)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCS
T ss_pred cccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEecC
Confidence 54 566699999964 557779999976431 134678999999985444 4567776654 456899999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccC-------------------------------------------
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG------------------------------------------- 262 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g------------------------------------------- 262 (720)
|..+. +.. .. ...++.+++..|..||+..
T Consensus 99 G~~l~-~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 99 GQDLL-SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp SEETT-TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred CcccC-cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 97664 211 12 1245566666666666543
Q ss_pred ---------------cccccCcceeEEEcCCCceeeecccccee
Q 004999 263 ---------------VLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 263 ---------------IvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
++|+|++|.|||++.++.+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776678999998763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.1e-10 Score=120.13 Aligned_cols=139 Identities=15% Similarity=0.217 Sum_probs=101.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEee--cCCCCHHHHHHHHHHHHHHHhcC--CCceeeeccceeccC-CCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVR--FDNLEPESVRFMAREIHILRRLD--HINVIKLEGLVTSRM-SCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~--~~~~~~~~~~~~~~Ei~iL~~L~--HpnIvkl~~~~~~~~-~~~lyLV~E 222 (720)
.|+.|.++.||++... +..+++|+.. ..... .....+.+|+.+|+.|. +..+++++.++.+.. .+..|+|||
T Consensus 45 ~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp ECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 3999999999999863 4568888876 33211 12346788999999997 455778887765421 145799999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccc------------------------------------------
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS------------------------------------------ 260 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~------------------------------------------ 260 (720)
|++|..+.... -..+++.+...++.+++..|..||.
T Consensus 122 ~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 122 FVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp CCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred ecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 99997653211 1246888899999999999999996
Q ss_pred ----------------cCcccccCcceeEEEcCCCc--eeeecccccee
Q 004999 261 ----------------RGVLHRDIKGSNLLIDNNGI--LKIADFGLASF 291 (720)
Q Consensus 261 ----------------~gIvHrDIKP~NILld~~g~--vKL~DFGla~~ 291 (720)
..++|+|+++.|||++.++. +.|+||+.+..
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987753 69999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=3.4e-10 Score=119.32 Aligned_cols=181 Identities=18% Similarity=0.177 Sum_probs=116.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCc--eeeeccceeccC-CCeEEEEEee
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HIN--VIKLEGLVTSRM-SCSLYLVFEY 223 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-Hpn--Ivkl~~~~~~~~-~~~lyLV~Ey 223 (720)
.|+.|.+..||++. ..+++|+... ......+.+|+.+|+.|. +.. +.+++....... ....|+|||+
T Consensus 27 ~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp EEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred ecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 38999999999873 3488998653 244567889999999883 333 233433322211 1235899999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-------------------------------------------
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS------------------------------------------- 260 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~------------------------------------------- 260 (720)
++|..+..... ..++..+...++.|++..|..||+
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99976543211 245777777788888877777774
Q ss_pred ---------------cCcccccCcceeEEEcC--CCceeeeccccceecCCCCCCCccccccccCC---CChhhhcCC-c
Q 004999 261 ---------------RGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWY---RPPELLLGA-T 319 (720)
Q Consensus 261 ---------------~gIvHrDIKP~NILld~--~g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y---~APE~l~~~-~ 319 (720)
..++|+|++|.|||++. .+.+.|+||+.+...++.. .......+ ..|+.+... .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhhccccCHHHHHHHHH
Confidence 13799999999999998 4568999999987643211 00111111 233322110 0
Q ss_pred CCC------------ccccchhhHHHHHHHHhCCCCC
Q 004999 320 YYG------------TAVDLWSTGCILAELYAGKPIM 344 (720)
Q Consensus 320 ~y~------------~~sDIWSLG~iL~ELltG~ppf 344 (720)
.|+ ...+.|+++.++|.+.+|.+.|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 011 1258999999999999998654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.2e-06 Score=92.54 Aligned_cols=133 Identities=14% Similarity=0.153 Sum_probs=90.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCC---ceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI---NVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.++.|....||+. +..+++|+.. .......+.+|+.+|+.|.+. .|.+++.+... ..+..|+||||+
T Consensus 26 ~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i 95 (306)
T 3tdw_A 26 SLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKV 95 (306)
T ss_dssp EEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECC
T ss_pred ecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEecc
Confidence 4888999999998 4558888853 234556789999999999652 24555555432 245678999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccc--------------------------------------------
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-------------------------------------------- 260 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-------------------------------------------- 260 (720)
+|..+..... ..++..+...++.++...|..||+
T Consensus 96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9976543211 123444455555555555444443
Q ss_pred ----------------cCcccccCcceeEEEcC---CCc-eeeeccccceec
Q 004999 261 ----------------RGVLHRDIKGSNLLIDN---NGI-LKIADFGLASFY 292 (720)
Q Consensus 261 ----------------~gIvHrDIKP~NILld~---~g~-vKL~DFGla~~~ 292 (720)
..++|+|+++.|||++. ++. +.|+||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24699999999999987 455 589999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.2e-06 Score=89.95 Aligned_cols=132 Identities=16% Similarity=0.146 Sum_probs=86.0
Q ss_pred ecccCce-EEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYS-NVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g-~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+..|..+ .||+......+..++||+... .....+.+|..+|+.|. +--|.+++.++.+ .+..|+|||+++|
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G 104 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPG 104 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCS
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCC
Confidence 4555555 699988777777899998763 34556789999999884 3346677777665 5678999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhcccccc-----------------------------------------------
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH----------------------------------------------- 259 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH----------------------------------------------- 259 (720)
..+...... .......++.++...|..||
T Consensus 105 ~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 543321110 00111122222222222222
Q ss_pred -----------ccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 260 -----------SRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 260 -----------~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877778999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=8e-06 Score=87.48 Aligned_cols=83 Identities=10% Similarity=0.100 Sum_probs=52.0
Q ss_pred ee-cccCceEEEEEEEC---C---CCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcC-C--CceeeeccceeccC-CC
Q 004999 148 LI-GQGTYSNVYRARDL---D---QKKIVALKKVRFDNL-EPESVRFMAREIHILRRLD-H--INVIKLEGLVTSRM-SC 215 (720)
Q Consensus 148 ~L-G~G~~g~Vy~a~~~---~---tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~-H--pnIvkl~~~~~~~~-~~ 215 (720)
.| +.|....+|+.... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.++.+.. .+
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 47 88999999998753 1 256789998654320 0000124577888888874 2 34666776654321 13
Q ss_pred eEEEEEeeccccccc
Q 004999 216 SLYLVFEYMEHDLAG 230 (720)
Q Consensus 216 ~lyLV~Ey~~g~ll~ 230 (720)
..|+||||++|..+.
T Consensus 107 ~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 107 TPFFLMDYVEGVVPP 121 (357)
T ss_dssp SCEEEEECCCCBCCC
T ss_pred CceEEEEecCCCChh
Confidence 568999999986543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=7.3e-06 Score=89.37 Aligned_cols=75 Identities=17% Similarity=0.120 Sum_probs=47.2
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC--CH---HHHHHHHHHHHHHHhcCC--C-ceeeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL--EP---ESVRFMAREIHILRRLDH--I-NVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~--~~---~~~~~~~~Ei~iL~~L~H--p-nIvkl~~~~~~~~~~~lyL 219 (720)
.||.|.++.||++.+..+++.|+||....... .. .....+..|+.+|+.+.. + .+.+++.+ + ....++
T Consensus 37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d--~~~~~l 112 (397)
T 2olc_A 37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--TEMAVT 112 (397)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--TTTTEE
T ss_pred ECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c--CCccEE
Confidence 49999999999998666678899998653211 00 112346779999988742 3 34455543 2 233589
Q ss_pred EEeeccc
Q 004999 220 VFEYMEH 226 (720)
Q Consensus 220 V~Ey~~g 226 (720)
||||++|
T Consensus 113 vmE~l~g 119 (397)
T 2olc_A 113 VMEDLSH 119 (397)
T ss_dssp EECCCTT
T ss_pred EEEeCCC
Confidence 9999986
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.84 E-value=0.00015 Score=76.31 Aligned_cols=31 Identities=26% Similarity=0.402 Sum_probs=27.9
Q ss_pred cCcccccCcceeEEEcCCCceeeecccccee
Q 004999 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 261 ~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00057 Score=72.45 Aligned_cols=72 Identities=19% Similarity=0.214 Sum_probs=54.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC---CCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD---HINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~---HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.|+.|.+..+|+... ++..++||+.... ....+..|+..|+.|. ...|++++.+... ....|+||||+
T Consensus 43 ~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l 113 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEAL 113 (312)
T ss_dssp EECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECC
T ss_pred EeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEec
Confidence 489999999999975 4667889987642 2456788999998883 3567777776654 46789999999
Q ss_pred cccc
Q 004999 225 EHDL 228 (720)
Q Consensus 225 ~g~l 228 (720)
+|..
T Consensus 114 ~G~~ 117 (312)
T 3jr1_A 114 NKSK 117 (312)
T ss_dssp CCCC
T ss_pred cCCC
Confidence 9853
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00019 Score=78.83 Aligned_cols=32 Identities=9% Similarity=0.424 Sum_probs=28.3
Q ss_pred cccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 259 H~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
+...++|+|+++.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999998777 99999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00051 Score=72.10 Aligned_cols=137 Identities=14% Similarity=0.099 Sum_probs=72.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc--eeeeccce----eccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN--VIKLEGLV----TSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--Ivkl~~~~----~~~~~~~lyLV~ 221 (720)
.|+.|....||++... +| .+++|+..... . ...+..|+.++..|...+ +.+++... .....+..++||
T Consensus 29 ~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTT-KD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred ccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3888988999999753 34 58899887521 1 123456777777763222 33333211 001134578999
Q ss_pred eecccccccc---------------cc--CCC---C---CCCHHHHHHHHHh---------------hhhcccccc----
Q 004999 222 EYMEHDLAGL---------------AS--HPG---L---KFSEAQVKCYMQQ---------------LLCGLDHCH---- 259 (720)
Q Consensus 222 Ey~~g~ll~~---------------~~--~~~---~---~lse~~~~~i~~Q---------------Il~gL~yLH---- 259 (720)
+|++|..+.. +. ... . ..........+.+ +...+.+|.
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9999854221 00 000 0 0111110111111 111222222
Q ss_pred ---ccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 260 ---SRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 260 ---~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
..+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 2469999999999999887666899999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00065 Score=70.94 Aligned_cols=131 Identities=18% Similarity=0.117 Sum_probs=71.7
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEEEeec-
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEYM- 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV~Ey~- 224 (720)
+.|+.|....+|++ ..+++|+...... ..-...+|+.+++.+...++ .+++.+.. ..-++|+||+
T Consensus 24 ~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~~~~~~----~~~~~v~e~i~ 90 (301)
T 3dxq_A 24 LERLGGLTNLVFRA------GDLCLRIPGKGTE---EYINRANEAVAAREAAKAGVSPEVLHVDP----ATGVMVTRYIA 90 (301)
T ss_dssp EEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEECT----TTCCEEEECCT
T ss_pred eEcCCcccccccee------eeEEEECCCCCcc---ceeCHHHHHHHHHHHHHcCCCCceEEEEC----CCCEEEEeecC
Confidence 34999999999999 3488898764311 00112467777777742222 45544332 2246899999
Q ss_pred ccccccc-------------------ccCCCCCC----C-HHHHHHHHHhhh---------------------hcccc-c
Q 004999 225 EHDLAGL-------------------ASHPGLKF----S-EAQVKCYMQQLL---------------------CGLDH-C 258 (720)
Q Consensus 225 ~g~ll~~-------------------~~~~~~~l----s-e~~~~~i~~QIl---------------------~gL~y-L 258 (720)
+|..+.. +......+ . ...+..+..++. ..|.- -
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 7644321 00011111 1 112222221111 11100 0
Q ss_pred cccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 259 H~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
....++|+|+.+.||| ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 1224899999999999 5677789999998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0035 Score=69.25 Aligned_cols=71 Identities=18% Similarity=0.158 Sum_probs=47.9
Q ss_pred eecccCceEEEEEEECC-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~-------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyL 219 (720)
.|+.|....||++.... ++..|+||+..... . ...+.+|+.+++.|...+| +++++.+.. .+
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~------g~ 149 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG------GR 149 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT------EE
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC------CE
Confidence 38889999999998643 25679999884321 1 1344579999998853333 566655432 38
Q ss_pred EEeeccccc
Q 004999 220 VFEYMEHDL 228 (720)
Q Consensus 220 V~Ey~~g~l 228 (720)
||||++|..
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999999843
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0025 Score=69.36 Aligned_cols=134 Identities=16% Similarity=0.147 Sum_probs=80.9
Q ss_pred ecccCceEEEEEEECC-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEE
Q 004999 149 IGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~-------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV 220 (720)
|..|-...+|++.... ++..|+||+..... .....+.+|..+++.|. +.-..++++++.. .+|
T Consensus 58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~v 128 (379)
T 3feg_A 58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE------GRL 128 (379)
T ss_dssp C-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EEE
T ss_pred cCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------ccE
Confidence 7778889999998642 35679999863211 12344568999998884 3223566655432 289
Q ss_pred Eeecccccccccc------------------CC----CCCC--CHHHHHHHHHhhhhc-------------------ccc
Q 004999 221 FEYMEHDLAGLAS------------------HP----GLKF--SEAQVKCYMQQLLCG-------------------LDH 257 (720)
Q Consensus 221 ~Ey~~g~ll~~~~------------------~~----~~~l--se~~~~~i~~QIl~g-------------------L~y 257 (720)
|||++|..+.... .. +... -+.++..++.++... +..
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 9999985443110 00 1112 245667777665332 112
Q ss_pred cc--------ccCcccccCcceeEEEcCC----Cceeeecccccee
Q 004999 258 CH--------SRGVLHRDIKGSNLLIDNN----GILKIADFGLASF 291 (720)
Q Consensus 258 LH--------~~gIvHrDIKP~NILld~~----g~vKL~DFGla~~ 291 (720)
|. ...++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 2359999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0073 Score=63.33 Aligned_cols=137 Identities=13% Similarity=0.093 Sum_probs=77.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCC--ceeeeccc---eeccCCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI--NVIKLEGL---VTSRMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIvkl~~~---~~~~~~~~lyLV~E 222 (720)
.|+ |....||++.. .+|+.+++|+.+...... ..+..|..+++.|... .+++++.. ......+..++||+
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~ 107 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 107 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence 377 88889998864 346679999987543332 3456688888877422 24444432 00001345688999
Q ss_pred ecccccccc---------------c---cCC-----CCCCCHHHH----HHH------------------HHhhhhcccc
Q 004999 223 YMEHDLAGL---------------A---SHP-----GLKFSEAQV----KCY------------------MQQLLCGLDH 257 (720)
Q Consensus 223 y~~g~ll~~---------------~---~~~-----~~~lse~~~----~~i------------------~~QIl~gL~y 257 (720)
|++|..+.. + ... ...++.... ..+ +.+++..+.-
T Consensus 108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~ 187 (328)
T 1zyl_A 108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA 187 (328)
T ss_dssp CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence 999853321 0 000 011221111 111 1111111111
Q ss_pred c----cccCcccccCcceeEEEcCCCceeeecccccee
Q 004999 258 C----HSRGVLHRDIKGSNLLIDNNGILKIADFGLASF 291 (720)
Q Consensus 258 L----H~~gIvHrDIKP~NILld~~g~vKL~DFGla~~ 291 (720)
+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1 234689999999999998 4 899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0014 Score=70.38 Aligned_cols=71 Identities=10% Similarity=0.070 Sum_probs=41.5
Q ss_pred ecccCceEEEEEEECC--------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCc-eeeeccceeccCCCeEEE
Q 004999 149 IGQGTYSNVYRARDLD--------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHIN-VIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~--------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-Ivkl~~~~~~~~~~~lyL 219 (720)
|+.|....||++.... .+..|++|+..... ........|..+++.|...+ +.++++.+ . -++
T Consensus 41 l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~--~~~ 111 (369)
T 3c5i_A 41 ILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF----N--GGR 111 (369)
T ss_dssp C----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----T--TEE
T ss_pred eCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec----C--CcE
Confidence 8888889999998643 12678899875421 11111357888888874333 34555433 1 268
Q ss_pred EEeeccccc
Q 004999 220 VFEYMEHDL 228 (720)
Q Consensus 220 V~Ey~~g~l 228 (720)
||||++|..
T Consensus 112 v~e~i~G~~ 120 (369)
T 3c5i_A 112 IEEWLYGDP 120 (369)
T ss_dssp EEECCCSEE
T ss_pred EEEEecCCc
Confidence 999999853
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0066 Score=64.66 Aligned_cols=32 Identities=25% Similarity=0.359 Sum_probs=28.2
Q ss_pred cCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 261 ~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
..++|+|+.+.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999887653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0085 Score=66.78 Aligned_cols=74 Identities=18% Similarity=0.156 Sum_probs=47.4
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+.|+.|-...+|++.....+..|+||+...... ..+. ..+|..+|+.|...++ .++++++. . .+||||++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~id-R~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~I~ 184 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIIN-REREKKISCILYNKNIAKKIYVFFT---N---GRIEEFMD 184 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSC-HHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEECCC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcC-HHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEeeC
Confidence 358889999999998755457899998753211 0000 1579999999965444 56666552 2 25999999
Q ss_pred cccc
Q 004999 226 HDLA 229 (720)
Q Consensus 226 g~ll 229 (720)
|..+
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 8433
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0027 Score=65.74 Aligned_cols=71 Identities=17% Similarity=0.147 Sum_probs=48.7
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCC---ceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHI---NVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~Hp---nIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
.+|.|..+.||+... .+|+.|.+|+....... ....|.+|+..|+.|.-. .+++++++ . .-++||||+
T Consensus 22 ~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~----~~~lv~e~l 92 (288)
T 3f7w_A 22 ERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D----DRTLAMEWV 92 (288)
T ss_dssp EEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E----TTEEEEECC
T ss_pred ecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--c----CceEEEEee
Confidence 399999999999985 56888999986643321 123467899999988422 23444433 1 237899998
Q ss_pred ccc
Q 004999 225 EHD 227 (720)
Q Consensus 225 ~g~ 227 (720)
++.
T Consensus 93 ~~~ 95 (288)
T 3f7w_A 93 DER 95 (288)
T ss_dssp CCC
T ss_pred ccc
Confidence 753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0046 Score=61.82 Aligned_cols=96 Identities=15% Similarity=0.020 Sum_probs=62.9
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccc-cccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHC-HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yL-H~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
|...+...+.+|+|+++|.++.|.+..|.-+ +...-..+=+.|..|+|..+|.|.+.+ ..+. ...
T Consensus 35 L~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------~~~ 100 (229)
T 2yle_A 35 LEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------AGE 100 (229)
T ss_dssp HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-------------------
T ss_pred HHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------ccc
Confidence 4455556777999999999999999998765 111222344567999999999988764 1110 012
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHh
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA 339 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt 339 (720)
..+.|||.+.. ..+.+.-|||||+++|..+-
T Consensus 101 ~~~~~pe~~~~--~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 101 PPPVAGKLGYS--QCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------CCSSS--SSCHHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhccc--cchHHHHHHHHHHHHHHHhh
Confidence 23668887642 24678899999999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.49 E-value=0.0019 Score=68.31 Aligned_cols=32 Identities=28% Similarity=0.349 Sum_probs=27.9
Q ss_pred ccCcccccCcceeEEEcCC----Cceeeecccccee
Q 004999 260 SRGVLHRDIKGSNLLIDNN----GILKIADFGLASF 291 (720)
Q Consensus 260 ~~gIvHrDIKP~NILld~~----g~vKL~DFGla~~ 291 (720)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4579999999999999875 6899999998875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.07 E-value=0.058 Score=59.42 Aligned_cols=72 Identities=8% Similarity=0.016 Sum_probs=45.6
Q ss_pred eecccCceEEEEEEECCC-------CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDLDQ-------KKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~t-------g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyL 219 (720)
.|..|-...+|++..... +..|+||+..... +..-...+|..+++.|. +.-..++++.+. -++
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~------~~~ 147 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP------EGR 147 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET------TEE
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC------CCE
Confidence 388888999999987521 5779999864321 11111257888888874 222345554321 268
Q ss_pred EEeeccccc
Q 004999 220 VFEYMEHDL 228 (720)
Q Consensus 220 V~Ey~~g~l 228 (720)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.76 E-value=0.098 Score=56.88 Aligned_cols=29 Identities=28% Similarity=0.529 Sum_probs=25.0
Q ss_pred cccccCcceeEEE------cCCCceeeecccccee
Q 004999 263 VLHRDIKGSNLLI------DNNGILKIADFGLASF 291 (720)
Q Consensus 263 IvHrDIKP~NILl------d~~g~vKL~DFGla~~ 291 (720)
++|+|+.+.|||+ +.+..+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998864
|
| >3p34_A Serine/threonine-protein kinase PLK1; phosphoprotein binding domain, PLK1, kinase, transferase; HET: TPO; 1.40A {Homo sapiens} PDB: 3p2z_A* 3p2w_A* 3p35_A* 3p36_A* 3p37_A* 3q1i_A* 4e67_A* 4e9c_A* 4e9d_A* 2ogq_A 2ojs_A* 2ojx_A 3bzi_A* 3mhn_A* 3mhq_A 3mq8_B* 4h5x_B 4h70_B* 4h71_B* 4hco_B* ... | Back alignment and structure |
|---|
Probab=93.76 E-value=0.0072 Score=60.90 Aligned_cols=31 Identities=19% Similarity=-0.005 Sum_probs=26.3
Q ss_pred hhcCCCCCCCCCccccccCCCcccccccccc
Q 004999 559 AKAGKNTDDAPKISTGADLSTGLVAARRSLL 589 (720)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (720)
.|++||+|||+|||+||+||++.+++-=++.
T Consensus 47 ~wVskWVDYS~KYG~GYqLsdgsvGVlFND~ 77 (232)
T 3p34_A 47 FWVSKWVDYSDKYGLGYQLCDNSVGVLFNDS 77 (232)
T ss_dssp CCEEEEEEETTTTEEEEEETTSCEEEEETTS
T ss_pred eeeeeeecccCccceEEEecCCcEEEEEcCC
Confidence 4567999999999999999999998865543
|
| >1q4k_B Serine/threonine-protein kinase PLK; six-stranded anti-parallel beta sheet with one alpha helix, transferase; HET: TPO; 2.30A {Homo sapiens} SCOP: d.223.1.2 d.223.1.2 | Back alignment and structure |
|---|
Probab=93.40 E-value=0.0095 Score=61.11 Aligned_cols=30 Identities=20% Similarity=0.018 Sum_probs=25.4
Q ss_pred hhcCCCCCCCCCccccccCCCccccccccc
Q 004999 559 AKAGKNTDDAPKISTGADLSTGLVAARRSL 588 (720)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (720)
.|+.||+||++|||+||+||||.+++-=++
T Consensus 65 ~wVsKWVDYSnKYG~GYqLsdgsvGvlFND 94 (259)
T 1q4k_B 65 FWVSKWVDYSDKYGLGYQLCDNSVGVLFND 94 (259)
T ss_dssp CCEEEEEEETTTTEEEEEETTSCEEEEETT
T ss_pred cceeeccccccccceeEEecCCcEEEEEeC
Confidence 456799999999999999999998875443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.08 E-value=0.16 Score=56.41 Aligned_cols=59 Identities=12% Similarity=0.178 Sum_probs=15.5
Q ss_pred ecccCceEEEEEEECCCCeEEEE------EEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecccee
Q 004999 149 IGQGTYSNVYRARDLDQKKIVAL------KKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVT 210 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAI------K~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~ 210 (720)
|| ||.||++........||+ |..+......+....+.+|..+++.++|||+++.+++..
T Consensus 150 lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 150 VG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp SS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred CC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 66 999999998665567888 776654445555667889999999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 720 | ||||
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-80 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-77 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-72 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-71 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-69 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-69 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-68 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-68 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-67 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-64 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-63 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-63 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-62 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-62 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-61 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-59 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-56 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-54 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-53 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-53 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-52 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-47 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-46 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-25 |
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (653), Expect = 6e-80
Identities = 126/300 (42%), Positives = 174/300 (58%), Gaps = 12/300 (4%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IGQGT+ V++AR + VALKKV +N + REI IL+ L H NV+ L +
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 209 VTSRMS------CSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
++ S S+YLVF++ EHDLAGL S+ +KF+ +++K MQ LL GL + H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 137
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN---QPLTSRVVTLWYRPPELLLGAT 319
+LHRD+K +N+LI +G+LK+ADFGLA + +N T+RVVTLWYRPPELLLG
Sbjct: 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATI 378
YG +DLW GCI+AE++ PIM G TE QL I +LCGS + + W
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257
Query: 379 FKPQQPYKRCVAETFKDFPAPALA--LMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 436
+ + KR V + K + A L++ LL +DPA R + AL +FF P+P D
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (635), Expect = 1e-77
Identities = 107/297 (36%), Positives = 165/297 (55%), Gaps = 7/297 (2%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL---EPESVRFMAREIHILRRLDHINVIK 204
+G+G ++ VY+ARD + +IVA+KK++ + + R REI +L+ L H N+I
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 205 LEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
L + ++ LVF++ME DL + L + + +K YM L GL++ H +L
Sbjct: 65 LLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
HRD+K +NLL+D NG+LK+ADFGLA + T +VVT WYR PELL GA YG
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFGARMYGVG 181
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
VD+W+ GCILAEL P +PG ++++QL +IF+ G+P+E+ W + P
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPK 441
+ F L L++ L +P R +A AL+ ++F+ +P P LP+
Sbjct: 242 -GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 5e-72
Identities = 109/319 (34%), Positives = 158/319 (49%), Gaps = 13/319 (4%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G Y V A D K VA+KK+ + R + REI IL R H N+I +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIND 73
Query: 208 LV---TSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
++ T +YLV M DL L S + ++ Q+L GL + HS VL
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVL 131
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSRVVTLWYRPPELLLGATYYG 322
HRD+K SNLL++ LKI DFGLA DPD + LT V T WYR PE++L + Y
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 191
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
++D+WS GCILAE+ + +PI PG+ ++QL+ I + GSPS++ A +
Sbjct: 192 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLS 251
Query: 383 QPYKRCV--AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
P+K V F + + AL L++ +L+ +P R AL + DPS P
Sbjct: 252 LPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY---DPSDEP 308
Query: 441 KYPPSKEFDAKIRDEEARR 459
+FD ++ D +
Sbjct: 309 IAEAPFKFDMELDDLPKEK 327
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 9e-71
Identities = 106/321 (33%), Positives = 155/321 (48%), Gaps = 18/321 (5%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+IG G++ VY+A+ D ++VA+KKV D RF RE+ I+R+LDH N+++L
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRY 80
Query: 208 LVTSRMSCS----LYLVFEYMEHDLAGLASH---PGLKFSEAQVKCYMQQLLCGLDHCHS 260
S L LV +Y+ + +A H VK YM QL L + HS
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 261 RGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
G+ HRDIK NLL+D + +LK+ DFG A + +P S + + +YR PEL+ GAT
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGAT 198
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
Y +++D+WS GC+LAEL G+PI PG + V+QL +I K+ G+P+ + R+ +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439
PQ P A+AL LL P R + A FF L L
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF--DELRDPNVKL 316
Query: 440 PKYPPSKEFDAKIRDEEARRQ 460
P + E +
Sbjct: 317 PNGRDTPALFNFTTQELSSNP 337
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 1e-69
Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 31/287 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G+G Y V A + ++ VA+K V +EI I + L+H NV+K G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKFYG 70
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
R YL EY P + E + + QL+ G+ + H G+ HRD
Sbjct: 71 --HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 128
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYGTAVD 326
IK NLL+D LKI+DFGLA+ + + + L +++ TL Y PELL ++ VD
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 327 LWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386
+WS G +L + AG+ ++ Q + +K +
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-------------------- 228
Query: 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
+K + LAL+ +L +P+ R + + ++ KPL
Sbjct: 229 ------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN-KPLK 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-69
Identities = 99/314 (31%), Positives = 152/314 (48%), Gaps = 12/314 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G Y V A D VA+KK+ + RE+ +L+ + H NVI L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 208 LVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ T + YLV +M DL L H K E +++ + Q+L GL + H+ G+
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGI 142
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRD+K NL ++ + LKI DFGLA D +T VVT WYR PE++L Y
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
VD+WS GCI+AE+ GK + G ++QL +I K+ G+P ++ ++ + A +
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 384 PY--KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPK 441
P K+ A + A+ L+E +L +D R +A AL +F D + K
Sbjct: 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQK 318
Query: 442 YPPSKEFDAKIRDE 455
Y S + + DE
Sbjct: 319 YDDSFDDVDRTLDE 332
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 1e-68
Identities = 115/307 (37%), Positives = 166/307 (54%), Gaps = 17/307 (5%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 189
++F+K++K IG+GTY VY+AR+ ++VALKK+R D R
Sbjct: 2 ENFQKVEK-----------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR 50
Query: 190 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYM 248
EI +L+ L+H N++KL ++ + LYLVFE++ DL + + +K Y+
Sbjct: 51 EISLLKELNHPNIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308
QLL GL CHS VLHRD+K NLLI+ G +K+ADFGLA + T VVTLW
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLW 167
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYW 368
YR PE+LLG YY TAVD+WS GCI AE+ + + PG +E++QL +IF+ G+P E W
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227
Query: 369 RKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
+ ++ ++ +L+ +L DP R SA +AL FF
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287
Query: 429 --MKPLP 433
KP+P
Sbjct: 288 DVTKPVP 294
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-68
Identities = 104/314 (33%), Positives = 150/314 (47%), Gaps = 12/314 (3%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G Y +V A D VA+KK+ + RE+ +L+ + H NVI L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 208 LVTSRMSC----SLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ T S +YLV M DL + K ++ V+ + Q+L GL + HS +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRD+K SNL ++ + LKI DFGLA D + T V T WYR PE++L +Y
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQ 198
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRK--SKLPHATIFKP 381
VD+WS GCI+AEL G+ + PG ++QL I +L G+P + +K S+ I
Sbjct: 199 TVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 258
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPK 441
Q K A F A+ L+E +L +D R +AA AL +F P D
Sbjct: 259 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP 318
Query: 442 YPPSKEFDAKIRDE 455
Y S E + DE
Sbjct: 319 YDQSFESRDLLIDE 332
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 222 bits (566), Expect = 1e-67
Identities = 102/298 (34%), Positives = 154/298 (51%), Gaps = 15/298 (5%)
Query: 130 DSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAR 189
+ + L+K IG+GTY VY+A++ + + ALKK+R + + R
Sbjct: 2 EKYHGLEK-----------IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIR 49
Query: 190 EIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQ 249
EI IL+ L H N++KL ++ ++ L LVFE+++ DL L K ++
Sbjct: 50 EISILKELKHSNIVKLYDVIHTK--KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLL 107
Query: 250 QLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWY 309
QLL G+ +CH R VLHRD+K NLLI+ G LKIADFGLA + + +VTLWY
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-EIVTLWY 166
Query: 310 RPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369
R P++L+G+ Y T +D+WS GCI AE+ G P+ PG +E +QL +IF++ G+P+ W
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
K + L+ +L +DP R +A AL +F
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 6e-66
Identities = 108/281 (38%), Positives = 156/281 (55%), Gaps = 4/281 (1%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+GTY V++A++ + +IVALK+VR D+ + REI +L+ L H N+++L +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI 268
+ S LVFE+ + DL VK ++ QLL GL CHSR VLHRD+
Sbjct: 70 LHSDKKL--TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDL 127
Query: 269 KGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLW 328
K NLLI+ NG LK+A+FGLA + + ++ VVTLWYRPP++L GA Y T++D+W
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMW 186
Query: 329 STGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKR 387
S GCI AEL P+ PG +QL +IF+L G+P+E+ W P P
Sbjct: 187 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246
Query: 388 CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
+ A L++ LL +P R SA AL+ +F+
Sbjct: 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 216 bits (552), Expect = 9e-65
Identities = 67/324 (20%), Positives = 114/324 (35%), Gaps = 35/324 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G + V+R + A K V + + +EI + L H ++ L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ +++E+M +L + K SE + YM+Q+ GL H H +H
Sbjct: 91 AFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 148
Query: 267 DIKGSNLLI--DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
D+K N++ + LK+ DFGL + DP Q + T + PE+ G G
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEG-KPVGYY 205
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+WS G + L +G G + E L + + + +
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF---------------- 249
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPP 444
+ LL DP R + AL + T P S +P
Sbjct: 250 ---------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 300
Query: 445 SKEFDAKIRDEEARRQGGSKGQRM 468
+K D+ +A + R+
Sbjct: 301 TKIRDSIKTKYDAWPEPLPPLGRI 324
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-64
Identities = 62/317 (19%), Positives = 118/317 (37%), Gaps = 34/317 (10%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+ D FEK+ + +G G V++ ++A K + + + +
Sbjct: 4 KDDDFEKISE-----------LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 52
Query: 188 AREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCY 247
RE+ +L + ++ G S + + E+M+ + E +
Sbjct: 53 -RELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 109
Query: 248 MQQLLCGLDHCHSR-GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306
++ GL + + ++HRD+K SN+L+++ G +K+ DFG++ S V T
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGT 166
Query: 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSE 365
Y PE L G T+Y D+WS G L E+ G+ PI P + +L ++ G +E
Sbjct: 167 RSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 366 DYWR-----KSKLPHATIFKPQQPYKRCVAETFKDFPAP---------ALALMETLLSID 411
R + + +P + + P + L +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 412 PADRGSAASALRSEFFT 428
PA+R + F
Sbjct: 286 PAERADLKQLMVHAFIK 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 2e-64
Identities = 82/338 (24%), Positives = 138/338 (40%), Gaps = 41/338 (12%)
Query: 126 PRRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-PESV 184
P A+ F K D +FS IG G++ VY ARD+ ++VA+KK+ + + E
Sbjct: 2 PDVAELFFKDDPE-KLFSD-LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 185 RFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQV 244
+ + +E+ L++L H N I+ G + +LV EY + L E ++
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHT--AWLVMEYCLGSASDLLEVHKKPLQEVEI 117
Query: 245 KCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304
L GL + HS ++HRD+K N+L+ G++K+ DFG AS P S V
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFV 172
Query: 305 VTLWYRPPELLLGATY--YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 362
T ++ PE++L Y VD+WS G EL KP + + L+ I +
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ---- 228
Query: 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422
+ +E F++ +++ L P DR ++ L
Sbjct: 229 ----------------NESPALQSGHWSEYFRN-------FVDSCLQKIPQDRPTSEVLL 265
Query: 423 RSEFFTMKPLPCDPSSLPKYPPS--KEFDAKIRDEEAR 458
+ F + P L + +E D + +
Sbjct: 266 KHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 1e-63
Identities = 81/282 (28%), Positives = 119/282 (42%), Gaps = 36/282 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVR-FMAREIHILRRLDHINVIKLE 206
+G+G + NVY AR+ K I+ALK + LE V + RE+ I L H N+++L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
G + +YL+ EY KF E + Y+ +L L +CHS+ V+HR
Sbjct: 73 GYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHR 130
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
DIK NLL+ + G LKIADFG + + + TL Y PPE++ G + VD
Sbjct: 131 DIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG-RMHDEKVD 186
Query: 327 LWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386
LWS G + E GKP T E +I ++ + +
Sbjct: 187 LWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------------- 225
Query: 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
A L+ LL +P+ R L + T
Sbjct: 226 --------FVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-63
Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 50/308 (16%)
Query: 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
RA+ +E L IG G+Y + R KI+ K++ + ++ + +
Sbjct: 2 RAEDYEVLYT-----------IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQML 50
Query: 188 AREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK---FSEAQ 243
E+++LR L H N+++ + R + +LY+V EY E DLA + + + E
Sbjct: 51 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 110
Query: 244 VKCYMQQLLCGLDHCHSRG-----VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
V M QL L CH R VLHRD+K +N+ +D +K+ DFGLA + D +
Sbjct: 111 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 170
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358
+ V T +Y PE + Y D+WS GC+L EL A P ++ E KI +
Sbjct: 171 -AKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
Query: 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSA 418
+ ++P+ + ++ +L++ R S
Sbjct: 229 ---------GKFRRIPY-------------------RYSDELNEIITRMLNLKDYHRPSV 260
Query: 419 ASALRSEF 426
L +
Sbjct: 261 EEILENPL 268
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 2e-63
Identities = 66/314 (21%), Positives = 128/314 (40%), Gaps = 45/314 (14%)
Query: 132 FEKLDKSLSIFSRSFY----LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM 187
+E + + L+ F+ +G G + VY+A++ + + A K + + E +
Sbjct: 1 YEHVTRDLNP--EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDY 56
Query: 188 AREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKC 246
EI IL DH N++KL + L+++ E+ + + +E+Q++
Sbjct: 57 MVEIDILASCDHPNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQV 114
Query: 247 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306
+Q L L++ H ++HRD+K N+L +G +K+ADFG+++ Q S + T
Sbjct: 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGT 173
Query: 307 LWYRPPELLLGATY----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 362
++ PE+++ T Y D+WS G L E+ +P + L KI K
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK-SEP 232
Query: 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422
P+ + + ++ L + R + + L
Sbjct: 233 PTLAQP-------------------------SRWSSNFKDFLKKCLEKNVDARWTTSQLL 267
Query: 423 RSEFFTM---KPLP 433
+ F T+ KP+
Sbjct: 268 QHPFVTVDSNKPIR 281
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 211 bits (539), Expect = 5e-63
Identities = 70/340 (20%), Positives = 123/340 (36%), Gaps = 37/340 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G + V+R + ++ K + P + EI I+ +L H +I L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHD 93
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ + L+ E++ +L + K SEA+V YM+Q GL H H ++H
Sbjct: 94 AFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 151
Query: 267 DIKGSNLLID--NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
DIK N++ + +KI DFGLA+ +PD + + T + PE++ G
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDR-EPVGFY 208
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+W+ G + L +G G ++E L + + ED +
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF---------------- 252
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT--MKPLPCDPSSLPKY 442
A ++ LL +P R + AL + L S
Sbjct: 253 ---------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 303
Query: 443 PPSKEFDAKIRDEEARRQGGSKGQRMDLERRGTRESRAIP 482
++ K D A + + R+ + I
Sbjct: 304 KIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIY 343
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-62
Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 37/301 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IGQG VY A D+ + VA++++ + EI ++R + N++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLD 84
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
L++V EY+ E Q+ ++ L L+ HS V+HRD
Sbjct: 85 SYLV--GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 327
IK N+L+ +G +K+ DFG + P+Q++ ++ V T ++ PE++ YG VD+
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTR-KAYGPKVDI 199
Query: 328 WSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKR 387
WS G + E+ G+P + L+ I G+P
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNP------------------- 239
Query: 388 CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-KPLPCDPSSLPKYPPSK 446
+ A + L +D RGSA L+ +F + KPL S P +K
Sbjct: 240 ------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL---SSLTPLIAAAK 290
Query: 447 E 447
E
Sbjct: 291 E 291
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (531), Expect = 8e-62
Identities = 92/330 (27%), Positives = 157/330 (47%), Gaps = 23/330 (6%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG G V A D + VA+KK+ + RE+ +++ ++H N+I L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 208 LVTSRMSCS----LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ T + + +YLV E M+ L ++ ++ + Q+LCG+ H HS G+
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRD+K SN+++ ++ LKI DFGLA + +T VVT +YR PE++LG Y
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG-MGYKE 197
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
VD+WS GCI+ E+ K + PGR ++Q +K+ + G+P ++ +K + + +
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257
Query: 384 PYKR-------------CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430
Y +E K + A L+ +L IDPA R S AL+ + +
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317
Query: 431 PLPCDPSSLPKYPPSKEFDAKIRDEEARRQ 460
P + + P K+ D + E ++
Sbjct: 318 YDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-61
Identities = 110/287 (38%), Positives = 153/287 (53%), Gaps = 13/287 (4%)
Query: 149 IGQGTYSNVYRARDL-DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIK 204
IG+G Y V++ARDL + + VALK+VR E RE+ +LR L +H NV++
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 205 LEGLVT---SRMSCSLYLVFEYMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS 260
L + T + L LVFE+++ D L P +K M QLL GLD HS
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 261 RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATY 320
V+HRD+K N+L+ ++G +K+ADFGLA Y TS VVTLWYR PE+LL +
Sbjct: 135 HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRAPEVLLQ-SS 191
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
Y T VDLWS GCI AE++ KP+ G ++V+QL KI + G P E+ W + F
Sbjct: 192 YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 251
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+ + + D L+ L+ +PA R SA SAL +F
Sbjct: 252 SKSAQP--IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-61
Identities = 62/311 (19%), Positives = 116/311 (37%), Gaps = 36/311 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G+G + V+R + KK K V+ + V+ +EI IL H N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHLHE 68
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
S L ++FE++ D+ + + +E ++ Y+ Q+ L HS + H
Sbjct: 69 SFESM--EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 267 DIKGSNLLIDN--NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTA 324
DI+ N++ + +KI +FG A P N Y PE+ TA
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQH-DVVSTA 183
Query: 325 VDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+WS G ++ L +G T + + I + E+ +
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---------------- 227
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYPP 444
K+ A+ ++ LL + R +A+ AL+ + K +
Sbjct: 228 ---------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKH 278
Query: 445 SKEFDAKIRDE 455
+ + I+ +
Sbjct: 279 RRYYHTLIKKD 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 201 bits (513), Expect = 1e-59
Identities = 85/292 (29%), Positives = 142/292 (48%), Gaps = 21/292 (7%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 206
+G+G YS V+ A ++ + V +K ++ P + + REI IL L N+I L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPNIITLA 96
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+V +S + LVFE++ + ++ ++ YM ++L LD+CHS G++HR
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTD--FKQLYQ-TLTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 267 DIKGSNLLIDN-NGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
D+K N++ID+ + L++ D+GLA FY P Q RV + +++ PELL+ Y ++
Sbjct: 154 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSL 211
Query: 326 DLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPS-EDYWRKSKLPHATIFKPQQ 383
D+WS GC+LA + K P G +QL +I K+ G+ DY K + F
Sbjct: 212 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 271
Query: 384 PY-------KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428
+ +E AL ++ LL D R +A A+ +F
Sbjct: 272 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 1e-59
Identities = 77/314 (24%), Positives = 124/314 (39%), Gaps = 36/314 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
++G G +S V A D +K+VA+K + LE + EI +L ++ H N++ L+
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME-NEIAVLHKIKHPNIVALDD 74
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ S LYL+ + + +L G ++E + Q+L + + H G++HR
Sbjct: 75 IYESG--GHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 267 DIKGSNLLI---DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
D+K NLL D + + I+DFGL+ DP L++ T Y PE+L Y
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQ-KPYSK 188
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
AVD WS G I L G P + + +I K YW
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW--------------- 233
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP 443
D A + L+ DP R + AL+ +
Sbjct: 234 ----------DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSE 283
Query: 444 PSKEFDAKIRDEEA 457
K+ AK + ++A
Sbjct: 284 QIKKNFAKSKWKQA 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 199 bits (508), Expect = 2e-59
Identities = 73/294 (24%), Positives = 117/294 (39%), Gaps = 44/294 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPES-------VRFMAREIHILRRL-DH 199
++G+G S V R K A+K + S +E+ ILR++ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 200 INVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHC 258
N+I+L+ + +LVF+ M+ +L + SE + + M+ LL +
Sbjct: 70 PNIIQLKDTYETN--TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICAL 126
Query: 259 HSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
H ++HRD+K N+L+D++ +K+ DFG + DP + L T Y PE++ +
Sbjct: 127 HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLAPEIIECS 184
Query: 319 T-----YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKL 373
YG VD+WSTG I+ L AG P R ++ L I W
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW----- 239
Query: 374 PHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
D+ L+ L + P R +A AL FF
Sbjct: 240 --------------------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-58
Identities = 57/290 (19%), Positives = 114/290 (39%), Gaps = 33/290 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG G++ VY+ + VA+K + P+ ++ E+ +LR+ H+N++ G
Sbjct: 15 RIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
T+ L +V ++ E L KF ++ +Q G+D+ H++ ++HR
Sbjct: 72 YSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLG--ATYYGT 323
D+K +N+ + + +KI DFGLA+ ++ ++ + PE++ Y
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
D+++ G +L EL G+ +Q+ + +
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG-----------------------RG 225
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433
+++ + P LM L +R L S + LP
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-58
Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 45/303 (14%)
Query: 127 RRADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVR 185
+R + F+ +G+G++S V AR+L + A+K + ++ + V
Sbjct: 5 KRPEDFKFGKI-----------LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 53
Query: 186 FMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVK 245
++ RE ++ RLDH +KL LY Y ++ F E +
Sbjct: 54 YVTRERDVMSRLDHPFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTR 111
Query: 246 CYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305
Y +++ L++ H +G++HRD+K N+L++ + ++I DFG A P+ Q + V
Sbjct: 112 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV 171
Query: 306 -TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPS 364
T Y PELL + DLW+ GCI+ +L AG P E KI KL
Sbjct: 172 GTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP 230
Query: 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424
E ++ +D L+E LL +D R
Sbjct: 231 EKFF----------------------PKARD-------LVEKLLVLDATKRLGCEEMEGY 261
Query: 425 EFF 427
Sbjct: 262 GPL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 55/284 (19%), Positives = 106/284 (37%), Gaps = 36/284 (12%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG- 207
IG+G++ VY+ D + VA +++ L + E +L+ L H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 208 -LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VL 264
T + + LV E M ++ + +Q+L GL H+R ++
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 136
Query: 265 HRDIKGSNLLI-DNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
HRD+K N+ I G +KI D GLA+ + + T + PE+ Y
Sbjct: 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFMAPEMYEEK--YDE 191
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
+VD+++ G + E+ + Q+++ P+
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------------------- 232
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427
+ + K+ ++E + + +R S L FF
Sbjct: 233 SFDKVAIPEVKE-------IIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-54
Identities = 62/305 (20%), Positives = 116/305 (38%), Gaps = 40/305 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPE----SVRFMAREIHILRRLDHINVI 203
+G G ++ V + R+ A K ++ + S + RE+ IL+ + H NVI
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 204 KLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L + ++ + L+ E + +E + +++Q+L G+ + HS +
Sbjct: 77 TLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 134
Query: 264 LHRDIKGSNLLIDNNGI----LKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
H D+K N+++ + + +KI DFGLA D + T + PE++
Sbjct: 135 AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNY-E 191
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
G D+WS G I L +G G T+ E L + + ++Y+
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF----------- 240
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSL 439
+ A A + LL DP R + +L+ + KP +
Sbjct: 241 --------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI--KPKDTQQALS 284
Query: 440 PKYPP 444
+
Sbjct: 285 SAWSH 289
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 56/322 (17%), Positives = 110/322 (34%), Gaps = 40/322 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLE 206
++G G V + + ++ ALK ++ RE+ + R +++++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIV 71
Query: 207 GLVTSRMSC--SLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+ + + L +V E ++ +L + F+E + M+ + + + HS
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 263 VLHRDIKGSNLLID---NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGAT 319
+ HRD+K NLL N ILK+ DFG A + + T +Y PE+L
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVAPEVLGP-E 188
Query: 320 YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
Y + D+WS G I+ L G P + + ++
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE-------- 240
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT-MKPLPCDPSS 438
+ + L+ LL +P R + + + +P P
Sbjct: 241 -------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 287
Query: 439 LPKYPPSKEFDAKIRDEEARRQ 460
+ + + EE
Sbjct: 288 TSRVLKEDKERWEDVKEEMTSA 309
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 184 bits (467), Expect = 1e-53
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 31/284 (10%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
++G G S V+ ARDL + VA+K +R D +P RE L+H ++ +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 207 GLVTSR--MSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVL 264
+ Y+V EY++ H + + + L+ H G++
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGII 133
Query: 265 HRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP--LTSRVVTLWYRPPELLLGATYYG 322
HRD+K +N++I +K+ DFG+A N + + T Y PE G +
Sbjct: 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VD 192
Query: 323 TAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
D++S GC+L E+ G+P G + V ++ + P
Sbjct: 193 ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH-------------- 238
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEF 426
+ A A++ L+ +P +R A+ +R++
Sbjct: 239 -----------EGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-52
Identities = 70/301 (23%), Positives = 116/301 (38%), Gaps = 50/301 (16%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLD--HIN 201
L+G G + +VY + VA+K V D + E + + E+ +L+++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 202 VIKLEGLVTSRMSCSLYLVFEYME--HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCH 259
VI+L S L+ E E DL + G E + + Q+L + HCH
Sbjct: 71 VIRLLDWFERPDS--FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH 127
Query: 260 SRGVLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA 318
+ GVLHRDIK N+LID N G LK+ DFG + + T T Y PPE +
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYH 184
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378
Y+G + +WS G +L ++ G E+ + F+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR-------------------- 224
Query: 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSS 438
+ + L+ L++ P+DR + + LP + +
Sbjct: 225 ---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269
Query: 439 L 439
+
Sbjct: 270 I 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 181 bits (461), Expect = 8e-52
Identities = 70/306 (22%), Positives = 126/306 (41%), Gaps = 42/306 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMA----REIHILRRLDHINVI 203
+IG+G + VY R D K+ A+K + ++ + +A + ++ D ++
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 204 KLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
+ + L + + M FSEA ++ Y +++ GL+H H+R V
Sbjct: 71 CMSYAFHTP--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFV 128
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
++RD+K +N+L+D +G ++I+D GLA + + + V T Y PE+L Y +
Sbjct: 129 VYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDS 185
Query: 324 AVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
+ D +S GC+L +L G ++ H+I ++ + + +
Sbjct: 186 SADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP--------------- 229
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFFTMKPLPCDPSS 438
F +L+E LL D R A S FF + L
Sbjct: 230 ----------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF--RSLDWQMVF 277
Query: 439 LPKYPP 444
L KYPP
Sbjct: 278 LQKYPP 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 1e-50
Identities = 61/286 (21%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G + V+ K VA+K ++ ++ P++ E +++++L H +++L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFL---AEANLMKQLQHQRLVRLYA 75
Query: 208 LVTSRMSCSLYLVFEYMEHDLAG--LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
+VT +Y++ EYME+ L + G+K + ++ Q+ G+ R +H
Sbjct: 76 VVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD++ +N+L+ + KIADFGLA + ++ + + PE + +
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKS 191
Query: 326 DLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+WS G +L E+ G+ PG T E + + + ++ +P
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-------------------GYRMVRP 232
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFT 428
+ P LM P DR + +FFT
Sbjct: 233 ---------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 63/304 (20%), Positives = 119/304 (39%), Gaps = 49/304 (16%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+GQG + V+ + VA+K ++ + PE+ +E ++++L H +++L +
Sbjct: 25 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL---QEAQVMKKLRHEKLVQLYAV 80
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
V+ +Y+V EYM G Q+ Q+ G+ + +HR
Sbjct: 81 VSEE---PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 137
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D++ +N+L+ N + K+ADFGLA + ++ + + PE L + D
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSD 196
Query: 327 LWSTGCILAEL-YAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
+WS G +L EL G+ PG E L ++ + ++ P
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------------------GYRMPCP- 236
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFTMKPLPCDPSSLPKYP 443
+ P LM +P +R + ++FT S+ P+Y
Sbjct: 237 --------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT--------STEPQYQ 280
Query: 444 PSKE 447
P +
Sbjct: 281 PGEN 284
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 7e-50
Identities = 67/283 (23%), Positives = 114/283 (40%), Gaps = 36/283 (12%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-LEPESVRFMAREIHILRR-LDHINVIKL 205
++G+G++ V+ A + A+K ++ D L + V E +L +H + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 206 EGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
++ + L+ V EY+ KF ++ Y +++ GL HS+G+++
Sbjct: 69 FCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVY 126
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+K N+L+D +G +KIADFG+ + + T Y PE+LLG Y +V
Sbjct: 127 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQ-KYNHSV 184
Query: 326 DLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385
D WS G +L E+ G+ G+ E E H I P P
Sbjct: 185 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM--------------------DNPFYP- 223
Query: 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS-EFF 427
+ A L+ L +P R +R F
Sbjct: 224 --------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (433), Expect = 1e-48
Identities = 69/326 (21%), Positives = 136/326 (41%), Gaps = 53/326 (16%)
Query: 131 SFEKLDKSLSIFSRSFY--------LIGQGTYSNVYRARDLDQKK---IVALKKVRFDNL 179
+FE ++++ F++ +IG G + V K VA+K ++
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 180 EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLK 238
E + F+ E I+ + DH NVI LEG+VT S + ++ E+ME+ L +
Sbjct: 68 EKQRRDFL-SEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQ 124
Query: 239 FSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
F+ Q+ ++ + G+ + +HRD+ N+L+++N + K++DFGL+ F + D +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184
Query: 299 PLTSRVV----TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQL 353
P + + + + PE + + +A D+WS G ++ E+ + G+ T + +
Sbjct: 185 PTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 354 HKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPA 413
+ I + ++ P D P+ LM D
Sbjct: 244 NAIEQ-------------------DYRLPPP---------MDCPSALHQLMLDCWQKDRN 275
Query: 414 DRGSAASALRSEFFTMKPLPCDPSSL 439
R + T+ + +P+SL
Sbjct: 276 HRPKFGQIVN----TLDKMIRNPNSL 297
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-48
Identities = 62/281 (22%), Positives = 107/281 (38%), Gaps = 37/281 (13%)
Query: 149 IGQGTYSNVYRAR---DLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIK 204
+G G++ V R + VA+K ++ D L +PE++ RE++ + LDH N+I+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L G+V + + +V E L F + Y Q+ G+ + S+
Sbjct: 76 LYGVVLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF 132
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYG 322
+HRD+ NLL+ ++KI DFGL + + + + L +
Sbjct: 133 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 192
Query: 323 TAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381
A D W G L E++ G+ G + LHKI K +
Sbjct: 193 HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------------------EGERL 234
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422
+P +D P +M + P DR + +
Sbjct: 235 PRP---------EDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 170 bits (431), Expect = 4e-48
Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 42/286 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
+G G++ V+ R + A+K ++ + + + V E +L + H +I++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
G ++++ +Y+E +F K Y ++ L++ HS+ +++R
Sbjct: 71 GTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYR 128
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
D+K N+L+D NG +KI DFG A + + T Y PE++ Y ++D
Sbjct: 129 DLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKP-YNKSID 183
Query: 327 LWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386
WS G ++ E+ AG ++ KI + + P
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------AELRFP------------ 221
Query: 387 RCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFF 427
F L+ L++ D + R +F
Sbjct: 222 -------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-48
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 37/277 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG G + V+ L++ K VA+K +R + E E ++ +L H +++L G+
Sbjct: 13 IGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFI---EEAEVMMKLSHPKLVQLYGV 68
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
+ LVFE+MEH L+ F+ + + G+ + V+HRD
Sbjct: 69 CLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRD 126
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 327
+ N L+ N ++K++DFG+ F DQ T + + PE+ + Y + D+
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDV 185
Query: 328 WSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386
WS G ++ E+++ GK R+ E + I +T F+ +P
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------------------STGFRLYKP-- 224
Query: 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+ +M P DR + + LR
Sbjct: 225 -------RLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 53/289 (18%), Positives = 106/289 (36%), Gaps = 40/289 (13%)
Query: 149 IGQGTYSNVYRARDLDQK--KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G + V + +K K VA+K ++ + +P + E +++++LD+ ++++
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
G+ + S LV E E + + + Q+ G+ + +HR
Sbjct: 75 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGATYYGTA 324
D+ N+L+ KI+DFGL+ D+N + + PE + + +
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSK 190
Query: 325 VDLWSTGCILAE-LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383
D+WS G ++ E G+ G E + K +
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------------GERMGC 231
Query: 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS---ALRSEFFTM 429
P P LM + D +R A+ LR+ ++ +
Sbjct: 232 P---------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 2e-47
Identities = 56/313 (17%), Positives = 103/313 (32%), Gaps = 41/313 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG G++ ++Y D+ + VA+K P+ + E I + + I
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGGVGIPTIR 69
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
+ +V E + L L + KFS V Q++ +++ HS+ +HRD
Sbjct: 70 WCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD 128
Query: 268 IKGSNLLI---DNNGILKIADFGLASFYDPDQN------QPLTSRVVTLWYRPPELLLGA 318
+K N L+ ++ I DFGLA Y + + + T Y LG
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG- 187
Query: 319 TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378
DL S G +L G G + K ++
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS------------------ 229
Query: 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA---LRSEFFTMKPLPCD 435
++ + K +P+ + S+ D+ + R+ F
Sbjct: 230 ---EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDY 286
Query: 436 PS--SLPKYPPSK 446
++ K+ S+
Sbjct: 287 VFDWNMLKFGASR 299
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 67/286 (23%), Positives = 110/286 (38%), Gaps = 39/286 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLE 206
L+G+GT+ V R+ + A+K +R + + + V E +L+ H + L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 207 GLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHR 266
+ L V EY F+E + + Y +++ L++ HSR V++R
Sbjct: 72 --YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 129
Query: 267 DIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVD 326
DIK NL++D +G +KI DFGL D + + T Y PE+L YG AVD
Sbjct: 130 DIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLED-NDYGRAVD 187
Query: 327 LWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386
W G ++ E+ G+ + I + + P
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------EEIRFP-- 225
Query: 387 RCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFF 427
+ A +L+ LL DP R A + FF
Sbjct: 226 -------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 167 bits (423), Expect = 2e-47
Identities = 50/279 (17%), Positives = 87/279 (31%), Gaps = 38/279 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G++ ++ +L + VA+K + P+ R +L I + G
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDE-YRTYKLLAGCTGIPNVYYFG 70
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
+ LV + + L L G KFS V +Q+L + H + +++RD
Sbjct: 71 ----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126
Query: 268 IKGSNLLIDN-----NGILKIADFGLASFYDPD------QNQPLTSRVVTLWYRPPELLL 316
IK N LI ++ + DFG+ FY + + T Y L
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 317 GATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376
G DL + G + G G K ++
Sbjct: 187 G-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG---------------- 229
Query: 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADR 415
++ + E FP M ++
Sbjct: 230 -----EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 5e-47
Identities = 55/290 (18%), Positives = 110/290 (37%), Gaps = 42/290 (14%)
Query: 149 IGQGTYSNVYRA--RDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLE 206
+G G + +V + R ++ VA+K ++ + ++ M RE I+ +LD+ +++L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM-REAQIMHQLDNPYIVRLI 75
Query: 207 GLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
G+ + +L LV E L + + V + Q+ G+ + + +H
Sbjct: 76 GVCQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV--TLWYRPPELLLGATYYGT 323
RD+ N+L+ N KI+DFGL+ D + L + PE + + +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSS 191
Query: 324 AVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
D+WS G + E + G+ E + I + + +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------------------GKRME 232
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAAS---ALRSEFFTM 429
P + P ALM DR + +R+ ++++
Sbjct: 233 CP---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 6e-47
Identities = 56/279 (20%), Positives = 105/279 (37%), Gaps = 43/279 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
IG+G + +V K VA+K ++ + + E ++ +L H N+++L G
Sbjct: 14 TIGKGEFGDVMLGDYRGNK--VAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 208 LVTSRMSCSLYLVFEYMEH-DLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLH 265
++ LY+V EYM L L S + + + +++ +H
Sbjct: 68 VIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 126
Query: 266 RDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAV 325
RD+ N+L+ + + K++DFGL Q + + + + PE L + T
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALRE-KKFSTKS 181
Query: 326 DLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384
D+WS G +L E+Y+ G+ P + + ++ K +K P
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------------------GYKMDAP 222
Query: 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
P +M+ +D A R S
Sbjct: 223 ---------DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 52/277 (18%), Positives = 111/277 (40%), Gaps = 37/277 (13%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
+G G + V + Q VA+K ++ ++ + E ++ L H +++L G+
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFI---EEAKVMMNLSHEKLVQLYGV 67
Query: 209 VTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
T + ++++ EYM + L +F Q+ + + +++ S+ LHRD
Sbjct: 68 CTKQRP--IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 125
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 327
+ N L+++ G++K++DFGL+ + D+ + + PPE+L+ + + + D+
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDI 184
Query: 328 WSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386
W+ G ++ E+Y+ GK T E I A + +P
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEHI-------------------AQGLRLYRP-- 223
Query: 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+M + +R + L
Sbjct: 224 -------HLASEKVYTIMYSCWHEKADERPTFKILLS 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (416), Expect = 2e-46
Identities = 53/276 (19%), Positives = 105/276 (38%), Gaps = 31/276 (11%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G Y VY VA+K ++ D +E E +E +++ + H N+++L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL---KEAAVMKEIKHPNLVQLLG 80
Query: 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRD 267
+ T + F + L L + S + Q+ +++ + +HRD
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 140
Query: 268 IKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDL 327
+ N L+ N ++K+ADFGL+ D + + PE L + D+
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDV 199
Query: 328 WSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKR 387
W+ G +L E+ ++ Q++++ + ++ ++P
Sbjct: 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLE------------------KDYRMERP--- 238
Query: 388 CVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+ P LM +P+DR S A +
Sbjct: 239 ------EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 4e-46
Identities = 71/321 (22%), Positives = 130/321 (40%), Gaps = 43/321 (13%)
Query: 148 LIGQGTYSNVYRARDLDQK---KIVALKKVRFDNL--EPESVRFMAREIHILRRLDHI-N 201
++G G Y V+ R + K+ A+K ++ + + ++ E +L +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSR 261
++ L + L+L+ +Y+ +F+E +V+ Y+ +++ L+H H
Sbjct: 91 LVTLHYAFQTE--TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148
Query: 262 GVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGA-TY 320
G+++RDIK N+L+D+NG + + DFGL+ + D+ + T+ Y P+++ G +
Sbjct: 149 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 208
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
+ AVD WS G ++ EL G E +I + Y
Sbjct: 209 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP------------ 256
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFFTMKPLPCD 435
++ A A L++ LL DP R A FF + + D
Sbjct: 257 -------------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF--QKINWD 301
Query: 436 PSSLPKYPPSKEFDAKIRDEE 456
+ K P F IRDE
Sbjct: 302 DLAAKKVPAP--FKPVIRDEL 320
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 53/281 (18%), Positives = 108/281 (38%), Gaps = 38/281 (13%)
Query: 148 LIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
IG+G + +V++ + + VA+K + + +F+ +E +R+ DH +++K
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFL-QEALTMRQFDHPHIVK 72
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L G++T ++++ E +L A + Y QL L + S+
Sbjct: 73 LIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGT 323
+HRDI N+L+ +N +K+ DFGL+ + + + + + + PE + +
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS- 188
Query: 324 AVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382
A D+W G + E+ G G + + +I + +P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------GERLPMP-------- 231
Query: 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+ P +LM + DP+ R
Sbjct: 232 -----------PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (411), Expect = 6e-45
Identities = 65/344 (18%), Positives = 121/344 (35%), Gaps = 62/344 (18%)
Query: 95 SIPKASEGEQVAAGWPAWLAAVAGEAIQGWVPRRA-----DSFEKLDKSLSIFSRSFYLI 149
+ K SE E V +LA + ++ W D F+++ +
Sbjct: 5 AAKKGSEQESVKE----FLAKAKEDFLKKWETPSQNTAQLDQFDRIKT-----------L 49
Query: 150 GQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGL 208
G G++ V + + A+K + + + + + E IL+ ++ ++KLE
Sbjct: 50 GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 209 VTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDI 268
+ + + + + L +FSE + Y Q++ ++ HS +++RD+
Sbjct: 110 FKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167
Query: 269 KGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLW 328
K NLLID G +++ DFG A + T PE++L Y AVD W
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPEIILS-KGYNKAVDWW 222
Query: 329 STGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRC 388
+ G ++ E+ AG P ++ KI
Sbjct: 223 ALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----------------------- 259
Query: 389 VAETFKDFPAPALALMETLLSIDPADR-----GSAASALRSEFF 427
F + L+ LL +D R ++F
Sbjct: 260 ------HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 67/294 (22%), Positives = 106/294 (36%), Gaps = 33/294 (11%)
Query: 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGL 208
IG+G + V+R + ++ VA+K + E F EI+ L H N++
Sbjct: 11 IGKGRFGEVWRGKWRGEE--VAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 209 VTSRMSC--SLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS----- 260
L+LV +Y EH L + + + + GL H H
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV--TVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 261 ---RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---PLTSRVVTLWYRPPEL 314
+ HRD+K N+L+ NG IAD GLA +D + RV T Y PE+
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 315 LLGATY-----YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369
L + D+++ G + E+ I G E QL + PS + R
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSI-GGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
K +P P + E + +M + A R +A +
Sbjct: 243 KVVCEQ--KLRPNIPNRWQSCEALRVM----AKIMRECWYANGAARLTALRIKK 290
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 6e-44
Identities = 68/307 (22%), Positives = 114/307 (37%), Gaps = 62/307 (20%)
Query: 148 LIGQGTYSNVYRARDLDQKKI-----VALKKVRFDNLEPESVRFMAREIHILRRL-DHIN 201
++G G + V A K VA+K ++ E M E+ ++ +L H N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALM-SELKMMTQLGSHEN 102
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSE------------------- 241
++ L G T S +YL+FEY + DL KFSE
Sbjct: 103 IVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 242 ---AQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298
+ C+ Q+ G++ + +HRD+ N+L+ + ++KI DFGLA D N
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 299 PL-TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKI 356
+ + + + + PE L Y D+WS G +L E+++ G PG +K+
Sbjct: 221 VVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL 279
Query: 357 FKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG 416
+ FK QP +M++ + D R
Sbjct: 280 IQ------------------NGFKMDQP---------FYATEEIYIIMQSCWAFDSRKRP 312
Query: 417 SAASALR 423
S +
Sbjct: 313 SFPNLTS 319
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 2e-43
Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 63/306 (20%)
Query: 149 IGQGTYSNVYRAR-----DLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
IG+G + V++AR + +VA+K ++ + F RE ++ D+ N++
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ-REAALMAEFDNPNIV 79
Query: 204 KLEGLVTSRMSCSLYLVFEYMEH-DLAGL-----------------------ASHPGLKF 239
KL G + + L+FEYM + DL +S
Sbjct: 80 KLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 240 SEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLA-SFYDPDQNQ 298
S A+ C +Q+ G+ + R +HRD+ N L+ N ++KIADFGL+ + Y D +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197
Query: 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIF 357
+ + + + PPE + Y T D+W+ G +L E+++ G G E ++ +
Sbjct: 198 ADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV- 255
Query: 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS 417
R + ++ P LM S PADR S
Sbjct: 256 -----------RDGNIL----------------ACPENCPLELYNLMRLCWSKLPADRPS 288
Query: 418 AASALR 423
S R
Sbjct: 289 FCSIHR 294
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 158 bits (399), Expect = 3e-43
Identities = 79/337 (23%), Positives = 131/337 (38%), Gaps = 51/337 (15%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207
+G G +S V+ A+D+ VA+K VR D + E+ EI +L+R++ + K +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDS 76
Query: 208 LVTSRMSCSLYLVFEYMEHD---------------LAGLASHPGLKFSEAQVKCYMQQLL 252
+ + + L F + + LA + + VK +QLL
Sbjct: 77 MGANHI-LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 253 CGLDHC-HSRGVLHRDIKGSNLLIDNNGI------LKIADFGLASFYDPDQNQPLTSRVV 305
GLD+ G++H DIK N+L++ +KIAD G A +YD + +R
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR-- 193
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHKIFKL 359
YR PE+LLGA +G D+WST C++ EL G + + + + +I +L
Sbjct: 194 --EYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 360 CGSPSEDYWRKSKLPHATI-------------FKPQQPYKRCVAETFKDFPAPALALMET 406
G R K F P + + KD +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 407 LLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP 443
+L +DP R A + + L + +P
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLK-DTLGMEEIRVPDRE 346
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 63/284 (22%), Positives = 106/284 (37%), Gaps = 39/284 (13%)
Query: 148 LIGQGTYSNVYRARDLD---QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
+IG+G + VY LD +K A+K + E +F+ E I++ H NV+
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL-TEGIIMKDFSHPNVLS 92
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L G + R S +V YM+H DL + + + + Q+ G+ S+
Sbjct: 93 LLG-ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL---TSRVVTLWYRPPELLLGATY 320
+HRD+ N ++D +K+ADFGLA + + T + + + E L
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QK 210
Query: 321 YGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379
+ T D+WS G +L EL G P P + + + R+ P
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------GRRLLQP----- 256
Query: 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+ P P +M R S + +
Sbjct: 257 --------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 58/322 (18%), Positives = 111/322 (34%), Gaps = 46/322 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALK---KVRFDNLEPESVRFMAREIHILRRLDHINVIK 204
++G G + VY+ + + + V + K + P++ + + E +++ +D+ +V +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 205 LEGLVTSRMSCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGV 263
L G+ + ++ L+ + M L + + Q+ G+++ R +
Sbjct: 76 LLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 132
Query: 264 LHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV-TLWYRPPELLLGATYYG 322
+HRD+ N+L+ +KI DFGLA ++ + + + E +L Y
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH-RIYT 191
Query: 323 TAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381
D+WS G + EL G G E + K +
Sbjct: 192 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------------GERL 232
Query: 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM-----KPLPCDP 436
QP +M ID R + EF M + L
Sbjct: 233 PQP---------PICTIDVYMIMVKCWMIDADSRPKFRELII-EFSKMARDPQRYLVIQG 282
Query: 437 SSLPKYPPSKE--FDAKIRDEE 456
P + F + DEE
Sbjct: 283 DERMHLPSPTDSNFYRALMDEE 304
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 63/302 (20%), Positives = 105/302 (34%), Gaps = 57/302 (18%)
Query: 148 LIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHIN 201
+G G + V A D VA+K ++ E M E+ +L L +H+N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM-SELKVLSYLGNHMN 88
Query: 202 VIKLEGLVTSRMSCSLYLVFEYMEH------------------DLAGLASHPGLKFSEAQ 243
++ L G T ++ EY + + L
Sbjct: 89 IVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 244 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303
+ + Q+ G+ S+ +HRD+ N+L+ + I KI DFGLA D N +
Sbjct: 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 304 VV-TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCG 361
+ + PE + Y D+WS G L EL++ G PG + +K+ K
Sbjct: 207 ARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK--- 262
Query: 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA 421
F+ P + PA +M+T DP R +
Sbjct: 263 ---------------EGFRMLSP---------EHAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 422 LR 423
++
Sbjct: 299 VQ 300
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-41
Identities = 60/302 (19%), Positives = 120/302 (39%), Gaps = 39/302 (12%)
Query: 148 LIGQGTYSNVYRARDLD----QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+IG G + VY+ ++ VA+K ++ E + V F+ E I+ + H N+I
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL-GEAGIMGQFSHHNII 72
Query: 204 KLEGLVTSRMSCSLYLVFEYMEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG 262
+LEG+++ + ++ EYME+ +FS Q+ ++ + G+ + +
Sbjct: 73 RLEGVISKYKP--MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 263 VLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS--RVVTLWYRPPELLLGATY 320
+HRD+ N+L+++N + K++DFGL+ + D T+ + + + PE + +
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190
Query: 321 YGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380
+A D+WS G ++ E+ ++ K F+
Sbjct: 191 T-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN------------------DGFR 231
Query: 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440
P D P+ LM + A R A + + P +L
Sbjct: 232 LPTP---------MDCPSAIYQLMMQCWQQERARRPKFADIVS-ILDKLIRAPDSLKTLA 281
Query: 441 KY 442
+
Sbjct: 282 DF 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 66/317 (20%), Positives = 117/317 (36%), Gaps = 56/317 (17%)
Query: 148 LIGQGTYSNVYRARDLD--QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIK 204
+IG+G + V +AR + A+K+++ + + F E+ +L +L H N+I
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIIN 75
Query: 205 LEGLVTSRMSCSLYLVFEYMEH----------------DLAGLASHPGLKFSEAQVKCYM 248
L G LYL EY H +A+ S Q+ +
Sbjct: 76 LLG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 249 QQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTLW 308
+ G+D+ + +HRD+ N+L+ N + KIADFGL+ + + T + +
Sbjct: 134 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVR 191
Query: 309 YRPPELLLGATYYGTAVDLWSTGCILAE-LYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367
+ E L + Y T D+WS G +L E + G G T E K+ +
Sbjct: 192 WMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--------- 241
Query: 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SE 425
++ ++P + LM P +R S A L +
Sbjct: 242 ----------GYRLEKP---------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282
Query: 426 FFTMKPLPCDPSSLPKY 442
+ + + K+
Sbjct: 283 MLEERKTYVNTTLYEKF 299
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 54/299 (18%), Positives = 98/299 (32%), Gaps = 52/299 (17%)
Query: 148 LIGQGTYSNVYRARDLDQK-----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV 202
+G+G + V A + VA+K ++ E M+ ++ H+NV
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 203 IKLEGLVTSRMSCSLYLVFEYMEHDL----------------AGLASHPGLKFSEAQVKC 246
+ L G T L ++ E+ + + + C
Sbjct: 80 VNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 247 YMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV- 305
Y Q+ G++ SR +HRD+ N+L+ ++KI DFGLA D +
Sbjct: 139 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 198
Query: 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPS 364
L + PE + Y D+WS G +L E+++ PG E+ + K
Sbjct: 199 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK------ 251
Query: 365 EDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423
+ + P M +P+ R + + +
Sbjct: 252 ------------EGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 55/307 (17%), Positives = 112/307 (36%), Gaps = 49/307 (15%)
Query: 149 IGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVI 203
+GQG++ VY + + VA+K V E + F+ E +++ + +V+
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL-NEASVMKEFNCHHVV 86
Query: 204 KLEGLVTSRMSCSLYLVFEYME----------HDLAGLASHPGLKFSEAQVKCYMQQLLC 253
+L G+V+ ++ E M A + S +++ ++
Sbjct: 87 RLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 254 GLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS-FYDPDQNQPLTSRVVTLWYRPP 312
G+ + ++ +HRD+ N ++ + +KI DFG+ Y+ D + ++ + + P
Sbjct: 145 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204
Query: 313 ELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371
E L + T D+WS G +L E+ + G + + L + +
Sbjct: 205 ESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------------MEG 251
Query: 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKP 431
L + + P LM +P R S + S M+P
Sbjct: 252 GLL----------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295
Query: 432 LPCDPSS 438
+ S
Sbjct: 296 GFREVSF 302
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 59/301 (19%), Positives = 109/301 (36%), Gaps = 56/301 (18%)
Query: 148 LIGQGTYSNVYRARDLDQKK-------IVALKKVRFDNLEPESVRFMAREIHILRRL-DH 199
+G+G + V A + K VA+K ++ D E + + E+ +++ + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI-SEMEMMKMIGKH 78
Query: 200 INVIKLEGLVTSRMSCSLYLVFEYMEH----------------DLAGLASHPGLKFSEAQ 243
N+I L G T LY++ EY + +P + S
Sbjct: 79 KNIINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 244 VKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLT-S 302
+ Q+ G+++ S+ +HRD+ N+L+ + ++KIADFGLA T +
Sbjct: 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGS 362
+ + + PE L Y D+WS G +L E++ VE+L K+ K
Sbjct: 197 GRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK---- 251
Query: 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASAL 422
+ +P + +M P+ R + +
Sbjct: 252 --------------EGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 423 R 423
Sbjct: 289 E 289
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (255), Expect = 1e-25
Identities = 29/202 (14%), Positives = 67/202 (33%), Gaps = 30/202 (14%)
Query: 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFM--------AREIHILRRLDH 199
L+G+G S V+ + +K + + + V+ + R +
Sbjct: 7 LMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 200 INVIKLEG--LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDH 257
+ KL+G + ++ E ++ + + +L +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVAK 118
Query: 258 CHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR---VVTLWYRPPEL 314
+ RG++H D+ N+L+ GI I DF + + + + R + ++
Sbjct: 119 FYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITYFSRT-- 175
Query: 315 LLGATYYGTAVDLWSTGCILAE 336
Y T D+ S + +
Sbjct: 176 ------YRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 720 | |||
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.0 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.65 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.64 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.06 | |
| d2ogqa1 | 124 | Serine/threonine-protein kinase plk C-terminal dom | 94.43 |
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=480.42 Aligned_cols=292 Identities=37% Similarity=0.665 Sum_probs=245.0
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCC---HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE---PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~---~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+++||+|+||+||+|++..+|+.||||+++..... ....+.+.+|+.+|++++|||||++++++.. .+.+|||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivmE 80 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVFD 80 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehhh
Confidence 34599999999999999999999999999765432 2224568899999999999999999999987 677999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
||.++++..+......+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~~ 159 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTH 159 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCc-ccccc
Confidence 99998888777777789999999999999999999999999999999999999999999999999998664332 33345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.+||++|+|||++.+...|+.++||||||||+|||++|.+||.+.++.+++.+|++.+|.|..+.|..............
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 68999999999998777789999999999999999999999999999999999999999999888765322211111111
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPK 441 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~ 441 (720)
.+ ...+...+..+++.+.+||.+||++||++||||.|+|+||||+..|.|+.+..+|.
T Consensus 240 ~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~ 297 (299)
T d1ua2a_ 240 FP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPR 297 (299)
T ss_dssp CC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCC
T ss_pred CC-CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCC
Confidence 11 11234456678999999999999999999999999999999999999988877774
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=459.89 Aligned_cols=253 Identities=28% Similarity=0.416 Sum_probs=210.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|+++.+|+.||||++..... .+..+.+.+|+.+|++|+|||||++++++.+ ...+|||||||+|+
T Consensus 12 ~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECCTTE
T ss_pred EEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEEEeccCCC
Confidence 39999999999999999999999999986543 2334568899999999999999999999987 67899999999976
Q ss_pred ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-CCCccccccc
Q 004999 228 LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVVT 306 (720)
Q Consensus 228 ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~t~~~gT 306 (720)
.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|..+.... ....+..+||
T Consensus 89 ~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT 168 (271)
T d1nvra_ 89 ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168 (271)
T ss_dssp EGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSC
T ss_pred cHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeC
Confidence 665555666689999999999999999999999999999999999999999999999999998764332 2334567899
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
+.|+|||++.+...++.++||||||||||||++|++||.+.................
T Consensus 169 ~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~----------------------- 225 (271)
T d1nvra_ 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------------------- 225 (271)
T ss_dssp GGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-----------------------
T ss_pred cCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----------------------
Confidence 999999999988766789999999999999999999998766544433333211110
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
...+..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 226 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ---LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ---STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ---CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 1123467899999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=457.68 Aligned_cols=248 Identities=32% Similarity=0.460 Sum_probs=215.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+.||+|+||.||+|+++.+++.||||++..... +......+.+|+.+|++++|||||++++++.+ ...+|||||||+
T Consensus 12 ~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ivmEy~~ 89 (263)
T d2j4za1 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYLILEYAP 89 (263)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEEEECCT
T ss_pred EEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEEEEEeecC
Confidence 349999999999999999999999999975432 12234568899999999999999999999987 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..... ......+|
T Consensus 90 ~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~---~~~~~~~G 166 (263)
T d2j4za1 90 LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---SRRTTLCG 166 (263)
T ss_dssp TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---CCCEETTE
T ss_pred CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---CcccccCC
Confidence 876665555556799999999999999999999999999999999999999999999999999986543 23355689
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+.+..+.+.-.
T Consensus 167 t~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~------------------------ 221 (263)
T d2j4za1 167 TLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF------------------------ 221 (263)
T ss_dssp EGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC------------------------
T ss_pred CCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------------------
Confidence 99999999998866 79999999999999999999999999988888877754210
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..+..+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 222 -----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 222 -----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 112357899999999999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=456.56 Aligned_cols=284 Identities=39% Similarity=0.649 Sum_probs=235.0
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||+|++..+|+.||||+++...........+.+|+.+|++++|||||++++++.+ ...+||||||+.+
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv~e~~~~ 85 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLVFEFLHQ 85 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEECCSE
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEEEeecCC
Confidence 34999999999999999999999999998765444445778999999999999999999999987 6789999999998
Q ss_pred ccccccc-CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 227 DLAGLAS-HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~-~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
+++.... .....+++.+++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|...... .......+|
T Consensus 86 ~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~g 164 (298)
T d1gz8a_ 86 DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVV 164 (298)
T ss_dssp EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SBCTTCCBC
T ss_pred chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC-cccceeecc
Confidence 8666553 34567999999999999999999999999999999999999999999999999999876432 234455689
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.....++.++||||||||+|+|++|+.||.+.+..+++.++++..+.+.+..|.................
T Consensus 165 t~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T d1gz8a_ 165 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244 (298)
T ss_dssp CCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCC
T ss_pred cceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccccc
Confidence 99999999998888779999999999999999999999999999999999999999998877754221111111111111
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLP 433 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~ 433 (720)
..........+++++.+||.+||++||.+|||+.|+|+||||+..+.|
T Consensus 245 ~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 122344556789999999999999999999999999999999876544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=455.21 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=211.3
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecc
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~ 207 (720)
++++|+.++. ||+|+||.||+|+++.+|+.||||++..........+.+.+|+.+|++|+|||||++++
T Consensus 2 r~edy~~~~~-----------iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~ 70 (269)
T d2java1 2 RAEDYEVLYT-----------IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70 (269)
T ss_dssp CGGGEEEEEE-----------EEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEE
T ss_pred CchhCEEeEE-----------EecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEE
Confidence 4567777776 99999999999999999999999999988777777888999999999999999999999
Q ss_pred ceeccCCCeEEEEEeeccccccccccC----CCCCCCHHHHHHHHHhhhhccccccccC-----cccccCcceeEEEcCC
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASH----PGLKFSEAQVKCYMQQLLCGLDHCHSRG-----VLHRDIKGSNLLIDNN 278 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~----~~~~lse~~~~~i~~QIl~gL~yLH~~g-----IvHrDIKP~NILld~~ 278 (720)
++.+.....+|||||||+|+.+..+.. .+..+++.+++.++.||+.||.|||+.| |+||||||+||||+.+
T Consensus 71 ~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~ 150 (269)
T d2java1 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK 150 (269)
T ss_dssp EEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT
T ss_pred EEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC
Confidence 987655678999999999765554432 3457999999999999999999999876 9999999999999999
Q ss_pred CceeeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 004999 279 GILKIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 279 g~vKL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~ 358 (720)
|.+||+|||+|..+.... ......+||+.|+|||++.+.. |+.++||||||||||||+||.+||.+.+..+.+.+|..
T Consensus 151 ~~vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~ 228 (269)
T d2java1 151 QNVKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228 (269)
T ss_dssp SCEEECCHHHHHHC------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CcEEEeeccceeecccCC-CccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 999999999998765322 2345568999999999998766 79999999999999999999999999988887777754
Q ss_pred hcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccC
Q 004999 359 LCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFF 427 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f 427 (720)
... ......+++++.+||.+||+.||.+|||+.|+|+|||+
T Consensus 229 ~~~----------------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 GKF----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCC----------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 210 11224678999999999999999999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-54 Score=453.99 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=217.3
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++++.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+ ...+||||||
T Consensus 23 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmEy 98 (293)
T d1yhwa1 23 TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEY 98 (293)
T ss_dssp CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEE--CCEEEEEEEe
Confidence 3334499999999999999999999999999865432 23568899999999999999999999987 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
|+|+.+..+... ..+++.+++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..+.... ......
T Consensus 99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~~~~~~ 176 (293)
T d1yhwa1 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTM 176 (293)
T ss_dssp CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-CCBCCC
T ss_pred cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc-cccccc
Confidence 998766655543 369999999999999999999999999999999999999999999999999998765433 334566
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+||+.|+|||++.+.. |+.++||||||||||+|++|.+||.+.+..+.+..+.... .+.
T Consensus 177 ~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~------------------- 235 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE------------------- 235 (293)
T ss_dssp CSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC-------------------
T ss_pred ccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCC-------------------
Confidence 8999999999998865 7999999999999999999999999998888877765531 111
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 236 ------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 ------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0122457899999999999999999999999999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.7e-53 Score=458.28 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=226.9
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+|++|+|||||++++++.+ ...+|||||
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE 103 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYE 103 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEE
Confidence 344445999999999999999999999999997543 3455778999999999999999999999987 678999999
Q ss_pred ecccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC--CCceeeeccccceecCCCCCCC
Q 004999 223 YMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN--NGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 223 y~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~--~g~vKL~DFGla~~~~~~~~~~ 299 (720)
||+|+.+ ..+......+++.+++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|..+... ..
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--~~ 181 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QS 181 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--SC
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--cc
Confidence 9997544 555455667999999999999999999999999999999999999964 688999999999876433 33
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+||+.|+|||++.+.. |+.++||||||||+|||++|++||.+.+..+.+..|......+..
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-------------- 246 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD-------------- 246 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC--------------
T ss_pred cceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------------
Confidence 45678999999999998876 799999999999999999999999999999988888764332221
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLP 440 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p 440 (720)
..+..+++.+.+||.+||++||.+|||++|+|+||||+....+..+..+|
T Consensus 247 -----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~~~~~~~ 296 (350)
T d1koaa2 247 -----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296 (350)
T ss_dssp -----------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCSCCCCBC
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCchhhCC
Confidence 22346889999999999999999999999999999999877666555444
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=456.20 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=213.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+||+|+||.||+|++..+++.||||++..... .....+.+.+|+.+|++|+|||||++++++.+ ...+|||||||+|
T Consensus 15 ~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ivmEy~~g 92 (288)
T d1uu3a_ 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKN 92 (288)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEEEEECCCTT
T ss_pred EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEEEEEEccCC
Confidence 49999999999999999999999999975432 22345678999999999999999999999877 6789999999998
Q ss_pred cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC-CCcccccc
Q 004999 227 DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-QPLTSRVV 305 (720)
Q Consensus 227 ~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-~~~t~~~g 305 (720)
+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+..... ......+|
T Consensus 93 g~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~G 172 (288)
T d1uu3a_ 93 GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172 (288)
T ss_dssp EEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCC
T ss_pred CCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccC
Confidence 66655555556899999999999999999999999999999999999999999999999999998754332 23445689
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+.+.+|.+.-.
T Consensus 173 T~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~------------------------ 227 (288)
T d1uu3a_ 173 TAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY------------------------ 227 (288)
T ss_dssp CGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC------------------------
T ss_pred CccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCC------------------------
Confidence 99999999998876 79999999999999999999999999998888888764210
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHH------HHhCccCCCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAAS------ALRSEFFTMKP 431 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e------~L~hp~f~~~~ 431 (720)
..+..+++.+.+||.+||++||.+|||++| +++||||+...
T Consensus 228 -----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 228 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp -----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 112357899999999999999999999987 58899998654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.8e-54 Score=456.43 Aligned_cols=253 Identities=27% Similarity=0.432 Sum_probs=219.4
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
+.++.||+|+||.||+|++..+++.||||+++.... .....+.+.+|+.+|++|+|||||++++++.+ ...+|||||
T Consensus 18 ~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv~E 95 (309)
T d1u5ra_ 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVME 95 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CCEEEEEEE
Confidence 334449999999999999999999999999987655 34556778999999999999999999999987 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
||.++++..+......+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|..... ...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----~~~ 170 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANS 170 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----BCC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-----CCc
Confidence 999988876666667899999999999999999999999999999999999999999999999999986532 244
Q ss_pred cccccCCCChhhhcCC--cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 303 RVVTLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~--~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
.+||+.|+|||++.+. ..|+.++||||||||||||++|.+||.+.+..+.+.++......+
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~----------------- 233 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA----------------- 233 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------------
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-----------------
Confidence 6899999999999753 348999999999999999999999999998888887776521110
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus 234 ----------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 234 ----------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ----------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ----------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 0113578999999999999999999999999999999753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=444.19 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=212.8
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc--CCCeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR--MSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~--~~~~lyLV~Ey~ 224 (720)
..||+|+||+||+|++..+++.||+|++..........+.+.+|+.+|++|+|||||++++++... ....+|||||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 359999999999999999999999999988776777778899999999999999999999998653 245689999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccC--cccccCcceeEEEc-CCCceeeeccccceecCCCCCCCcc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRG--VLHRDIKGSNLLID-NNGILKIADFGLASFYDPDQNQPLT 301 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~g--IvHrDIKP~NILld-~~g~vKL~DFGla~~~~~~~~~~~t 301 (720)
+|+.+..+......+++.+++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|..... ....
T Consensus 95 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~---~~~~ 171 (270)
T d1t4ha_ 95 TSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAK 171 (270)
T ss_dssp CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT---TSBE
T ss_pred CCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC---CccC
Confidence 98777666655668999999999999999999999998 99999999999996 578999999999986432 2345
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+||+.|+|||++.+. |+.++||||||||||||++|++||.+......+.+.+.. +.++
T Consensus 172 ~~~GT~~Y~aPE~~~~~--~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~----------------- 231 (270)
T d1t4ha_ 172 AVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP----------------- 231 (270)
T ss_dssp ESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC-----------------
T ss_pred CcccCccccCHHHhCCC--CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC-----------------
Confidence 66899999999998753 899999999999999999999999887666555443321 1111
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
......+++++.+||.+||+.||++|||++|+|+||||+
T Consensus 232 --------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 --------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 112245788999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=454.59 Aligned_cols=257 Identities=24% Similarity=0.343 Sum_probs=216.8
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.+|++|+|||||++++++.+ ...+||||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvm 88 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILI 88 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEE
Confidence 4555556999999999999999999999999998653 3345678899999999999999999999987 67899999
Q ss_pred eeccccccccc-cCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 222 EYMEHDLAGLA-SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 222 Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
|||+|+.+..+ ......+++.+++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|...... ....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~~ 167 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 167 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHHH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC-cccc
Confidence 99998766554 334557999999999999999999999999999999999999999999999999999765321 1123
Q ss_pred cccccccCCCChhhhcC----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 301 TSRVVTLWYRPPELLLG----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
...+||+.|+|||++.+ ...|+.++||||||||||||+||++||.+.+..+.+.++.+... +
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~-~------------- 233 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-P------------- 233 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC-C-------------
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-C-------------
Confidence 35679999999999853 34489999999999999999999999999988888877765210 0
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.......+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 234 ------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 ------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 01122457899999999999999999999999999999974
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-53 Score=448.69 Aligned_cols=283 Identities=36% Similarity=0.612 Sum_probs=236.1
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++++.||+|+||+||+|+++ +|+.||||+++...........+.+|+.+|++++|||||++++++.. .+.+|+|||
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~~e 80 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLVFE 80 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEEEE
T ss_pred ceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEEEE
Confidence 344445999999999999985 78999999998765444445778999999999999999999999987 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|+.++++..+......+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 159 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTH 159 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc-cccce
Confidence 99999988888878889999999999999999999999999999999999999999999999999998764322 23345
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.++++.|+|||++.+...++.++||||||||+|||++|++||.+.+..+++.++++..+.+....|..............
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 57899999999999887789999999999999999999999999999999999999999998888765322111111111
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
..........+..+++.+.+||.+||++||++|||+.|+|+||||++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 11122234556788999999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-54 Score=454.81 Aligned_cols=259 Identities=27% Similarity=0.378 Sum_probs=204.0
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.|.+.++||+|+||.||+|+++.+++.||||++....... ....+.+|+.+|++|+|||||++++++.+ ...+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 34566667999999999999999999999999998765432 23567899999999999999999999977 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc---CCCceeeeccccceecCCCCC
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID---NNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld---~~g~vKL~DFGla~~~~~~~~ 297 (720)
||||+|+.+..++.....+++.+++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence 99999765554444566899999999999999999999999999999999999995 5789999999999876432
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......+||+.|+|||++.+.. |+.++||||||||||||++|.+||.+....+....+.+....+.
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------------- 229 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------------- 229 (307)
T ss_dssp ---------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-------------
T ss_pred CeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-------------
Confidence 2345568999999999998866 89999999999999999999999999998888888765322211
Q ss_pred ccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 378 IFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 378 ~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
...+..+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 230 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 230 ------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 12235689999999999999999999999999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=447.27 Aligned_cols=260 Identities=24% Similarity=0.305 Sum_probs=222.7
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCC----HHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCe
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----PESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCS 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~----~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~ 216 (720)
++|++.+.||+|+||.||+|+++.+|+.||||++...... ....+.+.+|+.+|++|+|||||++++++.+ ...
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCE
Confidence 4556666699999999999999999999999999865432 2235678999999999999999999999987 678
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC----ceeeeccccceec
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG----ILKIADFGLASFY 292 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g----~vKL~DFGla~~~ 292 (720)
+|||||||+|+.+..+......+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|...
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999866655555556799999999999999999999999999999999999998877 4999999999876
Q ss_pred CCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 293 DPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 293 ~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
... ......++|+.|+|||++.+.. |+.++||||||||||||++|.+||.+.+..+.+..+......+..
T Consensus 168 ~~~--~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------- 237 (293)
T d1jksa_ 168 DFG--NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------- 237 (293)
T ss_dssp TTS--CBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH-------
T ss_pred CCC--ccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc-------
Confidence 432 2345568899999999998765 799999999999999999999999999999988888664333322
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..+..+++.+.+||.+||+.||.+|||++|+|+||||+..
T Consensus 238 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 238 ------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp ------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred ------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 2235689999999999999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.9e-53 Score=456.52 Aligned_cols=256 Identities=24% Similarity=0.390 Sum_probs=221.5
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++.+.||+|+||.||+|++..+|+.||||+++... ......+.+|+.+|++|+|||||+++++|.+ ...+|||||
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~ivmE 106 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLILE 106 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEEEE
Confidence 344445999999999999999999999999998653 3345678899999999999999999999987 678999999
Q ss_pred ecccccc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEc--CCCceeeeccccceecCCCCCCC
Q 004999 223 YMEHDLA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLID--NNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 223 y~~g~ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld--~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
||+|+.+ ..+...+..|++.+++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|..+... ..
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--~~ 184 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EI 184 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--SC
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC--Cc
Confidence 9997555 55555666799999999999999999999999999999999999997 6789999999999987543 33
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+||+.|+|||++.+.. |+.++||||||||||||+||.+||.+.+..+.+..|.+....++.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~-------------- 249 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE-------------- 249 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS--------------
T ss_pred eeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--------------
Confidence 45668899999999998876 899999999999999999999999999999998888764333221
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..+..+++++.+||.+||++||.+|||+.|+|+||||+..
T Consensus 250 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 250 -----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -----------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 2235689999999999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-54 Score=460.76 Aligned_cols=284 Identities=22% Similarity=0.314 Sum_probs=212.6
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecc
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~ 207 (720)
+.++|+.++. ||+|+||.||+|++..+|+.||||+++... .......+.+|+.+|++|+|||||++++
T Consensus 4 ~~d~y~~~~~-----------iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 71 (322)
T d1s9ja_ 4 KDDDFEKISE-----------LGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYG 71 (322)
T ss_dssp CGGGEEEEEE-----------EECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEE
T ss_pred CccCCEEEEE-----------EecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 3456666666 999999999999999999999999998653 3445567899999999999999999999
Q ss_pred ceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCceeeecc
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGILKIADF 286 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~vKL~DF 286 (720)
+|.+ ...+|||||||.|+.+..+......+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+||
T Consensus 72 ~~~~--~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DF 149 (322)
T d1s9ja_ 72 AFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 149 (322)
T ss_dssp EEEC--SSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred EEEE--CCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeC
Confidence 9987 67899999999987666655555679999999999999999999997 59999999999999999999999999
Q ss_pred ccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCh
Q 004999 287 GLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVE-QLHKIFKLCGSPSE 365 (720)
Q Consensus 287 Gla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e-~l~~i~~~~g~p~~ 365 (720)
|+|..+... ..+..+||++|+|||++.+.. |+.++||||||||+|||++|+.||.+.+..+ +...+....+.+..
T Consensus 150 Gla~~~~~~---~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 225 (322)
T d1s9ja_ 150 GVSGQLIDS---MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225 (322)
T ss_dssp CCCHHHHHH---TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred CCccccCCC---ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence 999865322 234568999999999999876 8999999999999999999999998865433 22222222222221
Q ss_pred hh----hhhcCCC-CccccCCCCccchhh----hcc-----cCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 366 DY----WRKSKLP-HATIFKPQQPYKRCV----AET-----FKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 366 ~~----w~~~~l~-~~~~~~~~~~~~~~~----~e~-----~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
.. +...... ......+.......+ ... ...++.++.+||.+||++||.+|||++|+|+||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 11 0000000 000000000000000 000 1135789999999999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=456.78 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=218.3
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
++||+|+||.||+|+++.+|+.||||+++.... .....+.+.+|+.+|++++|||||++++++.+ ...+|+|||||.
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~iv~ey~~ 88 (337)
T d1o6la_ 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYAN 88 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEEEEECCT
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccccccceeccC
Confidence 349999999999999999999999999986432 22345678899999999999999999999987 678999999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
|+.+..+......+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..... .......+|
T Consensus 89 gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~~~~~~G 167 (337)
T d1o6la_ 89 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCG 167 (337)
T ss_dssp TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCCBCCCEE
T ss_pred CCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC-Cccccccee
Confidence 8777666666678999999999999999999999999999999999999999999999999999865432 334556789
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
|+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+.+..+....
T Consensus 168 T~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~------------------------- 221 (337)
T d1o6la_ 168 TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE------------------------- 221 (337)
T ss_dssp CGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------------------------
T ss_pred CHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC-------------------------
Confidence 99999999998876 7999999999999999999999999999888877775421
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTM 429 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~ 429 (720)
...+..+++++.+||.+||++||.+|+ ++.++++||||+.
T Consensus 222 ----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred ----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 112346899999999999999999999 4999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=448.09 Aligned_cols=296 Identities=43% Similarity=0.693 Sum_probs=236.0
Q ss_pred CccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeecc
Q 004999 128 RADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEG 207 (720)
Q Consensus 128 ~~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~ 207 (720)
.+..|+.+++ ||+|+||+||+|++..+|+.||||++............+.+|+.+|++|+||||+++++
T Consensus 8 ~~~rY~i~~~-----------LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~ 76 (318)
T d3blha1 8 EVSKYEKLAK-----------IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76 (318)
T ss_dssp BGGGEEEEEE-----------EEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccCCEEEEEE-----------EecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEe
Confidence 3456666665 99999999999999999999999999876555555567889999999999999999999
Q ss_pred ceeccC------CCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCce
Q 004999 208 LVTSRM------SCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGIL 281 (720)
Q Consensus 208 ~~~~~~------~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~v 281 (720)
++.... ...+|+|||||.++++.........+++.+++.++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 77 ~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp EEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE
T ss_pred eeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcE
Confidence 875422 34689999999998888877777889999999999999999999999999999999999999999999
Q ss_pred eeeccccceecCCCC---CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 004999 282 KIADFGLASFYDPDQ---NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFK 358 (720)
Q Consensus 282 KL~DFGla~~~~~~~---~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~ 358 (720)
||+|||++..+.... .......+||++|+|||++.+...|+.++||||||||+|||++|++||.+.+..+.+..+.+
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 999999998764322 22334457899999999999887789999999999999999999999999999999999999
Q ss_pred hcCCCChhhhhhcCCCCc-cccCCCCccchhhhccc--CCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 359 LCGSPSEDYWRKSKLPHA-TIFKPQQPYKRCVAETF--KDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 359 ~~g~p~~~~w~~~~l~~~-~~~~~~~~~~~~~~e~~--~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
..+.+..+.|........ ..+.............+ ...++.+.+||.+||++||++|||+.|+|+||||+..|.|+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 999988876654221111 00000000001111111 13467899999999999999999999999999999877655
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-53 Score=445.54 Aligned_cols=282 Identities=39% Similarity=0.635 Sum_probs=229.9
Q ss_pred ccceeecccCceEEEEEEECCC-CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc---CCCceeeeccceecc---CCCe
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQ-KKIVALKKVRFDNLEPESVRFMAREIHILRRL---DHINVIKLEGLVTSR---MSCS 216 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~t-g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L---~HpnIvkl~~~~~~~---~~~~ 216 (720)
++++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+|+.| +||||++++++|... ....
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 3344499999999999999765 67899999976544333333456788877766 799999999988532 2357
Q ss_pred EEEEEeeccccccccc-cCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCC
Q 004999 217 LYLVFEYMEHDLAGLA-SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPD 295 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~-~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~ 295 (720)
+|++||||+++++... ......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~- 168 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 168 (305)
T ss_dssp EEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG-
T ss_pred EEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc-
Confidence 8999999998766433 34556799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.......+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+++.+|++.++.|....|.......
T Consensus 169 -~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 246 (305)
T d1blxa_ 169 -QMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246 (305)
T ss_dssp -GGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred -cccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence 23345678999999999998876 8999999999999999999999999999999999999999999988876543322
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
...+.... ..........+++.+.+||.+||++||++|||+.|+|+||||+..
T Consensus 247 ~~~~~~~~--~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 247 RQAFHSKS--AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GGGSCCCC--CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hhhhcccc--ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 22222111 112334566789999999999999999999999999999999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=449.75 Aligned_cols=297 Identities=32% Similarity=0.511 Sum_probs=236.3
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCe
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCS 216 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~ 216 (720)
..|++++.||+|+||+||+|++..+|+.||||+++.........+.+.+|+.+|+.|+|||||+++++|.... ...
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 3455556699999999999999999999999999877667777888999999999999999999999987532 236
Q ss_pred EEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC
Q 004999 217 LYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ 296 (720)
Q Consensus 217 lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~ 296 (720)
+|||||||+.++..... ...|++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 98 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-- 173 (346)
T d1cm8a_ 98 FYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 173 (346)
T ss_dssp CEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred EEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC--
Confidence 89999999765554433 34699999999999999999999999999999999999999999999999999987643
Q ss_pred CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 297 NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 297 ~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
..+..++|+.|+|||++.+...++.++||||||||+|||++|++||.+.+..+.+..+....+.++.++|........
T Consensus 174 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (346)
T d1cm8a_ 174 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251 (346)
T ss_dssp --SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred --ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence 345678999999999999877789999999999999999999999999999999999999999999988765332211
Q ss_pred cccCC--CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCCCCCCCCC
Q 004999 377 TIFKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDPSSLPKYP 443 (720)
Q Consensus 377 ~~~~~--~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p~~~p~~~ 443 (720)
..+.. .......+...+..+++.+.+||.+||.+||.+|||+.|+|+||||+....+...+..+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~~~~ 320 (346)
T d1cm8a_ 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYD 320 (346)
T ss_dssp HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCCCCC
T ss_pred hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCCCCC
Confidence 10000 00011123445667899999999999999999999999999999999766555544444444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-52 Score=449.24 Aligned_cols=279 Identities=36% Similarity=0.562 Sum_probs=229.7
Q ss_pred ccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc----CCCeEEE
Q 004999 144 RSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSCSLYL 219 (720)
Q Consensus 144 r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~----~~~~lyL 219 (720)
+..++||+|+||+||+|++..+|+.||||++..... .+.+|+.+|++|+|||||+++++|... ....+||
T Consensus 23 ~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred EeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 334459999999999999999999999999976542 124799999999999999999988542 2346899
Q ss_pred EEeecccccccccc---CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceecCCC
Q 004999 220 VFEYMEHDLAGLAS---HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPD 295 (720)
Q Consensus 220 V~Ey~~g~ll~~~~---~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~ 295 (720)
|||||++++...+. .....+++.+++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||++..+...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 99999987655443 3556799999999999999999999999999999999999999876 8999999999876432
Q ss_pred CCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 296 QNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 296 ~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
......+||+.|+|||++.+...|+.++||||||||+|||++|++||.+.+..+++.++++.+|.+..+.|.......
T Consensus 177 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 177 --EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp --SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred --cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 334556899999999999887779999999999999999999999999999999999999999999999887643322
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.....+..............+++.+.+||.+||.+||++|||+.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 2221111111111222345689999999999999999999999999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.4e-53 Score=449.76 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=219.2
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
+.+.||+|+||.||+|+++.+|+.||||+++.... .....+.+.+|+.+|++++|||||++++++.+ ...+|+||||
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~ivmE~ 85 (316)
T d1fota_ 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMIMDY 85 (316)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEEECC
T ss_pred EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeeeeEeee
Confidence 33449999999999999999999999999975432 22335678899999999999999999999987 6789999999
Q ss_pred ccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccc
Q 004999 224 MEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSR 303 (720)
Q Consensus 224 ~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~ 303 (720)
|.|+.+..+......+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..... .....
T Consensus 86 ~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~----~~~~~ 161 (316)
T d1fota_ 86 IEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTL 161 (316)
T ss_dssp CCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----CBCCC
T ss_pred cCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----ccccc
Confidence 99988777777777899999999999999999999999999999999999999999999999999987643 23456
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+||+.|+|||++.+.. |+.++||||||||||||++|++||.+.+..+.+.++...-.
T Consensus 162 ~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------------------- 218 (316)
T d1fota_ 162 CGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------------------- 218 (316)
T ss_dssp CSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC----------------------
T ss_pred cCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCC----------------------
Confidence 8999999999998766 79999999999999999999999999999888888865211
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
..+..+++++.+||.+||.+||.+|+ |++++|+||||+..
T Consensus 219 -------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 219 -------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred -------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 11245789999999999999999996 99999999999853
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=431.23 Aligned_cols=285 Identities=38% Similarity=0.654 Sum_probs=241.3
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|++++.||+|+||+||+|++..+++.||||+++...........+.+|+.+|+.++||||+++++++.. ...+++|||
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv~~ 81 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLVFE 81 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEE
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEEee
Confidence 445555999999999999999999999999998876666777889999999999999999999999987 678999999
Q ss_pred eccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 223 YMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 223 y~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
++.++++..+......+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....... .....
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSA 160 (292)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SCCCS
T ss_pred eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC-cccee
Confidence 99998888777777889999999999999999999999999999999999999999999999999998765332 23344
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCC-CCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKP-IMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~p-pf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+++.|+|||++.+...++.++||||||||+|||++|+. +|.+.+..+++.++....+.+....|............+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 5678999999999887778999999999999999999885 477888889999999999998887765432211111112
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
..............+++.+.+||.+||++||.+||||.|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 2222233445566789999999999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-52 Score=452.04 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=220.9
Q ss_pred ccchhhhhhhhccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeecc
Q 004999 129 ADSFEKLDKSLSIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEG 207 (720)
Q Consensus 129 ~~~ye~l~~~~~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~ 207 (720)
.+.|+.++. ||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||++++
T Consensus 40 ld~y~i~~~-----------lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 108 (350)
T d1rdqe_ 40 LDQFDRIKT-----------LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108 (350)
T ss_dssp GGGEEEEEE-----------EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccCeEEEEE-----------eecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccc
Confidence 456666666 9999999999999999999999999975432 2233567889999999999999999999
Q ss_pred ceeccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccc
Q 004999 208 LVTSRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFG 287 (720)
Q Consensus 208 ~~~~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFG 287 (720)
++.. ...+|+||||+.|+.+.........+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||
T Consensus 109 ~~~~--~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 109 SFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEC--SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccc--ccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeece
Confidence 9877 67899999999987766665555689999999999999999999999999999999999999999999999999
Q ss_pred cceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 288 LASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 288 la~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
+|+.+.. .....+||+.|+|||++.+.. |+.++||||||||||||+||.+||.+.+....+.+|.....
T Consensus 187 ~a~~~~~----~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~------ 255 (350)
T d1rdqe_ 187 FAKRVKG----RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV------ 255 (350)
T ss_dssp TCEECSS----CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC------
T ss_pred eeeeccc----ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC------
Confidence 9997643 234568999999999998866 79999999999999999999999999998888888865321
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCCC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTMK 430 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~~ 430 (720)
..+..+++++.+||.+||++||.+|+ |++++|+||||+..
T Consensus 256 -----------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 256 -----------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred -----------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 11246889999999999999999995 99999999999853
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-51 Score=431.99 Aligned_cols=255 Identities=28% Similarity=0.397 Sum_probs=217.2
Q ss_pred ceeecccCceEEEEEEECCCCeEEEEEEeecCCCC-------HHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeE
Q 004999 146 FYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE-------PESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSL 217 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~-------~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~l 217 (720)
.+.||+|+||+||+|++..+|+.||||+++..... ....+.+.+|+.+|++|+ |||||++++++.+ ...+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~--~~~~ 85 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET--NTFF 85 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc--Ccce
Confidence 34499999999999999999999999999876432 123346889999999997 9999999999987 7889
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|||||||+|+.+..+......+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 86 ~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-- 163 (277)
T d1phka_ 86 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-- 163 (277)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT--
T ss_pred EEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccCC--
Confidence 999999987555444444568999999999999999999999999999999999999999999999999999987543
Q ss_pred CCccccccccCCCChhhhcC-----CcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 298 QPLTSRVVTLWYRPPELLLG-----ATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~-----~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
...+..+||+.|+|||++.+ ...|+.++||||+|||||||++|++||.+.+..+.+..+......+.
T Consensus 164 ~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~-------- 235 (277)
T d1phka_ 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG-------- 235 (277)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC--------
T ss_pred CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 23455789999999999863 33478999999999999999999999999998888888765322211
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTM 429 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~ 429 (720)
......+|+++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 236 -----------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 236 -----------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp -----------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred -----------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 1123468999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=440.40 Aligned_cols=255 Identities=23% Similarity=0.346 Sum_probs=219.6
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
|.+.+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+|+.++|||||++++++.+ ...+|||||
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lvmE 81 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIFE 81 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEe
Confidence 344455999999999999999999999999998653 333457899999999999999999999987 678999999
Q ss_pred ecccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC--CceeeeccccceecCCCCCCC
Q 004999 223 YMEHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN--GILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 223 y~~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~--g~vKL~DFGla~~~~~~~~~~ 299 (720)
||+|+ |...+...+..+++.+++.|+.||+.||.|||++||+||||||+||||+.+ +.+||+|||++..... ...
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~--~~~ 159 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDN 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--TCE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--CCc
Confidence 99975 444444455579999999999999999999999999999999999999854 4899999999987643 233
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....++|+.|+|||++.+.. |+.++||||||||||+|++|.+||.+.+..+.+..|.+....++...
T Consensus 160 ~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------ 226 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------------ 226 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------------
T ss_pred ccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh------------
Confidence 45567899999999998776 79999999999999999999999999999999999887554444333
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
++.+++++.+||.+||.+||.+|||+.|+|+||||+..
T Consensus 227 -------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 227 -------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 34689999999999999999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.7e-51 Score=447.44 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=207.3
Q ss_pred cceeecccCceEEEEEEECCCCeEEEEEEeecCCC----CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL----EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~----~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.++||+|+||.||+|++..+|+.||||++..... ..........|+.+++.++|||||++++++.. ...+|||
T Consensus 8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~~~~iv 85 (364)
T d1omwa3 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFI 85 (364)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSEEEEE
T ss_pred eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CCEEEEE
Confidence 33449999999999999999999999999975432 11222223345667777789999999999877 6789999
Q ss_pred EeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCc
Q 004999 221 FEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~ 300 (720)
||||+|+.+..++.....+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|..+... ..
T Consensus 86 mE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~---~~ 162 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KP 162 (364)
T ss_dssp ECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS---CC
T ss_pred EEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC---cc
Confidence 999997766665555668999999999999999999999999999999999999999999999999999876433 23
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+||+.|+|||++.+...|+.++||||||||||||+||++||.+....+....+......+
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~----------------- 225 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA----------------- 225 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC-----------------
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC-----------------
Confidence 456899999999999876668999999999999999999999998765433322221111110
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCC-----HHHHHhCccCCCC
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGS-----AASALRSEFFTMK 430 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpT-----a~e~L~hp~f~~~ 430 (720)
...+..+++++.+||.+||++||.+||| |+++|+||||+..
T Consensus 226 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 226 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp ---------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred ---------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 1123468999999999999999999999 8999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=440.05 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=214.6
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHH-hcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILR-RLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~-~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
++||+|+||+||+|++..+++.||||+++.... .....+.+.+|+.++. .++|||||++++++.+ ...+|||||||
T Consensus 8 ~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~yivmEy~ 85 (320)
T d1xjda_ 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLFFVMEYL 85 (320)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred eEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCceeEEEeec
Confidence 349999999999999999999999999975422 1223455667777765 6899999999999987 67899999999
Q ss_pred cccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 225 EHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 225 ~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+|+.+..+......+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++...... ....+..+
T Consensus 86 ~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~ 164 (320)
T d1xjda_ 86 NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFC 164 (320)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TCCBCCCC
T ss_pred CCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc-cccccccC
Confidence 98777666666668999999999999999999999999999999999999999999999999999865432 33445568
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
||+.|+|||++.+.. |+.++||||||||+|||++|+.||.+.+..+.+.+|... .+
T Consensus 165 gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~--------------------- 220 (320)
T d1xjda_ 165 GTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP--------------------- 220 (320)
T ss_dssp SCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC---------------------
T ss_pred CCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC---------------------
Confidence 999999999998876 799999999999999999999999999988888877542 11
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHH-HHHhCccCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAA-SALRSEFFTMK 430 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~-e~L~hp~f~~~ 430 (720)
..+..+++++.+||.+||++||.+|||+. ++++||||+..
T Consensus 221 ------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 221 ------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 11246899999999999999999999995 89999999853
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-51 Score=442.65 Aligned_cols=288 Identities=30% Similarity=0.500 Sum_probs=227.1
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceecc----CCCeE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSR----MSCSL 217 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~----~~~~l 217 (720)
.|++++.||+|+||+||+|++..+|+.||||+++....+......+.+|+.+|++++|||||+++++|... ....+
T Consensus 18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 35666669999999999999999999999999988777777778899999999999999999999998643 24689
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
|+|||||.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 98 ~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~--~ 172 (355)
T d2b1pa1 98 YLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--S 172 (355)
T ss_dssp EEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc--c
Confidence 9999999999887664 3689999999999999999999999999999999999999999999999999886543 2
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
...+..++|+.|+|||++.+.. |++++||||+||++|||++|++||.+.+...++.++....+.+..++|.........
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp --------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred cccccccccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 3445668899999999998865 799999999999999999999999999999999999999999999887642211000
Q ss_pred -----ccCCCCccchhh--------hcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCC
Q 004999 378 -----IFKPQQPYKRCV--------AETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCD 435 (720)
Q Consensus 378 -----~~~~~~~~~~~~--------~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~ 435 (720)
............ ......+++++.+||.+||.+||++||||+|+|+||||+....+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~ 322 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAE 322 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHH
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccc
Confidence 000000000000 1111234678999999999999999999999999999997655443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=434.40 Aligned_cols=288 Identities=34% Similarity=0.519 Sum_probs=229.2
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC----CCeEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM----SCSLY 218 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~----~~~ly 218 (720)
|++++.||+|+||+||+|++..+|+.||||+++....+....+.+.+|+.+|++|+|||||++++++.... ...+|
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 44444599999999999999999999999999877767777788999999999999999999999875421 23345
Q ss_pred EEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC
Q 004999 219 LVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ 298 (720)
Q Consensus 219 LV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~ 298 (720)
+++++++|+|... ... ..+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .
T Consensus 100 i~~~~~gg~L~~~-~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~----~ 173 (348)
T d2gfsa1 100 LVTHLMGADLNNI-VKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----D 173 (348)
T ss_dssp EEEECCSEEHHHH-HTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT----G
T ss_pred EEEeecCCchhhh-ccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC----c
Confidence 5555444555444 433 369999999999999999999999999999999999999999999999999997543 2
Q ss_pred CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 299 PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 299 ~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......|.+..+.+..+.+..........
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 33456789999999999888778999999999999999999999999999999999999999998887654322111110
Q ss_pred cCC--CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCCCC
Q 004999 379 FKP--QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPCDP 436 (720)
Q Consensus 379 ~~~--~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~~p 436 (720)
+.. .......+...+..+++.+.+||.+||++||.+|||+.|+|+||||+....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~ 313 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC
Confidence 000 0001112334456789999999999999999999999999999999976655443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.2e-50 Score=421.93 Aligned_cols=262 Identities=23% Similarity=0.314 Sum_probs=213.3
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC--CeE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--CSL 217 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~--~~l 217 (720)
+.|++.++||+|+||.||+|++..+|+.||||+++.... +......+.+|+.+|+.++|||||++++++..... ..+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 345555669999999999999999999999999987655 45667789999999999999999999998876432 358
Q ss_pred EEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-
Q 004999 218 YLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ- 296 (720)
Q Consensus 218 yLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~- 296 (720)
|||||||+|+.+..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.++|+|||++.......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 9999999987777666666689999999999999999999999999999999999999999999999999987653222
Q ss_pred -CCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 297 -NQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 297 -~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.......+||+.|+|||++.+.. |+.++||||||||||||+||.+||.+.+..+.+.++......++
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 234 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP----------- 234 (277)
T ss_dssp ------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG-----------
T ss_pred cccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC-----------
Confidence 22345568999999999998765 79999999999999999999999999999888887765432221
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFT 428 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~ 428 (720)
.....++|+.+.+||.+||++||.+||+..+.|.|+|++
T Consensus 235 --------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 --------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 123357899999999999999999999666666677764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=426.76 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=207.9
Q ss_pred ccccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCH----HHHHHHHHHHHHHHhcC--CCceeeeccceeccC
Q 004999 140 SIFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEP----ESVRFMAREIHILRRLD--HINVIKLEGLVTSRM 213 (720)
Q Consensus 140 ~~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~----~~~~~~~~Ei~iL~~L~--HpnIvkl~~~~~~~~ 213 (720)
++.|++.++||+|+||.||+|++..+|+.||||+++...... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 445666677999999999999999999999999998653321 12234678999999996 8999999999977
Q ss_pred CCeEEEEEeeccc-cccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCC-Cceeeecccccee
Q 004999 214 SCSLYLVFEYMEH-DLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNN-GILKIADFGLASF 291 (720)
Q Consensus 214 ~~~lyLV~Ey~~g-~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~-g~vKL~DFGla~~ 291 (720)
...+|+||||+.+ +++..+......+++.+++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+|..
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 6789999999975 4444444445679999999999999999999999999999999999999854 7999999999987
Q ss_pred cCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhc
Q 004999 292 YDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKS 371 (720)
Q Consensus 292 ~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~ 371 (720)
... ...+..+||+.|+|||++.+...++.++||||||||||||++|++||.+.+ .+.+. .
T Consensus 161 ~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~--------- 220 (273)
T d1xwsa_ 161 LKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--Q--------- 220 (273)
T ss_dssp CCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--C---------
T ss_pred ccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc--c---------
Confidence 533 234567899999999999887766888999999999999999999997642 12221 0
Q ss_pred CCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 372 KLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 372 ~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
......+|+++.+||.+||++||++|||+.|+|+||||+..
T Consensus 221 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 221 ------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 01124689999999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=429.53 Aligned_cols=289 Identities=34% Similarity=0.523 Sum_probs=229.8
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccC---CCeEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRM---SCSLYL 219 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~---~~~lyL 219 (720)
|++++.||+|+||+||+|++..+|+.||||+++... .....+.+.+|+.+|+.|+||||+++++++.... ...+||
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 444555999999999999999999999999997644 3555677899999999999999999999886532 234677
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN-- 297 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~-- 297 (720)
+|++++|+|...+.. ..+++.+++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++........
T Consensus 89 ~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~ 166 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 166 (345)
T ss_dssp EEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBC
T ss_pred EEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccc
Confidence 777776777665543 3699999999999999999999999999999999999999999999999999987643222
Q ss_pred CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcc
Q 004999 298 QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHAT 377 (720)
Q Consensus 298 ~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~ 377 (720)
......+||+.|+|||++.....|+.++||||+|||+|||++|++||.+.+..++...+...++.+..............
T Consensus 167 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T d1pmea_ 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246 (345)
T ss_dssp CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHH
T ss_pred eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhh
Confidence 23445678999999999977777899999999999999999999999999999999999998888877664332211111
Q ss_pred c--cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCCCCCC
Q 004999 378 I--FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMKPLPC 434 (720)
Q Consensus 378 ~--~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~~~~~ 434 (720)
. ..........+...+..+++.+.+||.+||++||.+|||+.|+|+||||+....+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 0 00111111123455678899999999999999999999999999999999765443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-49 Score=423.63 Aligned_cols=278 Identities=29% Similarity=0.488 Sum_probs=222.5
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEE
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
|++++.||+|+||+||+|++..+|+.||||+++... .+.+.+|+.+|+.+. ||||+++++++.......+|+||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 334444999999999999999999999999997542 356789999999995 99999999998765567899999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC-ceeeeccccceecCCCCCCCc
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG-ILKIADFGLASFYDPDQNQPL 300 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g-~vKL~DFGla~~~~~~~~~~~ 300 (720)
|||.++.+..+. ..+++.+++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|...... ...
T Consensus 112 e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~--~~~ 186 (328)
T d3bqca1 112 EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEY 186 (328)
T ss_dssp ECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT--CCC
T ss_pred eecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC--Ccc
Confidence 999987665543 3699999999999999999999999999999999999998765 6999999999876543 234
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhh-cCCCCccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRK-SKLPHATI 378 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g-~~~~e~l~~i~~~~g~p~~~~w~~-~~l~~~~~ 378 (720)
...++|+.|+|||++.+...|+.++|||||||++|||++|..||.. .+..++...+.+.+|.+....|.. ........
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 5668899999999999887789999999999999999999988764 556778888888888665544332 22211111
Q ss_pred cC------CCCccch-hhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 379 FK------PQQPYKR-CVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 379 ~~------~~~~~~~-~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
+. ....+.. ........+++++.+||.+||++||.+|||++|+|+||||++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 10 1111111 1112334578999999999999999999999999999999864
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=418.49 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=202.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|+.. ..||||+++....+....+.|.+|+.+|++++|||||++++++.. ..+|||||||+++
T Consensus 15 ~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 15 RIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLAIVTQWCEGS 88 (276)
T ss_dssp EEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCEEEEECCCEE
T ss_pred EEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEEEEEecCCCC
Confidence 3999999999999853 359999998776667778889999999999999999999998753 4689999999975
Q ss_pred cc-ccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCC-CCCcccccc
Q 004999 228 LA-GLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQ-NQPLTSRVV 305 (720)
Q Consensus 228 ll-~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~-~~~~t~~~g 305 (720)
.+ ..+......+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|....... ........|
T Consensus 89 ~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~g 168 (276)
T d1uwha_ 89 SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168 (276)
T ss_dssp EHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCC
T ss_pred CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccccccc
Confidence 55 4444555679999999999999999999999999999999999999999999999999998764322 233455678
Q ss_pred ccCCCChhhhcCC--cCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 306 TLWYRPPELLLGA--TYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 306 T~~Y~APE~l~~~--~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
|+.|+|||++.+. ..|+.++||||||||||||+||+.||.+.+....+..+......++
T Consensus 169 t~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p------------------- 229 (276)
T d1uwha_ 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP------------------- 229 (276)
T ss_dssp CGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC-------------------
T ss_pred CcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC-------------------
Confidence 9999999999753 3479999999999999999999999999887777666554322111
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.+.....++|+.+.+||.+||+.||.+|||+.+++++
T Consensus 230 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 ----DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ----CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0123345789999999999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=432.81 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=200.8
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceecc--CCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSR--MSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~--~~~~lyLV~Ey~ 224 (720)
+||+|+||.||+|++..+++.||||+++.. ..+.+|+.++.++ +|||||+++++|.+. ....+|||||||
T Consensus 19 ~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 699999999999999999999999999742 3467899987655 899999999988652 246799999999
Q ss_pred ccc-ccccccCC-CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeeccccceecCCCCCCC
Q 004999 225 EHD-LAGLASHP-GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 225 ~g~-ll~~~~~~-~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~~~~~~~~~ 299 (720)
+|+ |...+... ...|++.+++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+|...... ..
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~--~~ 169 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NS 169 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC--CC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC--Cc
Confidence 865 44444443 346999999999999999999999999999999999999985 567999999999876543 23
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....+||+.|+|||++.+.. |+.++||||||||||+|+||++||.+.+..+....+........ +
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~--------------~ 234 (335)
T d2ozaa1 170 LTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--------------Y 234 (335)
T ss_dssp CCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS--------------S
T ss_pred cccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC--------------C
Confidence 45668999999999988766 89999999999999999999999998776555544433211100 0
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhCccCCCC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRSEFFTMK 430 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~hp~f~~~ 430 (720)
.. + ......+++++.+||.+||++||.+|||+.|+|+||||...
T Consensus 235 ~~--~-----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 235 EF--P-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SC--C-----TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CC--C-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 00 0 11123578999999999999999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=416.65 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=205.0
Q ss_pred eecccCceEEEEEEEC--CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDL--DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~--~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|.+. .+++.||||+++....+....+.+.+|+.+|++|+|||||++++++.. ..+|||||||+
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~~ 90 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMAE 90 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECCT
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcCC
Confidence 4999999999999864 456889999998765566667789999999999999999999999854 35799999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC--Ccccc
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLTSR 303 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~--~~t~~ 303 (720)
++.+..+......+++.++..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...... .....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 8777666666678999999999999999999999999999999999999999999999999999876543322 22334
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.||+.|+|||++.+.. |+.++||||||||+|||+| |.+||.+.+..+....+.+.. .
T Consensus 171 ~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~-~-------------------- 228 (277)
T d1xbba_ 171 KWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE-R-------------------- 228 (277)
T ss_dssp CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-C--------------------
T ss_pred CCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC-C--------------------
Confidence 6899999999998776 7999999999999999998 899999988877666654311 0
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHH---HhCccCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA---LRSEFFT 428 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~---L~hp~f~ 428 (720)
...+..+|+++.+||.+||+.||++|||++++ |+|+|+.
T Consensus 229 -------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 -------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 11224688999999999999999999999998 5666653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-49 Score=416.50 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=196.2
Q ss_pred cceeecccCceEEEEEEECCCCe---EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQKK---IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg~---~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
..++||+|+||.||+|++..+++ .||||++.... .....+.|.+|+.+|++|+|||||++++++.. ...+||||
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~iv~ 106 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIIT 106 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCEEEEEE
Confidence 34579999999999999987664 58899886543 45566789999999999999999999999876 56799999
Q ss_pred eecccccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-
Q 004999 222 EYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP- 299 (720)
Q Consensus 222 Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~- 299 (720)
|||+++.+.. +......+++.+++.|+.||+.||.|||++||+||||||+||||+.++++||+|||+++.+.......
T Consensus 107 Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~ 186 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186 (299)
T ss_dssp ECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred EecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcce
Confidence 9999876654 44445679999999999999999999999999999999999999999999999999998764332211
Q ss_pred ---ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCC
Q 004999 300 ---LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPH 375 (720)
Q Consensus 300 ---~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~ 375 (720)
.....+|+.|+|||++.+.. |+.++||||||||||||+| |.+||.+.+..+.+..+.+....
T Consensus 187 ~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------- 252 (299)
T d1jpaa_ 187 YTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL------------- 252 (299)
T ss_dssp ---------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-------------
T ss_pred eeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------------
Confidence 12245789999999998766 7999999999999999998 89999999888877776542111
Q ss_pred ccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 376 ATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 376 ~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
....++++.+.+||.+||+.||.+|||+.+++++
T Consensus 253 ---------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 ---------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ---------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1124688999999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-49 Score=417.52 Aligned_cols=242 Identities=22% Similarity=0.342 Sum_probs=200.7
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++..+++.||||+++..... .+.+.+|+.+|++|+|||||++++++.+ ...+|||||||+++
T Consensus 24 ~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv~E~~~~g 98 (287)
T d1opja_ 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYG 98 (287)
T ss_dssp ETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEee--CCeeEEEeecccCc
Confidence 499999999999999999999999999765433 4568899999999999999999999876 67799999999975
Q ss_pred cccccc--CCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 228 LAGLAS--HPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 ll~~~~--~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+..+. .....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+..........+...|
T Consensus 99 ~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g 178 (287)
T d1opja_ 99 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178 (287)
T ss_dssp BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEE
T ss_pred chHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccc
Confidence 544333 345679999999999999999999999999999999999999999999999999998765544444444568
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
|+.|+|||++.+.. |+.++||||||||+|||++|. ++|.+.+..+.. +++.....
T Consensus 179 ~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~-~~i~~~~~---------------------- 234 (287)
T d1opja_ 179 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYR---------------------- 234 (287)
T ss_dssp CGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-HHHHTTCC----------------------
T ss_pred cccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH-HHHhcCCC----------------------
Confidence 99999999998776 799999999999999999966 455555544433 33321111
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 235 -----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 235 -----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1123468899999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=412.17 Aligned_cols=246 Identities=23% Similarity=0.376 Sum_probs=205.5
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
+.||+|+||.||+|++. ++..||||+++..... .+.+.+|+.+|++++|||||++++++.. ..+|||||||++
T Consensus 19 ~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 19 ERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYIITEYMEN 91 (272)
T ss_dssp EEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECCTT
T ss_pred EEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEEEEeCCC
Confidence 34999999999999975 5788999999865543 3468999999999999999999998754 457999999997
Q ss_pred cccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccc
Q 004999 227 DLAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRV 304 (720)
Q Consensus 227 ~ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~ 304 (720)
+.+..+.. ....+++.+++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+........+...
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccccccC
Confidence 76654333 2235899999999999999999999999999999999999999999999999999987654444445567
Q ss_pred cccCCCChhhhcCCcCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCC
Q 004999 305 VTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQ 383 (720)
Q Consensus 305 gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG-~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~ 383 (720)
+|+.|+|||++.+.. |+.++||||||||||||+|| .++|.+.+..+.+..+.....
T Consensus 172 gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~---------------------- 228 (272)
T d1qpca_ 172 FPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR---------------------- 228 (272)
T ss_dssp CCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------------------
T ss_pred CcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------------------
Confidence 899999999998766 79999999999999999995 577777777776666543210
Q ss_pred ccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh--CccCC
Q 004999 384 PYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFT 428 (720)
Q Consensus 384 ~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~--hp~f~ 428 (720)
...+..+++++.+||.+||+.||++|||+.++++ ++||+
T Consensus 229 ------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 229 ------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0112468899999999999999999999999998 88886
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=407.73 Aligned_cols=242 Identities=24% Similarity=0.355 Sum_probs=193.5
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++. ++..||||+++...... +.+.+|+.++++++|||||++++++.. ...+|||||||+++
T Consensus 12 ~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 12 EIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHG 85 (263)
T ss_dssp EEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEEECCTTC
T ss_pred EEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceecc--CCceEEEEEecCCC
Confidence 3999999999999986 56789999998655433 458899999999999999999999976 56799999999976
Q ss_pred cccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccccccc
Q 004999 228 LAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVT 306 (720)
Q Consensus 228 ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT 306 (720)
.+.. +......+++..++.|+.||+.||.|||+++|+||||||+||||+.++.+||+|||+++..............||
T Consensus 86 ~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt 165 (263)
T d1sm2a_ 86 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165 (263)
T ss_dssp BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------------C
T ss_pred cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecceecC
Confidence 5544 445556789999999999999999999999999999999999999999999999999987755444444456789
Q ss_pred cCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCcc
Q 004999 307 LWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPY 385 (720)
Q Consensus 307 ~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~ 385 (720)
+.|+|||++.+.. |+.++|||||||+||||+| |.++|.+.+..+.+..+......
T Consensus 166 ~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~----------------------- 221 (263)
T d1sm2a_ 166 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL----------------------- 221 (263)
T ss_dssp TTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-----------------------
T ss_pred cccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-----------------------
Confidence 9999999998776 8999999999999999999 57888888777777766542110
Q ss_pred chhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 386 KRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 386 ~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
..+..+++.+.+||..||+.||++|||++++|+|
T Consensus 222 -----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 -----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123568899999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=410.59 Aligned_cols=247 Identities=22% Similarity=0.287 Sum_probs=207.2
Q ss_pred ecccCceEEEEEEECC--CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccc
Q 004999 149 IGQGTYSNVYRARDLD--QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEH 226 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~--tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g 226 (720)
||+|+||.||+|.+.. ++..||||+++... .....+.|.+|+.+|++|+|||||++++++.. ..+|||||||++
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~~lvmE~~~~ 92 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EALMLVMEMAGG 92 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEECCTT
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeEEEEEEeCCC
Confidence 9999999999998754 45679999997543 45667789999999999999999999998864 458999999997
Q ss_pred cccccc-cCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCC--CCcccc
Q 004999 227 DLAGLA-SHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN--QPLTSR 303 (720)
Q Consensus 227 ~ll~~~-~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~--~~~t~~ 303 (720)
+.+..+ ......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..... ......
T Consensus 93 g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~ 172 (285)
T d1u59a_ 93 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172 (285)
T ss_dssp EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSS
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccccccccccc
Confidence 655544 45556799999999999999999999999999999999999999999999999999987754332 222345
Q ss_pred ccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCC
Q 004999 304 VVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQ 382 (720)
Q Consensus 304 ~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~ 382 (720)
.||+.|+|||++.+.. |+.++|||||||+||||+| |.+||.+.+..+.+..+.+..
T Consensus 173 ~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~---------------------- 229 (285)
T d1u59a_ 173 KWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------------------- 229 (285)
T ss_dssp CCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----------------------
T ss_pred ccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------------
Confidence 6899999999998766 7999999999999999998 899999988877776664311
Q ss_pred CccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHH---HhCccCC
Q 004999 383 QPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASA---LRSEFFT 428 (720)
Q Consensus 383 ~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~---L~hp~f~ 428 (720)
..+.+..+|+++.+||.+||+.||++|||+.++ |+|.|+.
T Consensus 230 ------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 ------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 012235689999999999999999999999888 6788874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=402.67 Aligned_cols=241 Identities=20% Similarity=0.339 Sum_probs=208.1
Q ss_pred ecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 149 IGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
||+|+||.||+|+++ +++.||||+++...... +.+.+|+.++++++|||||++++++.+ .+.+|+||||++++.
T Consensus 12 iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 12 LGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGC 85 (258)
T ss_dssp CCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEEEECCTTEE
T ss_pred EecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEEEEccCCCc
Confidence 999999999999984 78889999998765543 457899999999999999999999876 577999999998654
Q ss_pred -cccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccccc
Q 004999 229 -AGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVVTL 307 (720)
Q Consensus 229 -l~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~gT~ 307 (720)
...+......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...............+|+
T Consensus 86 l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~ 165 (258)
T d1k2pa_ 86 LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165 (258)
T ss_dssp HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCG
T ss_pred HHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCC
Confidence 4444555667999999999999999999999999999999999999999999999999999877555544555667899
Q ss_pred CCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCccc
Q 004999 308 WYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQPYK 386 (720)
Q Consensus 308 ~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~ 386 (720)
.|+|||++.+.. |+.++|||||||++|||+| |+.||.+.+..+...++.+....
T Consensus 166 ~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~------------------------ 220 (258)
T d1k2pa_ 166 RWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL------------------------ 220 (258)
T ss_dssp GGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC------------------------
T ss_pred CcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC------------------------
Confidence 999999998776 7999999999999999998 89999999988877777542111
Q ss_pred hhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 387 RCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 387 ~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
..+..+++.+.+||.+||+.||++|||+.++|+|
T Consensus 221 ----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 ----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1123578899999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=415.87 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=199.7
Q ss_pred eeecccCceEEEEEEECCCCe-----EEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEE
Q 004999 147 YLIGQGTYSNVYRARDLDQKK-----IVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~-----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
++||+|+||.||+|++..+++ .||+|++.... .......+.+|+.+|.++ +|||||++++++.+ ...+|||
T Consensus 43 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv 119 (325)
T d1rjba_ 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTL--SGPIYLI 119 (325)
T ss_dssp EEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred eEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--CCeEEEE
Confidence 349999999999999865543 69999987543 233456788999999998 89999999999977 6779999
Q ss_pred Eeecccccccccc-CC----------------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC
Q 004999 221 FEYMEHDLAGLAS-HP----------------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN 277 (720)
Q Consensus 221 ~Ey~~g~ll~~~~-~~----------------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~ 277 (720)
||||+++.+..++ .. ...+++.+++.|+.||+.||.|||++|||||||||+|||++.
T Consensus 120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~ 199 (325)
T d1rjba_ 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET
T ss_pred EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccccc
Confidence 9999975544433 22 135899999999999999999999999999999999999999
Q ss_pred CCceeeeccccceecCCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHH
Q 004999 278 NGILKIADFGLASFYDPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHK 355 (720)
Q Consensus 278 ~g~vKL~DFGla~~~~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~ 355 (720)
++.+||+|||+|+........ ......||+.|+|||++.+.. |+.++||||||||||||+| |.+||.+.+..+.+.+
T Consensus 200 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~ 278 (325)
T d1rjba_ 200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK 278 (325)
T ss_dssp TTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876433322 233456899999999998766 7999999999999999997 8999999877677666
Q ss_pred HHHhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 356 IFKLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 356 i~~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
+.+....+ ..+..+++.+.+||.+||+.||++|||++|+++|
T Consensus 279 ~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 279 LIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 65432111 1224678999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=403.42 Aligned_cols=247 Identities=23% Similarity=0.368 Sum_probs=199.1
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++..+ ..||||+++...... +.|.+|+.+|++++|||||++++++.+ ..+|+|||||+++
T Consensus 24 ~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv~Ey~~~g 96 (285)
T d1fmka3 24 KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIVTEYMSKG 96 (285)
T ss_dssp EEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEECCCTTC
T ss_pred EEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEEEEecCCC
Confidence 399999999999998765 569999998665443 468899999999999999999998854 4579999999987
Q ss_pred ccccccC--CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 228 LAGLASH--PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 ll~~~~~--~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+..+.. ....+++.+++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++.+........+...+
T Consensus 97 ~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 176 (285)
T d1fmka3 97 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176 (285)
T ss_dssp BHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------------C
T ss_pred chhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccc
Confidence 5554433 23469999999999999999999999999999999999999999999999999998775554445556678
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG-~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
|+.|+|||++.+.. ++.++||||||||||||+|| .++|.+....+.+..+.+....
T Consensus 177 t~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---------------------- 233 (285)
T d1fmka3 177 PIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------------------- 233 (285)
T ss_dssp CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------------------
T ss_pred cccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------------------
Confidence 99999999998766 79999999999999999995 5777777777777766542211
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh--CccCCCC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR--SEFFTMK 430 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~--hp~f~~~ 430 (720)
.....+++++.+||.+||+.||++|||+.+++. ++||+..
T Consensus 234 ------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 ------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 123467899999999999999999999999988 8899753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=401.04 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=193.8
Q ss_pred eeecccCceEEEEEEECCC---CeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQ---KKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~t---g~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
++||+|+||.||+|++..+ +..||||+++... .....+.+.+|+.+|++++|||||++++++.+ +.+||||||
T Consensus 13 ~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~~~iv~E~ 88 (273)
T d1mp8a_ 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NPVWIIMEL 88 (273)
T ss_dssp EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SSCEEEEEC
T ss_pred EEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CeEEEEEEe
Confidence 3499999999999998654 3568899886433 45556778999999999999999999998853 568999999
Q ss_pred ccccccc-cccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCccc
Q 004999 224 MEHDLAG-LASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTS 302 (720)
Q Consensus 224 ~~g~ll~-~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~ 302 (720)
|.++.+. .+......+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+........+.
T Consensus 89 ~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~ 168 (273)
T d1mp8a_ 89 CTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168 (273)
T ss_dssp CTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------------
T ss_pred ccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcceeccc
Confidence 9976554 344455679999999999999999999999999999999999999999999999999998765444444455
Q ss_pred cccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCC
Q 004999 303 RVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKP 381 (720)
Q Consensus 303 ~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~ 381 (720)
..+|+.|+|||++.+.. |+.++||||||||||||+| |.+||.+.+..+.+..+.....
T Consensus 169 ~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~-------------------- 227 (273)
T d1mp8a_ 169 GKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER-------------------- 227 (273)
T ss_dssp --CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC--------------------
T ss_pred eecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------------------
Confidence 67899999999998766 7999999999999999998 8999999888887777653210
Q ss_pred CCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 382 QQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 382 ~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
...++.+|+.+.+||.+||+.||.+|||+.+++++
T Consensus 228 --------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 228 --------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11235689999999999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=395.52 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=194.4
Q ss_pred cceeecccCceEEEEEEECCCC----eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEE
Q 004999 145 SFYLIGQGTYSNVYRARDLDQK----KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 145 ~~~~LG~G~~g~Vy~a~~~~tg----~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
..++||+|+||.||+|.+..++ ..||||+++... .......|.+|+.+|++|+|||||++++++.. ...+|+|
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~--~~~~~~v 87 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--YKPMMII 87 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEE
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec--CCceEEE
Confidence 3456999999999999987654 469999997543 34555678999999999999999999999876 6679999
Q ss_pred Eeecccccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC-
Q 004999 221 FEYMEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ- 298 (720)
Q Consensus 221 ~Ey~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~- 298 (720)
||||.++++.. +......+++.++..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+++.+......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 167 (283)
T d1mqba_ 88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167 (283)
T ss_dssp EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----------
T ss_pred EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCccc
Confidence 99999876554 3345567999999999999999999999999999999999999999999999999999876433222
Q ss_pred -CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCc
Q 004999 299 -PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHA 376 (720)
Q Consensus 299 -~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG-~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~ 376 (720)
......||+.|+|||++.+.. |+.++||||||||||||++| .++|.+....+.+..+.... .
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~-------------- 231 (283)
T d1mqba_ 168 YTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-R-------------- 231 (283)
T ss_dssp ------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-C--------------
T ss_pred eEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-C--------------
Confidence 223346799999999998776 79999999999999999995 56666666666555543311 0
Q ss_pred cccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 377 TIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 377 ~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+++..+.+||..||+.||++|||+.++++
T Consensus 232 -------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 -------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1122457889999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=416.15 Aligned_cols=257 Identities=25% Similarity=0.389 Sum_probs=211.4
Q ss_pred ceeecccCceEEEEEEE---CCCCeEEEEEEeecCCC--CHHHHHHHHHHHHHHHhcCC-CceeeeccceeccCCCeEEE
Q 004999 146 FYLIGQGTYSNVYRARD---LDQKKIVALKKVRFDNL--EPESVRFMAREIHILRRLDH-INVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 146 ~~~LG~G~~g~Vy~a~~---~~tg~~VAIK~l~~~~~--~~~~~~~~~~Ei~iL~~L~H-pnIvkl~~~~~~~~~~~lyL 219 (720)
.+.||+|+||.||+|++ ..+|+.||||+++.... +....+.+.+|+.+|++++| |||+++++++.+ ...+|+
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~~~~~~ 106 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--ETKLHL 106 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--TTEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--CCceee
Confidence 33499999999999987 45789999999875432 22234567899999999976 899999999877 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP 299 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~ 299 (720)
||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.......
T Consensus 107 v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~ 186 (322)
T d1vzoa_ 107 ILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 186 (322)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG
T ss_pred eeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccccc
Confidence 99999987666666666678999999999999999999999999999999999999999999999999998775544444
Q ss_pred ccccccccCCCChhhhcCCc-CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGAT-YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~-~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....||+.|+|||.+.+.. .|+.++||||||||||||++|..||.+....+....+.+....+
T Consensus 187 ~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--------------- 251 (322)
T d1vzoa_ 187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--------------- 251 (322)
T ss_dssp GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---------------
T ss_pred ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC---------------
Confidence 55678999999999998654 46889999999999999999999998876655555554421110
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCC-----CHHHHHhCccCCC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRG-----SAASALRSEFFTM 429 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRp-----Ta~e~L~hp~f~~ 429 (720)
....+..+++.+.+||.+||++||.+|| |++|+|+||||+.
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred ----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 0112346899999999999999999999 5899999999975
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=404.43 Aligned_cols=245 Identities=20% Similarity=0.289 Sum_probs=196.9
Q ss_pred eeecccCceEEEEEEECCCCe----EEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 147 YLIGQGTYSNVYRARDLDQKK----IVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~----~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
++||+|+||.||+|.+..+|+ .||+|+++... .....+.+.+|+.+|++|+|||||++++++.+ ...++|||
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~~~~v~e 90 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT---STVQLITQ 90 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEE
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCeeEEEE
Confidence 349999999999999988876 57888876432 23445678999999999999999999999875 34677778
Q ss_pred ecc-ccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCC-c
Q 004999 223 YME-HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQP-L 300 (720)
Q Consensus 223 y~~-g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~-~ 300 (720)
|+. |+++..+......+++.+++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|..+....... .
T Consensus 91 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 170 (317)
T d1xkka_ 91 LMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170 (317)
T ss_dssp CCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC----
T ss_pred eccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccccccc
Confidence 776 45666666667789999999999999999999999999999999999999999999999999998765433322 2
Q ss_pred cccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCcccc
Q 004999 301 TSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIF 379 (720)
Q Consensus 301 t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~ 379 (720)
....||+.|+|||++.+.. |+.++|||||||+||||+| |.+||.+.+..+....+.+.. .+
T Consensus 171 ~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~---------------- 232 (317)
T d1xkka_ 171 EGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL---------------- 232 (317)
T ss_dssp ----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CC----------------
T ss_pred cccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CC----------------
Confidence 3446899999999998876 8999999999999999998 789999887766655554321 10
Q ss_pred CCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 380 KPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 380 ~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.....+++.+.+||.+||+.||.+|||+.++++|
T Consensus 233 -----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 -----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 1224678999999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=395.63 Aligned_cols=248 Identities=22% Similarity=0.334 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEECC-----CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEE
Q 004999 147 YLIGQGTYSNVYRARDLD-----QKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~-----tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
+.||+|+||.||+|++.. +++.||||+++... .....+.+.+|+.++.++ +|+|||.+++++... ...+|+|
T Consensus 19 ~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~~iv 96 (299)
T d1ywna1 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP-GGPLMVI 96 (299)
T ss_dssp EEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TSCCEEE
T ss_pred eEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-CCeEEEE
Confidence 349999999999999754 45789999987543 344556778888888877 689999999887653 4578999
Q ss_pred EeeccccccccccC----------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 221 FEYMEHDLAGLASH----------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~----------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
||||+++.+..++. ....+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||+
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~ 176 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 176 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEEC
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEc
Confidence 99999765544332 12358999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCC
Q 004999 285 DFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGS 362 (720)
Q Consensus 285 DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG-~ppf~g~~~~e~l~~i~~~~g~ 362 (720)
|||+|+....... ...+..+||+.|+|||++.+.. |+.++||||||||+|||+|| .+||.+....+.+..++.....
T Consensus 177 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~ 255 (299)
T d1ywna1 177 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 255 (299)
T ss_dssp C------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred cCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC
Confidence 9999986643332 2334567899999999998866 79999999999999999986 5788887665555554432111
Q ss_pred CChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 363 p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
+ ..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 256 ~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 256 M---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1 1224578999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=393.56 Aligned_cols=244 Identities=27% Similarity=0.367 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEEC-CCC--eEEEEEEeecCCC-CHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeec
Q 004999 149 IGQGTYSNVYRARDL-DQK--KIVALKKVRFDNL-EPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~-~tg--~~VAIK~l~~~~~-~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
||+|+||.||+|+.. .++ ..||||++..... ..+..+.|.+|+.+|++|+|||||++++++.+ ..+|+|||||
T Consensus 16 iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~~~~lv~e~~ 92 (273)
T d1u46a_ 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---PPMKMVTELA 92 (273)
T ss_dssp CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEEEECC
T ss_pred EecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---cchheeeeee
Confidence 999999999999864 333 4689999987654 34556789999999999999999999999864 3579999999
Q ss_pred ccc-ccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC--Ccc
Q 004999 225 EHD-LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ--PLT 301 (720)
Q Consensus 225 ~g~-ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~--~~t 301 (720)
+++ +...+......+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...... ...
T Consensus 93 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~ 172 (273)
T d1u46a_ 93 PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 172 (273)
T ss_dssp TTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC--
T ss_pred cCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecC
Confidence 864 44444445557999999999999999999999999999999999999999999999999999977443322 222
Q ss_pred ccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccC
Q 004999 302 SRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFK 380 (720)
Q Consensus 302 ~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~ 380 (720)
...+|..|+|||++.+.. |+.++||||||||+|||+| |.+||.+.+..+.+..+.+....+
T Consensus 173 ~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~----------------- 234 (273)
T d1u46a_ 173 HRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL----------------- 234 (273)
T ss_dssp ---CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-----------------
T ss_pred ccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-----------------
Confidence 345788999999998866 7999999999999999998 899999999998888876532111
Q ss_pred CCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 381 PQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 381 ~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.....+|+.+.+||.+||+.||.+|||+.++++
T Consensus 235 ----------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 235 ----------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 123468899999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-46 Score=394.01 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=201.3
Q ss_pred ecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 149 IGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
||+|+||.||+|++. .+++.||||+++... ..+..+.+.+|+.+|++++||||+++++++.. ...+++||||
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~~v~e~ 97 (301)
T d1lufa_ 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAV--GKPMCLLFEY 97 (301)
T ss_dssp EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEEEEEC
T ss_pred EeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeecc--CCceEEEEEe
Confidence 999999999999875 356889999987543 45566789999999999999999999999876 6779999999
Q ss_pred ccccccccccC------------------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCC
Q 004999 224 MEHDLAGLASH------------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNG 279 (720)
Q Consensus 224 ~~g~ll~~~~~------------------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g 279 (720)
+.++.+..++. ....+++.++..|+.||+.||+|||+++||||||||+||||+.++
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~ 177 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 177 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCC
Confidence 98654433221 123489999999999999999999999999999999999999999
Q ss_pred ceeeeccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHH
Q 004999 280 ILKIADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIF 357 (720)
Q Consensus 280 ~vKL~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~ 357 (720)
.+||+|||+++.+..... ...+...+|+.|+|||++.+.. |+.++||||||||||||++|. +||.+.+..+.+..+.
T Consensus 178 ~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~ 256 (301)
T d1lufa_ 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVR 256 (301)
T ss_dssp CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHH
Confidence 999999999986643322 2334567899999999998766 899999999999999999985 7899998888877765
Q ss_pred HhcCCCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 358 KLCGSPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 358 ~~~g~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
+.. ......++++++.+||..||+.||.+|||+.|+++
T Consensus 257 ~~~----------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 257 DGN----------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCC----------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 421 11223468899999999999999999999999965
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=384.13 Aligned_cols=237 Identities=21% Similarity=0.342 Sum_probs=189.9
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEeecccc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEYMEHD 227 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~ 227 (720)
.||+|+||.||+|++ +|..||||+++... ..+.+.+|+.+|++++|||||++++++.+. .+.+||||||++++
T Consensus 14 ~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~ey~~~g 86 (262)
T d1byga_ 14 TIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEEECCCTTE
T ss_pred EEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcEEEEEeccCCC
Confidence 399999999999998 47789999997543 345688999999999999999999988653 35689999999876
Q ss_pred ccccccCC--CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCCCcccccc
Q 004999 228 LAGLASHP--GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQPLTSRVV 305 (720)
Q Consensus 228 ll~~~~~~--~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~~~t~~~g 305 (720)
.+..++.. ...+++..++.++.||+.||.|||+.+|+||||||+|||++.+|.+||+|||+++..... .....+
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~~ 162 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKL 162 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------------C
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC----Cccccc
Confidence 55544432 234899999999999999999999999999999999999999999999999999865332 233467
Q ss_pred ccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCCCChhhhhhcCCCCccccCCCCc
Q 004999 306 TLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSKLPHATIFKPQQP 384 (720)
Q Consensus 306 T~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~~~~~~~ 384 (720)
|+.|+|||++.+.. |+.++||||||||+|||+| |++||.+.+..+.+..+.+..
T Consensus 163 ~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~------------------------ 217 (262)
T d1byga_ 163 PVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------------------ 217 (262)
T ss_dssp CTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC------------------------
T ss_pred cccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------------------------
Confidence 89999999998766 7999999999999999998 789998887766666653210
Q ss_pred cchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 385 YKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 385 ~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
..+.+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus 218 ----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 218 ----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 112334678999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=384.44 Aligned_cols=243 Identities=22% Similarity=0.363 Sum_probs=195.9
Q ss_pred ecccCceEEEEEEECCCC-------eEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEE
Q 004999 149 IGQGTYSNVYRARDLDQK-------KIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLV 220 (720)
Q Consensus 149 LG~G~~g~Vy~a~~~~tg-------~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV 220 (720)
||+|+||.||+|++..++ ..||||+++... .......+.+|+.++.++ +|||||++++++.+ ...+|+|
T Consensus 21 iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~--~~~~~~v 97 (299)
T d1fgka_ 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVI 97 (299)
T ss_dssp CC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEE
T ss_pred EeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc--CCeEEEE
Confidence 999999999999976554 479999997654 445567788999999888 79999999999987 6779999
Q ss_pred EeeccccccccccCC----------------CCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeee
Q 004999 221 FEYMEHDLAGLASHP----------------GLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIA 284 (720)
Q Consensus 221 ~Ey~~g~ll~~~~~~----------------~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~ 284 (720)
||||+++.+..++.. ...+++.+++.++.||+.||.|||+++||||||||+|||++.++.+||+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~ 177 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEec
Confidence 999997655544321 2458999999999999999999999999999999999999999999999
Q ss_pred ccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcCC
Q 004999 285 DFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCGS 362 (720)
Q Consensus 285 DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g~ 362 (720)
|||++........ .......+|+.|+|||++.+.. |+.++||||||||||||++ |.+||.+.+..+.+..+... ..
T Consensus 178 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~ 255 (299)
T d1fgka_ 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HR 255 (299)
T ss_dssp STTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CC
T ss_pred cchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 9999987643332 2334557899999999998765 8999999999999999998 78999888776655544321 11
Q ss_pred CChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 363 PSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 363 p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
+ .....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 256 ~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 256 M---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp C---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 1 122468899999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=389.27 Aligned_cols=243 Identities=27% Similarity=0.314 Sum_probs=197.2
Q ss_pred eecccCceEEEEEEECCCCeE--EEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEEeec
Q 004999 148 LIGQGTYSNVYRARDLDQKKI--VALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVFEYM 224 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~--VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~Ey~ 224 (720)
+||+|+||.||+|++..++.. ||||+++... ..+..+.+.+|+.+|.++ +|||||++++++.. ...+||||||+
T Consensus 17 ~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~iV~ey~ 93 (309)
T d1fvra_ 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 93 (309)
T ss_dssp EEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEEEEEECCC
T ss_pred EEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCeeEEEEEec
Confidence 499999999999999888875 6777765432 234456789999999999 79999999999987 67899999999
Q ss_pred cccccccccC----------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeecccc
Q 004999 225 EHDLAGLASH----------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGL 288 (720)
Q Consensus 225 ~g~ll~~~~~----------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGl 288 (720)
+++.+..++. ....+++.++..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~ 173 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 173 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccc
Confidence 9765544432 235799999999999999999999999999999999999999999999999999
Q ss_pred ceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCC-CCCCCCChHHHHHHHHHhcCCCChhh
Q 004999 289 ASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGK-PIMPGRTEVEQLHKIFKLCGSPSEDY 367 (720)
Q Consensus 289 a~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~-ppf~g~~~~e~l~~i~~~~g~p~~~~ 367 (720)
+....... ......+|..|+|||.+.+.. |+.++||||||||+|||++|. +||.+.+..+.+..+.+..
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~------- 243 (309)
T d1fvra_ 174 SRGQEVYV--KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------- 243 (309)
T ss_dssp EESSCEEC--CC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC-------
T ss_pred cccccccc--cccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC-------
Confidence 98653322 223446899999999998776 799999999999999999965 7888888777766653311
Q ss_pred hhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 368 WRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 368 w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
.......+++.+.+||.+||+.||++|||+.++|++
T Consensus 244 ---------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 ---------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp ---------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 011234678999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-45 Score=383.63 Aligned_cols=261 Identities=21% Similarity=0.228 Sum_probs=203.9
Q ss_pred ccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEE
Q 004999 142 FSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 142 f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
.|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.++|+|++.++..+... ....|+||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~-~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE-GDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec-CCEEEEEE
Confidence 355555699999999999999999999999998865432 2367899999999877766655444332 67889999
Q ss_pred eeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC---CCceeeeccccceecCCCCC-
Q 004999 222 EYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN---NGILKIADFGLASFYDPDQN- 297 (720)
Q Consensus 222 Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~---~g~vKL~DFGla~~~~~~~~- 297 (720)
||+++++...+......+++..+..++.||+.||+|||++||+||||||+|||++. +..+||+|||+|..+.....
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 99999888877777778999999999999999999999999999999999999864 45799999999998743322
Q ss_pred -----CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhhhcC
Q 004999 298 -----QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWRKSK 372 (720)
Q Consensus 298 -----~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~~~ 372 (720)
......+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.........+.+.... .
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----~----- 232 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K----- 232 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH----H-----
T ss_pred cceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----c-----
Confidence 1234557999999999998876 799999999999999999999999887665544433221100 0
Q ss_pred CCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHH---HHHhCccCCC
Q 004999 373 LPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAA---SALRSEFFTM 429 (720)
Q Consensus 373 l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~---e~L~hp~f~~ 429 (720)
...........+|+++.+||..||+.||++||++. ++|+|.|.+.
T Consensus 233 ------------~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 233 ------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ------------HHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------CCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00012234467899999999999999999999986 5578887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=381.13 Aligned_cols=247 Identities=21% Similarity=0.233 Sum_probs=196.8
Q ss_pred eeecccCceEEEEEEECCCC---eEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEee
Q 004999 147 YLIGQGTYSNVYRARDLDQK---KIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFEY 223 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg---~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~Ey 223 (720)
.+||+|+||+||+|++..++ ..||||+++.. .+....+.|.+|+.+|++|+|||||++++++... ...+|+||||
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E~ 110 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPY 110 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEEC
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEEE
Confidence 35999999999999986643 36999998743 3566678899999999999999999999987653 4679999999
Q ss_pred cccccccc-ccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceecCCCCCC---C
Q 004999 224 MEHDLAGL-ASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQNQ---P 299 (720)
Q Consensus 224 ~~g~ll~~-~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~~---~ 299 (720)
|+++.+.. +......+++..+..++.||+.||.|||+.+|+||||||+||||++++.+||+|||+++........ .
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~ 190 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence 99766554 4445667889999999999999999999999999999999999999999999999999876433222 2
Q ss_pred ccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCC-CChHHHHHHHHHhcCCCChhhhhhcCCCCccc
Q 004999 300 LTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPG-RTEVEQLHKIFKLCGSPSEDYWRKSKLPHATI 378 (720)
Q Consensus 300 ~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g-~~~~e~l~~i~~~~g~p~~~~w~~~~l~~~~~ 378 (720)
.....||+.|+|||++.+.. |+.++||||||||||||+||..||.. .+..+....+.... .
T Consensus 191 ~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~-~---------------- 252 (311)
T d1r0pa_ 191 KTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-R---------------- 252 (311)
T ss_dssp TTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC-C----------------
T ss_pred cccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-C----------------
Confidence 23456899999999998766 79999999999999999997655554 33333333332210 0
Q ss_pred cCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 379 FKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 379 ~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
......+++.+.+||..||+.||++|||+.|+++|
T Consensus 253 -----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 -----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01124678899999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=384.07 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=203.0
Q ss_pred eecccCceEEEEEEE-----CCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhc-CCCceeeeccceeccCCCeEEEEE
Q 004999 148 LIGQGTYSNVYRARD-----LDQKKIVALKKVRFDNLEPESVRFMAREIHILRRL-DHINVIKLEGLVTSRMSCSLYLVF 221 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~-----~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L-~HpnIvkl~~~~~~~~~~~lyLV~ 221 (720)
+||+|+||.||+|++ ..+++.||||+++... .......+.+|+.+++++ +|||||++++++.+ ...+||||
T Consensus 30 ~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--~~~~~lvm 106 (311)
T d1t46a_ 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVIT 106 (311)
T ss_dssp EEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred EEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--CCEEEEEE
Confidence 399999999999986 3577899999998654 345566789999999999 69999999999977 56799999
Q ss_pred eeccccccccccC------------------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceee
Q 004999 222 EYMEHDLAGLASH------------------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKI 283 (720)
Q Consensus 222 Ey~~g~ll~~~~~------------------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL 283 (720)
|||+++.+..++. ....+++.+++.|+.||+.||.|||++|||||||||+||||+.++.+||
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki 186 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI 186 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEE
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccc
Confidence 9999765544332 2236899999999999999999999999999999999999999999999
Q ss_pred eccccceecCCCCC-CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHh-CCCCCCCCChHHHHHHHHHhcC
Q 004999 284 ADFGLASFYDPDQN-QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYA-GKPIMPGRTEVEQLHKIFKLCG 361 (720)
Q Consensus 284 ~DFGla~~~~~~~~-~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELlt-G~ppf~g~~~~e~l~~i~~~~g 361 (720)
+|||+++....... ...+..++|+.|+|||++.+.. |+.++|||||||+||||+| |.++|.+....+.+.++.+...
T Consensus 187 ~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~ 265 (311)
T d1t46a_ 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF 265 (311)
T ss_dssp CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTC
T ss_pred cccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999987654332 2234457899999999998765 7999999999999999998 7788888877777766654321
Q ss_pred CCChhhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 362 SPSEDYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 362 ~p~~~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.+ .....+++.+.+||.+||+.||.+|||+.++|+
T Consensus 266 ~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 266 RM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 112357899999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=383.94 Aligned_cols=244 Identities=18% Similarity=0.247 Sum_probs=202.2
Q ss_pred eecccCceEEEEEEEC-----CCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCCCeEEEEEe
Q 004999 148 LIGQGTYSNVYRARDL-----DQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMSCSLYLVFE 222 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~-----~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~~~lyLV~E 222 (720)
.||+|+||.||+|.+. .++..||||+++... .......+.+|+.++++++|||||++++++.. ...+++|||
T Consensus 27 ~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e 103 (308)
T d1p4oa_ 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ--GQPTLVIME 103 (308)
T ss_dssp EEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--SSSCEEEEE
T ss_pred EEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec--CCceeEEEe
Confidence 3999999999999875 245789999997543 44556678999999999999999999999876 567899999
Q ss_pred eccccccccccC----------CCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccceec
Q 004999 223 YMEHDLAGLASH----------PGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLASFY 292 (720)
Q Consensus 223 y~~g~ll~~~~~----------~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~~~ 292 (720)
||.++.+..+.. .-..+++.++..++.||+.||.|||+++|+||||||+||||+.++++||+|||+++.+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~ 183 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGG
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceec
Confidence 998765443322 1235799999999999999999999999999999999999999999999999999866
Q ss_pred CCCCCC-CccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCChhhhhh
Q 004999 293 DPDQNQ-PLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAG-KPIMPGRTEVEQLHKIFKLCGSPSEDYWRK 370 (720)
Q Consensus 293 ~~~~~~-~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG-~ppf~g~~~~e~l~~i~~~~g~p~~~~w~~ 370 (720)
...... ..+..++|+.|+|||.+.+.. |+.++||||||||||||+|| .+||.+.+..+.+..+.+..
T Consensus 184 ~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~---------- 252 (308)
T d1p4oa_ 184 YETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG---------- 252 (308)
T ss_dssp GGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC----------
T ss_pred cCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC----------
Confidence 433222 223346899999999998776 79999999999999999998 48899988888777765421
Q ss_pred cCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 371 SKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 371 ~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
.......+++.+.+||.+||+.||.+|||+.++++
T Consensus 253 ------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 253 ------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123467899999999999999999999999998
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-43 Score=379.45 Aligned_cols=281 Identities=28% Similarity=0.400 Sum_probs=214.1
Q ss_pred cccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-----------CCceeeeccceec
Q 004999 143 SRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-----------HINVIKLEGLVTS 211 (720)
Q Consensus 143 ~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-----------HpnIvkl~~~~~~ 211 (720)
|++++.||+|+||+||+|++..+|+.||||+++.. ....+.+.+|+.+|+.++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45555699999999999999999999999999754 334456788999998875 5789999988876
Q ss_pred cCCCeEEEEEeecccc---ccccccCCCCCCCHHHHHHHHHhhhhccccccc-cCcccccCcceeEEEcCCCc------e
Q 004999 212 RMSCSLYLVFEYMEHD---LAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS-RGVLHRDIKGSNLLIDNNGI------L 281 (720)
Q Consensus 212 ~~~~~lyLV~Ey~~g~---ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~-~gIvHrDIKP~NILld~~g~------v 281 (720)
......+++|+++... ...........+++..++.++.||+.||.|||+ .||+||||||+||||+.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 5556677777776542 222333455678999999999999999999997 89999999999999987653 9
Q ss_pred eeeccccceecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCC------hHHHHHH
Q 004999 282 KIADFGLASFYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRT------EVEQLHK 355 (720)
Q Consensus 282 KL~DFGla~~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~------~~e~l~~ 355 (720)
||+|||.+..... .....+||+.|+|||++.+.. |+.++|||||||++++|++|+.||.+.. ..+.+..
T Consensus 172 kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 172 KIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEeeccccccccc----ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 9999999986532 234567899999999999766 7999999999999999999999997543 4567788
Q ss_pred HHHhcCCCChhhhhhcCCCC----------ccccCCCCccchhhhc---ccCCCCHhHHHHHHHhcccCCCCCCCHHHHH
Q 004999 356 IFKLCGSPSEDYWRKSKLPH----------ATIFKPQQPYKRCVAE---TFKDFPAPALALMETLLSIDPADRGSAASAL 422 (720)
Q Consensus 356 i~~~~g~p~~~~w~~~~l~~----------~~~~~~~~~~~~~~~e---~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L 422 (720)
++..+|.++.+.+....... ........+....... .....++.+.+||.+||.+||.+||||.|+|
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 88889988877664432211 0000011111111111 1223467899999999999999999999999
Q ss_pred hCccCCCCC
Q 004999 423 RSEFFTMKP 431 (720)
Q Consensus 423 ~hp~f~~~~ 431 (720)
+||||+..+
T Consensus 327 ~Hp~f~~~~ 335 (362)
T d1q8ya_ 327 NHPWLKDTL 335 (362)
T ss_dssp TCGGGTTCT
T ss_pred cCcccCCCC
Confidence 999998543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-42 Score=366.18 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=204.3
Q ss_pred cccccceeecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC-CceeeeccceeccCCCeEEE
Q 004999 141 IFSRSFYLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH-INVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 141 ~f~r~~~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H-pnIvkl~~~~~~~~~~~lyL 219 (720)
+.|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.|.| +||+.+++++.. ....|+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~ 78 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVL 78 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEE
Confidence 3456666799999999999999999999999998764322 235789999999965 899999988876 678999
Q ss_pred EEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcC-----CCceeeeccccceecCC
Q 004999 220 VFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDN-----NGILKIADFGLASFYDP 294 (720)
Q Consensus 220 V~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~-----~g~vKL~DFGla~~~~~ 294 (720)
||||+++++...+...+..+++..+..++.|++.||+|||++||+||||||+||||+. ++.+||+|||+|+.+..
T Consensus 79 vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 79 VIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 9999998888777777778999999999999999999999999999999999999964 57899999999987643
Q ss_pred CCC------CCccccccccCCCChhhhcCCcCCCccccchhhHHHHHHHHhCCCCCCCCChH---HHHHHHHHhcCCCCh
Q 004999 295 DQN------QPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCILAELYAGKPIMPGRTEV---EQLHKIFKLCGSPSE 365 (720)
Q Consensus 295 ~~~------~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~---e~l~~i~~~~g~p~~ 365 (720)
... ......+||+.|+|||++.+.. |+.++||||||||+|||++|..||.+.... +.+.++....-.+
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-- 235 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS--
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC--
Confidence 221 1233457999999999998866 799999999999999999999999875433 3333332211000
Q ss_pred hhhhhcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHh
Q 004999 366 DYWRKSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALR 423 (720)
Q Consensus 366 ~~w~~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~ 423 (720)
...+.++++|+++.+||..|+..+|++||+...+.+
T Consensus 236 ----------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 236 ----------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp ----------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123445678999999999999999999998766544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=372.80 Aligned_cols=264 Identities=23% Similarity=0.231 Sum_probs=183.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCceeeeccceeccCC--CeEEEEEeecc
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINVIKLEGLVTSRMS--CSLYLVFEYME 225 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~~~~~--~~lyLV~Ey~~ 225 (720)
.||+|+||.||+|++ +|+.||||+++... ........|+..+..++|||||++++++..... ..+|||||||+
T Consensus 10 ~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 10 SIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 499999999999986 68899999987542 211222345556667899999999999876433 36899999999
Q ss_pred ccccccccCCCCCCCHHHHHHHHHhhhhccccccc--------cCcccccCcceeEEEcCCCceeeeccccceecCCCCC
Q 004999 226 HDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHS--------RGVLHRDIKGSNLLIDNNGILKIADFGLASFYDPDQN 297 (720)
Q Consensus 226 g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~--------~gIvHrDIKP~NILld~~g~vKL~DFGla~~~~~~~~ 297 (720)
++.+..++... .+++.+++.++.|++.||.|||+ +|||||||||+||||+.++.+||+|||++..+.....
T Consensus 85 ~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~ 163 (303)
T d1vjya_ 85 HGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163 (303)
T ss_dssp TCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred CCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc
Confidence 86665555433 68999999999999999999996 5999999999999999999999999999987643322
Q ss_pred ---CCccccccccCCCChhhhcCCc-----CCCccccchhhHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCChhhhh
Q 004999 298 ---QPLTSRVVTLWYRPPELLLGAT-----YYGTAVDLWSTGCILAELYAGKPIMPGRTEVEQLHKIFKLCGSPSEDYWR 369 (720)
Q Consensus 298 ---~~~t~~~gT~~Y~APE~l~~~~-----~y~~~sDIWSLG~iL~ELltG~ppf~g~~~~e~l~~i~~~~g~p~~~~w~ 369 (720)
......+||+.|+|||++.+.. .|+.++||||||||||||+||.++|............. ....+......
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 242 (303)
T d1vjya_ 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-VPSDPSVEEMR 242 (303)
T ss_dssp EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-SCSSCCHHHHH
T ss_pred ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-ccccchHHHHH
Confidence 1234568999999999987642 25778999999999999999988774432111000000 00000000000
Q ss_pred hcCCCCccccCCCCccchhhhcccCCCCHhHHHHHHHhcccCCCCCCCHHHHHhC
Q 004999 370 KSKLPHATIFKPQQPYKRCVAETFKDFPAPALALMETLLSIDPADRGSAASALRS 424 (720)
Q Consensus 370 ~~~l~~~~~~~~~~~~~~~~~e~~~~~~~~~~dLI~~mL~~DP~kRpTa~e~L~h 424 (720)
... ....+.+..+.. ......+..+.+||.+||+.||++|||+.|++++
T Consensus 243 ~~~--~~~~~~p~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 243 KVV--CEQKLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHH--TTSCCCCCCCGG----GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHH--hccccCCCCCcc----cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000 000011111100 0011233458899999999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.7e-23 Score=205.03 Aligned_cols=168 Identities=18% Similarity=0.192 Sum_probs=118.2
Q ss_pred eeecccCceEEEEEEECCCCeEEEEEEeecCCCC----------------HHHHHHHHHHHHHHHhcCCCceeeecccee
Q 004999 147 YLIGQGTYSNVYRARDLDQKKIVALKKVRFDNLE----------------PESVRFMAREIHILRRLDHINVIKLEGLVT 210 (720)
Q Consensus 147 ~~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~----------------~~~~~~~~~Ei~iL~~L~HpnIvkl~~~~~ 210 (720)
+.||+|+||.||+|++. +|+.||||+++..... ......+.+|..++.++.|.+++..+++..
T Consensus 6 ~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~ 84 (191)
T d1zara2 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG 84 (191)
T ss_dssp EEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET
T ss_pred CEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC
Confidence 45999999999999984 6899999997642110 111234567899999999999998875421
Q ss_pred ccCCCeEEEEEeeccccccccccCCCCCCCHHHHHHHHHhhhhccccccccCcccccCcceeEEEcCCCceeeeccccce
Q 004999 211 SRMSCSLYLVFEYMEHDLAGLASHPGLKFSEAQVKCYMQQLLCGLDHCHSRGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 211 ~~~~~~lyLV~Ey~~g~ll~~~~~~~~~lse~~~~~i~~QIl~gL~yLH~~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
.+|||||+++..... +++..+..++.||+.+|.|||++||+||||||+||||++++ ++|+|||+|.
T Consensus 85 ------~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a~ 150 (191)
T d1zara2 85 ------NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150 (191)
T ss_dssp ------TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTCE
T ss_pred ------CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCcc
Confidence 279999999865543 34455778999999999999999999999999999998654 8999999997
Q ss_pred ecCCCCCCCccccccccCCCChhhhcCCcCCCccccchhhHHHH
Q 004999 291 FYDPDQNQPLTSRVVTLWYRPPELLLGATYYGTAVDLWSTGCIL 334 (720)
Q Consensus 291 ~~~~~~~~~~t~~~gT~~Y~APE~l~~~~~y~~~sDIWSLG~iL 334 (720)
.............-.+ . -.+.+ . ..|+..+|+||+.--+
T Consensus 151 ~~~~~~~~~~l~rd~~--~-~~~~f-~-r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 151 EVGEEGWREILERDVR--N-IITYF-S-RTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETTSTTHHHHHHHHHH--H-HHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred cCCCCCcHHHHHHHHH--H-HHHHH-c-CCCCCcccHHHHHHHH
Confidence 6532211100000000 0 01112 1 2378999999986443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.00 E-value=2.8e-06 Score=84.23 Aligned_cols=75 Identities=15% Similarity=0.087 Sum_probs=47.8
Q ss_pred cccCceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcC-CCceeeeccceeccCCCeEEEEEeeccccc
Q 004999 150 GQGTYSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLD-HINVIKLEGLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 150 G~G~~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIvkl~~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
+-++.+.||+.. .++..+.||+....... ....+.+|..++..|. +--+.+++.+... .+..|+||++++|..
T Consensus 23 ~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~~~l~G~~ 96 (263)
T d1j7la_ 23 EGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLMSEADGVL 96 (263)
T ss_dssp CCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCSSEE
T ss_pred CCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEEEeccccc
Confidence 334457899886 34556788887543211 1223567888888774 3335666665544 567899999999865
Q ss_pred cc
Q 004999 229 AG 230 (720)
Q Consensus 229 l~ 230 (720)
+.
T Consensus 97 ~~ 98 (263)
T d1j7la_ 97 CS 98 (263)
T ss_dssp HH
T ss_pred cc
Confidence 53
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=4.4e-05 Score=74.89 Aligned_cols=73 Identities=15% Similarity=0.129 Sum_probs=48.3
Q ss_pred ecccCc-eEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCC--CceeeeccceeccCCCeEEEEEeecc
Q 004999 149 IGQGTY-SNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDH--INVIKLEGLVTSRMSCSLYLVFEYME 225 (720)
Q Consensus 149 LG~G~~-g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~H--pnIvkl~~~~~~~~~~~lyLV~Ey~~ 225 (720)
+..|.. +.||+... ..+..+++|....... ..+.+|+.+|+.|.. -.+.+++.+..+ .+..|+||+|++
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeee
Confidence 445554 67899975 4566688898664432 235678888887743 335566665544 567899999999
Q ss_pred cccc
Q 004999 226 HDLA 229 (720)
Q Consensus 226 g~ll 229 (720)
|..+
T Consensus 90 G~~~ 93 (255)
T d1nd4a_ 90 GQDL 93 (255)
T ss_dssp SEET
T ss_pred cccc
Confidence 8554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.65 E-value=2.1e-05 Score=83.42 Aligned_cols=75 Identities=20% Similarity=0.170 Sum_probs=47.0
Q ss_pred eecccCceEEEEEEECCCCeEEEEEEeecCC-C----CHHHHHHHHHHHHHHHhcC-C--CceeeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDLDQKKIVALKKVRFDN-L----EPESVRFMAREIHILRRLD-H--INVIKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~tg~~VAIK~l~~~~-~----~~~~~~~~~~Ei~iL~~L~-H--pnIvkl~~~~~~~~~~~lyL 219 (720)
.||.|....||++.+..+++.|+||...... . .+-...++..|..+|+.+. + ..+++++.+. ....++
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d----~~~~~l 108 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMAVT 108 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTTEE
T ss_pred EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc----CCCCEE
Confidence 3999999999999988788889999754310 0 1112334567888887763 2 3456665443 233578
Q ss_pred EEeeccc
Q 004999 220 VFEYMEH 226 (720)
Q Consensus 220 V~Ey~~g 226 (720)
|||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999986
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.67 E-value=0.0029 Score=66.27 Aligned_cols=72 Identities=18% Similarity=0.157 Sum_probs=48.2
Q ss_pred eecccCceEEEEEEECC-------CCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce-eeeccceeccCCCeEEE
Q 004999 148 LIGQGTYSNVYRARDLD-------QKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV-IKLEGLVTSRMSCSLYL 219 (720)
Q Consensus 148 ~LG~G~~g~Vy~a~~~~-------tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI-vkl~~~~~~~~~~~lyL 219 (720)
.|+.|-.-.+|++.... ..+.|.+++.-... . .. ...+|..+++.+.-.+| .++++++.. .+
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~--~i-dr~~E~~i~~~ls~~gl~Pkll~~~~~------g~ 118 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T--ES-HLVAESVIFTLLSERHLGPKLYGIFSG------GR 118 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C--HH-HHHHHHHHHHHHHHTTSSSCEEEEETT------EE
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h--hh-HHHHHHHHHHHHHhCCCCCeEEEEcCC------ce
Confidence 48889999999998653 34567777765221 1 12 34589999998853343 567766532 58
Q ss_pred EEeecccccc
Q 004999 220 VFEYMEHDLA 229 (720)
Q Consensus 220 V~Ey~~g~ll 229 (720)
||||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999998543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.64 E-value=0.0023 Score=65.29 Aligned_cols=71 Identities=15% Similarity=0.139 Sum_probs=44.4
Q ss_pred ceEEEEEEECCCCeEEEEEEeecCCCCHHHHHHHHHHHHHHHhcCCCce--eeec---cceeccCCCeEEEEEeeccccc
Q 004999 154 YSNVYRARDLDQKKIVALKKVRFDNLEPESVRFMAREIHILRRLDHINV--IKLE---GLVTSRMSCSLYLVFEYMEHDL 228 (720)
Q Consensus 154 ~g~Vy~a~~~~tg~~VAIK~l~~~~~~~~~~~~~~~Ei~iL~~L~HpnI--vkl~---~~~~~~~~~~lyLV~Ey~~g~l 228 (720)
--.||++.. .+|..|++|+.+...... +.+..|+..|..|...+| +..+ +-.........+.|++++.|..
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 458999985 568889999988765433 446678888888743222 1111 1111111456788999998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.06 E-value=0.063 Score=53.37 Aligned_cols=30 Identities=27% Similarity=0.462 Sum_probs=27.4
Q ss_pred cCcccccCcceeEEEcCCCceeeeccccce
Q 004999 261 RGVLHRDIKGSNLLIDNNGILKIADFGLAS 290 (720)
Q Consensus 261 ~gIvHrDIKP~NILld~~g~vKL~DFGla~ 290 (720)
.||||+|+.++|||++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 579999999999999988888899999885
|
| >d2ogqa1 d.223.1.2 (A:371-494) Serine/threonine-protein kinase plk C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Polo-box domain superfamily: Polo-box domain family: Polo-box duplicated region domain: Serine/threonine-protein kinase plk C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.43 E-value=0.0021 Score=56.30 Aligned_cols=29 Identities=21% Similarity=0.045 Sum_probs=25.3
Q ss_pred hcCCCCCCCCCccccccCCCccccccccc
Q 004999 560 KAGKNTDDAPKISTGADLSTGLVAARRSL 588 (720)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 588 (720)
|+.||+||++|||+||+||++.+++-=+.
T Consensus 40 ~V~KWvDYS~KyGlgY~LSdgtvGV~FND 68 (124)
T d2ogqa1 40 WVSKWVDYSDKYGLGYQLCDNSVGVLFND 68 (124)
T ss_dssp CEEEEEEETTTTEEEEEETTSCEEEEETT
T ss_pred EeEeeeecCCCceEEEEEcCCcEEEEEeC
Confidence 46699999999999999999999985444
|